Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

ABSTRACT

Fusion proteins containing a targeting sequence, an exosporium protein, or an exosporium protein fragment that targets the fusion protein to the exosporium of a  Bacillus cereus  family member are provided. Recombinant  Bacillus cereus  family members expressing such fusion proteins are also provided. Genetically inactivated  Bacillus cereus  family members and recombinant  Bacillus cereus  family members that overexpress exosporium proteins are also provided. Seeds coated with the recombinant  Bacillus cereus  family members and methods for using the recombinant  Bacillus cereus  family members (e.g., for stimulating plant growth) are also provided. Various modifications of the recombinant  Bacillus cereus  family members that express the fusion proteins are further provided. Fusion proteins comprising a spore coat protein and a protein or peptide of interest, recombinant bacteria that express such fusion proteins, seeds coated with such recombinant bacteria, and methods for using such recombinant bacteria (e.g., for stimulating plant growth) are also provided.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No.62/051,885, filed Sep. 17, 2014, the content of which is incorporatedherein by reference in its entirety.

REFERENCE TO SEQUENCE LISTING SUBMITTED ELECTRONICALLY

The official copy of the sequence listing is submitted electronicallyvia EFS-Web as an ASCII-formatted sequence listing with a file named“3005.US Gene Sequence Listing.txt” created on Sep. 10, 2015, and havinga size of 488 kilobytes, and is filed concurrently with thespecification. The sequence listing contained in this ASCII-formatteddocument is part of the specification and is herein incorporated byreference in its entirety.

FIELD OF THE INVENTION

The present invention generally relates to fusion proteins containing atargeting sequence, an exosporium protein, or an exosporium proteinfragment that targets the fusion protein to the exosporium of a Bacilluscereus family member. The invention also relates to recombinant Bacilluscereus family members expressing such fusion proteins, formulationscontaining the recombinant Bacillus cereus family members, seeds coatedwith the recombinant Bacillus cereus family members, and methods forusing the recombinant Bacillus cereus family members (e.g., forstimulating plant growth, protecting a plant from a pathogen, enhancingstress resistance in a plant, immobilizing a recombinant Bacillus cereusfamily member spore on a plant, stimulating germination of plant seeds,and delivering nucleic acids to plants). The invention additionallyrelates to recombinant Bacillus cereus family members that overexpress aprotease or a nuclease, wherein overexpression of the protease ornuclease partially or completely inactivates spores of the Bacilluscereus family member or renders the spores more susceptible to physicalor chemical inactivation. The present invention further relates torecombinant Bacillus cereus family members that overexpress exosporiumproteins, seeds coated with such recombinant Bacillus cereus familymembers, and methods of using such recombinant Bacillus cereus familymembers (e.g., for stimulating plant growth, enhancing stress resistancein plants, and protecting plants from pathogens).

The invention further relates to various modifications of therecombinant Bacillus cereus family members that express the fusionproteins, including: (i) overexpression of modulator proteins thatmodulate the expression of the fusion protein in the recombinantBacillus cereus members; (ii) genetic inactivation of the recombinantBacillus cereus family members; and (iii) mutations or other geneticalterations of the recombinant Bacillus cereus family members that allowfor the collection of exosporium fragments containing the fusionprotein. The invention also relates to various methods for using theexosporium fragments.

The invention further relates to fusion proteins comprising a spore coatprotein and a protein or peptide of interest, recombinant bacteria thatexpress such fusion proteins, seeds coated with such recombinantbacteria, and methods for using such recombinant bacteria (e.g., forstimulating plant growth, protecting a plant from a pathogen, enhancingstress resistance in a plant, immobilizing a recombinant bacterial sporeon a plant, stimulating germination of plant seeds, and deliveringnucleic acids to plants).

The present invention further relates to biologically pure bacterialcultures of novel strains of bacteria.

The present invention additionally relates to plant seeds coated with anenzyme that catalyzes the production of nitric oxide or a superoxidedismutase, or with a recombinant spore-forming bacterium thatoverexpresses an enzyme that catalyzes the production of nitric oxide ora superoxide dismutase.

The invention also relates to methods for delivering beneficial bacteriaand enzymes or vaccines to animals, and other methods of use.

BACKGROUND OF THE INVENTION

Within the zone surrounding a plant's roots is a region called therhizosphere. In the rhizosphere, bacteria, fungi, and other organismscompete for nutrients and for binding to the root structures of theplant. Both detrimental and beneficial bacteria and fungi can occupy therhizosphere. The bacteria, fungi, and the root system of the plant canall be influenced by the actions of peptides, enzymes, and otherproteins in the rhizosphere. Augmentation of soil or treatment of plantswith certain of these peptides, enzymes, or other proteins would havebeneficial effects on the overall populations of beneficial soilbacteria and fungi, create a healthier overall soil environment forplant growth, improve plant growth, and provide for the protection ofplants against certain bacterial and fungal pathogens. However, previousattempts to introduce peptides, enzymes, and other proteins into soil toinduce such beneficial effects on plants have been hampered by the lowsurvival of enzymes, proteins, and peptides in soil. Additionally, theprevalence of proteases naturally present in the soil leads todegradation of the proteins in the soil. The environment around theroots of a plant (the rhizosphere) is a unique mixture of bacteria,fungi, nutrients, and roots that has different qualities than that ofnative soil. The symbiotic relationship between these organisms isunique, and could be altered for the better with inclusion of exogenousproteins. The high concentration of fungi and bacteria in therhizosphere causes even greater degradation of proteins due toabnormally high levels of proteases and other elements detrimental toproteins in the soil. In addition, enzymes and other proteins introducedinto soil can dissipate away from plant roots quickly.

Thus, there exists a need in the art for a method for effectivelydelivering peptides, enzymes, and other proteins to plants (e.g., toplant root systems) and for extending the period of time during whichsuch molecules remain active. Furthermore, there exists a need in theart for a method of selectively targeting such peptides, enzymes, andproteins to the rhizosphere and to plant leaves and plant roots inparticular.

SUMMARY OF THE INVENTION

The features of the invention are defined in the appended claims. Otherobjects and features will be in part apparent and in part pointed outhereinafter.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A and 1B show alignments of the amino acid sequence of anamino-terminal portion of Bacillus anthracis Sterne strain BclA and withthe corresponding region from various exosporium proteins from Bacilluscereus family members.

FIG. 2 shows exemplary fluorescent microscopy results for the expressionof fusion proteins containing various exosporium proteins linked to anmCherry reporter on the exosporium of a recombinant Bacillus cereusfamily member.

FIG. 3 provides data showing to recombinant Bacillus thuringiensisBT013A spores expressing a fusion protein comprising a DNA bindingprotein.

FIG. 4 is a transmission electron micrograph showing exosporiumfragments and a Bacillus cereus family member spore from which theexosporium has been lost, generated using a recombinant Bacillus cereusfamily member having a knock-out mutation of its CotE gene.

FIG. 5 is a photograph of an SDS-PAGE gel showing a protein markerstandard (lane 1) and proteins from exosporium fragments generated usinga recombinant Bacillus cereus family member having a knock-out mutationof its CotE gene (lane 2).

FIG. 6 provides data illustrating enzyme activity of an acid phosphatasein exosporium fragments derived from a Bacillus cereus family memberhaving a knock-out mutation of its CotE gene.

FIG. 7 provides data illustrating that Bacillus cereus family memberEE349 reduces the inhibitory effects of herbicide on root length inlentils.

FIG. 8 provides data illustrating increased phosphatase activity in aBacillus cereus family member modified to overexpress acid phosphatase(AcpC).

FIG. 9 provides data showing the endoglucanase activity of recombinantBacillus thuringiensis spores expressing a CotC-endoglucanase fusionprotein.

FIG. 10 provides bright-field and fluorescence microscopy images showingdetection of RNA on the surface of recombinant B. thuringiensis sporesexpressing a fusion protein comprising amino acids 20-35 of SEQ ID NO: 1and SspC bound to either single-stranded RNA (ssRNA) or double-strandedRNA (dsRNA).

FIG. 11 provides a photograph showing the effects of the microRNA MIR319on soy height and root development, following delivery to soybean plantsusing recombinant B. thuringiensis spores expressing a fusion proteincomprising amino acids 20-35 of SEQ ID NO: 1 and SspC bound to MIR319.

FIG. 12 provides bright-field and fluorescence microscopy images showingdetection of GFP and mCherry in the gut of nematodes fed normal OP50 E.coli bacterial food (two right-hand panels) or nematodes fed B.thuringiensis spores expressing a fusion protein comprising amino acids20-35 of SEQ ID NO: 1 and either GFP or mCherry (three left-handpanels).

FIG. 13 provides a fluorescence microscopy image showing detection ofendophytic bacteria isolated from inside of corn plants treated withBacillus thuringiensis EE-B00184 expressing a fusion protein comprisingamino acids 20-35 of SEQ ID NO: 1 and GFP. Arrows denote single spores.

FIG. 14 provides a photograph showing fluorescence of bacterial coloniescontaining recombinant Bacillus cereus family members expressing afusion protein comprising amino acids 20-35 of SEQ ID NO: 1 and GFP,isolated from inside of corn plants grown from seeds coated with therecombinant bacteria.

FIG. 15 provides a transmission electron micrographs showing: (A) intactspores of Bacillus thuringiensis BT013A surrounded by attachedexosporium; (B) spores of CotE knockout strain of Bacillus thuringiensisBT013A, with detached exosporium; and (C) a purified exosporium fragmentpreparation of exosporium fragments derived from a CotE knockout strainof Bacillus thuringiensis BT013A.

DEFINITIONS

When the articles “a,” “an,” “one,” “the,” and “said” are used herein,the mean “at least one” or “one or more” unless otherwise indicated.

The terms “agriculturally acceptable carrier” and “carrier” are usedinterchangeably herein.

The term “animal” encompasses any non-human animal as well as humans.For example, where the term “animal” is used herein, the animal can be amammal (e.g., a human, a sheep, goat, cow, pig, deer, alpaca, bison,camel, donkey, horse, mule, llama, rabbit, dog, or cat), a bird (e.g., achicken, turkey, duck, goose, quail, or pheasant), a fish (e.g., salmon,trout, tilapia, tuna, catfish, or a carp), or a crustacean (e.g., ashrimp, prawn, lobster, crab, or crayfish).

A “biologically pure bacterial culture” refers to a culture of bacteriacontaining no other bacterial species in quantities sufficient tointerfere with the replication of the culture or be detected by normalbacteriological techniques. Stated another way, it is a culture whereinvirtually all of the bacterial cells present are of the selected strain.

The terms “comprising,” “including,” and “having” are intended to beinclusive and mean that there may be additional elements other than thelisted elements.

The term “bioactive peptide” refers to any peptide that exerts abiological activity. “Bioactive peptides” can be generated, for example,via the cleavage of a protein, peptide, proprotein, or preproprotein bya protease or peptidase.

The term “effective amount” refers to a quantity which is sufficient toresult in a statistically significant increase of growth and/or ofprotein yield and/or of grain yield of a plant as compared to thegrowth, protein yield and grain yield of the control-treated plant.

An “enzyme involved in the production or activation of a plant growthstimulating compound” includes any enzyme that catalyzes any step in abiological synthesis pathway for a compound that stimulates plant growthor alters plant structure, or any enzyme that catalyzes the conversionof an inactive or less active derivative of a compound that stimulatesplant growth or alters plant structure to an active or more active formof the compound. Such compounds include, for example, but are notlimited to, small molecule plant hormones such as auxins and cytokinins,bioactive peptides, and small plant growth stimulating moleculessynthesized by bacteria or fungi in the rhizosphere (e.g.,2,3-butanediol).

The term “fusion protein” as used herein refers to a protein having apolypeptide sequence that comprises sequences derived from two or moreseparate proteins. A fusion protein can be generated by joining togethera nucleic acid molecule that encodes all or part of a first polypeptidewith a nucleic acid molecule that encodes all or part of a secondpolypeptide to create a nucleic acid sequence which, when expressed,yields a single polypeptide having functional properties derived fromeach of the original proteins.

The term “germination rate” as used herein refers to the number of seedsthat germinate during a particular time period. For example, agermination rate of 85% indicates that 85 out of 100 seeds germinateduring a given time period.

The term “inactivate” or “inactivation” as used herein in reference tothe inactivation of spores of a recombinant Bacillus cereus familymember or a recombinant spore-forming bacterium means that the sporesare unable to germinate, or that the spores can germinate, but aredamaged such that germination does not result in a living bacterium. Theterms “partially inactivate” or “partial inactivation” mean that apercentage of the spores are inactivated, but that some spores retainthe ability to germinate and return to a live, replicating state. Theterm “genetic inactivation” refers to inactivation of spores arecombinant Bacillus cereus family member or recombinant spore-formingbacterium by a mutation of the spore's DNA that results in complete orpartial inactivation of the spore. The terms “physical inactivation” and“chemical inactivation refer to inactivation of spores using anyphysical or chemical means, e.g., by heat treatment, gamma irradiation,x-ray irradiation, UV-A irradiation, UV-B irradiation, or treatment witha solvent such as gluteraldehyde, formaldehyde, hydrogen peroxide,acetic acid, bleach, chloroform, or phenol, or any combination thereof.

The terms “immobilizing a recombinant Bacillus cereus family memberspore on a plant” and “immobilizing a spore of a recombinantspore-forming bacterium on a plant” refers to the binding of arecombinant Bacillus cereus family member spore or a spore of arecombinant spore-forming bacterium to plant, e.g., to a root of a plantor to an aerial portion of a plant such as a leaf, stem, flower, orfruit, such that the spore is maintained at the plant's root structureor aerial portion instead of dissipating into the plant growth medium orinto the environment surrounding the aerial portions of the plant.

The term “inoculant” as described in this invention is defined inseveral Federal, or State regulations as (1) “soil or plant inoculantsshall include any carrier or culture of a specific micro-organism ormixture of micro-organisms represented to improve the soil or thegrowth, quality, or yield of plants, and shall also include any seed orfertilizer represented to be inoculated with such a culture” (New YorkState 10-A Consolidated Law); (2) “substances other than fertilizers,manufactured, sold or represented for use in the improvement of thephysical condition of the soil or to aid plant growth or crop yields”(Canada Fertilizers Act); (3) “a formulation containing pure orpredetermined mixtures of living bacteria, fungi or virus particles forthe treatment of seed, seedlings or other plant propagation material forthe purpose of enhancing the growth capabilities or disease resistanceor otherwise altering the properties of the eventual plants or crop” (Adhoc European Working Group, 1997) or (4) “meaning any chemical orbiological substance of mixture of substances or device distributed inthis state to be applied to soil, plants or seeds for soil correctivepurposes; or which is intended to improve germination, growth, quality,yield, product quality, reproduction, flavor, or other desirablecharacteristics of plants or which is intended to produce any chemical,biochemical, biological or physical change in soil” (Section 14513 ofthe California Food and Agriculture Code).

A “modulator protein” includes any protein that, when overexpressed in aBacillus cereus family member expressing any of the fusion proteinsdescribed herein, modulates expression of the fusion protein, such thatthe expression of the fusion protein is increased or decreased ascompared to expression of the fusion protein in a Bacillus cereus familymember that does not overexpress the modulator protein.

A “plant growth medium” includes any material that is capable ofsupporting the growth of a plant.

A “plant immune system enhancer protein or peptide” as used hereinincludes any protein or peptide that has a beneficial effect on theimmune system of a plant.

The term “plant growth stimulating protein or peptide” as used hereinincludes any protein or peptide that increases plant growth in a plantexposed to the protein or peptide.

The term “probiotic” as used herein refers to microorganisms (e.g.,bacteria) that provide health benefits when consumed by or administeredto an animal.

The terms “promoting plant growth” and “stimulating plant growth” areused interchangeably herein, and refer to the ability to enhance orincrease at least one of the plant's height, weight, leaf size, rootsize, or stem size, to increase protein yield from the plant or toincrease grain yield of the plant.

A “protein or peptide that protects a plant from a pathogen” as usedherein includes any protein or peptide that makes a plant exposed to theprotein or peptide less susceptible to infection with a pathogen.

A “protein or peptide that enhances stress resistance in a plant” asused herein includes any protein or peptide that makes a plant exposedto the protein or peptide more resistant to stress.

The term “plant binding protein or peptide” refers to any peptide orprotein capable of specifically or non-specifically binding to any partof a plant (e.g., roots or aerial portions of a plant such as leavesfoliage, stems, flowers, or fruits) or to plant matter.

The term “pyrethrinase” refers to any enzyme that degrades a pyrethrinor a pyrethroid.

The term “rhizosphere” is used interchangeably with “root zone” todenote that segment of the soil that surrounds the roots of a plant andis influenced by them.

The term “targeting sequence” as used herein refers to a polypeptidesequence that, when present as part of a longer polypeptide or aprotein, results in the localization of the longer polypeptide or theprotein to a specific subcellular location. The targeting sequencesdescribed herein result in localization of proteins to the exosporium ofa Bacillus cereus family member.

DESCRIPTION OF THE INVENTION I. Fusion Proteins for Expression inBacillus Cereus Family Members and Recombinant Bacillus Cereus FamilyMembers Expressing Such Fusion Proteins

The present invention relates to fusion proteins comprising a targetingsequence, an exosporium protein, or an exosporium protein fragmenttargets the fusion protein to the exosporium of a Bacillus cereus familymember and at least one protein or peptide of interest. When expressedin Bacillus cereus family member bacteria, these fusion proteins aretargeted to the exosporium layer of the spore and are physicallyoriented such that the protein or peptide of interest is displayed onthe outside of the spore.

This Bacillus exosporium display (BEMD) system can be used to deliverpeptides, enzymes, and other proteins to plants (e.g., to plant foliage,fruits, flowers, stems, or roots) or to a plant growth medium such assoil. Peptides, enzymes, and proteins delivered to the soil or anotherplant growth medium in this manner persist and exhibit activity in thesoil for extended periods of time. Introduction of recombinant Bacilluscereus family member bacteria expressing the fusion proteins describedherein into soil or the rhizosphere of a plant leads to a beneficialenhancement of plant growth in many different soil conditions. The useof the BEMD to create these enzymes allows them to continue to exerttheir beneficial results to the plant and the rhizosphere over the firstmonths of a plants life.

A. Targeting Sequences, Exosporium Proteins, and Exosporium ProteinFragments for Targeting Proteins or Peptides of Interest to theExosporium of a Bacillus cereus Family Member

For ease of reference, descriptions of the amino acid sequences for thetargeting sequences, exosporium proteins, and exosporium proteinfragments that can be used for targeting of proteins or peptides ofinterest to the exosporium of a Bacillus cereus family members, areprovided in Table 1 together with their SEQ ID NOs.

TABLE 1 Peptide and protein sequences used for targeting of proteins orpeptides of interest to the exosporium of Bacillus cereus family membersProtein, protein fragment, or targeting sequence SEQ ID NO. AA 1-41 ofBclA (B. anthracis Sterne)  1* Full length BclA (B. anthracis Sterne) 2* AA 1-33 of BetA/BAS3290 (B. anthracis Sterne)  3 Full lengthBetA/BAS3290 (B. anthracis Sterne)  4 Met + AA 2-43 of BAS4623 (B.anthracis Sterne)  5 Full length BAS4623(B. anthracis Sterne)  6 AA 1-34of BclB (B. anthracis Sterne)  7 Full length BclB (B. anthracis Sterne) 8 AA 1-30 of BAS1882 (B. anthracis Sterne)  9 Full length BAS1882 (B.anthracis Sterne) 10 AA 1-39 of gene 2280 (B. weihenstephensis KBAB4) 11Full length KBAB4 gene 2280 (B. weihenstephensis KBAB4) 12 AA 1-39 ofgene 3572 (B. weihenstephensis KBAB4) 13 Full Length KBAB4 gene 3572 (B.weihenstephensis KBAB4) 14 AA 1-49 of Exosporium Leader Peptide (B.cereus VD200) 15 Full Length Exosporium Leader Peptide (B. cereus VD200)16 AA 1-33 of Exosporium Leader Peptide (B. cereus VD166) 17 Full LengthExosporium Leader Peptide (B. cereus VD166) 18 AA 1-39 of hypotheticalprotein IKG_04663 (B. cereus VD200) 19 Hypothetical protein IKG_04663,partial (B. cereus VD200) 20 AA 1-39 of YVTN β-propeller protein (B.weihenstephensis KBAB4) 21 Full length YVTN β-propeller protein (B.weihenstephensis KBAB4) 22 AA 1-30 of hypothetical proteinbcerkbab4_2363 23 (B. weihenstephensis KBAB4) Full length hypotheticalprotein bcerkbab4_2363 24 (B. weihenstephensis KBAB4) AA 1-30 ofhypothetical protein bcerkbab4_2131 25 (B. weihenstephensis KBAB4) Fulllength hypothetical protein bcerkbab4_2131 26 (B. weihenstephensisKBAB4) AA 1-36 of triple helix repeat containing collagen 27 (B.weihenstephensis KBAB4) Full length triple helix repeat-containingcollagen KBAB4 28 (B. weihenstephensis KBAB4) AA 1-39 of hypotheticalprotein bmyco0001_21660 (B. mycoides 2048) 29 Full length hypotheticalprotein bmyco0001_21660 (B. mycoides 2048) 30 AA 1-30 of hypotheticalprotein bmyc0001_22540 (B. mycoides 2048) 31 Full length hypotheticalprotein bmyc0001_22540 (B. mycoides 2048) 32 AA 1-21 of hypotheticalprotein bmyc0001_21510 (B. mycoides 2048) 33 Full length hypotheticalprotein bmyc0001_21510 (B. mycoides 2048) 34 AA 1-22 of collagen triplehelix repeat protein (B. thuringiensis 35646) 35 Full length collagentriple helix repeat protein (B. thuringiensis 35646) 36 AA 1-35 ofhypothetical protein WP_69652 (B. cereus) 43 Full length hypotheticalprotein WP_69652 (B. cereus) 44 AA 1-41 of exosporium leader WP016117717(B. cereus) 45 Full length exosporium leader WP016117717 (B. cereus) 46AA 1-49 of exosporium peptide WP002105192 (B. cereus) 47 Full lengthexosporium peptide WP002105192 (B. cereus) 48 AA 1-38 of hypotheticalprotein WP87353 (B. cereus) 49 Full length hypothetical protein WP87353(B. cereus) 50 AA 1-39 of exosporium peptide 02112369 (B. cereus) 51Full length exosporium peptide 02112369 (B. cereus) 52 AA 1-39 ofexosporium protein WP016099770 (B. cereus) 53 Full length exosporiumprotein WP016099770 (B. cereus) 54 AA 1-36 of hypothetical proteinYP006612525 (B. thuringiensis) 55 Full length hypothetical proteinYP006612525 (B. thuringiensis) 56 AA 1-136 of hypothetical proteinTIGR03720 (B. mycoides)  57** Full length hypothetical protein TIGR03720(B. mycoides)  58** AA 1-36 of collagen triple helix repeat domainprotein 59 (B. cereus ATCC 10987) Full length collagen triple helixrepeat domain protein 60 (B. cereus ATCC 10987) AA 1-39 of collagen-likeprotein (B. cereus E33L) 61 Full length collagen-like protein (B. cereusE33L) 62 AA 1-41 of triple helix repeat-containing collagen 63 (B.weihenstephanensis KBAB4) Full length triple helix repeat-containingcollagen 64 (B. weihenstephanensis KBAB4) AA 1-30 of hypotheticalprotein BALH_2230 65 (B. thuringiensis str. Al Hakam) Full lengthhypothetical protein BALH_2230 66 (B. thuringiensis str. Al Hakam) AA1-33 of triple helix repeat-containing collagen (B. cereus ATCC 14579)67 Full length triple helix repeat-containing collagen (B. cereus ATCC14579) 68 AA 1-44 of collagen triple helix repeat (B. cereus) 69 Fulllength collagen triple helix repeat (B. cereus) 70 AA 1-38 of triplehelix repeat-containing collagen (B. cereus ATCC 14579) 71 Full lengthtriple helix repeat-containing collagen (B. cereus ATCC 14579) 72 AA1-30 of hypothetical protein BCZK1835 (B. cereus E33L) 73 Full lengthhypothetical protein BCZK1835 (B. cereus E33L) 74 AA 1-48 of triplehelix repeat-containing collagen 75 (B. weihenstephanensis KBAB4) Fulllength triple helix repeat-containing collagen 76 (B. weihenstephanensisKBAB4) AA 1-30 of triple helix repeat-containing collagen (B. cereusATCC 14579) 77 Full length triple helix repeat-containing collagen (B.cereus ATCC 14579) 78 AA 1-39 of hypothetical protein BC4725 (B. cereusATCC 14579) 79 Full length hypothetical protein BC4725 (B. cereus ATCC14579) 80 AA 1-44 of hypothetical protein BCZK4476 (B. cereus E33L) 81Full length hypothetical protein BCZK4476 (B. cereus E33L) 82 AA 1-40 oftriple helix repeat-containing collagen 83 (B. anthracis str. ‘AmesAncestor’) Full length triple helix repeat-containing collagen 84 (B.anthracis str. ‘Ames Ancestor’) AA 1-34 of BclA protein (B.thuringiensis serovar konkukian str. 97-27) 85 Full length BclA protein(B. thuringiensis serovar konkukian str. 97-27) 86 AA 1-34 of conservedhypothetical protein (B. cereus ATCC 10987) 87 Full length conservedhypothetical protein (B. cereus ATCC 10987) 88 AA 1-34 of triple helixrepeat-containing collagen (B. cereus ATCC 14579) 89 Full length triplehelix repeat-containing collagen (B. cereus ATCC 14579) 90 AA 1-99 ofexosporium leader peptide partial sequence (B. cereus) 91 Exosporiumleader peptide partial sequence (B. cereus) 92 AA 1-136 of hypotheticalprotein ER45_27600, partial sequence 93 (B. weihenstephanensis)Hypothetical protein ER45_27600, partial sequence (B.weihenstephanensis) 94 AA 1-196 of BclA (B. anthracis Sterne)  95* Met +AA 20-35 of BclA (B. anthracis Sterne) 96 Met + AA 12-27 of BetA/BAS3290(B. anthracis Sterne) 97 Met + AA 18-33 of gene 2280 (B.weihenstephensis KBAB4) 98 Met + AA 18-33 of gene 3572 (B.weihenstephensis KBAB4) 99 Met + AA 12-27 of Exosporium Leader Peptide(B. cereus VD166) 100  Met + AA 18-33 of YVTN β-propeller protein 101 (B. weihenstephensis KBAB4) Met + AA 9-24 of hypothetical proteinbcerkbab4_2363 102  (B. weihenstephensis KBAB4) Met + AA 9-24 ofhypothetical protein bcerkbab4_2131 103  (B. weihenstephensis KBAB4)Met + AA 9-24 of hypothetical protein bmyc0001_22540 104  (B. mycoides2048) Met + AA 9-24 of BAS1882 (B. anthracis Sterne) 105  Met + AA 20-35of exosporium leader WP016117717 (B. cereus) 106  Met + AA 9-24 ofhypothetical protein BALH_2230 107  (B. thuringiensis str. Al Hakam)Full length InhA (B. mycoides) 108  Full length BAS1141 (ExsY) (B.anthracis Sterne) 109  Full length BAS1144 (BxpB/ExsFA) (B. anthracisSterne) 110  Full length BAS1145 (CotY) (B. anthracis Sterne) 111  Fulllength BAS1140 (B. anthracis Sterne) 112  Full length ExsFB (B.anthracis H9401) 113  Full length InhA1 (B. thuringiensis HD74) 114 Full length ExsJ (B. cereus ATCC 10876) 115  Full length ExsH (B.cereus) 116  Full length YjcA (B. anthracis Ames) 117  Full length YjcB(B. anthracis) 118  Full length BclC (B. anthracis Sterne) 119  Fulllength acid phosphatase 120  (Bacillus thuringiensis serovar konkukianstr. 97-27) Full length InhA2 (B. thuringiensis HD74) 121  Full lengthInhA3 (B. mycoides) 122  AA = amino acids *B. anthracis Sterne strainBclA has 100% sequence identity with B. thuringiensis BclA. Thus, SEQ IDNOs: 1, 2, and 95 also represent amino acids 1-41 of B. thuringiensisBclA, full length B. thuringiensis BclA, and amino acids 1-196 of B.thuringiensis BclA, respectively. Likewise, SEQ ID NO: 96 alsorepresents a methionine residue plus amino acids 20-35 of B.thuringiensis BclA. **B. mycoides hypothetical protein TIGR03720 has100% sequence identity with B. mycoides hypothetical proteinWP003189234. Thus, SEQ ID NOs: 57 and 58 also represent amino acids1-136 of B. mycoides hypothetical protein WP003189234 and full length B.mycoides hypothetical protein WP003189234, respectively.

Bacillus is a genus of rod-shaped bacteria. The Bacillus cereus familyof bacteria includes any Bacillus species that is capable of producingan exosporium. Thus, the Bacillus cereus family of bacteria includes thespecies Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis,Bacillus mycoides, Bacillus pseudomycoides, Bacillus samanii, Bacillusgaemokensis, Bacillus weihenstephensis, and Bacillus toyoiensis. Understressful environmental conditions, Bacillus cereus family bacteriaundergo sporulation and form oval endospores that can stay dormant forextended periods of time. The outermost layer of the endospores is knownas the exosporium and comprises a basal layer surrounded by an externalnap of hair-like projections. Filaments on the hair-like nap arepredominantly formed by the collagen-like glycoprotein BclA, while thebasal layer is comprised of a number of different proteins. Anothercollagen-related protein, BclB, is also present in the exosporium andexposed on endospores of Bacillus cereus family members. BclA, the majorconstituent of the surface nap, has been shown to be attached to theexosporium with its amino-terminus (N-terminus) positioned at the basallayer and its carboxy-terminus (C-terminus) extending outward from thespore.

It was previously discovered that certain sequences from the N-terminalregions of BclA and BclB could be used to target a peptide or protein tothe exosporium of a Bacillus cereus endospore (see U.S. PatentApplication Publication Nos. 2010/0233124 and 2011/0281316, and Thompsonet al., Targeting of the BclA and BclB proteins to the Bacillusanthracis spore surface, Molecular Microbiology 70(2):421-34 (2008)). Itwas also found that the BetA/BAS3290 protein of Bacillus anthracislocalized to the exosporium.

In particular, amino acids 20-35 of BclA from Bacillus anthracis Sternestrain have been found to be sufficient for targeting to the exosporium.A sequence alignment of amino acids 1-41 of BclA (SEQ ID NO: 1) with thecorresponding N-terminal regions of several other Bacillus cereus familyexosporium proteins and Bacillus cereus family proteins having relatedsequences is shown in FIGS. 1A and 1B. As can be seen from FIGS. 1A and1B, there is a region of high-homology among all of the proteins in theregion corresponding to amino acids 20-41 of BclA. However, in thesesequences, the amino acids corresponding to amino acids 36-41 of BclAcontain secondary structure and are not necessary for fusion proteinlocalization to the exosporium. The conserved targeting sequence regionof BclA (amino acids 20-35 of SEQ ID NO: 1) is shown in bold in FIGS. 1Aand 1B and corresponds to the minimal targeting sequence needed forlocalization to the exosporium. A more highly conserved region spanningamino acids 25-35 of BclA within the targeting sequence is underlined inthe sequences in FIGS. 1A and 1B, and is the recognition sequence forExsFA/BxpB/ExsFB and homologs, which direct and assemble the describedproteins on the surface of the exosporium. The amino acid sequences ofSEQ ID NOs. 3, 5, and 7 in FIG. 1A are amino acids 1-33 of Bacillusanthracis Sterne strain BetA/BAS3290, a methionine followed by aminoacids 2-43 of Bacillus anthracis Sterne strain BAS4623, and amino acids1-34 of Bacillus anthracis Sterne strain BclB, respectively. (ForBAS4623, it was found that replacing the valine present at position 1 inthe native protein with a methionine resulted in better expression.) Ascan be seen from FIG. 1A, each of these sequences contains a conservedregion corresponding to amino acids 20-35 of BclA (SEQ ID NO: 1; shownin bold), and a more highly conserved region corresponding to aminoacids 20-35 of BclA (underlined).

Additional proteins from Bacillus cereus family members also contain theconserved targeting region. In particular, in FIGS. 1A and 1B, SEQ IDNO: 9 is amino acids 1-30 of Bacillus anthracis Sterne strain BAS1882,SEQ ID NO: 11 is amino acids 1-39 of the Bacillus weihenstephensis KBAB42280 gene product, SEQ ID NO: 13 is amino acids 1-39 of the Bacillusweihenstephensis KBAB4 3572 gene product, SEQ ID NO: 15 is amino acids1-49 of Bacillus cereus VD200 exosporium leader peptide, SEQ ID NO: 17is amino acids 1-33 of Bacillus cereus VD166 exosporium leader peptide,SEQ ID NO: 19 is amino acids 1-39 of Bacillus cereus VD200 hypotheticalprotein IKG_04663, SEQ ID NO: 21 is amino acids 1-39 of Bacillusweihenstephensis KBAB4 YVTN β-propeller protein, SEQ ID NO: 23 is aminoacids 1-30 of Bacillus weihenstephensis KBAB4 hypothetical proteinbcerkbab4_2363, SEQ ID NO: 25 is amino acids 1-30 of Bacillusweihenstephensis KBAB4 hypothetical protein bcerkbab4_2131, SEQ ID NO:27 is amino acids 1-36 of Bacillus weihenstephensis KBAB4 triple helixrepeat containing collagen, SEQ ID NO: 29 is amino acids 1-39 ofBacillus mycoides 2048 hypothetical protein bmyco0001_21660, SEQ ID NO:31 is amino acids 1-30 of Bacillus mycoides 2048 hypothetical proteinbmyc0001_22540, SEQ ID NO: 33 is amino acids 1-21 of Bacillus mycoides2048 hypothetical protein bmyc0001_21510, SEQ ID NO: 35 is amino acids1-22 of Bacillus thuringiensis 35646 collagen triple helix repeatprotein, SEQ ID NO: 43 is amino acids 1-35 of Bacillus cereushypothetical protein WP_69652, SEQ ID NO: 45 is amino acids 1-41 ofBacillus cereus exosporium leader WP016117717, SEQ ID NO: 47 is aminoacids 1-49 of Bacillus cereus exosporium peptide WP002105192, SEQ ID NO:49 is amino acids 1-38 of Bacillus cereus hypothetical protein WP87353,SEQ ID NO: 51 is amino acids 1-39 of Bacillus cereus exosporium peptide02112369, SEQ ID NO: 53 is amino acids 1-39 of Bacillus cereusexosporium protein WP016099770, SEQ ID NO: 55 is amino acids 1-36 ofBacillus thuringiensis hypothetical protein YP006612525, SEQ ID NO: 57is amino acids 1-136 of Bacillus mycoides hypothetical proteinTIGR03720, SEQ ID NO: 59 is amino acids 1-36 of B. cereus ATCC 10987collagen triple helix repeat domain protein, SEQ ID NO: 61 is aminoacids 1-39 of B. cereus E33L collagen-like protein, SEQ ID NO: 63 isamino acids 1-41 of B. weihenstephanensis KBAB4 triple helixrepeat-containing collagen, SEQ ID NO: 65 is amino acids 1-30 of B.thuringiensis str. Al Hakam hypothetical protein BALH_2230, SEQ ID NO:67 is amino acids 1-33 of B. cereus ATCC 14579 triple helixrepeat-containing collagen, SEQ ID NO: 69 is amino acids 1-44 of B.cereus collagen triple helix repeat, SEQ ID NO: 71 is amino acids 1-38of B. cereus ATCC 14579 triple helix repeat-containing collagen, SEQ IDNO: 73 is amino acids 1-30 of B. cereus E33L hypothetical proteinBCZK1835, SEQ ID NO: 75 is amino acids 1-48 of B. weihenstephanensisKBAB4 triple helix repeat-containing collagen, SEQ ID NO: 77 is aminoacids 1-30 of B. cereus ATCC 14579 triple helix repeat-containingcollagen, SEQ ID NO: 79 is amino acids 1-39 of B. cereus ATCC 14579hypothetical protein BC4725, SEQ ID NO: 81 is amino acids 1-44 of B.cereus E33L hypothetical protein BCZK4476, SEQ ID NO: 83 is amino acids1-40 of B. anthracis str. ‘Ames Ancestor’ triple helix repeat-containingcollagen, SEQ ID NO: 85 is amino acids 1-34 of B. thuringiensis serovarkonkukian str. 97-27 BclA protein, SEQ ID NO: 87 is amino acids 1-34 ofB. cereus ATCC 10987 conserved hypothetical protein, SEQ ID NO: 89 isamino acids 1-34 of B. cereus ATCC 14579 triple helix repeat-containingcollagen, SEQ ID NO: 91 is amino acids 1-99 of B. cereus exosporiumleader peptide partial sequence, and SEQ ID NO: 93 is amino acids 1-136of B. weihenstephanensis hypothetical protein ER45_27600. As shown inFIGS. 1A and 1B, each of the N-terminal regions of these proteinscontains a region that is conserved with amino acids 20-35 of BclA (SEQID NO: 1), and a more highly conserved region corresponding to aminoacids 25-35 of BclA.

Any portion of BclA which includes amino acids 20-35 can be used as totarget a fusion protein to the exosporium. In addition, full-lengthexosporium proteins or exosporium protein fragments can be used fortargeting the fusion proteins to the exosporium. Thus, full-length BclAor a fragment of BclA that includes amino acids 20-35 can be used fortargeting to the exosporium. For example, full length BclA (SEQ ID NO:2) or a midsized fragment of BclA that lacks the carboxy-terminus suchas SEQ ID NO: 95 (amino acids 1-196 of BclA) can be used to target thefusion proteins to the exosporium. Midsized fragments such as thefragment of SEQ ID NO: 95 have less secondary structure than full lengthBclA and has been found to be suitable for use as a targeting sequence.The targeting sequence can also comprise much shorter portions of BclAwhich include amino acids 20-35, such as SEQ ID NO: 1 (amino acids 1-41of BclA), amino acids 1-35 of SEQ ID NO: 1, amino acids 20-35 of SEQ IDNO: 1, or SEQ ID NO: 96 (a methionine residue linked to amino acids20-35 of BclA). Even shorter fragments of BclA which include only someof amino acids 20-35 also exhibit the ability to target fusion proteinsto the exosporium. For example, the targeting sequence can compriseamino acids 22-31 of SEQ ID NO: 1, amino acids 22-33 of SEQ ID NO: 1, oramino acids 20-31 of SEQ ID NO: 1.

Alternatively, any portion of BetA/BAS3290, BAS4623, BclB, BAS1882, theKBAB4 2280 gene product, the KBAB4 3572 gene product, B. cereus VD200exosporium leader peptide, B. cereus VD166 exosporium leader peptide, B.cereus VD200 hypothetical protein IKG_04663, B. weihenstephensis KBAB4YVTN β-propeller protein, B. weihenstephensis KBAB4 hypothetical proteinbcerkbab4_2363, B. weihenstephensis KBAB4 hypothetical proteinbcerkbab4_2131, B. weihenstephensis KBAB4 triple helix repeat containingcollagen, B. mycoides 2048 hypothetical protein bmyco0001_21660, B.mycoides 2048 hypothetical protein bmyc0001_22540, B. mycoides 2048hypothetical protein bmyc0001_21510, B. thuringiensis 35646 collagentriple helix repeat protein, B. cereus hypothetical protein WP_69652, B.cereus exosporium leader WP016117717, B. cereus exosporium peptideWP002105192, B. cereus hypothetical protein WP87353, B. cereusexosporium peptide 02112369, B. cereus exosporium protein WP016099770,B. thuringiensis hypothetical protein YP006612525, B. mycoideshypothetical protein TIGR03720, B. cereus ATCC 10987 collagen triplehelix repeat domain protein, B. cereus E33L collagen-like protein, B.weihenstephanensis KBAB4 triple helix repeat-containing collagen, B.thuringiensis str. Al Hakam hypothetical protein BALH_2230, B. cereusATCC 14579 triple helix repeat-containing collagen, B. cereus collagentriple helix repeat, B. cereus ATCC 14579 triple helix repeat-containingcollagen, B. cereus E33L hypothetical protein BCZK1835, B.weihenstephanensis KBAB4 triple helix repeat-containing collagen, B.cereus ATCC 14579 triple helix repeat-containing collagen, B. cereusATCC 14579 hypothetical protein BC4725, B. cereus E33L hypotheticalprotein BCZK4476, B. anthracis str. ‘Ames Ancestor’ triple helixrepeat-containing collagen, B. thuringiensis serovar konkukian str.97-27 BclA protein, B. cereus ATCC 10987 conserved hypothetical protein,B. cereus ATCC 14579 triple helix repeat-containing collagen, B. cereusexosporium leader peptide partial sequence, or B. weihenstephanensishypothetical protein ER45_27600 which includes the amino acidscorresponding to amino acids 20-35 of BclA can serve as the targetingsequence.

As can be seen from FIG. 1A, amino acids 12-27 of BetA/BAS3290, aminoacids 23-38 of BAS4623, amino acids 13-28 of BclB, amino acids 9-24 ofBAS1882, amino acids 18-33 of KBAB4 2280 gene product, amino acids 18-33of KBAB4 3572 gene product, amino acids 28-43 of B. cereus VD200exosporium leader peptide, amino acids 12-27 of B. cereus VD166exosporium leader peptide, amino acids 18-33 of B. cereus VD200hypothetical protein IKG_04663, amino acids 18-33 B. weihenstephensisKBAB4 YVTN β-propeller protein, amino acids 9-24 of B. weihenstephensisKBAB4 hypothetical protein bcerkbab4_2363, amino acids 9-24 of B.weihenstephensis KBAB4 hypothetical protein bcerkbab4_2131, amino acids15-30 of B. weihenstephensis KBAB4 triple helix repeat containingcollagen, amino acids 18-33 of B. mycoides 2048 hypothetical proteinbmyco0001_21660, amino acids 9-24 of B. mycoides 2048 hypotheticalprotein bmyc0001_22540, amino acids 1-15 of B. mycoides 2048hypothetical protein bmyc0001_21510, amino acids 1-16 of B.thuringiensis 35646 collagen triple helix repeat protein, amino acids14-29 of B. cereus hypothetical protein WP_69652, amino acids 20-35 ofB. cereus exosporium leader WP016117717, amino acids 28-43 of B. cereusexosporium peptide WP002105192, amino acids 17-32 of B. cereushypothetical protein WP87353, amino acids 18-33 of B. cereus exosporiumpeptide 02112369, amino acids 18-33 of B. cereus exosporium proteinWP016099770, amino acids 15-30 of B. thuringiensis hypothetical proteinYP006612525, and amino acids 115-130 of B. mycoides hypothetical proteinTIGR03720 correspond to amino acids 20-35 of BclA. As can be seen fromFIG. 1B, amino acids 15-30 of B. cereus ATCC 10987 collagen triple helixrepeat domain protein, amino acids 18-33 of B. cereus E33L collagen-likeprotein, amino acids 20-35 of B. weihenstephanensis KBAB4 triple helixrepeat-containing collagen, amino acids 9-24 of B. thuringiensis str. AlHakam hypothetical protein BALH_2230, amino acids 12-27 of B. cereusATCC 14579 triple helix repeat-containing collagen, amino acids 23-38 ofB. cereus collagen triple helix repeat, amino acids 17-32 of B. cereusATCC 14579 triple helix repeat-containing collagen, amino acids 9-24 ofB. cereus E33L hypothetical protein BCZK1835, amino acids 27-42 of B.weihenstephanensis KBAB4 triple helix repeat-containing collagen, aminoacids 9-24 of B. cereus ATCC 14579 triple helix repeat-containingcollagen, amino acids 18-33 of B. cereus ATCC 14579 hypothetical proteinBC4725, amino acids 23-38 of B. cereus E33L hypothetical proteinBCZK4476, amino acids 19-34 B. anthracis str. ‘Ames Ancestor’ triplehelix repeat-containing collagen, amino acids 13-28 of B. thuringiensisserovar konkukian str. 97-27 BclA protein, amino acids 13-28 of B.cereus ATCC 10987 conserved hypothetical protein, amino acids 13-28 ofB. cereus ATCC 14579 triple helix repeat-containing collagen, aminoacids 78-93 of B. cereus exosporium leader peptide partial sequence, andamino acids 115-130 of B. weihenstephanensis hypothetical proteinER45_27600 correspond to amino acids 20-35 of BclA. Thus, any portion ofthese proteins that includes the above-listed corresponding amino acidscan serve as the targeting sequence.

Furthermore, any amino acid sequence comprising amino acids 20-35 ofBclA, or any of the above-listed corresponding amino acids can serve asthe targeting sequence.

Thus, the targeting sequence can comprise amino acids 1-35 of SEQ ID NO:1, amino acids 20-35 of SEQ ID NO: 1, SEQ ID NO: 1, SEQ ID NO: 96, aminoacids 22-31 of SEQ ID NO: 1, amino acids 22-33 of SEQ ID NO: 1, or aminoacids 20-31 of SEQ ID NO: 1. Alternatively, the targeting sequenceconsists of amino acids 1-35 of SEQ ID NO: 1, amino acids 20-35 of SEQID NO: 1, SEQ ID NO: 1, or SEQ ID NO: 96. Alternatively, the targetingsequence can consist of amino acids 22-31 of SEQ ID NO: 1, amino acids22-33 of SEQ ID NO: 1, or amino acids 20-31 of SEQ ID NO: 1.Alternatively, the exosporium protein can comprise full length BclA (SEQID NO: 2), or the exosporium protein fragment can comprise a midsizedfragment of BclA that lacks the carboxy-terminus, such as SEQ ID NO: 59(amino acids 1-196 of BclA). Alternatively, the exosporium proteinfragment can consist of SEQ ID NO: 59.

The targeting sequence can comprise amino acids 2-35 of SEQ ID NO: 1;amino acids 5-35 of SEQ ID NO: 1; amino acids 8-35 of SEQ ID NO: 1;amino acids 10-35 of SEQ ID NO: 1; or amino acids 15-35 of SEQ ID NO: 1.

The targeting sequence can also comprise amino acids 1-27 of SEQ ID NO:3, amino acids 12-27 of SEQ ID NO: 3, or SEQ ID NO: 3, or the exosporiumprotein can comprise full length BetA/BAS3290 (SEQ ID NO: 4). It hasalso been found that a methionine residue linked to amino acids 12-27 ofBetA/BAS3290 can be used as a targeting sequence. Thus, the targetingsequence can comprise SEQ ID NO: 97. The targeting sequence can alsocomprise amino acids 14-23 of SEQ ID NO: 3, amino acids 14-25 of SEQ IDNO: 3, or amino acids 12-23 of SEQ ID NO: 3.

The targeting sequence can comprise amino acids 2-27 of SEQ ID NO: 3;amino acids 5-27 of SEQ ID NO: 3; amino acids 8-27 of SEQ ID NO: 3; oramino acids 10-27 of SEQ ID NO: 3.

The targeting sequence can also comprise amino acids 1-38 of SEQ ID NO:5, amino acids 23-38 of SEQ ID NO: 5, or SEQ ID NO: 5, or the exosporiumprotein can comprise full length BAS4623 (SEQ ID NO: 6).

The targeting sequence can comprise amino acids 2-38 of SEQ ID NO: 5;amino acids 5-38 of SEQ ID NO: 5; amino acids 8-38 of SEQ ID NO: 5;amino acids 10-38 of SEQ ID NO: 5; amino acids 15-38 of SEQ ID NO: 5; oramino acids 20-38 of SEQ ID NO: 5.

Alternatively, the targeting sequence can comprise amino acids 1-28 ofSEQ ID NO: 7, amino acids 13-28 of SEQ ID NO: 7, or SEQ ID NO: 7, or theexosporium protein can comprise full length BclB (SEQ ID NO:8).

The targeting sequence can comprise amino acids 2-28 of SEQ ID NO: 7;amino acids 5-28 of SEQ ID NO: 7; amino acids 8-28 of SEQ ID NO: 7; oramino acids 10-28 of SEQ ID NO: 7.

The targeting sequence can also comprise amino acids 1-24 of SEQ ID NO:9, amino acids 9-24 of SEQ ID NO: 9, or SEQ ID NO: 9, or the exosporiumprotein can comprise full length BAS1882 (SEQ ID NO: 10). A methionineresidue linked to amino acids 9-24 of BAS1882 can also be used as atargeting sequence. Thus, the targeting sequence can comprise SEQ ID NO:105.

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO: 9;amino acids 5-24 of SEQ ID NO: 9; or amino acids 8-24 of SEQ ID NO: 9.

The targeting sequence can also comprise amino acids 1-33 of SEQ IDNO:11, amino acids 18-33 of SEQ ID NO: 11, or SEQ ID NO: 11, or theexosporium protein can comprise the full length B. weihenstephensisKBAB4 2280 gene product (SEQ ID NO: 12). A methionine residue linked toamino acids 18-33 of the B. weihenstephensis KBAB4 2280 gene product canalso be used as a targeting sequence. Thus, the targeting sequence cancomprise SEQ ID NO: 98.

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 11;amino acids 5-33 of SEQ ID NO: 11; amino acids 8-33 of SEQ ID NO: 11;amino acids 10-33 of SEQ ID NO: 11; or amino acids 15-33 of SEQ ID NO:11.

The targeting sequence can also comprise amino acids 1-33 of SEQ ID NO:13, amino acids 18-33 of SEQ ID NO: 13, or SEQ ID NO:13, or theexosporium protein can comprise the full length B. weihenstephensisKBAB4 3572 gene product (SEQ ID NO:14). A methionine residue linked toamino acids 18-33 of the B. weihenstephensis KBAB4 3572 gene product canalso be used as a targeting sequence. Thus, the targeting sequence cancomprise SEQ ID NO: 99.

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 13;amino acids 5-33 of SEQ ID NO: 13; amino acids 8-33 of SEQ ID NO: 13;amino acids 10-33 of SEQ ID NO: 13; or amino acids 15-33 of SEQ ID NO:13;

Alternatively, the targeting sequence can comprise amino acids 1-43 ofSEQ ID NO: 15, amino acids 28-43 of SEQ ID NO: 15, or SEQ ID NO:15, orthe exosporium protein can comprise full length B. cereus VD200exosporium leader peptide (SEQ ID NO:16).

The targeting sequence can comprise amino acids 2-43 of SEQ ID NO: 15;amino acids 5-43 of SEQ ID NO: 15; amino acids 8-43 of SEQ ID NO: 15;amino acids 10-43 of SEQ ID NO: 15; amino acids 15-43 of SEQ ID NO: 15;amino acids 20-43 of SEQ ID NO: 15; or amino acids 25-43 of SEQ ID NO:15.

The targeting sequence can also comprise amino acids 1-27 of SEQ ID NO:17, amino acids 12-27 of SEQ ID NO: 17, or SEQ ID NO: 17, or theexosporium protein can comprise full-length B. cereus VD166 exosporiumleader peptide (SEQ ID NO:18). A methionine residue linked to aminoacids 12-27 of the B. cereus VD166 exosporium leader peptide can also beused as a targeting sequence. Thus, the targeting sequence can compriseSEQ ID NO: 100.

The targeting sequence can comprise amino acids 2-27 of SEQ ID NO: 17;amino acids 5-27 of SEQ ID NO: 17; amino acids 8-27 of SEQ ID NO: 17; oramino acids 10-27 of SEQ ID NO: 17.

The targeting sequence can also comprise amino acids 1-33 of SEQ ID NO:19, amino acids 18-33 of SEQ ID NO: 19, or SEQ ID NO:19, or theexosporium protein can comprise full length B. cereus VD200 hypotheticalprotein IKG_04663 (SEQ ID NO:20).

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 19;amino acids 5-33 of SEQ ID NO: 19; amino acids 8-33 of SEQ ID NO: 19;amino acids 10-33 of SEQ ID NO: 19; or amino acids 15-33 of SEQ ID NO:19.

Alternatively, the targeting sequence comprises amino acids 1-33 of SEQID NO: 21, amino acids 18-33 of SEQ ID NO: 21, or SEQ ID NO:21, or theexosporium protein can comprise full length B. weihenstephensis KBAB4YVTN β-propeller protein (SEQ ID NO:22). A methionine residue linked toamino acids 18-33 of the B. weihenstephensis KBAB4 YVTN β-propellerprotein can also be used as a targeting sequence. Thus, the targetingsequence can comprise SEQ ID NO: 101.

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 21;amino acids 5-33 of SEQ ID NO: 21; amino acids 8-33 of SEQ ID NO: 21;amino acids 10-33 of SEQ ID NO: 21; or amino acids 15-33 of SEQ ID NO:21.

The targeting sequence can also comprise amino acids 1-24 of SEQ ID NO:23, amino acids 9-24 of SEQ ID NO: 23, or SEQ ID NO:23, or theexosporium protein can comprise full length B. weihenstephensis KBAB4hypothetical protein bcerkbab4_2363 (SEQ ID NO:24). A methionine residuelinked to amino acids 9-24 of B. weihenstephensis KBAB4 hypotheticalprotein bcerkbab4_2363 can also be used as a targeting sequence. Thus,the targeting sequence can comprise SEQ ID NO: 102.

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO:23;amino acids 5-24 of SEQ ID NO: 23; or amino acids 8-24 of SEQ ID NO: 23.

The targeting sequence comprise amino acids 1-24 of SEQ ID NO: 25, aminoacids 9-24 of SEQ ID NO: 25, or SEQ ID NO: 25, or the exosporium proteincan comprise full length B. weihenstephensis KBAB4 hypothetical proteinbcerkbab4_2131 (SEQ ID NO:26). A methionine residue linked to aminoacids 9-24 of B. weihenstephensis KBAB4 hypothetical proteinbcerkbab4_2131 can also be used as a targeting sequence. Thus, thetargeting sequence can comprise SEQ ID NO: 103.

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO: 25;amino acids 5-24 of SEQ ID NO: 25; or amino acids 8-24 of SEQ ID NO: 25.

Alternatively, the targeting sequence comprises amino acids 1-30 of SEQID NO: 27, amino acids 15-30 of SEQ ID NO: 27, or SEQ ID NO:27, or theexosporium protein can comprise full length B. weihenstephensis KBAB4triple helix repeat containing collagen (SEQ ID NO:28).

The targeting sequence can comprise amino acids 2-30 of SEQ ID NO: 27;amino acids 5-30 of SEQ ID NO: 27; amino acids 8-30 of SEQ ID NO: 27; oramino acids 10-30 of SEQ ID NO: 27.

The targeting sequence can also comprise amino acids 1-33 of SEQ ID NO:29, amino acids 18-33 of SEQ ID NO: 29, or SEQ ID NO:29, or theexosporium protein can comprise full length B. mycoides 2048hypothetical protein bmyco0001_21660 (SEQ ID NO:30).

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 29;amino acids 5-33 of SEQ ID NO: 29; amino acids 8-33 of SEQ ID NO: 29;amino acids 10-33 of SEQ ID NO: 29; or amino acids 15-33 of SEQ ID NO:29.

The targeting sequence can also comprise amino acids 1-24 of SEQ ID NO:31, amino acids 9-24 of SEQ ID NO: 31, or SEQ ID NO:31, or theexosporium protein can comprise full length B. mycoides 2048hypothetical protein bmyc0001_22540 (SEQ ID NO:32). A methionine residuelinked to amino acids 9-24 of B. mycoides 2048 hypothetical proteinbmyc0001_22540 can also be used as a targeting sequence. Thus, thetargeting sequence can comprise SEQ ID NO: 104.

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO: 31;amino acids 5-24 of SEQ ID NO: 31; or amino acids 8-24 of SEQ ID NO: 31.

Alternatively, the targeting sequence comprises amino acids 1-15 of SEQID NO: 33, SEQ ID NO:33, or the exosporium protein comprises full lengthB. mycoides 2048 hypothetical protein bmyc0001_21510 (SEQ ID NO:34).

The targeting sequence can also comprise amino acids 1-16 of SEQ ID NO:35, SEQ ID NO:35, or the exosporium protein can comprise full length B.thuringiensis 35646 collagen triple helix repeat protein (SEQ ID NO:36).

The targeting sequence can comprise amino acids 1-29 of SEQ ID NO:43,amino acids 14-29 of SEQ ID NO: 43, or SEQ ID NO: 43, or the exosporiumprotein can comprise full length B. cereus hypothetical protein WP_69652(SEQ ID NO: 44).

The targeting sequence can comprise amino acids 2-29 of SEQ ID NO: 43;amino acids 5-29 of SEQ ID NO: 43; amino acids 8-29 of SEQ ID NO: 43; oramino acids 10-29 of SEQ ID NO: 43.

Alternatively, the targeting sequence can comprise amino acids 1-35 ofSEQ ID NO: 45, amino acids 20-35 of SEQ ID NO: 45, or SEQ ID NO: 45, orthe exosporium protein can comprise full length B. cereus exosporiumleader WP016117717 (SEQ ID NO: 46). A methionine residue linked to aminoacids 20-35 of B. cereus exosporium leader WP016117717 can also be usedas a targeting sequence. Thus, the targeting sequence can comprise SEQID NO: 106.

The targeting sequence can comprise amino acids 2-35 of SEQ ID NO: 45;amino acids 5-35 of SEQ ID NO: 45; amino acids 8-35 of SEQ ID NO: 45;amino acids 10-35 of SEQ ID NO: 45; or amino acids 15-35 of SEQ ID NO:45.

The targeting sequence can comprise amino acids 1-43 of SEQ ID NO: 47,amino acids 28-43 of SEQ ID NO: 47, or SEQ ID NO: 47, or the exosporiumprotein can comprise full length B. cereus exosporium peptideWP002105192 (SEQ ID NO: 48).

The targeting sequence can comprise amino acids 2-43 of SEQ ID NO: 47;amino acids 5-43 of SEQ ID NO: 47; amino acids 8-43 of SEQ ID NO: 47;amino acids 10-43 of SEQ ID NO: 47; amino acids 15-43 of SEQ ID NO: 47;amino acids 20-43 of SEQ ID NO: 47; or amino acids 25-43 of SEQ ID NO:47.

The targeting sequence can comprise amino acids 1-32 of SEQ ID NO: 49,amino acids 17-32 of SEQ ID NO: 49, or SEQ ID NO: 49, or the exosporiumprotein can comprise full length B. cereus hypothetical protein WP87353(SEQ ID NO: 50).

The targeting sequence can comprise amino acids 2-32 of SEQ ID NO: 49;amino acids 5-32 of SEQ ID NO: 49; amino acids 8-32 of SEQ ID NO: 49;amino acids 10-32 of SEQ ID NO: 49; or amino acids 15-32 of SEQ ID NO:49.

Alternatively, the targeting sequence can comprise amino acids 1-33 ofSEQ ID NO: 51, amino acids 18-33 of SEQ ID NO: 51, or SEQ ID NO: 51, orthe exosporium protein can comprise full length B. cereus exosporiumpeptide 02112369 (SEQ ID NO: 52).

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 51;amino acids 5-33 of SEQ ID NO: 51; amino acids 8-33 of SEQ ID NO: 51;amino acids 10-33 of SEQ ID NO: 51; or amino acids 15-33 of SEQ ID NO:51;

The targeting sequence can comprise amino acids 1-33 of SEQ ID NO: 53,amino acids 18-33 of SEQ ID NO: 53, or SEQ ID NO: 53, or the exosporiumprotein can comprise full length B. cereus exosporium proteinWP016099770 (SEQ ID NO: 54).

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 53;amino acids 5-33 of SEQ ID NO: 53; amino acids 8-33 of SEQ ID NO: 53;amino acids 10-33 of SEQ ID NO: 53; or amino acids 15-33 of SEQ ID NO:53.

Alternatively, the targeting sequence can comprise acids 1-30 of SEQ IDNO: 55, amino acids 15-30 of SEQ ID NO: 55, or SEQ ID NO: 55, or theexosporium protein can comprise full length B. thuringiensishypothetical protein YP006612525 (SEQ ID NO: 56).

The targeting sequence can comprise amino acids 2-30 of SEQ ID NO: 55;amino acids 5-30 of SEQ ID NO: 55; amino acids 8-30 of SEQ ID NO: 55; oramino acids 10-30 of SEQ ID NO: 55.

The targeting sequence can also comprise amino acids 1-130 of SEQ ID NO:57, amino acids 115-130 of SEQ ID NO: 57, or SEQ ID NO: 57, or theexosporium protein can comprise full length B. mycoides hypotheticalprotein TIGR03720 (SEQ ID NO: 58).

The targeting sequence can comprise amino acids 2-130 of SEQ ID NO: 57;amino acids 5-130 of SEQ ID NO: 57; amino acids 10-130 of SEQ ID NO: 57;amino acids 20-130 of SEQ ID NO: 57; amino acids 30-130 of SEQ ID NO:57; amino acids 40-130 of SEQ ID NO: 57; amino acids 50-130 of SEQ IDNO: 57; amino acids 60-130 of SEQ ID NO: 57; amino acids 70-130 of SEQID NO: 57; amino acids 80-130 of SEQ ID NO: 57; amino acids 90-130 ofSEQ ID NO: 57; amino acids 100-130 of SEQ ID NO: 57; or amino acids110-130 of SEQ ID NO: 57.

The targeting sequence can comprise amino acids 1-30 of SEQ ID NO: 59;or SEQ ID NO: 59; or the exosporium protein can comprise full length B.cereus ATCC 10987 collagen triple helix repeat domain protein (SEQ IDNO: 60).

The targeting sequence can comprise amino acids 2-30 of SEQ ID NO: 59;amino acids 4-30 of SEQ ID NO: 59; or amino acids 6-30 of SEQ ID NO: 59.

The targeting sequence can comprise amino acids 1-33 of SEQ ID NO: 61;amino acids 18-33 of SEQ ID NO: 61; or SEQ ID NO: 61; or the exosporiumprotein can comprise full length B. cereus E33L collagen-like protein(SEQ ID NO: 62).

The targeting sequence can comprise amino acids 2-33 of SEQ ID NO: 61;amino acids 5-33 of SEQ ID NO: 61; amino acids 10-33 of SEQ ID NO: 61;or amino acids 15-33 of SEQ ID NO: 61.

The targeting sequence can comprise amino acids 1-35 of SEQ ID NO: 63;or SEQ ID NO: 63; or the exosporium protein can comprise full length B.weihenstephanensis KBAB4 triple helix repeat-containing collagen (SEQ IDNO: 64).

The targeting sequence can comprise amino acids 2-35 of SEQ ID NO: 63;amino acids 5-35 of SEQ ID NO: 63; amino acids 8-35 of SEQ ID NO: 63;amino acids 10-35 of SEQ ID NO: 63; or amino acids 15-35 of SEQ ID NO:63.

The targeting sequence can comprise amino acids 1-24 of SEQ ID NO: 65;acids 9-24 of SEQ ID NO: 65; SEQ ID NO: 65; or SEQ ID NO: 107; or theexosporium protein can comprise full length B. thuringiensis str. AlHakam hypothetical protein BALH_2230 (SEQ ID NO: 66).

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO: 65;or amino acids 5-24 of SEQ ID NO: 65.

The targeting sequence can comprise acids 1-27 of SEQ ID NO: 67; aminoacids 12-27 of SEQ ID NO: 67; or SEQ ID NO: 67; or the exosporiumprotein can comprise full length B. cereus ATCC 14579 triple helixrepeat-containing collagen (SEQ ID NO: 68).

The targeting sequence can comprise amino acids 2-27 of SEQ ID NO: 67;amino acids 5-27 of SEQ ID NO: 67; or amino acids 10-27 of SEQ ID NO:67.

The targeting sequence can comprise amino acids 1-38 of SEQ ID NO: 69;amino acids 23-38 of SEQ ID NO: 69; or SEQ ID NO: 69; or the exosporiumprotein can comprise full length B. cereus collagen triple helix repeat(SEQ ID NO: 70).

The targeting sequence can comprise amino acids 2-38 of SEQ ID NO: 69;amino acids 5-38 of SEQ ID NO: 69; amino acids 10-38 of SEQ ID NO: 69;or amino acids 15-38 of SEQ ID NO: 69.

The exosporium protein can comprise full length B. cereus ATCC 14579triple helix repeat-containing collagen (SEQ ID NO: 72).

The targeting sequence can comprise SEQ ID NO: 73, or the exosporiumprotein can comprise full length B. cereus E33L hypothetical proteinBCZK1835 (SEQ ID NO: 74).

The targeting sequence can comprise amino acids 1-42 of SEQ ID NO: 75;amino acids 27-42 of SEQ ID NO: 75; or SEQ ID NO: 75; or the exosporiumprotein can comprise full length B. weihenstephanensis KBAB4 triplehelix repeat-containing collagen (SEQ ID NO: 76).

The targeting sequence can comprise amino acids 2-42 of SEQ ID NO: 75;amino acids 5-42 of SEQ ID NO: 75; amino acids 10-42 of SEQ ID NO: 75;amino acids 15-42 of SEQ ID NO: 75; amino acids 20-42 of SEQ ID NO: 75;or amino acids 25-42 of SEQ ID NO: 75.

The targeting sequence can comprise amino acids 1-24 of SEQ ID NO: 77;amino acids 9-24 of SEQ ID NO: 77; or SEQ ID NO: 77; or the exosporiumprotein can comprise full length B. cereus ATCC 14579 triple helixrepeat-containing collagen (SEQ ID NO: 78).

The targeting sequence can comprise amino acids 2-24 of SEQ ID NO: 77;or amino acids 5-24 of SEQ ID NO: 77;

The exosporium protein can comprise full length B. cereus ATCC 14579hypothetical protein BC4725 (SEQ ID NO: 80).

The targeting sequence can comprise amino acids 1-38 of SEQ ID NO: 81;amino acids 23-38 of SEQ ID NO: 81; or SEQ ID NO: 81; or the exosporiumprotein can comprise full length B. cereus E33L hypothetical proteinBCZK4476 (SEQ ID NO: 82).

The targeting sequence can comprise amino acids 2-38 of SEQ ID NO: 81;acids 5-38 of SEQ ID NO: 81; amino acids 10-38 of SEQ ID NO: 81; aminoacids 15-38 of SEQ ID NO: 81; or amino acids 20-38 of SEQ ID NO: 81.

The targeting sequence can comprise amino acids 1-34 of SEQ ID NO: 83;or SEQ ID NO: 83; or the exosporium protein can comprise full length B.anthracis str. ‘Ames Ancestor’ triple helix repeat-containing collagen(SEQ ID NO: 84).

The exosporium protein can comprise full length B. thuringiensis serovarkonkukian str. 97-27 BclA protein (SEQ ID NO: 86).

The targeting sequence can comprise amino acids 1-28 of SEQ ID NO: 87;amino acids 13-28 of SEQ ID NO: 87; or SEQ ID NO: 87; or the exosporiumprotein can comprise full length B. cereus ATCC 10987 conservedhypothetical protein (SEQ ID NO: 88).

The targeting sequence can comprise amino acids 2-28 of SEQ ID NO: 87;amino acids 5-28 of SEQ ID NO: 87; or amino acids 10-28 of SEQ ID NO:87.

The targeting sequence can comprise amino acids 1-28 of SEQ ID NO: 89;or SEQ ID NO: 89; or the exosporium protein can comprise full length B.cereus ATCC 14579 triple helix repeat-containing collagen (SEQ ID NO:90).

The targeting sequence can comprise amino acids 2-28 of SEQ ID NO: 89;amino acids 5-28 of SEQ ID NO: 89; or amino acids 10-28 of SEQ ID NO: 89

The targeting sequence can comprise amino acids 1-93 of SEQ ID NO: 91;or SEQ ID NO: 91; or the exosporium protein can comprise B. cereusexosporium leader peptide partial sequence (SEQ ID NO: 92).

The targeting sequence can comprise amino acids 2-93 of SEQ ID NO: 91;amino acids 10-93 of SEQ ID NO: 91; amino acids 20-93 of SEQ ID NO: 91;amino acids 30-93 of SEQ ID NO: 91; amino acids 40-93 of SEQ ID NO: 91;amino acids 50-93 of SEQ ID NO: 91; or amino acids 60-93 of SEQ ID NO:91.

The targeting sequence can comprise amino acids 1-130 of SEQ ID NO: 93;or SEQ ID NO: 93; or the exosporium protein can comprise B.weihenstephanensis) hypothetical protein ER45_27600, partial sequence(SEQ ID NO: 94).

The targeting sequence can comprise amino acids 2-130 of SEQ ID NO: 93;amino acids 10-130 of SEQ ID NO: 93; amino acids 20-130 of SEQ ID NO:93; or amino acids 30-130 of SEQ ID NO: 93.

Furthermore, as illustrated in the Examples provided hereinbelow, it hasbeen found that sequences shorter than amino acids 20-35 of BclA can beused to target a fusion protein to the exosporium of a recombinantBacillus cereus family member. In particular, amino acids 20-33 of BclA,amino acids 20-31 of BclA, amino acids 21-33 of BclA, or amino acids23-31 of BclA can be used to target a fusion protein to the exosporiumof a recombinant Bacillus cereus family member. Thus, the targetingsequence can consist of amino acids 20-33 of SEQ ID NO: 1, amino acids20-31 of SEQ ID NO: 1, amino acids 21-33 of SEQ ID NO: 1, or amino acids23-31 of SEQ ID NO: 1. The corresponding regions of any of the SEQ IDNOs. shown in FIGS. 1A and 1B can also be used to target a fusionprotein to the exosporium of a recombinant Bacillus cereus familymember. By “corresponding regions,” it is meant that when the sequencesare aligned with SEQ ID NO: 1, as shown in FIGS. 1A and 1B, the regionsof the other amino acid sequences that align with the amino acids of SEQID NO: are the “corresponding regions” of those sequences. Thus, forexample, amino acids 12-25 of SEQ ID NO: 3, amino acids 23-36 of SEQ IDNO: 5, amino acids 13-26 of SEQ ID NO: 7, etc. can be used to target afusion protein to the exosporium of a recombinant Bacillus cereus familymember, since these regions align with amino acids 20-33 of SEQ ID NO: 1as shown in FIG. 1A.

Even shorter regions within amino acids 20-35 of BclA can also be usedfor targeting a fusion protein to the exosporium of a recombinantBacillus cereus family member. In particular, any amino acid sequencethat includes amino acids 25-30 of SEQ ID NO: 1 or the correspondingamino acids from any of the sequences shown in FIGS. 1A and 1B can beused. A skilled person will recognize that starting with amino acids25-30 of SEQ ID NO: 1 or the corresponding region of any of thesequences shown in FIGS. 1A and 1B, additional amino acids can be addedto the amino-terminus, the carboxy terminus, or both the amino- andcarboxy termini to create a targeting sequence that will be effectivefor targeting a fusion protein to the exosporium of a recombinantBacillus cereus family member.

In addition, it can readily be seen from the sequence alignment in FIGS.1A and 1B that while amino acids 20-35 of BclA are conserved, and aminoacids 25-35 are more conserved, some degree of variation can occur inthis region without affecting the ability of the targeting sequence totarget a protein to the exosporium. FIGS. 1A and 1B list the percentidentity of each of corresponding amino acids of each sequence to aminoacids 20-35 of BclA (“20-35% Identity”) and to amino acids 25-35 of BclA(“25-35% Identity”). Thus, for example, as compared to amino acids 20-35of BclA, the corresponding amino acids of BetA/BAS3290 are about 81.3%identical, the corresponding amino acids of BAS4623 are about 50.0%identical, the corresponding amino acids of BclB are about 43.8%identical, the corresponding amino acids of BAS1882 are about 62.5%identical, the corresponding amino acids of the KBAB4 2280 gene productare about 81.3% identical, and the corresponding amino acids of theKBAB4 3572 gene product are about 81.3% identical. The sequenceidentities over this region for the remaining sequences are listed inFIGS. 1A and 1B.

With respect to amino acids 25-35 of BclA, the corresponding amino acidsof BetA/BAS3290 are about 90.9% identical, the corresponding amino acidsof BAS4623 are about 72.7% identical, the corresponding amino acids ofBclB are about 54.5% identical, the corresponding amino acids of BAS1882are about 72.7% identical, the corresponding amino acids of the KBAB42280 gene product are about 90.9% identical, and the corresponding aminoacids of the KBAB4 3572 gene product are about 81.8% identical. Thesequence identities over this region for the remaining sequences arelisted in FIGS. 1A and 1B.

Thus, the targeting sequence can comprise an amino acid sequence havingat least about 43% identity with amino acids 20-35 of SEQ ID NO: 1,wherein the identity with amino acids 25-35 is at least about 54%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 43% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 54%.

The targeting sequence can also comprise an amino acid sequence havingat least about 50% identity with amino acids 20-35 of SEQ ID NO: 1,wherein the identity with amino acids 25-35 is at least about 63%.Alternatively the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 50% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 63%.

The targeting sequence can also comprise an amino acid sequence havingat least about 50% identity with amino acids 20-35 of SEQ ID NO: 1,wherein the identity with amino acids 25-35 is at least about 72%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 50% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 72%.

The targeting sequence can also comprise an amino acid sequence havingat least about 56% identity with amino acids 20-35 of SEQ ID NO: 1,wherein the identity with amino acids 25-35 is at least about 63%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 56% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 63%.

Alternatively, the targeting sequence can comprise an amino sequencehaving at least about 62% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.The targeting sequence can also consist of an amino acid sequenceconsisting of 16 amino acids and having at least about 62% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 of SEQ ID NO:1 is at least about 72%.

The targeting sequence can comprise an amino acid sequence having atleast 68% identity with amino acids 20-35 of SEQ ID NO: 1, wherein theidentity with amino acids 25-35 is at least about 81%. Alternatively,the targeting sequence consists of an amino acid sequence consisting of16 amino acids and having at least 68% identity with amino acids 20-35of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 81%.

The targeting sequence can also comprises an amino sequence having atleast about 75% identity with amino acids 20-35 of SEQ ID NO: 1, whereinthe identity with amino acids 25-35 is at least about 72%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 75% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 of SEQ ID NO:1 is at least about 72%.

The targeting sequence can also comprise an amino sequence having atleast about 75% identity with amino acids 20-35 of SEQ ID NO: 1, whereinthe identity with amino acids 25-35 is at least about 81%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 75% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 of SEQ ID NO:1 is at least about 81%.

The targeting sequence can also comprise an amino acid sequence havingat least about 81% identity with amino acids 20-35 of SEQ ID NO:1,wherein the identity with amino acids 25-35 is at least about 81%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 81% identity withamino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids25-35 is at least about 81%.

The targeting sequence can comprise an amino acid sequence having atleast about 81% identity with amino acids 20-35 of SEQ ID NO: 1, whereinthe identity with amino acids 25-35 is at least about 90%.Alternatively, the targeting sequence consists of an amino acid sequenceconsisting of 16 amino acids and having at least about 81% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 90%.

The skilled person will recognize that variants of the above sequencescan also be used as targeting sequences, so long as the targetingsequence comprises amino acids 20-35 of BclA, the corresponding aminoacids of BetA/BAS3290, BAS4263, BclB, BAS1882, the KBAB4 2280 geneproduct, or the KBAB 3572 gene product, or a sequence comprising any ofthe above noted sequence identities to amino acids 20-35 and 25-35 ofBclA is present.

Certain Bacillus cereus family exosporium proteins which lack regionshaving homology to amino acids 25-35 of BclA can also be used to targeta peptide or protein to the exosporium of a Bacillus cereus familymember. In particular, the fusion proteins can comprise an exosporiumprotein comprising SEQ ID NO: 108 (B. mycoides InhA), an exosporiumprotein comprising SEQ ID NO: 109 (B. anthracis Sterne BAS1141 (ExsY)),an exosporium protein comprising SEQ ID NO: 110 (B. anthracis SterneBAS1144 (BxpB/ExsFA)), an exosporium protein comprising SEQ ID NO: 111(B. anthracis Sterne BAS1145 (CotY)), an exosporium protein comprisingSEQ ID NO: 112 (B. anthracis Sterne BAS1140), an exosporium proteincomprising SEQ ID NO: 113 (B. anthracis H9401 ExsFB), an exosporiumprotein comprising SEQ ID NO: 114 (B. thuringiensis HD74 InhA1), anexosporium protein comprising SEQ ID NO: 115 (B. cereus ATCC 10876ExsJ), an exosporium protein comprising SEQ ID NO: 116 (B. cereus ExsH),an exosporium protein comprising SEQ ID NO: 117 (B. anthracis AmesYjcA), an exosporium protein comprising SEQ ID NO: 118 (B. anthracisYjcB), an exosporium protein comprising SEQ ID NO: 119 (B. anthracisSterne BclC), an exosporium protein comprising SEQ ID NO: 120 (Bacillusthuringiensis serovar konkukian str. 97-27 acid phosphatase), anexosporium protein comprising SEQ ID NO: 121 (B. thuringiensis HD74InhA2), or an exosporium protein comprising SEQ ID NO: 122 (B. mycoidesInhA3). Inclusion of an exosporium protein comprising any of SEQ ID NOs:108-122 in the fusion proteins described herein will result in targetingto the exosporium of a B. cereus family member.

Moreover, exosporium proteins having a high degree of sequence identitywith any of the full-length exosporium proteins or the exosporiumprotein fragments described above can also be used to target a peptideor protein to the exosporium of a Bacillus cereus family member. Thus,the fusion protein can comprise an exosporium protein or exosporiumprotein fragment comprising an amino acid sequence having at least 85%identity with any one of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20,22, 24, 26, 28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62,64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108,109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and122. Alternatively, the fusion protein can comprise an exosporiumprotein having at least 90%, at least 95%, at least 98%, at least 99%,or 100% identity with any one of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16,18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58,60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94,95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120,121, and 122.

During sporulation of a recombinant Bacillus cereus family memberexpressing any of the fusion proteins described herein, the targetingmotif, exosporium protein, or exosporium protein fragment is recognizedby the spore exosporium assembly machinery and directed to theexosporium, resulting in display of the protein or peptide of interestportion of the fusion protein on the outside of the spore.

As illustrated further by the Examples provided hereinbelow, the use ofdifferent targeting sequences allows for control of the expression levelof the fusion protein on the surface of the Bacillus cereus familymember spore. Use of certain of the targeting sequences described hereinwill result in a higher level of expression of the fusion protein,whereas use of others of the targeting sequences will result in lowerlevels of expression of the fusion protein on the surface of the spore.

In any of the fusion proteins described herein, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise theamino acid sequence GXT at its carboxy terminus, wherein X is any aminoacid.

In any of the fusion proteins described herein, the targeting sequence,exosporium protein, or exosporium protein fragment, can comprise analanine residue at the position of the targeting sequence thatcorresponds to amino acid 20 of SEQ ID NO: 1.

In any of the fusion proteins described herein, the targeting sequence,exosporium protein, or exosporium protein fragment can further comprisea methionine, serine, or threonine residue at the amino acid positionimmediately preceding the first amino acid of the targeting sequence,exosporium protein, or exosporium protein fragment or at the position ofthe targeting sequence that corresponds to amino acid 20 of SEQ ID NO:1.

B. Fusion Proteins for Expression in Recombinant Bacillus cereus FamilyMembers

The present invention relates to fusion proteins comprising at least oneprotein or peptide of interest and a targeting sequence or exosporiumprotein. When the protein or peptide of interest is any protein orpeptide of interest, the fusion protein can comprise: (1) a targetingsequence comprising amino acids 1-30 of SEQ ID NO: 59; (2) a targetingsequence comprising SEQ ID NO: 59; (3) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 60;(4) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 59;(5) a targeting sequence comprising amino acids 4-30 of SEQ ID NO: 59;(6) a targeting sequence comprising amino acids 6-30 of SEQ ID NO: 59;(7) a targeting sequence comprising amino acids 1-33 of SEQ ID NO: 61;(8) a targeting sequence comprising amino acids 18-33 of SEQ ID NO: 61;(9) a targeting sequence comprising SEQ ID NO: 61; (10) an exosporiumprotein comprising an amino acid sequence having at least 85% sequenceidentity with SEQ ID NO: 62; (11) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 61; (12) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 61; (13) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 61; (14) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 61; (15) a targeting sequence comprising aminoacids 1-35 of SEQ ID NO: 63; (16) a targeting sequence comprising SEQ IDNO: 63; (17) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 64; (18) a targetingsequence comprising amino acids 2-35 of SEQ ID NO: 63; (19) a targetingsequence comprising amino acids 5-35 of SEQ ID NO: 63; (20) a targetingsequence comprising amino acids 8-35 of SEQ ID NO: 63; (21) a targetingsequence comprising amino acids 10-35 of SEQ ID NO: 63; (22) a targetingsequence comprising amino acids 15-35 of SEQ ID NO: 63; (23) a targetingsequence comprising amino acids 1-24 of SEQ ID NO: 65; (24) a targetingsequence comprising amino acids 9-24 of SEQ ID NO: 65; (25) a targetingsequence comprising SEQ ID NO: 65; (26) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 66;(27) a targeting sequence comprising SEQ ID NO: 107; (28) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 65; (29) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 65; (30) a targetingsequence comprising amino acids 1-27 of SEQ ID NO: 67; (31) a targetingsequence comprising amino acids 12-27 of SEQ ID NO: 67; (32) a targetingsequence comprising SEQ ID NO: 67; (33) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 68;(34) an targeting sequence comprising amino acids 2-27 of SEQ ID NO: 67;(35) a targeting sequence comprising amino acids 5-27 of SEQ ID NO: 67;(36) a targeting sequence comprising amino acids 10-27 of SEQ ID NO: 67;(37) a targeting sequence comprising amino acids 1-38 of SEQ ID NO: 69;(38) a targeting sequence comprising amino acids 23-38 of SEQ ID NO: 69;(39) a targeting sequence comprising SEQ ID NO: 69; (40) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 70; (41) a targeting sequence comprising amino acids2-38 of SEQ ID NO: 69; (42) a targeting sequence comprising amino acids5-38 of SEQ ID NO: 69; (43) a targeting sequence comprising amino acids10-38 of SEQ ID NO: 69; (44) a targeting sequence comprising amino acids15-38 of SEQ ID NO: 69; (45) an exosporium protein comprising SEQ ID NO:72; (46) a targeting sequence comprising SEQ ID NO: 73; (47) anexosporium protein comprising an amino acid sequence having at least 95%identity with SEQ ID NO: 74; (48) a targeting sequence comprising aminoacids 1-42 of SEQ ID NO: 75; (49) a targeting sequence comprising aminoacids 27-42 of SEQ ID NO: 75; (50) a targeting sequence comprising SEQID NO: 75; (51) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 76; (52) a targetingsequence comprising amino acids 2-42 of SEQ ID NO: 75; (53) a targetingsequence comprising amino acids 5-42 of SEQ ID NO: 75; (54) a targetingsequence comprising amino acids 10-42 of SEQ ID NO: 75; (55) a targetingsequence comprising amino acids 15-42 of SEQ ID NO: 75; (56) a targetingsequence comprising amino acids 20-42 of SEQ ID NO: 75; (57) a targetingsequence comprising amino acids 25-42 of SEQ ID NO: 75; (58) a targetingsequence comprising amino acids 1-24 of SEQ ID NO: 77; (59) a targetingsequence comprising amino acids 9-24 of SEQ ID NO: 77; (60) a targetingsequence comprising SEQ ID NO: 77; (61) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 78;(62) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 77;(63) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 77;(64) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 80; (65) a targeting sequencecomprising amino acids 1-38 of SEQ ID NO: 81; (66) a targeting sequencecomprising amino acids 23-38 of SEQ ID NO: 81; (67) a targeting sequencecomprising SEQ ID NO: 81; (68) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO: 82; (69) atargeting sequence comprising amino acids 2-38 of SEQ ID NO: 81; (70) atargeting sequence comprising amino acids 5-38 of SEQ ID NO: 81; (71) atargeting sequence comprising amino acids 10-38 of SEQ ID NO: 81; (72) atargeting sequence comprising amino acids 15-38 of SEQ ID NO: 81; (73) atargeting sequence comprising amino acids 20-38 of SEQ ID NO: 81; (74) atargeting sequence comprising amino acids 1-34 of SEQ ID NO: 83; (75) atargeting sequence comprising SEQ ID NO: 83; (76) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 84; (77) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 86; (78) a targetingsequence comprising amino acids 1-28 of SEQ ID NO: 87; (79) a targetingsequence comprising amino acids 13-28 of SEQ ID NO: 87; (80) a targetingsequence comprising SEQ ID NO: 87; (81) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 88;(82) a targeting sequence comprising amino acids 2-28 of SEQ ID NO: 87;(83) a targeting sequence comprising amino acids 5-28 of SEQ ID NO: 87;(84) a targeting sequence comprising amino acids 10-28 of SEQ ID NO: 87;(85) a targeting sequence comprising amino acids 1-28 of SEQ ID NO: 89;(86) a targeting sequence comprising SEQ ID NO: 89; (87) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 90; (88) a targeting sequence comprising amino acids2-28 of SEQ ID NO: 89; (89) a targeting sequence comprising amino acids5-28 of SEQ ID NO: 89; (90) a targeting sequence comprising amino acids10-28 of SEQ ID NO: 89; (91) a targeting sequence comprising amino acids1-93 of SEQ ID NO: 91; (92) a targeting sequence comprising SEQ ID NO:91; (93) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 92; (94) a targeting sequencecomprising amino acids 2-93 of SEQ ID NO: 91; (95) a targeting sequencecomprising amino acids 10-93 of SEQ ID NO: 91; (96) a targeting sequencecomprising amino acids 20-93 of SEQ ID NO: 91; (97) a targeting sequencecomprising amino acids 30-93 of SEQ ID NO: 91; (98) a targeting sequencecomprising amino acids 40-93 of SEQ ID NO: 91; (99) a targeting sequencecomprising amino acids 50-93 of SEQ ID NO: 91; (100) a targetingsequence comprising amino acids 60-93 of SEQ ID NO: 91; (101) atargeting sequence comprising amino acids 1-130 of SEQ ID NO: 93; (102)a targeting sequence comprising SEQ ID NO: 93; (103) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 94; (104) a targeting sequence comprising amino acids2-130 of SEQ ID NO: 93; (105) a targeting sequence comprising aminoacids 10-130 of SEQ ID NO: 93; (106) a targeting sequence comprisingamino acids 20-130 of SEQ ID NO: 93; (107) a targeting sequencecomprising amino acids 30-130 of SEQ ID NO: 93; or (108) an exosporiumprotein comprising an amino acid sequence having at least 85% sequenceidentity with SEQ ID NO: 122.

For example, when the protein or peptide of interest is any protein orpeptide of interest, the fusion protein can comprise: (1) a targetingsequence comprising amino acids 2-30 of SEQ ID NO: 59; (2) a targetingsequence comprising amino acids 4-30 of SEQ ID NO: 59; (3) a targetingsequence comprising amino acids 6-30 of SEQ ID NO: 59; (4) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 61; (5) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 61; (6) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 61; (7) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 61; (8) a targetingsequence comprising amino acids 2-35 of SEQ ID NO: 63; (9) a targetingsequence comprising amino acids 5-35 of SEQ ID NO: 63; (10) a targetingsequence comprising amino acids 8-35 of SEQ ID NO: 63; (11) a targetingsequence comprising amino acids 10-35 of SEQ ID NO: 63; (12) a targetingsequence comprising amino acids 15-35 of SEQ ID NO: 63; (13) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 65; (14) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 65; (15) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 67; (16) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 67; (17) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 67; (18) a targetingsequence comprising amino acids 2-38 of SEQ ID NO: 69; (19) a targetingsequence comprising amino acids 5-38 of SEQ ID NO: 69; (20) a targetingsequence comprising amino acids 10-38 of SEQ ID NO: 69; (21) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 69; (22) a targetingsequence comprising amino acids 2-42 of SEQ ID NO: 75; (23) a targetingsequence comprising amino acids 5-42 of SEQ ID NO: 75; (24) a targetingsequence comprising amino acids 10-42 of SEQ ID NO: 75; (25) a targetingsequence comprising amino acids 15-42 of SEQ ID NO: 75; (26) a targetingsequence comprising amino acids 20-42 of SEQ ID NO: 75; (27) a targetingsequence comprising amino acids 25-42 of SEQ ID NO: 75; (28) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 77; (29) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 77; (30) a targetingsequence comprising amino acids 2-38 of SEQ ID NO: 81; (31) a targetingsequence comprising amino acids 5-38 of SEQ ID NO: 81; (32) a targetingsequence comprising amino acids 10-38 of SEQ ID NO: 81; (33) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 81; (34) a targetingsequence comprising amino acids 20-38 of SEQ ID NO: 81; (35) a targetingsequence comprising amino acids 2-28 of SEQ ID NO: 87; (36) a targetingsequence comprising amino acids 5-28 of SEQ ID NO: 87; (37) a targetingsequence comprising amino acids 10-28 of SEQ ID NO: 87; (38) a targetingsequence comprising amino acids 2-28 of SEQ ID NO: 89; (39) a targetingsequence comprising amino acids 5-28 of SEQ ID NO: 89; (40) a targetingsequence comprising amino acids 10-28 of SEQ ID NO: 89; (41) a targetingsequence comprising amino acids 2-93 of SEQ ID NO: 91; (42) a targetingsequence comprising amino acids 10-93 of SEQ ID NO: 91; (43) a targetingsequence comprising amino acids 20-93 of SEQ ID NO: 91; (44) a targetingsequence comprising amino acids 30-93 of SEQ ID NO: 91; (45) a targetingsequence comprising amino acids 40-93 of SEQ ID NO: 91; (46) a targetingsequence comprising amino acids 50-93 of SEQ ID NO: 91; (47) a targetingsequence comprising amino acids 60-93 of SEQ ID NO: 91; (48) a targetingsequence comprising amino acids 2-130 of SEQ ID NO: 93; (49) a targetingsequence comprising amino acids 10-130 of SEQ ID NO: 93; (50) atargeting sequence comprising amino acids 20-130 of SEQ ID NO: 93; or(51) a targeting sequence comprising amino acids 30-130 of SEQ ID NO:93.

Alternatively, when the protein or peptide of interest is any protein orpeptide of interest, the fusion protein can comprise: (1) a targetingsequence consisting of amino acids 20-33 of SEQ ID NO: 1; (2) atargeting sequence consisting of amino acids 21-33 of SEQ ID NO: 1; (3)a targeting sequence consisting of amino acids 23-31 of SEQ ID NO: 1;(4) a targeting sequence consisting of amino acids 1-15 of SEQ ID NO:96; (5) a targeting sequence consisting of amino acids 1-13 of SEQ IDNO: 96; (6) a targeting sequence consisting of amino acids 12-25 of SEQID NO: 3; (7) a targeting sequence consisting of amino acids 13-25 ofSEQ ID NO: 3; (8) a targeting sequence consisting of amino acids 15-23of SEQ ID NO: 3; (9) a targeting sequence consisting of amino acids 1-15of SEQ ID NO: 97; (10) a targeting sequence consisting of amino acids1-13 of SEQ ID NO: 98; (11) a targeting sequence consisting of aminoacids 23-36 of SEQ ID NO: 5; (12) a targeting sequence consisting ofamino acids 23-34 of SEQ ID NO: 5; (13) a targeting sequence consistingof amino acids 24-36 of SEQ ID NO: 5; (14) a targeting sequenceconsisting of amino acids 26-34 of SEQ ID NO: 5; (15) a targetingsequence consisting of amino acids 13-26 of SEQ ID NO: 7; (16) atargeting sequence consisting of amino acids 13-24 of SEQ ID NO: 7; (17)a targeting sequence consisting of amino acids 14-26 of SEQ ID NO: 7;(18) a targeting sequence consisting of amino acids 16-24 of SEQ ID NO:7; (19) a targeting sequence consisting of amino acids 9-22 of SEQ IDNO: 9; (20) a targeting sequence consisting of amino acids 9-20 of SEQID NO: 9; (21) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 9; (22) a targeting sequence consisting of amino acids 12-20of SEQ ID NO: 9; (23) a targeting sequence consisting of amino acids1-15 of SEQ ID NO: 105; (24) a targeting sequence consisting of aminoacids 1-13 of SEQ ID NO: 105; (25) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 11; (26) a targeting sequence consistingof amino acids 18-29 of SEQ ID NO: 11; (27) a targeting sequenceconsisting of amino acids 19-31 of SEQ ID NO: 11; (28) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 98; (29) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 98; (30)a targeting sequence consisting of amino acids 18-31 of SEQ ID NO: 13;(31) a targeting sequence consisting of amino acids 18-29 of SEQ ID NO:13; (32) a targeting sequence consisting of amino acids 19-31 of SEQ IDNO: 13; (33) a targeting sequence consisting of amino acids 21-29 of SEQID NO: 13; (34) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 99; (35) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 99; (36) a targeting sequence consisting of amino acids28-41 of SEQ ID NO: 15; (37) a targeting sequence consisting of aminoacids 28-39 of SEQ ID NO: 15; (38) a targeting sequence consisting ofamino acids 29-41 of SEQ ID NO: 15; (39) a targeting sequence consistingof amino acids 31-39 of SEQ ID NO: 15; (40) a targeting sequenceconsisting of amino acids 12-25 of SEQ ID NO: 17; (41) a targetingsequence consisting of amino acids 13-25 of SEQ ID NO: 17; (42) atargeting sequence consisting of amino acids 1-15 of SEQ ID NO: 100;(43) a targeting sequence consisting of amino acids 18-31 of SEQ ID NO:19; (44) a targeting sequence consisting of amino acids 18-29 of SEQ IDNO: 19; (45) a targeting sequence consisting of amino acids 19-31 of SEQID NO: 19; (46) a targeting sequence consisting of amino acids 21-29 ofSEQ ID NO: 19; (47) a targeting sequence consisting of amino acids 18-31of SEQ ID NO: 21; (48) a targeting sequence consisting of amino acids18-29 of SEQ ID NO: 21; (49) a targeting sequence consisting of aminoacids 19-31 of SEQ ID NO: 21; (50) a targeting sequence consisting ofamino acids 21-29 of SEQ ID NO: 21; (51) a targeting sequence consistingof amino acids 1-15 of SEQ ID NO: 101; (52) a targeting sequenceconsisting of amino acids 1-13 of SEQ ID NO: 101; (53) a targetingsequence consisting of amino acids 9-22 of SEQ ID NO: 23; (54) atargeting sequence consisting of amino acids 9-20 of SEQ ID NO: 23; (55)a targeting sequence consisting of amino acids 10-22 of SEQ ID NO: 23;(56) a targeting sequence consisting of amino acids 12-20 of SEQ ID NO:23; (57) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 102; (58) a targeting sequence consisting of amino acids 1-13 of SEQID NO: 102; (59) a targeting sequence consisting of amino acids 9-22 ofSEQ ID NO: 25; (60) a targeting sequence consisting of amino acids 9-20of SEQ ID NO: 25; (61) a targeting sequence consisting of amino acids10-22 of SEQ ID NO: 25; (62) a targeting sequence consisting of aminoacids 12-20 of SEQ ID NO: 25; (63) a targeting sequence consisting ofamino acids 1-15 of SEQ ID NO: 103; (64) a targeting sequence consistingof amino acids 1-13 of SEQ ID NO: 103; (65) a targeting sequenceconsisting of amino acids 15-28 of SEQ ID NO: 27; (66) a targetingsequence consisting of amino acids 15-26 of SEQ ID NO: 27; (67) atargeting sequence consisting of amino acids 16-28 of SEQ ID NO: 27;(68) a targeting sequence consisting of amino acids 18-26 of SEQ ID NO:27; (69) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 104; (70) a targeting sequence consisting of amino acids 1-13 of SEQID NO: 104; (71) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 33; (72) a targeting sequence consisting of amino acids 1-11of SEQ ID NO: 33; (73) a targeting sequence consisting of amino acids3-11 of SEQ ID NO: 33; (74) a targeting sequence consisting of aminoacids 1-14 of SEQ ID NO: 35; (75) a targeting sequence consisting ofamino acids 1-12 of SEQ ID NO: 35; (76) a targeting sequence consistingof amino acids 2-14 of SEQ ID NO: 35; (77) a targeting sequenceconsisting of amino acids 14-27 of SEQ ID NO: 43; (78) a targetingsequence consisting of amino acids 14-25 of SEQ ID NO: 43; (79) atargeting sequence consisting of amino acids 15-27 of SEQ ID NO: 43;(80) a targeting sequence consisting of amino acids 20-33 of SEQ ID NO:45; (81) a targeting sequence consisting of amino acids 20-31 of SEQ IDNO: 45; (82) a targeting sequence consisting of amino acids 21-33 of SEQID NO: 45; (83) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 106; (84) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 106; (85) a targeting sequence consisting of amino acids28-41 of SEQ ID NO: 47; (86) a targeting sequence consisting of aminoacids 28-39 of SEQ ID NO: 47; (87) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 53; (88) a targeting sequence consistingof amino acids 18-29 of SEQ ID NO: 53; (89) a targeting sequenceconsisting of amino acids 19-31 of SEQ ID NO: 53; (90) a targetingsequence comprising amino acids 18-31 of SEQ ID NO: 61; (91) a targetingsequence comprising amino acids 18-29 of SEQ ID NO: 61; (92) a targetingsequence comprising amino acids 19-31 of SEQ ID NO: 61; (93) a targetingsequence comprising amino acids 9-22 of SEQ ID NO: 65; (94) a targetingsequence comprising amino acids 9-20 of SEQ ID NO: 65; (95) a targetingsequence comprising amino acids 10-22 of SEQ ID NO: 65; (96) a targetingsequence comprising amino acids 1-15 of SEQ ID NO: 107; (97) a targetingsequence comprising amino acids 1-13 of SEQ ID NO: 107; (98) a targetingsequence comprising amino acids 12-25 of SEQ ID NO: 67; (99) a targetingsequence comprising amino acids 12-23 of SEQ ID NO: 67; (100) atargeting sequence comprising amino acids 13-25 of SEQ ID NO: 67; (101)a targeting sequence comprising amino acids 15-23 of SEQ ID NO: 67;(102) a targeting sequence comprising amino acids 23-36 of SEQ ID NO:69; (103) a targeting sequence comprising amino acids 23-34 of SEQ IDNO: 69; (104) a targeting sequence comprising amino acids 24-36 of SEQID NO: 69; (105) a targeting sequence comprising amino acids 26-34 ofSEQ ID NO: 69; (106) a targeting sequence comprising amino acids 27-40of SEQ ID NO: 75; (107) a targeting sequence comprising amino acids27-38 of SEQ ID NO: 75; (108) a targeting sequence comprising aminoacids 9-22 of SEQ ID NO: 77; (109) a targeting sequence comprising aminoacids 9-20 of SEQ ID NO: 77; (110) a targeting sequence comprising aminoacids 10-22 of SEQ ID NO: 77; (111) a targeting sequence comprisingamino acids 12-20 of SEQ ID NO: 77; (112) a targeting sequencecomprising amino acids 23-36 of SEQ ID NO: 81; (113) a targetingsequence comprising amino acids 23-34 of SEQ ID NO: 81; (114) atargeting sequence comprising amino acids 24-36 of SEQ ID NO: 81; (115)a targeting sequence comprising amino acids 26-34 of SEQ ID NO: 81;(116) a targeting sequence comprising amino acids 13-26 of SEQ ID NO:87; (117) a targeting sequence comprising amino acids 13-24 of SEQ IDNO: 87; or (118) a targeting sequence comprising amino acids 14-26 ofSEQ ID NO: 87. The targeting sequence can also consist of any of thesesequences.

The present invention relates to fusion proteins comprising at least oneprotein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment. The protein or peptide ofinterest can be an enzyme that catalyzes the production of nitric oxideor a nucleic acid binding protein or peptide. When the protein orpeptide of interest comprises an enzyme that catalyzes the production ofnitric oxide or a nucleic acid binding protein or peptide, the targetingsequence, exosporium protein, or exosporium protein fragment can be anytargeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of a recombinantBacillus cereus family member. For example, the targeting sequenceexosporium protein or exosporium protein fragment can be any of thetargeting sequences, exosporium proteins, or exosporium proteinfragments listed above in paragraphs [00166]-[00168] for use with anyprotein or peptide of interest or: (1) a targeting sequence comprisingan amino acid sequence having at least about 43% identity with aminoacids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids 25-35is at least about 54%; (2) a targeting sequence comprising amino acids1-35 of SEQ ID NO: 1; (3) a targeting sequence comprising amino acids20-35 of SEQ ID NO: 1; (4) a targeting sequence comprising SEQ ID NO: 1;(5) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 2; (6) a targeting sequencecomprising amino acids 2-35 of SEQ ID NO: 1; (7) a targeting sequencecomprising amino acids 5-35 of SEQ ID NO: 1; (8) a targeting sequencecomprising amino acids 8-35 of SEQ ID NO: 1; (9) a targeting sequencecomprising amino acids 10-35 of SEQ ID NO: 1; (10) a targeting sequencecomprising amino acids 15-35 of SEQ ID NO: 1; (11) a targeting sequencecomprising amino acids 1-27 of SEQ ID NO: 3; (12) a targeting sequencecomprising amino acids 12-27 of SEQ ID NO: 3; (13) a targeting sequencecomprising SEQ ID NO: 3; (14) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO: 4; (15) atargeting sequence comprising amino acids 2-27 of SEQ ID NO: 3; (16) atargeting sequence comprising amino acids 5-27 of SEQ ID NO: 3; (17) atargeting sequence comprising amino acids 8-27 of SEQ ID NO: 3; (18) atargeting sequence comprising amino acids 10-27 of SEQ ID NO: 3; (19) atargeting sequence comprising amino acids 1-38 of SEQ ID NO: 5; (20) atargeting sequence comprising amino acids 23-38 of SEQ ID NO: 5; (21) atargeting sequence comprising SEQ ID NO: 5; (22) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 6; (23) a targeting sequence comprising amino acids 2-38 of SEQID NO: 5; (24) a targeting sequence comprising amino acids 5-38 of SEQID NO: 5; (25) a targeting sequence comprising amino acids 8-38 of SEQID NO: 5; (26) a targeting sequence comprising amino acids 10-38 of SEQID NO: 5; (27) a targeting sequence comprising amino acids 15-38 of SEQID NO: 5; (28) a targeting sequence comprising amino acids 20-38 of SEQID NO: 5; (29) a targeting sequence comprising amino acids 1-28 of SEQID NO: 7; (30) a targeting sequence comprising amino acids 13-28 of SEQID NO: 7; (31) a targeting sequence comprising SEQ ID NO: 7; (32) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 8; (33) a targeting sequence comprising aminoacids 2-28 of SEQ ID NO: 7; (34) a targeting sequence comprising aminoacids 5-28 of SEQ ID NO: 7; (35) a targeting sequence comprising aminoacids 8-28 of SEQ ID NO: 7; (36) a targeting sequence comprising aminoacids 10-28 of SEQ ID NO: 7; (37) a targeting sequence comprising aminoacids 1-24 of SEQ ID NO: 9; (38) a targeting sequence comprising aminoacids 9-24 of SEQ ID NO: 9; (39) a targeting sequence comprising SEQ IDNO: 9; (40) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 10; (41) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 9; (42) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 9; (43) a targetingsequence comprising amino acids 8-24 of SEQ ID NO: 9; (44) a targetingsequence comprising amino acids 1-33 of SEQ ID NO:11; (45) a targetingsequence comprising amino acids 18-33 of SEQ ID NO: 11; (46) a targetingsequence comprising SEQ ID NO: 11; (47) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 12;(48) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 11;(49) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 11;(50) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 11;(51) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 11;(52) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 11;(53) a targeting sequence comprising amino acids 1-33 of SEQ ID NO: 13;(54) a targeting sequence comprising amino acids 18-33 of SEQ ID NO: 13;(55) a targeting sequence comprising SEQ ID NO:13; (56) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:14; (57) a targeting sequence comprising amino acids 2-33of SEQ ID NO: 13; (58) a targeting sequence comprising amino acids 5-33of SEQ ID NO: 13; (59) a targeting sequence comprising amino acids 8-33of SEQ ID NO: 13; (60) a targeting sequence comprising amino acids 10-33of SEQ ID NO: 13; (61) a targeting sequence comprising amino acids 15-33of SEQ ID NO: 13; (62) a targeting sequence comprising amino acids 1-43of SEQ ID NO: 15; (63) a targeting sequence comprising amino acids 28-43of SEQ ID NO: 15; (64) a targeting sequence comprising SEQ ID NO:15;(65) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:16; (66) a targeting sequencecomprising amino acids 2-43 of SEQ ID NO: 15; (67) a targeting sequencecomprising amino acids 5-43 of SEQ ID NO: 15; (68) a targeting sequencecomprising amino acids 8-43 of SEQ ID NO: 15; (69) a targeting sequencecomprising amino acids 10-43 of SEQ ID NO: 15; (70) a targeting sequencecomprising amino acids 15-43 of SEQ ID NO: 15; (71) a targeting sequencecomprising amino acids 20-43 of SEQ ID NO: 15; (72) a targeting sequencecomprising amino acids 25-43 of SEQ ID NO: 15; (73) a targeting sequencecomprising amino acids 1-27 of SEQ ID NO: 17; (74) a targeting sequencecomprising amino acids 12-27 of SEQ ID NO: 17; (75) a targeting sequencecomprising SEQ ID NO:17; (76) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:18; (77) atargeting sequence comprising amino acids 2-27 of SEQ ID NO: 17; (78) atargeting sequence comprising amino acids 5-27 of SEQ ID NO: 17; (79) atargeting sequence comprising amino acids 8-27 of SEQ ID NO: 17; (80) atargeting sequence comprising amino acids 10-27 of SEQ ID NO: 17; (81) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 19; (82) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 19; (83) atargeting sequence comprising SEQ ID NO:19; (84) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:20; (85) a targeting sequence comprising amino acids 2-33 of SEQID NO: 19; (86) a targeting sequence comprising amino acids 5-33 of SEQID NO: 19; (87) a targeting sequence comprising amino acids 8-33 of SEQID NO: 19; (88) a targeting sequence comprising amino acids 10-33 of SEQID NO: 19; (89) a targeting sequence comprising amino acids 15-33 of SEQID NO: 19; (90) a targeting sequence comprising amino acids 1-33 of SEQID NO: 21; (91) a targeting sequence comprising amino acids 18-33 of SEQID NO: 21; (92) a targeting sequence comprising SEQ ID NO:21; (93) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:22; (94) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 21; (95) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 21; (96) a targeting sequence comprising aminoacids 8-33 of SEQ ID NO: 21; (97) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 21; (98) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 21; (99) a targeting sequence comprising aminoacids 1-24 of SEQ ID NO: 23; (100) a targeting sequence comprising aminoacids 9-24 of SEQ ID NO: 23; (101) a targeting sequence comprising SEQID NO:23; (102) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:24; (103) a targetingsequence comprising amino acids 2-24 of SEQ ID NO:23; (104) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 23; (105) a targetingsequence comprising amino acids 8-24 of SEQ ID NO: 23; (106) a targetingsequence comprising amino acids 1-24 of SEQ ID NO: 25; (107) a targetingsequence comprising amino acids 9-24 of SEQ ID NO: 25; (108) a targetingsequence comprising SEQ ID NO:25; (109) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:26;(110) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 25;(111) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 25;(112) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 25;(113) a targeting sequence comprising amino acids 1-30 of SEQ ID NO: 27;(114) a targeting sequence comprising amino acids 15-30 of SEQ ID NO:27; (115) a targeting sequence comprising SEQ ID NO:27; (116) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:28; (117) a targeting sequence comprising aminoacids 2-30 of SEQ ID NO: 27; (118) a targeting sequence comprising aminoacids 5-30 of SEQ ID NO: 27; (119) a targeting sequence comprising aminoacids 8-30 of SEQ ID NO: 27; (120) a targeting sequence comprising aminoacids 10-30 of SEQ ID NO: 27; (121) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 29; (122) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 29; (123) a targeting sequencecomprising SEQ ID NO:29; (124) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:30; (125) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 29; (126) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 29; (127) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 29; (128) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 29; (129)a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 29;(130) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 31;(131) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 31;(132) a targeting sequence comprising SEQ ID NO:31; (133) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:32; (134) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 31; (135) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 31; (136) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 31; (137) a targeting sequence comprising amino acids1-15 of SEQ ID NO: 33; (138) a targeting sequence comprising SEQ IDNO:33; (139) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:34; (140) a targetingsequence comprising amino acids 1-16 of SEQ ID NO: 35; (141) a targetingsequence comprising SEQ ID NO:35; (142) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:36;(143) a targeting sequence comprising amino acids 1-29 of SEQ ID NO:43;(144) a targeting sequence comprising amino acids 14-29 of SEQ ID NO:43; (145) a targeting sequence comprising SEQ ID NO: 43; (146) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 44; (147) a targeting sequence comprising aminoacids 2-29 of SEQ ID NO: 43; (148) a targeting sequence comprising aminoacids 5-29 of SEQ ID NO: 43; (149) a targeting sequence comprising aminoacids 8-29 of SEQ ID NO: 43; (150) a targeting sequence comprising aminoacids 10-29 of SEQ ID NO: 43; (151) a targeting sequence comprisingamino acids 1-35 of SEQ ID NO: 45; (152) a targeting sequence comprisingamino acids 20-35 of SEQ ID NO: 45; (153) a targeting sequencecomprising SEQ ID NO: 45; (154) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 46;(155) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 45;(156) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 45;(157) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 45;(158) a targeting sequence comprising amino acids 10-35 of SEQ ID NO:45; (159) a targeting sequence comprising amino acids 15-35 of SEQ IDNO: 45; (160) a targeting sequence comprising amino acids 1-43 of SEQ IDNO: 47; (161) a targeting sequence comprising amino acids 28-43 of SEQID NO: 47; (162) a targeting sequence comprising SEQ ID NO: 47; (163) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 48; (164) a targeting sequence comprising aminoacids 2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising aminoacids 5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising aminoacids 8-43 of SEQ ID NO: 47; (167) a targeting sequence comprising aminoacids 10-43 of SEQ ID NO: 47; (168) a targeting sequence comprisingamino acids 15-43 of SEQ ID NO: 47; (169) a targeting sequencecomprising amino acids 20-43 of SEQ ID NO: 47; (170) a targetingsequence comprising amino acids 25-43 of SEQ ID NO: 47; (171) atargeting sequence comprising amino acids 1-32 of SEQ ID NO: 49; (172) atargeting sequence comprising amino acids 17-32 of SEQ ID NO: 49; (173)a targeting sequence comprising SEQ ID NO: 49; (174) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 50; (175) a targeting sequence comprising amino acids2-32 of SEQ ID NO: 49; (176) a targeting sequence comprising amino acids5-32 of SEQ ID NO: 49; (177) a targeting sequence comprising amino acids8-32 of SEQ ID NO: 49; (178) a targeting sequence comprising amino acids10-32 of SEQ ID NO: 49; (179) a targeting sequence comprising aminoacids 15-32 of SEQ ID NO: 49; (180) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 51; (181) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 51; (182) a targeting sequencecomprising SEQ ID NO: 51; (183) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 52;(184) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 51;(185) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 51;(186) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 51;(187) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:51; (188) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 51; (189) a targeting sequence comprising amino acids 1-33 of SEQ IDNO: 53; (190) a targeting sequence comprising amino acids 18-33 of SEQID NO: 53; (191) a targeting sequence comprising SEQ ID NO: 53; (192) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 54; (193) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 53; (194) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 53; (195) a targeting sequence comprising aminoacids 8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 53; (197) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 53; (198) a targeting sequencecomprising amino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequencecomprising amino acids 15-30 of SEQ ID NO: 55; (200) a targetingsequence comprising SEQ ID NO: 55; (201) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 56; (202) a targeting sequence comprising amino acids 2-30 of SEQID NO: 55; (203) a targeting sequence comprising amino acids 5-30 of SEQID NO: 55; (204) a targeting sequence comprising amino acids 8-30 of SEQID NO: 55; (205) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 55; (206) a targeting sequence comprising amino acids 1-130of SEQ ID NO: 57; (207) a targeting sequence comprising amino acids115-130 of SEQ ID NO: 57; (208) a targeting sequence comprising SEQ IDNO: 57; (209) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 58; (210) a targetingsequence comprising amino acids 2-130 of SEQ ID NO: 57; (211) atargeting sequence comprising amino acids 5-130 of SEQ ID NO: 57; (212)a targeting sequence comprising amino acids 10-130 of SEQ ID NO: 57;(213) a targeting sequence comprising amino acids 20-130 of SEQ ID NO:57; (214) a targeting sequence comprising amino acids 30-130 of SEQ IDNO: 57; (215) a targeting sequence comprising amino acids 40-130 of SEQID NO: 57; (216) a targeting sequence comprising amino acids 50-130 ofSEQ ID NO: 57; (217) a targeting sequence comprising amino acids 60-130of SEQ ID NO: 57; (218) a targeting sequence comprising amino acids70-130 of SEQ ID NO: 57; (219) a targeting sequence comprising aminoacids 80-130 of SEQ ID NO: 57; (220) a targeting sequence comprisingamino acids 90-130 of SEQ ID NO: 57; (221) a targeting sequencecomprising amino acids 100-130 of SEQ ID NO: 57; (222) a targetingsequence comprising amino acids 110-130 of SEQ ID NO: 57; (223) anexosporium protein fragment comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 95; (224) a targeting sequencecomprising SEQ ID NO: 96; (225) a targeting sequence comprising SEQ IDNO: 97; (226) a targeting sequence comprising SEQ ID NO: 98; (227) atargeting sequence comprising SEQ ID NO: 99; (228) a targeting sequencecomprising SEQ ID NO: 100; (229) a targeting sequence comprising SEQ IDNO: 101; (230) a targeting sequence comprising SEQ ID NO: 102; (231) atargeting sequence comprising SEQ ID NO: 103; (232) a targeting sequencecomprising SEQ ID NO: 104; (233) a targeting sequence comprising SEQ IDNO: 105; (234) a targeting sequence comprising SEQ ID NO: 106; (235) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 108; (236) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 109;(237) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 110; (238) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 111; (239) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 112; (240) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 113; (241) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 114;(242) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 115; (243) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 116; (244) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 117; (245) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 118; (246) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 119;(247) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 120; (248) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 121; (249) a targeting sequence comprising amino acids 22-31 ofSEQ ID NO: 1; (250) a targeting sequence comprising amino acids 22-33 ofSEQ ID NO: 1; (251) a targeting sequence comprising amino acids 20-31 ofSEQ ID NO: 1; (252) a targeting sequence comprising amino acids 14-23 ofSEQ ID NO: 3; (253) a targeting sequence comprising amino acids 14-25 ofSEQ ID NO: 3; or (254) a targeting sequence comprising amino acids 12-23of SEQ ID NO: 3.

For example, when the protein or peptide of interest comprises an enzymethat catalyzes the production of nitric oxide or a nucleic acid bindingprotein or peptide, the targeting sequence, exosporium protein, orexosporium protein fragment can be: (1) a targeting sequence comprisingamino acids 2-35 of SEQ ID NO: 1; (2) a targeting sequence comprisingamino acids 5-35 of SEQ ID NO: 1; (3) a targeting sequence comprisingamino acids 8-35 of SEQ ID NO: 1; (4) a targeting sequence comprisingamino acids 10-35 of SEQ ID NO: 1; (5) a targeting sequence comprisingamino acids 15-35 of SEQ ID NO: 1; (6) a targeting sequence comprisingamino acids 2-27 of SEQ ID NO: 3; (7) a targeting sequence comprisingamino acids 5-27 of SEQ ID NO: 3; (8) a targeting sequence comprisingamino acids 8-27 of SEQ ID NO: 3; (9) a targeting sequence comprisingamino acids 10-27 of SEQ ID NO: 3; (10) a targeting sequence comprisingamino acids 2-38 of SEQ ID NO: 5; (11) a targeting sequence comprisingamino acids 5-38 of SEQ ID NO: 5; (12) a targeting sequence comprisingamino acids 8-38 of SEQ ID NO: 5; (13) a targeting sequence comprisingamino acids 10-38 of SEQ ID NO: 5; (14) a targeting sequence comprisingamino acids 15-38 of SEQ ID NO: 5; (15) a targeting sequence comprisingamino acids 20-38 of SEQ ID NO: 5; (16) a targeting sequence comprisingamino acids 2-28 of SEQ ID NO: 7; (17) a targeting sequence comprisingamino acids 5-28 of SEQ ID NO: 7; (18) a targeting sequence comprisingamino acids 8-28 of SEQ ID NO: 7; (19) a targeting sequence comprisingamino acids 10-28 of SEQ ID NO: 7; (20) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 9; (21) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 9; (22) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 9; (23) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 11; (24) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 11; (25) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 11; (26) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 11; (27) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 11; (28) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 13; (29) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 13; (30) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 13; (31) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 13; (32) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 13; (33) a targeting sequence comprisingamino acids 2-43 of SEQ ID NO: 15; (34) a targeting sequence comprisingamino acids 5-43 of SEQ ID NO: 15; (35) a targeting sequence comprisingamino acids 8-43 of SEQ ID NO: 15; (36) a targeting sequence comprisingamino acids 10-43 of SEQ ID NO: 15; (37) a targeting sequence comprisingamino acids 15-43 of SEQ ID NO: 15; (38) a targeting sequence comprisingamino acids 20-43 of SEQ ID NO: 15; (39) a targeting sequence comprisingamino acids 25-43 of SEQ ID NO: 15; (40) a targeting sequence comprisingamino acids 2-27 of SEQ ID NO: 17; (41) a targeting sequence comprisingamino acids 5-27 of SEQ ID NO: 17; (42) a targeting sequence comprisingamino acids 8-27 of SEQ ID NO: 17; (43) a targeting sequence comprisingamino acids 10-27 of SEQ ID NO: 17; (44) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 19; (45) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 19; (46) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 19; (47) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 19; (48) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 19; (49) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 21; (50) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 21; (51) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 21; (52) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 21; (53) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 21; (54) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO:23; (55) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 23; (56) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 23; (57) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 25; (58) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 25; (59) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 25; (60) a targeting sequence comprisingamino acids 2-30 of SEQ ID NO: 27; (61) a targeting sequence comprisingamino acids 5-30 of SEQ ID NO: 27; (62) a targeting sequence comprisingamino acids 8-30 of SEQ ID NO: 27; (63) a targeting sequence comprisingamino acids 10-30 of SEQ ID NO: 27; (64) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 29; (65) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 29; (66) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 29; (67) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 29; (68) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 29; (69) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 31; (70) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 31; (71) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 31; (72) a targeting sequence comprisingamino acids 2-29 of SEQ ID NO: 43; (73) a targeting sequence comprisingamino acids 5-29 of SEQ ID NO: 43; (74) a targeting sequence comprisingamino acids 8-29 of SEQ ID NO: 43; (75) a targeting sequence comprisingamino acids 10-29 of SEQ ID NO: 43; (76) a targeting sequence comprisingamino acids 2-35 of SEQ ID NO: 45; (77) a targeting sequence comprisingamino acids 5-35 of SEQ ID NO: 45; (78) a targeting sequence comprisingamino acids 8-35 of SEQ ID NO: 45; (79) a targeting sequence comprisingamino acids 10-35 of SEQ ID NO: 45; (80) a targeting sequence comprisingamino acids 15-35 of SEQ ID NO: 45; (81) a targeting sequence comprisingamino acids 2-43 of SEQ ID NO: 47; (82) a targeting sequence comprisingamino acids 5-43 of SEQ ID NO: 47; (83) a targeting sequence comprisingamino acids 8-43 of SEQ ID NO: 47; (84) a targeting sequence comprisingamino acids 10-43 of SEQ ID NO: 47; (85) a targeting sequence comprisingamino acids 15-43 of SEQ ID NO: 47; (86) a targeting sequence comprisingamino acids 20-43 of SEQ ID NO: 47; (87) a targeting sequence comprisingamino acids 25-43 of SEQ ID NO: 47; (88) a targeting sequence comprisingamino acids 2-32 of SEQ ID NO: 49; (89) a targeting sequence comprisingamino acids 5-32 of SEQ ID NO: 49; (90) a targeting sequence comprisingamino acids 8-32 of SEQ ID NO: 49; (91) a targeting sequence comprisingamino acids 10-32 of SEQ ID NO: 49; (92) a targeting sequence comprisingamino acids 15-32 of SEQ ID NO: 49; (93) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 51; (94) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 51; (95) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 51; (96) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 51; (97) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 51; (98) a targeting sequence comprisingamino acids 2-33 of SEQ ID NO: 53; (99) a targeting sequence comprisingamino acids 5-33 of SEQ ID NO: 53; (100) a targeting sequence comprisingamino acids 8-33 of SEQ ID NO: 53; (101) a targeting sequence comprisingamino acids 10-33 of SEQ ID NO: 53; (102) a targeting sequencecomprising amino acids 15-33 of SEQ ID NO: 53; (103) a targetingsequence comprising amino acids 2-30 of SEQ ID NO: 55; (104) a targetingsequence comprising amino acids 5-30 of SEQ ID NO: 55; (105) a targetingsequence comprising amino acids 8-30 of SEQ ID NO: 55; (106) a targetingsequence comprising amino acids 10-30 of SEQ ID NO: 55; (107) atargeting sequence comprising amino acids 2-130 of SEQ ID NO: 57; (108)a targeting sequence comprising amino acids 5-130 of SEQ ID NO: 57;(109) a targeting sequence comprising amino acids 10-130 of SEQ ID NO:57; (110) a targeting sequence comprising amino acids 20-130 of SEQ IDNO: 57; (111) a targeting sequence comprising amino acids 30-130 of SEQID NO: 57; (112) a targeting sequence comprising amino acids 40-130 ofSEQ ID NO: 57; (113) a targeting sequence comprising amino acids 50-130of SEQ ID NO: 57; (114) a targeting sequence comprising amino acids60-130 of SEQ ID NO: 57; (115) a targeting sequence comprising aminoacids 70-130 of SEQ ID NO: 57; (116) a targeting sequence comprisingamino acids 80-130 of SEQ ID NO: 57; (117) a targeting sequencecomprising amino acids 90-130 of SEQ ID NO: 57; (118) a targetingsequence comprising amino acids 100-130 of SEQ ID NO: 57; or (119) atargeting sequence comprising amino acids 110-130 of SEQ ID NO: 57.

A fusion protein is provided which comprises an antigen or a remediationenzyme and a targeting sequence or exosporium protein. The targetingsequence or exosporium protein can comprise any of the targetingsequences or exosporium proteins listed above in paragraphs[00166]-[00168] for use with any protein or peptide of interest or: (1)a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 1; (2) atargeting sequence comprising amino acids 5-35 of SEQ ID NO: 1; (3) atargeting sequence comprising amino acids 8-35 of SEQ ID NO: 1; (4) atargeting sequence comprising amino acids 10-35 of SEQ ID NO: 1; (5) atargeting sequence comprising amino acids 15-35 of SEQ ID NO: 1; (6) atargeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; (7) atargeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; (8) atargeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; (9) atargeting sequence comprising amino acids 2-27 of SEQ ID NO: 3; (10) atargeting sequence comprising amino acids 5-27 of SEQ ID NO: 3; (11) atargeting sequence comprising amino acids 8-27 of SEQ ID NO: 3; (12) atargeting sequence comprising amino acids 10-27 of SEQ ID NO: 3; (13) atargeting sequence comprising amino acids 14-23 of SEQ ID NO: 3; (14) atargeting sequence comprising amino acids 14-25 of SEQ ID NO: 3; (15) atargeting sequence comprising amino acids 12-23 of SEQ ID NO: 3; (16) atargeting sequence comprising amino acids 2-38 of SEQ ID NO: 5; (17) atargeting sequence comprising amino acids 5-38 of SEQ ID NO: 5; (18) atargeting sequence comprising amino acids 8-38 of SEQ ID NO: 5; (19) atargeting sequence comprising amino acids 10-38 of SEQ ID NO: 5; (20) atargeting sequence comprising amino acids 15-38 of SEQ ID NO: 5; (21) atargeting sequence comprising amino acids 20-38 of SEQ ID NO: 5; (22) atargeting sequence comprising amino acids 2-28 of SEQ ID NO: 7; (23) atargeting sequence comprising amino acids 5-28 of SEQ ID NO: 7; (24) atargeting sequence comprising amino acids 8-28 of SEQ ID NO: 7; (25) atargeting sequence comprising amino acids 10-28 of SEQ ID NO: 7; (26) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 9; (27) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 9; (28) atargeting sequence comprising SEQ ID NO: 9; (29) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 10; (30) a targeting sequence comprising amino acids 2-24 of SEQID NO: 9; (31) a targeting sequence comprising amino acids 5-24 of SEQID NO: 9; (32) a targeting sequence comprising amino acids 8-24 of SEQID NO: 9; (33) a targeting sequence comprising amino acids 1-33 of SEQID NO:11; (34) a targeting sequence comprising amino acids 18-33 of SEQID NO: 11; (35) a targeting sequence comprising SEQ ID NO: 11; (36) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 12; (37) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 11; (38) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 11; (39) a targeting sequence comprising aminoacids 8-33 of SEQ ID NO: 11; (40) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 11; (41) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 11; (42) a targeting sequence comprising aminoacids 1-33 of SEQ ID NO: 13; (43) a targeting sequence comprising aminoacids 18-33 of SEQ ID NO: 13; (44) a targeting sequence comprising SEQID NO:13; (45) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:14; (46) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 13; (47) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 13; (48) a targetingsequence comprising amino acids 8-33 of SEQ ID NO: 13; (49) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 13; (50) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 13; (51) a targetingsequence comprising amino acids 1-43 of SEQ ID NO: 15; (52) a targetingsequence comprising amino acids 28-43 of SEQ ID NO: 15; (53) a targetingsequence comprising SEQ ID NO:15; (54) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:16;(55) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 15;(56) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 15;(57) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 15;(58) a targeting sequence comprising amino acids 10-43 of SEQ ID NO: 15;(59) a targeting sequence comprising amino acids 15-43 of SEQ ID NO: 15;(60) a targeting sequence comprising amino acids 20-43 of SEQ ID NO: 15;(61) a targeting sequence comprising amino acids 25-43 of SEQ ID NO: 15;(62) a targeting sequence comprising amino acids 1-27 of SEQ ID NO: 17;(63) a targeting sequence comprising amino acids 12-27 of SEQ ID NO: 17;(64) a targeting sequence comprising SEQ ID NO:17; (65) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:18; (66) a targeting sequence comprising amino acids 2-27of SEQ ID NO: 17; (67) a targeting sequence comprising amino acids 5-27of SEQ ID NO: 17; (68) a targeting sequence comprising amino acids 8-27of SEQ ID NO: 17; (69) a targeting sequence comprising amino acids 10-27of SEQ ID NO: 17; (70) a targeting sequence comprising amino acids 1-33of SEQ ID NO: 19; (71) a targeting sequence comprising amino acids 18-33of SEQ ID NO: 19; (72) a targeting sequence comprising SEQ ID NO:19;(73) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:20; (74) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 19; (75) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 19; (76) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 19; (77) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 19; (78) a targeting sequencecomprising amino acids 15-33 of SEQ ID NO: 19; (79) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 21; (80) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 21; (81) a targeting sequencecomprising SEQ ID NO:21; (82) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:22; (83) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 21; (84) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 21; (85) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 21; (86) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 21; (87) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 21; (88) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 23; (89) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 23; (90) atargeting sequence comprising SEQ ID NO:23; (91) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:24; (92) a targeting sequence comprising amino acids 2-24 of SEQID NO:23; (93) a targeting sequence comprising amino acids 5-24 of SEQID NO: 23; (94) a targeting sequence comprising amino acids 8-24 of SEQID NO: 23; (95) a targeting sequence comprising amino acids 1-24 of SEQID NO: 25; (96) a targeting sequence comprising amino acids 9-24 of SEQID NO: 25; (97) a targeting sequence comprising SEQ ID NO:25; (98) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:26; (99) a targeting sequence comprising aminoacids 2-24 of SEQ ID NO: 25; (100) a targeting sequence comprising aminoacids 5-24 of SEQ ID NO: 25; (101) a targeting sequence comprising aminoacids 8-24 of SEQ ID NO: 25; (102) a targeting sequence comprising aminoacids 1-30 of SEQ ID NO: 27; (103) a targeting sequence comprising aminoacids 15-30 of SEQ ID NO: 27; (104) a targeting sequence comprising SEQID NO:27; (105) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:28; (106) a targetingsequence comprising amino acids 2-30 of SEQ ID NO: 27; (107) a targetingsequence comprising amino acids 5-30 of SEQ ID NO: 27; (108) a targetingsequence comprising amino acids 8-30 of SEQ ID NO: 27; (109) a targetingsequence comprising amino acids 10-30 of SEQ ID NO: 27; (110) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 29; (111) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 29; (112)a targeting sequence comprising SEQ ID NO:29; (113) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:30; (114) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 29; (115) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 29; (116) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 29; (117) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 29; (118) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 29; (119) a targeting sequence comprisingamino acids 1-24 of SEQ ID NO: 31; (120) a targeting sequence comprisingamino acids 9-24 of SEQ ID NO: 31; (121) a targeting sequence comprisingSEQ ID NO:31; (122) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO:32; (123) atargeting sequence comprising amino acids 2-24 of SEQ ID NO: 31; (124) atargeting sequence comprising amino acids 5-24 of SEQ ID NO: 31; (125) atargeting sequence comprising amino acids 8-24 of SEQ ID NO: 31; (126) atargeting sequence comprising amino acids 1-15 of SEQ ID NO: 33; (127) atargeting sequence comprising SEQ ID NO:33; (128) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:34; (129) a targeting sequence comprising amino acids 1-16 of SEQID NO: 35; (130) a targeting sequence comprising SEQ ID NO:35; (131) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:36; (132) a targeting sequence comprising aminoacids 1-29 of SEQ ID NO:43; (133) a targeting sequence comprising aminoacids 14-29 of SEQ ID NO: 43; (134) a targeting sequence comprising SEQID NO: 43; (135) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 44; (136) a targetingsequence comprising amino acids 2-29 of SEQ ID NO: 43; (137) a targetingsequence comprising amino acids 5-29 of SEQ ID NO: 43; (138) a targetingsequence comprising amino acids 8-29 of SEQ ID NO: 43; (139) a targetingsequence comprising amino acids 10-29 of SEQ ID NO: 43; (140) atargeting sequence comprising amino acids 1-35 of SEQ ID NO: 45; (141) atargeting sequence comprising amino acids 20-35 of SEQ ID NO: 45; (142)a targeting sequence comprising SEQ ID NO: 45; (143) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 46; (144) a targeting sequence comprising amino acids2-35 of SEQ ID NO: 45; (145) a targeting sequence comprising amino acids5-35 of SEQ ID NO: 45; (146) a targeting sequence comprising amino acids8-35 of SEQ ID NO: 45; (147) a targeting sequence comprising amino acids10-35 of SEQ ID NO: 45; (148) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 45; (149) a targeting sequence comprisingamino acids 1-43 of SEQ ID NO: 47; (150) a targeting sequence comprisingamino acids 28-43 of SEQ ID NO: 47; (151) a targeting sequencecomprising SEQ ID NO: 47; (152) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 48;(153) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 47;(154) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 47;(155) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 47;(156) a targeting sequence comprising amino acids 10-43 of SEQ ID NO:47; (157) a targeting sequence comprising amino acids 15-43 of SEQ IDNO: 47; (158) a targeting sequence comprising amino acids 20-43 of SEQID NO: 47; (159) a targeting sequence comprising amino acids 25-43 ofSEQ ID NO: 47; (160) a targeting sequence comprising amino acids 1-32 ofSEQ ID NO: 49; (161) a targeting sequence comprising amino acids 17-32of SEQ ID NO: 49; (162) a targeting sequence comprising SEQ ID NO: 49;(163) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 50; (164) a targeting sequencecomprising amino acids 2-32 of SEQ ID NO: 49; (165) a targeting sequencecomprising amino acids 5-32 of SEQ ID NO: 49; (166) a targeting sequencecomprising amino acids 8-32 of SEQ ID NO: 49; (167) a targeting sequencecomprising amino acids 10-32 of SEQ ID NO: 49; (168) a targetingsequence comprising amino acids 15-32 of SEQ ID NO: 49; (169) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 51; (170) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 51; (171)a targeting sequence comprising SEQ ID NO: 51; (172) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 52; (173) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 51; (174) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 51; (175) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 51; (176) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 51; (177) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 51; (178) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 53; (179) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 53; (180) a targeting sequencecomprising SEQ ID NO: 53; (181) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 54;(182) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 53;(183) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 53;(184) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 53;(185) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:53; (186) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 53; (187) a targeting sequence comprising amino acids 1-30 of SEQ IDNO: 55; (188) a targeting sequence comprising amino acids 15-30 of SEQID NO: 55; (189) a targeting sequence comprising SEQ ID NO: 55; (190) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 56; (191) a targeting sequence comprising aminoacids 2-30 of SEQ ID NO: 55; (192) a targeting sequence comprising aminoacids 5-30 of SEQ ID NO: 55; (193) a targeting sequence comprising aminoacids 8-30 of SEQ ID NO: 55; (194) a targeting sequence comprising aminoacids 10-30 of SEQ ID NO: 55; (195) a targeting sequence comprisingamino acids 1-130 of SEQ ID NO: 57; (196) a targeting sequencecomprising amino acids 115-130 of SEQ ID NO: 57; (197) a targetingsequence comprising SEQ ID NO: 57; (198) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 58; (199) a targeting sequence comprising amino acids 2-130 ofSEQ ID NO: 57; (200) a targeting sequence comprising amino acids 5-130of SEQ ID NO: 57; (201) a targeting sequence comprising amino acids10-130 of SEQ ID NO: 57; (202) a targeting sequence comprising aminoacids 20-130 of SEQ ID NO: 57; (203) a targeting sequence comprisingamino acids 30-130 of SEQ ID NO: 57; (204) a targeting sequencecomprising amino acids 40-130 of SEQ ID NO: 57; (205) a targetingsequence comprising amino acids 50-130 of SEQ ID NO: 57; (206) atargeting sequence comprising amino acids 60-130 of SEQ ID NO: 57; (207)a targeting sequence comprising amino acids 70-130 of SEQ ID NO: 57;(208) a targeting sequence comprising amino acids 80-130 of SEQ ID NO:57; (209) a targeting sequence comprising amino acids 90-130 of SEQ IDNO: 57; (210) a targeting sequence comprising amino acids 100-130 of SEQID NO: 57; (211) a targeting sequence comprising amino acids 110-130 ofSEQ ID NO: 57; (212) a targeting sequence comprising SEQ ID NO: 97;(213) a targeting sequence comprising SEQ ID NO: 98; (214) a targetingsequence comprising SEQ ID NO: 99; (215) a targeting sequence comprisingSEQ ID NO: 100; (216) a targeting sequence comprising SEQ ID NO: 101;(217) a targeting sequence comprising SEQ ID NO: 102; (218) a targetingsequence comprising SEQ ID NO: 103; (219) a targeting sequencecomprising SEQ ID NO: 104; (220) a targeting sequence comprising SEQ IDNO: 105; (221) a targeting sequence comprising SEQ ID NO: 106; (222) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 108; (223) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 109;(224) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 110; (225) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 111; (226) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 112; (227) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 113; (228) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 114;(229) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 115; (230) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 116; (231) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 117; (232) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 118; (233) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 119;(234) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 120; or (235) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 121.

A fusion protein is provided which comprises an enzyme suitable forbreaking an emulsion or gel in a hydraulic fracturing fluid or anantibacterial protein or peptide and a targeting sequence, exosporiumprotein, or exosporium protein fragment. The targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences or exosporium proteins listed above inparagraphs [00166]-[00168] for use with any protein or peptide ofinterest or: (1) a targeting sequence comprising an amino acid sequencehaving at least about 43% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 54%;(2) a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1;(3) a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1;(4) a targeting sequence comprising SEQ ID NO: 1; (5) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 2; (6) a targeting sequence comprising amino acids 2-35of SEQ ID NO: 1; (7) a targeting sequence comprising amino acids 5-35 ofSEQ ID NO: 1; (8) a targeting sequence comprising amino acids 8-35 ofSEQ ID NO: 1; (9) a targeting sequence comprising amino acids 10-35 ofSEQ ID NO: 1; (10) a targeting sequence comprising amino acids 15-35 ofSEQ ID NO: 1; (11) a targeting sequence comprising amino acids 1-27 ofSEQ ID NO: 3; (12) a targeting sequence comprising amino acids 12-27 ofSEQ ID NO: 3; (13) a targeting sequence comprising SEQ ID NO: 3; (14) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 4; (15) a targeting sequence comprising aminoacids 2-27 of SEQ ID NO: 3; (16) a targeting sequence comprising aminoacids 5-27 of SEQ ID NO: 3; (17) a targeting sequence comprising aminoacids 8-27 of SEQ ID NO: 3; (18) a targeting sequence comprising aminoacids 10-27 of SEQ ID NO: 3; (19) a targeting sequence comprising aminoacids 1-38 of SEQ ID NO: 5; (20) a targeting sequence comprising aminoacids 23-38 of SEQ ID NO: 5; (21) a targeting sequence comprising SEQ IDNO: 5; (22) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 6; (23) a targetingsequence comprising amino acids 2-38 of SEQ ID NO: 5; (24) a targetingsequence comprising amino acids 5-38 of SEQ ID NO: 5; (25) a targetingsequence comprising amino acids 8-38 of SEQ ID NO: 5; (26) a targetingsequence comprising amino acids 10-38 of SEQ ID NO: 5; (27) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 5; (28) a targetingsequence comprising amino acids 20-38 of SEQ ID NO: 5; (29) a targetingsequence comprising amino acids 1-28 of SEQ ID NO: 7; (30) a targetingsequence comprising amino acids 13-28 of SEQ ID NO: 7; (31) a targetingsequence comprising SEQ ID NO: 7; (32) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 8;(33) a targeting sequence comprising amino acids 2-28 of SEQ ID NO: 7;(34) a targeting sequence comprising amino acids 5-28 of SEQ ID NO: 7;(35) a targeting sequence comprising amino acids 8-28 of SEQ ID NO: 7;(36) a targeting sequence comprising amino acids 10-28 of SEQ ID NO: 7;(37) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 9;(38) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 9;(39) a targeting sequence comprising SEQ ID NO: 9; (40) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 10; (41) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 9; (42) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 9; (43) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 9; (44) a targeting sequence comprising amino acids1-33 of SEQ ID NO:11; (45) a targeting sequence comprising amino acids18-33 of SEQ ID NO: 11; (46) a targeting sequence comprising SEQ ID NO:11; (47) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 12; (48) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 11; (49) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 11; (50) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 11; (51) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 11; (52) a targeting sequencecomprising amino acids 15-33 of SEQ ID NO: 11; (53) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 13; (54) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 13; (55) a targeting sequencecomprising SEQ ID NO:13; (56) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:14; (57) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 13; (58) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 13; (59) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 13; (60) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 13; (61) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 13; (62) atargeting sequence comprising amino acids 1-43 of SEQ ID NO: 15; (63) atargeting sequence comprising amino acids 28-43 of SEQ ID NO: 15; (64) atargeting sequence comprising SEQ ID NO:15; (65) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:16; (66) a targeting sequence comprising amino acids 2-43 of SEQID NO: 15; (67) a targeting sequence comprising amino acids 5-43 of SEQID NO: 15; (68) a targeting sequence comprising amino acids 8-43 of SEQID NO: 15; (69) a targeting sequence comprising amino acids 10-43 of SEQID NO: 15; (70) a targeting sequence comprising amino acids 15-43 of SEQID NO: 15; (71) a targeting sequence comprising amino acids 20-43 of SEQID NO: 15; (72) a targeting sequence comprising amino acids 25-43 of SEQID NO: 15; (73) a targeting sequence comprising amino acids 1-27 of SEQID NO: 17; (74) a targeting sequence comprising amino acids 12-27 of SEQID NO: 17; (75) a targeting sequence comprising SEQ ID NO:17; (76) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:18; (77) a targeting sequence comprising aminoacids 2-27 of SEQ ID NO: 17; (78) a targeting sequence comprising aminoacids 5-27 of SEQ ID NO: 17; (79) a targeting sequence comprising aminoacids 8-27 of SEQ ID NO: 17; (80) a targeting sequence comprising aminoacids 10-27 of SEQ ID NO: 17; (81) a targeting sequence comprising aminoacids 1-33 of SEQ ID NO: 19; (82) a targeting sequence comprising aminoacids 18-33 of SEQ ID NO: 19; (83) a targeting sequence comprising SEQID NO:19; (84) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 20; (85) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 19; (86) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 19; (87) a targetingsequence comprising amino acids 8-33 of SEQ ID NO: 19; (88) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 19; (89) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 19; (90) a targetingsequence comprising amino acids 1-33 of SEQ ID NO: 21; (91) a targetingsequence comprising amino acids 18-33 of SEQ ID NO: 21; (92) a targetingsequence comprising SEQ ID NO:21; (93) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:22;(94) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 21;(95) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 21;(96) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 21;(97) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 21;(98) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 21;(99) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 23;(100) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 23;(101) a targeting sequence comprising SEQ ID NO:23; (102) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 24; (103) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 23; (104) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 23; (105) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 23; (106) a targeting sequence comprising amino acids1-24 of SEQ ID NO: 25; (107) a targeting sequence comprising amino acids9-24 of SEQ ID NO: 25; (108) a targeting sequence comprising SEQ IDNO:25; (109) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:26; (110) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 25; (111) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 25; (112) a targetingsequence comprising amino acids 8-24 of SEQ ID NO: 25; (113) a targetingsequence comprising amino acids 1-30 of SEQ ID NO: 27; (114) a targetingsequence comprising amino acids 15-30 of SEQ ID NO: 27; (115) atargeting sequence comprising SEQ ID NO:27; (116) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:28; (117) a targeting sequence comprising amino acids 2-30 of SEQID NO: 27; (118) a targeting sequence comprising amino acids 5-30 of SEQID NO: 27; (119) a targeting sequence comprising amino acids 8-30 of SEQID NO: 27; (120) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 27; (121) a targeting sequence comprising amino acids 1-33 ofSEQ ID NO: 29; (122) a targeting sequence comprising amino acids 18-33of SEQ ID NO: 29; (123) a targeting sequence comprising SEQ ID NO:29;(124) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:30; (125) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 29; (126) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 29; (127) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 29; (128) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 29; (129) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 29; (130) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 31; (131) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 31; (132) atargeting sequence comprising SEQ ID NO:31; (133) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:32; (134) a targeting sequence comprising amino acids 2-24 of SEQID NO: 31; (135) a targeting sequence comprising amino acids 5-24 of SEQID NO: 31; (136) a targeting sequence comprising amino acids 8-24 of SEQID NO: 31; (137) a targeting sequence comprising amino acids 1-15 of SEQID NO: 33; (138) a targeting sequence comprising SEQ ID NO:33; (139) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:34; (140) a targeting sequence comprising aminoacids 1-16 of SEQ ID NO: 35; (141) a targeting sequence comprising SEQID NO:35; (142) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:36; (143) a targetingsequence comprising amino acids 1-29 of SEQ ID NO:43; (144) a targetingsequence comprising amino acids 14-29 of SEQ ID NO: 43; (145) atargeting sequence comprising SEQ ID NO: 43; (146) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 44; (147) a targeting sequence comprising amino acids 2-29 of SEQID NO: 43; (148) a targeting sequence comprising amino acids 5-29 of SEQID NO: 43; (149) a targeting sequence comprising amino acids 8-29 of SEQID NO: 43; (150) a targeting sequence comprising amino acids 10-29 ofSEQ ID NO: 43; (151) a targeting sequence comprising amino acids 1-35 ofSEQ ID NO: 45; (152) a targeting sequence comprising amino acids 20-35of SEQ ID NO: 45; (153) a targeting sequence comprising SEQ ID NO: 45;(154) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 46; (155) a targeting sequencecomprising amino acids 2-35 of SEQ ID NO: 45; (156) a targeting sequencecomprising amino acids 5-35 of SEQ ID NO: 45; (157) a targeting sequencecomprising amino acids 8-35 of SEQ ID NO: 45; (158) a targeting sequencecomprising amino acids 10-35 of SEQ ID NO: 45; (159) a targetingsequence comprising amino acids 15-35 of SEQ ID NO: 45; (160) atargeting sequence comprising amino acids 1-43 of SEQ ID NO: 47; (161) atargeting sequence comprising amino acids 28-43 of SEQ ID NO: 47; (162)a targeting sequence comprising SEQ ID NO: 47; (163) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 48; (164) a targeting sequence comprising amino acids2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising amino acids5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising amino acids8-43 of SEQ ID NO: 47; (167) a targeting sequence comprising amino acids10-43 of SEQ ID NO: 47; (168) a targeting sequence comprising aminoacids 15-43 of SEQ ID NO: 47; (169) a targeting sequence comprisingamino acids 20-43 of SEQ ID NO: 47; (170) a targeting sequencecomprising amino acids 25-43 of SEQ ID NO: 47; (171) a targetingsequence comprising amino acids 1-32 of SEQ ID NO: 49; (172) a targetingsequence comprising amino acids 17-32 of SEQ ID NO: 49; (173) atargeting sequence comprising SEQ ID NO: 49; (174) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 50; (175) a targeting sequence comprising amino acids 2-32 of SEQID NO: 49; (176) a targeting sequence comprising amino acids 5-32 of SEQID NO: 49; (177) a targeting sequence comprising amino acids 8-32 of SEQID NO: 49; (178) a targeting sequence comprising amino acids 10-32 ofSEQ ID NO: 49; (179) a targeting sequence comprising amino acids 15-32of SEQ ID NO: 49; (180) a targeting sequence comprising amino acids 1-33of SEQ ID NO: 51; (181) a targeting sequence comprising amino acids18-33 of SEQ ID NO: 51; (182) a targeting sequence comprising SEQ ID NO:51; (183) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 52; (184) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 51; (185) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 51; (186) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 51; (187) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 51; (188) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 51; (189) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 53; (190) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 53; (191)a targeting sequence comprising SEQ ID NO: 53; (192) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 54; (193) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 53; (194) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 53; (195) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 53; (197) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 53; (198) a targeting sequence comprisingamino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequence comprisingamino acids 15-30 of SEQ ID NO: 55; (200) a targeting sequencecomprising SEQ ID NO: 55; (201) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 56;(202) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 55;(203) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 55;(204) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 55;(205) a targeting sequence comprising amino acids 10-30 of SEQ ID NO:55; (206) a targeting sequence comprising amino acids 1-130 of SEQ IDNO: 57; (207) a targeting sequence comprising amino acids 115-130 of SEQID NO: 57; (208) a targeting sequence comprising SEQ ID NO: 57; (209) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 58; (210) a targeting sequence comprising aminoacids 2-130 of SEQ ID NO: 57; (211) a targeting sequence comprisingamino acids 5-130 of SEQ ID NO: 57; (212) a targeting sequencecomprising amino acids 10-130 of SEQ ID NO: 57; (213) a targetingsequence comprising amino acids 20-130 of SEQ ID NO: 57; (214) atargeting sequence comprising amino acids 30-130 of SEQ ID NO: 57; (215)a targeting sequence comprising amino acids 40-130 of SEQ ID NO: 57;(216) a targeting sequence comprising amino acids 50-130 of SEQ ID NO:57; (217) a targeting sequence comprising amino acids 60-130 of SEQ IDNO: 57; (218) a targeting sequence comprising amino acids 70-130 of SEQID NO: 57; (219) a targeting sequence comprising amino acids 80-130 ofSEQ ID NO: 57; (220) a targeting sequence comprising amino acids 90-130of SEQ ID NO: 57; (221) a targeting sequence comprising amino acids100-130 of SEQ ID NO: 57; (222) a targeting sequence comprising aminoacids 110-130 of SEQ ID NO: 57; (223) an exosporium protein fragmentcomprising an amino acid sequence having at least 85% identity with SEQID NO: 95; (224) a targeting sequence comprising SEQ ID NO: 96; (225) atargeting sequence comprising SEQ ID NO: 97; (226) a targeting sequencecomprising SEQ ID NO: 98; (227) a targeting sequence comprising SEQ IDNO: 99; (228) a targeting sequence comprising SEQ ID NO: 100; (229) atargeting sequence comprising SEQ ID NO: 101; (230) a targeting sequencecomprising SEQ ID NO: 102; (231) a targeting sequence comprising SEQ IDNO: 103; (232) a targeting sequence comprising SEQ ID NO: 104; (233) atargeting sequence comprising SEQ ID NO: 105; (234) a targeting sequencecomprising SEQ ID NO: 106; (235) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 108;(236) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 109; (237) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 110; (238) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 111; (239) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 112; (240) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 113;(241) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 114; (242) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 115; (243) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 116; (244) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 117; (245) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 118;(246) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 119; (247) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 120; (248) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 121; (249) atargeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; (250) atargeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; (251) atargeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; (252) atargeting sequence comprising amino acids 14-23 of SEQ ID NO: 3; (253) atargeting sequence comprising amino acids 14-25 of SEQ ID NO: 3; or(254) a targeting sequence comprising amino acids 12-23 of SEQ ID NO: 3.

When the protein or peptide of interest comprises an antigen, aremediation enzyme, an enzyme suitable for breaking an emulsion or gelin a hydraulic fracturing fluid or an antibacterial protein or peptide,preferably, the targeting sequence or exosporium protein comprises anyof the targeting sequences or exosporium proteins listed above inparagraph [00167] for use with any protein or peptide of interest or:(1) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 1;(2) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 1;(3) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 1;(4) a targeting sequence comprising amino acids 10-35 of SEQ ID NO: 1;(5) a targeting sequence comprising amino acids 15-35 of SEQ ID NO: 1;(6) a targeting sequence comprising amino acids 2-27 of SEQ ID NO: 3;(7) a targeting sequence comprising amino acids 5-27 of SEQ ID NO: 3;(8) a targeting sequence comprising amino acids 8-27 of SEQ ID NO: 3;(9) a targeting sequence comprising amino acids 10-27 of SEQ ID NO: 3;(10) a targeting sequence comprising amino acids 2-38 of SEQ ID NO: 5;(11) a targeting sequence comprising amino acids 5-38 of SEQ ID NO: 5;(12) a targeting sequence comprising amino acids 8-38 of SEQ ID NO: 5;(13) a targeting sequence comprising amino acids 10-38 of SEQ ID NO: 5;(14) a targeting sequence comprising amino acids 15-38 of SEQ ID NO: 5;(15) a targeting sequence comprising amino acids 20-38 of SEQ ID NO: 5;(16) a targeting sequence comprising amino acids 2-28 of SEQ ID NO: 7;(17) a targeting sequence comprising amino acids 5-28 of SEQ ID NO: 7;(18) a targeting sequence comprising amino acids 8-28 of SEQ ID NO: 7;(19) a targeting sequence comprising amino acids 10-28 of SEQ ID NO: 7;(20) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 9;(21) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 9;(22) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 9;(23) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 11;(24) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 11;(25) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 11;(26) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 11;(27) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 11;(28) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 13;(29) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 13;(30) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 13;(31) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 13;(32) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 13;(33) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 15;(34) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 15;(35) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 15;(36) a targeting sequence comprising amino acids 10-43 of SEQ ID NO: 15;(37) a targeting sequence comprising amino acids 15-43 of SEQ ID NO: 15;(38) a targeting sequence comprising amino acids 20-43 of SEQ ID NO: 15;(39) a targeting sequence comprising amino acids 25-43 of SEQ ID NO: 15;(40) a targeting sequence comprising amino acids 2-27 of SEQ ID NO: 17;(41) a targeting sequence comprising amino acids 5-27 of SEQ ID NO: 17;(42) a targeting sequence comprising amino acids 8-27 of SEQ ID NO: 17;(43) a targeting sequence comprising amino acids 10-27 of SEQ ID NO: 17;(44) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 19;(45) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 19;(46) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 19;(47) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 19;(48) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 19;(49) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 21;(50) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 21;(51) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 21;(52) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 21;(53) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 21;(54) a targeting sequence comprising amino acids 2-24 of SEQ ID NO:23;(55) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 23;(56) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 23;(57) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 25;(58) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 25;(59) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 25;(60) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 27;(61) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 27;(62) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 27;(63) a targeting sequence comprising amino acids 10-30 of SEQ ID NO: 27;(64) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 29;(65) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 29;(66) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 29;(67) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 29;(68) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 29;(69) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 31;(70) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 31;(71) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 31;(72) a targeting sequence comprising amino acids 2-29 of SEQ ID NO: 43;(73) a targeting sequence comprising amino acids 5-29 of SEQ ID NO: 43;(74) a targeting sequence comprising amino acids 8-29 of SEQ ID NO: 43;(75) a targeting sequence comprising amino acids 10-29 of SEQ ID NO: 43;(76) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 45;(77) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 45;(78) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 45;(79) a targeting sequence comprising amino acids 10-35 of SEQ ID NO: 45;(80) a targeting sequence comprising amino acids 15-35 of SEQ ID NO: 45;(81) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 47;(82) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 47;(83) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 47;(84) a targeting sequence comprising amino acids 10-43 of SEQ ID NO: 47;(85) a targeting sequence comprising amino acids 15-43 of SEQ ID NO: 47;(86) a targeting sequence comprising amino acids 20-43 of SEQ ID NO: 47;(87) a targeting sequence comprising amino acids 25-43 of SEQ ID NO: 47;(88) a targeting sequence comprising amino acids 2-32 of SEQ ID NO: 49;(89) a targeting sequence comprising amino acids 5-32 of SEQ ID NO: 49;(90) a targeting sequence comprising amino acids 8-32 of SEQ ID NO: 49;(91) a targeting sequence comprising amino acids 10-32 of SEQ ID NO: 49;(92) a targeting sequence comprising amino acids 15-32 of SEQ ID NO: 49;(93) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 51;(94) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 51;(95) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 51;(96) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 51;(97) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 51;(98) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 53;(99) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 53;(100) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 53;(101) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:53; (102) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 53; (103) a targeting sequence comprising amino acids 2-30 of SEQ IDNO: 55; (104) a targeting sequence comprising amino acids 5-30 of SEQ IDNO: 55; (105) a targeting sequence comprising amino acids 8-30 of SEQ IDNO: 55; (106) a targeting sequence comprising amino acids 10-30 of SEQID NO: 55; (107) a targeting sequence comprising amino acids 2-130 ofSEQ ID NO: 57; (108) a targeting sequence comprising amino acids 5-130of SEQ ID NO: 57; (109) a targeting sequence comprising amino acids10-130 of SEQ ID NO: 57; (110) a targeting sequence comprising aminoacids 20-130 of SEQ ID NO: 57; (111) a targeting sequence comprisingamino acids 30-130 of SEQ ID NO: 57; (112) a targeting sequencecomprising amino acids 40-130 of SEQ ID NO: 57; (113) a targetingsequence comprising amino acids 50-130 of SEQ ID NO: 57; (114) atargeting sequence comprising amino acids 60-130 of SEQ ID NO: 57; (115)a targeting sequence comprising amino acids 70-130 of SEQ ID NO: 57;(116) a targeting sequence comprising amino acids 80-130 of SEQ ID NO:57; (117) a targeting sequence comprising amino acids 90-130 of SEQ IDNO: 57; (118) a targeting sequence comprising amino acids 100-130 of SEQID NO: 57; (119) a targeting sequence comprising amino acids 110-130 ofSEQ ID NO: 57.

When the protein or peptide of interest comprises an antigen, aremediation enzyme, an enzyme suitable for breaking an emulsion or gelin a hydraulic fracturing fluid or an antibacterial protein or peptide,more preferably, the targeting sequence or exosporium protein comprisesany of the targeting sequences or exosporium proteins listed above inparagraph [00167] for use with any protein or peptide of interest or:(1) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 9;(2) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 9;(3) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 9;(4) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 11;(5) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 11;(6) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 11;(7) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 11;(8) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 11;(9) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 13;(10) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 13;(11) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 13;(12) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 13;(13) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 13;(14) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 15;(15) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 15;(16) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 15;(17) a targeting sequence comprising amino acids 10-43 of SEQ ID NO: 15;(18) a targeting sequence comprising amino acids 15-43 of SEQ ID NO: 15;(19) a targeting sequence comprising amino acids 20-43 of SEQ ID NO: 15;(20) a targeting sequence comprising amino acids 25-43 of SEQ ID NO: 15;(21) a targeting sequence comprising amino acids 2-27 of SEQ ID NO: 17;(22) a targeting sequence comprising amino acids 5-27 of SEQ ID NO: 17;(23) a targeting sequence comprising amino acids 8-27 of SEQ ID NO: 17;(24) a targeting sequence comprising amino acids 10-27 of SEQ ID NO: 17;(25) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 19;(26) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 19;(27) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 19;(28) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 19;(29) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 19;(30) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 21;(31) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 21;(32) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 21;(33) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 21;(34) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 21;(35) a targeting sequence comprising amino acids 2-24 of SEQ ID NO:23;(36) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 23;(37) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 23;(38) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 25;(39) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 25;(40) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 25;(41) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 27;(42) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 27;(43) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 27;(44) a targeting sequence comprising amino acids 10-30 of SEQ ID NO: 27;(45) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 29;(46) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 29;(47) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 29;(48) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 29;(49) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 29;(50) a targeting sequence comprising amino acids 2-24 of SEQ ID NO: 31;(51) a targeting sequence comprising amino acids 5-24 of SEQ ID NO: 31;(52) a targeting sequence comprising amino acids 8-24 of SEQ ID NO: 31;(53) a targeting sequence comprising amino acids 2-29 of SEQ ID NO: 43;(54) a targeting sequence comprising amino acids 5-29 of SEQ ID NO: 43;(55) a targeting sequence comprising amino acids 8-29 of SEQ ID NO: 43;(56) a targeting sequence comprising amino acids 10-29 of SEQ ID NO: 43;(57) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 45;(58) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 45;(59) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 45;(60) a targeting sequence comprising amino acids 10-35 of SEQ ID NO: 45;(61) a targeting sequence comprising amino acids 15-35 of SEQ ID NO: 45;(62) a targeting sequence comprising amino acids 2-43 of SEQ ID NO: 47;(63) a targeting sequence comprising amino acids 5-43 of SEQ ID NO: 47;(64) a targeting sequence comprising amino acids 8-43 of SEQ ID NO: 47;(65) a targeting sequence comprising amino acids 10-43 of SEQ ID NO: 47;(66) a targeting sequence comprising amino acids 15-43 of SEQ ID NO: 47;(67) a targeting sequence comprising amino acids 20-43 of SEQ ID NO: 47;(68) a targeting sequence comprising amino acids 25-43 of SEQ ID NO: 47;(69) a targeting sequence comprising amino acids 2-32 of SEQ ID NO: 49;(70) a targeting sequence comprising amino acids 5-32 of SEQ ID NO: 49;(71) a targeting sequence comprising amino acids 8-32 of SEQ ID NO: 49;(72) a targeting sequence comprising amino acids 10-32 of SEQ ID NO: 49;(73) a targeting sequence comprising amino acids 15-32 of SEQ ID NO: 49;(74) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 51;(75) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 51;(76) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 51;(77) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 51;(78) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 51;(79) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 53;(80) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 53;(81) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 53;(82) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 53;(83) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 53;(84) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 55;(85) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 55;(86) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 55;(87) a targeting sequence comprising amino acids 10-30 of SEQ ID NO: 55;(88) a targeting sequence comprising amino acids 2-130 of SEQ ID NO: 57;(89) a targeting sequence comprising amino acids 5-130 of SEQ ID NO: 57;(90) a targeting sequence comprising amino acids 10-130 of SEQ ID NO:57; (91) a targeting sequence comprising amino acids 20-130 of SEQ IDNO: 57; (92) a targeting sequence comprising amino acids 30-130 of SEQID NO: 57; (93) a targeting sequence comprising amino acids 40-130 ofSEQ ID NO: 57; (94) a targeting sequence comprising amino acids 50-130of SEQ ID NO: 57; (95) a targeting sequence comprising amino acids60-130 of SEQ ID NO: 57; (96) a targeting sequence comprising aminoacids 70-130 of SEQ ID NO: 57; (97) a targeting sequence comprisingamino acids 80-130 of SEQ ID NO: 57; (98) a targeting sequencecomprising amino acids 90-130 of SEQ ID NO: 57; (99) a targetingsequence comprising amino acids 100-130 of SEQ ID NO: 57; (100) atargeting sequence comprising amino acids 110-130 of SEQ ID NO: 57.

When the protein or peptide of interest comprises an antigen, aremediation enzyme, an enzyme suitable for breaking an emulsion or gelin a hydraulic fracturing fluid or an antibacterial protein or peptide,even more preferably, the targeting sequence or exosporium proteincomprises: (1) a targeting sequence comprising amino acids 5-24 of SEQID NO: 9; (2) a targeting sequence comprising amino acids 8-24 of SEQ IDNO: 9; (3) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 11; (4) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 11; (5) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 11; (6) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 11; (7) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 13; (8) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 13; (9) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 13; (10) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 13; (11) a targeting sequence comprising amino acids 5-43 of SEQ IDNO: 15; (12) a targeting sequence comprising amino acids 8-43 of SEQ IDNO: 15; (13) a targeting sequence comprising amino acids 10-43 of SEQ IDNO: 15; (14) a targeting sequence comprising amino acids 15-43 of SEQ IDNO: 15; (15) a targeting sequence comprising amino acids 20-43 of SEQ IDNO: 15; (16) a targeting sequence comprising amino acids 25-43 of SEQ IDNO: 15; (17) a targeting sequence comprising amino acids 5-27 of SEQ IDNO: 17; (18) a targeting sequence comprising amino acids 8-27 of SEQ IDNO: 17; (19) a targeting sequence comprising amino acids 10-27 of SEQ IDNO: 17; (20) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 19; (21) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 19; (22) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 19; (23) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 19; (24) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 21; (25) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 21; (26) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 21; (27) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 21; (28) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 23; (29) a targeting sequence comprising amino acids 8-24 of SEQ IDNO: 23; (30) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 25; (31) a targeting sequence comprising amino acids 8-24 of SEQ IDNO: 25; (32) a targeting sequence comprising amino acids 5-30 of SEQ IDNO: 27; (33) a targeting sequence comprising amino acids 8-30 of SEQ IDNO: 27; (34) a targeting sequence comprising amino acids 10-30 of SEQ IDNO: 27; (35) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 29; (36) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 29; (37) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 29; (38) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 29; (39) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 31; (40) a targeting sequence comprising amino acids 8-24 of SEQ IDNO: 31; (41) a targeting sequence comprising amino acids 5-29 of SEQ IDNO: 43; (42) a targeting sequence comprising amino acids 8-29 of SEQ IDNO: 43; (43) a targeting sequence comprising amino acids 10-29 of SEQ IDNO: 43; (44) a targeting sequence comprising amino acids 5-35 of SEQ IDNO: 45; (45) a targeting sequence comprising amino acids 8-35 of SEQ IDNO: 45; (46) a targeting sequence comprising amino acids 10-35 of SEQ IDNO: 45; (47) a targeting sequence comprising amino acids 15-35 of SEQ IDNO: 45; (48) a targeting sequence comprising amino acids 5-43 of SEQ IDNO: 47; (49) a targeting sequence comprising amino acids 8-43 of SEQ IDNO: 47; (50) a targeting sequence comprising amino acids 10-43 of SEQ IDNO: 47; (51) a targeting sequence comprising amino acids 15-43 of SEQ IDNO: 47; (52) a targeting sequence comprising amino acids 20-43 of SEQ IDNO: 47; (53) a targeting sequence comprising amino acids 25-43 of SEQ IDNO: 47; (54) a targeting sequence comprising amino acids 5-32 of SEQ IDNO: 49; (55) a targeting sequence comprising amino acids 8-32 of SEQ IDNO: 49; (56) a targeting sequence comprising amino acids 10-32 of SEQ IDNO: 49; (57) a targeting sequence comprising amino acids 15-32 of SEQ IDNO: 49; (58) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 51; (59) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 51; (60) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 51; (61) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 51; (62) a targeting sequence comprising amino acids 5-33 of SEQ IDNO: 53; (63) a targeting sequence comprising amino acids 8-33 of SEQ IDNO: 53; (64) a targeting sequence comprising amino acids 10-33 of SEQ IDNO: 53; (65) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 53; (66) a targeting sequence comprising amino acids 5-30 of SEQ IDNO: 55; (67) a targeting sequence comprising amino acids 8-30 of SEQ IDNO: 55; (68) a targeting sequence comprising amino acids 10-30 of SEQ IDNO: 55; (69) a targeting sequence comprising amino acids 5-130 of SEQ IDNO: 57; (70) a targeting sequence comprising amino acids 10-130 of SEQID NO: 57; (71) a targeting sequence comprising amino acids 20-130 ofSEQ ID NO: 57; (72) a targeting sequence comprising amino acids 30-130of SEQ ID NO: 57; (73) a targeting sequence comprising amino acids40-130 of SEQ ID NO: 57; (74) a targeting sequence comprising aminoacids 50-130 of SEQ ID NO: 57; (75) a targeting sequence comprisingamino acids 60-130 of SEQ ID NO: 57; (76) a targeting sequencecomprising amino acids 70-130 of SEQ ID NO: 57; (77) a targetingsequence comprising amino acids 80-130 of SEQ ID NO: 57; (78) atargeting sequence comprising amino acids 90-130 of SEQ ID NO: 57; (79)a targeting sequence comprising amino acids 100-130 of SEQ ID NO: 57;(80) a targeting sequence comprising amino acids 110-130 of SEQ ID NO:57; (81) a targeting sequence comprising amino acids 4-30 of SEQ ID NO:59; (82) a targeting sequence comprising amino acids 6-30 of SEQ ID NO:59; (83) a targeting sequence comprising amino acids 5-33 of SEQ ID NO:61; (84) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:61; (85) a targeting sequence comprising amino acids 15-33 of SEQ ID NO:61; (86) a targeting sequence comprising amino acids 5-35 of SEQ ID NO:63; (87) a targeting sequence comprising amino acids 8-35 of SEQ ID NO:63; (88) a targeting sequence comprising amino acids 10-35 of SEQ ID NO:63; (89) a targeting sequence comprising amino acids 15-35 of SEQ ID NO:63; (90) a targeting sequence comprising amino acids 5-24 of SEQ ID NO:65; (91) a targeting sequence comprising amino acids 5-27 of SEQ ID NO:67; (92) a targeting sequence comprising amino acids 10-27 of SEQ ID NO:67; (93) a targeting sequence comprising amino acids 5-38 of SEQ ID NO:69; (94) a targeting sequence comprising amino acids 10-38 of SEQ ID NO:69; (95) a targeting sequence comprising amino acids 15-38 of SEQ ID NO:69; (96) a targeting sequence comprising amino acids 5-42 of SEQ ID NO:75; (97) a targeting sequence comprising amino acids 10-42 of SEQ ID NO:75; (98) a targeting sequence comprising amino acids 15-42 of SEQ ID NO:75; (99) a targeting sequence comprising amino acids 20-42 of SEQ ID NO:75; (100) a targeting sequence comprising amino acids 25-42 of SEQ IDNO: 75; (101) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 77; (102) a targeting sequence comprising amino acids 5-38 of SEQ IDNO: 81; (103) a targeting sequence comprising amino acids 10-38 of SEQID NO: 81; (104) a targeting sequence comprising amino acids 15-38 ofSEQ ID NO: 81; (105) a targeting sequence comprising amino acids 20-38of SEQ ID NO: 81; (106) a targeting sequence comprising amino acids 5-28of SEQ ID NO: 87; (107) a targeting sequence comprising amino acids10-28 of SEQ ID NO: 87; (108) a targeting sequence comprising aminoacids 5-28 of SEQ ID NO: 89; (109) a targeting sequence comprising aminoacids 10-28 of SEQ ID NO: 89; (110) a targeting sequence comprisingamino acids 10-93 of SEQ ID NO: 91; (111) a targeting sequencecomprising amino acids 20-93 of SEQ ID NO: 91; (112) a targetingsequence comprising amino acids 30-93 of SEQ ID NO: 91; (113) atargeting sequence comprising amino acids 40-93 of SEQ ID NO: 91; (114)a targeting sequence comprising amino acids 50-93 of SEQ ID NO: 91;(115) a targeting sequence comprising amino acids 60-93 of SEQ ID NO:91; (116) a targeting sequence comprising amino acids 10-130 of SEQ IDNO: 93; (117) a targeting sequence comprising amino acids 20-130 of SEQID NO: 93; or (118) a targeting sequence comprising amino acids 30-130of SEQ ID NO: 93.

The protein or peptide of interest of the fusion protein described abovecan comprise an antigen.

The protein or peptide of interest of the fusion protein described abovecan comprise a remediation enzyme.

The protein or peptide of interest of the fusion protein described abovecan comprise an enzyme suitable for breaking an emulsion or gel in ahydraulic fracturing fluid.

The protein or peptide of interest of the fusion protein described abovecan comprise an antibacterial protein or peptide.

C. Recombinant Bacillus cereus Family Members that Express FusionProteins

The present invention further relates to recombinant Bacillus cereusfamily members that express a fusion protein. The fusion protein can beany of the fusion proteins described above in Section I.B.

II. Modulation of Fusion Protein Expression in Recombinant Bacilluscereus Family Members that Express a Fusion Protein by Co-Overexpressionof Modulator Proteins

Recombinant Bacillus cereus family members that express the fusionproteins described herein display the protein or peptide of interestportion of the fusion protein on the outside of their spores. It hasbeen found that overexpression of certain exosporium proteins (referredto herein as “modulator proteins”) in a recombinant Bacillus cereusfamily member that also expresses a fusion protein allows for modulation(i.e., increasing or decreasing) the expression level of the fusionprotein, thereby increasing or decreasing the amount of the protein orpeptide of interest that is displayed on the outside of the spore. Theability to the control the amount of the protein or peptide of interestthat is displayed on the outside of the spore is beneficial, since insome cases, it will be desirable to increase the amount of the proteinor peptide of interest that is displayed. For example, where the proteinof interest is an enzyme that degrades a plant nutrient source, it maybe desirable to increase the amount of the enzyme displayed on thespore, such that greater enzymatic activity and greater stimulation ofplant growth can be achieved upon introducing the spores into a plantgrowth medium or application of the spores to a plant or plant seed oran area surrounding a plant or a plant seed. In other instances, it willbe desirable to decrease the amount of the protein or peptide ofinterest that is displayed. For example, where the protein or peptide ofinterest comprises a plant immune system enhancer protein or peptide, itmay be desirable to decrease the amount of the protein or peptidedisplayed on the spore, since excess stimulation of a plant's immunesystem can lead to undesirable effects.

As is described further hereinbelow, the recombinant Bacillus cereusfamily members that express a modulator protein can be used in any ofthe various fields and methods described herein, and for any of the usesdescribed herein. For example, the recombinant Bacillus cereus familymembers that express a modulator protein can be used in methods forstimulating plant growth; methods for protecting a plant from apathogen; methods for enhancing stress resistance in plants; methods forimmobilizing recombinant Bacillus cereus family member spores on plants;methods for stimulating germination of a plant seed; methods fordelivering nucleic acids to a plant; methods for delivering nucleicacids to animals, insects, worms (e.g., nematodes), fungi, orprotozoans; methods for delivering enzymes to a plant; methods foraltering a property of a plant; methods for delivering proteins orpeptides to an animal; vaccines and methods of producing an immunogenicresponse in a subject; methods for reducing contaminants in anenvironment; methods for phytoremediation of contaminated soil; methodsof treating a hydraulic fracturing fluid to break an emulsion or gelwithin the fluid; methods of disinfecting a surface; and for uses suchas grease, oil, or fat treatment or degumming; leather hide processing;biofuel, biodiesel, or bioethanol formation; sugar processing orconversion; starch treatment; paper or linen processing; animal orfungal byproduct treatment or amino acid recovery; targeted digestion offacility wastes; feed or food additives; dietary supplements; animalnutrition; industrial cleaning; grain processing; cosmeticmanufacturing; odor control; food or beverage processing; brewingenhancement or additives; detergent additives; or textile or yarnprocessing.

For many applications of proteins (e.g., enzymes), there is a biologicalresponse curve wherein an optimal concentration of a protein or enzymeleads to the desired effect, and an excess of the protein or too smallof an amount of the protein leads to undesirable or diminished effects.One example of this biological curve is the demonstration that abiological drug, such as the protein drug insulin for diabetestreatment, requires an optimum dose in order to reduce blood sugarlevels in diabetic patients. Too little insulin leads to an insufficientresponse and maintenance of undesired elevated blood sugar levels andpotential hyperkalemia. Too great of a dose of insulin leads to lowblood sugar levels and potential hypokalemia and related morbidity.

Similar biological response curves exist for many of the proteins andpeptides of interest comprised within the fusion proteins describedherein. Thus, for the various fields of use and methods for therecombinant Bacillus cereus family members described herein, it may bedesirable to modulate the expression level of the protein or peptide ofinterest on the exosporium. By increasing or decreasing the expressionlevels of the protein or peptide of interest on the exosporium of therecombinant Bacillus cereus family member, expression levels can beoptimized to maintain the overall expression level of the protein orpeptide of interest at the most effective concentration.

For example, it would be desirable to modulate expression levels of thefusion protein in cases where the protein or peptide of interestcomprises a protein or peptide involved in direct signaling in plants,such as the flagellin peptide flg22, and the recombinant Bacillus cereusfamily member expressing the fusion protein is to be applied to a plantto provide a beneficial effect to the plant. Such modulation would bebeneficial to avoid a signaling response that is great enough that itwould lead to detrimental responses to the plant (e.g., too great of aresponse to flg22 can result in necrosis), or a signaling response thatis low enough that it would yield a poor or insufficient response to thepeptide.

A biological response curve would also be relevant for recombinantBacillus cereus family members expressing a fusion protein wherein theprotein or peptide of interest comprises an antigen. In such cases, itwould be desirable to modulate the expression level of the fusionprotein comprising the antigen to achieve an optimal range forgenerating a proper immune response in an animal. Too large of a dosecould lead to injection site edema and unwanted inflammation, whereastoo small of a dose could lead to insufficient vaccination or immuneresponse.

Modulation of the expression level of a fusion protein on the exosporiumof a recombinant Bacillus cereus family member also provides benefits,for example, when the recombinant Bacillus cereus family member is usedfor breaking an emulsion or gel in a hydraulic fracturing fluid.Polysaccharide gels are frequently used in the hydraulic fracturingprocessing gels. These gels require breaking. When the gel solution isready to break, the operator will desire that the break, which is anenzymatic reaction, happen at a particular optimized rate. Breaking thegel too quickly can lead to undesired side effects such as pooling ofundigested gel fragments. On the other hand, breaking the gel too slowlyleads to long wait times and increased expense. Using the techniquesdescribed hereinbelow, the enzyme levels on the exosporium of arecombinant Bacillus cereus family member expressing a fusion proteincomprising an enzyme suitable for breaking an emulsion or gel in ahydraulic fracturing fluid can be modulated to ensure that an optimizedlevel of enzyme is present for breaking gels, leading to preferredresults when used in the field.

A recombinant Bacillus cereus family member is provided that expresses:(i) a fusion protein comprising at least one protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member; and (ii) a modulatorprotein, wherein the expression of the modulator protein is increased ascompared to expression of the modulator protein in a wild-type Bacilluscereus family member under the same conditions. The modulator protein,when co-expressed with the fusion protein in the recombinant Bacilluscereus family member, results in increased or decreased expression ofthe fusion protein as compared to the expression level of the fusionprotein in a recombinant Bacillus cereus family member that does notexpress the modulator protein at an increased level under the sameconditions as compared to the expression of the modulator protein in awild-type Bacillus cereus family member.

The modulator protein can comprise an ExsY protein, an ExsFA/BxpBprotein, a CotY protein, a CotO protein, an ExsFB protein, an InhA1protein, an InhA2 protein, an ExsJ protein, an ExsH protein, a YjcAprotein, a YjcB protein, a BclC protein, an AcpC protein, an InhA3protein, an alanine racemase 1, an alanine racemase 2, a BclA protein, aBclB protein, a BxpA protein, a BclE protein, a BetA/BAS3290 protein, aCotE protein, an ExsA protein, an ExsK protein, an ExsB protein, a YabGprotein, a Tgl protein, a SODA1 protein, a SODA2 protein, a variant ofany thereof, or a combination of any thereof.

For example, the modulator protein, when co-expressed in the recombinantBacillus cereus family member with the fusion protein, results inincreased expression of the fusion protein as compared to the expressionlevel of the fusion protein in a recombinant Bacillus cereus familymember that does not express the modulator protein at an increased levelunder the same conditions as compared to the expression of the modulatorprotein in a wild-type Bacillus cereus family member. Where themodulator protein, when co-expressed in the recombinant Bacillus cereusfamily member with the fusion protein, results in such increasedexpression of the fusion protein, the modulator protein can comprise aBclB protein, a CotE protein, a BxpB protein, a CotO protein, a BclAprotein, a variant of any thereof, or a combination of any thereof

Alternatively, the modulator protein, when co-expressed in therecombinant Bacillus cereus family member with the fusion protein,results in decreased expression of the fusion protein as compared to theexpression level of the fusion protein in a recombinant Bacillus cereusfamily member that does not express the modulator protein at anincreased level under the same conditions as compared to the expressionof the modulator protein in a wild-type Bacillus cereus family member.Where the modulator protein, when co-expressed in the recombinantBacillus cereus family member with the fusion protein, results in suchdecreased expression of the fusion protein, the modulator protein cancomprise a BclC protein, an ApcC protein, a YjcB protein, a variant ofany thereof, or a combination of any thereof.

For example, the modulator protein can comprise a CotO protein, a BclBprotein, an ExsFA/BxpB protein, a YjcB protein, a variant of anythereof, or a combination of any thereof.

For ease of reference, descriptions of the modulator proteins and theirSEQ ID NOs. are listed in Table 2 below.

TABLE 2 Amino Acid Sequences for Modulator Proteins Modulator ProteinSEQ ID NO. ExsY, Bacillus thuringiensis 123 ExsFA/BxpB, Bacillusthuringiensis 124 CotY, Bacillus cereus 125 CotO, Bacillus anthracis 126ExsFB, Variant 1, Bacillus cereus 127 ExsFB, Variant 2, Bacillus cereus128 InhA1, Bacillus cereus 129 InhA3, Bacillus mycoides 130 ExsJ,Bacillus cereus ATCC 10876 131 ExsH, Bacillus cereus 132 YjcA, Bacilluscereus 133 YjcB, Variant 1, Bacillus cereus 134 YjcB, Variant 2,Bacillus cereus 135 BclC, Bacillus anthracis 136 AcpC, Bacillus cereus137 InhA2, Bacillus cereus 138 Alanine racemase 1, Bacillus cereus 139Alanine racemase 2, Bacillus cereus 140 BclA, variant 1, Bacillusanthracis Sterne 141 BclA, variant 2, Bacillus anthracis 142 BclB,variant 1, Bacillus anthracis Sterne 143 BclB, variant 2, Bacillusanthracis Sterne 144 BxpA, Bacillus anthracis 145 BAS4623/BclE, variant1, Bacillus anthracis Sterne 146 BAS4623/BclE, variant 2, Bacillusanthracis Sterne 147 BetA/BAS3290, Bacillus anthracis 148 CotE, Bacilluscereus group 149 ExsA, Bacillus cereus 150 ExsK, Bacillus cereus AH187151 ExsB, Bacillus cereus 152 YabG, Bacillus cereus 153 Tgl, Bacilluscereus group 154 SODA1, Bacillus cereus 155 SODA2, Bacillusthuringiensis 156

Many of the modulator proteins have homologs, paralogs, or geneticrearrangements. Thus, many proteins that have at least 70% homology toany of the modulator sequences listed above in Table 2 will retain theability to act as modulator proteins when overexpressed in a recombinantBacillus cereus family member that also expresses any of the fusionproteins described herein. In addition, many of the modulator proteins(e.g., BclA, BclB, and BclE) have internal repeat regions that candiffer significantly between strains. Additions or reductions in thenumber of repeats in the internal repeat region would affect overallsequence homology, but so long as the homology of amino- andcarboxy-terminal regions of the protein retain at least 75% sequenceidentity to any of the amino acid sequences of the modulator proteinslisted in the table above, such homologs would be expected to retain theability to act as modulator proteins.

Thus, for example, the modulator protein can comprise an amino acidsequence having at least 70% sequence identity with any of SEQ ID NOs:123-156.

The modulator protein can comprise an amino acid sequence having atleast 75% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having atleast 85% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having atleast 90% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having atleast 95% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having atleast 98% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having atleast 99% sequence identity with any of SEQ ID NOs: 123-156.

The modulator protein can comprise an amino acid sequence having 100%sequence identity with any of SEQ ID NOs: 123-156.

For example, the modulator protein can comprise SEQ ID NO: 124, 126,134, 135, 143, or 144.

The recombinant Bacillus cereus family members that express a modulatorprotein can comprise a vector encoding the modulator protein. Forexample, the vector can comprise a multicopy plasmid. Multicopy plasmidsallow for high expression levels of the modulator protein.

III. Promoters for Expression of Fusion Proteins and/or ModulatorProteins in Recombinant Bacillus cereus Family Members

When the fusion protein comprises a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of a Bacillus cereus family member, the DNA encodingthe fusion protein is suitably under the control of a sporulationpromoter which will cause expression of the fusion protein on theexosporium of a B. cereus family member endospore (e.g., a native bclApromoter from a B. cereus family member).

Thus, any of the fusion proteins described above in Section 1.B can beexpressed in the recombinant Bacillus cereus family member under thecontrol of a sporulation promoter that is native to the targetingsequence, exosporium protein, or exosporium protein fragment of thefusion protein, or a portion of such a promoter.

Similarly, any of the modulator proteins described above in Section IIcan be expressed under the control of its native promoter or a portionthereof.

Any of the fusion proteins or modulator proteins can be expressed underthe control of a high-expression sporulation promoter.

The high-expression sporulation promoter comprises a sigma-Ksporulation-specific polymerase promoter sequence.

For ease of reference, exemplary nucleotide sequences for promoters thatcan be used to express any of the fusion proteins or any of themodulator proteins in a recombinant Bacillus cereus family member areprovided in Table 3 below, together with their SEQ ID NOs. Table 3 alsoprovides exemplary minimal promoter sequences for many of the promoters.In Table 3, sigma-K sporulation-specific polymerase promoter sequencesin the promoters are indicated by bold and underlined text. Several ofthe sequences have multiple sigma K sequences that overlap with oneanother. The overlaps are indicated by double underlining in the table.The promoter sequences are immediately upstream of the start codon foreach of the indicated genes. In other words, in the sequences shown inTable 3 below, the last nucleotide of the promoter sequence immediatelyprecedes the first nucleotide of the start codon for the coding regionof the gene encoding the indicated protein.

TABLE 3Promoter Sequences for Expression of Fusion Proteins and ModulatorProteins in Recombinant Bacillus cereus family members Promoter(SEQ ID NO) Promoter Sequence ExsY promoterTTTCTTAATCCTTTACCCTTTACTTTTGTAAAAGTTGATACACTT (B. cereus F837/76)CCATCCGGCTCTGTAATTTCTAATTCATCAATAAATGGTCTTCG (SEQ ID NO: 157)CAAAAAGCCTGTAATTTTATCATAAACAATTAAACGAGTGAGCCTAAAAGCAGCTAACGCGAAAATAAAAAATAAAAGCCAGCTTGTAAACAGCATAATTCCACCTTCCCTTATCCTCTTTCGCCTATTTAAAAAAAGGTCTTGAGATTGTGACCAAATCTCCTCAACTCC A ATATCTTATTAATGTAAATACAAACAAGAAGATAAGGA ExsY minimal promoter ACCAAATCTCCTCAACTCCAATATCTTA TTAATGTAAATACAA (B. cereus F837/76) ACAAGAAGATAAGGA(SEQ ID NO: 158) ExsFA/BxpB promoterACCACCTACCGACGATCCAATCTGTACATTCCTAGCTGTACCA (B. anthracis Sterne)AATGCAAGATTAATATCGACTAACACTTGTCTTACTGTTGATTT (SEQ ID NO: 159)AAGTTGCTTCTGTGCGATTCAATGCTTGCGTGATGTTACGATTT AAAACTAAATAATGAGCTAAGCATGGATTG GGTGGCAGAATT ATCTGCCACCCAATCCATGCTTAACGAGTATTATTATGTAAATTTCTTAAAATTGGGAACTTGTCTAGAACATAGAACCTGTCCTTTT CATTAACTGAAAGTAGAAACAGATAAAGGAGTGAAAAAC ExsFA/BxpB minimal ACATAGAACCTGTCCTTTTCATTAACTG AAAGTAGAAACAGAT promoter (B. anthracis AAAGGAGTGAAAAAC Sterne)(SEQ ID NO: 160) CotY/CotZ promoter TAGAAGAAGAACGCCGACTACTTTATGTCGCAATTACACGGGC (B. anthracis Sterne)GAAAGAAGAACTTTACATTTCCTCTCCGCAATTTTTTAGAGGA (SEQ ID NO: 161)AAAAAATTAGATATATCTCGTTTTTTATACACTGTGCGAAAAGATTTACCTGAAAAGACATCCACTAAATAAGGATGTCTTTTTTTATATTGTATTATGTACATCCCTACTATATAAATTCCCTGCTTTTATCGTAAGAATTAACGTAATATCAACCATATCCCGTT CATATTGT AGTAGTGTATGTCAGAACTCACGAGAAGGAGTGAACATA CotY/CotZ minimalTCAACCATATCCCGTT CATATTGTA GTAGTGTATGTCAGAACT promoter CACGAGAAGGAGTGAACATA (B. anthracis Sterne) (SEQ ID NO: 162)CotO promoter  TAACTCAATCTTAAGAGAAATTGAGGAGCGCGCACCACTTCGT (B. cereus)CGTACAACAACGCAAGAAGAAGTTGGGGATACAGCAGTATTCT (SEQ ID NO: 163)TATTCAGTGATTTAGCACGCGGCGTAACAGGAGAAAACATTCA CGTTGATTCAGGGTAT CATATCTTAGGATA AATATAATA TTAA TTTTAAAGGACAATCTCTACATGTTGAGATTGTCCTTTTTATTTGTTCTTAGAAAGAACGATTTTTAACGAAAGTTCTTACCACGTTATGAATATAAGTATAATAGTACACGATTTATTCAGCTACGT CotO minimal promoter ACGTTGATTCAGGGTAT CATATCTTA GGATA AATATAATA TTA (B. cereus)ATTTTAAAGGACAATCTCTACATGTTGAGATTGTCCTTTTTATT (SEQ ID NO: 164)TGTTCTTAGAAAGAACGATTTTTAACGAAAGTTCTTACCACGTTATGAATATAAGTATAATAGTACACGATTTATTCAGCTACGT ExsFB promoter CATAAAAATCTACTTTTCTTGTCAAAGAGTATGCTTATATGCGT (B. cereus F837/76)GCTCTTTTTATTTGGTTTTCTTTCATTTCTAAATAACATTTTCAA (SEQ ID NO: 165)CTCTATTCATACTATTCTTTCAACTTTAGGTTACAAACTATTTCTGTAAGCGTAGTGTTTCTTTTGTACTATAGGCAGTTAGTTTTATCCATAACAGTACACCTCTGCACTATTCACTATAAATTTT CATATA TT ATATTGTGCTTGTCCAAAACATGTGGTTATTACTCACGCGAT CTAAATGAAAGAAAGGAGTGAAAATExsFB minimal promoter  ACTATTCACTATAAATTTT CATATATTA TATTGTGCTTGTCCAA(B. cereus F837/76) AACATGTGGTTATTACTCACGCGATCTAAATGAAAGAAAGGAG(SEQ ID NO: 166) TGAAAAT InhA1 promoter (B.AATACATGATAATGAAATCCGATTTTGTGTTTTATATAGTGAAT thuringiensis serovarTATCAAATATTGTGTAGATGAAACAAAGATAAAATCCCCATTA kurstaki str. HD-1)AACTCCCTCTATGGAAATTATAAATTGTTCGATAAAAACTTTCA (SEQ ID NO: 167)ATATTTTCAGAAAACATTGTTGAATTGTGATATATTCGTATGCTAACTATGAAATTTTTACAAATATATTAAAAACATTA CATAATA TGACTAAATATTGAAAAAATATTGAATTTTTAATAAAATTTAA TTTGTAATA CATATTATTTATTAGGGGAGGAAATAAGGG InhA1 minimal promoter  AAAATTTAATTTGTAATACATATTATT TATTAGGGGAGGAAAT (B. thuringiensis serovar AAGGGkurstaki str. HD-1) (SEQ ID NO: 168) InhA2 promoter AATTGTGCATATTGTCTTTTAAATTTTCTATCTAAGTTATTTAAT (B. mycoidesATATAATAAATAACTCTTTTTTGTGAGTTTTTTTGATACGAGGT strain 219298)AAATAATCAGTACAGGGTCTGACCAGAGGACTGGAGGGCATG (SEQ ID NO: 169)ATTCTATAAGGGAATATTTACTATTCCATGATTATAGAACTATGTCTTTTTTATTGTATATAGAAGGGGGGATAGGTC TATATTATA GAACTTATATATATTGTGCATTCCATATTATC AATTATCTAAAT TTTAAGTCTTGTTACAATTAATAAGGGAGGAAATAGTAInhA2 minimal promoter  ACTTATATATATTGTGCATTC CATATTATC AATTATCTAAATTT(B. mycoides strain  TAAGTCTTGTTACAATTAATAAGGGAGGAAATAGTA 219298) (SEQ ID NO: 170) ExsJ promoter (B.AATGACGTTTTCAAGTTTGATTATCATTCATGTTTCCTATTTTAA thuringiensis serovarGAGAAACATATAACTCAACTACTTTTTTCAATGG CATCTTTTA kurstaki)TAGTACTTAGAATAGGAAAACACTCAACTATAAGAAAAGTAA (SEQ ID NO: 171) GGAGGAAATAAExsJ minimal promoter  ACTACTTTTTTCAATGG CATCTTTTA TAGTACTTAGAATAGGA(B. thuringiensis  AAACACTCAACTATAAGAAAAGTAAGGAGGAAATAAserovar kurstaki) (SEQ ID NO: 172) ExsH promoter ATATGCTAATGCTTAGTTTTTATACTCAAGTTAAAATGTGCTTT (B. cereus F837/76)TGGACCTAAGAGATAAACGTGGAAA AATAAAATA AACTCTTA (SEQ ID NO: 173)AGTTTAGGTGTTTAATCTAAGCAGTCAATTATTAAAAA CATAT AATT AATATGTGAGTCATGAACATAATTAA ATAATGTTTTCAA GTTTAATTATCGTTCATGTTTCCTATTTTAAGCAGAACAAATAACTCAATTACTTTTTTCGATTGGATCTTTTTTAACTCTTATAATAGGAAAACACTCAACTATAAAAATAAGTAAGGAGGAAATAA ExsH minimal promoter AATATGTGAGTCATGAA CATAATTA AATAATGTTTTCAAGTTT (B. cereus F837/76)AATTATCGTTCATGTTTCCTATTTTAAGCAGAACAAATAACTCA (SEQ ID NO: 174)ATTACTTTTTTCGATTGGATCTTTTTTAACTCTTATAATAGGAAAACACTCAACTATAAAAATAAGTAAGGAGGAAATAA YjcA promoterTATAAAATAAAAGGGCGTGTATTTGCTACTGATGCAGTATTGT (B. thuringiensis serovarGTGCGCCTAAAAATGGAATTTCACAACCAGATCCACATGTTGT kurstaki str. HD73)TGTAGAACAATCTTGTAATTCATTGATGAATTTTACAACGTCAA (SEQ ID NO: 175)CTACACAATGAGAAGAGCCATGGTGTTTATTTTCGTTACAACTCATTAATGTCACTCCTTATCTTCTTGTTTGTATTTACATT AATAA GATATTGGAGTTGAGGAGATTTGGTCACAATCTCAAGACCTTTTTTTTAAATAGGCGAAAGAGGATAAGGGAAGGTGGAATT YjcA minimal promoterTCTTGTTTGTATTTACATT AATAAGATA TTGGAGTTGAGGAGAT (B. thuringiensis serovarTTGGTCACAATCTCAAGACCTTTTTTTTAAATAGGCGAAAGAG kurstaki str. HD73)GATAAGGGAAGGTGGAATT (SEQ ID NO: 176) YjcB promoterATCAACTTTTACAAAAGTAAAGGGTAAAGGATTAAGAAAGTG (B. thuringiensis serovarGATTGGCGAATTATTAAGCTGTTATTGGTGTACAGGTGTATGG kurstaki str. HD73)GTTAGTGCTTTTTTATTAGTTTTATATAATTGGATTCCGATCGTT (SEQ ID NO: 177)GCAGAGCCGTTACTTGCATTATTAGCTATTGCAGGAGCAGCAG CAATCATTGAAACGATTACAGGATATTTTA TGGGAG AATAAT ATA TTTTCATAATACGAGAAAAAGCGGAGTTTAAAAGAATGAGGGAACGGAAATAAAGAGTTGTT CATATAGTA AATAGACAGAA YjcB minimal promoterACGGAAATAAAGAGTTGTT CATATAGTA AATAGACAGAA (B. thuringiensis serovarkurstaki str. HD73) (SEQ ID NO: 178) BclC promoterTGAAGTATCTAGAGCTAATTTACGCAAAGGAATCTCAGGACAA (B. anthracis Sterne)CACTTTCGCAACACC TATATTTTA AATTTAATAAAAAAAGAGA (SEQ ID NO: 179)CTCCGGAGTCAGAAATTATAAAGCTAGCTGGGTTCAAATCAAAAATTTCACTAAAACGATATTATCAATACGCAGAAAATGGAAAAAACGCCTTATCATAAGGCGTTTTTTCCATTTTTTCTTCAAACAAACGATTTTACTATGACCATTTAACTAATTTTTG CATCTACTA TGATGAGTTTCATTCACATTCTCATTAGAAAGGAGAGATTTA BclC minimal promoterACCATTTAACTAATTTTTG CATCTACTA TGATGAGTTTCATTCA (B. anthracis Sterne)CATTCTCATTAGAAAGGAGAGATTTA (SEQ ID NO: 180) AcpC promoter GACTATGTTTATTCAG GATAAAATA TAGCACTACACTCTCTCCT (B. cereus F837/76)CTTATTATGTAGCATCTCTCTAATCCATCATTTGTTTCATTTAGT (SEQ ID NO: 181)TAAAATTGTAAATAAAATCACATGATTTGTCAATTATAATTGTCATTTCGACAATTAAACTTGTCAAAATAATTCTCATCATTTTTTCTCATCTTTCTAATATAGGACATACTACTATATATACAAAAGAC AATATGCAAATGTT CATACAAAAAATATTATTTTTCGA TATAT AATA TTAACTGATTTTCTAACATCAAGGAGGGTACATAcpC minimal promoter  AGACAATATGCAAATGTT CATACAAAA AATATTATTTTTCGA T(B. cereus F837/76) ATATAATA TTAACTGATTTTCTAACATCAAGGAGGGTACAT(SEQ ID NO: 182) InhA3 promoter (B. ATAGTGAGTAATATGGTAATCCATAGATTAAATAGTATA GAA thuringiensis serovarAATATTTAATTCTTATTTTTATTAAAAAAGCATGAATCCCAGAT kurstaki str. HD73)TTACTGGGTTTTGATTGTAACTAAGAA CATATAAAA GTTCACT (SEQ ID NO: 183)GTTATTTATAGGAGAGTCTGTTTGTTTT TATATCTTA TGTATTT CACCCTG CATAAAAA AATATTTCTCAACATTTTATTTGTTGAAAAATATTGAATATTCGTATTATAACGAATATTATGTTGTTATCGGCAAAAAACGATAATTTGCAGACACTGGGGAGGAAATACA InhA3 minimal promoter TCTTATGTATTTCACCCTG CATAAAAAA ATATTTCTCAACATTT (B. thuringiensis serovarTATTTGTTGAAAAATATTGAATATTCGTATTATAACGAATATTA kurstaki str. HD73)TGTTGTTATCGGCAAAAAACGATAATTTGCAGACACTGGGGAG (SEQ ID NO: 184) GAAATACAAlanine racemase 1  CTTCGTCAGCAATAAGTGTGAGCGGAGAATTGGTTGATCTTGGpromoter  CTTTACAATTGGAGCATTGACGAAAGACTCTTTAACGTGGTCG(B. cereus F837/76) CATAACGGA GTAGAATATATGCTCGTGTCTAAAGGTTTAGAGC(SEQ ID NO: 185) CGAAGGAGCTATTAATGGTTGCTCGTTCAGTTACAGAGAAGCAAGTGAAGTAAACTTCTTAGACGTGGTGATATATGTGCACCACG TCTTTTCTTAGTTTGAAGGGTGGATTTCATAAAAGA AG CATAT AAAA GAATAAGCTTCG CATATCGTG TATAAGGAAGTGTATTTAlanine racemase 1  ATAAAAGAATAAGCTTCG CATATCGTG TATAAGGAAGTGTATminimal promoter  TT (B. cereus F837/76) (SEQ ID NO: 186)Alanine racemase 2  CATTTCAAATAATGAACGCTTCGATTGAATCGGAGCTATTTTCApromoter (B. AATCAATTTCAGTATATTGATCCAGCATTTGAATAGAAGTATCthuringiensis serovar AACAGCAACTTTAAGTTGATGCAATGCAGATTGTACAAACATTkurstaki str. HD73) GTAATTCTCCTCTTCTCCG TATATAATA GTTTCTTGAGGGTATT(SEQ ID NO: 187) ATATCATGCTCAAAATTCCGAAAATTCTAGTAGTTTGACTAG C ATATTGAAAAGTAT TATATTGTA AAAGGT CATATGAAA CGTGAAATAGAATGGAATGCAATTATTGAGTTAGGAGTTAGACCA Alanine racemase 2  TTATATTGTA AAAGGT CATATGAAA CGTGAAATAGAATGGAA minimal promoter (B. TGCAATTATTGAGTTAGGAGTTAGACCA thuringiensis serovar kurstaki str. HD73)(SEQ ID NO: 188) BclA promoter ATCGATGGAACCTGTATCAACCACTATAATTTCATCCACAATTT (B. cereus F837/76)TTTCAACTGAGTCTAAACAACGGGCTATTGTCTTCTCCTCATCT (SEQ ID NO: 189) CGAACAATCATACATAAACTA ATTGTAATTCCTTGCTTGTTCA ACATAATCACCCTCTTCCAAATCAATCATATGTTA TA CATATA CTA AACTTTCCATTTTTTTAAATTGTTCAAGTAGTTTAAGATTTCTTTTCAATAATTCAAATGTCCGTGTCATTTTCTTTCGGTTTTG C ATCTACTATATAATGAACGCTTTATGGAGGTGAATTT BclA minimal promoter  AATCAAT CATATGTTATA CATATACTA AACTTTCCATTTTTTT (B. cereus F837/76)AAATTGTTCAAGTAGTTTAAGATTTCTTTTCAATAATTCAAATG (SEQ ID NO: 190)TCCGTGTCATTTTCTTTCGGTTTTG CATCTACTA TATAATGAAC GCTTTATGGAGGTGAATTTBclB promoter (B. GACCTGTAAGTCTGTAGGGAAGAATAATTTCAAGAGCCAGTGAthuringiensis serovar TAATAGATTTTTTTGTTTTTTCATTCTTATCTTGAATATAAATCAkonkukian str. 97-27) CCT CATCTTTTA ATTAGAACGTAACCAATTTAGTATTTTGAAA(SEQ ID NO: 191) TAGAGCTAT CATTTTATA ATATGAATACTACTAGTTATAGAAACGGCAAAAAGTTTAATATATGTAAAAATCATTTGGATATGAAA AAAGTAGC CATAGATTTTTTCGAAATGATAAATGTTTTATTTT GTTAATTAGGAAACAAAAATGTGGAATGAGGGGGATTTAABclB minimal promoter  ATATGAAAAAAGTAGC CATAGATTT TTTCGAAATGATAAATGT(B. thuringiensis  TTTATTTTGTTAATTAGGAAACAAAAATGTGGAATGAGGGGGAserovar konkukian str. TTTAA 97-27) (SEQ ID NO: 192) BxpA promoter  TTTTCATCTGCTA CATCGTGAAGTAATGCTGCCATTTCAATTAT (B. anthracis AAAACGATTTCCTCCTTCTTGCTCGGATAAAGAAATCGCCAGTT str. Sterne) TATGTACACGCTCAATATGATA CCAATCATGCCCACTGGCATC (SEQ ID NO: 193)TTTTTCTAAAATATGTTTTACAAAAGTAATTGTTTTTTCTATCTTTTCTTGTTTTGTCATTTTATCTTCACCCAGTTACTTATTGTAACA CGCCCGCATTTTTT CATCA CATATTTTC TTGTCCGCC CATACA CTA GGTGGTAGGCATCATCATGAAGGAGGAATAGATBxpA minimal promoter  ACATATTTTC TTGTCCGCC CATACACTA GGTGGTAGGCATCAT(B. anthracis str. Sterne) CATGAAGGAGGAATAGAT (SEQ ID NO: 194)BclE promoter (B.  GGTGACGACAA CATATACAA GAGGCACTCCTGCTGGTACTGTAanthracis ΔSterne) ACAGGAACAAATATGGGGCAAAGTGTAAATA CATCGGGTA TA(SEQ ID NO: 195) GCACAAGCTGTCCCGAATACA GATAATATG GATTCAACGGCGGGACTCCCTTAAGAAATTAGGGGAGTCTTTATTTGGAAAAAGAGCTTATGTTACATAAAAACAGGAGTAATTGTTTTAAAAGTAGTATTGGTGACGTTGTTAGAAAATACAATTTAAGTAGAAGGTGCG TTTTTATATGA AATATATTTTATAGCTGTACTTTACCTTTCAAG BclE minimal promoter  ACAAGCTGTCCCGAATACAGATAATATG GATTCAACGGCGGG (B .anthracis ΔSterne)ACTCCCTTAAGAAATTAGGGGAGTCTTTATTTGGAAAAAGAGC (SEQ ID NO: 196)TTATGTTACATAAAAACAGGAGTAATTGTTTTAAAAGTAGTATTGGTGACGTTGTTAGAAAATACAATTTAAGTAGAAGGTGCGTT TTTATATGA AATATATTTTATAGCTGTACTTTACCTTTCAAG BetA promoterATTTATTTCATTCAATTTTTCCTATTTAGTACCTACCGCACTCAC (B. anthracis Sterne)AAAAAGCACCTCTCATTAATTTATATTATAGTCATTGAAATCTA (SEQ ID NO: 197)ATTTAATGAAATCAT CATACTATA TGTTTTATAAGAAGTAAAG GTAC CATACTTA ATTAATACATATCTATACACTTCAATATCACAGCATGCAGTTGAATTATATCCAACTTTCATTTCAAATTAAATAAGTGCCTCCGCTATTGTGAATGTCATTTACTCTCCCTACTA CAT TTAATAATTATGACAAGCAATCATAGGAGGTTACTAC BetA minimal promoter TAAGAAGTAAAGGTACCATACTTA A TTAATACATATCTATACA (B. anthracis Sterne)CTTCAATATCACAGCATGCAGTTGAATTATATCCAACTTTCATT (SEQ ID NO: 198)TCAAATTAAATAAGTGCCTCCGCTATTGTGAATGTCATTTACTC TCCCTACTA CATTTAATAATTATGACAAGCAATCATAGGAGGT TACTAC CotE promoter (B. AGTTGTACAAGAATTTAAATCTTCACAAA CATATGTAA ATGAC cereus AH820)TTACTACAGCTAGTTGCAAGTACGATTTCTAACAACGTAACAG (SEQ ID NO: 199)ATGAAATATTAATTTCAACTAATGGCGATGTATTGAAGGGTGAAACGGGCGCAGCGGTAGAAAGTAAAAAAGGAAATTGTGGTTGTTAAAGAGATGTCGAAATGACATCTCTTTTTTTAGTGGATTAAACGTAAGTTCTTCTCAAAAAAAGAATGACACATTCCGCTATTGT CACG CATATGATTAAGTGAATAGTGATTGAGGAGGGTTACGA CotE minimal promoter  ACATTCCGCTATTGTCACGCATATGATT AAGTGAATAGTGATT (B. cereus AH820) GAGGAGGGTTACGA(SEQ ID NO: 200) ExsA promoter (B. cereusAACGTTATTAGCGTAGACAAACAAGTAACGGCAGAAGCAGTTC strain ATCC 10876) TTGCATTAAATC GTATGTTAGAGCGTGTGTAAAGCAACGGTAT (SEQ ID NO: 201)TCCCGTTGCTTTTTTTCATA CATATAATC ATAACGAGAACGAA ATGGG CATACATTGTTTTGAAGAAATCATTGTGGTTCTTTATGCTTATTCCACTTCGAATGATATTGAAAATCGAAGAAGTGATAAAAGTAAAAAGAAGTTAATGTTATTTAGAAAGAGTTACTTCATG AGATTTGTTACTTATA GATAAGTTATACAGGAGGGGGAAAAT ExsA minimal promoter (B. TCATGAGATTTGTTACTTATAGATAAGTTA TACAGGAGGGGGA cereus strain ATCC 10876) AAAT (SEQ ID NO: 202)ExsK promoter (B. AAGCCGCGGTCAATGCTGTATATGCA AATAAGATT GCAGCTTTthuringiensis serovar ACCTGAAGAAGAGCGT GATAGCTTC ATTGCTGAAAAACGAGAkonkukian str. 97-27) AGAGTATAAGAAAGATATTGATATTTACCATTTAGCATCAGAG(SEQ ID NO: 203) ATGGTCATTGATGGTATTGTTCATCCAAACAATTTAAGAGAAGAGTTAAAAGGACGATTCGAAATGTATATGAGTAAATATCAAGT ATTTACGGATCGTAAA CATCCTGTTTATCCAGTTTAAAAGCCC TATTTAGGGCTTTCTTGCTCAAAAAGTTAAGGAGGGGAAAACAExsK minimal promoter (B. TCAAGTATTTACGGATCGTAAA CATCCTGTT TATCCAGTTTAAthuringiensis serovar AAGCCCTATTTAGGGCTTTCTTGCTCAAAAAGTTAAGGAGGGGkonkukian str. 97-27) AAAACA (SEQ ID NO: 204) ExsB promoter AGGATTTCAGTGGGACGCCTCCTCTCTTCTTACATTAAATTAAT (B. cereus F837/76)CATACTATA AAATGAAAGAAATGAAATGAAAAATAGCGGAAA (SEQ ID NO: 205)AATCAGAAATTTTTTCTGGTAG TATACAATATGTTA CAATAAGCTTTGTCAATGAAAGAAGGAATTCCGTGCAATGCACGGGAGAGGTTCGCGAACTCCCTCTATAAAAAACTATGGAAACAAC AATAT CTTTAGGTATTGTTTTGTTTTTTTATTGTGACAGTTCAAGAACGTTCTTTCTTCTTATTCGTAGTAGAGAAGGAGAATGAGTGAA ExsB minimal promoter ACTATGGAAACAAC AATATCTTT AGGTATTGTTTTGTTTTTTTA (B. cereus F837/76)TTGTGACAGTTCAAGAACGTTCTTTCTTCTTATTCGTAGTAGAG (SEQ ID NO: 206)AAGGAGAATGAGTGAA YabG promoter  TTTTGCACAACGCCGTAAAACTTTAATG AATAATTTATCA AAT (B. cereus AH820) AATTTA AATGGTTTCCCGAAAGATAAAGAGCTGTTGGATCGAA(SEQ ID NO: 207) TTTTAACAGAAGTAGGAATTGATCCAAAACGAAGAGGCGAAACGCTATCTATCGAAGAGTTTGCGACATTAAGTAATGCATTAGTT CTT CATAAGTTATCATAAGAATACAAAAGGGACAGTTCAATTT GAACTGTCCCTTTTGTCACCTTTCTCCTCCTAAATTCATACTTT A AAAACAGGTAAGATGGCCTAACGAGTTTGGAGGTAGGAGAYabG minimal promoter  TCTCCTCCTAAATT CATACTTTA AAAACAGGTAAGATGGCCTA(B. cereus AH820) ACGAGTTTGGAGGTAGGAGA (SEQ ID NO: 208) Tgl promoter (B.GGAAACAGAAGTCATCCCATTTGAAAATGCAGCAGGTCGTATT thuringiensis serovarATAGCTGATTTCGTTATGGTTTATCCGCCAGGGATTCCAATCTT konkukian str. 97-27)TACTCCGGGGGAAATTATTACACAAGACAACTTAGAGTATATT (SEQ ID NO: 209)CGTAAAAACTTAGAAGCAGGTTTACCTGTACAAGGTCCTGAAGATATGACATTACAAACATTACGCGTGATCAAAGAGTACAAGCCTATCAGTTGATAGGCTTTTTTTCACCCTTTTTCCCTTTTCT CATA CGATATTATGTAATGTAACGTATAGGTGGGGATACTACT Tgl minimal promoter (B.ACCCTTTTTCCCTTTTCT CATACGATA TTATGTAATGTAACGTA thuringiensis serovarTAGGTGGGGATACTACT konkukian str. 97-27) (SEQ ID NO: 210)Superoxide dismutase ATTGTGGACCCTTAGCTCAGCTGGTTAGAGCAGACGGCTCATA(SODA1) promoter (B. ACCGTCCGGTCGTAGGTTCGAGTCCTACAGGGTCCATATCCATTcereus F837/76) TCACATGTTTATTATGTCGGCAGGAAGCTTCCTTGTAGAAGGG(SEQ ID NO: 211) AGCTTTTTTTATGAAATATATGAGCATTTTAATTGAAATGAAGTGGGAATTTTGCTACTTTAATGATAGCAAGACAATGTGATTTATTTGTTTGCACCCTATGGCAATTAGGGTAGAATGAAGTTGTATGT CACTTAAGTGGCAATA CATAAACTGGGAGGAATATAACA Superoxide dismutase ACTTAAGTGGCAATA CATAAACTGGGAGGAATATAACA (SODA1) minimal promoter (B. cereus F837/76)(SEQ ID NO: 212) Superoxide dismutaseAATATAACAGAAAATTCTGATGTTTTTTCAAATCCTATAATAAG (SODA2) promoter (B.GAGTGTTCCGTATGATGCCTT TATATTTTC CGGAAGATAAAAC cereus AH820) AG AATATATTATTCCAGGGATTGTTTGTGTTCTATTTATCATCG (SEQ ID NO: 213)GTGCGATTGCTACGTGGCGTATGTTCATTCGTGTATCAAAACGAGAAGCAGAGCGATTACAGAAAGTTGAAGAAAAGCTGTTAGCTGAAAAGAAACAGTAACTCATTTTTGTATGTTTCCCTCTATGCTCGGACAATCTAAGGGCAGAATGTATTTTGGAGGGAATGAA Superoxide dismutaseTCCGGAAGATAAAACAG AATATATTA TTCCAGGGATTGTTTGT (SODA2) minimal promoterGTTCTATTTATCATCGGTGCGATTGCTACGTGGCGTATGTTCAT (B. cereus AH820)TCGTGTATCAAAACGAGAAGCAGAGCGATTACAGAAAGTTGA (SEQ ID NO: 214)AGAAAAGCTGTTAGCTGAAAAGAAACAGTAACTCATTTTTGTATGTTTCCCTCTATGCTCGGACAATCTAAGGGCAGAATGTATTTT GGAGGGAATGAA BclA promoterTAATCACCCTCTTCCAAATCAAT CATATGTTA TA CATATACTA (B. anthracis Sterne)AACTTTCCATTTTTTTAAATTGTTCAAGTAGTTTAAGATTTCTT (SEQ ID NO: 215)TTCAATAATTCAAATGTCCGTGTCATTTTCTTTCGGTTTTG CAT CTACTATATAATGAACGCTTTATGGAGGTGAATTT BAS1882 promoter (B.AATTACATAACAAGAACTACATTAGGGAGCAAGCAGTCTAGCG anthracis Sterne)AAAGCTAACTGCTTTTTTATTAAATAACTATTTTATTAAATTTC (SEQ ID NO: 216)ATATATACAATCGCTTGTCCATTTCATTTGGCTCTACCCACG CA TTTACTATTAGTAATATGAATTTTTCAGAGGTGGATTTTATT Gene 3572 promoterCTATGATTTAAGATACACAATAGCAAAAGAGAAA CATATTAT (B. weihenstephensis ATAACGATAAATGAAACTTATGTATATGTATGGTAACTGTATA KBAB 4)TATTACTACAATACAGTATACTCATAGGAGGTAGGT (SEQ ID NO: 217) YVTN β-propeller GGTAGGTAGATTTGAAATATGATGAAGAAAAGGAATAACTAA protein promoterAAGGAGTCGATATCCGACTCCTTTTAGTTATAAATAATGTGGA (B. weihenstephensisATTAGAGTATAATTTTATATAGGTATATTGTATTAGATGAACGC KBAB 4)TTTATCCTTTAATTGTGATTAATGATGGATTGTAAGAGAAGGG (SEQ ID NO: 218)GCTTACAGTCCTTTTTTTATGGTGTTCTATAAGCCTTTTTAAAAGGGGTACCACCCCACACCCAAAAACAGGGGGGGTTATAACTACATATTGGATGTTTTGTAACGTACAAGAATCGGTATTAATTACCCTGTAAATAAGTTATGTGTATATAAGGTAACTT TATATATTC TCCTACAATAAAATAAAGGAGGTAATAAA Cry1A promoterAACCCTTAATGCATTGGTTAAACATTGTAAAGTCTAAAGCATG (B. thuringiensis GATAATGGGCGAGAAGTAAGTAGATTGTTAACACCCTGGGTCA HD-73)AAAATTGATATTTAGTAAAATTAGTTGCACTTTGTGCATTTTTT (SEQ ID NO: 219) CATAAGATGAGT CATATGTTT TAAATTGTAGTAATGAAAAAC AGTAT TATAT CATA ATGAATTGGTATCTTAATAAAAGAGATGG AGGTAACTTA ExsY promoterTAATTCCACCTTCCCTTATCCTCTTTCGCCTATTTAAAAAAAGG (B. thuringiensis serovarTCTTGAGATTGTGACCAAATCTCCTCAACTCC AATATCTTA TTA konkukian str. 97-27)ATGTAAATACAAACAAGAAGATAAGGA (SEQ ID NO: 220) CotY promoterAGGATGTCTTTTTTTATATTGTATTATGTACATCCCTACTATATA (B. thuringiensis AATTCCCTGCTTTTATCGTAAGAATTAACGTAATATCAACCATA Al Hakam) TCCCGTT CATATTGTAGTAGTGTATGTCAGAACTCACGAGAAG (SEQ ID NO: 221) GAGTGAACATAA YjcA promoterTTAATGTCACTCCTTATCTTCTTGTTTGTATTTACATT AATAAG (B. thuringiensis  ATATTGGAGTTGAGGAGATTTGGTCACAATCTCAAGACCTTTTT serovar kurstakiTTTAAATAGGCGAAAGAGGATAAGGGAAGGTGGAATT str. HD73) (SEQ ID NO: 222)YjcB promoter ATATATTTTCATAATACGAGAAAAAGCGGAGTTTAAAAGAATG(B. thuringiensis  AGGGAACGGAAATAAAGAGTTGTT CATATAGTA AATAGACAGserovarkurstaki AA str. HD73) (SEQ ID NO: 223) ExsFA/BxpB promoterAAACTAAATAATGAGCTAAGCATGGATTGGGTGGCAGAATTAT (B. thuringiensis CTGCCACCCAATC CATGCTTAA CGAGTATTATTATGTAAATTT Al Hakam)CTTAAAATTGGGAACTTGTCTAGAACATAGAACCTGTCCTTTT C (SEQ ID NO: 224) ATTAACTGAAAGTAGAAACAGATAAAGGAGTGAAAAAC Rhamnose promoterATTCACTACAACGGGGATGAGTTTGATGCGGATA CATATGAG (B. thuringiensis  AAGTACCGGAAAGTGTTTGTAGAA CATTACAA AGATATATTAT Al Hakam)CTCCATCATAAAGGAGAGATGCAAAG (SEQ ID NO: 225) CotO promoter CGCGCACCACTTCGTCGTACAACAACGCAAGAAGAAGTTGGGG (B. anthracis Sterne)ATACAGCAGTATTCTTATTCAGTGATTTAGCACGCGGCGTAAC (SEQ ID NO: 226)AGGAGAAAACATTCACGTTGATTCAGGGTAT CATATCTTA GGATAAATATAATATTAATTTTAAAGGACAATCTCTACATGTTGAGATTGTCCTTTTTATTTGTTCTTAGAAAGAACGATTTTTAACGAAAGTTCTTACCACGTTATGAATATAAGTATAATAGTACACGATTT ATTCAGCTACGTASigma K promoter TATATCATATGTAAAATTAGTTCTTATTCCCA CATATCATA TAG(B. anthracis Sterne) AATCGC CATATTATA CATGCAGAAAACTAAGTATGGTATTATT(SEQ ID NO: 227) CTTAAATTGTTTAGCACCTTCTAATATTACAGATAGAATCCGTCATTTTCAACAGTGAACATGGATTTCTTCTGAACACAACTCTTTTTCTTTCCTTATTTCCAAAAAGAAAAGCAGCCCATTTTAAAATAC GGCTGCTTGTAATGTACATTAInhA1 promoter TATCACATAACTCTTTATTTTTAATATTTCGA CATAAAGTG AAA(B. thuringiensis  CTTTAATCAGTGGGGGCTTTGTTCATCCCCCCACTGATTATTAAAl Hakam) TTGAACCAAGGGATAAAAAGATAGAGGGTCTGACCAGAAAAC (SEQ ID NO: 228)TGGAGGGCATGATTCTATAACAAAAAGCTTAATGTTTATAGAATTATGTCTTTTTATATAGGGAGGGTAGTAAACAGAGATTTGGACAAAAATGCACCGATTTATCTGAATTTTAAGTTTTATAAAGGG GAGAAATGBclA cluster glycosyl ATTTTTTACTTAGCAGTAAAACTGATATCAGTTTTACTGCTTTTTtransferase operon 1 CATTTTTAAATTCAATCATTAAATCTTCCTTTTCTACATAGT CA(B. thuringiensis TAATGTT GTATGACATTCCGTAGGAGGCACTTATA serovar konkukianstr. 97-27) (SEQ ID NO: 229) BclA cluster glycosylACATAAATTCACCTCCATAAAGCGTTCATTATATAGTAGATGC transferase operon 2AAAACCGAAAGAAAATGACACGGACATTTGAATTATTGAAAA (B. thuringiensisGAAATCTTAAACTACTTGAACAATTTAAAAAAATGGAAAGTTT serovar kurstakiAGTATATGTATAA CATATGATT GATTTGGAAGAGGGTGATTA str. HD73) (SEQ ID NO: 230)Glycosyl transferase TTCTATTTTCCAA CATAACATG CTACGATTAAATGGTTTTTTGCpromoter AAATGCCTTCTTGGGAAGAAGGATTAGAGCGTTTTTTTATAGA (B. thuringiensisAACCAAAAGTCATTAACAATTTTAAGTTAATGACTTTTTTGTTT Al Hakam) GCCTTTAAGAGGTTTTATGTTACTATAATTATAGTATCAGGTAC (SEQ ID NO: 231)TAATAACAAGTATAAGTATTTCTGGGAGGATATATCA

The sigma-K sporulation-specific polymerase promoter sequences in thepromoter sequences shown in Table 3 result in high expression levels ofthe fusion protein or modulator protein during late sporulation. Theconsensus sequence for the sigma-K sporulation-specific polymerasepromoter sequence is CATANNNTN; however, this sequence can comprise upto two mutations and still be functional. The sigma-Ksporulation-specific polymerase promoter sequence is generally foundupstream of the ribosome binding site (RBS).

Promoters having a high degree of sequence identity to any of thesequences shown above in Table 3 can also be used to express the fusionproteins or the modulator proteins.

For example, the fusion protein or modulator protein can be expressedunder the control of a promoter comprising a nucleic acid sequencehaving at least 80% identity with a nucleic acid sequence of any one ofSEQ ID NOs: 157-231.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a nucleic acid sequence having at least90% identity with a nucleic acid sequence of any one of SEQ ID NOs:157-231.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a nucleic acid sequence having at least95% identity with a nucleic acid sequence of any one of SEQ ID NOs:157-231.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a nucleic acid sequence having at least98% identity with a nucleic acid sequence of any one of SEQ ID NOs:157-231.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a nucleic acid sequence having at least99% identity with a nucleic acid sequence of any one of SEQ ID NOs:157-231.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a nucleic acid sequence having 100%identity with a nucleic acid sequence of any one of SEQ ID NOs: 157-231.

For example, the modulator protein or fusion protein can be expressedunder the control of a BclA promoter (e.g., SEQ ID NO: 189, 190, 215,229 or 230), a CotY promoter (e.g., SEQ ID NO: 161, 162 or 221), an ExsYpromoter (e.g., SEQ ID NO: 157, 158 or 220), or a rhamnose promoter(e.g., SEQ ID NO: 225). For example, the fusion protein can be expressedunder the control of a promoter comprising a nucleic acid sequencehaving at least 80% identity with a nucleic acid sequence of any one ofSEQ ID NOs: 157, 158, 161, 162, 189, 190, 215, 220, 221, 225, 229, or230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having at least 85% identity with anucleic acid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189,190, 215, 220, 221, 225, 229, or 230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having at least 90% identity with anucleic acid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189,190, 215, 220, 221, 225, 229, or 230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having at least 95% identity with anucleic acid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189,190, 215, 220, 221, 225, 229, or 230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having at least 98% identity with anucleic acid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189,190, 215, 220, 221, 225, 229, or 230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having at least 99% identity with anucleic acid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189,190, 215, 220, 221, 225, 229, or 230.

The fusion protein can be expressed under the control of a promotercomprising a nucleic acid sequence having 100% identity with a nucleicacid sequence of any one of SEQ ID NOs: 157, 158, 161, 162, 189, 190,215, 220, 221, 225, 229, or 230.

The fusion protein or modulator protein can be expressed under thecontrol of a promoter comprising a sigma-K sporulation specificpolymerase promoter sequence, wherein the sigma-K sporulation-specificpolymerase promoter sequence or sequences have 100% identity with thecorresponding nucleotides of any of SEQ ID NOs: 157-231.

The fusion proteins can be expressed under the control of a promoterthat is native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein. Thus, for example,where the targeting sequence is derived from BclA, the fusion proteincan be expressed under the control of a native BclA promoter (e.g., SEQID NO: 189, 190, 215, 229 or 230).

The modulator proteins can be expressed under the control of theirnative promoters. Thus, for example, where the modulator proteincomprises CotO, the CotO can be expressed under the control of a nativeCotO promoter (e.g., SEQ ID NO: 163 or 226). Native promoter sequencesfor each of the modulator proteins are provided above in Table 3.

Table 3 also provides exemplary minimal promoter sequences for eachmodulator protein. The modulator proteins and fusion proteins can beexpressed under any of these minimal promoter sequences. For example,the modulator protein can be expressed under a minimal promoter thatcomprises a portion of the native promoter sequence. For instance, wherethe modulator protein comprises CotO, the CotO can be expressed underthe minimal CotO promoter (SEQ ID NO: 164).

Alternatively, the modulator proteins can be expressed under the controlof any promoter comprising a sigma-K sporulation-specific polymerasepromoter sequence, regardless of whether the promoter is the nativepromoter for the modulator protein. As can be seen from Table 3, each ofthe native promoters and the minimal promoters for the modulatorproteins contains at least one sigma-K sporulation-specific polymerasepromoter sequence. Thus, for example, where the modulator protein isBxpB, the BxpB can be expressed under the control of a BclA promoter(e.g., SEQ ID NO: 189, 190, 215, 229 or 230) or any of the otherpromoters listed in Table 3.

Furthermore, the modulator protein or the fusion protein can beexpressed under a portion of any of the promoters listed above in Table3, so long as the portion of the promoter includes a sigma-Ksporulation-specific polymerase promoter sequence. For example, themodulator protein can be expressed under a promoter region thatcomprises the first 25, 50, 100, 150, 200, 250, or 300 nucleotidesupstream of the start codon, so long as that region comprises a sigma-Ksporulation-specific polymerase promoter sequence.

IV. Mutations and Other Genetic Alterations to Recombinant Bacilluscereus Family Members that Allow for Collection of Free Exosporium

As is described further hereinbelow, the recombinant Bacillus cereusfamily members that express fusion proteins comprising a protein orpeptide of interest and a targeting sequence, an exosporium protein, oran exosporium protein fragment that targets the fusion protein to theexosporium of the recombinant Bacillus cereus family member can be usedto deliver proteins or peptides of interest to plants, seeds, a plantgrowth medium, or an area surrounding a seed or a plant (e.g., via soildrench, foliar application, or as a seed treatment). In addition, therecombinant Bacillus cereus family members can be used to delivernucleic acid molecules to animals, insects, worms (e.g., nematodes),fungi, and protozoans; to deliver proteins or peptides to an animal; invaccines and for producing an immunogenic response; for remediation; fortreating a hydraulic fracturing fluid to break an emulsion or gel withinthe fluid; for disinfection; and for various other uses describedhereinbelow. However, in some cases, the presence of the livingmicroorganisms may not be desirable, and instead, it would be desirableto separate the living spore from the fusion proteins in the exosporiumon the outside surface of the spore. For example, in some applicationsit will be desirable to increase enzyme activity without concern forspore integrity. In such situations, the exosporium fragments may bepreferred over living microorganisms having the enzyme on theirexosporium.

In addition, for some uses, it may be desirable to reduce the density ofthe product. In such instances, it would be desirable to separate thedense spore from the exosporium (containing the fusion proteins). In thefield of vaccines, it may be desirable to separate the spore from theexosporium (containing fusion proteins that comprise an antigen) inorder to remove potential antigens present on the spore itself from thevaccine preparation. Furthermore, under some circumstances the presenceof live spores would lead to potential for bacterial growth in aproduct, which would be undesirable for some applications (e.g., animalfeed supplementation and leather hide processing).

Mutations or other genetic alterations (e.g., overexpression of aprotein) can be introduced into the recombinant Bacillus cereus familymembers that allow free exosporium to be separated from spores of therecombinant Bacillus cereus family member. This separation processyields exosporium fragments that contain the fusion proteins but thatare substantially free of the spores themselves. By “substantially freeof spores” it is meant that once the free exosporium is separated fromthe spores, a preparation is obtained that contains less than 5% byvolume of spores, preferably less than 3% by volume of spores, even morepreferably less than 1% by volume of spores, and most preferablycontains no spores or if spores are present, they are undetectable.These exosporium fragments can be used in place of the recombinantBacillus cereus family members themselves and can be used to deliverproteins or peptides of interest to plants, seeds, a plant growthmedium, or an area surrounding a seed or a plant, or for any of theother purposes described herein.

Thus, a recombinant Bacillus cereus family member is provided thatexpresses a fusion protein comprising at least one protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member. The recombinant Bacilluscereus family member comprises a mutation or expresses a protein,wherein the expression of the protein is increased as compared to theexpression of the protein in a wild-type Bacillus cereus family memberunder the same conditions. The mutation or the increased expression ofthe protein results in Bacillus cereus spores having an exosporium thatis easier to remove from the spore as compared to the exosporium of awild-type spore.

A further recombinant Bacillus cereus family member is provided thatexpresses a fusion protein comprising at least one protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member. The recombinant Bacilluscereus family member: (i) comprises a mutation in a CotE gene; (ii)expresses an ExsY protein, wherein the expression of the ExsY protein isincreased as compared to the expression of the ExsY protein in awild-type Bacillus cereus family member under the same conditions, andwherein the ExsY protein comprises a carboxy-terminal tag comprising aglobular protein; (iii) expresses a BclB protein, wherein the expressionof the BclB protein is increased as compared to the expression of theBclB protein in a wild-type Bacillus cereus family member under the sameconditions; (iv) expresses a YjcB protein, wherein the expression of theYjcB protein is increased as compared to the expression of the YjcBprotein in a wild-type Bacillus cereus family member under the sameconditions; (v) comprises a mutation in an ExsY gene; (vi) comprises amutation in a CotY gene; (vii) comprises a mutation in an ExsA gene; or(viii) comprises a mutation in a CotO gene.

The recombinant Bacillus cereus family member can comprise a mutation inthe CotE gene, such as a knock-out of the CotE gene or a dominantnegative form of the CotE gene. The mutation in the CotE gene canpartially or completely inhibit the ability of CotE to attach theexosporium to the spore.

The recombinant Bacillus cereus family member can express an ExsYprotein. The ExsY protein comprises a carboxy-terminal tag comprising aglobular protein (e.g., a green fluorescent protein (GFP) or a variantthereof), and the expression of the ExsY protein is increased ascompared to the expression of the ExsY protein in a wild-type Bacilluscereus family member under the same conditions. The globular protein canhave a molecular weight of between 25 kDa and 100 kDa. Expression of theExsY protein comprising the carboxy-terminal tag comprising a globularprotein can also inhibit binding of the ExsY protein to its targets inthe exosporium.

The recombinant Bacillus cereus family member can express a BclBprotein, which may result in the formation of a fragile exosporium. Theexpression of the BclB protein can be increased as compared to theexpression of the BclB protein in a wild-type Bacillus cereus familymember under the same conditions.

The recombinant Bacillus cereus family member can express a YjcBprotein, which may cause the exosporium to form in pieces rather than ina complete structure. The expression of the YjcB protein can beincreased as compared to the expression of the YjcB protein in awild-type Bacillus cereus family member under the same conditions.

The recombinant Bacillus cereus family member can comprise a mutation anExsY gene, such as a knock-out of the ExsY gene. The mutation in theExsY gene can partially or completely inhibit the ability of ExsY tocomplete the formation of the exosporium or attach the exosporium to thespore.

The recombinant Bacillus cereus family member can comprise a mutation aCotY gene, such as a knock-out of the CotY gene. The mutation in theCotY gene can result in the formation of a fragile exosporium.

The recombinant Bacillus cereus family member can comprise a mutation anExsA gene, such as a knock-out of the ExsA gene. The mutation in theExsA gene can result in the formation of a fragile exosporium.

The recombinant Bacillus cereus family member can comprise a mutation aCotO gene, such as a knock-out of the CotO gene or a dominant negativeform of the CotO gene. The mutation in the CotO gene can cause theexosporium to form in strips.

Exosporium fragments can be prepared from any of these recombinantBacillus cereus family members and used for various purposes asdescribed further hereinbelow. The exosporium fragments comprise thefusion proteins. Upon purification of the exosporium fragments thatcontain the fusion proteins from the spores, a cell-free proteinpreparation is obtained in which the fusion proteins are stabilized andsupported through covalent bonds to the exosporium fragments.

Due to the strong covalent bonds between the fusion proteins and theexosporium fragments, the fusion proteins become resistant to heat. Theheat resistance of the fusion proteins bound to the exosporium fragmentsallows them to be used for applications that require heat-resistantproteins or enzymes (e.g., in feed additives).

V. Inactivation of Spores of Bacillus Genus Bacteria, Including Sporesof Recombinant Bacillus cereus Family Members

Spores of bacteria of the genus Bacillus can be genetically inactivated.Genetic inactivation of the spores can be advantageous, for examplebecause it allows for delivery of spores to a plant or a plant growthmedium while eliminating any detrimental effects that the live bacteriamight have on a plant. In addition, use of inactivated spores canprovide many of the same benefits (e.g., prevention of bacterial growthin a product) as discussed above in Section IV with respect to the useof exosporium fragments.

A. Genetic Inactivation by Overexpression of a Protease or a Nuclease

A recombinant bacterium of the genus Bacillus that expresses a proteaseor a nuclease is provided. The expression of the protease or nuclease isincreased as compared to the expression of the protease or the nucleasein a wild-type bacterium of the genus Bacillus under the sameconditions. The increased expression of the protease or the nucleasepartially or completely inactivates spores of the recombinant bacteriumof the genus Bacillus or renders spores of the recombinant bacterium ofthe genus Bacillus more susceptible to physical or chemicalinactivation.

The recombinant bacterium of the genus Bacillus is preferably arecombinant Bacillus cereus family member.

The recombinant Bacillus cereus family member can also express a fusionprotein comprising at least one protein or peptide of interest and atargeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of the recombinantBacillus cereus family member.

The recombinant bacterium of the genus Bacillus can express both aprotease and a nuclease, wherein the expression of the protease isincreased as compared to the expression of the protease in a wild-typebacterium of the genus Bacillus under the same conditions and theexpression of the nuclease is increased as compared to the expression ofthe nuclease in a wild-type bacterium of the genus Bacillus under thesame conditions.

The protease of the recombinant bacterium can comprise a non-specificprotease.

The protease of the recombinant bacterium can comprise a serineprotease, a threonine protease, a cysteine protease, an aspartateprotease, a glutamic acid protease, an alkaline protease, a subtilisin,a histidine protease, or a metalloprotease.

The protease of the recombinant bacterium can comprise a germinationspore protease, such as a Bacillus subtilis germination spore protease,a Bacillus mycoides germination spore protease, or a Bacillusthuringiensis germination spore protease.

The germination spore protease can comprise an active form of thegermination spore protease. This protease is naturally inactive in thespore. Upon germination, the protease becomes active due to cleavage ofthe protease into a proprotein active form. Thus, the recombinantbacterium can comprise an active protease rather than the naturallyinactive form. The active protease can digest the protective SASPproteins in the spore prior to germination.

The nuclease of the recombinant bacterium can comprise an endonucleaseor an exonuclease. The nuclease can comprise a non-specificendonuclease, such as Bacillus subtilis endonuclease 1. For example, thegermination spore protease and endonuclease 1 can have the amino acidsequences listed below in Table 4.

TABLE 4 Amino acid sequences of a germination spore protease andendonuclease 1 Protein SEQ ID NO. Endonuclease 1, B. subtilis 168 232GPR Protease, B. subtilis 168 233 GPR Protease, B. cereus 234

A protease or a nuclease having a high degree of amino acid identity tothe sequences listed above in Table 4 can also be used.

Thus, for example, the germination spore protease can comprise an aminoacid sequence having at least 85% identity with SEQ ID NO: 233 or 234.

The germination spore protease can comprise an amino acid sequencehaving at least 90% identity with SEQ ID NO: 233 or 234.

The germination spore protease can comprise an amino acid sequencehaving at least 95% identity with SEQ ID NO: 233 or 234.

The germination spore protease can comprise an amino acid sequencehaving at least 98% identity with SEQ ID NO: 233 or 234.

The germination spore protease can comprise an amino acid sequencehaving at least 99% identity with SEQ ID NO: 233 or 234.

The germination spore protease can comprise an amino acid sequencehaving 100% identity with SEQ ID NO: 233 or 234.

Similarly, the non-specific endonuclease can comprise an amino acidhaving at least 85% identity with SEQ ID NO: 232.

The non-specific endonuclease can comprise an amino acid having at least90% identity with SEQ ID NO: 232.

The non-specific endonuclease can comprise an amino acid having at least95% identity with SEQ ID NO: 232.

The non-specific endonuclease can comprise an amino acid having at least98% identity with SEQ ID NO: 232.

The non-specific endonuclease can comprise an amino acid having at least99% identity with SEQ ID NO: 232.

The non-specific endonuclease can comprise an amino acid having 100%identity with SEQ ID NO: 232.

The protease or nuclease can be expressed under the control of apromoter comprising a sigma G promoter sequence. For example, thepromoter can have one of the sequences shown in Table 5 below. Theconsensus sequence for binding of the sigma G transcription factor isCATNNTA, where N is any nucleotide. The sigma G promoter sequences inthe promoters in Table 5 are indicated by bold and underlined text.

TABLE 5 Promoter Sequences having sigma G sequences PromoterNucleic Acid Sequence GPR Protease, B.GTAACTAAAGCTTCTACAGTTTTAACAGCTGAACGCATGTCAGACTT subtilis 168GATAGAAGCGTTATGTGCACGACGCTCTTCGCTAAGTTTAGCGCGTT (SEQ ID NO: 235)TGATAGCAGATTTAATGTTTGC CATACTT TTCACCTCCCTGGTGCGA TCGAGTGACTCGATACTTACATAGAA CAAGTGATATTCTATCAAACG GAGAAGAGAATTGCAATAGCGAGATCAATGAAATTTCATGTAA AGG AAAGAATGACCTTATATATTTTTGGGGAATCTAACTATATTTACTATGAATTGCGGAGGAGATACG GPR Protease GCAATAGCGAGATCAATGAAATTT CATGTAAAGGAAAGAATGACCT minimal promoter,TATATATTTTTGGGGAATCTAACTATATTTACTATGAATTGCGGAGG B. subtilis 168 AGATACG(SEQ ID NO: 236) GPR Protease, B.TTTCACCTCCTAAGATACAACCTGTAGCACAGTGTCTTAAGGTTAAA subtilis 168TCTTCTTCACAATAGAACAAATTGTATTCTATCAAACACACCTTTAG (SEQ ID NO: 237)ATTGCAATATAAATGTAAAGTATTTTT CATTGAA GGTTCTCTTTTTAG CATGATTTATTCAGCAAATGGCAACAATATAGGTACTTAATGTGAA GGAGGCCCCTGT GPR ProteaseGAAGGTTCTCTTTTTAG CATGATT TATTCAGCAAATGGCAACAATAT minimal promoter,AGGTACTTAATGTGAAGGAGGCCCCTGT B. subtilis 168 (SEQ ID NO: 238) SASPα, GCTTTGTTGATTTCGAGCCGTATATTCAAGAAGCGGTAGATAACATT B. subtilis 168GAGACAATGACCCTTTATAGCGAACAAGAAGCTAACGATAAATTCG (SEQ ID NO: 239)CTGAACTCTTTTAAATCAATTTTCAGCTCCTGTATACAATTACCAAAGTTTTTCTGAATGAAGCCATGTGTTTTGACA CATTCTA TACTCACAAG GAGGTGAGACAC SASPαminimal GAATGAAGCCATGTGTTTTGACA CATTCTA TACTCACAAGGAGGTG promoter, B. AGACAC subtilis 168 (SEQ ID NO: 240) SASPβ, B. AAACGGCTAAGCTTTTTTTATTTCTCAAGATTTACCACACAATTCTCC subtilis 168GCATGATTTTCCGGCCATTTTAACATAATACGTAGTAACAAGCCGGC (SEQ ID NO: 241)AAAGCATTGGGTTACGCCGAGGCGGCAGTGACACCCGAGAAGGGTTCACAGATTGGTGCAACTCCAGTTAACCCAAC CATACTA AATAAAAA GGAGATTTTACAC SASPβminimal GATTGGTGCAACTCCAGTTAACCCAAC CATACTA AATAAAAAGGAG promoter, ATTTTACAC B. subtilis 168 (SEQ ID NO: 242) SASPγ, B. TTCGCTTCTCCCACTTAATCTGATTTACATTCCAAGGAATCCAATGAT subtilis 168TTATATGGAGATCTGAAACATAATCAATTTTCATTTTGTCTCCACCTT (SEQ ID NO: 243)TCTTAATGAAAAATTTATTTCTTTGGCGTGTATAAATTAAAATAATCT CTC CATAATATGATTCAAACAAGCTTGTTTTCATTACACTTTAGGAG ATGAATAAG SASPγ minimalGTATAAATTAAAATAATCTCTC CATAATA TGATTCAAACAAGCTTGT promoter, TTTCATTACACTTTAGGAGATGAATAAG B. subtilis 168 (SEQ ID NO: 244) SASPδ, B. TACAGTCCTCTCCATTTTGACATTCCATATTCAGGCAACCGCACATA subtilis 168AAATGACAGCAGA CATTCTA TAGTCTGCGCCACCCCGGCTCAGAGG (SEQ ID NO: 245)CCGGGGTTTTATTTTTCTCCACAACAATTGCCAGCATAAATAAACCCCGTATATTTCAAACTAAATACGCGTTAAGAATTTCTTTATCGAAAAA GGAGATGAAAAAG SASPδminimal GCAACCGCACATAAAATGACAGCAGA CATTCTA TAGTCTGCGCCAC promoter, CCCGGCTCAGAGGCCGGGGTTTTATTTTTCTCCACAACAATTGCCAG B. subtilisCATAAATAAACCCCGTATATTTCAAACTAAATACGCGTTAAGAATTT 168CTTTATCGAAAAAGGAGATGAAAAAG (SEQ ID NO: 246)

Expression of a nuclease or protease under a sigma G promoter allows forsite-specific expression of the nuclease or protease in the forespore,where the enzyme's activity is directed towards the forespore and, theregion where the bacterial target DNA is located. Extensive cleavage ofthe forespore DNA is lethal to the bacterial spore when it begins togerminate.

For example, as illustrated further in the Examples providedhereinbelow, overexpression of germination spore protease (GPR) in itsactive form in the forespore of a Bacillus cereus family member duringsporulation results in proteolytic cleavage of proteins in the foresporeand inactivation of the spore and/or renders the spore more sensitive toinactivation by ultraviolet or gamma irradiation. Similarly,overexpression of a non-specific endonuclease in the forespore duringsporulation destroys the DNA in the spore, leading to a high number ofinactivated spore particle. These methods for inactivating Bacilluscereus family member spores can be used separately or in conjunctionwith each other and/or with other spore inactivation methods.

Expression of genes in Bacillus spores is tightly regulated byexpression of specific sporulation sigma factors that direct the RNApolymerase to the genes that need to be expressed during each stage ofsporulation. Late expression of genes in the forespore, where bacterialDNA and essential proteins are packaged, is regulated by the sigmafactor sigma G. During late sporulation, the bacterial DNA is packagedwith protective proteins called small acid soluble proteins (SASPs).These SASP proteins include SASPα, SASPβ, and SASPγ, among others. TheSASP proteins protect the bacterial DNA from UV irradiation and otherassaults. Upon germination, the proprotein germination spore protease isactivated and digests these SASP proteins.

By expressing a GPR under the control of a sigma G promoter, the GPR isexpressed in the forespore and the protective SASP proteins are degradedas sporulation commences, leaving the bacterial DNA more susceptible todegradation. Similarly, expression of a non-specific nuclease under thecontrol of a sigma G promoter leads to digestion of the host DNA. Sincethe spore is unable to repair the large scale damage to its DNA, thisultimately leads to killing of the spore. Overexpression of a GPR and anon-specific endonuclease can be used together to both degrade theprotective SASP proteins and the host DNA.

The protease or the nuclease can be expressed under the control of anypromoter comprising a sigma G promoter sequence.

Thus, the protease or nuclease can be expressed under the control of anyof the promoters listed in Table 5 above. In addition, the protease ornuclease can be expressed under the control of a promoter having a highdegree of sequence identity with any of the promoter sequences listedabove in Table 5.

For example, the promoter can comprise a nucleic acid sequence having atleast 95% identity with a nucleic acid sequence of any of SEQ ID NOs:235-246.

The promoter can comprise a nucleic acid sequence having at least 98%identity with a nucleic acid sequence of any of SEQ ID NOs: 235-246.

The promoter can comprise a nucleic acid sequence having at least 99%identity with a nucleic acid sequence of any of SEQ ID NOs: 235-246.

The promoter can comprise a nucleic acid sequence having 100% identitywith a nucleic acid sequence of any of SEQ ID NOs: 235-246.

In any of the recombinant bacteria of the genus Bacillus that express aprotease or a nuclease, spores of the recombinant bacterium of the genusBacillus can be more susceptible to inactivation, for example, byultraviolet irradiation, gamma irradiation, or by treatment with bleach,hydrogen peroxide, chloroform, phenol, or acetic acid, as compared tothe same spores that do not expresses the protease or the nuclease at anincreased level as compared to expression of the protease or thenuclease in a wild-type bacterium of the genus Bacillus, treated underthe same conditions.

B. Genetic Inactivation by Mutation of a Gene Encoding a GerminationReceptor, a Spore Core Lytic Enzyme, a Small Acid-Soluble Spore Protein(SASP), or a Spore Coat Protein

Spores of any of the recombinant Bacillus cereus family member sporesthat express a fusion protein comprising a targeting sequence, anexosporium protein, or an exosporium protein fragment that targets thefusion protein to the exosporium of the recombinant Bacillus cereusfamily member can also be genetically inactivated or rendered moresusceptible to physical or chemical inactivation by modification of theBacillus cereus family member to comprise a mutation.

Such mutations include knock-out or other inactivating mutations in oneor more genes encoding a germination receptor. The germination receptorgenes include, for example, GerA, GerB, GerK, GerH, GerI, GerG, GerL,GerQ, GerR, GerS, GerN, GerU, or GerX.

Such mutations also include knock-out or other inactivating mutations inspore cortex lytic enzymes. For example, the spore cortex lytic enzymesSleB and CwJ can be mutated to inactivate spores. Such mutations preventoutgrowth of the spore upon germination and effectively inactivate thespores.

Such mutations further include knock-out or other inactivating mutationsof SASP genes (e.g., SASPα, SASPβ, or SASPγ). Such mutations eliminatethe UV protection of the spores and render them more susceptible toinactivation by ultraviolet irradiation and other methods.

Such methods also include making knock-out or other inactivatingmutations in genes encoding spore coat or cortex proteins (e.g., CotA,CotB, or CotC). Such mutations render the spores more susceptible toinactivation by physical or chemical methods such as exposure toultraviolet irradiation, gamma irradiation, or treatment with solventssuch as bleach, hydrogen peroxide, chloroform, phenol, or acetic acid.

Thus, the present invention relates to a recombinant Bacillus cereusfamily member that expresses a fusion protein comprising at least oneprotein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member. Therecombinant Bacillus cereus family member comprises a mutation thatpartially or completely inactivates spores of the recombinant Bacilluscereus family member or renders spores of the recombinant Bacilluscereus family more susceptible to physical or chemical inactivation ascompared to the same spores that do not comprise the mutation. Themutation comprises a mutation in a gene encoding a germination receptor,a mutation in a gene encoding a spore cortex lytic enzyme, a mutation ina gene encoding a small acid-soluble spore protein (SASP), or a mutationin a gene encoding a spore coat or cortex protein.

The present invention further relates to a recombinant Bacillus cereusfamily member that expresses a fusion protein as described in Section Iabove. The recombinant Bacillus cereus family member comprises amutation that partially or completely inactivates spores of therecombinant Bacillus cereus family member or renders spores of therecombinant Bacillus cereus family more susceptible to physical orchemical inactivation as compared to the same spores that do notcomprise the mutation.

Any of the recombinant Bacillus cereus family members described above inSection V.A that express a protease or a nuclease can also comprise amutation that partially or completely inactivates spores of therecombinant Bacillus cereus family member or renders spores of therecombinant Bacillus cereus family more susceptible to physical orchemical inactivation as compared to the same spores that do notcomprise the mutation. For example, the mutation can comprise a mutationin a gene encoding a germination receptor, a mutation in a gene encodinga spore cortex lytic enzyme, a mutation in a gene encoding a smallacid-soluble spore protein (SASP), or a mutation in a gene encoding aspore coat or cortex protein.

For example, the mutation can comprise a mutation in a gene encoding agermination receptor, such as a knock-out mutation of the gene encodingthe germination receptor. The germination receptor can comprise GerA,GerB, GerK, GerH, GerI, GerG, GerL, GerQ, GerR, GerS, GerN, GerU, orGerX.

For example, the mutation can comprise a mutation in a gene encoding aspore cortex lytic enzyme, such as a knock-out mutation of the geneencoding the spore cortex lytic enzyme. The spore cortex lytic enzymecan comprise SleB or CwlJ.

For example, the mutation can comprise a mutation in a gene encoding aSASP, such as a mutation in a SspA gene, a mutation in a SspB gene, amutation in a SspC gene, a mutation in a SspD gene, a mutation in a SspEgene, a mutation in a SspF gene, a mutation in a SspG gene, a mutationin a SspH gene, a mutation in a SspI gene, a mutation in a SspJ gene, amutation in a SspK gene, a mutation in a SspL gene, a mutation in a SspMgene, a mutation in a SspN gene, a mutation in a SspO gene, a mutationin a SspP gene, or a combination thereof. The SASP can comprise SASPα,SASPβ, or SASPγ. The spores of the recombinant Bacillus cereus familymember may be more susceptible to inactivation by ultravioletirradiation or gamma irradiation as compared to the same spores that donot comprise the mutation in the gene encoding the SASP.

For example, the mutation can comprise a mutation in a gene encoding aspore coat or cortex protein, such as a knock-out mutation of the geneencoding the spore coat or cortex protein. The spore coat or cortexprotein can comprise CotA, CotB, or CotC. The spores of the recombinantBacillus cereus family member may be more susceptible to inactivation byultraviolet irradiation, gamma irradiation or by treatment with bleach,hydrogen peroxide, chloroform, phenol, or acetic acid, as compared tothe same spores that do not comprise the mutation in the spore coat orcortex protein, treated under the same conditions.

VI. Recombinant Bacillus cereus Family Members that OverexpressExosporium Enzymes that have Beneficial Effects on Plants or DelayGermination of Bacillus cereus Family Member Spores

Recombinant Bacillus cereus family members that overexpress variousexosporium proteins to provide beneficial effects on plants or delayspore germination are also provided.

A recombinant Bacillus cereus family member that expresses an exosporiumprotein is provided, wherein the expression of the exosporium protein isincreased as compared to the expression of the exosporium protein in awild-type Bacillus cereus family member under the same conditions. Theexosporium protein can comprise an exosporium enzyme, wherein theexosporium enzyme comprises an enzyme involved in nutrientsolubilization, an inosine-uridine hydrolase, a protease, an enzyme thatcatalyzes the degradation of a free radical, an arginase, or an alanineracemase. Alternatively, the exosporium protein can comprise a BclAprotein, a BclB protein, a CotE protein a CotO protein, an ExsY protein,an ExsFA/BxpB protein, a CotY protein, an ExsFB protein, an ExsJprotein, an ExsH protein, a YjcA protein, a YjcB protein, a BclCprotein, a BxpA protein, a BclE protein, a BetA/BAS3290 protein, an ExsAprotein, an ExsK protein, an ExsB protein, a YabG protein, or a Tglprotein.

The exosporium protein is preferably not part of a fusion protein.

Exemplary amino acid sequences for AcpC, InhA1, InhA2, InhA3, SODA1, andSODA2 are provided above in Tables 1 and 2. Exemplary sequences foralanine racemase 1, alanine racemase 2, arginase, IunH1, and IunH2 areprovided by the SEQ ID NOs. referenced in Table 6 below.

TABLE 6 Exemplary amino acid sequences for exosporium enzymes Proteinand Strain SEQ ID NO. Alanine Racemase 1, B. anthracis ΔSterne 247Alanine Racemase 2, Bacillus cereus F837/78 248 Arginase, Bacillusthuringiensis pondicheriensis 249 4BA1 IunH1, B. cereus Str. CI 250IunH2, Bacillus thuringiensis 251

Overexpression of inosine-uridine hydrolases and alanine racemaseshinders the ability of spores to germinate and thereby maintains thespores in a dormant stage and increases the stability of the spores.

The SODA enzymes and arginase degrade free radicals. Spores thatoverexpress these enzymes have increased resistance to stress caused byfree radicals.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises an enzyme involved in nutrientsolubilization, the enzyme involved in nutrient solubilization cancomprise an enzyme involved in phosphate solubilization, such as an acidphosphatase (e.g., AcpC). The acid phosphatase can comprise an aminoacid sequence having at least 90% identity with SEQ ID NO: 137.

The acid phosphatase can comprise an amino acid sequence having at least95% identity with SEQ ID NO: 137.

The acid phosphatase can comprise an amino acid sequence having at least98% identity with SEQ ID NO: 137.

The acid phosphatase can comprise an amino acid sequence having at least99% identity with SEQ ID NO: 137.

The acid phosphatase can comprise an amino acid sequence having 100%identity with SEQ ID NO: 137.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises an inosine-uridine hydrolase, theinosine-uridine hydrolase can comprise IunH1 or IunH2. Theinosine-uridine hydrolase can comprise an amino acid sequence having atleast 85% identity with SEQ ID NO: 250 or 251.

The inosine-uridine hydrolase can comprise an amino acid sequence havingat least 90% identity with SEQ ID NO: 250 or 251.

The inosine-uridine hydrolase can comprise an amino acid sequence havingat least 95% identity with SEQ ID NO: 250 or 251.

The inosine-uridine hydrolase can comprise an amino acid sequence havingat least 98% identity with SEQ ID NO: 250 or 251.

The inosine-uridine hydrolase can comprise an amino acid sequence havingat least 99% identity with SEQ ID NO: 250 or 251.

The inosine-uridine hydrolase can comprise an amino acid sequence having100% identity with SEQ ID NO: 250 or 251.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises a protease, the protease can be ametalloprotease (e g, InhA1, InhA2, or InhA3). The metalloprotease cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having at least85% identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having at least90% identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having at least95% identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having at least98% identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having at least99% identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

The metalloprotease can comprise an amino acid sequence having 100%identity with SEQ ID NO: 114, 121, 122, 129, 130, or 138.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises an enzyme that catalyzes the degradation ofa free radical, the enzyme that catalyzes the degradation of a freeradical can comprise a superoxide dismutase (e.g., superoxide dismutase1 (SODA1) or superoxide dismutase 2 (SODA2)). The superoxide dismutasecan comprise an amino acid sequence having at least 85% identity withSEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 90% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 95% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 98% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 99% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having 100%identity with SEQ ID NO: 155 or 156.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises an arginase, the arginase can comprise aBacillus thuringiensis arginase. The arginase can comprise an amino acidsequence having at least 85% identity with SEQ ID NO: 249.

The arginase can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 249.

The arginase can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 249.

The arginase can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 249.

The arginase can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 249.

The arginase can comprise an amino acid sequence having 100% identitywith SEQ ID NO: 249.

Where the exosporium protein comprises an exosporium enzyme, and theexosporium enzyme comprises an alanine racemase, the alanine racemasecan comprise alanine racemase 1 (ALR1) or alanine racemase 2 (ALR2). Thealanine racemase can comprise an amino acid sequence having at least 85%identity with SEQ ID NO: 247 or 248.

The alanine racemase can comprise an amino acid sequence having at least90% identity with SEQ ID NO: 247 or 248.

The alanine racemase can comprise an amino acid sequence having at least95% identity with SEQ ID NO: 247 or 248.

The alanine racemase can comprise an amino acid sequence having at least98% identity with SEQ ID NO: 247 or 248.

The alanine racemase can comprise an amino acid sequence having at least99% identity with SEQ ID NO: 247 or 248.

The alanine racemase can comprise an amino acid sequence having 100%identity with SEQ ID NO: 247 or 248.

The exosporium protein can comprise a BclA protein, a BclB protein, aCotE protein a CotO protein, an ExsY protein, an ExsFA/BxpB protein, aCotY protein, an ExsFB protein, an ExsJ protein, an ExsH protein, a YjcAprotein, a YjcB protein, a BclC protein, a BxpA protein, a BclE protein,a BetA/BAS3290 protein, an ExsA protein, an ExsK protein, an ExsBprotein, a YabG protein, or a Tgl protein. The exosporium proteinpreferably comprises a BclA protein, a BclB protein, a CotE protein, ora CotO protein. Exemplary amino acid sequences for these exosporiumproteins can be found in Table 2 above.

The exosporium protein can comprise a BclA protein. The BclA protein cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 141 or 142.

The BclA protein can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 141 or 142.

The BclA protein can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 141 or 142.

The BclA protein can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 141 or 142.

The BclA protein can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 141 or 142.

The BclA protein can comprise an amino acid sequence having 100%identity with SEQ ID NO: 141 or 142.

The exosporium protein can comprise a BclB protein. The BclB protein cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 143 or 144.

The BclB protein can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 143 or 144.

The BclB protein can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 143 or 144.

The BclB protein can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 143 or 144.

The BclB protein can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 143 or 144.

The BclB protein can comprise an amino acid sequence having 100%identity with SEQ ID NO: 143 or 144.

The exosporium protein can comprise a CotE protein. The CotE protein cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 149.

The CotE protein can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 149.

The CotE protein can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 149.

The CotE protein can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 149.

The CotE protein can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 149.

The CotE protein can comprise an amino acid sequence having 100%identity with SEQ ID NO: 149.

The exosporium protein can comprise a CotO protein. The CotO protein cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 126.

The CotO protein can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 126.

The CotO protein can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 126.

The CotO protein can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 126.

The CotO protein can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 126.

The CotO protein can comprise an amino acid sequence having at least100% identity with SEQ ID NO: 126.

The exosporium protein can comprise an ExsY protein. The ExsY proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 123.

The exosporium protein can comprise an ExsFA/BxpB protein. TheExsFA/BxpB protein can comprise an amino acid sequence having at least85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100%identity with SEQ ID NO:124.

The exosporium protein can comprise a CotY protein. The CotY protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:125.

The exosporium protein can comprise an ExsFB protein. The ExsFB proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 127 or 128.

The exosporium protein can comprise an ExsJ protein. The ExJ protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:131.

The exosporium protein can comprise an ExsH protein. The ExsH proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 132.

The exosporium protein can comprise a YjcA protein. The YjcA protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:133.

The exosporium protein can comprise a YjcB protein. The YjcB protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:134 or 135.

The exosporium protein can comprise a BclC protein. The BclC protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% with SEQ ID NO: 136.

The exosporium protein can comprise a BxpA protein. The BxpA protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% with SEQ ID NO: 145.

The exosporium protein can comprise a BclE protein. The BclE protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:146 or 147.

The exosporium protein can comprise a BetA/BAS3290 protein. TheBetA/BAS3290 protein can comprise an amino acid sequence having at least85%, at least 90%, at least 95%, at least 98%, at least 99%, or 100%identity with SEQ ID NO: 148.

The exosporium protein can comprise an ExsA protein. The ExsA proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 150.

The exosporium protein can comprise an ExsK protein. The ExsK proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 151.

The exosporium protein can comprise an ExsB protein. The ExsB proteincan comprise an amino acid sequence having at least 85%, at least 90%,at least 95%, at least 98%, at least 99%, or 100% identity with SEQ IDNO: 152.

The exosporium protein can comprise a YabG protein. The YabG protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:153.

The exosporium protein can comprise a Tgl protein. The Tjl protein cancomprise an amino acid sequence having at least 85%, at least 90%, atleast 95%, at least 98%, at least 99%, or 100% identity with SEQ ID NO:156.

The recombinant Bacillus cereus family member can also express a fusionprotein comprising at least one protein or peptide of interest and atargeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of the recombinantBacillus cereus family member.

VII. Expression of Fusion Proteins in Endophytic Bacillus cereus FamilyMembers, in Bacillus cereus Family Members Capable of DegradingHerbicides or Pesticides, or in Probiotic Bacillus cereus Family Members

Any of the fusion proteins comprising a protein or peptide of interestand a targeting sequence, an exosporium protein, or an exosporiumprotein fragment that targets the fusion protein to the exosporium of arecombinant Bacillus cereus family member, can be expressed anendophytic Bacillus cereus family member, a strain of bacteria that iscapable of degrading an herbicide or a pesticide, or a probiotic strainof bacteria.

The expression of the fusion proteins in an endophytic strain ofbacteria provides the ability to deliver the protein or peptide ofinterest into the plant itself. The endophytic strains can be deliveredto plants using various methods, e.g., the endophytic strains can bedelivered via seed treatment, treatment of the plant growth medium(e.g., soil), irrigation, application to the plant itself (e.g., foliarapplication to the aerial portions of a plant). Once inside the plant,the bacteria multiply and colonize the internal tissues of the plant.

As is explained further hereinbelow, probiotic strains of bacteria thatexpress of the fusion proteins, and in particular strains that are bothprobiotic and endophytic that express the fusion proteins, are useful inmethods for delivering the proteins or peptides of interest (e.g.,enzymes) to animals.

While any of the fusion proteins comprising a protein or peptide ofinterest and a targeting sequence, an exosporium protein, or anexosporium protein fragment that targets the fusion protein to theexosporium of a recombinant Bacillus cereus family member can beexpressed in Bacillus cereus family member strain that is capable ofdegrading an herbicide or a pesticide, as explained further hereinbelow,these strains are particularly useful in methods for decontamination ofan environment contaminated with an herbicide and/or a pesticide.

The present invention therefore relates to a recombinant Bacillus cereusfamily member that expresses a fusion protein comprising at least oneprotein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member,wherein the recombinant Bacillus cereus family member comprises anendophytic strain of bacteria, a strain of bacteria that is capable ofdegrading an herbicide or a pesticide, or a probiotic strain ofbacteria.

The endophytic strain of bacteria can comprise Bacillus cereus familymember EE349, Bacillus cereus family member EE439, Bacillusthuringiensis EE417, Bacillus cereus EE444, or Bacillus thuringiensisEE319, Bacillus thuringiensis EE-B00184, Bacillus cereus family memberEE-B00377, Bacillus pseudomycoides EE-B00366, or Bacillus mycoidesEE-B00363.

For example, the endophytic strain of bacteria can comprise Bacilluscereus family member EE439, Bacillus thuringiensis EE417, Bacilluscereus EE444, or Bacillus thuringiensis EE319, Bacillus thuringiensisEE-B00184, Bacillus cereus family member EE-B00377, Bacilluspseudomycoides EE-B00366, or Bacillus mycoides EE-B00363.

The strain of bacteria that is capable of degrading an herbicide or apesticide can comprise Bacillus cereus family member EE349, Bacilluscereus family member EE-B00377, Bacillus pseudomycoides EE-B00366, orBacillus mycoides EE-B00363.

The probiotic strain of bacteria can comprise Bacillus cereus familymember EE349, Bacillus cereus family member EE439, Bacillusthuringiensis EE417, or Bacillus cereus EE444.

The present invention further relates to a recombinant Bacillus cereusfamily member that expresses a fusion protein comprising at least oneprotein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member,wherein the recombinant Bacillus cereus family member comprises anendophytic strain of bacteria, and the fusion protein comprises any ofthe fusion proteins described in Section I above.

VIII. Targeting Sequences, Exosporium Proteins, and Exosporium ProteinFragments for Use in: (a) Recombinant Bacillus cereus Family Membersthat Express a Fusion Protein and Co-Overexpress a Modulator Protein;(b) Recombinant Bacillus cereus Family Members that Comprise a Mutationor Other Genetic Alteration that Allows for Collection of FreeExosporium; (c) Recombinant Bacillus cereus Family Members thatOverexpress a Protease or a Nuclease; (d) Recombinant Bacillus cereusFamily Members that Express a Fusion Protein and Overexpress anExosporium Protein that has Beneficial Effects on Plants; or (e) orEndophytic Recombinant Bacillus cereus Family Members that ExpressFusion Proteins

Any of the targeting sequences, exosporium proteins, or exosporiumproteins described in this section can be in any of the fusion proteinsin:

-   -   (a) any of the recombinant Bacillus cereus family members that        express a fusion protein and overexpress a modulator protein,        described in Section II above;    -   (b) any of the recombinant Bacillus cereus family members that        express a fusion protein and comprise a mutation or other        genetic alteration that allows for collection of free        exosporium, described in Section IV above;    -   (c) any of the recombinant Bacillus cereus family members that        expresses a fusion protein and overexpress a protease or a        nuclease, described above in Section V.A;    -   (d) any of the recombinant Bacillus cereus family members that        express a fusion protein and overexpress an exosporium protein        that has beneficial effects on plants, described in Section VI        above; and    -   (e) any of the endophytic recombinant Bacillus cereus family        members that express a fusion protein, described in Section VII        above.

In any of the recombinant Bacillus cereus members (a) through (e), thetargeting sequence, exosporium protein, or exosporium protein fragmentcan comprise: (1) a targeting sequence comprising an amino acid sequencehaving at least about 43% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 54%;(2) a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 1;(3) a targeting sequence comprising amino acids 20-35 of SEQ ID NO: 1;(4) a targeting sequence comprising SEQ ID NO: 1; (5) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 2; (6) a targeting sequence comprising amino acids 2-35of SEQ ID NO: 1; (7) a targeting sequence comprising amino acids 5-35 ofSEQ ID NO: 1; (8) a targeting sequence comprising amino acids 8-35 ofSEQ ID NO: 1; (9) a targeting sequence comprising amino acids 10-35 ofSEQ ID NO: 1; (10) a targeting sequence comprising amino acids 15-35 ofSEQ ID NO: 1; (11) a targeting sequence comprising amino acids 1-27 ofSEQ ID NO: 3; (12) a targeting sequence comprising amino acids 12-27 ofSEQ ID NO: 3; (13) a targeting sequence comprising SEQ ID NO: 3; (14) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 4; (15) a targeting sequence comprising aminoacids 2-27 of SEQ ID NO: 3; (16) a targeting sequence comprising aminoacids 5-27 of SEQ ID NO: 3; (17) a targeting sequence comprising aminoacids 8-27 of SEQ ID NO: 3; (18) a targeting sequence comprising aminoacids 10-27 of SEQ ID NO: 3; (19) a targeting sequence comprising aminoacids 1-38 of SEQ ID NO: 5; (20) a targeting sequence comprising aminoacids 23-38 of SEQ ID NO: 5; (21) a targeting sequence comprising SEQ IDNO: 5; (22) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 6; (23) a targetingsequence comprising amino acids 2-38 of SEQ ID NO: 5; (24) a targetingsequence comprising amino acids 5-38 of SEQ ID NO: 5; (25) a targetingsequence comprising amino acids 8-38 of SEQ ID NO: 5; (26) a targetingsequence comprising amino acids 10-38 of SEQ ID NO: 5; (27) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 5; (28) a targetingsequence comprising amino acids 20-38 of SEQ ID NO: 5; (29) a targetingsequence comprising amino acids 1-28 of SEQ ID NO: 7; (30) a targetingsequence comprising amino acids 13-28 of SEQ ID NO: 7; (31) a targetingsequence comprising SEQ ID NO: 7; (32) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 8;(33) a targeting sequence comprising amino acids 2-28 of SEQ ID NO: 7;(34) a targeting sequence comprising amino acids 5-28 of SEQ ID NO: 7;(35) a targeting sequence comprising amino acids 8-28 of SEQ ID NO: 7;(36) a targeting sequence comprising amino acids 10-28 of SEQ ID NO: 7;(37) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 9;(38) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 9;(39) a targeting sequence comprising SEQ ID NO: 9; (40) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 10; (41) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 9; (42) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 9; (43) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 9; (44) a targeting sequence comprising amino acids1-33 of SEQ ID NO:11; (45) a targeting sequence comprising amino acids18-33 of SEQ ID NO: 11; (46) a targeting sequence comprising SEQ ID NO:11; (47) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 12; (48) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 11; (49) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 11; (50) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 11; (51) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 11; (52) a targeting sequencecomprising amino acids 15-33 of SEQ ID NO: 11; (53) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 13; (54) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 13; (55) a targeting sequencecomprising SEQ ID NO:13; (56) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:14; (57) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 13; (58) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 13; (59) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 13; (60) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 13; (61) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 13; (62) atargeting sequence comprising amino acids 1-43 of SEQ ID NO: 15; (63) atargeting sequence comprising amino acids 28-43 of SEQ ID NO: 15; (64) atargeting sequence comprising SEQ ID NO:15; (65) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:16; (66) a targeting sequence comprising amino acids 2-43 of SEQID NO: 15; (67) a targeting sequence comprising amino acids 5-43 of SEQID NO: 15; (68) a targeting sequence comprising amino acids 8-43 of SEQID NO: 15; (69) a targeting sequence comprising amino acids 10-43 of SEQID NO: 15; (70) a targeting sequence comprising amino acids 15-43 of SEQID NO: 15; (71) a targeting sequence comprising amino acids 20-43 of SEQID NO: 15; (72) a targeting sequence comprising amino acids 25-43 of SEQID NO: 15; (73) a targeting sequence comprising amino acids 1-27 of SEQID NO: 17; (74) a targeting sequence comprising amino acids 12-27 of SEQID NO: 17; (75) a targeting sequence comprising SEQ ID NO:17; (76) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:18; (77) a targeting sequence comprising aminoacids 2-27 of SEQ ID NO: 17; (78) a targeting sequence comprising aminoacids 5-27 of SEQ ID NO: 17; (79) a targeting sequence comprising aminoacids 8-27 of SEQ ID NO: 17; (80) a targeting sequence comprising aminoacids 10-27 of SEQ ID NO: 17; (81) a targeting sequence comprising aminoacids 1-33 of SEQ ID NO: 19; (82) a targeting sequence comprising aminoacids 18-33 of SEQ ID NO: 19; (83) a targeting sequence comprising SEQID NO:19; (84) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:20; (85) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 19; (86) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 19; (87) a targetingsequence comprising amino acids 8-33 of SEQ ID NO: 19; (88) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 19; (89) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 19; (90) a targetingsequence comprising amino acids 1-33 of SEQ ID NO: 21; (91) a targetingsequence comprising amino acids 18-33 of SEQ ID NO: 21; (92) a targetingsequence comprising SEQ ID NO:21; (93) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:22;(94) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 21;(95) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 21;(96) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 21;(97) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 21;(98) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 21;(99) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 23;(100) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 23;(101) a targeting sequence comprising SEQ ID NO:23; (102) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:24; (103) a targeting sequence comprising amino acids2-24 of SEQ ID NO:23; (104) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 23; (105) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 23; (106) a targeting sequence comprising amino acids1-24 of SEQ ID NO: 25; (107) a targeting sequence comprising amino acids9-24 of SEQ ID NO: 25; (108) a targeting sequence comprising SEQ IDNO:25; (109) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:26; (110) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 25; (111) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 25; (112) a targetingsequence comprising amino acids 8-24 of SEQ ID NO: 25; (113) a targetingsequence comprising amino acids 1-30 of SEQ ID NO: 27; (114) a targetingsequence comprising amino acids 15-30 of SEQ ID NO: 27; (115) atargeting sequence comprising SEQ ID NO:27; (116) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:28; (117) a targeting sequence comprising amino acids 2-30 of SEQID NO: 27; (118) a targeting sequence comprising amino acids 5-30 of SEQID NO: 27; (119) a targeting sequence comprising amino acids 8-30 of SEQID NO: 27; (120) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 27; (121) a targeting sequence comprising amino acids 1-33 ofSEQ ID NO: 29; (122) a targeting sequence comprising amino acids 18-33of SEQ ID NO: 29; (123) a targeting sequence comprising SEQ ID NO:29;(124) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:30; (125) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 29; (126) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 29; (127) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 29; (128) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 29; (129) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 29; (130) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 31; (131) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 31; (132) atargeting sequence comprising SEQ ID NO:31; (133) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:32; (134) a targeting sequence comprising amino acids 2-24 of SEQID NO: 31; (135) a targeting sequence comprising amino acids 5-24 of SEQID NO: 31; (136) a targeting sequence comprising amino acids 8-24 of SEQID NO: 31; (137) a targeting sequence comprising amino acids 1-15 of SEQID NO: 33; (138) a targeting sequence comprising SEQ ID NO:33; (139) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:34; (140) a targeting sequence comprising aminoacids 1-16 of SEQ ID NO: 35; (141) a targeting sequence comprising SEQID NO:35; (142) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:36; (143) a targetingsequence comprising amino acids 1-29 of SEQ ID NO:43; (144) a targetingsequence comprising amino acids 14-29 of SEQ ID NO: 43; (145) atargeting sequence comprising SEQ ID NO: 43; (146) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 44; (147) a targeting sequence comprising amino acids 2-29 of SEQID NO: 43; (148) a targeting sequence comprising amino acids 5-29 of SEQID NO: 43; (149) a targeting sequence comprising amino acids 8-29 of SEQID NO: 43; (150) a targeting sequence comprising amino acids 10-29 ofSEQ ID NO: 43; (151) a targeting sequence comprising amino acids 1-35 ofSEQ ID NO: 45; (152) a targeting sequence comprising amino acids 20-35of SEQ ID NO: 45; (153) a targeting sequence comprising SEQ ID NO: 45;(154) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 46; (155) a targeting sequencecomprising amino acids 2-35 of SEQ ID NO: 45; (156) a targeting sequencecomprising amino acids 5-35 of SEQ ID NO: 45; (157) a targeting sequencecomprising amino acids 8-35 of SEQ ID NO: 45; (158) a targeting sequencecomprising amino acids 10-35 of SEQ ID NO: 45; (159) a targetingsequence comprising amino acids 15-35 of SEQ ID NO: 45; (160) atargeting sequence comprising amino acids 1-43 of SEQ ID NO: 47; (161) atargeting sequence comprising amino acids 28-43 of SEQ ID NO: 47; (162)a targeting sequence comprising SEQ ID NO: 47; (163) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 48; (164) a targeting sequence comprising amino acids2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising amino acids5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising amino acids8-43 of SEQ ID NO: 47; (167) a targeting sequence comprising amino acids10-43 of SEQ ID NO: 47; (168) a targeting sequence comprising aminoacids 15-43 of SEQ ID NO: 47; (169) a targeting sequence comprisingamino acids 20-43 of SEQ ID NO: 47; (170) a targeting sequencecomprising amino acids 25-43 of SEQ ID NO: 47; (171) a targetingsequence comprising amino acids 1-32 of SEQ ID NO: 49; (172) a targetingsequence comprising amino acids 17-32 of SEQ ID NO: 49; (173) atargeting sequence comprising SEQ ID NO: 49; (174) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 50; (175) a targeting sequence comprising amino acids 2-32 of SEQID NO: 49; (176) a targeting sequence comprising amino acids 5-32 of SEQID NO: 49; (177) a targeting sequence comprising amino acids 8-32 of SEQID NO: 49; (178) a targeting sequence comprising amino acids 10-32 ofSEQ ID NO: 49; (179) a targeting sequence comprising amino acids 15-32of SEQ ID NO: 49; (180) a targeting sequence comprising amino acids 1-33of SEQ ID NO: 51; (181) a targeting sequence comprising amino acids18-33 of SEQ ID NO: 51; (182) a targeting sequence comprising SEQ ID NO:51; (183) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 52; (184) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 51; (185) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 51; (186) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 51; (187) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 51; (188) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 51; (189) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 53; (190) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 53; (191)a targeting sequence comprising SEQ ID NO: 53; (192) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 54; (193) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 53; (194) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 53; (195) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 53; (197) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 53; (198) a targeting sequence comprisingamino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequence comprisingamino acids 15-30 of SEQ ID NO: 55; (200) a targeting sequencecomprising SEQ ID NO: 55; (201) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 56;(202) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 55;(203) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 55;(204) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 55;(205) a targeting sequence comprising amino acids 10-30 of SEQ ID NO:55; (206) a targeting sequence comprising amino acids 1-130 of SEQ IDNO: 57; (207) a targeting sequence comprising amino acids 115-130 of SEQID NO: 57; (208) a targeting sequence comprising SEQ ID NO: 57; (209) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 58; (210) a targeting sequence comprising aminoacids 2-130 of SEQ ID NO: 57; (211) a targeting sequence comprisingamino acids 5-130 of SEQ ID NO: 57; (212) a targeting sequencecomprising amino acids 10-130 of SEQ ID NO: 57; (213) a targetingsequence comprising amino acids 20-130 of SEQ ID NO: 57; (214) atargeting sequence comprising amino acids 30-130 of SEQ ID NO: 57; (215)a targeting sequence comprising amino acids 40-130 of SEQ ID NO: 57;(216) a targeting sequence comprising amino acids 50-130 of SEQ ID NO:57; (217) a targeting sequence comprising amino acids 60-130 of SEQ IDNO: 57; (218) a targeting sequence comprising amino acids 70-130 of SEQID NO: 57; (219) a targeting sequence comprising amino acids 80-130 ofSEQ ID NO: 57; (220) a targeting sequence comprising amino acids 90-130of SEQ ID NO: 57; (221) a targeting sequence comprising amino acids100-130 of SEQ ID NO: 57; (222) a targeting sequence comprising aminoacids 110-130 of SEQ ID NO: 57; (223) an exosporium protein fragmentcomprising an amino acid sequence having at least 85% identity with SEQID NO: 95; (224) a targeting sequence comprising SEQ ID NO: 96; (225) atargeting sequence comprising SEQ ID NO: 97; (226) a targeting sequencecomprising SEQ ID NO: 98; (227) a targeting sequence comprising SEQ IDNO: 99; (228) a targeting sequence comprising SEQ ID NO: 100; (229) atargeting sequence comprising SEQ ID NO: 101; (230) a targeting sequencecomprising SEQ ID NO: 102; (231) a targeting sequence comprising SEQ IDNO: 103; (232) a targeting sequence comprising SEQ ID NO: 104; (233) atargeting sequence comprising SEQ ID NO: 105; (234) a targeting sequencecomprising SEQ ID NO: 106; (235) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 108;(236) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 109; (237) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 110; (238) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 111; (239) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 112; (240) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 113;(241) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 114; (242) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 115; (243) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 116; (244) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 117; (245) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 118;(246) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 119; (247) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 120; (248) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 121; (249) atargeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; (250) atargeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; (251) atargeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; (252) atargeting sequence comprising amino acids 14-23 of SEQ ID NO: 3; (253) atargeting sequence comprising amino acids 14-25 of SEQ ID NO: 3; (254) atargeting sequence comprising amino acids 12-23 of SEQ ID NO: 3; (255) atargeting sequence comprising amino acids 1-30 of SEQ ID NO: 59; (256) atargeting sequence comprising SEQ ID NO: 59; (257) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 60; (258) a targeting sequence comprising amino acids 2-30 of SEQID NO: 59; (259) a targeting sequence comprising amino acids 4-30 of SEQID NO: 59; (260) a targeting sequence comprising amino acids 6-30 of SEQID NO: 59; (261) a targeting sequence comprising amino acids 1-33 of SEQID NO: 61; (262) a targeting sequence comprising amino acids 18-33 ofSEQ ID NO: 61; (263) a targeting sequence comprising SEQ ID NO: 61;(264) an exosporium protein comprising an amino acid sequence having atleast 85% sequence identity with SEQ ID NO: 62; (265) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 61; (266) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 61; (267) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 61; (268) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 61; (269)a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 63; (270)a targeting sequence comprising SEQ ID NO: 63; (271) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 64; (272) a targeting sequence comprising amino acids2-35 of SEQ ID NO: 63; (273) a targeting sequence comprising amino acids5-35 of SEQ ID NO: 63; (274) a targeting sequence comprising amino acids8-35 of SEQ ID NO: 63; (275) a targeting sequence comprising amino acids10-35 of SEQ ID NO: 63; (276) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 63; (277) a targeting sequence comprisingamino acids 1-24 of SEQ ID NO: 65; (278) a targeting sequence comprisingamino acids 9-24 of SEQ ID NO: 65; (279) a targeting sequence comprisingSEQ ID NO: 65; (280) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 66; (281) atargeting sequence comprising SEQ ID NO: 107; (282) a targeting sequencecomprising amino acids 2-24 of SEQ ID NO: 65; (283) a targeting sequencecomprising amino acids 5-24 of SEQ ID NO: 65; (284) a targeting sequencecomprising amino acids 1-27 of SEQ ID NO: 67; (285) a targeting sequencecomprising amino acids 12-27 of SEQ ID NO: 67; (286) a targetingsequence comprising SEQ ID NO: 67; (287) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 68; (288) an targeting sequence comprising amino acids 2-27 ofSEQ ID NO: 67; (289) a targeting sequence comprising amino acids 5-27 ofSEQ ID NO: 67; (290) a targeting sequence comprising amino acids 10-27of SEQ ID NO: 67; (291) a targeting sequence comprising amino acids 1-38of SEQ ID NO: 69; (292) a targeting sequence comprising amino acids23-38 of SEQ ID NO: 69; (293) a targeting sequence comprising SEQ ID NO:69; (294) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 70; (295) a targeting sequencecomprising amino acids 2-38 of SEQ ID NO: 69; (296) a targeting sequencecomprising amino acids 5-38 of SEQ ID NO: 69; (297) a targeting sequencecomprising amino acids 10-38 of SEQ ID NO: 69; (298) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 69; (299) anexosporium protein comprising SEQ ID NO: 72; (300) a targeting sequencecomprising SEQ ID NO: 73; (301) an exosporium protein comprising anamino acid sequence having at least 95% identity with SEQ ID NO: 74;(302) a targeting sequence comprising amino acids 1-42 of SEQ ID NO: 75;(303) a targeting sequence comprising amino acids 27-42 of SEQ ID NO:75; (304) a targeting sequence comprising SEQ ID NO: 75; (305) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 76; (306) a targeting sequence comprising aminoacids 2-42 of SEQ ID NO: 75; (307) a targeting sequence comprising aminoacids 5-42 of SEQ ID NO: 75; (308) a targeting sequence comprising aminoacids 10-42 of SEQ ID NO: 75; (309) a targeting sequence comprisingamino acids 15-42 of SEQ ID NO: 75; (310) a targeting sequencecomprising amino acids 20-42 of SEQ ID NO: 75; (311) a targetingsequence comprising amino acids 25-42 of SEQ ID NO: 75; (312) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 77; (313) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 77; (314) atargeting sequence comprising SEQ ID NO: 77; (315) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 78; (316) a targeting sequence comprising amino acids 2-24 of SEQID NO: 77; (317) a targeting sequence comprising amino acids 5-24 of SEQID NO: 77; (318) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 80; (319) a targetingsequence comprising amino acids 1-38 of SEQ ID NO: 81; (320) a targetingsequence comprising amino acids 23-38 of SEQ ID NO: 81; (321) atargeting sequence comprising SEQ ID NO: 81; (322) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 82; (323) a targeting sequence comprising amino acids 2-38 of SEQID NO: 81; (324) a targeting sequence comprising amino acids 5-38 of SEQID NO: 81; (325) a targeting sequence comprising amino acids 10-38 ofSEQ ID NO: 81; (326) a targeting sequence comprising amino acids 15-38of SEQ ID NO: 81; (327) a targeting sequence comprising amino acids20-38 of SEQ ID NO: 81; (328) a targeting sequence comprising aminoacids 1-34 of SEQ ID NO: 83; (329) a targeting sequence comprising SEQID NO: 83; (330) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 84; (331) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 86; (332) a targeting sequence comprising amino acids1-28 of SEQ ID NO: 87; (333) a targeting sequence comprising amino acids13-28 of SEQ ID NO: 87; (334) a targeting sequence comprising SEQ ID NO:87; (335) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 88; (336) a targeting sequencecomprising amino acids 2-28 of SEQ ID NO: 87; (337) a targeting sequencecomprising amino acids 5-28 of SEQ ID NO: 87; (338) a targeting sequencecomprising amino acids 10-28 of SEQ ID NO: 87; (339) a targetingsequence comprising amino acids 1-28 of SEQ ID NO: 89; (340) a targetingsequence comprising SEQ ID NO: 89; (341) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 90; (342) a targeting sequence comprising amino acids 2-28 of SEQID NO: 89; (343) a targeting sequence comprising amino acids 5-28 of SEQID NO: 89; (344) a targeting sequence comprising amino acids 10-28 ofSEQ ID NO: 89; (345) a targeting sequence comprising amino acids 1-93 ofSEQ ID NO: 91; (346) a targeting sequence comprising SEQ ID NO: 91;(347) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 92; (348) a targeting sequencecomprising amino acids 2-93 of SEQ ID NO: 91; (349) a targeting sequencecomprising amino acids 10-93 of SEQ ID NO: 91; (350) a targetingsequence comprising amino acids 20-93 of SEQ ID NO: 91; (351) atargeting sequence comprising amino acids 30-93 of SEQ ID NO: 91; (352)a targeting sequence comprising amino acids 40-93 of SEQ ID NO: 91;(353) a targeting sequence comprising amino acids 50-93 of SEQ ID NO:91; (354) a targeting sequence comprising amino acids 60-93 of SEQ IDNO: 91; (355) a targeting sequence comprising amino acids 1-130 of SEQID NO: 93; (356) a targeting sequence comprising SEQ ID NO: 93; (357) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 94; (358) a targeting sequence comprising aminoacids 2-130 of SEQ ID NO: 93; (359) a targeting sequence comprisingamino acids 10-130 of SEQ ID NO: 93; (360) a targeting sequencecomprising amino acids 20-130 of SEQ ID NO: 93; (361) a targetingsequence comprising amino acids 30-130 of SEQ ID NO: 93; (362) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 122; (363) a targeting sequence consisting ofamino acids 20-33 of SEQ ID NO: 1; (364) a targeting sequence consistingof amino acids 21-33 of SEQ ID NO: 1; (365) a targeting sequenceconsisting of amino acids 23-31 of SEQ ID NO: 1; (366) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 96; (367) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 96;(368) a targeting sequence consisting of amino acids 12-25 of SEQ ID NO:3; (369) a targeting sequence consisting of amino acids 13-25 of SEQ IDNO: 3; (370) a targeting sequence consisting of amino acids 15-23 of SEQID NO: 3; (371) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 97; (372) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 98; (373) a targeting sequence consisting of amino acids23-36 of SEQ ID NO: 5; (374) a targeting sequence consisting of aminoacids 23-34 of SEQ ID NO: 5; (375) a targeting sequence consisting ofamino acids 24-36 of SEQ ID NO: 5; (376) a targeting sequence consistingof amino acids 26-34 of SEQ ID NO: 5; (377) a targeting sequenceconsisting of amino acids 13-26 of SEQ ID NO: 7; (378) a targetingsequence consisting of amino acids 13-24 of SEQ ID NO: 7; (379) atargeting sequence consisting of amino acids 14-26 of SEQ ID NO: 7;(380) a targeting sequence consisting of amino acids 16-24 of SEQ ID NO:7; (381) a targeting sequence consisting of amino acids 9-22 of SEQ IDNO: 9; (382) a targeting sequence consisting of amino acids 9-20 of SEQID NO: 9; (383) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 9; (384) a targeting sequence consisting of amino acids 12-20of SEQ ID NO: 9; (385) a targeting sequence consisting of amino acids1-15 of SEQ ID NO: 105; (386) a targeting sequence consisting of aminoacids 1-13 of SEQ ID NO: 105; (387) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 11; (388) a targeting sequenceconsisting of amino acids 18-29 of SEQ ID NO: 11; (389) a targetingsequence consisting of amino acids 19-31 of SEQ ID NO: 11; (390) atargeting sequence consisting of amino acids 1-15 of SEQ ID NO: 98;(391) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:98; (392) a targeting sequence consisting of amino acids 18-31 of SEQ IDNO: 13; (393) a targeting sequence consisting of amino acids 18-29 ofSEQ ID NO: 13; (394) a targeting sequence consisting of amino acids19-31 of SEQ ID NO: 13; (395) a targeting sequence consisting of aminoacids 21-29 of SEQ ID NO: 13; (396) a targeting sequence consisting ofamino acids 1-15 of SEQ ID NO: 99; (397) a targeting sequence consistingof amino acids 1-13 of SEQ ID NO: 99; (398) a targeting sequenceconsisting of amino acids 28-41 of SEQ ID NO: 15; (399) a targetingsequence consisting of amino acids 28-39 of SEQ ID NO: 15; (400) atargeting sequence consisting of amino acids 29-41 of SEQ ID NO: 15;(401) a targeting sequence consisting of amino acids 31-39 of SEQ ID NO:15; (402) a targeting sequence consisting of amino acids 12-25 of SEQ IDNO: 17; (403) a targeting sequence consisting of amino acids 13-25 ofSEQ ID NO: 17; (404) a targeting sequence consisting of amino acids 1-15of SEQ ID NO: 100; (405) a targeting sequence consisting of amino acids18-31 of SEQ ID NO: 19; (406) a targeting sequence consisting of aminoacids 18-29 of SEQ ID NO: 19; (407) a targeting sequence consisting ofamino acids 19-31 of SEQ ID NO: 19; (408) a targeting sequenceconsisting of amino acids 21-29 of SEQ ID NO: 19; (409) a targetingsequence consisting of amino acids 18-31 of SEQ ID NO: 21; (410) atargeting sequence consisting of amino acids 18-29 of SEQ ID NO: 21;(411) a targeting sequence consisting of amino acids 19-31 of SEQ ID NO:21; (412) a targeting sequence consisting of amino acids 21-29 of SEQ IDNO: 21; (413) a targeting sequence consisting of amino acids 1-15 of SEQID NO: 101; (414) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 101; (415) a targeting sequence consisting of amino acids9-22 of SEQ ID NO: 23; (416) a targeting sequence consisting of aminoacids 9-20 of SEQ ID NO: 23; (417) a targeting sequence consisting ofamino acids 10-22 of SEQ ID NO: 23; (418) a targeting sequenceconsisting of amino acids 12-20 of SEQ ID NO: 23; (419) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 102; (420) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 102;(421) a targeting sequence consisting of amino acids 9-22 of SEQ ID NO:25; (422) a targeting sequence consisting of amino acids 9-20 of SEQ IDNO: 25; (423) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 25; (424) a targeting sequence consisting of amino acids12-20 of SEQ ID NO: 25; (425) a targeting sequence consisting of aminoacids 1-15 of SEQ ID NO: 103; (426) a targeting sequence consisting ofamino acids 1-13 of SEQ ID NO: 103; (427) a targeting sequenceconsisting of amino acids 15-28 of SEQ ID NO: 27; (428) a targetingsequence consisting of amino acids 15-26 of SEQ ID NO: 27; (429) atargeting sequence consisting of amino acids 16-28 of SEQ ID NO: 27;(430) a targeting sequence consisting of amino acids 18-26 of SEQ ID NO:27; (431) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 104; (432) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 104; (433) a targeting sequence consisting of amino acids1-13 of SEQ ID NO: 33; (434) a targeting sequence consisting of aminoacids 1-11 of SEQ ID NO: 33; (435) a targeting sequence consisting ofamino acids 3-11 of SEQ ID NO: 33; (436) a targeting sequence consistingof amino acids 1-14 of SEQ ID NO: 35; (437) a targeting sequenceconsisting of amino acids 1-12 of SEQ ID NO: 35; (438) a targetingsequence consisting of amino acids 2-14 of SEQ ID NO: 35; (439) atargeting sequence consisting of amino acids 14-27 of SEQ ID NO: 43;(440) a targeting sequence consisting of amino acids 14-25 of SEQ ID NO:43; (441) a targeting sequence consisting of amino acids 15-27 of SEQ IDNO: 43; (442) a targeting sequence consisting of amino acids 20-33 ofSEQ ID NO: 45; (443) a targeting sequence consisting of amino acids20-31 of SEQ ID NO: 45; (444) a targeting sequence consisting of aminoacids 21-33 of SEQ ID NO: 45; (445) a targeting sequence consisting ofamino acids 1-15 of SEQ ID NO: 106; (446) a targeting sequenceconsisting of amino acids 1-13 of SEQ ID NO: 106; (447) a targetingsequence consisting of amino acids 28-41 of SEQ ID NO: 47; (448) atargeting sequence consisting of amino acids 28-39 of SEQ ID NO: 47;(449) a targeting sequence consisting of amino acids 18-31 of SEQ ID NO:53; (450) a targeting sequence consisting of amino acids 18-29 of SEQ IDNO: 53; (451) a targeting sequence consisting of amino acids 19-31 ofSEQ ID NO: 53; (452) a targeting sequence comprising amino acids 18-31of SEQ ID NO: 61; (453) a targeting sequence comprising amino acids18-29 of SEQ ID NO: 61; (454) a targeting sequence comprising aminoacids 19-31 of SEQ ID NO: 61; (455) a targeting sequence comprisingamino acids 9-22 of SEQ ID NO: 65; (456) a targeting sequence comprisingamino acids 9-20 of SEQ ID NO: 65; (457) a targeting sequence comprisingamino acids 10-22 of SEQ ID NO: 65; (458) a targeting sequencecomprising amino acids 1-15 of SEQ ID NO: 107; (459) a targetingsequence comprising amino acids 1-13 of SEQ ID NO: 107; (460) atargeting sequence comprising amino acids 12-25 of SEQ ID NO: 67; (461)a targeting sequence comprising amino acids 12-23 of SEQ ID NO: 67;(462) a targeting sequence comprising amino acids 13-25 of SEQ ID NO:67; (463) a targeting sequence comprising amino acids 15-23 of SEQ IDNO: 67; (464) a targeting sequence comprising amino acids 23-36 of SEQID NO: 69; (465) a targeting sequence comprising amino acids 23-34 ofSEQ ID NO: 69; (466) a targeting sequence comprising amino acids 24-36of SEQ ID NO: 69; (467) a targeting sequence comprising amino acids26-34 of SEQ ID NO: 69; (468) a targeting sequence comprising aminoacids 27-40 of SEQ ID NO: 75; (469) a targeting sequence comprisingamino acids 27-38 of SEQ ID NO: 75; (470) a targeting sequencecomprising amino acids 9-22 of SEQ ID NO: 77; (471) a targeting sequencecomprising amino acids 9-20 of SEQ ID NO: 77; (472) a targeting sequencecomprising amino acids 10-22 of SEQ ID NO: 77; (473) a targetingsequence comprising amino acids 12-20 of SEQ ID NO: 77; (474) atargeting sequence comprising amino acids 23-36 of SEQ ID NO: 81; (475)a targeting sequence comprising amino acids 23-34 of SEQ ID NO: 81;(476) a targeting sequence comprising amino acids 24-36 of SEQ ID NO:81; (477) a targeting sequence comprising amino acids 26-34 of SEQ IDNO: 81; (478) a targeting sequence comprising amino acids 13-26 of SEQID NO: 87; (479) a targeting sequence comprising amino acids 13-24 ofSEQ ID NO: 87; or (480) a targeting sequence comprising amino acids14-26 of SEQ ID NO: 87.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 50% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 63%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 56% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 63%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 50% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 62% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 75% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 68% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 81%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 75% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 81%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 81%.

For example, the targeting sequence can comprise an amino acid sequencehaving at least about 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 90%.

For example, the targeting sequence can consist of: (a) an amino acidsequence consisting of 16 amino acids and having at least about 43%identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identitywith amino acids 25-35 is at least about 54%; (b) amino acids 1-35 ofSEQ ID NO: 1; (c) amino acids 20-35 of SEQ ID NO: 1; (d) SEQ ID NO: 1;(e) SEQ ID NO: 96; or (f) SEQ ID NO: 120.

The targeting sequence can consist of the amino acid sequence asdescribed in these examples.

The fusion protein can comprise an exosporium protein or an exosporiumprotein fragment comprising an amino acid sequence having at least 90%identity with SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110,111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and 122.

The fusion protein can comprise an exosporium protein or an exosporiumprotein fragment comprising an amino acid sequence having at least 95%identity with SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110,111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and 122.

The fusion protein can comprise an exosporium protein or an exosporiumprotein fragment comprising an amino acid sequence having at least 98%identity with SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110,111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and 122.

The fusion protein can comprise an exosporium protein or an exosporiumprotein fragment comprising an amino acid sequence having at least 99%identity with SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110,111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, and 122.

The fusion protein can comprise an exosporium protein or an exosporiumprotein fragment comprising an amino acid sequence having 100% identitywith SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30,32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72,74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110, 111, 112,113, 114, 115, 116, 117, 118, 119, 120, 121, and 122.

The fusion protein can comprise an exosporium protein comprising anamino acid sequence having at least 90% identity with SEQ ID NO: 60, 62,64, 66, 68, 70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94 or 122.

The fusion protein can comprise an exosporium protein comprising anamino acid sequence having at least 95% identity with SEQ ID NO: 60, 62,64, 66, 68, 70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94 or 122.

The fusion protein can comprise an exosporium protein comprising anamino acid sequence having at least 98% identity with SEQ ID NO: 60, 62,64, 66, 68, 70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94 or 122.

The fusion protein can comprise an exosporium protein comprising anamino acid sequence having at least 99% identity with SEQ ID NO: 60, 62,64, 66, 68, 70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94 or 122.

The fusion protein can comprise an exosporium protein comprising anamino acid sequence having 100% identity with SEQ ID NO: 60, 62, 64, 66,68, 70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94 or 122.

The targeting sequence, exosporium protein, or exosporium proteinfragment of the fusion protein can comprise the amino acid sequence GXTat its carboxy terminus, wherein X is any amino acid.

The targeting sequence, exosporium protein, or exosporium proteinfragment can comprise an alanine residue at the position of thetargeting sequence that corresponds to amino acid 20 of SEQ ID NO: 1.

The targeting sequence, exosporium protein, or exosporium proteinfragment can further comprise a methionine, serine, or threonine residueat the amino acid position immediately preceding the first amino acid ofthe targeting sequence, exosporium protein, or exosporium proteinfragment or at the position of the targeting sequence that correspondsto amino acid 20 of SEQ ID NO: 1.

IX. Fusion Proteins Comprising a Protein or Peptide of Interest and aSpore Coat Protein, Recombinant Spore-Coat Forming Bacteria, and SeedsCoated with Recombinant Spore-Coat Forming Bacteria

A. Spore Coat Proteins that can be Used to Target a Fusion ProteinComprising the Spore Coat Protein to a Surface of a Spore of aRecombinant Spore Forming Bacterium

A number of spore coat proteins can be used to display proteins orpeptides of interest on a surface of a spore of a recombinantspore-forming bacterium. Such bacteria include any spore-formingbacteria, and in particular include spore-forming bacteria of thegenuses Bacillus, Lysinibacillus, Virginibacillus, Clostridia, andPaenibacillus. Spore-forming bacteria of the genus Bacillus includeBacillus cereus family members as well as other Bacillus species thatare not Bacillus cereus family members (e.g., Bacillus species bacteriathat lack an exosporium). These spore coat proteins include CotB, CotC,CgeA, CotB/H, CotG, spore coat protein X, and CotY. For ease ofreference, the descriptions of the amino acid sequences for exemplaryspore coat proteins that can be used for targeting of proteins orpeptides of interest to a spore surface of a recombinant spore-formingbacterium are provided in Table 7 below, together with their SEQ ID NOs.

TABLE 7 Spore coat protein sequences used for targeting of proteins andpeptides of interest to a spore surface of a recombinant spore-formingbacterium Spore coat protein SEQ ID NO. CotB (Bacillus subtilis) 252CotC (Bacillus subtilis) 253 CgeA (Bacillus amyloliquefaciens) 254CotB/H (Bacillus amyloliquefaciens) 255 CotG (Bacillus subtilis) 256Spore Coat Protein X (Bacillus megaterium) 257 CotY (Bacillusamyloliquefaciens) 258 CotY (Bacillus licheniformis) 259

B. Fusion Proteins Comprising a Protein or Peptide of Interest and aSpore Coat Protein

The present invention also relates to fusion proteins comprising atleast one protein or peptide of interest and a spore coat protein,wherein the spore coat protein comprises a CotB/H protein, a sporeprotein X protein, or a CotY protein, wherein the CotY protein comprisesan amino acid sequence having at least 80% identity with SEQ ID NO: 258or 259.

For example, the spore coat protein can comprise a CotB/H protein.

For example, the spore coat protein can comprise a spore protein Xprotein.

For example, the spore coat protein can comprise a CotY protein, whereinthe CotY protein comprises an amino acid sequence having at least 80%identity with SEQ ID NO: 258 or 259.

The spore coat protein can comprises an amino acid sequence having atleast 85% identity with SEQ ID NO: 255, 257, 258, or 259.

The spore coat protein can comprises an amino acid sequence having atleast 90% identity with SEQ ID NO: 255, 257, 258, or 259.

The spore coat protein can comprises an amino acid sequence having atleast 95% identity with SEQ ID NO: 255, 257, 258, or 259.

The spore coat protein can comprises an amino acid sequence having atleast 98% identity with SEQ ID NO: 255, 257, 258, or 259.

The spore coat protein can comprises an amino acid sequence having atleast 99% identity with SEQ ID NO: 255, 257, 258, or 259.

The spore coat protein can comprises an amino acid sequence having atleast 100% identity with SEQ ID NO: 255, 257, 258, or 259.

C. Recombinant Spore-Coat Forming Bacteria that Express Fusion Proteinsand Plant Seeds Coated with Recombinant Spore-Coat Forming Bacteria

Recombinant spore-forming bacteria that expresses any of the fusionproteins described in Section IX.B are provided. The recombinantspore-forming bacteria can comprise an endophytic strain of bacteria, aplant growth-promoting strain of bacteria, or a strain of bacteria thatis both endophytic and plant growth-promoting.

The present invention further relates to a recombinant spore-formingbacterium that expresses a fusion protein comprising at least oneprotein or peptide of interest and a spore coat protein that targets thefusion protein to the surface of a spore of the bacterium, wherein thespore coat protein comprises a CotB protein, a CotC protein, a CgeAprotein, a CotB/H protein, a CotG protein, a spore coat protein Xprotein, or a CotY protein; and wherein the recombinant spore-formingbacterium comprises an endophytic strain of bacteria, a plantgrowth-promoting strain of bacteria, or a strain of bacteria that isboth endophytic and plant growth-promoting.

Expression of the fusion protein in an endophytic strain of bacteriaallows for delivery of the protein or peptide of interest internally toa plant. The endophytic strains can be delivered to plants using variousmethods, e.g., the endophytic strains can be delivered via seedtreatment, treatment of the plant growth medium (e.g., soil),irrigation, application to the plant itself (e.g., foliar application tothe aerial portions of a plant). Once inside the plant, the bacteriamultiply and colonize the internal tissues of the plant.

The present invention also relates to plant seeds coated with arecombinant spore-forming bacterium, wherein the recombinantspore-forming bacterium expresses a fusion protein comprising at leastone protein or peptide of interest and a spore coat protein that targetsthe fusion protein to the surface of a spore of the bacterium, whereinthe spore coat protein comprises a cotB protein, a CotC protein, a CgeAprotein, a CotB/H protein, a Cot G protein, a spore protein X protein,or a cotY protein.

The recombinant spore-coat forming bacterium can comprise a bacterium ofthe genus Bacillus or Lysinibacillus.

The present invention further relates to a recombinant bacterium of thegenus Bacillus, wherein the recombinant bacterium comprises arecombinant spore-forming bacterium and wherein the recombinantspore-forming bacterium expresses a fusion protein comprising at leastone protein or peptide of interest and a spore coat protein that targetsthe fusion protein to the surface of a spore of the bacterium, whereinthe spore coat protein comprises a CotB protein, a CotC protein, a CgeAprotein, a CotB/H protein, a Cot G protein, a spore coat protein Xprotein, or a CotY protein. The recombinant spore-coat forming bacteriumexpresses a protease or a nuclease, wherein the expression of theprotease or nuclease is increased as compared to the expression of theprotease or the nuclease in a wild-type bacterium of the genus Bacillusunder the same conditions, and wherein the increased expression of theprotease or the nuclease partially or completely inactivates spores ofthe recombinant bacterium of the genus Bacillus or renders spores of therecombinant bacterium of the genus Bacillus more susceptible to physicalor chemical inactivation. The protease or nuclease can be any of theproteases or nucleases described above in Section V.A, and can beexpressed under the control of any of the promoters described above inSection V.A. The invention further relates to plant seeds coated withsuch spore-forming bacteria. The recombinant bacterium can comprise anendophytic strain of bacteria, a plant growth-promoting strain ofbacteria, or a strain of bacteria that is both endophytic and plantgrowth-promoting.

In any of the plant seeds described in this Section, the recombinantspore-forming bacterium can comprise an endophytic strain of bacteria, aplant growth-promoting strain of bacteria, or a strain of bacteria thatis both endophytic and plant growth-promoting.

In any of the recombinant spore-forming bacteria or seeds, theendophytic strain of bacteria, the plant growth-promoting strain ofbacteria, or the strain of bacteria that is both endophytic and plantgrowth-promoting can comprise Bacillus megaterium EE385, Bacillus sp.EE387, Bacillus circulans EE388, Bacillus subtilis EE405, Lysinibacillusfusiformis EE442, or Lysinibacillus sphaericus EE443, Bacillus pumilusEE-B00143, Bacillus subtilis EE148, Bacillus subtilis EE218, or Bacillusmegaterium EE281. For example, the endophytic strain of bacteria cancomprise Bacillus subtilis EE405 or Bacillus megaterium EE385.

Alternatively, the endophytic strain, the plant growth-promoting strainof bacteria, or the strain of bacteria that is both endophytic and plantgrowth-promoting of bacteria can comprise Bacillus cereus family memberEE349, Bacillus cereus family member EE439, Bacillus thuringiensisEE417, Bacillus cereus EE444, or Bacillus thuringiensis EE319, Bacillusthuringiensis EE-B00184, Bacillus cereus family member EE-B00377,Bacillus pseudomycoides EE-B00366, Bacillus mycoides EE-B00363, Bacillusmycoides BT155, Bacillus mycoides EE118, Bacillus mycoides EE141,Bacillus mycoides BT46-3, Bacillus cereus family member EE128, Bacillusthuringiensis BT013A, or Bacillus cereus family member EE349.

In any of the recombinant spore-forming bacteria or seeds, the sporecoat protein can comprise an amino acid sequence having at least 85%identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 90% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 95% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 98% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 99% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having 100%identity with any of SEQ ID NOs: 252-259.

A recombinant spore-forming bacterium that expresses a fusion proteincomprising at least one protein or peptide of interest and a proteinthat targets the fusion protein to the surface of a spore of thebacterium is also provided. The recombinant spore-forming bacterium isnot a recombinant Bacillus cereus family member. The protein thattargets the fusion protein to the surface of a spore of the bacteriumcomprises amino acids 20-35 of SEQ ID NO: 1, SEQ ID NO: 96, or an aminoacid sequence having at least 85% identity with SEQ ID NO: 108, SEQ IDNO: 111, SEQ ID NO: 114, SEQ ID NO: 120, or SEQ ID NO: 121.

The protein that targets the fusion protein of the surface of a spore ofthe bacterium can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 108, SEQ ID NO: 111, SEQ ID NO: 114, SEQ ID NO:120, or SEQ ID NO: 121.

The protein that targets the fusion protein of the surface of a spore ofthe bacterium can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 108, SEQ ID NO: 111, SEQ ID NO: 114, SEQ ID NO:120, or SEQ ID NO: 121.

The protein that targets the fusion protein of the surface of a spore ofthe bacterium can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 108, SEQ ID NO: 111, SEQ ID NO: 114, SEQ ID NO:120, or SEQ ID NO: 121.

The protein that targets the fusion protein of the surface of a spore ofthe bacterium can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 108, SEQ ID NO: 111, SEQ ID NO: 114, SEQ ID NO:120, or SEQ ID NO: 121.

The protein that targets the fusion protein of the surface of a spore ofthe bacterium can comprise an amino acid sequence having at least 100%identity with SEQ ID NO: 108, SEQ ID NO: 111, SEQ ID NO: 114, SEQ ID NO:120, or SEQ ID NO: 121.

For example, the protein that targets the fusion protein to a surface ofa spore of the bacterium can comprise amino acids 20-35 of SEQ ID NO: 1,SEQ ID NO: 96, SEQ ID NO: 108, SEQ ID NO: 120, or SEQ ID NO: 121.

The recombinant-spore forming bacterium comprises an endophytic strainof bacteria, a plant growth-promoting strain of bacteria, or a strain ofbacteria that is both endophytic and plant growth-promoting. Forexample, the endophytic strain of bacteria, the plant growth-promotingstrain of bacteria, or the strain of bacteria that is both endophyticand plant growth-promoting comprises Bacillus megaterium EE385, Bacillussp. EE387, Bacillus circulans EE388, Bacillus subtilis EE405,Lysinibacillus fusiformis EE442, Lysinibacillus sphaericus EE443,Bacillus pumilus EE-B00143, Bacillus subtilis EE148, Bacillus subtilisEE218, or Bacillus megaterium EE281. The endophytic strain of bacteriapreferably comprises Bacillus sp. EE387.

X. Methods for Making the Fusion Proteins

Any of the fusion proteins described herein can be made using standardcloning and molecular biology methods known in the art. For example, agene encoding a protein or peptide of interest (e.g., a gene encoding aplant growth stimulating protein or peptide) can be amplified bypolymerase chain reaction (PCR) and ligated to DNA coding for any of theabove-described targeting sequences, exosporium proteins, exosporiumprotein fragments, or spore coat proteins, to form a DNA molecule thatencodes the fusion protein. The DNA molecule encoding the fusion proteincan be cloned into any suitable vector, for example a plasmid vector.The vector suitably comprises a multiple cloning site into which the DNAmolecule encoding the fusion protein can be easily inserted. The vectoralso suitably contains a selectable marker, such as an antibioticresistance gene, such that bacteria transformed, transfected, or matedwith the vector can be readily identified and isolated. Where the vectoris a plasmid, the plasmid suitably also comprises an origin ofreplication. Alternatively, DNA coding for the fusion protein can beintegrated into the chromosomal DNA of the B. cereus family member orspore-forming bacterium host.

XI. Tags, Markers, and Linkers that can be Included in the FusionProteins

Any of the fusion proteins described herein can also comprise additionalpolypeptide sequences that are not part of the targeting sequence,exosporium protein, exosporium protein fragment, or the plant growthstimulating protein or peptide, the protein or peptide that protects aplant from a pathogen, the protein or peptide that enhances stressresistance in a plant, or the plant binding protein or peptide. Forexample, the fusion protein can include tags or markers to facilitatepurification or visualization of the fusion protein (e.g., apolyhistidine tag or a fluorescent protein such as GFP or YFP) orvisualization of recombinant Bacillus cereus family member sporesexpressing the fusion protein.

Expression of fusion proteins on the exosporium of a Bacillus cereusfamily member or on a surface of a spore of a spore-forming bacteriumusing the targeting sequences, exosporium proteins, exosporium proteinfragments, and spore coat proteins described herein is enhanced due to alack of secondary structure in the amino-termini of these sequences,which allows for native folding of the fused proteins and retention ofactivity. Proper folding can be further enhanced by the inclusion of ashort amino acid linker between the targeting sequence, exosporiumprotein, exosporium protein fragment, spore coat protein, and theprotein or peptide of interest.

Thus, any of the fusion proteins described herein can comprise an aminoacid linker between the targeting sequence, the exosporium protein, theexosporium protein fragment, or the spore coat protein and the proteinor peptide of interest.

The linker can comprise a polyalanine linker or a polyglycine linker. Alinker comprising a mixture of both alanine and glycine residues canalso be used.

For example, in a fusion protein where the targeting sequence comprisesSEQ ID NO: 1, a fusion protein can have one of the following structures:

No linker: SEQ ID NO: 1-POI

Alanine Linker: SEQ ID NO: 1-A_(n)-POI

Glycine Linker: SEQ ID NO: 1-G_(n)-POI

Mixed Alanine and Glycine Linker: SEQ ID NO: 1-(A/G)_(n)-POI

where A_(n), G_(n), and (A/G)_(n) are any number of alanines, any numberof glycines, or any number of a mixture of alanines and glycines,respectively. For example, n can be 1 to 25, and is preferably 6 to 10.Where the linker comprises a mixture of alanine and glycine residues,any combination of glycine and alanine residues can be used. In theabove structures, “POI” represents the protein or peptide of interest.

Alternatively or in addition, the linker can comprise a proteaserecognition site. Inclusion of a protease recognition site allows fortargeted removal, upon exposure to a protease that recognizes theprotease recognition site, of the protein or peptide of interest.

XII. Proteins and Peptides of Interest

The protein or peptide of interest can comprise any protein or peptide.

The protein or peptide of interest in the fusion proteins describedherein can comprise, for example: (a) a plant growth stimulating proteinor peptide; (b) a protein or peptide that protects a plant from apathogen; (c) a protein or peptide that enhances stress resistance of aplant; (d) a plant binding protein or peptide; (e) an enzyme thatcatalyzes the production of nitric oxide; (f) a nucleic acid bindingprotein or peptide; or (g) a plant signaling molecule or a protein orpeptide that alters the composition of a plant; (h) an antigen; (i) aremediation enzyme; (j) an enzyme suitable for breaking an emulsion orgel in a hydraulic fracturing fluid; or (k) an antibacterial protein orpeptide.

A. Plant Growth Stimulating Proteins or Peptides

The protein or peptide of interest can comprise a plant growthstimulating protein or peptide.

The plant growth stimulating protein or peptide can comprise a peptidehormone, a non-hormone peptide, an enzyme involved in the production oractivation of a plant growth stimulating compound, or an enzyme thatdegrades or modifies a bacterial, fungal, or plant nutrient source.

For example, the plant growth stimulating protein or peptide cancomprise a peptide hormone.

The peptide hormone can comprise a phytosulfokine (e.g.,phytosulfokine-α), clavata 3 (CLV3), systemin, ZmlGF, or a SCR/SP11.

The plant growth stimulating protein or peptide can comprise anon-hormone peptide.

The non-hormone peptide can comprise a RKN 16D10, Hg-Syv46, an eNOD40peptide, melittin, mastoparan, Mas7, RHPP, POLARIS, or kunitz trypsininhibitor (KTI).

The plant growth stimulating protein or peptide can comprise an enzymeinvolved in the production or activation of a plant growth stimulatingcompound. The enzyme involved in the production or activation of a plantgrowth stimulating compound can be any enzyme that catalyzes any step ina biological synthesis pathway for a compound that stimulates plantgrowth or alters plant structure, or any enzyme that catalyzes theconversion of an inactive or less active derivative of a compound thatstimulates plant growth or alters plant structure into an active or moreactive form of the compound.

The plant growth stimulating compound can comprise a compound producedby bacteria or fungi in the rhizosphere, e.g., 2,3-butanediol.

Alternatively, the plant growth stimulating compound can comprise aplant growth hormone.

The plant growth hormone can comprise a cytokinin or a cytokininderivative, ethylene, an auxin or an auxin derivative, a gibberellicacid or a gibberellic acid derivative, abscisic acid or an abscisic acidderivative, or a jasmonic acid or a jasmonic acid derivative.

Where the plant growth stimulating compound comprises a cytokinin or acytokinin derivative, the cytokinin or the cytokinin derivative cancomprise kinetin, cis-zeatin, trans-zeatin, 6-benzylaminopurine,dihydroxyzeatin, N6-(D2-isopentenyl) adenine, ribosylzeatin,N6-(D2-isopentenyl) adenosine, 2-methylthio-cis-ribosylzeatin,cis-ribosylzeatin, trans-ribosylzeatin,2-methylthio-trans-ribosylzeatin, ribosylzeatin-5-monosphosphate,N6-methylaminopurine, N6-dimethylaminopurine, 2′-deoxyzeatin riboside,4-hydroxy-3-methyl-trans-2-butenylaminopurine, ortho-topolin,meta-topolin, benzyladenine, ortho-methyltopolin, meta-methyltopolin, ora combination thereof.

Where the plant growth stimulating compound comprises an auxin or anauxin derivative, the auxin or the auxin derivative can comprise anactive auxin, an inactive auxin, a conjugated auxin, a naturallyoccurring auxin, or a synthetic auxin, or a combination thereof. Forexample, the auxin or auxin derivative can comprise indole-3-aceticacid, indole-3-pyruvic acid, indole-3-acetaldoxime, indole-3-acetamide,indole-3-acetonitrile, indole-3-ethanol, indole-3-pyruvate,indole-3-acetaldoxime, indole-3-butyric acid, a phenylacetic acid,4-chloroindole-3-acetic acid, a glucose-conjugated auxin, or acombination thereof.

The enzyme involved in the production or activation of a plant growthstimulating compound can comprise an acetoin reductase, anindole-3-acetamide hydrolase, a tryptophan monooxygenase, anacetolactate synthetase, an α-acetolactate decarboxylase, a pyruvatedecarboxylase, a diacetyl reductase, a butanediol dehydrogenase, anaminotransferase (e.g., tryptophan aminotransferase), a tryptophandecarboxylase, an amine oxidase, an indole-3-pyruvate decarboxylase, anindole-3-acetaldehyde dehydrogenase, a tryptophan side chain oxidase, anitrile hydrolase, a nitrilase, a peptidase, a protease, an adenosinephosphate isopentenyltransferase, a phosphatase, an adenosine kinase, anadenine phosphoribosyltransferase, CYP735A, a 5′ribonucleotidephosphohydrolase, an adenosine nucleosidase, a zeatin cis-transisomerase, a zeatin O-glucosyltransferase, a β-glucosidase, acis-hydroxylase, a CK cis-hydroxylase, a CK N-glucosyltransferase, a2,5-ribonucleotide phosphohydrolase, an adenosine nucleosidase, a purinenucleoside phosphorylase, a zeatin reductase, a hydroxylamine reductase,a 2-oxoglutarate dioxygenase, a gibberellic 2B/3B hydrolase, agibberellin 3-oxidase, a gibberellin 20-oxidase, a chitosanase, achitinase, a β-1,3-glucanase, a β-1,4-glucanase, a β-1,6-glucanase, anaminocyclopropane-1-carboxylic acid deaminase, or an enzyme involved inproducing a nod factor (e.g., nodA, nodB, or nodI).

Where the enzyme comprises a protease or peptidase, the protease orpeptidase can be a protease or peptidase that cleaves proteins,peptides, proproteins, or preproproteins to create a bioactive peptide.The bioactive peptide can be any peptide that exerts a biologicalactivity.

Examples of bioactive peptides include RKN 16D10 and RHPP.

The protease or peptidase that cleaves proteins, peptides, proproteins,or preproproteins to create a bioactive peptide can comprise subtilisin,an acid protease, an alkaline protease, a proteinase, an endopeptidase,an exopeptidase, thermolysin, papain, pepsin, trypsin, pronase, acarboxylase, a serine protease, a glutamic protease, an aspartateprotease, a cysteine protease, a threonine protease, or ametalloprotease.

The protease or peptidase can cleave proteins in a protein-rich meal(e.g., soybean meal or yeast extract).

Where the enzyme comprises a chitosanase, the chitosanase can comprisean amino acid sequence having at least 85% identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 100%identity with SEQ ID NO: 313.

For example, the fusion protein can comprise amino acids 20-35 of BclA(amino acids 20-35 of SEQ ID NO: 1) as the targeting sequence and anamino acid sequence comprising SEQ ID NO: 313 as the enzyme that isspecific for a cellular component of a bacterium or fungus. The fusionprotein can further comprise a linker (e.g., a polyalanine linker)between the targeting sequence and the enzyme.

The plant growth stimulating protein or peptide can comprise an enzymethat degrades or modifies a bacterial, fungal, or plant nutrient source.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a cellulase, a lipase, a lignin oxidase, aprotease, a glycoside hydrolase, a phosphatase, a nitrogenase, anuclease, an amidase, a nitrate reductase, a nitrite reductase, anamylase, an ammonia oxidase, a ligninase, a glucosidase, aphospholipase, a phytase, a pectinase, a glucanase, a sulfatase, aurease, a xylanase, or a siderophore.

When introduced into a plant growth medium or applied to a plant, seed,or an area surrounding a plant or a plant seed, fusion proteinscomprising enzymes that degrade or modify a bacterial, fungal, or plantnutrient source can aid in the processing of nutrients in the vicinityof the plant and result in enhanced uptake of nutrients by the plant orby beneficial bacteria or fungi in the vicinity of the plant.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a cellulase.

The cellulase can comprise an endocellulase (e.g., an endoglucanase suchas a Bacillus subtilis endoglucanase, a Bacillus thuringiensisendoglucanase, a Bacillus cereus endoglucanase, or a Bacillus clausiiendoglucanase), an exocellulase (e.g., a Trichoderma reeseiexocellulase), or a β-glucosidase (e.g., a Bacillus subtilisβ-glucosidase, a Bacillus thuringiensis β-glucosidase, a Bacillus cereusβ-glucosidase, or a Bacillus clausii β-glucosidase). The cellulasepreferably comprises a Bacillus subtilis endoglucanase.

The endoglucanase can comprise an amino acid sequence having at least85% identity with SEQ ID NO: 311.

The endoglucanase can comprise an amino acid sequence having at least90% identity with SEQ ID NO: 311.

The endoglucanase can comprise an amino acid sequence having at least95% identity with SEQ ID NO: 311.

The endoglucanase can comprise an amino acid sequence having at least98% identity with SEQ ID NO: 311.

The endoglucanase can comprise an amino acid sequence having at least99% identity with SEQ ID NO: 311.

The endoglucanase can comprise an amino acid sequence having 100%identity with SEQ ID NO: 311.

For example, the fusion protein can comprise amino acids 20-35 of BclA(amino acids 20-35 of SEQ ID NO: 1) as the targeting sequence and anamino acid sequence comprising SEQ ID NO: 311 as the enzyme thatdegrades or modifies a bacterial, fungal, or plant nutrient source. Thefusion protein can further comprise a linker (e.g., a polyalaninelinker) between the targeting sequence and the enzyme.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a lipase (e.g., a Bacillus subtilis lipase,a Bacillus thuringiensis lipase, a Bacillus cereus lipase, or a Bacillusclausii lipase).

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a lignin oxidase. For example, the ligninoxidase can comprise a lignin peroxidase, a laccase, a glyoxal oxidase,a ligninase, or a manganese peroxidase.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a protease. For example, the protease cancomprise a subtilisin, an acid protease, an alkaline protease, aproteinase, a peptidase, an endopeptidase, an exopeptidase, athermolysin, a papain, a pepsin, a trypsin, a pronase, a carboxylase, aserine protease, a glutamic protease, an aspartate protease, a cysteineprotease, a threonine protease, or a metalloprotease.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a phosphatase. For example, the phosphatasecan comprise a phosphoric monoester hydrolase, a phosphomonoesterase(e.g., PhoA4), a phosphoric diester hydrolase, a phosphodiesterase, atriphosphoric monoester hydrolase, a phosphoryl anhydride hydrolase, apyrophosphatase, a phytase (e.g., a Bacillus subtilis EE148 phytase or aBacillus thuringiensis BT013A phytase), a trimetaphosphatase, or atriphosphatase.

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a nitrogenase. For example the nitrogenasecan comprise a Nif family nitrogenase (e.g., Paenibacillus massiliensisNifBDEHKNXV).

The enzyme that degrades or modifies a bacterial, fungal, or plantnutrient source can comprise a phospholipase. For example, thephospholipase can comprise a phospholipase A1, a phospholipase A2, aphospholipase C, a phospholipase D, or a lysophospholipase. Thephospholipase preferably comprises a phospholipsae C.

The phospholipase C can comprise an amino acid sequence having at least85% identity with SEQ ID NO: 312.

The phospholipase C can comprise an amino acid sequence having at least90% identity with SEQ ID NO: 312.

The phospholipase C can comprise an amino acid sequence having at least95% identity with SEQ ID NO: 312.

The phospholipase C can comprise an amino acid sequence having at least98% identity with SEQ ID NO: 312.

The phospholipase C can comprise an amino acid sequence having at least99% identity with SEQ ID NO: 312.

The phospholipase C can comprise an amino acid sequence having 100%identity with SEQ ID NO: 312.

For example, the fusion protein can comprise amino acids 20-35 of BclA(amino acids 20-35 of SEQ ID NO: 1) as the targeting sequence and anamino acid sequence comprising SEQ ID NO: 312 as the enzyme thatdegrades or modifies a bacterial, fungal, or plant nutrient source. Thefusion protein can further comprise a linker (e.g., a polyalaninelinker) between the targeting sequence and the enzyme.

B. Proteins or Peptides that Protect Plants from Pathogens

The protein or peptide of interest can comprise a protein or peptidethat protects a plant from a pathogen.

The protein or peptide that protects a plant from a pathogen cancomprise a plant immune system enhancer protein or peptide.

For example, the plant immune system enhancer protein or peptide cancomprise a harpin, a harpin-like protein, an α-elastin, a β-elastin, asystemin, a phenylalanine ammonia-lyase, an elicitin, a defensin, acryptogein, a flagellin protein, or a flagellin peptide (e.g., flg22).

The protein or peptide that protects a plant from a pathogen can be aprotein or peptide that has antibacterial activity, antifungal activity,or both antibacterial and antifungal activity. Examples of such proteinsand peptides include bacteriocins, lysozymes, lysozyme peptides (e.g.,LysM), siderophores, avidins, streptavidins, non-ribosomal activepeptides, conalbumins, albumins, lactoferrins, lactoferrin peptides(e.g., LfcinB), and TasA.

The protein or peptide that protects a plant from a pathogen can be aprotein or a peptide that has insecticidal activity, helminthicidalactivity, suppresses insect or worm predation, or a combination thereof.For example, the protein or peptide that protects a plant from apathogen can comprise an insecticidal bacterial toxin (e.g., a VIPinsecticidal protein), an endotoxin, a Cry toxin (e.g., a Cry toxin fromBacillus thuringiensis), a protease inhibitor protein or peptide (e.g.,a trypsin inhibitor or an arrowhead protease inhibitor), a cysteineprotease, or a chitinase. Where the Cry toxin comprises a Cry toxin fromBacillus thuringiensis, the Cry toxin can be a Cry5B protein or a Cry2Aprotein. Cry5B and Cry2A have both insecticidal and nematocidalactivity.

The protein that protects a plant from a pathogen can comprise anenzyme. For example, the enzyme can comprise a protease or a lactonase.The proteases and lactonases can be specific for a bacterial signalingmolecule (e.g., a bacterial lactone homoserine signaling molecule).

Where the enzyme comprises a lactonase, the lactonase can comprise1,4-lactonase, 2-pyrone-4,6-dicarboxylate lactonase, 3-oxoadipateenol-lactonase, actinomycin lactonase, deoxylimonate A-ring-lactonase,gluconolactonase L-rhamnono-1,4-lactonase, limonin-D-ring-lactonase,steroid-lactonase, triacetate-lactonase, or xylono-1,4-lactonase.

The enzyme can comprise an enzyme that is specific for a cellularcomponent of a bacterium or fungus. For example, the enzyme can comprisea β-1,3-glucanase, a β-1,4-glucanase, a β-1,6-glucanase, a chitosanase,a chitinase, a chitosanase-like enzyme, a lyticase, a peptidase, aproteinase, a protease (e.g., an alkaline protease, an acid protease, ora neutral protease), a mutanolysin, a stapholysin, or a lysozyme.

Where the enzyme comprises a chitosanase, the chitosanase can comprisean amino acid sequence having at least 85% identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 90%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 95%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 98%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 99%identity with SEQ ID NO: 313.

The chitosanase can comprise an amino acid sequence having at least 100%identity with SEQ ID NO: 313.

For example, the fusion protein can comprise amino acids 20-35 of BclA(amino acids 20-35 of SEQ ID NO: 1) as the targeting sequence and anamino acid sequence comprising SEQ ID NO: 313 as the enzyme that isspecific for a cellular component of a bacterium or fungus. The fusionprotein can further comprise a linker (e.g., a polyalanine linker)between the targeting sequence and the enzyme.

For any of the above proteins or peptides that protect a plant from apathogen, the pathogen can comprise a protein or a peptide of interestthat protects a plant from a bacterial pathogen, a fungal pathogen, aworm pathogen, or an insect pathogen.

For example, the bacterial pathogen can comprise an α-classProteobacterium, a β-class Proteobacterium, a γ-class Proteobacterium,or a combination thereof; or wherein the bacterial pathogen comprisesAgrobacterium tumefaciens, Pantoea stewartii, Erwinia carotovora,Ralstonia solanacearum, Pseudomonas syringae, Pseudomonas aeruginosa,Xanthomonas campestris, or a combination thereof.

The protein or peptide that protects a plant from a pathogen cancomprise a protein or peptide protects the plant from predation by aworm or an insect pathogen.

The worm or insect pathogen can comprise an army worm, a black cutworm,a European corn borer, a fall armyworm, a cutworm, a Japanese beetle, alesser cornstalk borer, a maize billbug, a seed corn maggot, a webworm,a southern cornstalk borer, a southern corn rootworm, a southern potatowireworm, a stalk borer, a sugarcane beetle, a white grub, a cabbagelooper, a boll weevil, a yellow striped armyworm, a cereal leaf beetle,a chinch bug, an aphid, a beet armyworm, a Mexican bean beetle, asoybean looper, soybean stem borer, or a combination thereof.

C. Proteins or Peptides that Enhance Stress-Resistance in Plants

The protein or peptide of interest can comprise a protein or peptidethat enhances stress resistance in a plant.

For example, the protein or peptide that enhances stress resistance in aplant can comprise an enzyme that degrades a stress-related compound.Stress-related compounds include, but are not limited to,aminocyclopropane-1-carboxylic acid (ACC), reactive oxygen species,nitric oxide, oxylipins, and phenolics. Specific reactive oxygen speciesinclude hydroxyl, hydrogen peroxide, oxygen, and superoxide.

The enzyme that degrades a stress-related compound can comprise asuperoxide dismutase, an oxidase, a catalase, anaminocyclopropane-1-carboxylic acid deaminase, a peroxidase, anantioxidant enzyme, or an antioxidant peptide.

When the enzyme that degrades a stress-related compound comprises asuperoxide dismutase, the superoxide dismutase can comprise superoxidedismutase 1 (SODA1) or superoxide dismutase 2 (SODA2).

The superoxide dismutase can comprise an amino acid sequence having atleast 85% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 90% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 95% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 98% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 99% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having 100%identity with SEQ ID NO: 155 or 156.

The protein or peptide that enhances stress resistance in a plant cancomprise a protein or peptide that protects a plant from anenvironmental stress. The environmental stress can comprise, forexample, drought, flood, heat, freezing, salt, heavy metals, low pH,high pH, or a combination thereof. For instance, the protein or peptidethat protects a plant from an environmental stress can comprises an icenucleation protein, a prolinase, a phenylalanine ammonia lyase, anisochorismate synthase, an isochorismate pyruvate lyase, or a cholinedehydrogenase.

D. Plant Binding Proteins or Peptides

The protein or peptide of interest can comprise a plant binding proteinor peptide. The plant binding protein or peptide can be any protein orpeptide that is capable of specifically or non-specifically binding toany part of a plant (e.g., a plant root or an aerial portion of a plantsuch as a leaf, stem, flower, or fruit) or to plant matter. Thus, forexample, the plant binding protein or peptide can be a root bindingprotein or peptide, or a leaf binding protein or peptide.

Suitable plant binding proteins and peptides include adhesins (e.g.,rhicadhesin), flagellins, omptins, lectins, expansins, biofilmstructural proteins (e.g., TasA or YuaB) pilus proteins, curlusproteins, intimins, invasins, agglutinins, and afimbrial proteins.

E. Enzymes that Catalyze the Production of Nitric Oxide

Many plant species do not inherently have a high germination rate. Forsuch plants, it would be desirable to increase the germination rate.Nitric oxide is a powerful germinant that when present in proximity to aplant seed, increases germination.

The present invention relates to fusion proteins comprising any of thetargeting sequences, exosporium proteins, exosporium protein fragments,or spore coat proteins described herein and an enzyme that catalyzes theproduction of nitric oxide synthase. Thus, the protein or peptide ofinterest can comprise an enzyme that catalyzes the production of nitricoxide. Fusion proteins comprising an enzyme that catalyzes theproduction of nitric oxide can be expressed in recombinant Bacilluscereus family members or recombinant spore-forming bacteria for thepurpose of delivering the enzyme that catalyzes the production of nitricoxide to a plant seed, a plant, a plant growth medium, or an areasurrounding a plant or a plant seed, and thereby stimulatinggermination.

For example, the enzyme that catalyzes the production of nitric oxidecan comprise a nitric oxide synthase (e.g., a Bacillus thuringiensisnitric oxide synthase or a Bacillus subtilis nitric oxide synthase, forexample a nitric oxide synthase from Bacillus thuringiensis BT013A orBacillus subtilis 168) or an arginase.

For example, the nitric oxide synthase can comprise one of the aminoacid sequences described below in Table 8.

TABLE 8 Exemplary nitric oxide synthase sequences Nitric oxide synthaseSEQ ID NO. Bacillus subtilis Nitric Oxide Synthatase 260 Bacillusthuringiensis Nitric Oxide Synthatase 261

The nitric oxide synthase can also comprise a sequence having a highdegree of sequence identity with the nitric oxide synthase sequencesshown in Table 8 above. For example, the nitric oxide synthase cancomprise an amino acid sequence having at least 85% sequence identitywith SEQ ID NO: 260 or 261.

The nitric oxide synthase can comprise an amino acid sequence having atleast 90% sequence identity with SEQ ID NO: 260 or 261.

the nitric oxide synthase can comprise an amino acid sequence having atleast 95% sequence identity with SEQ ID NO: 260 or 261.

the nitric oxide synthase can comprise an amino acid sequence having atleast 98% sequence identity with SEQ ID NO: 260 or 261.

the nitric oxide synthase can comprise an amino acid sequence having atleast 99% sequence identity with SEQ ID NO: 260 or 261.

the nitric oxide synthase can comprise an amino acid sequence having atleast 100% sequence identity with SEQ ID NO: 260 or 261.

When the protein or peptide of interest comprises a nitric oxidesynthase, the fusion protein can comprise one of the amino acidsequences shown in Table 9 below. In the sequences shown in Table 9below, the targeting sequence is shown in boldface text, a six aminoacid alanine linker is indicated by underlining, and the sequence of thenitric oxide synthase is shown in plain text. Thus, the fusion proteincan comprise SEQ ID NO: 262 or 263.

TABLE 9 Exemplary fusion proteins comprising a nitric oxide synthaseFusion protein (SEQ ID NO) Amino Acid Sequence Met + Amino acids MAFDPNLVGPTLPPIPP AAAAAAMEEKE 20-35 of BclA, ILWNEAKAFIAACYQELGKEEEVKDRLA alanine linker, DIKSEIDLTGSYVHTKEELEHGAKMAWR and Bacillus  NSNRCIGRLFWNSLNVIDRRDVRTKEEVsubtilis Nitric RDALFHHIETATNNGKIRPTITIFPPEE Oxide SynthataseKGEKQVEIWNHQLIRYAGYESDGERIGD (SEQ ID NO: 262)PASCSLTAACEELGWRGERTDFDLLPLI FRMKGDEQPVWYELPRSLVIEVPITHPDIEAFSDLELKWYGVPIISDMKLEVGGIH YNAAPFNGWYMGTEIGARNLADEKRYDKLKKVASVIGIAADYNTDLWKDQALVELN KAVLHSYKKQGVSIVDHHTAASQFKRFEEQEEEAGRKLTGDWTWLIPPISPAATHI FHRSYDNSIVKPNYFYQDKPYE Met + Amino acids MAFDPNLVGPTLPPIPP AAAAAAMSKTK 20-35 of BclA, QLIEEASHFITICYKELSKEHFIEERMK alanine linker, LEIQAEIEKTGTYEHTFEELVHGSRMAW and Bacillus RNSNRCIGRFWSKMHILDAREVNDEEGVthuringiensis Nitric YHALIHHIKYATNDGKVKPTITIFKQYQ Oxide Synthatase GEENNIRIYNHQLIRYAGYKTEMGVTGD (SEQ ID NO: 263)SHSTAFTDFCQELGWQGEGTNFDVLPLV FSIDGKAPIYKEIPKEEVKEVPIEHPEYPISSLGAKWYGVPMISDMRLEIGGISYT AAPFNGWYMGTEIGARNLADHDRYNLLPAVAEMMDLDTSRNGTLWKDKALIELNVA VLHSFKKQGVSIVDHHTAAQQFQQFEKQEAACGRVVTGNWVWLIPPLSPATTHIYH KPYPNEILKPNFFH

Nitric oxide synthases from a number species, including Bacillusthuringiensis, Bacillus cereus, Bacillus subtilis and Bacillus mycoidescan be used as the protein or peptide of interest in the fusionproteins.

F. Nucleic Acid Binding Proteins and Peptides

The delivery of nucleic acids to plants in the field would be desirable,but has been hampered by the instability of nucleic acids, which degraderapidly when introduced the environment (e.g., into a plant growthmedium such as soil).

The present invention relates to fusion proteins comprising any of thetargeting sequences, exosporium proteins, exosporium protein fragments,or spore coat proteins described herein and a nucleic acid bindingprotein or peptide. Such fusion proteins stabilize nucleic acids and canbe used to deliver nucleic acids to soil and/or to plants.

Thus, the protein or peptide of interest can comprise a nucleic acidbinding protein or peptide. For example, the nucleic acid bindingprotein or peptide can comprise an RNA binding protein or peptide or aDNA binding protein or peptide.

The RNA binding protein or peptide can comprise a non-specific RNAbinding protein or peptide or a specific RNA binding protein or peptide.

For example, the RNA binding peptide can comprise an Hfq protein (e.g.,a Bacillus thuringiensis Hqf protein).

The DNA binding protein or peptide can comprise a small acid-solublespore protein (SASP). For example, the SASP can comprise a SASP encodedby an SspA gene, an SspB gene, an SspC gene, an SspD gene, an SspE gene,an SspF gene, an SspG gene, an SspH gene, an SspI gene, an SspJ gene, anSspK gene, an SspL gene, an SspM gene, an SspN gene, an SspO gene, or anSspP gene. For example, the SASP can comprise a SASPα, a SASPβ, or aSASPγ. The SASP can comprise a Bacillus thuringiensis SASP.

The nucleic acid binding protein can comprise one of the amino acidsequences described below in Table 10.

TABLE 10 Exemplary SASP and Hfq sequences Fusion protein SEQ ID NO.SASPα 264 SASPγ 265 Hfq 266

The nucleic acid binding protein can also comprise a sequence having ahigh degree of sequence identity with any of the sequences shown abovein Table 10. For example, the nucleic acid binding protein can comprisea nucleic acid sequence having at least 85% identity with any of SEQ IDNOs: 264-266.

The nucleic acid binding protein can comprise a nucleic acid sequencehaving at least 90% identity with any of SEQ ID NOs: 264-266.

The nucleic acid binding protein can comprise a nucleic acid sequencehaving at least 95% identity with any of SEQ ID NOs: 264-266.

The nucleic acid binding protein can comprise a nucleic acid sequencehaving at least 98% identity with any of SEQ ID NOs: 264-266.

The nucleic acid binding protein can comprise a nucleic acid sequencehaving at least 99% identity with any of SEQ ID NOs: 264-266.

The nucleic acid binding protein can comprise a nucleic acid sequencehaving at least 100% identity with any of SEQ ID NOs: 264-266.

For example, when the protein or peptide of interest comprises a nucleicacid binding protein or peptide, the fusion protein can comprise one ofthe amino acid sequences shown in Table 11 below. In the sequences shownin Table 11 below, the targeting sequence is shown in boldface text, asix amino acid alanine linker is indicated by underlining, and thesequence of the nucleic acid binding protein or peptide (SASPα, SASPβ,or Hfq) is shown in plain text. Thus, for example, the fusion proteincan comprise SEQ ID NO: 267, 268, or 269.

TABLE 11 Exemplary fusion proteins comprising a nucleic acid binding protein Fusion protein (SEQ ID NO)Amino Acid Sequence Met + Amino acids  MAFDPNLVGPTLPPIPP AAAAAAAAMA20-35 of BclA, alanine QQSRSRSNNNNDLLIPQAASAIEQMKL linker, and SASPαEIASEFGVQLGAETTSRANGSVGGEIT (SEQ ID NO: 267) KRLVRLAQQNMGGQFH Met +Amino acids  MAFDPNLVGPTLPPIPP AAAAAAAAMA 20-35 of BclA, alanineNNNSGNSNNLLVPGAAQAIDQMKLEIA linker, and SASPγKSEFGVNLGADTTSRANGSVGGEITRL (SEQ ID NO: 268) VSFAQQNMGGGQF Met +Amino acids  MAFDPNLVGPTLPPIPP AAAAAAAAMK 20-35 of BclA, alaninePINIQDQFLNQIRKENTYVTVFLLNGF linker, and Hfq QLRGQVKGFDNFTVLLESEGKQQLIYK(SEQ ID NO: 269) HAISTFAPQKNVQLELE

Nucleases can also be used to both bind to and cleave nucleic acidmolecules. Nucleases have high affinity for RNA and DNA molecules, andexert their enzymatic activity by cleaving RNA and/or DNA molecules intosmaller RNA and/or DNA fragments. Nucleases can be specific, recognizingand cleaving specific DNA or RNA sequences, or non-specific, cleavingany DNA and/or RNA that they come in contact with. Nucleases can becategorized into exonucleases (nucleases that cleave nucleotides off ofthe ends of RNA and/or DNA molecules), or endonucleases (nucleases thatcleave a phosphodiester bond within a polynucleotide chain). Eachnuclease enzyme has an active site that comprises particular amino acidsthat act to catalyze the cleavage of the nucleic acid molecule. Mutationof these active sites can inactivate the active site and allow for highaffinity binding of the nuclease to its nucleic acid substrate, withoutcleavage of the substrate. Thus, such mutants can bind to and stabilizethe nucleic acid molecule without cleaving the nucleic acid molecule.

Thus, the nucleic acid binding protein can comprise a nuclease (e.g., anuclease having an inactivated active site).

When the protein or peptide of interest comprises a nucleic acid bindingprotein or peptide, a nucleic acid molecule can be bound to the nucleicacid binding protein or peptide. The nucleic acid can comprise, forexample, a modulating RNA molecule; an RNAi molecule; a microRNA; anaptamer; or a DNA molecule that encodes a modulating RNA molecule, anRNAi molecule, a microRNA, or an aptamer.

XIII. Recombinant Bacillus cereus Family Member Hosts

As described above, a Bacillus cereus family member can serve as a hostfor expression of fusion proteins comprising a targeting sequence, anexosporium protein, or an exosporium protein fragment that targets thefusion protein to the exosporium of the Bacillus cereus family member;serve as a host for expression of modulator proteins that modulate theexpression of a fusion protein; can serve as a host for overexpressionof an exosporium enzyme; can be genetically inactivated; or can comprisea mutation or other genetic alteration that allows for collection offree exosporium.

The recombinant Bacillus cereus family member can coexpress two or moreof any of the fusion proteins discussed above. For example, therecombinant Bacillus cereus family member can coexpress at least onefusion protein that comprises a plant binding protein or peptide,together with a fusion protein comprising a plant growth stimulatingprotein or peptide, a fusion protein comprising a protein or peptidethat protects a plant from a pathogen, a fusion protein comprisingprotein or peptide that enhances stress resistance in a plant, a fusionprotein comprising an enzyme that catalyzes the production of nitricoxide, or a fusion protein comprising a nucleic acid binding protein orpeptide.

The recombinant Bacillus cereus family member can comprise any Bacillusspecies that is capable of producing an exosporium. For example, therecombinant Bacillus cereus family member can comprise Bacillusanthracis, Bacillus cereus, Bacillus thuringiensis, Bacillus mycoides,Bacillus pseudomycoides, Bacillus samanii, Bacillus gaemokensis,Bacillus weihenstephensis, Bacillus toyoiensis, or a combinationthereof. In particular, the recombinant Bacillus cereus family membercan comprise Bacillus thuringiensis or Bacillus mycoides.

To generate a recombinant Bacillus cereus family member expressing afusion protein, any Bacillus cereus family member can be conjugated,transduced, or transformed with a vector encoding the fusion proteinusing standard methods known in the art (e.g., by electroporation). Thebacteria can then be screened to identify transformants by any methodknown in the art. For example, where the vector includes an antibioticresistance gene, the bacteria can be screened for antibiotic resistance.Alternatively, DNA encoding the fusion protein can be integrated intothe chromosomal DNA of a B. cereus family member host. The recombinantBacillus cereus family member can then exposed to conditions which willinduce sporulation. Suitable conditions for inducing sporulation areknown in the art. For example, the recombinant Bacillus cereus familymember can be plated onto agar plates, and incubated at a temperature ofabout 30° C. for several days (e.g., 3 days).

Inactivated strains, non-toxic strains, or genetically manipulatedstrains of any of the above species can also suitably be used. Forexample, a Bacillus thuringiensis that lacks the Cry toxin can be used.Alternatively or in addition, once the recombinant B. cereus familymember spores expressing the fusion protein have been generated, theycan be inactivated to prevent further germination once in use. Anymethod for inactivating bacterial spores that is known in the art can beused. Suitable methods include, without limitation, heat treatment,gamma irradiation, x-ray irradiation, UV-A irradiation, UV-Birradiation, chemical treatment (e.g., treatment with gluteraldehyde,formaldehyde, hydrogen peroxide, acetic acid, bleach, or any combinationthereof), or a combination thereof. Alternatively, spores derived fromnontoxigenic strains, or genetically or physically inactivated strains,can be used.

Many Bacillus cereus family member strains have inherent beneficialattributes. For example, some strains have plant-growth promotingeffects. Any of the recombinant Bacillus cereus family members describedherein can comprise a plant-growth promoting strain of bacteria.

The plant-growth promoting strain of bacteria can comprise a strain ofbacteria that produces an insecticidal toxin (e.g., a Cry toxin),produces a fungicidal compound (e.g., a β-1,3-glucanase, a chitosanase,a lyticase, or a combination thereof), produces a nematocidal compound(e.g., a Cry toxin), produces a bacteriocidal compound, is resistant toone or more antibiotics, comprises one or more freely replicatingplasmids, binds to plant roots, colonizes plant roots, forms biofilms,solubilizes nutrients, secretes organic acids, or any combinationthereof.

For example, where the recombinant Bacillus cereus family membercomprises a plant-growth promoting strain of bacteria, the plantgrowth-promoting strain of bacteria can comprise (a) Bacillus mycoidesBT155 (NRRL No. B-50921), (b) Bacillus mycoides EE118 (NRRL No.B-50918), (c) Bacillus mycoides EE141 (NRRL No. B-50916), (d) Bacillusmycoides BT46-3 (NRRL No. B-50922), (e) Bacillus cereus family memberEE128 (NRRL No. B-50917), (f) Bacillus thuringiensis BT013A (NRRL No.B-50924), (g) Bacillus cereus family member EE349 (NRRL No. B-50928),(h) Bacillus cereus family member EE-B00377 (NRRL B-67119), (i) Bacilluspseudomycoides EE-B00366 (NRRL B-67120), or (j) Bacillus mycoidesEE-B00363 (NRRL B-67121). Each of the strains (a) through (g) wasdeposited with the United States Department of Agriculture (USDA)Agricultural Research Service (ARS), having the address 1815 NorthUniversity Street, Peoria, Ill. 61604 U.S.A., on Mar. 10, 2014, and isidentified by the NRRL deposit number provided in parentheses. Bacillusthuringiensis BT013A is also known as Bacillus thuringiensis 4Q7. Eachof the strains (h) through (j) were deposited with the USDA ARS on Aug.19, 2015, and is identified by the NRRL deposit number provided inparentheses.

It is hereby certified that the deposits were made in compliance withthe terms of the Budapest Treaty and that: (a) during the pendency ofthis application, access to the deposited organisms will be afforded tothe Commissioner upon request; (b) all restrictions upon availability tothe public of the deposited materials will be irrevocably removed upongranting of the patent, subject to 37 C.F.R. §1.808(b); (c) the depositwill be maintained for a period of 30 years or 5 years after the lastrequest or for the effective life of the patent, whichever is longer;and (d) the deposit will be replaced if it should ever becomenon-viable.

These plant-growth promoting strains were isolated from the rhizospheresof various vigorous plants and were identified by their 16S rRNAsequences (listed below in Table 12), and through biochemical assays.The strains were identified at least to their genus designation by meansof conventional biochemistry and morphological indicators. Biochemicalassays for confirmed Gram-positive strains such as Bacillus includedgrowth on PEA medium and nutrient agar, microscopic examination, growthon 5% and 7.5% NaCl medium, growth at pH 5 and pH 9, growth at 42° C.and 50° C., the ability to produce acid upon fermentation withcellobiose, lactose, glycerol, glucose, sucrose, d-mannitol, and starch;fluorescent pigment production; gelatin hydrolysis; nitrate reduction;catalase production, starch hydrolysis; oxidase reaction, ureaseproduction and motility. Identification of these strains anddemonstration of their plant-growth promoting effects are describedfurther in the Examples hereinbelow.

TABLE 12 Partial 16S rRNA sequences for plant-growth promoting Bacilluscereus family members SEQ ID NO. for partial 16S Strain ribosomal RNAsequence Bacillus mycoides EE118 270 Bacillus mycoides EE141 271Bacillus mycoides BT46-3 272 Bacillus cereus family member EE128 273Bacillus thuringiensis BT013A 274 Bacillus cereus family member EE349275 Bacillus mycoides BT155 276

For example, the recombinant Bacillus cereus family member comprising aplant-growth promoting strain of bacteria can comprise Bacillus mycoidesBT155, Bacillus mycoides EE141, or Bacillus thuringiensis BT013A.

The recombinant Bacillus cereus family member can comprises anendophytic strain of bacteria. For example, the endophytic strain ofbacteria can comprise Bacillus cereus family member EE349, Bacilluscereus family member EE439, Bacillus thuringiensis EE417, Bacilluscereus EE444, or Bacillus thuringiensis EE319, Bacillus thuringiensisEE-B00184, Bacillus cereus family member EE-B00377; Bacilluspseudomycoides EE-B00366; or Bacillus mycoides EE-B00363.

Bacillus cereus family member EE349 is also a plant growth promotingstrain of bacteria and is described above. As discussed further in theExamples below, Bacillus cereus family member EE349 has also been foundto be endophytic.

Bacillus cereus family member EE439, Bacillus thuringiensis EE417,Bacillus cereus EE444, Bacillus thuringiensis EE319, Bacillusthuringiensis EE-B00184, Bacillus cereus family member EE-B00377;Bacillus pseudomycoides EE-B00366; or Bacillus mycoides EE-B00363 aredescribed further below in Section XIV.

The endophytic strain of bacteria can comprise Bacillus cereus familymember EE439, Bacillus thuringiensis EE417, Bacillus cereus EE444,Bacillus thuringiensis EE319, Bacillus thuringiensis EE-B00184, Bacilluscereus family member EE-B00377; Bacillus pseudomycoides EE-B00366; orBacillus mycoides EE-B00363.

The recombinant Bacillus cereus family member can comprise a strain ofbacteria that is capable of degrading an herbicide or a pesticide. Asdiscussed further below in the Examples, Bacillus cereus family memberEE349, Bacillus cereus family member EE-B00377, Bacillus pseudomycoidesEE-B00366, and Bacillus mycoides EE-B00363 have been found to be capableof degrading herbicides and/or pesticides. Thus, when the recombinantBacillus cereus family member comprises a strain of bacteria that iscapable of degrading an herbicide, the strain of bacteria that iscapable of degrading an herbicide can comprise Bacillus cereus familymember EE349, Bacillus cereus family member EE-B00377, Bacilluspseudomycoides EE-B00366, or Bacillus mycoides EE-B00363.

The strain of bacteria that is capable of degrading an herbicide or apesticide can degrade a sulfonylurea herbicide (e.g., sulfentrazone), anaryl triazine herbicide, dicamba, 2,4-D, a phenoxy herbicide, apyrethrin, a pyrethroid, or a combination thereof.

The strain of bacteria that is capable of degrading a pesticide can be astrain of bacteria that is capable of degrading a pyrethrin.

The recombinant Bacillus cereus family member can comprise a probioticstrain of bacteria. For example, the probiotic strain of bacteria cancomprise Bacillus cereus family member EE349, Bacillus cereus familymember EE439, Bacillus thuringiensis EE417, or Bacillus cereus EE444.

The recombinant Bacillus cereus family member can comprise aninactivating mutation in its BclA gene, its CotE gene, or its CotO gene(e.g., a knock-out of the BclA gene, CotE gene, or CotO gene). Forexample, the recombinant Bacillus cereus family member can comprise aninactivating mutation in its BclA gene (e.g., a knock-out of the BclAgene). It has been found that expression of fusion proteins in arecombinant Bacillus cereus family member having such a mutation resultsin increased expression levels of the fusion protein.

XIV. Endophytic Bacterial Strains

The present invention further relates to endophytic bacterial strains.While many bacteria of the rhizosphere have a symbiotic relationshipwith the plant, only a small subset of these bacteria are capable ofbeing internalized into the plant and growing endophytically. Asdescribed further in the Examples hereinbelow, several Bacillus cereusfamily member strains and several non-Bacillus cereus family memberbacterial strains were isolated from corn seedlings and found to havethe ability to grow endophytically in plants.

A. Endophytic Bacillus cereus Family Members

The present invention relates to biologically pure bacterial cultures ofbacteria that have the ability to grow endophytically. The bacterialstrain in each of these bacterial cultures can be: (a) Bacillus cereusfamily member EE439 (NRRL B-50979); (b) Bacillus thuringiensis EE417(NRRL B-50974); (c) Bacillus cereus EE444 (NRRL B-50977); (d) Bacillusthuringiensis EE319 (NRRL B-50983), (e) Bacillus thuringiensis EE-B00184(NRRL B-67122); (f) Bacillus cereus family member EE-B00377 (NRRLB-67119); (g) Bacillus pseudomycoides EE-B00366 (NRRL B-67120); or (h)Bacillus mycoides EE-B00363 (NRRL B-67121). Each of strains (a) through(c) was deposited with the United States Department of Agriculture(USDA) Agricultural Research Service (ARS), having the address 1815North University Street, Peoria, Ill. 61604 U.S.A., on Sep. 10, 2014,and are identified by the NRRL numbers provided in parentheses followingthe names of each strain. Strain (d) was deposited with the USDA ARS onSep. 17, 2014 and is identified by the NRRL number provided inparentheses following the name of the strain. Each of strains (e)through (h) was deposited with the USDA ARS on Aug. 19, 2015 and areidentified by the NRRL numbers provided in parentheses following thenames of each strain.

It is hereby certified that the deposits were made in compliance withthe terms of the Budapest Treaty and that: (a) during the pendency ofthis application, access to the deposited organisms will be afforded tothe Commissioner upon request; (b) all restrictions upon availability tothe public of the deposited materials will be irrevocably removed upongranting of the patent, subject to 37 C.F.R. §1.808(b); (c) the depositwill be maintained for a period of 30 years or 5 years after the lastrequest or for the effective life of the patent, whichever is longer;and (d) the deposit will be replaced if it should ever becomenon-viable.

The novel strains disclosed herein were identified by 16S ribosomal RNA(rRNA) sequencing. Thus, Bacillus cereus family member EE439 has a 16Sribosomal RNA sequence having at least 98%, at least 99%, or 100%sequence identity with the sequence of SEQ ID NO: 277. Bacillusthuringiensis EE417 has a 16S ribosomal RNA sequence having at least98%, at least 99%, or 100% sequence identity with the sequence of SEQ IDNO: 278. Bacillus cereus EE444 has a 16S ribosomal RNA sequence havingat least 98%, at least 99%, or 100% sequence identity with the sequenceof SEQ ID NO: 279. Bacillus thuringiensis EE319 has a 16S ribosomal RNAsequence having at least 98%, at least 99%, or 100% sequence identitywith the sequence of SEQ ID NO: 280. Bacillus thuringiensis EE-B00184has a 16S ribosomal RNA sequence having at least 98%, at least 99%, or100% sequence identity with the sequence of SEQ ID NO: 301. Bacilluscereus family member EE-B00377 has a 16S ribosomal RNA sequence havingat least 98%, at least 99%, or 100% sequence identity with the sequenceof SEQ ID NO: 304. Bacillus pseudomycoides EE-B00366 has a 16S ribosomalRNA sequence having at least 98%, at least 99%, or 100% sequenceidentity with the sequence of SEQ ID NO: 303. Bacillus mycoidesEE-B00363 (NRRL B-67121) and the bacteria has a 16S ribosomal RNAsequence having at least 98%, at least 99%, or 100% sequence identitywith the sequence of SEQ ID NO: 302. The 16S rRNA sequences are listedbelow in Table 13.

TABLE 13 Partial 16S rRNA sequences for Bacillus cereus family memberendophytic strains SEQ ID NO. for partial Strain 16S rRNA sequenceBacillus cereus family member EE439 277 Bacillus thuringiensis EE417 278Bacillus cereus EE444 279 Bacillus thuringiensis EE319 280 Bacillusthuringiensis EE-B00184 301 Bacillus mycoides EE-B00363 302 Bacilluspseudomycoides EE-B00366 303 Bacillus cereus family member EE-B00377 304

The present invention further relates to a biologically pure bacterialculture wherein the bacteria in the bacterial culture are mutants ofBacillus cereus family member EE439, Bacillus thuringiensis EE417,Bacillus cereus EE444, Bacillus thuringiensis EE319, Bacillusthuringiensis EE-B00184, Bacillus cereus family member EE-B00377,Bacillus pseudomycoides EE-B00366, or Bacillus mycoides EE-B00363comprising one or more mutations, wherein the bacteria are endophytic.

B. Other Endophytic Bacterial Strains

The present invention also relates to other biologically pure bacterialcultures of bacteria (non-Bacillus cereus family members) that have theability to grow endophytically. These strains were isolated from cornseedlings, as described in detail below in the Examples.

The bacterial strain in each of these bacterial cultures can be (a)Bacillus megaterium EE385 (NRRL B-50980), (b) Bacillus sp. EE387 (NRRLB-50981), (c) Bacillus circulans EE388 (NRRL B-50982), (d) Bacillussubtilis EE405 (NRRL B-50978), (e) Lysinibacillus fusiformis EE442 (NRRLB-50975), (f) Lysinibcaillus sphaericus EE443 (NRRL B-50976), or (g)Bacillus pumilus EE-B00143 (NRRL B-67123). Each of the strains (a)through (f) was deposited with the United States Department ofAgriculture (USDA) Agricultural Research Service (ARS), having theaddress 1815 North University Street, Peoria, Ill. 61604 U.S.A., on Sep.10, 2014, and are identified by the NRRL numbers provided in parenthesesfollowing the names of each strain. Following deposit, Bacillus sp.EE387 was determined to be a Bacillus pumilus-like strain. Strain (g)was deposited with the USDA ARS on Aug. 19, 2015 and is identified bythe NRRL number provided in parentheses following its name.

The novel strains disclosed herein were identified by 16S ribosomal RNA(rRNA) sequencing. Thus, Bacillus megaterium EE385 has a 16S ribosomalRNA sequence having at least 98%, at least 99%, or 100% sequenceidentity with the sequence of SEQ ID NO: 281. Bacillus sp. EE387 has a16S ribosomal RNA sequence having at least 98%, at least 99%, or 100%sequence identity with the sequence of SEQ ID NO: 282. Bacilluscirculans EE388 has a 16S ribosomal RNA sequence having at least 98%, atleast 99%, or 100% sequence identity with the sequence of SEQ ID NO:283. Bacillus subtilis EE405 has a 16S ribosomal RNA sequence having atleast 98%, at least 99%, or 100% sequence identity with the sequence ofSEQ ID NO: 284. Lysinibacillus fusiformis EE442 has a 16S ribosomal RNAsequence having at least 98%, at least 99%, or 100% sequence identitywith the sequence of SEQ ID NO: 285. Lysinibcaillus sphaericus EE443 hasa 16S ribosomal RNA sequence having at least 98%, at least 99%, or 100%sequence identity with the sequence of SEQ ID NO: 286. Bacillus pumilusEE-B00143 has a 16S ribosomal RNA sequence having at least 98%, at least99%, or 100% sequence identity with the sequence of SEQ ID NO: 305. The16s rRNA sequences are listed below in Table 14.

TABLE 14 Partial 16S rRNA sequences for non-Bacillus cereus familymember endophytic strains SEQ ID NO. for partial Strain (SEQ ID NO) 16SrRNA sequence Bacillus megaterium EE385 281 Bacillus sp. EE387 282Bacillus circulans EE388 283 Bacillus subtilis EE405 284 Lysinibacillusfusiformis EE442 285 Lysinibcaillus sphaericus EE443 286 Bacilluspumilus EE-B00143 305

The present invention further relates to a biologically pure bacterialculture wherein the bacteria in the bacterial culture are mutants ofBacillus megaterium EE385, Bacillus sp. EE387, Bacillus circulans EE388,Bacillus subtilis EE405, Lysinibacillus fusiformis EE442, orLysinibcaillus sphaericus EE443, comprising one or more mutations,wherein the bacteria are endophytic.

The present invention also relates to a biologically pure bacterialculture wherein the bacteria in the bacterial culture are mutants ofBacillus megaterium EE385, Bacillus sp. EE387, Bacillus circulans EE388,Bacillus subtilis EE405, Lysinibacillus fusiformis EE442, orLysinibcaillus sphaericus EE443, comprising one or more mutations,wherein the bacteria are probiotic.

XV. Inoculums

The invention further relates to inoculums of any of the biologicallypure bacterial strains described above in the preceding section. Theinoculums are for application to plants, plant seeds, a plant growthmedium, or an area surrounding a plant or a plant seed, wherein theinoculum comprises an effective amount of any one of the biologicallypure bacterial cultures and an agriculturally acceptable carrier.

The inoculum can comprise an effective amount of a mixture comprising atleast two of the biologically pure bacterial cultures described above inthe immediately preceding section.

The inoculum can further comprise an effective amount of arhizobacteria. The rhizobacteria can be a biologically pure bacterialculture of a rhizobacteria strain. The rhizobacteria can compriseBradyrhizobium genus bacteria (e.g., Bradyrhizobium japonicum),Rhizobium genus bacteria (e.g., Rhizobium phaseoli, Rhizobiumleguminosarum, or a combination thereof), or a combination thereof.

XVI. Plant Seeds Coated with an Enzyme that Catalyzes the Production ofNitric Oxide or with Recombinant Bacteria that Overexpress an Enzymethat Catalyzes the Production of Nitric Oxide

A plant seed is also provided which is coated with: (i) an enzyme thatcatalyzes the production of nitric oxide; (ii) a superoxide dismutase or(iii) a recombinant microorganism that expresses an enzyme thatcatalyzes the production of nitric oxide or a superoxide dismutase,wherein the expression of the enzyme that catalyzes the production ofnitric oxide or the superoxide dismutase is increased as compared to theexpression of the enzyme that catalyzes the production of nitric oxideor the superoxide dismutase in a wild-type microorganism under the sameconditions.

The enzyme that catalyzes the production of nitric oxide can comprise anitric oxide synthase or an arginase.

The enzyme that catalyzes the production of nitric oxide can comprise anitric oxide synthase, such as a nitric oxide synthase from Bacillusthuringiensis BT013A or Bacillus subtilis 168.

For example, the nitric oxide synthase can comprise an amino acidsequence having at least 85% sequence identity with SEQ ID NO: 260 or261.

The nitric oxide synthase can comprise an amino acid sequence having atleast 90% sequence identity with SEQ ID NO: 260 or 261.

The nitric oxide synthase can comprise an amino acid sequence having atleast 95% sequence identity with SEQ ID NO: 260 or 261.

The nitric oxide synthase can comprise an amino acid sequence having atleast 98% sequence identity with SEQ ID NO: 260 or 261.

The nitric oxide synthase can comprise an amino acid sequence having atleast 99% sequence identity with SEQ ID NO: 260 or 261.

The nitric oxide synthase can comprise an amino acid sequence having100% sequence identity with SEQ ID NO: 260 or 261.

The superoxide dismutase can comprise superoxide dismutase 1 (SODA1) orsuperoxide dismutase 2 (SODA2).

The superoxide dismutase comprises an amino acid sequence having atleast 85% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase comprises an amino acid sequence having atleast 90% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase comprises an amino acid sequence having atleast 95% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase comprises an amino acid sequence having atleast 98% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase comprises an amino acid sequence having atleast 99% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase comprises an amino acid sequence having atleast 100% identity with SEQ ID NO: 155 or 156.

When the plant seed is coated with the recombinant microorganism, therecombinant microorganism can comprise a Bacillus species, Escherechiacoli, an Aspergillus species such as Aspergillus niger, or aSaccharomyces species such as Saccharomyces cerevisiae.

For example, the recombinant microorganism can comprise a Bacilluscereus family member, Bacillus subtilis, Bacillus licheniformis, orBacillus megaterium.

Amino acid sequences for exemplary nitric oxide synthetase enzymes areprovided above in Table 8. Amino acid sequences for exemplary superoxidedismutases are provided above in Table 2.

XVII. Formulations

Formulations are provided which comprise a recombinant Bacillus cereusfamily member as described herein, exosporium fragments derived fromspores of a recombinant Bacillus cereus family member as describedherein or a recombinant spore-forming bacterium as described herein, andan agriculturally acceptable carrier.

The agriculturally acceptable carrier can comprise an additive, such asan oil, a gum, a resin, a clay, a polyoxyethylene glycol, a terpene, aviscid organic, a fatty acid ester, a sulfated alcohol, an alkylsulfonate, a petroleum sulfonate, an alcohol sulfate, a sodium alkylbutane diamate, a polyester of sodium thiobutane dioate, a benzeneacetonitrile derivative, a proteinaceous material, or a combinationthereof.

The agriculturally acceptable carrier can comprise a thickener, such asa long chain alkylsulfonate of polyethylene glycol, a polyoxyethyleneoleate, or a combination thereof; a surfactant such as a heavy petroleumoil, a heavy petroleum distillate, a polyol fatty acid ester, apolyethoxylated fatty acid ester, an aryl alkyl polyoxyethylene glycol,an alkyl amine acetate, an alkyl aryl sulfonate, a polyhydric alcohol,an alkyl phosphate, or a combination thereof; or an anti-caking agentsuch as a sodium salt (e.g., a sodium salt of monomethyl naphthalenesulfonate, a sodium salt of dimethyl naphthalene sulfonate, a sodiumsulfite, a sodium sulfate, or a combination thereof), a calciumcarbonate, diatomaceous earth, or a combination thereof.

The additive can comprise a proteinaceous material such as a milkproduct, wheat flour, soybean meal, blood, albumin, gelatin, alfalfameal, yeast extract, or a combination thereof;

The agriculturally acceptable carrier can comprise vermiculite,charcoal, sugar factory carbonation press mud, rice husk, carboxymethylcellulose, peat, perlite, fine sand, calcium carbonate, flour, alum, astarch, talc, polyvinyl pyrrolidone, or a combination thereof.

The formulation can comprise a seed coating formulation, a liquidformulation for application to plants or to a plant growth medium, or asolid formulation for application to plants or to a plant growth medium.The seed coating formulation can comprise an aqueous or oil-basedsolution for application to seeds or a powder or granular formulationfor application to seeds. The liquid formulation for application toplants or to a plant growth medium can comprise a concentratedformulation or a ready-to-use formulation. The solid formulation forapplication to plants or to a plant growth medium can comprise agranular formulation or a powder agent.

The formulation further can comprise a fertilizer, a micronutrientfertilizer material, an insecticide, an herbicide, a plant growthamendment, a fungicide, an insecticide, a molluscicide, an algicide, abacterial inoculant, a fungal inoculant, or a combination thereof.

The bacterial inoculant can comprise a bacterial inoculant of the genusRhizobium, a bacterial inoculant of the genus Bradyrhizobium, abacterial inoculant of the genus Mesorhizobium, a bacterial inoculant ofthe genus Azorhizobium, a bacterial inoculant of the genusAllorhizobium, a bacterial inoculant of the genus Sinorhizobium, abacterial inoculant of the genus Kluyvera, a bacterial inoculant of thegenus Azotobacter, a bacterial inoculant of the genus Pseudomonas, abacterial inoculant of the genus Azospirillium, a bacterial inoculant ofthe genus Bacillus, a bacterial inoculant of the genus Streptomyces, abacterial inoculant of the genus Paenibacillus, a bacterial inoculant ofthe genus Paracoccus, a bacterial inoculant of the genus Enterobacter, abacterial inoculant of the genus Alcaligenes, a bacterial inoculant ofthe genus Mycobacterium, a bacterial inoculant of the genus Trichoderma,a bacterial inoculant of the genus Gliocladium, a bacterial inoculant ofthe genus Glomus, a bacterial inoculant of the genus Klebsiella, or acombination thereof.

The bacterial inoculant can comprise a plant-growth promoting strain ofbacteria. The plant-growth promoting strain of bacteria can produce aninsecticidal toxin, produce a fungicidal compound, produce a nematocidalcompound, produce a bacteriocidal compound, can be resistant to one ormore antibiotics, can comprise one or more freely replicating plasmids,bind to plant roots, colonize plant roots, form biofilms, solubilizenutrients, secrete organic acids, or combinations thereof.

For example, the bacterial inoculant can comprise Bacillus aryabhattaiCAP53 (NRRL No. B-50819), Bacillus aryabhattai CAP56 (NRRL No. B-50817),Bacillus flexus BT054 (NRRL No. B-50816), Paracoccus kondratievae NC35(NRRL No. B-50820), Bacillus mycoides BT155 (NRRL No. B-50921),Enterobacter cloacae CAP12 (NRRL No. B-50822), Bacillus nealsonii BOBA57(NRRL No. NRRL B-50821), Bacillus mycoides EE118 (NRRL No. B-50918),Bacillus subtilis EE148 (NRRL No. B-50927), Alcaligenes faecalis EE107(NRRL No. B-50920), Bacillus mycoides EE141 (NRRL NO. B-50916), Bacillusmycoides BT46-3 (NRRL No. B-50922), Bacillus cereus family member EE128(NRRL No. B-50917), Bacillus thuringiensis BT013A (NRRL No. B-50924),Paenibacillus massiliensis BT23 (NRRL No. B-50923), Bacillus cereusfamily member EE349 (NRRL No. B-50928), Bacillus subtilis EE218 (NRRLNo. B-50926), Bacillus megaterium EE281 (NRRL No. B-50925), Bacilluscereus family member EE-B00377 (NRRL B-67119); Bacillus pseudomycoidesEE-B00366 (NRRL B-67120), Bacillus mycoides EE-B00363 (NRRL B-67121),Bacillus pumilus EE-B00143 (NRRL B-67123), or Bacillus thuringiensisEE-B00184 (NRRL B-67122) or a combination thereof. Each of these strainswas deposited with the United States Department of Agriculture (USDA)Agricultural Research Service (ARS), having the address 1815 NorthUniversity Street, Peoria, Ill. 61604 U.S.A., on Mar. 7, 2013 (Bacillusaryabhattai CAP53, Bacillus aryabhattai CAP56, Bacillus flexus BT054,Paracoccus kondratievae NC35, Enterobacter cloacae CAP12, and Bacillusnealsonii BOBA57), on Mar. 10, 2014 (Bacillus mycoides BT155, Bacillusmycoides EE118, Bacillus subtilis EE148, Alcaligenes faecalis EE107,Bacillus mycoides EE141, Bacillus mycoides BT46-3, Bacillus cereusfamily member EE128, Bacillus thuringiensis BT013A, Paenibacillusmassiliensis BT23, Bacillus cereus family member EE349, Bacillussubtilis EE218, and Bacillus megaterium EE281), or on Aug. 19, 2015(Bacillus cereus family member EE-B00377; Bacillus pseudomycoidesEE-B00366, Bacillus mycoides EE-B00363, Bacillus pumilus EE-B00143, orBacillus thuringiensis EE-B00184) and is identified by the NRRL numbersprovided in parentheses.

These plant-growth promoting strains were isolated from the rhizospheresof various vigorous plants and were identified by their 16S rRNAsequences, and through biochemical assays. The strains were identifiedat least to their genus designation by means of conventionalbiochemistry and morphological indicators. Biochemical assays forconfirmed Gram-negative strains such as Paracoccus kondratievae,Alcaligenes faecalis, and Enterobacter cloacae included growth onMacConkey medium and nutrient agar, microscopic examination, growth on5% and 7.5% NaCl medium, growth at pH 5 and pH 9, growth at 42° C. and50° C., the ability to produce acid upon fermentation with cellobiose,lactose, glycerol, glucose, sucrose, d-mannitol, and starch; fluorescentpigment production; gelatin hydrolysis; nitrate reduction; starchhydrolysis; oxidase reaction, catalase production, urease production andmotility. Similarly, the biochemical assays for confirmed Gram-positivestrains such as Bacillus and Paenibacillus included growth on PEA mediumand nutrient agar, microscopic examination, growth on 5% and 7.5% NaClmedium, growth at pH 5 and pH 9, growth at 42° C. and 50° C., theability to produce acid upon fermentation with cellobiose, lactose,glycerol, glucose, sucrose, d-mannitol, and starch; fluorescent pigmentproduction; gelatin hydrolysis; nitrate reduction; catalase production,starch hydrolysis; oxidase reaction, urease production and motility.Identification of these strains and demonstration of their plant-growthpromoting effects are described further in the Examples hereinbelow.Partial 16S rRNA sequences for the strains Bacillus mycoides BT155,Bacillus mycoides EE118, Bacillus mycoides EE141, Bacillus mycoidesBT46-3, Bacillus cereus family member EE128, Bacillus thuringiensisBT013A, and Bacillus cereus family member EE349 are provided in Table 12above. Partial 16S rRNA sequences for the strains Bacillus aryabhattaiCAP53, Bacillus aryabhattai CAP56, Bacillus Plexus BT054, Paracoccuskondratievae NC35, Enterobacter cloacae CAP12, Bacillus nealsoniiBOBA57, Bacillus subtilis EE148, Alcaligenes faecalis EE107,Paenibacillus massiliensis BT23, Bacillus subtilis EE218, and Bacillusmegaterium EE281 are listed in Table 15 below.

TABLE 15 Partial 16S rRNA sequences for additional plant-growthpromoting strains of bacteria SEQ ID NO. for partial 16S Strainribosomal RNA sequence Bacillus aryabhattai CAP53 287 Bacillusaryabhattai CAP56 288 Bacillus Plexus BT054 289 Paracoccus kondratievaeNC35 290 Enterobacter cloacae CAP12 291 Bacillus nealsonii BOBA57 292Bacillus subtilis EE148 293 Alcaligenes faecalis EE107 294 Paenibacillusmassiliensis BT23 295 Bacillus subtilis EE218 296 Bacillus megateriumEE281 297

For example, the formulation can comprise a plant-growth promotingstrain of bacteria comprising Paracoccus kondratievae NC35, Bacillusaryabhattai CAP53, or Bacillus megaterium EE281, wherein the formulationfurther comprises any of the recombinant Bacillus cereus family membersdescribed herein, including any of the recombinant plant-growthpromoting Bacillus cereus family member strains herein (e.g.,recombinant Bacillus mycoides BT155, Bacillus mycoides EE141, orBacillus thuringiensis BT013A).

The fungal inoculant can comprise a fungal inoculant of the familyGlomeraceae, a fungal inoculant of the family Claroidoglomeraceae, afungal inoculant of the family Gigasporaceae, a fungal inoculant of thefamily Acaulosporaceae, a fungal inoculant of the familySacculosporaceae, a fungal inoculant of the family Entrophosporaceae, afungal inoculant of the family Pacidsporaceae, a fungal inoculant of thefamily Diversisporaceae, a fungal inoculant of the familyParaglomeraceae, a fungal inoculant of the family Archaeosporaceae, afungal inoculant of the family Geosiphonaceae, a fungal inoculant of thefamily Ambisporaceae, a fungal inoculant of the familyScutellosporaceae, a fungal inoculant of the family Dentiscultataceae, afungal inoculant of the family Racocetraceae, a fungal inoculant of thephylum Basidiomycota, a fungal inoculant of the phylum Ascomycota, afungal inoculant of the phylum Zygomycota, or a combination thereof.

The spore-forming bacterium, alone or in combination with theinsecticide, can further comprise an effective amount of at least onefungicide.

Typical fungicidal ingredients also include Captan(N-trichloromethyl)thio-4-cyclohexane-1,2-dicarboximide), Fludioxoni 1(4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1-H-pyrrol-3-carbonitril;carbendazim iprodione (commercially available under the tradenameRovral®), tebuconazole, thiabendazole, azoxystrobin, prochloraz, andOxadixyl (N-(2,6-dimethylphenyl)-2-methoxy-N-(2-oxo-3-oxazolidinyl)acetamide).

If a formulation, plant seed, or inoculum comprises a fungicide, thefungicide can comprise aldimorph, ampropylfos, ampropylfos potassium,andoprim, anilazine, azaconazole, azoxystrobin, benalaxyl, benodanil,benomyl, benzamacril, benzamacryl-isobutyl, bialaphos, binapacryl,biphenyl, bitertanol, blasticidin-S, boscalid, bromuconazole,bupirimate, buthiobate, calcium polysulphide, capsimycin, captafol,captan, carbendazim, carvon, quinomethionate, chlobenthiazone,chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlozolinate,clozylacon, cufraneb, cymoxanil, cyproconazole, cyprodinil, cyprofuram,debacarb, dichlorophen, diclobutrazole, diclofluanid, diclomezine,dicloran, diethofencarb, dimethirimol, dimethomorph, dimoxystrobin,diniconazole, diniconazole-M, dinocap, diphenylamine, dipyrithione,ditalimfos, dithianon, dodemorph, dodine, drazoxolon, edifenphos,epoxiconazole, etaconazole, ethirimol, etridiazole, famoxadon,fenapanil, fenarimol, fenbuconazole, fenfuram, fenitropan, fenpiclonil,fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam,ferimzone, fluazinam, flumetover, fluoromide, fluquinconazole,flurprimidol, flusilazole, flusulfamide, flutolanil, flutriafol, folpet,fosetyl-aluminium, fosetyl-sodium, fthalide, fuberidazole, furalaxyl,furametpyr, furcarbonil, furconazole, furconazole-cis, furmecyclox,guazatine, hexachlorobenzene, hexaconazole, hymexazole, imazalil,imibenconazole, iminoctadine, iminoctadine albesilate, iminoctadinetriacetate, iodocarb, iprobenfos (IBP), iprodione, irumamycin,isoprothiolane, isovaledione, kasugamycin, kresoxim-methyl, copperpreparations, such as: copper hydroxide, copper naphthenate, copperoxychloride, copper sulphate, copper oxide, oxine-copper and Bordeauxmixture, mancopper, mancozeb, maneb, meferimzone, mepanipyrim, mepronil,metalaxyl, metconazole, methasulfocarb, methfuroxam, metiram,metomeclam, metsulfovax, mildiomycin, myclobutanil, myclozolin, nickeldimethyldithiocarbamate, nitrothal-isopropyl, nuarimol, ofurace,oxadixyl, oxamocarb, oxolinic acid, oxycarboxim, oxyfenthiin,paclobutrazole, pefurazoate, penconazole, pencycuron, phosdiphen,pimaricin, piperalin, polyoxin, polyoxorim, probenazole, prochloraz,procymidone, propamocarb, propanosine-sodium, propiconazole, propineb,prothiocinazole, pyrazophos, pyrifenox, pyrimethanil, pyroquilon,pyroxyfur, quinconazole, quintozene (PCNB), sulphur and sulphurpreparations, tebuconazole, tecloftalam, tecnazene, tetcyclasis,tetraconazole, thiabendazole, thicyofen, thifluzamide,thiophanate-methyl, tioxymid, tolclofos-methyl, tolylfluanid,triadimefon, triadimenol, triazbutil, triazoxide, trichlamide,tricyclazole, tridemorph, trifloxystrobin, triflumizole, triforine,uniconazole, validamycin A, vinclozolin, viniconazole, zarilamide,zineb, ziram and also Dagger G, OK-8705, OK-8801,a-(1,1-dimethylethyl)-(3-(2-phenoxyethyl)-1H-1,2,4-triazole-1-ethanol,a-(2,4-dichlorophenyl)-[3-fluoro-3-propyl-1H-1,2,4-triazole-1-ethanol,a-(2,4-dichlorophenyl)-[3-methoxy-a-methyl-1H-1,2,4-triazole-1-ethanol,a-(5-methyl-1,3-dioxan-5-yl)-[3-[[4-(trifluoromethyl)-phenyl]-methylene]-1H-1,2,4-triazole-1-ethanol,(5RS,6RS)-6-hydroxy-2,2,7,7-tetramethyl-5-(1H-1,2,4-triazol-1-yl)-3-octanone,(E)-a-(methoxyimino)-N-methyl-2-phenoxy-phenylacetamide,1-isopropyl{2-methyl-1-[[[1-(4-methylphenyl)-ethyl]-amino]-carbonyl]-propyl}carbamate,1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-ethanone-O-(phenylmethyl)-oxime,1-(2-methyl-1-naphthalenyl)-1H-pyrrole-2,5-dione,1-(3,5-dichlorophenyl)-3-(2-propenyl)-2,5-pyrrolidindione,1-[(diiodomethyl)-sulphonyl]-4-methyl-benzene,1-[[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]-methyl]-1H-imidazole,1-[[2-(4-chlorophenyl)-3-phenyloxiranyl]-methyl]-1H-1,2,4-triazole,1-[1-[2-[(2,4-dichlorophenyl)-methoxy]-phenyl]-ethenyl]-1H-imidazole,1-methyl-5-nonyl-2-(phenylmethyl)-3-pyrrolidinole,2′,6′-dibromo-2-methyl-4′-trifluoromethoxy-4′-trifluoro-methyl-1,3-thiazole-carboxanilide,2,2-dichloro-N-[1-(4-chlorophenyl)-ethyl]-1-ethyl-3-methyl-cyclopropanecarboxamide,2,6-dichloro-5-(methylthio)-4-pyrimidinyl-thiocyanate,2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide,2,6-dichloro-N-[[4-(trifluoromethyl)-phenyl]-methyl]-benzamide,2-(2,3,3-triiodo-2-propenyl)-2H-tetrazole,2-[(1-methylethyl)-sulphonyl]-5-(trichloromethyl)-1,3,4-thiadiazole,2-[[6-deoxy-4-O-(4-O-methyl-(3-D-glycopyranosyl)-a-D-glucopyranosyl]-amino]-4-methoxy-1H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile,2-aminobutane, 2-bromo-2-(bromomethyl)-pentanedinitrile,2-chloro-N-(2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl)-3-pyridinecarboxamide,2-chloro-N-(2,6-dimethylphenyl)-N-(isothiocyanatomethyl)-acetamide,2-phenylphenol (OPP),3,4-dichloro-1-[4-(difluoromethoxy)-phenyl]-pyrrole-2,5-dione,3,5-dichloro-N-[cyano[(1-methyl-2-propynyl)-oxy]-methyl]-benzamide,3-(1,1-dimethylpropyl-1-oxo-1H-indene-2-carbonitrile,3-[2-(4-chlorophenyl)-5-ethoxy-3-isoxazolidinyl]-pyridine,4-chloro-2-cyano-N,N-dimethyl-5-(4-methylphenyl)-1H-imidazole-1-sulphonamide,4-methyl-tetrazolo[1,5-a]quinazolin-5(4H)-one,8-(1,1-dimethylethyl)-N-ethyl-N-propyl-1,4-dioxaspiro[4,5]decane-2-methanamine,8-hydroxyquinoline sulphate,9H-xanthene-2-[(phenylamino)-carbonyl]-9-carboxylic hydrazide,bis-(1-methylethyl)-3-methyl-4-[(3-methylbenzoyl)-oxy]-2,5-thiophenedicarboxylate,cis-1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)-cycloheptanol,cis-4-[3-[4-(1,1-dimethylpropyl)-phenyl-2-methylpropyl]-2,6-dimethyl-morpholinehydrochloride, ethyl[(4-chlorophenyl)-azo]-cyanoacetate, potassiumbicarbonate, methanetetrathiol-sodium salt, methyl1-(2,3-dihydro-2,2-dimethyl-inden-1-yl)-1H-imidazole-5-carboxylate,methyl N-(2,6-dimethylphenyl)-N-(5-isoxazolylcarbonyl)-DL-alaninate,methyl N-(chloroacetyl)-N-(2,6-dimethylphenyl)-DL-alaninate,N-(2,3-dichloro-4-hydroxyphenyl)-1-methyl-cyclohexanecarboxamide,N-(2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-furanyl)-acetamide,N-(2,6-dimethylphenyl)-2-methoxy-N-(tetrahydro-2-oxo-3-thienyl)-acetamide,N-(2-chloro-4-nitrophenyl)-4-methyl-3-nitro-benzenesulphonamide,N-(4-cyclohexylphenyl)-1,4,5,6-tetrahydro-2-pyrimidinamine,N-(4-hexylphenyl)-1,4,5,6-tetrahydro-2-pyrimidinamine,N-(5-chloro-2-methylphenyl)-2-methoxy-N-(2-oxo-3-oxazolidinyl)-acetamide,N-(6-methoxy)-3-pyridinyl)-cyclopropanecarboxamide,N-[2,2,2-trichloro-1-[(chloroacetyl)-amino]-ethyl]-benzamide,N-[3-chloro-4,5-bis(2-propinyloxy)-phenyl]-N′-methoxy-methanimidamide,N-formyl-N-hydroxy-DL-alanine-sodium salt,0,0-diethyl[2-(dipropylamino)-2-oxoethyl]-ethylphosphoramidothioate,0-methyl S-phenyl phenylpropylphosphoramidothioate, S-methyl1,2,3-benzothiadiazole-7-carbothioate, andspiro[2H]-1-benzopyrane-2,1′(3′H)-isobenzofuran]-3′-one,N-trichloromethyl)thio-4-cyclohexane-1,2-dicarboximide,tetramethylthioperoxydicarbonic diamide, methylN-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate,4-(2,2-difluoro-1,3-benzodioxol-4-yl)-1-H-pyrrol-3-carbonitril or acombination thereof.

Additionally, suitable fungicides include the following: (1) a compoundcapable to inhibit the nucleic acid synthesis like benalaxyl,benalaxyl-M, bupirimate, chiralaxyl, clozylacon, dimethirimol,ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M, ofurace,oxadixyl, oxolinic acid; (2) a compound capable to inhibit the mitosisand cell division like benomyl, carbendazim, diethofencarb, ethaboxam,fuberidazole, pencycuron, thiabendazole thiophanate-methyl, zoxamide;(3) a compound capable to inhibit the respiration for example asCI-respiration inhibitor like diflumetorim; as CII-respiration inhibitorlike boscalid, fenfuram, flutolanil, furametpyr, furmecyclox, mepronil,oxycarboxine, penthiopyrad, thifluzamide; as CIII-respiration inhibitorlike amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestrobin,famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin,orysastrobin, picoxystrobin, trifloxystrobin; (4) a compound capable ofto act as an uncoupler like dinocap, fluazinam, meptyldinocap; (5) acompound capable to inhibit ATP production like fentin acetate, fentinchloride, fentin hydroxide; (6) a compound capable to inhibit AA andprotein biosynthesis like andoprim, blasticidin-S, cyprodinil,kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim,pyrimethanil; (7) a compound capable to inhibit the signal transductionlike fenpiclonil, quinoxyfen; (8) a compound capable to inhibit lipidand membrane synthesis like biphenyl, chlozolinate, edifenphos,etridiazole, iodocarb, iprobenfos, iprodione, isoprothiolane,procymidone, propamocarb, propamocarb hydrochloride, pyrazophos,tolclofos-methyl, vinclozolin; (9) a compound capable to inhibitergosterol biosynthesis like aldimorph, azaconazole, bitertanol,bromuconazole, cyproconazole, diclobutrazole, diniconazole,diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole,etaconazole, fenarimol, fenbuconazole, fenhexamid, fenpropidin,fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol,furconazole, furconazole-cis, hexaconazole, imazalil, imazalil sulfate,imibenconazole, metconazole, myclobutanil, naftifine, nuarimol,oxpoconazole, paclobutrazol, pefurazoate, penconazole, prochloraz,propiconazole, prothioconazole, pyributicarb, pyrifenox, simeconazole,spiroxamine, tebuconazole, terbinafine, tetraconazole, triadimefon,triadimenol, tridemorph, triflumizole, triforine, uniconazole,viniconazole, voriconazole; (10) a compound capable to inhibit cell wallsynthesis like benthiavalicarb, bialaphos, dimethomorph, flumorph,iprovalicarb, mandipropamid, polyoxins, polyoxorim, validamycin A; (11)a compound capable to inhibit melanine biosynthesis like carpropamid,diclocymet, fenoxanil, phthalide, pyroquilon, tricyclazole; (12) acompound capable to induce a host defense like acibenzolar-S-methyl,probenazole, tiadinil; (13) a compound capable to have a multisiteaction like Bordeaux mixture, captafol, captan, chlorothalonil, coppernaphthenate, copper oxide, copper oxychloride, copper preparations suchas copper hydroxide, copper sulphate, dichlofluanid, dithianon, dodine,dodine free base, ferbam, fluorofolpet, folpet, guazatine, guazatineacetate, iminoctadine, iminoctadine albesilate, iminoctadine triacetate,mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper,propineb, sulphur and sulphur preparations including calciumpolysulphide, tolylfluanid, zineb, ziram; (14) a compound selected inthe following list:(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylacetamide,(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide,1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol,1-[(4-methoxyphenoxy)methyl]-2,2-dimethylpropyl-1H-imidazole-1-carboxylat-e,2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine,2-butoxy-6-iodo-3-propyl-4H-chromen-4-one,2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)nicotinamide,2-phenylphenol and salts, 3,4,5-trichloropyridine-2,6-dicarbonitrile,3,4-dichloro-N-(2-cyanophenyl)isothiazole-5-carboxamide,3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine,5-chloro-6-(2,4,6-trifluorophenyl)-N-[(1R)-1,2,2-trimethylpropyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine,5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine,5-chloro-N-[(1R)-1,2-dimethylpropyl]-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, 8-hydroxyquinoline sulfate,benthiazole, bethoxazin, capsimycin, carvone, chinomethionat, cufraneb,cyflufenamid, cymoxanil, dazomet, debacarb, dichlorophen, diclomezine,dicloran, difenzoquat, difenzoquat methylsulphate, diphenylamine,ferimzone, flumetover, fluopicolide, fluoroimide, flusulfamide,fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene,irumamycin, isotianil, methasulfocarb,methyl(2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}thio)methyl]phenyl-}-3-methoxyacrylate,methyl1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylate,methyl isothiocyanate, metrafenone, mildiomycin,N-[2-(1,3-dimethylbutyl)phenyl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide,N-(4-chloro-2-nitrophenyl)-N-ethyl-4-methylbenzenesulfonamide,N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloronicotinamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloronicotinamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodonicotinamide,N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N&-lt;-(methylsulfonyl)valinamide,N—{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl-]methyl}-2-phenylacetamide,N-{2-[1,1′-bi(cyclopropyl)-2-yl]phenyl}-3-(difluoromethyl)-,1-methyl-1H-pyrazole-4-carboxamide,N-{2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl}-2-(trifluoromethyl)-benzamide,natamycin,N-ethyl-N-methyl-N′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)pr-poxy]phenyl}imidoformamide,N-ethyl-N-methyl-N′-{2-methyl-5-(difluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide,nickel dimethyldithiocarbamate, nitrothal-isopropyl,O-{1-[(4-methoxyphenoxy)methyl]-2,2-dimethylpropyl}1H-imidazole-1-carbothioate,octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts,phosphorous acid and its salts, piperalin, propamocarb fosetylate,propanosine-sodium, proquinazid, pyribencarb, pyrrolnitrine, quintozene,tecloftalam, tecnazene, triazoxide, trichlamide, valiphenal, zarilamid.

The fungicide can comprise a substituted benzene, a thiocarbamate, anethylene bis dithiocarbamate, a thiophthalidamide, a copper compound, anorganomercury compound, an organotin compound, a cadmium compound,anilazine, benomyl, cyclohexamide, dodine, etridiazole, iprodione,metlaxyl, thiamimefon, triforine, or a combination thereof.

If a formulation, plant seed, or inoculum comprises a fungicide, thefungicide can be a foliar fungicide. Foliar fungicides include copper,mancozeb, penthiopyrad, triazoles, cyproconazole, metconazole,propiconazole, prothioconazole, tebuconazole, azoxystrobin,pyraclastobin, fluoxastrobin, picoxystrobin, trifloxystrobin, sulfur,boscalid, thiophanate methyl, chlorothanonil, penthiopyrad,difenconazole, flutriafol, cyprodinil, fluzinam, iprodione, penflufen,cyazofamid, flutolanil, cymoxanil, dimethomorph, pyrimethanil, zoxamide,mandipropamid, metrinam, propamocarb, fenamidone, tetraconazole,chloronab, hymexazol, tolclofos, and fenbuconazole.

If a formulation, plant seed, or inoculum comprises a bacterialinoculant of the genus Bacillus, the bacterial inoculant can compriseBacillus argri, Bacillus aizawai, Bacillus albolactis, Bacillusamyloliquefaciens, Bacillus cereus, Bacillus coagulans, Bacillusendoparasiticus, Bacillus endorhythmos, Bacillus kurstaki, Bacilluslacticola, Bacillus lactimorbus, Bacillus lactis, Bacillus laterosporus,Bacillus lentimorbus, Bacillus licheniformis, Bacillus megaterium,Bacillus medusa, Bacillus metiens, Bacillus natto, Bacillus nigrificans,Bacillus popillae, Bacillus pumilus, Bacillus siamensis, Bacillussphearicus, Bacillus spp., Bacillus subtilis, Bacillus thuringiensis,Bacillus unifagellatu, or a combination thereof plus those listed in thecategory of Bacillus Genus in Bergey's Manual of SystematicBacteriology, First Ed. (1986), hereby incorporated in full byreference.

If a formulation, plant seed, or inoculum comprises an insecticide, theinsecticide can be a nematicide. Suitable nematicides include antibioticnematicides such as abamectin; carbamate nematicides such as acetoprole,Bacillus chitonosporus, chloropicrin, benclothiaz, benomyl, Burholderiacepacia, carbofuran, carbosulfan, and cleothocard; dazomet, DBCP, DCIP,alanycarb, aldicarb, aldoxycarb, oxamyl, diamidafos, fenamiphos,fosthietan, phosphamidon, cadusafos, chlorpyrifos, dichlofenthion,dimethoate, ethoprophos, fensulfothion, fostiazate, harpins, heterophos,imicyafos, isamidofos, isazofos, methomyl, mecarphon, Myrotheciumverrucaria, Paecilomyces lilacinus, phorate, phosphocarb, terbufos,thionazin, triazophos, dazomet, 1,2-dichloropropane,1,3-dichloropropene, furfural, iodomethane, metam, methyl bromide,methyl isothiocyanate, and xylenols.

For example and without limitation, the nematicide and insecticide canbe provided in the form of the commercial product Avicta Duo, which is amixture of abamectin and thiamethoxam commercially available fromSyngenta.

If a formulation, plant seed, or inoculum comprises a bactericide, itmay include streptomycin, penicillins, tetracyclines, ampicillin, andoxolinic acid.

The fertilizer can comprise a liquid fertilizer. The micronutrientfertilizer material can comprise boric acid, a borate, a boron frit,copper sulfate, a copper frit, a copper chelate, a sodium tetraboratedecahydrate, an iron sulfate, an iron oxide, iron ammonium sulfate, aniron frit, an iron chelate, a manganese sulfate, a manganese oxide, amanganese chelate, a manganese chloride, a manganese frit, a sodiummolybdate, molybdic acid, a zinc sulfate, a zinc oxide, a zinccarbonate, a zinc frit, zinc phosphate, a zinc chelate, or a combinationthereof.

The fertilizer can comprise ammonium sulfate, ammonium nitrate, ammoniumsulfate nitrate, ammonium chloride, ammonium bisulfate, ammoniumpolysulfide, ammonium thiosulfate, aqueous ammonia, anhydrous ammonia,ammonium polyphosphate, aluminum sulfate, calcium nitrate, calciumammonium nitrate, calcium sulfate, calcined magnesite, calciticlimestone, calcium oxide, calcium nitrate, dolomitic limestone, hydratedlime, calcium carbonate, diammonium phosphate, monoammonium phosphate,magnesium nitrate, magnesium sulfate, potassium nitrate, potassiumchloride, potassium magnesium sulfate, potassium sulfate, sodiumnitrates, magnesian limestone, magnesia, urea, urea-formaldehydes, ureaammonium nitrate, sulfur-coated urea, polymer-coated urea, isobutylidenediurea, K₂SO₄-2MgSO₄, kainite, sylvinite, kieserite, Epsom salts,elemental sulfur, marl, ground oyster shells, fish meal, oil cakes, fishmanure, blood meal, rock phosphate, super phosphates, slag, bone meal,wood ash, manure, bat guano, peat moss, compost, green sand, cottonseedmeal, feather meal, crab meal, fish emulsion, humic acid, or acombination thereof.

A formulation, plant seed, or inoculum can also include at least onebiological control agent selected from (1) bacteria, in particularspore-forming bacteria, (2) fungi or yeasts, and (3) isoflavones.Preference is given to combinations comprising as biological controlagent a bacterium, in particular a spore-forming, root-colonizingbacterium, or a bacterium useful as biofungicide, selected from thegroup consisting of [Group (1)]: (1.1) Bacillus agri, (1.2) Bacillusaizawai, (1.3) Bacillus albolactis, (1.4) Bacillus amyloliquefaciens,(1.5) Bacillus cereus, (1.6) Bacillus coagulans, (1.7) Bacillusendoparasiticus, (1.8) Bacillus endorhythmos, (1.9), (1.10) Bacilluskurstaki, (1.11) Bacillus lacticola, (1.12) Bacillus lactimorbus, (1.13)Bacillus lactis, (1.14) Bacillus laterosporus, (1.15) Bacilluslentimorbus, (1.16) Bacillus licheniformis, (1.17) Bacillus medusa,(1.18) Bacillus megaterium, (1.19) Bacillus metiens, (1.20) Bacillusnatto, (1.21) Bacillus nigrificans, (1.22) Bacillus popillae, (1.23)Bacillus pumilus, (1.24) Bacillus siamensis, (1.25) Bacillus sphaericus(products known as VectoLex.sup.S), (1.26) Bacillus subtilis, or B.subtilis var. amyloliquefaciens, (1.27) Bacillus thuringiensis, inparticular B. thuringiensis var. israelensis (products known asVectoBac®) or B. thuringiensis subsp. aizawai strain ABTS-1857 (productsknown as XenTari), or B. thuringiensis subsp. kurstaki strain HD-1(products known as Dipel ES), (1.28) Bacillus uniflagellatus, (1.29)Delftia acidovorans, in particular strain RAY209 (products known asBioBoost), (1.30) Lysobacter antibioticus, in particular strain 13-1(Biological Control 2008, 45, 288-296), (1.31) Lysobacter enzymogenes,in particular strain 3.1T8, (1.32) Pseudomonas chlororaphis, inparticular strain MA 342 (products known as Cedomon), (1.33) Pseudomonasproradix (products known as Proradix®), (1.34) Streptomyces galbus, inparticular strain K61 (products known as Mycostop®, cf. Crop Protection2006, 25, 468-475), (1.35) Streptomyces griseoviridis (products known asMycostop®).

Preference is further given to combinations comprising as biologicalcontrol agent a fungus or a yeast selected from the group consisting of[Group (2)]: (2.1) Ampelomyces quisqualis, in particular strain AQ 10(product known as AQ 10®), (2.2) Aureobasidium pullulans, in particularblastospores of strain DSM14940 or blastospores of strain DSM 14941 ormixtures thereof (product known as Blossom Protect®), (2.3) Beauveriabassiana, in particular strain ATCC 74040 (products known asNaturalis®), (2.4) Candida oleophila, in particular strain O (productsknown as Nexy), (2.5) Cladosporium cladosporioides H39 (cf. Eur. J.Plant Pathol. 2009, 123, 401-414), (2.6), (2.7) Dilophosphora alopecuri(products known as Twist Fungus), (2.8) Gliocladium catenulatum, inparticular strain J1446 (products known as Prestop), (2.9) Lecanicilliumlecanii (formerly known as Verticillium lecanii), in particular conidiaof strain KV01 (products known as Mycotal®, Vertalec®), (2.10)Metarhizium anisopliea (products known as BIO 1020), (2.11)Metschnikovia fructicola, in particular the strain NRRL Y-30752(products known as Shemer™), (2.12) Microsphaeropsis ochracea (productsknown as Microx), (2.13), (2.14) Nomuraea rileyi, (2.15), (2.16)Penicillium bilaii, in particular strain ATCC22348 (products known asJumpStart®, PB-50, Provide), (2.17) Pichia anomala, in particular strainWRL-076, (2.18) Pseudozyma flocculosa, in particular strain PF-A22 UL(products known as Sporodex L), (2.19) Pythium oligandrum DV74 (productsknown as Polyversum), (2.20) Trichoderma asperellum, in particularstrain ICC 012 (products known as Bioten), (2.21) Trichoderma harzianum,in particular T. harzianum T39 (products known e.g. as Trichodex).

Preference is further given to combinations comprising as biologicalcontrol agent an isoflavone selected from the group consisting of [Group(3)]: (3.1) genistein, (3.2) biochanin A10, (3.3) formononetin, (3.4)daidzein. (3.5) glycitein, (3.6) hesperetin, (3.7) naringenin, (3.8)chalcone, (3.9) coumarin, (3.10) Ambiol(2-methyl-4-dimethylaminomethyl-5-hydroxybenzimidazol dihydrochoride)(3.11) ascorbate and (3.12) pratensein and the salts and esters thereof.

If a formulation, plant seed, or inoculum comprises an insecticide, theinsecticide can include pyrethroids, organophosphates, caramoyloximes,pyrazoles, amidines, halogenated hydrocarbons, neonicotinoids, andcarbamates and derivatives thereof. Particularly suitable classes ofinsecticides include organophosphates, phenylpyrazoles and pyrethoids.Preferred insecticides are those known as terbufos, chlorpyrifos,chlorethoxyfos, tefluthrin, carbofuran, and tebupirimfos. Commerciallyavailable insecticides include thiomethoxam (commercially available fromSyngenta under the tradename Cruiser.

The insecticide can comprise an organophosphate, a carbamate, apyrethroid, an acaricide, an alkyl phthalate, boric acid, a borate, afluoride, sulfur, a haloaromatic substituted urea, a hydrocarbon ester,a biologically-based insecticide, or a combination thereof.

Suitable insecticides for use herein also include the following: (1)acetylcholine receptor agonists/antagonists such aschloronicotinyls/nconicotinoids, nicotine, bensultap or cartap. Suitableexamples of chloronicotinyls/neonicotinoids include acetamiprid,dinotefuran, nitenpyram, nithiazine, thiacloprid, thiamethoxam,imidaclothiz and(2E)-1-[(2-chloro-1,3-thiazol-5-yl)methyl]-3,5-dimethyl-N-nitro-1,3,5-tri-azinan-2-imine;(2) acetylcholinesterase (ACNE) inhibitors such as carbamates andorganophosphates. Suitable examples of carbamates include alanycarb,aldicarb, aldoxycarb, allyxycarb, aminocarb, bendiocarb, benfuracarb,bufencarb, butacarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran,carbosulfan, chloethocarb, dimetilan, ethiofencarb, fenobucarb,fenothiocarb, formetanate, furathiocarb, isoprocarb, metam-sodium,methomyl, metolcarb, oxamyl, phosphocarb, pirimicarb, promecarb,propoxur, thiofanox, triazamate, trimethacarb, XMC and xylylcarb.Suitable examples of organophosphates include acephate, azamethiphos,azinphos (-methyl, -ethyl), bromophos-ethyl, bromfenvinfos (-methyl),butathiofos, cadusafos, carbophenothion, chlorethoxyfos,chlorfenvinphos, chlormephos, chlorpyrifos (-methyl/-ethyl), coumaphos,cyanofenphos, cyanophos, demeton-S-methyl, demeton-S-methylsulphon,dialifos, diazinon, dichlofenthion, dichlorvos/DDVP, dicrotophos,dimethoate, dimethylvinphos, dioxabenzofos, disulfoton, EPN, ethion,ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion,fenthion, flupyrazofos, fonofos, formothion, fosmethilan, fosthiazate,heptenophos, iodofenphos, iprobenfos, isazofos, isofenphos, isopropylO-salicylate, isoxathion, malathion, mecarbam, methacrifos,methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate,oxydemeton-methyl, parathion (-methyl/-ethyl), phenthoate, phorate,phosalone, phosmet, phosphamidon, phosphocarb, phoxim, pirimiphos(-methyl/-ethyl), profenofos, propaphos, propetamphos, prothiofos,prothoate, pyraclofos, pyridaphenthion, pyridathion, quinalphos,sebufos, sulfotep, sulprofos, tebupirimfos, temephos, terbufos,tetrachlorvinphos, thiometon, triazophos, triclorfon and vamidothion;(3) sodium channel modulators/voltage-gated sodium channel blockers suchas pyrethroids and oxadiazines. Suitable examples of pyrethroids includeacrinathrin, allethrin (d-cis-trans, d-trans), beta-cyfluthrin,bifenthrin, bioallethrin, bioallethrin-S-cyclopentyl-isomer,bioethanomethrin, biopermethrin, bioresmethrin, chlovaporthrin,cis-resmethrin, cis-permethrin, clocythrin, cycloprothrin, cyfluthrin,cyhalothrin, cyphenothrin, DDT, deltamethrin, empenthrin (1R-isomer),esfenvalerate, etofenprox, fenfluthrin, fenpropathrin, fenpyrithrin,fenvalerate, flubrocythrinate, flucythrinate, flufenprox, flumethrin,fluvalinate, fubfenprox, gamma-cyhalothrin, imiprothrin, kadethrin,lambda-cyhalothrin, metofluthrin, permethrin (cis-, trans-), phenothrin(1R-trans isomer), prallethrin, profluthrin, protrifenbute,pyresmethrin, resmethrin, RU 15525, silafluofen, tau-fluvalinate,tefluthrin, terallethrin, tetramethrin (1R-isomer), tralocythrin,tralomethrin, transfluthrin, ZXI 8901 and pyrethrins (pyrethrum).Suitable example of oxadiazines includes indoxacarb; (4) acetylcholinereceptor modulators such as spinosyns. Suitable example of spinosynsincludes spinosad; (5) GABA-gated chloride channel antagonists such ascyclodiene organochlorines and fiproles. Suitable examples of cyclodieneorganochlorines include camphechlor, chlordane, endosulfan, gamma-HCH,HCH, heptachlor, lindane and methoxychlor. Suitable examples of fiprolesinclude acetoprole, and vaniliprole; (6) chloride channel activatorssuch as mectins. Suitable examples of mectins include abamectin,avermectin, emamectin, emamectin-benzoate, ivermectin, lepimectin,milbemectin and milbemycin; (7) juvenile hormone mimetics such asdiofenolan, epofenonane, fenoxycarb, hydroprene, kinoprene, methoprene,pyriproxifen, triprene; (8) ecdysone agonists/disruptors such asdiacylhydrazines. Suitable examples of diacylhydrazines includechromafenozide, halofenozide, methoxyfenozide and tebufenozide; (9)inhibitors of chitinbiosynthesis such as benzoylureas, buprofezin andcyromazine. Suitable examples of benzoylureas include bistrifluron,chlofluazuron, diflubenzuron, fluazuron, flucycloxuron, flufenoxuron,hexaflumuron, lufenuron, novaluron, noviflumuron, penfluron,teflubenzuron and triflumuron; (10) inhibitors of oxidativephosphorylation, ATP disruptors such as organotins and diafenthiuron.Suitable examples of organotins include azocyclotin, cyhexatin andfenbutatin oxide; (11) decouplers of oxidative phosphorylation bydisruption of the H proton gradient such as pyrroles and dinitrophenols.Suitable example of pyrroles includes chlorfenapyr. Suitable examples ofdinitrophenols include binapacyrl, dinobuton, dinocap and DNOC; (12)site I electron transport inhibitors such as METIs, hydramethylnone anddicofol. Suitable examples of METIs include fenazaquin, fenpyroximate,pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad; (13) site II electrontransport inhibitors such as rotenone; (14) site III electron transportinhibitors such as acequinocyl and fluacrypyrim; (15) microbialdisrupters of the intestinal membrane of insects such as Bacillusthuringiensis strains; (16) inhibitors of lipid synthesis such astetronic acids and tetramic acids. Suitable examples of tetronic acidsinclude spirodiclofen, spiromesifen and spirotetramat. Suitable exampleof tetramic acids includescis-3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-ylethyl carbonate (alias: carbonic acid,3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-ylethyl ester (CAS Reg. No.: 382608-10-8); (17) carboxamides such asflonicamid; (18) octopaminergic agonists such as amitraz; (19)inhibitors of the magnesium-stimulated ATPase such as propargite; (20)ryanodin receptor agonists such as phthalamides or rynaxapyr. Suitableexample of phthalamides includesN.sup.2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N.sup.1-[2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-1,2-benzenedicarbo-xamide(i.e. flubendiamide, CAS reg. No.: 272451-65-7); (21) nereistoxinanalogues such as thiocyclam hydrogen oxalate and thiosultap-sodium;(22) biologics, hormones or pheromones such as azadirachtin, Bacillusspec., Beauveria spec., codlemone, Metarrhizium spec., Paecilomycesspec., thuringiensis and Verticillium spec; (23) active compounds havingunknown or non-specified mechanisms of action such as fumigants,selective feeding inhibitors, mite growth inhibitors, amidoflumet;benclothiaz, benzoximate, bifenazate, bromopropylate, buprofezin,chinomethioat, chlordimeform, chlorobenzilate, chloropicrin,clothiazoben, cycloprene, cyflumetofen, dicyclanil, fenoxacrim,fentrifanil, flubenzimine, flufenerim, flutenzin, gossyplure,hydramethylnone, japonilure, metoxadiazone, petroleum, piperonylbutoxide, potassium oleate, pyrafluprole, pyridalyl, pyriprole,sulfluramid, tetradifon, tetrasul, triarathene, verbutin, furthermorethe compound 3-methylphenyl propylcarbamate (Tsumacide Z), the compound3-(5-chloro-3-pyridinyl)-8-(2,2,2-trifluoroethyl)-8-azabicyclo[3.2.1]octane-3-carbonitrile(CAS reg. No. 185982-80-3) and the corresponding 3-endo isomer (CAS reg.No. 185984-60-5) (cf. WO 96/37494, WO 98/25923), and also preparationscomprising insecticidal effective plant extracts, nematodes, fungi orviruses. Suitable examples of fumigants include aluminium phosphide,methyl bromide and sulphuryl fluoride. Suitable examples of selectivefeeding inhibitors include cryolite, flonicamid and pymetrozine.Suitable examples of mite growth inhibitors include clofentezine,etoxazole and hexythiazox.

Commercially available nematicidal ingredients include abamectin(commercially available from Syngenta under the tradename Avicta).

If a formulation, plant seed, or inoculum comprises an herbicide, theherbicide can comprise 2,4-D, 2,4-DB, acetochlor, acifluorfen, alachlor,ametryn, atrazine, aminopyralid, benefin, bensulfuron, bensulide,bentazon, bromacil, bromoxynil, butylate, carfentrazone, chlorimuron,chlorsulfuron, clethodim, clomazone, clopyralid, cloransulam, cycloate,DCPA, desmedipham, dicamba, dichlobenil, diclofop, diclosulam,diflufenzopyr, dimethenamid, diquat, diuron, DSMA, endothall, EPTC,ethalfluralin, ethofumesate, fenoxaprop, fluazifop-P, flucarbazone,flufenacet, flumetsulam, flumiclorac, flumioxazin, fluometuron,fluroxypyr, fomesafen, foramsulfuron, glufosinate, glyphosate,halosulfuron, hexazinone, imazamethabenz, imazamox, imazapic, imazaquin,imazethapyr, isoxaben, isoxaflutole, lactofen, linuron, MCPA, MCPB,mesotrione, metolachlor-s, metribuzin, metsulfuron, molinate, MSMA,napropamide, naptalam, nicosulfuron, norflurazon, oryzalin, oxadiazon,oxyfluorfen, paraquat, pelargonic acid, pendimethalin, phenmedipham,picloram, primisulfuron, prodiamine, prometryn, pronamide, propanil,prosulfuron, pyrazon, pyrithiobac, quinclorac, quizalofop, rimsulfuron,sethoxydim, siduron, simazine, sulfentrazone, sulfometuron,sulfosulfuron, tebuthiuron, terbacil, thiazopyr, thifensulfuron,thiobencarb, tralkoxydim, triallate, triasulfuron, tribenuron,triclopyr, trifluralin, triflusulfuron, or a combination thereof.

The herbicide can comprise a chlorophenoxy compound, a nitrophenoliccompound, a nitrocresolic compound, a dipyridyl compound, an acetamide,an aliphatic acid, an anilide, a benzamide, a benzoic acid, a benzoicacid derivative, anisic acid, an anisic acid derivative, a benzonitrile,benzothiadiazinone dioxide, a thiocarbamate, a carbamate, a carbanilate,chloropyridinyl, a cyclohexenone derivative, a dinitroaminobenzenederivative, a fluorodinitrotoluidine compound, isoxazolidinone,nicotinic acid, isopropylamine, an isopropylamine derivative,oxadiazolinone, a phosphate, a phthalate, a picolinic acid compound, atriazine, a triazole, a uracil, a urea derivative, endothall, sodiumchlorate, a sulfonylurea, an aryl triazine, or a combination thereof.

The formulation can comprise an herbicide and a strain of bacteria thatis capable of degrading the herbicide.

The strain of bacteria that is capable of degrading an herbicide cancomprise Bacillus cereus family member EE349 (NRRL No. B-50928),Bacillus cereus family member EE-B00377 (NRRL B-67119), Bacilluspseudomycoides EE-B00366 (NRRL B-67120), or Bacillus mycoides EE-B00363(NRRL B-67121), or a combination thereof.

The herbicide to be degraded can comprise a sulfonylurea such assulfentrazone, an aryl triazine, dicamba, a phenoxy herbicide, 2,4-D, apyrethrin, a pyrethroid, or a combination thereof

Binders can be included in the formulations, such ascarboxymethylcellulose and natural and synthetic polymers in the form ofpowders, granules, or latexes, such as gum Arabic, chitin, polyvinylalcohol and polyvinyl acetate, as well as natural phospholipids, such ascephalins and lecithins, and synthetic phospholipids. Binders includethose composed preferably of an adhesive polymer that can be natural orsynthetic without phytotoxic effect on the seed to be coated. Additionalbinders that can be included, either alone or in combination, include,for example, polyesters, polyether esters, polyanhydrides, polyesterurethanes, polyester amides; polyvinyl acetates; polyvinyl acetatecopolymers; polyvinyl alcohols and tylose; polyvinyl alcohol copolymers;polyvinylpyrolidones; polysaccharides, including starches, modifiedstarches and starch derivatives, dextrins, maltodextrins, alginates,chitosanes and celluloses, cellulose esters, cellulose ethers andcellulose ether esters including ethylcelluloses, methylcelluloses,hydroxymethylcelluloses, hydroxypropylcelluloses andcarboxymethylcellulose; fats; oils; proteins, including casein, gelatinand zeins; gum arabics; shellacs; vinylidene chloride and vinylidenechloride copolymers; lignosulfonates, in particular calciumlignosulfonates; polyacrylates, polymethacrylates and acryliccopolymers; polyvinylacrylates; polyethylene oxide; polybutenes,polyisobutenes, polystyrene, polybutadiene, polyethyteneamines,polyethylenamides; acrylamide polymers and copolymers; polyhydroxyethylacrylate, methylacrylamide monomers; and polychloroprene.

A variety of colorants may be employed, including organic chromophoresclassified nitroso, nitro, azo, including monoazo, bisazo, and polyazo,diphenylmethane, triarylmethane, xanthene, methane, acridine, thiazole,thiazine, indamine, indophenol, azine, oxazine, anthraquinone, andphthalocyanine.

Other additives that can be added include trace nutrients such as saltsof iron, manganese, boron, copper, cobalt, molybdenum, and zinc.

One or more preservatives (e.g., antimicrobial agents or other biocidalagents) may also be included for preservation and stabilization of theformulation. Examples of suitable bactericides include those based ondichlorophene and benzylalcohol hemi formal (Proxel® from ICI orActicide® RS from Thor Chemie and Kathon® MK from Dow Chemical) andisothiazolinone derivatives such as alkylisothiazolinones andbenzisothiazolinones (Acticide® MBS from Thor Chemie). As furtherexamples, suitable preservatives include MIT(2-methyl-4-isothiazolin-3-one), BIT (1,2-benzisothiazolin-3-one, whichcan be obtained from Avecia, Inc. as Proxel GXL as a solution in sodiumhydroxide and dipropylene glycol),5-chloro-2-(4-chlorobenzyl)-3(2H)-isothiazolone,5-chloro-2-methyl-2H-isothiazol-3-one,5-chloro-2-methyl-2H-isothiazol-3-one,5-chloro-2-methyl-2H-isothiazol-3-one-hydrochloride,4,5-dichloro-2-cyclohexyl-4-isothiazolin-3-one,4,5-dichloro-2-octyl-2H-isothiazol-3-one, 2-methyl-2H-isothiazol-3-one,2-methyl-2H-isothiazol-3-one-calcium chloride complex,2-octyl-2H-isothiazol-3-one and benzyl alcohol hemiformal.

Examples of suitable thickeners for the formulations includepolysaccharides, organic clays, or a water-soluble polymer that exhibitspseudoplastic properties in an aqueous medium, such as, for example, gumarabic, gum karaya, gum tragacanth, guar gum, locust bean gum, xanthangum, carrageenan, alginate salt, casein, dextran, pectin, agar,2-hydroxyethyl starch, 2-aminoethyl starch, 2-hydroxy ethyl cellulose,methyl cellulose, carboxymethyl cellulose salt, cellulose sulfate salt,polyacrylamide, alkali metal salts of the maleic anhydride copolymers,alkali metal salts of poly(meth)acrylate.

Suitable antifreeze ingredients for the formulation include, for exampleand without limitation, ethylene glycol, 1,2-propylene glycol,1,3-propylene glycol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol,1,4-pentanediol, 3-methyl-1,5-pentanediol, dimethyl-2,3-butanediol,trimethylol propane, mannitol, sorbitol, glycerol, pentaerythritol,1,4-cyclohexanedimethanol, xylenol, bisphenols such as bisphenol A orthe like. In addition, ether alcohols such as diethylene glycol,triethylene glycol, tetraethylene glycol, polyoxyethylene orpolyoxypropylene glycols of molecular weight up to about 4000,diethylene glycol monomethylether, diethylene glycol monoethylether,triethylene glycol monomethylether, butoxyethanol, butylene glycolmonobutylether, dipentaerythritol, tripentaerythritol,tetrapentaerythritol, diglycerol, triglycerol, tetraglycerol,pentaglycerol, hexaglycerol, heptaglycerol, octaglycerol andcombinations thereof.

XVIII. Plant Seeds

The present invention further relates to plant seeds coated with any ofthe recombinant Bacillus cereus family members described herein, withany of the recombinant spore-forming bacteria described herein, with anyof the biologically pure bacterial cultures described herein, with anyof the inoculums described herein, with any enzyme that catalyzes theproduction of nitric oxide, with any recombinant microorganism thatexpresses an enzyme that catalyzes the production of nitric oxide, orwith any of the formulations other than vaccines as described herein.

XIX. Methods Relating to Plants and Plant Seeds, Methods for DelayingGermination of a Spore of a Recombinant Bacillus cereus Family Member,and Methods for Making and Using Exosporium Fragments

The present invention further relates to methods for stimulating plantgrowth, methods for protecting a plant from a pathogen or enhancingstress resistance in a plant, methods for immobilizing recombinantBacillus cereus family member spores or recombinant spore formingbacteria on a plant, methods for stimulating germination of a plantseed, methods for delivering nucleic acids to plants, methods fordelaying germination of a spore of a recombinant Bacillus cereus familymember, methods for making and using exosporium fragments, and methodsfor delivering beneficial bacteria to animals.

A. Methods for Stimulating Plant Growth

The present invention relates to methods for stimulating plant growth.

One method for stimulating plant growth of the present inventioncomprises introducing into a plant growth medium any of the recombinantBacillus cereus family members described above or any of theformulations comprising a recombinant Bacillus cereus family memberdescribed above. Alternatively, any of the recombinant Bacillus cereusfamily members described above or any of the formulations comprising arecombinant Bacillus cereus family member described above can be appliedto a plant, a plant seed, or to an area surrounding a plant or a plantseed. In such methods, the recombinant Bacillus cereus family memberexpresses a fusion protein comprising a plant growth stimulating proteinor peptide. The plant growth stimulating protein or peptide can bephysically attached to the exosporium of the recombinant Bacillus cereusfamily member.

Another method for stimulating plant growth comprises introducing into aplant growth medium any of the recombinant spore-forming bacteriadescribed above or any of the formulations comprising a recombinantspore-forming bacterium described above. Alternatively, any of therecombinant spore-forming bacteria described above or any of theformulations comprising a recombinant spore-forming bacterium describedabove can be applied to a plant, a plant seed, or to an area surroundinga plant or a plant seed. In such methods, the recombinant spore-formingbacterium expresses a fusion protein comprising a plant growthstimulating protein or peptide. The plant growth stimulating protein orpeptide can be physically attached to the spore coat of the recombinantspore-forming bacterium.

Yet another method for stimulating plant growth comprises introducinginto a plant growth medium a recombinant Bacillus cereus family memberor a formulation comprising a recombinant Bacillus cereus family member.Alternatively, the recombinant Bacillus cereus family member or theformulation can be applied to a plant, a plant seed, or to an areasurrounding a plant or a plant seed. The recombinant Bacillus cereusfamily member expresses an enzyme involved in nutrient solubilization, aprotease, a BclA protein, a BclB protein, a CotE protein a CotO protein,an ExsY protein, an ExsFA/BxpB protein, a CotY protein, an ExsFBprotein, an ExsJ protein, an ExsH protein, a YjcA protein, a YjcBprotein, a BclC protein, a BxpA protein, a BclE protein, a BetA/BAS3290protein, an ExsA protein, an ExsK protein, an ExsB protein, a YabGprotein, or a Tgl protein, wherein the expression of the enzyme involvedin nutrient solubilization, the protease, a BclA protein, a BclBprotein, a CotE protein a CotO protein, an ExsY protein, an ExsFA/BxpBprotein, a CotY protein, an ExsFB protein, an ExsJ protein, an ExsHprotein, a YjcA protein, a YjcB protein, a BclC protein, a BxpA protein,a BclE protein, a BetA/BAS3290 protein, an ExsA protein, an ExsKprotein, an ExsB protein, a YabG protein, or a Tgl protein is increasedas compared to the expression of the enzyme involved in nutrientsolubilization, the protease, a BclA protein, a BclB protein, a CotEprotein a CotO protein, an ExsY protein, an ExsFA/BxpB protein, a CotYprotein, an ExsFB protein, an ExsJ protein, an ExsH protein, a YjcAprotein, a YjcB protein, a BclC protein, a BxpA protein, a BclE protein,a BetA/BAS3290 protein, an ExsA protein, an ExsK protein, an ExsBprotein, a YabG protein, or a Tgl protein in a wild-type Bacillus cereusfamily member under the same conditions.

Additional methods for stimulating plant growth, involving the use ofexosporium fragments derived from a recombinant Bacillus cereus familymember, are described below.

B. Methods for Protecting a Plant from a Pathogen or Enhancing StressResistance in a Plant

The present invention also relates to methods for protecting a plantfrom a pathogen or enhancing stress resistance in a plant.

One method for protecting a plant from a pathogen or enhancing stressresistance in a plant comprises introducing into a plant growth mediumany of the recombinant Bacillus cereus family members described above orany of the formulations comprising a recombinant Bacillus cereus familymember described above. Alternatively, any of the recombinant Bacilluscereus family members described above or any of the formulationscomprising a recombinant Bacillus cereus family member described abovecan be applied to a plant, a plant seed, or to an area surrounding aplant or a plant seed. In such methods, the recombinant Bacillus cereusfamily member expresses a fusion protein comprising a protein or peptidethat protects a plant from a pathogen or a protein or peptide thatenhances stress resistance in a plant. The protein or peptide thatprotects a plant from a pathogen or the protein or peptide that enhancesstress resistance in a plant can be physically attached to theexosporium of the recombinant Bacillus cereus family member.

Another method for protecting a plant from a pathogen or enhancingstress resistance in a plant comprises introducing into a plant growthmedium any of the recombinant spore-forming bacteria described above orany of the formulations comprising a recombinant spore-forming bacteriumdescribed above. Alternatively, any of the recombinant spore-formingbacteria described above or any of the formulations comprising arecombinant spore-forming bacterium described above can be applied to aplant, a plant seed, or to an area surrounding a plant or a plant seed.In such methods, the recombinant spore-forming bacterium expresses afusion protein comprising a protein or peptide that protects a plantfrom a pathogen or a protein or peptide that enhances stress resistancein a plant. The protein or peptide that protects a plant from a pathogenor the protein or peptide that enhances stress resistance in a plant canbe physically attached to the spore coat of the recombinantspore-forming bacterium.

In any of the methods for protecting a plant from a pathogen, plantsgrown in the plant growth medium comprising the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium arepreferably less susceptible to infection with the pathogen as comparedto plants grown under the same conditions in the identical plant growthmedium that does not contain the recombinant Bacillus cereus familymember or the recombinant spore-forming bacterium.

In any of the methods for enhancing stress resistance in a plant plantsgrown in the plant growth medium comprising the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium arepreferably less susceptible to stress as compared to plants grown underthe same conditions in the identical plant growth medium that does notcontain the recombinant Bacillus cereus family member or the recombinantspore-forming bacterium.

Another method for enhancing stress resistance in a plant comprisesintroducing into a plant growth medium a recombinant Bacillus cereusfamily member or a formulation comprising the recombinant Bacilluscereus family member. Alternatively, the recombinant Bacillus cereus orthe formulation can be applied to a plant, a plant seed, or to an areasurrounding a plant or a plant seed. The recombinant Bacillus cereusfamily member expresses a superoxide dismutase or an arginase, whereinthe expression of the superoxide dismutase or the arginase is increasedas compared to the expression of the superoxide dismutase or thearginase in a wild-type Bacillus cereus family member under the sameconditions.

Another method for protecting a plant from a pathogen comprisesintroducing into a plant growth medium a recombinant Bacillus cereusfamily member or a formulation comprising the recombinant Bacilluscereus family member. Alternatively, the recombinant Bacillus cereus orthe formulation can be applied to a plant, a plant seed, or to an areasurrounding a plant or a plant seed. The recombinant Bacillus cereusfamily member expresses a protease, wherein the expression of theprotease is increased as compared to the expression of the protease in awild-type Bacillus cereus family member under the same conditions.

Additional methods for protecting a plant from a pathogen or enhancingstress resistance in a plant, involving the use of exosporium fragmentsderived from a recombinant Bacillus cereus family member, are describedbelow.

C. Methods for Immobilizing Recombinant Bacillus cereus Family MemberSpores or Recombinant Spore Forming Bacteria on a Plant

The present invention further relates to methods for immobilizingrecombinant Bacillus cereus family member spores or recombinant sporeforming bacteria on a plant.

One method for immobilizing a recombinant Bacillus cereus family memberspore on a plant comprises introducing into a plant growth medium any ofthe recombinant Bacillus cereus family members described above or any ofthe formulations comprising a recombinant Bacillus cereus family memberdescribed above. Alternatively, any of the recombinant Bacillus cereusfamily members described above or any of the formulations comprising arecombinant Bacillus cereus family member described above can be appliedto a plant, a plant seed, or to an area surrounding a plant or a plantseed. In such methods, the recombinant Bacillus cereus family memberexpresses a fusion protein comprising a plant binding protein orpeptide. The plant binding protein or peptide can be physically attachedto the exosporium of the recombinant Bacillus cereus family member.

Another method for immobilizing a spore of a recombinant spore-formingbacterium on a plant comprises introducing into a plant growth mediumany of the recombinant spore-forming bacteria described above or any ofthe formulations comprising a recombinant spore-forming bacteriumdescribed above. Alternatively, any of the recombinant spore-formingbacteria described above or any of the formulations comprising arecombinant spore-forming bacterium described above can be applied to aplant, a plant seed, or to an area surrounding a plant or a plant seed.In such methods, the recombinant spore-forming bacterium expresses afusion protein comprising a plant binding peptide and the plant bindingprotein or peptide can be physically attached to the spore coat of therecombinant spore-forming bacterium.

The plant binding protein or peptide preferably selectively targets andmaintains the recombinant Bacillus cereus family member or therecombinant spore-forming bacterium on a plant. For example, the plantbinding protein or peptide can selectively target and maintain therecombinant Bacillus cereus family member on at plant roots,substructures of roots, an aerial portion of a plant, or a substructureof an aerial portion of a plant.

D. Methods for Stimulating Germination of a Plant Seed

1. Methods for Stimulating Germination Involving the Use of aRecombinant Bacillus cereus Family Member of a Recombinant Spore FormingBacterium

The present invention also provides methods for stimulating germinationof a plant seed.

One method for stimulating germination of a plant seed comprisesintroducing into a plant growth medium any of the recombinant Bacilluscereus family members described above or any of the formulationscomprising a recombinant Bacillus cereus family member described above.Alternatively, any of the recombinant Bacillus cereus family membersdescribed above or any of the formulations comprising a recombinantBacillus cereus family member described above can be applied to a plant,a plant seed, or to an area surrounding a plant or a plant seed. In suchmethods, the recombinant Bacillus cereus family member expresses afusion protein comprising an enzyme that catalyzes the production ofnitric oxide. The enzyme that catalyzes the production of nitric oxidecan be physically attached to the exosporium of the recombinant Bacilluscereus family member.

Another method for stimulating germination of a plant seed comprisesintroducing into a plant growth medium any of the recombinantspore-forming bacteria described above or any of the formulationscomprising a recombinant spore-forming bacterium described above.Alternatively, any of the recombinant spore-forming bacteria describedabove or any of the formulations comprising a recombinant spore-formingbacterium described above can be applied to a plant, a plant seed, or toan area surrounding a plant or a plant seed. In such methods, therecombinant spore-forming bacterium expresses a fusion proteincomprising an enzyme that catalyzes the production of nitric oxide, andthe enzyme that catalyzes the production of nitric oxide can bephysically attached to the spore coat of the recombinant spore-formingbacterium.

The above methods for stimulating germination of a plant seed preferablycomprise applying the recombinant Bacillus cereus family member, therecombinant spore-forming bacterium, or the formulation to a plant seed.

Any of the above methods for stimulating germination of a plant seed canfurther comprise applying a substrate for the enzyme that catalyzesproduction of nitric oxide to the plant growth medium, the plant seed,the plant, or the area surrounding the plant or the plant seed. Forexample, the method suitably further comprises adding L-arginine to theplant growth medium, the plant seed, the plant, or the area surroundingthe plant or the plant seed. For example, the L-arginine can be appliedto an aerial portion of the plant. The L-arginine is preferably appliedto the plant seed.

The presence of L-arginine enhances the reaction and leads to a morepronounced output of NO by the nitric oxide synthase. Furthermore,L-arginine on a plant seed, a plant growth medium, or an areasurrounding a plant can serve as a substrate for the production ofnitric oxide by native bacterial enzymes.

In any of the above methods for stimulating germination of a plant seed,seeds in the plant growth medium comprising the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium or seedsto which the recombinant Bacillus cereus family member or therecombinant spore-forming bacterium has been applied preferably have anincreased germination rate as compared to seeds grown under the sameconditions in the identical plant growth medium that does not containthe recombinant Bacillus cereus family member or the recombinantspore-forming bacterium or seeds to which the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium has notbeen applied, grown under the same conditions.

In any of the above methods for stimulating germination of a plant seed,seeds in the plant growth medium comprising the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium or seedsto which the recombinant Bacillus cereus family member or therecombinant spore-forming bacterium has been applied preferably have alonger taproot after germination as compared to seeds grown under thesame conditions in the identical plant growth medium that does notcontain the recombinant Bacillus cereus family member or the recombinantspore-forming bacterium or seeds to which the recombinant Bacilluscereus family member or the recombinant spore-forming bacterium has notbeen applied under the same conditions.

Additional methods for stimulating germination of a plant seed,involving the use of exosporium fragments derived from a recombinantBacillus cereus family member, are described below.

2. Methods for Stimulating Germination by Delivering to Plants Enzymesthat Catalyze the Production of Nitric Oxide or RecombinantMicroorganisms that Overexpress Such Enzymes

Yet another method for stimulating germination of a plant seed comprisesintroducing into a plant growth medium, or applying to a plant, a plantseed, or an area surrounding a plant or a plant seed: (i) an enzyme thatcatalyzes the production of nitric oxide; (ii) a superoxide dismutase;or (iii) a recombinant microorganism that expresses an enzyme thatcatalyzes the production of nitric oxide or a superoxide dismutase,wherein the expression of the enzyme that catalyzes the production ofnitric oxide or the superoxide dismutase is increased as compared to theexpression of the enzyme that catalyzes the production of nitric oxideor the superoxide dismutase in a wild type microorganism under the sameconditions.

The method preferably comprises applying the enzyme or the microorganismto a plant seed.

The method can further comprise applying a substrate for the enzyme thatcatalyzes production of nitric oxide to the plant growth medium, theplant seed, the plant, or the area surrounding the plant or the plantseed. For example, the method suitably further comprises addingL-arginine to the plant growth medium, the plant seed, the plant, or thearea surrounding the plant or the plant seed. For example, theL-arginine can be applied to an aerial portion of the plant. TheL-arginine is preferably applied to the plant seed.

Seeds in the plant growth medium comprising the enzyme or themicroorganism or seeds to which the enzyme or the microorganism has beenapplied preferably have an increased germination rate as compared toseeds grown under the same conditions in the identical plant growthmedium that does not contain enzyme or the microorganism or seeds towhich the enzyme or the microorganism has not been applied, grown underthe same conditions.

Seeds in the plant growth medium comprising the enzyme or themicroorganism or seeds to which the enzyme or the microorganism has beenapplied preferably have a longer taproot after germination as comparedto seeds grown under the same conditions in the identical plant growthmedium that does not contain the enzyme or the microorganism or seeds towhich the enzyme or the microorganism has not been applied under thesame conditions.

The enzyme that catalyzes the production of nitric oxide synthase cancomprise a nitric oxide synthase or an arginase. Where the enzyme thatcatalyzes the production of nitric oxide comprises a nitric oxidesynthase, the nitric oxide synthase can comprise, for example, a nitricoxide synthase from Bacillus thuringiensis BT013A or Bacillus subtilis168. For example, the nitric oxide synthase can have at least 85%sequence identity with SEQ ID NO: 260 or 261.

The nitric oxide synthase can have at least 90% sequence identity withSEQ ID NO: 260 or 261.

The nitric oxide synthase can have at least 95% sequence identity withSEQ ID NO: 260 or 261.

The nitric oxide synthase can have at least 98% sequence identity withSEQ ID NO: 260 or 261.

The nitric oxide synthase can have at least 99% sequence identity withSEQ ID NO: 260 or 261.

The nitric oxide synthase can have 100% sequence identity with SEQ IDNO: 260 or 261.

The superoxide dismutase can comprise a superoxide dismutase 1 (SODA1)or a superoxide dismutase 2 (SODA2). The superoxide dismutase cancomprise an amino acid sequence having at least 85% identity with SEQ IDNO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 90% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 95% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 98% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 99% identity with SEQ ID NO: 155 or 156.

The superoxide dismutase can comprise an amino acid sequence having atleast 100% identity with SEQ ID NO: 155 or 156.

The recombinant microorganism that expresses an enzyme that catalyzesthe production of nitric oxide can comprise a Bacillus species (e.g., aBacillus cereus family member, Bacillus subtilis, Bacilluslicheniformis, or Bacillus megaterium), Escherechia coli, an Aspergillusspecies (e.g., Aspergillus niger), or a Saccharomyces species (e.g.,Saccharomyces cerevisiae).

In any of the above methods, the enzyme or the recombinant microorganismcan be introduced into the plant growth medium, or applied to a plant, aplant seed, or an area surrounding a plant or a plant seed in aformulation comprising the enzyme or the recombinant microorganism andan agriculturally acceptable carrier. The formulation can comprise anyof the agriculturally acceptable carriers and other components discussedherein.

The enzyme that catalyzes the production of nitric oxide can bedelivered purified or unpurified, and can be delivered alone or incombination with other beneficial proteins, inoculants, or chemicals tothe plant seed, the plant growth medium, or an area surrounding theplant or the plant seed.

E. Methods for Delivering Nucleic Acids to Plants

Methods for delivering nucleic acids to plants are also provided by thepresent invention.

One method for delivering nucleic acids to a plant comprises introducinginto a plant growth medium any of the recombinant Bacillus cereus familymembers described above or any of the formulations comprising arecombinant Bacillus cereus family member described above.Alternatively, any of the recombinant Bacillus cereus family membersdescribed above or any of the formulations comprising a recombinantBacillus cereus family member described above can be applied to a plant,a plant seed, or to an area surrounding a plant or a plant seed. In suchmethods, the recombinant Bacillus cereus family member expresses afusion protein comprising a nucleic acid binding protein. The nucleicacid binding protein or peptide is bound to a nucleic acid molecule. Thenucleic acid binding protein or peptide can be physically attached tothe exosporium of the recombinant Bacillus cereus family member.

In such methods, the recombinant Bacillus cereus family member cancomprise an endophytic strain of bacteria. The endophytic strain ofbacteria can comprise Bacillus cereus family member EE349, Bacilluscereus family member EE439, Bacillus thuringiensis EE417, Bacilluscereus EE444, Bacillus thuringiensis EE319, Bacillus thuringiensisEE-B00184, Bacillus cereus family member EE-B00377, Bacilluspseudomycoides EE-B00366, or Bacillus mycoides EE-B00363. For example,the endophytic strain of bacteria can comprise Bacillus cereus familymember EE439, Bacillus thuringiensis EE417, Bacillus cereus EE444,Bacillus thuringiensis EE319, Bacillus thuringiensis EE-B00184, Bacilluscereus family member EE-B00377, Bacillus pseudomycoides EE-B00366, orBacillus mycoides EE-B00363.

Another method for delivering nucleic acids to a plant comprisesintroducing into a plant growth medium any of the recombinantspore-forming bacteria described above or any of the formulationscomprising a recombinant spore-forming bacterium described above.Alternatively, any of the recombinant spore-forming bacteria describedabove or any of the formulations comprising a recombinant spore-formingbacterium described above can be applied to a plant, a plant seed, or toan area surrounding a plant or a plant seed. In such methods, therecombinant spore-forming bacterium expresses a fusion proteincomprising a nucleic acid binding protein. The nucleic acid bindingprotein or peptide is bound to a nucleic acid molecule. The nucleic acidbinding protein or peptide can be physically attached to the spore coatof the recombinant spore-forming bacterium.

The recombinant spore-forming bacterium can comprise an endophyticstrain of bacteria. For example, the endophytic strain of bacteria cancomprise Bacillus megaterium EE385, Bacillus sp. EE387, Bacilluscirculans EE388, Bacillus subtilis EE405, Lysinibacillus fusiformisEE442, Lysinibacillus sphericus EE443, or Bacillus pumilus EE-B00143.

In any of the above methods for delivering nucleic acids to a plant, thenucleic acid molecule can comprise a modulating RNA molecule; an RNAimolecule; a microRNA; an aptamer; or a DNA molecule that encodes amodulating RNA molecule, an RNAi molecule, a microRNA, or an aptamer.

The nucleic acid molecules to be delivered to the plant can be producedby any means known the art (e.g., chemical synthesis, recombinantproduction by a microorganism, etc.). The nucleic acid molecules canthen be bound to the nucleic acid binding protein or peptide portion ofthe fusion proteins described herein in preparation for delivery of suchnucleic acids to a plant or plants. The nucleic acid binding proteinsand peptides immobilize and stabilize the nucleic acids and allow themto be delivered to the plant intact. The nucleic acid molecules to bedelivered to the plant can be in an active form, or in an inactive formthat can be processed into an active form by the plant.

To accomplish the binding of the nucleic acid molecules to the nucleicacid binding protein or peptide, the nucleic acids molecules can beincubated with the any of the recombinant Bacillus cereus members orrecombinant spore-forming bacteria described herein that express afusion protein comprising a nucleic acid binding protein or peptide.

Additional methods for delivering nucleic acids to a plant, involvingthe use of exosporium fragments derived from a recombinant Bacilluscereus family member, are described below.

F. Methods for Delaying Germination of a Spore of a Recombinant Bacilluscereus Family Member

The present invention further relates to a method for delayinggermination of a spore of a Bacillus cereus family member. The methodcomprises modifying the Bacillus cereus family member to express aninosine-uridine hydrolase or an alanine racemase, wherein the expressionof the inosine-uridine hydrolase or the alanine racemase is increased ascompared to the expression of the inosine-uridine hydrolase or thealanine racemase in a wild-type Bacillus cereus family member under thesame conditions.

G. Inactivation of the Bacillus cereus Family Member or RecombinantSpore Forming Bacterium Prior to Use

In any of the above methods that use a recombinant Bacillus cereusfamily member or a recombinant spore forming bacterium, the method canfurther comprise inactivating the recombinant Bacillus cereus familymember or the recombinant spore-forming bacterium prior to introductioninto the plant growth medium or application to a plant, a plant seed, oran area surrounding a plant or a plant seed.

For example, the inactivating can comprise subjecting the recombinantBacillus cereus family member or the recombinant spore-forming bacteriumto heat treatment; gamma irradiation; x-ray irradiation; UV-Airradiation; UV-B irradiation; treatment with gluteraldehyde,formaldehyde, hydrogen peroxide, acetic acid, bleach, chloroform, orphenol, or a combination thereof.

Alternatively or in addition, the inactivating can comprise modifyingthe recombinant Bacillus cereus family member recombinant orspore-forming bacterium to express a germination spore protease or anon-specific endonuclease, wherein the expression of the germinationspore protease or the non-specific endonuclease is increased as comparedto the expression of the germination spore protease or the non-specificendonuclease in a wild-type Bacillus cereus family member under the sameconditions, and wherein the recombinant spore-forming bacteriumcomprises a recombinant bacterium of the genus Bacillus.

H. Methods for Making and Using Exosporium Fragments

The present invention further relates to methods for making and usingexosporium fragments. These methods relate to the recombinant Bacilluscereus family members described in Section IV hereinabove, i.e.,recombinant Bacillus cereus family members that comprise a mutation oranother genetic alteration that allows for the collection of freeexosporium.

Thus, the present invention relates to a method for removing exosporiumfrom spores of a recombinant Bacillus cereus family member. The methodcomprises subjecting a suspension comprising any of the recombinantBacillus cereus family members described in Section IV hereinabove tocentrifugation or filtration to produce fragments of exosporium that areseparated from the spores. The exosporium fragments comprise the fusionprotein.

The method for removing exosporium from spores of a recombinant Bacilluscereus family member can comprise subjecting the suspension comprisingthe spores to centrifugation and collecting the supernatant, wherein thesupernatant comprises the fragments of the exosporium and issubstantially free of spores.

Alternatively, the method for removing exosporium from spores of arecombinant Bacillus cereus family member can comprise subjecting thesuspension comprising the spores to filtration and collecting thefiltrate, wherein the filtrate comprises the fragments of the exosporiumand is substantially free of spores.

The suspension of spores can be agitated or mechanically disrupted priorto centrifugation or filtration.

The exosporium fragments can also be separated from the spores bygradient centrifugation, affinity purification, or by allowing thespores to settle out of the suspension.

The present invention further relates to methods for using theexosporium fragments.

A method for stimulating plant growth is provided. The method comprisesintroducing exosporium fragments or a formulation of comprising theexosporium fragments and an agriculturally acceptable carrier into aplant growth medium. Alternatively, the exosporium fragments or theformulation can be applied to a plant, a plant seed, or an areasurrounding a plant or a plant seed. The exosporium fragments arederived from spores of a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises a plant growth stimulating protein or peptide.

A method for protecting a plant from a pathogen or enhancing stressresistance in a plant is also provided. The method comprises introducingexosporium fragments or a formulation of comprising the exosporiumfragments and an agriculturally acceptable carrier into a plant growthmedium. Alternatively, the exosporium fragments or the formulation canbe applied to a plant, a plant seed, or an area surrounding a plant or aplant seed. The exosporium fragments are derived from spores of arecombinant Bacillus cereus family member described in Section IVhereinabove and comprise the fusion protein. The fusion proteincomprises a protein or peptide that protects a plant from a pathogen ora protein or peptide that enhances stress resistance in a plant.

When the method is a method for protecting a plant from a pathogen, thefusion protein comprises protein or peptide that protects a plant from apathogen.

In the methods for protecting a plant from a pathogen, plants grown inthe plant growth medium comprising the exosporium fragments arepreferably less susceptible to infection with the pathogen as comparedto plants grown under the same conditions in the identical plant growthmedium that does not contain the exosporium fragments.

When the method is a method for enhancing stress resistance in a plant,the fusion protein comprises a protein or peptide that enhances stressresistance in a plant.

In the methods for enhancing stress resistance in a plant of, plantsgrown in the plant growth medium comprising the exosporium fragments arepreferably less susceptible to stress as compared to plants grown underthe same conditions in the identical plant growth medium that does notcontain the exosporium fragments.

A method for immobilizing exosporium fragments on a plant is alsoprovided. The method comprises introducing exosporium fragments or aformulation of comprising the exosporium fragments and an agriculturallyacceptable carrier into a plant growth medium. Alternatively, theexosporium fragments or the formulation can be applied to a plant, aplant seed, or an area surrounding a plant or a plant seed. Theexosporium fragments are derived from spores of a recombinant Bacilluscereus family member described in Section IV hereinabove and comprisethe fusion protein. The fusion protein comprises a plant binding proteinor peptide.

The plant binding protein or peptide preferably selectively targets andmaintains the exosporium fragments on a plant. For example, the plantbinding protein or peptide can selectively target and maintain theexosporium fragments on at plant roots, substructures of roots, anaerial portion of a plant, or a substructure of an aerial portion of aplant.

A method for stimulating germination of a plant seed is also provided.The method comprises introducing exosporium fragments or a formulationof comprising the exosporium fragments and an agriculturally acceptablecarrier into a plant growth medium. Alternatively, the exosporiumfragments or the formulation can be applied to a plant, a plant seed, oran area surrounding a plant or a plant seed. The exosporium fragmentsare derived from spores of a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises a superoxide dismutase or an enzyme thatcatalyzes the production of nitric oxide.

In the methods for stimulating germination, the method preferablycomprises applying the exosporium fragments to a plant seed.

The methods for stimulating germination can further comprise applying asubstrate for the enzyme that catalyzes production of nitric oxide tothe plant growth medium, the plant seed, the plant, or the areasurrounding the plant or the plant seed. For example, the methodsuitably further comprises adding L-arginine to the plant growth medium,the plant seed, the plant, or the area surrounding the plant or theplant seed. For example, the L-arginine can be applied to an aerialportion of the plant. The L-arginine is preferably applied to the plantseed.

The presence of L-arginine enhances the reaction and leads to a morepronounced output of NO by the nitric oxide synthase. Furthermore,L-arginine on a plant seed, a plant growth medium, or an areasurrounding a plant can serve as a substrate for the production ofnitric oxide by native bacterial enzymes.

In the methods for stimulating germination of a plant seed, seeds in theplant growth medium comprising the exosporium fragments or seeds towhich the exosporium fragments have been applied preferably have anincreased germination rate as compared to the same seeds grown under thesame conditions in the identical plant growth medium that does notcontain the exosporium fragments or the same seeds grown under the sameconditions to which the exosporium fragments have not been applied.

In the methods for stimulating germination of a plant seed, seeds in theplant growth medium comprising the exosporium fragments or seeds towhich the exosporium fragments have been applied preferably have alonger taproot after germination as compared to the same seeds grownunder the same conditions in the identical plant growth medium that doesnot contain the exosporium fragments or the same seeds grown under thesame conditions to which the exosporium fragments have not been applied.

A method for delivering nucleic acids to a plant is also provided. Themethod comprises introducing exosporium fragments or a formulation ofcomprising the exosporium fragments and an agriculturally acceptablecarrier into a plant growth medium. Alternatively, the exosporiumfragments or the formulation can be applied to a plant, a plant seed, oran area surrounding a plant or a plant seed. The exosporium fragmentsare derived from spores of a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises a nucleic acid binding protein or peptide. Thenucleic acid binding protein or peptide is bound to a nucleic acidmolecule.

In the method for delivering nucleic acids to a plant, the nucleic acidmolecule can comprise a modulating RNA molecule; an RNAi molecule; amicroRNA; an aptamer; or a DNA molecule that encodes a modulating RNAmolecule, an RNAi molecule, a microRNA, or an aptamer.

The nucleic acid molecules to be delivered to the plant can be producedby any means known the art (e.g., chemical synthesis, recombinantproduction by a microorganism, etc.). The nucleic acid molecules canthen be bound to the nucleic acid binding protein or peptide portion ofthe fusion proteins described herein in preparation for delivery of suchnucleic acids to a plant or plants. The nucleic acid binding proteinsand peptides immobilize and stabilize the nucleic acids and allow themto be delivered to the plant intact. The nucleic acid molecules to bedelivered to the plant can be in an active form, or in an inactive formthat can be processed into an active form by the plant.

To accomplish the binding of the nucleic acid molecules to the nucleicacid binding protein or peptide, the nucleic acids molecules can beincubated with the exosporium fragments containing a fusion proteincomprising a nucleic acid binding protein or peptide.

I. Plant Growth Medium

In any of the methods described herein involving the use of a plantgrowth medium, the plant growth medium can comprise soil, water, anaqueous solution, sand, gravel, a polysaccharide, mulch, compost, peatmoss, straw, logs, clay, soybean meal, yeast extract, or a combinationthereof.

Furthermore, the plant growth medium can be supplemented with asubstrate or a cofactor for an enzyme. For example, the substrate or thecofactor can comprise tryptophan, an adenosine monophosphate, anadenosine diphosphate, an adenosine triphosphate (e.g.,adenosine-3-triphosphate), indole, a trimetaphosphate, ferrodoxin,acetoin, diacetyl, pyruvate, acetolactate, pectin, cellulose,methylcellulose, starch, chitin, pectin, a protein meal, a cellulosederivative, a phosphate, acetoin, chitosan, an inactive derivative ofindole-3-acetic acid, an inactive derivative of gibberellic acid, axylan, an arabinoxylan, a fat, a wax, an oil, a phytic acid, a lignin, ahumic acid, choline, a choline derivative, proline, a polyproline, aproline-rich protein, a proline-rich meal, phenylalanine, chorismate,L-arginine, NADH, NADPH, ATP, GTP, cytochrome C, cytochrome p450, or acombination thereof.

J. Methods of Application

The methods described herein can comprise coating seeds with therecombinant Bacillus cereus family member, the recombinant spore-formingbacterium, or the exosporium fragments or a formulation containing therecombinant Bacillus cereus family member, the recombinant spore-formingbacterium, or the or exosporium fragments prior to planting.

The methods described herein can comprise applying the recombinantBacillus cereus family member, the recombinant spore-forming bacterium,or the exosporium fragments, or a formulation containing the recombinantBacillus cereus family member, the recombinant spore-forming bacterium,or the exosporium fragments to an aerial portion of a plant.

In the methods described herein, introducing the recombinant Bacilluscereus family member, the recombinant spore-forming bacterium, or theexosporium fragments into the plant growth medium can comprise applyinga liquid or solid formulation containing the recombinant Bacillus cereusfamily member, the recombinant spore-forming bacterium, or theexosporium fragments to the medium. The plant growth medium can comprisesoil (e.g., potting soil), compost, peat moss, sand, seed starter mix,or a combination thereof. The method can comprise applying theformulation to the plant growth medium prior to, concurrently with, orafter planting of seeds, seedlings, cuttings, bulbs, or plants in theplant growth medium.

K. Agrochemicals

In the methods described herein, the method can further compriseintroducing at least one agrochemical into the plant growth medium orapplying at least one agrochemical to plants or seeds.

The agrochemical can comprise a fertilizer (e.g., a liquid fertilizer),a micronutrient fertilizer material (e.g., boric acid, a borate, a boronfrit, copper sulfate, a copper frit, a copper chelate, a sodiumtetraborate decahydrate, an iron sulfate, an iron oxide, iron ammoniumsulfate, an iron frit, an iron chelate, a manganese sulfate, a manganeseoxide, a manganese chelate, a manganese chloride, a manganese frit, asodium molybdate, molybdic acid, a zinc sulfate, a zinc oxide, a zinccarbonate, a zinc frit, zinc phosphate, a zinc chelate, or a combinationthereof), an insecticide (e.g., an organophosphate, a carbamate, apyrethroid, an acaricide, an alkyl phthalate, boric acid, a borate, afluoride, sulfur, a haloaromatic substituted urea, a hydrocarbon ester,a biologically-based insecticide, or a combination thereof), anherbicide (e.g., a chlorophenoxy compound, a nitrophenolic compound, anitrocresolic compound, a dipyridyl compound, an acetamide, an aliphaticacid, an anilide, a benzamide, a benzoic acid, a benzoic acidderivative, anisic acid, an anisic acid derivative, a benzonitrile,benzothiadiazinone dioxide, a thiocarbamate, a carbamate, a carbanilate,chloropyridinyl, a cyclohexenone derivative, a dinitroaminobenzenederivative, a fluorodinitrotoluidine compound, isoxazolidinone,nicotinic acid, isopropylamine, an isopropylamine derivatives,oxadiazolinone, a phosphate, a phthalate, a picolinic acid compound, atriazine, a triazole, a uracil, a urea derivative, endothall, sodiumchlorate, or a combination thereof), a fungicide (e.g., a substitutedbenzene, a thiocarbamate, an ethylene bis dithiocarbamate, athiophthalidamide, a copper compound, an organomercury compound, anorganotin compound, a cadmium compound, anilazine, benomyl,cyclohexamide, dodine, etridiazole, iprodione, metlaxyl, thiamimefon,triforine, or a combination thereof), a molluscicide, an algicide, aplant growth amendment, a bacterial inoculant (e.g., a bacterialinoculant of the genus Rhizobium, a bacterial inoculant of the genusBradyrhizobium, a bacterial inoculant of the genus Mesorhizobium, abacterial inoculant of the genus Azorhizobium, a bacterial inoculant ofthe genus Allorhizobium, a bacterial inoculant of the genusSinorhizobium, a bacterial inoculant of the genus Kluyvera, a bacterialinoculant of the genus Azotobacter, a bacterial inoculant of the genusPseudomonas, a bacterial inoculant of the genus Azospirillium, abacterial inoculant of the genus Bacillus, a bacterial inoculant of thegenus Streptomyces, a bacterial inoculant of the genus Paenibacillus, abacterial inoculant of the genus Paracoccus, a bacterial inoculant ofthe genus Enterobacter, a bacterial inoculant of the genus Alcaligenes,a bacterial inoculant of the genus Mycobacterium, a bacterial inoculantof the genus Trichoderma, a bacterial inoculant of the genusGliocladium, a bacterial inoculant of the genus Glomus, a bacterialinoculant of the genus Klebsiella, or a combination thereof), a fungalinoculant (e.g., a fungal inoculant of the family Glomeraceae, a fungalinoculant of the family Claroidoglomeraceae, a fungal inoculant of thefamily Gigasporaceae, a fungal inoculant of the family Acaulosporaceae,a fungal inoculant of the family Sacculosporaceae, a fungal inoculant ofthe family Entrophosporaceae, a fungal inoculant of the familyPacidsporaceae, a fungal inoculant of the family Diversisporaceae, afungal inoculant of the family Paraglomeraceae, a fungal inoculant ofthe family Archaeosporaceae, a fungal inoculant of the familyGeosiphonaceae, a fungal inoculant of the family Ambisporaceae, a fungalinoculant of the family Scutellosporaceae, a fungal inoculant of thefamily Dentiscultataceae, a fungal inoculant of the familyRacocetraceae, a fungal inoculant of the phylum Basidiomycota, a fungalinoculant of the phylum Ascomycota, a fungal inoculant of the phylumZygomycota, or a combination thereof), or a combination thereof.

The fertilizer can comprise ammonium sulfate, ammonium nitrate, ammoniumsulfate nitrate, ammonium chloride, ammonium bisulfate, ammoniumpolysulfide, ammonium thiosulfate, aqueous ammonia, anhydrous ammonia,ammonium polyphosphate, aluminum sulfate, calcium nitrate, calciumammonium nitrate, calcium sulfate, calcined magnesite, calciticlimestone, calcium oxide, calcium nitrate, dolomitic limestone, hydratedlime, calcium carbonate, diammonium phosphate, monoammonium phosphate,magnesium nitrate, magnesium sulfate, potassium nitrate, potassiumchloride, potassium magnesium sulfate, potassium sulfate, sodiumnitrates, magnesian limestone, magnesia, urea, urea-formaldehydes, ureaammonium nitrate, sulfur-coated urea, polymer-coated urea, isobutylidenediurea, K₂SO₄-2MgSO₄, kainite, sylvinite, kieserite, Epsom salts,elemental sulfur, marl, ground oyster shells, fish meal, oil cakes, fishmanure, blood meal, rock phosphate, super phosphates, slag, bone meal,wood ash, manure, bat guano, peat moss, compost, green sand, cottonseedmeal, feather meal, crab meal, fish emulsion, humic acid, or acombination thereof.

The agrochemical can comprise any of the fungicides, bacterialinoculants, or herbicides, described above in section XVII.

L. Plants and Seeds

In any of the above methods relating to plants, the plant can be adicotyledon, a monocotyledon, or a gymnosperm.

For example, where the plant is a dicotyledon, the dicotyledon can beselected from the group consisting of bean, pea, tomato, pepper, squash,alfalfa, almond, aniseseed, apple, apricot, arracha, artichoke, avocado,bambara groundnut, beet, bergamot, black pepper, black wattle,blackberry, blueberry, bitter orange, bok-choi, Brazil nut, breadfruit,broccoli, broad bean, Brussels sprouts, buckwheat, cabbage, camelina,Chinese cabbage, cacao, cantaloupe, caraway seeds, cardoon, carob,carrot, cashew nuts, cassava, castor bean, cauliflower, celeriac,celery, cherry, chestnut, chickpea, chicory, chili pepper,chrysanthemum, cinnamon, citron, clementine, clove, clover, coffee, colanut, colza, corn, cotton, cottonseed, cowpea, crambe, cranberry, cress,cucumber, currant, custard apple, drumstick tree, earth pea, eggplant,endive, fennel, fenugreek, fig, filbert, flax, geranium, gooseberry,gourd, grape, grapefruit, guava, hemp, hempseed, henna, hop, horse bean,horseradish, indigo, jasmine, Jerusalem artichoke, jute, kale, kapok,kenaf, kohlrabi, kumquat, lavender, lemon, lentil, lespedeza, lettuce,lime, liquorice, litchi, loquat, lupine, macadamia nut, mace, mandarin,mangel, mango, medlar, melon, mint, mulberry, mustard, nectarine, nigerseed, nutmeg, okra, olive, opium, orange, papaya, parsnip, pea, peach,peanut, pear, pecan nut, persimmon, pigeon pea, pistachio nut, plantain,plum, pomegranate, pomelo, poppy seed, potato, sweet potato, prune,pumpkin, quebracho, quince, trees of the genus Cinchona, quinoa, radish,ramie, rapeseed, raspberry, rhea, rhubarb, rose, rubber, rutabaga,safflower, sainfoin, salsify, sapodilla, Satsuma, scorzonera, sesame,shea tree, soybean, spinach, squash, strawberry, sugar beet, sugarcane,sunflower, swede, sweet pepper, tangerine, tea, teff, tobacco, tomato,trefoil, tung tree, turnip, urena, vetch, walnut, watermelon, yerbamate, wintercress, shepherd's purse, garden cress, peppercress,watercress, pennycress, star anise, laurel, bay laurel, cassia, jamun,dill, tamarind, peppermint, oregano, rosemary, sage, soursop, pennywort,calophyllum, balsam pear, kukui nut, Tahitian chestnut, basil,huckleberry, hibiscus, passionfruit, star apple, sassafras, cactus, St.John's wort, loosestrife, hawthorn, cilantro, curry plant, kiwi, thyme,zucchini, ulluco, jicama, waterleaf, spiny monkey orange, yellow mombin,starfruit, amaranth, wasabi, Japanese pepper, yellow plum, mashua,Chinese toon, New Zealand spinach, bower spinach, ugu, tansy, chickweed,jocote, Malay apple, paracress, sowthistle, Chinese potato, horseparsley, hedge mustard, campion, agate, cassod tree, thistle, burnet,star gooseberry, saltwort, glasswort, sorrel, silver lace fern, collardgreens, primrose, cowslip, purslane, knotgrass, terebinth, tree lettuce,wild betel, West African pepper, yerba santa, tarragon, parsley,chervil, land cress, burnet saxifrage, honeyherb, butterbur, shiso,water pepper, perilla, bitter bean, oca, kampong, Chinese celery, lemonbasil, Thai basil, water mimosa, cicely, cabbage-tree, moringa, mauka,ostrich fern, rice paddy herb, yellow sawah lettuce, lovage, peppergrass, maca, bottle gourd, hyacinth bean, water spinach, catsear,fishwort, Okinawan spinach, lotus sweetjuice, gallant soldier, culantro,arugula, cardoon, caigua, mitsuba, chipilin, samphire, mampat, ebolo,ivy gourd, cabbage thistle, sea kale, chaya, huauzontle, Ethiopianmustard, magenta spreen, good king henry, epazole, lamb's quarters,centella plumed cockscomb, caper, rapini, napa cabbage, mizuna, Chinesesavoy, kai-lan, mustard greens, Malabar spinach, chard, marshmallow,climbing wattle, China jute, paprika, annatto seed, spearmint, savory,marjoram, cumin, chamomile, lemon balm, allspice, bilberry, cherimoya,cloudberry, damson, pitaya, durian, elderberry, feijoa, jackfruit,jambul, jujube, physalis, purple mangosteen, rambutan, redcurrant,blackcurrant, salal berry, satsuma, ugli fruit, azuki bean, black bean,black-eyed pea, borlotti bean, common bean, green bean, kidney bean,lima bean, mung bean, navy bean, pinto bean, runner bean, mangetout,snap pea, broccoflower, calabrese, nettle, bell pepper, raddichio,daikon, white radish, skirret, tat soi, broccolini, black radish,burdock root, fava bean, broccoli raab, lablab, lupin, sterculia, velvetbeans, winged beans, yam beans, mulga, ironweed, umbrella bush,tjuntjula, wakalpulka, witchetty bush, wiry wattle, chia, beech nut,candlenut, colocynth, mamoncillo, Maya nut, mongongo, ogbono nut,paradise nut, and cempedak.

Where the plant is a monocotyledon, the monocotyledon can be selectedfrom the group consisting of corn, wheat, oat, rice, barley, millet,banana, onion, garlic, asparagus, ryegrass, millet, fonio, raishan, nipagrass, turmeric, saffron, galangal, chive, cardamom, date palm,pineapple, shallot, leek, scallion, water chestnut, ramp, Job's tears,bamboo, ragi, spotless watermeal, arrowleaf elephant ear, Tahitianspinach, abaca, areca, bajra, betel nut, broom millet, broom sorghum,citronella, coconut, cocoyam, maize, dasheen, durra, durum wheat, edo,fique, formio, ginger, orchard grass, esparto grass, Sudan grass, guineacorn, Manila hemp, henequen, hybrid maize, jowar, lemon grass, maguey,bulrush millet, finger millet, foxtail millet, Japanese millet, prosomillet, New Zealand flax, oats, oil palm, palm palmyra, sago palm,redtop, sisal, sorghum, spelt wheat, sweet corn, sweet sorghum, taro,teff, timothy grass, triticale, vanilla, wheat, and yam.

Where the plant is a gymnosperm, the gymnosperm can be from a familyselected from the group consisting of Araucariaceae, Boweniaceae,Cephalotaxaceae, Cupressaceae, Cycadaceae, Ephedraceae, Ginkgoaceae,Gnetaceae, Pinaceae, Podocarpaceae, Taxaceae, Taxodiaceae,Welwitschiaceae, and Zamiaceae.

The plants and plant seeds described herein may include transgenicplants or plant seeds, such as transgenic cereals (wheat, rice), maize,soybean, potato, cotton, tobacco, oilseed rape and fruit plants (fruitof apples, pears, citrus fruits and grapes. Preferred transgenic plantsinclude corn, soybeans, potatoes, cotton, tobacco and oilseed rape.

Suitable transgenic plants and seeds can be characterized by the plant'sformation of toxins, especially from the Bacillus thuringiensis geneticmaterial by gene CryIA (a), CryIA (b), CryIA (c), CryIIA, CryIIIA,CryIIIB2, Cry9c, Cry2Ab, Cry3Bb, CryIF or a combination thereof). Theformation of toxins in plants increases the plant's resistance toinsects, arachnids, nematodes and slugs and snails (hereinafter referredto as “Bt plants”). Bt plants, for example, are commercially availableunder the tradename YIELD GARD® (for example maize, cotton, soybeans),KnockOut® (for example maize), StarLink® (for example maize),Bollgard®(cotton), Nucotn® (cotton) and NewLeaf® (potato) maizevarieties, cotton varieties, soybean varieties and potato varieties.Herbicide tolerance plants include plants under the trade names RoundupReady® (a glyphosate tolerance, such as corn, cotton, soybeans),Clearfield (for example maize), Liberty Link®(tolerance withglufosinate, for example oilseed rape), IMI® (with imidazolinonetolerance) and STS® (tolerance to a sulfonylurea, such as maize).

Plant seeds as described herein can be genetically modified (e.g., anyseed that results in a genetically modified plant or plant part thatexpresses herbicide tolerance, tolerance to environmental factors suchas water stress, drought, viruses, and nitrogen production, orresistance to bacterial, fungi or insect toxins). Suitable geneticallymodified seeds include those of cole crops, vegetables, fruits, trees,fiber crops, oil crops, tuber crops, coffee, flowers, legume, cereals,as well as other plants of the monocotyledonous and dicotyledonousspecies. Preferably, the genetically modified seeds include peanut,tobacco, grasses, wheat, barley, rye, sorghum, rice, rapeseed,sugarbeet, sunflower, tomato, pepper, bean, lettuce, potato, and carrot.Most preferably, the genetically modified seeds include cotton, soybean,and corn (sweet, field, seed, or popcorn).

Particularly useful transgenic plants which may be treated according tothe invention are plants containing transformation events, or acombination of transformation events, that are listed for example in thedatabases from various national or regional regulatory agencies (see forexample http://gmoinfo.jrc.it/gmp_browse.aspx andhttp://www.agbios.com/dbase.php).

XX. Methods for Delivering Beneficial Bacteria and Proteins or Peptidesto Animals

The present invention further relates to methods for deliveringbeneficial bacteria and/or proteins or peptides to animals.

The administration of bacterial strains that are both probiotic and arealso endophytic to a plant allows for entry of the bacteria into theplant where they divide and multiply. The endophytic and probioticstrains can be delivered to plants using various methods, e.g., theendophytic and probiotic strains can be delivered via seed treatment,treatment of the plant growth medium (e.g., soil), irrigation,application to the plant itself (e.g., foliar application to the aerialportions of a plant). Once inside the plant, the bacteria multiply andcolonize the internal tissues of the plant. The plant can then be fed toan animal, which allows for delivery of the probiotic bacteria to theanimal. Costs are decreased as to traditional methods for deliveringprobiotic bacteria to animals, since the endophytic nature of thebacteria allows them to divide and multiply within the plant. Byinitially delivering a small amount of a probiotic and endophytic strainof bacteria to a plant and allowing the bacteria to increase in numberinside the plant, the dose increases. In addition, the probiotic andendophytic strain can spread across a target crop prior to harvest anddigestion.

Bacterial strains that are capable of colonizing the phylloplane of aplant and are also probiotic can also be used for these purposes.Strains that are capable of colonizing the phylloplane of a plant can beinitially delivered to plants in small doses, and will then divide andcolonize the external surfaces of the plants.

Suitable bacterial strains that are both endophytic orphylloplane-colonizing and probiotic include those strains that can bothreplicate in the field in or on a plant and that provide benefits toanimals upon ingestion. Benefits of probiotic bacteria in animalsinclude but are not limited to regulation of the microbiome of thedigestive tract of the animal, secretion of enzymes that aid indigestion of plant material, and stimulation of the animals immunesystem. Examples of digestion-enhancing enzymes that would providebenefit include, but are not limited to cellulases, endoglucanases,exoglucanases, β-glucosidases, amylases, proteases, pectinases,xylanases, xylosidases, lipases, phospholipases, and lignases.

The Bacillus and Lysinibacillus genera are unique in that they contain alarge number of species that are both endophytic and thus colonizeplants, but that can also act as probiotics in vertebrates. Thus,Bacillus and Lysinibacillus species are highly suitable for delivery ofprobiotics to animals through passaging and growth in plants. CommonBacillus species that can be both endophytic and probiotic includeBacillus subtilis, Bacillus firmus, Bacillus amyloliquefaciens, Bacilluscereus, Bacillus toyocerin, Bacillus megaterium, Bacillus pumilus, andBacillus licheniformis. Lysinibacillus species that are both endophyticand probiotic can also be used.

A method for delivering beneficial bacteria to an animal is provided.The method comprises feeding to an animal a plant modified to comprise alevel of an endophytic and probiotic strain of bacteria that is greaterthan the level of the endophytic and probiotic strain of bacteria in thesame plant that has not been modified grown under the same conditions.

The plant fed to the animal can comprise a plant grown in a plant growthmedium containing the endophytic and probiotic strain of bacteria or aformulation comprising the endophytic and probiotic strain of bacteria,a plant to which the endophytic and probiotic strain of bacteria wasapplied, a plant grown from a plant seed to which the endophytic andprobiotic strain of bacteria was applied, a plant grown in an area towhich the endophytic and probiotic strain of bacteria was applied, or aseed grown in the area to which the endophytic and probiotic strain ofbacteria was applied.

The endophytic and probiotic strain of bacteria can comprise a Bacillusor Lysinibacillus species. For example, the Bacillus species cancomprise Bacillus subtilis, Bacillus firmus, Bacillus amyloliquefaciens,Bacillus cereus, Bacillus toyocerin, Bacillus megaterium, Bacilluspumilus, Bacillus licheniformis, or a combination thereof.

The endophytic and probiotic strain of bacteria can comprise Bacilluscereus family member EE349, Bacillus cereus family member EE439,Bacillus thuringiensis EE417, Bacillus cereus EE444, Bacillus megateriumEE385, Bacillus sp. EE387, Bacillus circulans EE388, Bacillus subtilisEE405, Lysinibacillus fusiformis EE442, Lysinibacillus sphericus EE443,Bacillus pumilus EE-B00143, or a combination thereof.

In addition, proteins or peptides (e.g., enzymes) can be delivered toanimals by feeding recombinant Bacillus cereus family members expressinga fusion protein containing the protein or peptide, exosporium fragmentscomprising such fusion proteins, or recombinant spore-forming bacteriaexpressing such fusion proteins to the animals. The recombinant Bacilluscereus family member or the recombinant spore-forming bacteria can be anendophytic strain of bacteria or a strain of bacteria that is capable ofcolonizing the phylloplane of a plant, which allows for delivery of theprotein or peptide to the animal via ingestion of a plant that has beencolonized by the bacteria. Probiotic recombinant Bacillus cereus familymember strains or strains of recombinant spore-forming bacteria can alsobe used so that the animal that ingests the recombinant Bacillus cereusfamily member or the recombinant spore-forming bacteria obtains both thebenefits of the probiotic bacteria and the benefits of the protein orpeptide. Recombinant Bacillus cereus family member strains and strainsof recombinant spore-forming bacteria that are both endophytic orphylloplane colonizing and probiotic can also be used to deliverproteins or peptides to animals.

Accordingly, a method for delivering proteins or peptides to an animalis also provided. The method comprises feeding to an animal arecombinant Bacillus cereus family member expressing a fusion proteincomprising a protein or peptide of interest and a targeting sequence,exosporium protein, or exosporium protein fragment that targets thefusion protein to the exosporium of the recombinant Bacillus cereusfamily member. Alternatively, the method comprises feeding to an animalexosporium fragments derived from a recombinant Bacillus cereus familymember expressing a fusion protein comprising a protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member.

The recombinant Bacillus cereus family member can comprise any of therecombinant Bacillus cereus family members described herein that expressa fusion protein.

The exosporium fragments can comprise exosporium fragments derived fromany of the Bacillus cereus family members described above in Section IV.

The recombinant Bacillus cereus family member can comprise an endophyticstrain of bacteria. The endophytic strain of bacteria can compriseBacillus cereus family member EE349, Bacillus cereus family memberEE439, Bacillus thuringiensis EE417, Bacillus cereus EE444, Bacillusthuringiensis EE319, Bacillus thuringiensis EE-B00184, Bacillus cereusfamily member EE-B00377, Bacillus pseudomycoides EE-B00366, or Bacillusmycoides EE-B00363. For example, the endophytic strain of bacteriacomprises Bacillus cereus family member EE439, Bacillus thuringiensisEE417, Bacillus cereus EE444, Bacillus thuringiensis EE319, Bacillusthuringiensis EE-B00184, Bacillus cereus family member EE-B00377,Bacillus pseudomycoides EE-B00366, or Bacillus mycoides EE-B00363.

The recombinant Bacillus cereus family member can comprise a probioticstrain of bacteria. The probiotic strain of bacteria can compriseBacillus cereus family member EE349 (NRRL No. B-50928), Bacillus cereusfamily member EE439 (NRRL B-50979), Bacillus thuringiensis EE417 (NRRLB-50979), Bacillus cereus EE444 (NRRL B-50977), Bacillus thuringiensisBT013A (NRRL No. B-50924), or a combination thereof.

The recombinant Bacillus cereus family member can be comprised within aplant that is fed to the animal.

Alternatively, the recombinant Bacillus cereus family can comprise astrain of bacteria that is capable of colonizing the phylloplane of aplant. For example, the strain of bacteria that is capable of colonizingthe phylloplane of a plant can comprise Bacillus mycoides BT155,Bacillus mycoides EE118, Bacillus mycoides EE141, Bacillus mycoidesBT46-3, Bacillus cereus family member EE218, Bacillus thuringiensisBT013A, Bacillus cereus family member EE-B00377, Bacillus pseudomycoidesEE-B00366, or Bacillus mycoides EE-B00363.

The recombinant Bacillus cereus family member can be present on thephylloplane of a plant that is fed to the animal.

The targeting sequence, exosporium protein, or exosporium proteinfragment can comprise: (1) a targeting sequence comprising an amino acidsequence having at least about 43% identity with amino acids 20-35 ofSEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 54%; (2) a targeting sequence comprising amino acids 1-35 of SEQID NO: 1; (3) a targeting sequence comprising amino acids 20-35 of SEQID NO: 1; (4) a targeting sequence comprising SEQ ID NO: 1; (5) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 2; (6) a targeting sequence comprising aminoacids 2-35 of SEQ ID NO: 1; (7) a targeting sequence comprising aminoacids 5-35 of SEQ ID NO: 1; (8) a targeting sequence comprising aminoacids 8-35 of SEQ ID NO: 1; (9) a targeting sequence comprising aminoacids 10-35 of SEQ ID NO: 1; (10) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 1; (11) a targeting sequence comprising aminoacids 1-27 of SEQ ID NO: 3; (12) a targeting sequence comprising aminoacids 12-27 of SEQ ID NO: 3; (13) a targeting sequence comprising SEQ IDNO: 3; (14) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 4; (15) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 3; (16) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 3; (17) a targetingsequence comprising amino acids 8-27 of SEQ ID NO: 3; (18) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 3; (19) a targetingsequence comprising amino acids 1-38 of SEQ ID NO: 5; (20) a targetingsequence comprising amino acids 23-38 of SEQ ID NO: 5; (21) a targetingsequence comprising SEQ ID NO: 5; (22) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 6;(23) a targeting sequence comprising amino acids 2-38 of SEQ ID NO: 5;(24) a targeting sequence comprising amino acids 5-38 of SEQ ID NO: 5;(25) a targeting sequence comprising amino acids 8-38 of SEQ ID NO: 5;(26) a targeting sequence comprising amino acids 10-38 of SEQ ID NO: 5;(27) a targeting sequence comprising amino acids 15-38 of SEQ ID NO: 5;(28) a targeting sequence comprising amino acids 20-38 of SEQ ID NO: 5;(29) a targeting sequence comprising amino acids 1-28 of SEQ ID NO: 7;(30) a targeting sequence comprising amino acids 13-28 of SEQ ID NO: 7;(31) a targeting sequence comprising SEQ ID NO: 7; (32) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 8; (33) a targeting sequence comprising amino acids 2-28of SEQ ID NO: 7; (34) a targeting sequence comprising amino acids 5-28of SEQ ID NO: 7; (35) a targeting sequence comprising amino acids 8-28of SEQ ID NO: 7; (36) a targeting sequence comprising amino acids 10-28of SEQ ID NO: 7; (37) a targeting sequence comprising amino acids 1-24of SEQ ID NO: 9; (38) a targeting sequence comprising amino acids 9-24of SEQ ID NO: 9; (39) a targeting sequence comprising SEQ ID NO: 9; (40)an exosporium protein comprising an amino acid sequence having at least85% identity with SEQ ID NO: 10; (41) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 9; (42) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 9; (43) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 9; (44) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO:11; (45) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 11; (46) a targeting sequence comprisingSEQ ID NO: 11; (47) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 12; (48) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 11; (49) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 11; (50) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 11; (51) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 11; (52) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 11; (53) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 13; (54) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 13; (55) atargeting sequence comprising SEQ ID NO:13; (56) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:14; (57) a targeting sequence comprising amino acids 2-33 of SEQID NO: 13; (58) a targeting sequence comprising amino acids 5-33 of SEQID NO: 13; (59) a targeting sequence comprising amino acids 8-33 of SEQID NO: 13; (60) a targeting sequence comprising amino acids 10-33 of SEQID NO: 13; (61) a targeting sequence comprising amino acids 15-33 of SEQID NO: 13; (62) a targeting sequence comprising amino acids 1-43 of SEQID NO: 15; (63) a targeting sequence comprising amino acids 28-43 of SEQID NO: 15; (64) a targeting sequence comprising SEQ ID NO:15; (65) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:16; (66) a targeting sequence comprising aminoacids 2-43 of SEQ ID NO: 15; (67) a targeting sequence comprising aminoacids 5-43 of SEQ ID NO: 15; (68) a targeting sequence comprising aminoacids 8-43 of SEQ ID NO: 15; (69) a targeting sequence comprising aminoacids 10-43 of SEQ ID NO: 15; (70) a targeting sequence comprising aminoacids 15-43 of SEQ ID NO: 15; (71) a targeting sequence comprising aminoacids 20-43 of SEQ ID NO: 15; (72) a targeting sequence comprising aminoacids 25-43 of SEQ ID NO: 15; (73) a targeting sequence comprising aminoacids 1-27 of SEQ ID NO: 17; (74) a targeting sequence comprising aminoacids 12-27 of SEQ ID NO: 17; (75) a targeting sequence comprising SEQID NO:17; (76) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:18; (77) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 17; (78) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 17; (79) a targetingsequence comprising amino acids 8-27 of SEQ ID NO: 17; (80) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 17; (81) a targetingsequence comprising amino acids 1-33 of SEQ ID NO: 19; (82) a targetingsequence comprising amino acids 18-33 of SEQ ID NO: 19; (83) a targetingsequence comprising SEQ ID NO:19; (84) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:20;(85) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 19;(86) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 19;(87) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 19;(88) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 19;(89) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 19;(90) a targeting sequence comprising amino acids 1-33 of SEQ ID NO: 21;(91) a targeting sequence comprising amino acids 18-33 of SEQ ID NO: 21;(92) a targeting sequence comprising SEQ ID NO:21; (93) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:22; (94) a targeting sequence comprising amino acids 2-33of SEQ ID NO: 21; (95) a targeting sequence comprising amino acids 5-33of SEQ ID NO: 21; (96) a targeting sequence comprising amino acids 8-33of SEQ ID NO: 21; (97) a targeting sequence comprising amino acids 10-33of SEQ ID NO: 21; (98) a targeting sequence comprising amino acids 15-33of SEQ ID NO: 21; (99) a targeting sequence comprising amino acids 1-24of SEQ ID NO: 23; (100) a targeting sequence comprising amino acids 9-24of SEQ ID NO: 23; (101) a targeting sequence comprising SEQ ID NO:23;(102) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:24; (103) a targeting sequencecomprising amino acids 2-24 of SEQ ID NO:23; (104) a targeting sequencecomprising amino acids 5-24 of SEQ ID NO: 23; (105) a targeting sequencecomprising amino acids 8-24 of SEQ ID NO: 23; (106) a targeting sequencecomprising amino acids 1-24 of SEQ ID NO: 25; (107) a targeting sequencecomprising amino acids 9-24 of SEQ ID NO: 25; (108) a targeting sequencecomprising SEQ ID NO:25; (109) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:26; (110) atargeting sequence comprising amino acids 2-24 of SEQ ID NO: 25; (111) atargeting sequence comprising amino acids 5-24 of SEQ ID NO: 25; (112) atargeting sequence comprising amino acids 8-24 of SEQ ID NO: 25; (113) atargeting sequence comprising amino acids 1-30 of SEQ ID NO: 27; (114) atargeting sequence comprising amino acids 15-30 of SEQ ID NO: 27; (115)a targeting sequence comprising SEQ ID NO:27; (116) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:28; (117) a targeting sequence comprising amino acids2-30 of SEQ ID NO: 27; (118) a targeting sequence comprising amino acids5-30 of SEQ ID NO: 27; (119) a targeting sequence comprising amino acids8-30 of SEQ ID NO: 27; (120) a targeting sequence comprising amino acids10-30 of SEQ ID NO: 27; (121) a targeting sequence comprising aminoacids 1-33 of SEQ ID NO: 29; (122) a targeting sequence comprising aminoacids 18-33 of SEQ ID NO: 29; (123) a targeting sequence comprising SEQID NO:29; (124) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:30; (125) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 29; (126) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 29; (127) a targetingsequence comprising amino acids 8-33 of SEQ ID NO: 29; (128) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 29; (129) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 29; (130)a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 31; (131)a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 31; (132)a targeting sequence comprising SEQ ID NO:31; (133) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:32; (134) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 31; (135) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 31; (136) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 31; (137) a targeting sequence comprising amino acids1-15 of SEQ ID NO: 33; (138) a targeting sequence comprising SEQ IDNO:33; (139) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:34; (140) a targetingsequence comprising amino acids 1-16 of SEQ ID NO: 35; (141) a targetingsequence comprising SEQ ID NO:35; (142) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:36;(143) a targeting sequence comprising amino acids 1-29 of SEQ ID NO:43;(144) a targeting sequence comprising amino acids 14-29 of SEQ ID NO:43; (145) a targeting sequence comprising SEQ ID NO: 43; (146) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 44; (147) a targeting sequence comprising aminoacids 2-29 of SEQ ID NO: 43; (148) a targeting sequence comprising aminoacids 5-29 of SEQ ID NO: 43; (149) a targeting sequence comprising aminoacids 8-29 of SEQ ID NO: 43; (150) a targeting sequence comprising aminoacids 10-29 of SEQ ID NO: 43; (151) a targeting sequence comprisingamino acids 1-35 of SEQ ID NO: 45; (152) a targeting sequence comprisingamino acids 20-35 of SEQ ID NO: 45; (153) a targeting sequencecomprising SEQ ID NO: 45; (154) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 46;(155) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 45;(156) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 45;(157) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 45;(158) a targeting sequence comprising amino acids 10-35 of SEQ ID NO:45; (159) a targeting sequence comprising amino acids 15-35 of SEQ IDNO: 45; (160) a targeting sequence comprising amino acids 1-43 of SEQ IDNO: 47; (161) a targeting sequence comprising amino acids 28-43 of SEQID NO: 47; (162) a targeting sequence comprising SEQ ID NO: 47; (163) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 48; (164) a targeting sequence comprising aminoacids 2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising aminoacids 5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising aminoacids 8-43 of SEQ ID NO: 47; (167) a targeting sequence comprising aminoacids 10-43 of SEQ ID NO: 47; (168) a targeting sequence comprisingamino acids 15-43 of SEQ ID NO: 47; (169) a targeting sequencecomprising amino acids 20-43 of SEQ ID NO: 47; (170) a targetingsequence comprising amino acids 25-43 of SEQ ID NO: 47; (171) atargeting sequence comprising amino acids 1-32 of SEQ ID NO: 49; (172) atargeting sequence comprising amino acids 17-32 of SEQ ID NO: 49; (173)a targeting sequence comprising SEQ ID NO: 49; (174) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 50; (175) a targeting sequence comprising amino acids2-32 of SEQ ID NO: 49; (176) a targeting sequence comprising amino acids5-32 of SEQ ID NO: 49; (177) a targeting sequence comprising amino acids8-32 of SEQ ID NO: 49; (178) a targeting sequence comprising amino acids10-32 of SEQ ID NO: 49; (179) a targeting sequence comprising aminoacids 15-32 of SEQ ID NO: 49; (180) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 51; (181) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 51; (182) a targeting sequencecomprising SEQ ID NO: 51; (183) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 52;(184) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 51;(185) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 51;(186) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 51;(187) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:51; (188) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 51; (189) a targeting sequence comprising amino acids 1-33 of SEQ IDNO: 53; (190) a targeting sequence comprising amino acids 18-33 of SEQID NO: 53; (191) a targeting sequence comprising SEQ ID NO: 53; (192) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 54; (193) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 53; (194) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 53; (195) a targeting sequence comprising aminoacids 8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 53; (197) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 53; (198) a targeting sequencecomprising amino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequencecomprising amino acids 15-30 of SEQ ID NO: 55; (200) a targetingsequence comprising SEQ ID NO: 55; (201) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 56; (202) a targeting sequence comprising amino acids 2-30 of SEQID NO: 55; (203) a targeting sequence comprising amino acids 5-30 of SEQID NO: 55; (204) a targeting sequence comprising amino acids 8-30 of SEQID NO: 55; (205) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 55; (206) a targeting sequence comprising amino acids 1-130of SEQ ID NO: 57; (207) a targeting sequence comprising amino acids115-130 of SEQ ID NO: 57; (208) a targeting sequence comprising SEQ IDNO: 57; (209) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 58; (210) a targetingsequence comprising amino acids 2-130 of SEQ ID NO: 57; (211) atargeting sequence comprising amino acids 5-130 of SEQ ID NO: 57; (212)a targeting sequence comprising amino acids 10-130 of SEQ ID NO: 57;(213) a targeting sequence comprising amino acids 20-130 of SEQ ID NO:57; (214) a targeting sequence comprising amino acids 30-130 of SEQ IDNO: 57; (215) a targeting sequence comprising amino acids 40-130 of SEQID NO: 57; (216) a targeting sequence comprising amino acids 50-130 ofSEQ ID NO: 57; (217) a targeting sequence comprising amino acids 60-130of SEQ ID NO: 57; (218) a targeting sequence comprising amino acids70-130 of SEQ ID NO: 57; (219) a targeting sequence comprising aminoacids 80-130 of SEQ ID NO: 57; (220) a targeting sequence comprisingamino acids 90-130 of SEQ ID NO: 57; (221) a targeting sequencecomprising amino acids 100-130 of SEQ ID NO: 57; (222) a targetingsequence comprising amino acids 110-130 of SEQ ID NO: 57; (223) anexosporium protein fragment comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 95; (224) a targeting sequencecomprising SEQ ID NO: 96; (225) a targeting sequence comprising SEQ IDNO: 97; (226) a targeting sequence comprising SEQ ID NO: 98; (227) atargeting sequence comprising SEQ ID NO: 99; (228) a targeting sequencecomprising SEQ ID NO: 100; (229) a targeting sequence comprising SEQ IDNO: 101; (230) a targeting sequence comprising SEQ ID NO: 102; (231) atargeting sequence comprising SEQ ID NO: 103; (232) a targeting sequencecomprising SEQ ID NO: 104; (233) a targeting sequence comprising SEQ IDNO: 105; (234) a targeting sequence comprising SEQ ID NO: 106; (235) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 108; (236) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 109;(237) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 110; (238) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 111; (239) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 112; (240) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 113; (241) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 114;(242) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 115; (243) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 116; (244) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 117; (245) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 118; (246) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 119;(247) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 120; (248) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 121; (249) a targeting sequence comprising amino acids 22-31 ofSEQ ID NO: 1; (250) a targeting sequence comprising amino acids 22-33 ofSEQ ID NO: 1; (251) a targeting sequence comprising amino acids 20-31 ofSEQ ID NO: 1; (252) a targeting sequence comprising amino acids 14-23 ofSEQ ID NO: 3; (253) a targeting sequence comprising amino acids 14-25 ofSEQ ID NO: 3; (254) a targeting sequence comprising amino acids 12-23 ofSEQ ID NO: 3; (255) a targeting sequence comprising amino acids 1-30 ofSEQ ID NO: 59; (256) a targeting sequence comprising SEQ ID NO: 59;(257) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 60; (258) a targeting sequencecomprising amino acids 2-30 of SEQ ID NO: 59; (259) a targeting sequencecomprising amino acids 4-30 of SEQ ID NO: 59; (260) a targeting sequencecomprising amino acids 6-30 of SEQ ID NO: 59; (261) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 61; (262) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 61; (263) a targetingsequence comprising SEQ ID NO: 61; (264) an exosporium proteincomprising an amino acid sequence having at least 85% sequence identitywith SEQ ID NO: 62; (265) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 61; (266) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 61; (267) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 61; (268) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 61; (269) a targeting sequence comprisingamino acids 1-35 of SEQ ID NO: 63; (270) a targeting sequence comprisingSEQ ID NO: 63; (271) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 64; (272) atargeting sequence comprising amino acids 2-35 of SEQ ID NO: 63; (273) atargeting sequence comprising amino acids 5-35 of SEQ ID NO: 63; (274) atargeting sequence comprising amino acids 8-35 of SEQ ID NO: 63; (275) atargeting sequence comprising amino acids 10-35 of SEQ ID NO: 63; (276)a targeting sequence comprising amino acids 15-35 of SEQ ID NO: 63;(277) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 65;(278) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 65;(279) a targeting sequence comprising SEQ ID NO: 65; (280) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 66; (281) a targeting sequence comprising SEQ ID NO:107; (282) a targeting sequence comprising amino acids 2-24 of SEQ IDNO: 65; (283) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 65; (284) a targeting sequence comprising amino acids 1-27 of SEQ IDNO: 67; (285) a targeting sequence comprising amino acids 12-27 of SEQID NO: 67; (286) a targeting sequence comprising SEQ ID NO: 67; (287) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 68; (288) an targeting sequence comprisingamino acids 2-27 of SEQ ID NO: 67; (289) a targeting sequence comprisingamino acids 5-27 of SEQ ID NO: 67; (290) a targeting sequence comprisingamino acids 10-27 of SEQ ID NO: 67; (291) a targeting sequencecomprising amino acids 1-38 of SEQ ID NO: 69; (292) a targeting sequencecomprising amino acids 23-38 of SEQ ID NO: 69; (293) a targetingsequence comprising SEQ ID NO: 69; (294) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 70; (295) a targeting sequence comprising amino acids 2-38 of SEQID NO: 69; (296) a targeting sequence comprising amino acids 5-38 of SEQID NO: 69; (297) a targeting sequence comprising amino acids 10-38 ofSEQ ID NO: 69; (298) a targeting sequence comprising amino acids 15-38of SEQ ID NO: 69; (299) an exosporium protein comprising SEQ ID NO: 72;(300) a targeting sequence comprising SEQ ID NO: 73; (301) an exosporiumprotein comprising an amino acid sequence having at least 95% identitywith SEQ ID NO: 74; (302) a targeting sequence comprising amino acids1-42 of SEQ ID NO: 75; (303) a targeting sequence comprising amino acids27-42 of SEQ ID NO: 75; (304) a targeting sequence comprising SEQ ID NO:75; (305) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 76; (306) a targeting sequencecomprising amino acids 2-42 of SEQ ID NO: 75; (307) a targeting sequencecomprising amino acids 5-42 of SEQ ID NO: 75; (308) a targeting sequencecomprising amino acids 10-42 of SEQ ID NO: 75; (309) a targetingsequence comprising amino acids 15-42 of SEQ ID NO: 75; (310) atargeting sequence comprising amino acids 20-42 of SEQ ID NO: 75; (311)a targeting sequence comprising amino acids 25-42 of SEQ ID NO: 75;(312) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 77;(313) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 77;(314) a targeting sequence comprising SEQ ID NO: 77; (315) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 78; (316) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 77; (317) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 77; (318) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO: 80; (319) atargeting sequence comprising amino acids 1-38 of SEQ ID NO: 81; (320) atargeting sequence comprising amino acids 23-38 of SEQ ID NO: 81; (321)a targeting sequence comprising SEQ ID NO: 81; (322) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 82; (323) a targeting sequence comprising amino acids2-38 of SEQ ID NO: 81; (324) a targeting sequence comprising amino acids5-38 of SEQ ID NO: 81; (325) a targeting sequence comprising amino acids10-38 of SEQ ID NO: 81; (326) a targeting sequence comprising aminoacids 15-38 of SEQ ID NO: 81; (327) a targeting sequence comprisingamino acids 20-38 of SEQ ID NO: 81; (328) a targeting sequencecomprising amino acids 1-34 of SEQ ID NO: 83; (329) a targeting sequencecomprising SEQ ID NO: 83; (330) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 84;(331) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 86; (332) a targeting sequencecomprising amino acids 1-28 of SEQ ID NO: 87; (333) a targeting sequencecomprising amino acids 13-28 of SEQ ID NO: 87; (334) a targetingsequence comprising SEQ ID NO: 87; (335) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 88; (336) a targeting sequence comprising amino acids 2-28 of SEQID NO: 87; (337) a targeting sequence comprising amino acids 5-28 of SEQID NO: 87; (338) a targeting sequence comprising amino acids 10-28 ofSEQ ID NO: 87; (339) a targeting sequence comprising amino acids 1-28 ofSEQ ID NO: 89; (340) a targeting sequence comprising SEQ ID NO: 89;(341) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 90; (342) a targeting sequencecomprising amino acids 2-28 of SEQ ID NO: 89; (343) a targeting sequencecomprising amino acids 5-28 of SEQ ID NO: 89; (344) a targeting sequencecomprising amino acids 10-28 of SEQ ID NO: 89; (345) a targetingsequence comprising amino acids 1-93 of SEQ ID NO: 91; (346) a targetingsequence comprising SEQ ID NO: 91; (347) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 92; (348) a targeting sequence comprising amino acids 2-93 of SEQID NO: 91; (349) a targeting sequence comprising amino acids 10-93 ofSEQ ID NO: 91; (350) a targeting sequence comprising amino acids 20-93of SEQ ID NO: 91; (351) a targeting sequence comprising amino acids30-93 of SEQ ID NO: 91; (352) a targeting sequence comprising aminoacids 40-93 of SEQ ID NO: 91; (353) a targeting sequence comprisingamino acids 50-93 of SEQ ID NO: 91; (354) a targeting sequencecomprising amino acids 60-93 of SEQ ID NO: 91; (355) a targetingsequence comprising amino acids 1-130 of SEQ ID NO: 93; (356) atargeting sequence comprising SEQ ID NO: 93; (357) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 94; (358) a targeting sequence comprising amino acids 2-130 ofSEQ ID NO: 93; (359) a targeting sequence comprising amino acids 10-130of SEQ ID NO: 93; (360) a targeting sequence comprising amino acids20-130 of SEQ ID NO: 93; (361) a targeting sequence comprising aminoacids 30-130 of SEQ ID NO: 93; (362) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 122;(363) a targeting sequence consisting of amino acids 20-33 of SEQ ID NO:1; (364) a targeting sequence consisting of amino acids 21-33 of SEQ IDNO: 1; (365) a targeting sequence consisting of amino acids 23-31 of SEQID NO: 1; (366) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 96; (367) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 96; (368) a targeting sequence consisting of amino acids12-25 of SEQ ID NO: 3; (369) a targeting sequence consisting of aminoacids 13-25 of SEQ ID NO: 3; (370) a targeting sequence consisting ofamino acids 15-23 of SEQ ID NO: 3; (371) a targeting sequence consistingof amino acids 1-15 of SEQ ID NO: 97; (372) a targeting sequenceconsisting of amino acids 1-13 of SEQ ID NO: 98; (373) a targetingsequence consisting of amino acids 23-36 of SEQ ID NO: 5; (374) atargeting sequence consisting of amino acids 23-34 of SEQ ID NO: 5;(375) a targeting sequence consisting of amino acids 24-36 of SEQ ID NO:5; (376) a targeting sequence consisting of amino acids 26-34 of SEQ IDNO: 5; (377) a targeting sequence consisting of amino acids 13-26 of SEQID NO: 7; (378) a targeting sequence consisting of amino acids 13-24 ofSEQ ID NO: 7; (379) a targeting sequence consisting of amino acids 14-26of SEQ ID NO: 7; (380) a targeting sequence consisting of amino acids16-24 of SEQ ID NO: 7; (381) a targeting sequence consisting of aminoacids 9-22 of SEQ ID NO: 9; (382) a targeting sequence consisting ofamino acids 9-20 of SEQ ID NO: 9; (383) a targeting sequence consistingof amino acids 10-22 of SEQ ID NO: 9; (384) a targeting sequenceconsisting of amino acids 12-20 of SEQ ID NO: 9; (385) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 105; (386) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 105;(387) a targeting sequence consisting of amino acids 18-31 of SEQ ID NO:11; (388) a targeting sequence consisting of amino acids 18-29 of SEQ IDNO: 11; (389) a targeting sequence consisting of amino acids 19-31 ofSEQ ID NO: 11; (390) a targeting sequence consisting of amino acids 1-15of SEQ ID NO: 98; (391) a targeting sequence consisting of amino acids1-13 of SEQ ID NO: 98; (392) a targeting sequence consisting of aminoacids 18-31 of SEQ ID NO: 13; (393) a targeting sequence consisting ofamino acids 18-29 of SEQ ID NO: 13; (394) a targeting sequenceconsisting of amino acids 19-31 of SEQ ID NO: 13; (395) a targetingsequence consisting of amino acids 21-29 of SEQ ID NO: 13; (396) atargeting sequence consisting of amino acids 1-15 of SEQ ID NO: 99;(397) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:99; (398) a targeting sequence consisting of amino acids 28-41 of SEQ IDNO: 15; (399) a targeting sequence consisting of amino acids 28-39 ofSEQ ID NO: 15; (400) a targeting sequence consisting of amino acids29-41 of SEQ ID NO: 15; (401) a targeting sequence consisting of aminoacids 31-39 of SEQ ID NO: 15; (402) a targeting sequence consisting ofamino acids 12-25 of SEQ ID NO: 17; (403) a targeting sequenceconsisting of amino acids 13-25 of SEQ ID NO: 17; (404) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 100; (405) atargeting sequence consisting of amino acids 18-31 of SEQ ID NO: 19;(406) a targeting sequence consisting of amino acids 18-29 of SEQ ID NO:19; (407) a targeting sequence consisting of amino acids 19-31 of SEQ IDNO: 19; (408) a targeting sequence consisting of amino acids 21-29 ofSEQ ID NO: 19; (409) a targeting sequence consisting of amino acids18-31 of SEQ ID NO: 21; (410) a targeting sequence consisting of aminoacids 18-29 of SEQ ID NO: 21; (411) a targeting sequence consisting ofamino acids 19-31 of SEQ ID NO: 21; (412) a targeting sequenceconsisting of amino acids 21-29 of SEQ ID NO: 21; (413) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 101; (414) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 101;(415) a targeting sequence consisting of amino acids 9-22 of SEQ ID NO:23; (416) a targeting sequence consisting of amino acids 9-20 of SEQ IDNO: 23; (417) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 23; (418) a targeting sequence consisting of amino acids12-20 of SEQ ID NO: 23; (419) a targeting sequence consisting of aminoacids 1-15 of SEQ ID NO: 102; (420) a targeting sequence consisting ofamino acids 1-13 of SEQ ID NO: 102; (421) a targeting sequenceconsisting of amino acids 9-22 of SEQ ID NO: 25; (422) a targetingsequence consisting of amino acids 9-20 of SEQ ID NO: 25; (423) atargeting sequence consisting of amino acids 10-22 of SEQ ID NO: 25;(424) a targeting sequence consisting of amino acids 12-20 of SEQ ID NO:25; (425) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 103; (426) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 103; (427) a targeting sequence consisting of amino acids15-28 of SEQ ID NO: 27; (428) a targeting sequence consisting of aminoacids 15-26 of SEQ ID NO: 27; (429) a targeting sequence consisting ofamino acids 16-28 of SEQ ID NO: 27; (430) a targeting sequenceconsisting of amino acids 18-26 of SEQ ID NO: 27; (431) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 104; (432) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 104;(433) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:33; (434) a targeting sequence consisting of amino acids 1-11 of SEQ IDNO: 33; (435) a targeting sequence consisting of amino acids 3-11 of SEQID NO: 33; (436) a targeting sequence consisting of amino acids 1-14 ofSEQ ID NO: 35; (437) a targeting sequence consisting of amino acids 1-12of SEQ ID NO: 35; (438) a targeting sequence consisting of amino acids2-14 of SEQ ID NO: 35; (439) a targeting sequence consisting of aminoacids 14-27 of SEQ ID NO: 43; (440) a targeting sequence consisting ofamino acids 14-25 of SEQ ID NO: 43; (441) a targeting sequenceconsisting of amino acids 15-27 of SEQ ID NO: 43; (442) a targetingsequence consisting of amino acids 20-33 of SEQ ID NO: 45; (443) atargeting sequence consisting of amino acids 20-31 of SEQ ID NO: 45;(444) a targeting sequence consisting of amino acids 21-33 of SEQ ID NO:45; (445) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 106; (446) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 106; (447) a targeting sequence consisting of amino acids28-41 of SEQ ID NO: 47; (448) a targeting sequence consisting of aminoacids 28-39 of SEQ ID NO: 47; (449) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 53; (450) a targeting sequenceconsisting of amino acids 18-29 of SEQ ID NO: 53; (451) a targetingsequence consisting of amino acids 19-31 of SEQ ID NO: 53; (452) atargeting sequence comprising amino acids 18-31 of SEQ ID NO: 61; (453)a targeting sequence comprising amino acids 18-29 of SEQ ID NO: 61;(454) a targeting sequence comprising amino acids 19-31 of SEQ ID NO:61; (455) a targeting sequence comprising amino acids 9-22 of SEQ ID NO:65; (456) a targeting sequence comprising amino acids 9-20 of SEQ ID NO:65; (457) a targeting sequence comprising amino acids 10-22 of SEQ IDNO: 65; (458) a targeting sequence comprising amino acids 1-15 of SEQ IDNO: 107; (459) a targeting sequence comprising amino acids 1-13 of SEQID NO: 107; (460) a targeting sequence comprising amino acids 12-25 ofSEQ ID NO: 67; (461) a targeting sequence comprising amino acids 12-23of SEQ ID NO: 67; (462) a targeting sequence comprising amino acids13-25 of SEQ ID NO: 67; (463) a targeting sequence comprising aminoacids 15-23 of SEQ ID NO: 67; (464) a targeting sequence comprisingamino acids 23-36 of SEQ ID NO: 69; (465) a targeting sequencecomprising amino acids 23-34 of SEQ ID NO: 69; (466) a targetingsequence comprising amino acids 24-36 of SEQ ID NO: 69; (467) atargeting sequence comprising amino acids 26-34 of SEQ ID NO: 69; (468)a targeting sequence comprising amino acids 27-40 of SEQ ID NO: 75;(469) a targeting sequence comprising amino acids 27-38 of SEQ ID NO:75; (470) a targeting sequence comprising amino acids 9-22 of SEQ ID NO:77; (471) a targeting sequence comprising amino acids 9-20 of SEQ ID NO:77; (472) a targeting sequence comprising amino acids 10-22 of SEQ IDNO: 77; (473) a targeting sequence comprising amino acids 12-20 of SEQID NO: 77; (474) a targeting sequence comprising amino acids 23-36 ofSEQ ID NO: 81; (475) a targeting sequence comprising amino acids 23-34of SEQ ID NO: 81; (476) a targeting sequence comprising amino acids24-36 of SEQ ID NO: 81; (477) a targeting sequence comprising aminoacids 26-34 of SEQ ID NO: 81; (478) a targeting sequence comprisingamino acids 13-26 of SEQ ID NO: 87; (479) a targeting sequencecomprising amino acids 13-24 of SEQ ID NO: 87; or (480) a targetingsequence comprising amino acids 14-26 of SEQ ID NO: 87.

For example, the targeting sequence can comprise or consist of an aminoacid sequence having at least about 50% identity with amino acids 20-35of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 63%.

The targeting sequence can comprise or consist of an amino acid sequencehaving at least about 50% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

The targeting sequence can comprise or consist of an amino acid sequencehaving at least about 56% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 63%.

The targeting sequence can comprise or consist of an amino sequencehaving at least about 62% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

The targeting sequence can comprise or consist of an amino acid sequencehaving at least about 68% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 81%.

The targeting sequence can comprise or consist of an amino sequencehaving at least about 75% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 72%.

The targeting sequence can comprise or consist of an amino sequencehaving at least about 75% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 81%.

The targeting sequence can comprise or consist of an amino acid sequencehaving at least about 81% identity with amino acids 20-35 of SEQ IDNO:1, wherein the identity with amino acids 25-35 is at least about 81%.

The targeting sequence can comprise or consist of an amino acid sequencehaving at least about 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least about 90%.

The targeting sequence can consist of: (a) an amino acid sequenceconsisting of 16 amino acids and having at least about 43% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 54%; (b) amino acids 1-35 of SEQ ID NO: 1; (c)amino acids 20-35 of SEQ ID NO: 1; (d) SEQ ID NO: 1; (e) SEQ ID NO: 96;or (f) SEQ ID NO: 120.

The exosporium protein or exosporium protein fragment can comprise anamino acid sequence having at least 90% identity with SEQ ID NO: 2, 4,6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46,48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80, 82, 84, 86,88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117,118, 119, 120, 121, and 122.

The exosporium protein or exosporium protein fragment can comprise anamino acid sequence having at least 95% identity with SEQ ID NO: 2, 4,6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46,48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80, 82, 84, 86,88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117,118, 119, 120, 121, and 122.

The exosporium protein or exosporium protein fragment can comprise anamino acid sequence having at least 98% identity with SEQ ID NO: 2, 4,6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46,48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80, 82, 84, 86,88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117,118, 119, 120, 121, and 122.

The exosporium protein or exosporium protein fragment can comprise anamino acid sequence having at least 99% identity with SEQ ID NO: 2, 4,6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46,48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80, 82, 84, 86,88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117,118, 119, 120, 121, and 122.

The exosporium protein or exosporium protein fragment can comprise anamino acid sequence having at least 100% identity with SEQ ID NO: 2, 4,6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 44, 46,48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80, 82, 84, 86,88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117,118, 119, 120, 121, and 122.

The targeting sequence, exosporium protein, or exosporium proteinfragment can comprise the amino acid sequence GXT at its carboxyterminus, wherein X is any amino acid.

The targeting sequence, exosporium protein, or exosporium proteinfragment can comprise an alanine residue at the position of thetargeting sequence that corresponds to amino acid 20 of SEQ ID NO: 1.

The targeting sequence, exosporium protein, or exosporium proteinfragment can further comprise a methionine, serine, or threonine residueat the amino acid position immediately preceding the first amino acid ofthe targeting sequence, exosporium protein, or exosporium proteinfragment or at the position of the targeting sequence that correspondsto amino acid 20 of SEQ ID NO: 1.

The fusion protein can further comprise an amino acid linker between thetargeting sequence, the exosporium protein, or the exosporium proteinfragment and the protein or peptide of interest. The linker can be anyof the linkers described above in Section XI.

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

A further method for delivering proteins or peptides to an animal isalso provided. The method comprises feeding to an animal a recombinantspore-forming bacterium. The recombinant spore-forming bacterium can beany of the recombinant spore-forming bacteria described above in SectionIX.

The recombinant spore-forming bacterium can be comprised within a plantthat is fed to the animal.

The recombinant spore-forming bacterium can comprise an endophytic andprobiotic strain of bacteria. For example, the endophytic and probioticstrain of bacteria can comprise Bacillus megaterium EE385 (NRRLB-50980), Bacillus sp. EE387 (NRRL B-50981), Bacillus circulans EE388(NRRL B-50982), Bacillus subtilis EE405 (NRRL B-50978), Lysinibacillusfusiformis EE442 (NRRL B-50975), or Lysinibacillus sphaericus EE443(NRRL B-50976), Bacillus pumilus EE-B00143 (NRRL B-67123), or acombination thereof.

In any of the above methods, the plant can be processed prior to feedingto the animal.

In any of the above methods involving feeding a plant to an animal, themethod can further comprise introducing the endophytic strain ofbacteria or a formulation comprising the endophytic strain of bacteriainto a plant growth medium. Alternatively, the method can compriseapplying the endophytic strain of bacteria or a formulation comprisingthe endophytic strain of bacteria to a plant, a plant seed, or an areasurrounding a plant or a plant seed. The plant fed to the animalcomprises a plant grown in a plant growth medium containing theendophytic and probiotic strain of bacteria or a formulation comprisingthe endophytic and probiotic strain of bacteria, a plant to which theendophytic and probiotic strain of bacteria was applied, a plant grownfrom a plant seed to which the endophytic and probiotic strain ofbacteria was applied, a plant grown in an area to which the endophyticand probiotic strain of bacteria was applied, or a seed grown in thearea to which the endophytic and probiotic strain of bacteria wasapplied.

In any of the above methods for delivering proteins or peptides to ananimal, the protein or peptide of interest comprises an enzyme. Forexample, the enzyme can comprise a xylanase, a xylosidase, a phytase, aphosphatase, a protease, a cellulase, an endoglucanase, an exogluconase,a glucanase, an amylase (e.g., α-amylase or a β-amylase), a lipase, aphospholipase, a glycosylase, a galactanase, an α-galactosidase, aβ-glucosidase, an amylase, a pectinase, a biotinase, apolygalacturonase, a ligninase, or a combination thereof. The lipase cancomprise a phospholipase A1, a phospholipase A2, a phospholipase C, aphospholipase D, a lysophospholipase, or a combination thereof. Theenzyme preferably comprises a xylanase or a phytase.

In any of the methods comprising feeding a plant to an animal, the plantcan be processed prior to feeding to the animal.

In any of the above methods comprising delivery of bacteria, proteins,or peptides to an animal, the animal can be a mammal (e.g., a sheep,goat, cow, pig, deer, alpaca, bison, camel, donkey, horse, mule, llama,rabbit, dog, or cat), a bird (e.g., a chicken, turkey, duck, goose,quail, or pheasant), a fish (e.g., salmon, trout, tilapia, tuna,catfish, or a carp), or a crustacean (e.g., a shrimp, prawn, lobster,crab, or crayfish).

XXI. Methods for Delivering Beneficial Nucleic Acids to Animals,Insects, Worms, Fungi, and Protozoans

The invention further relates to methods for delivering a nucleic acidmolecule to an animal, insect, worm, fungus, or protozoan.

The method can comprise feeding to an animal, an insect, or worm a plantmodified to comprise a level of the nucleic acid molecule that isgreater than the level of the nucleic acid molecule in the same plantthat has not been modified, grown under the same conditions.

A further method for delivering a nucleic acid molecule to an animal,insect, or worm is provided. The method can comprise feeding to ananimal, insect, or worm a recombinant Bacillus cereus family memberexpressing a fusion protein comprising a protein or peptide of interestand a targeting sequence, exosporium protein, or exosporium proteinfragment that targets the fusion protein to the exosporium of therecombinant Bacillus cereus family member. Alternatively, the method cancomprise feeding to an animal, insect, or worm a recombinantspore-forming bacterium that expresses a fusion protein comprising atleast one protein or peptide of interest and a spore coat protein thattargets the fusion protein to the surface of a spore of the bacterium.The protein or peptide of interest comprises a nucleic acid bindingprotein or peptide and the nucleic acid molecule is bound to the DNA orRNA binding protein or peptide. The nucleic acid binding protein orpeptide can be physically attached to the exosporium of the recombinantBacillus cereus family member or to the spore coat of the recombinantspore-forming bacterium.

Another method for delivering a nucleic acid molecule to an animal,insect, or worm is provided. The method comprises feeding to an animal,insect, or worm exosporium fragments derived from a recombinant Bacilluscereus family member. The exosporium fragments are derived from sporesof a recombinant Bacillus cereus family member described in Section IVhereinabove and comprise the fusion protein. The fusion proteincomprises a nucleic acid binding protein or peptide, and wherein thenucleic acid binding protein or peptide is bound to a nucleic acidmolecule.

The worm is preferably a nematode.

A method for delivering a nucleic acid molecule to a fungus or aprotozoan is provided. The method comprises contacting a fungus or aprotozoan with a recombinant Bacillus cereus family member expressing afusion protein comprising a protein or peptide of interest and atargeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of the recombinantBacillus cereus family member. Alternatively, the method comprisescontacting a fungus or a protozoan with a recombinant spore-formingbacterium that expresses a fusion protein comprising at least oneprotein or peptide of interest and a spore coat protein that targets thefusion protein to the surface of a spore of the bacterium. The proteinor peptide of interest comprises a nucleic acid binding protein orpeptide and the nucleic acid molecule is bound to the nucleic acidbinding protein or peptide.

A further method for delivering a nucleic acid molecule to a fungus or aprotozoan is provided. The method comprises contacting a fungus or aprotozoan with exosporium fragments. The exosporium fragments arederived from spores of a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises a nucleic acid binding protein or peptide, andwherein the nucleic acid binding protein or peptide is bound to anucleic acid molecule.

The nucleic acid molecule can comprise a modulating RNA molecule; anRNAi molecule; a microRNA; an aptamer; or a DNA molecule that encodes amodulating RNA molecule, an RNAi molecule, a microRNA, or an aptamer.

The recombinant Bacillus cereus family member can comprise any of therecombinant Bacillus cereus family members that express a fusionprotein.

The fusion protein can comprise any of the fusion proteins describedherein that include a nucleic acid binding protein.

The spore coat protein comprises a CotB protein, a CotC protein, a CgeAprotein, a CotB/H protein, a CotG protein, a spore coat protein Xprotein, or a CotY protein.

The spore coat protein can comprise an amino acid sequence having atleast 85% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 90% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 95% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 98% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having atleast 99% identity with any of SEQ ID NOs: 252-259.

The spore coat protein can comprise an amino acid sequence having 100%identity with any of SEQ ID NOs: 252-259.

The above-described methods can be used for numerous purposes. Forexample, these methods can be used to deliver RNA or DNA to animals forthe purpose of decreasing susceptibility of the animal to a disease ortreating a disease in the animal (e.g., organic disease such as stroke,diabetes, heart disease, and degenerative diseases). RNAs and DNAs havealso been demonstrated to be effective for eliminating or treatingdisease caused by animal pathogens, such as bacteria, viruses, worms(e.g., nematodes), and fungi. The RNAs and DNAs can act directly on thepathogen, or can work with the animal's immune system to activate orincrease the immune response.

In addition, the above methods can be used for eliminating pests,including insects, worms (e.g., nematodes), fungi, and protozoans.Delivery of specific RNAs or DNAs to the pest can lead to decreasedability to of the pest to infect a host (e.g., a plant host), decreasedfeeding on target hosts or plants, direct killing through blocking ofkey genes, or various other effects.

XXII. Vaccines and a Method of Producing an Immunogenic Response

A vaccine is provided which comprises a pharmaceutically acceptablecarrier and recombinant Bacillus cereus family member spores thatexpress a fusion protein as described above in paragraphs [00171],[00173]-[00176] of Section I wherein the protein or peptide of interestis an antigen or an immunogen.

A further vaccine is provided which comprises a pharmaceuticallyacceptable carrier and exosporium fragments. The exosporium fragmentsare derived from spores of a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises an antigen.

Yet another vaccine is provided which comprises a pharmaceuticallyacceptable carrier and a recombinant Bacillus cereus family member. Therecombinant Bacillus cereus family member is a recombinant Bacilluscereus family member as described above in Section II.

In the vaccines that comprise exosporium fragments or a recombinantBacillus cereus family member as described above in Section II, thetargeting sequence, exosporium protein, or exosporium protein fragmentcan comprise any of the targeting sequences, exosporium proteins, orexosporium protein fragments described herein. In particular, thetargeting sequence, exosporium protein, or exosporium protein fragmentcan comprise any of the targeting sequences, exosporium protein, orexosporium protein fragments described above in paragraphs[00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

When the protein or peptide of interest is an antigen, display of theantigen on the outside of the spore or on an exosporium fragmentprovides an immune system response to achieve vaccination againstvarious pathogens or diseases. Suitable antigens or small molecules arethose that are known or expected to illicit a desired immune responsethat is sufficient to yield a therapeutic or protective effect whenexpressed on the exterior of a Bacillus spore or displayed on anexosporium fragment. Suitability in large part will be determined by thefolding in the three-dimensional structure once the recombinant antigenis incorporated into the exosporium, i.e. the antigenic portion(s) ofthe recombinant molecule must be available for detection by the immunesystem.

The pathogens or diseases from which the antigen can be derived include,but are not limited to, Acintobacter infections, caused by Acinetobacterbaumannii; Actinomycosis, caused by Actinomyces israelii, Actinomycesgerencseriae, and Propionibacterium propionicus; African sleepingsickness, caused by Trypanosoma brucei; Acquired immune deficiencysyndrome (AIDS), caused by Human immunodeficiency virus; Amebiasis,caused by Entamoeba histolytica; Anaplasmosis, caused by Anaplasmagenus, Anthrax, caused by Bacillus anthracis; Arcanobacteriumhaemolyticum infection, caused by Arcanobacterium haemolyticum;Argentine hemorrhagic fever, caused by Junin virus; Ascariasis, causedby Ascaris lumbricoides, Astrovirus infection, caused by Astroviradaefamily; Babesiosis, Babesia genus; Bacillus cereus infection, caused byBacillus cereus; Bacterial pneumonia; Bacterial vaginosis; Bacteroidesinfection, caused by Bacteroides genus; Balantidiasis, caused byBalantidium coli; Baylisascaris infection, caused by Baylisascarisgenus; BK virus infection, caused by BK virus; Black piedra, caused byPiedraia hortae; Blastocystis hominis infection, caused by Blastocystishominis; Blastomycosis, caused by Blastomyces dermatitidis; Bolivianhemorrhagic fever, caused by Machupo virus; Borrelia infection, causedby Borrelia genus; Botulism (and Infant botulism), caused by the intakeof Clostridium botulinum toxin; Brazilian hemorrhagic fever, caused bySabia; Brucellosis, caused by Brucella genus; Burkholderia infection,caused by usually Burkholderia cepacia and other Burkholderia species;Buruli ulcer, caused by Mycobacterium ulcerans; Calicivirus infection(Norovirus and Sapovirus), caused by Caliciviridae family;Campylobacteriosis, caused by Campylobacter genus; Candidiasis(Moniliasis; Thrush) usually caused by Candida albicans and otherCandida species; Cat-scratch disease, caused by Bartonella henselae;Cellulitis, caused by usually Group A Streptococcus and Staphylococcus;Chagas Disease (American trypanosomiasis), caused by Trypanosoma cruzi;Chancroid, caused by Haemophilus ducreyi; Chickenpox, caused byVaricella zoster virus (VZV); Chlamydia, caused by Chlamydiatrachomatis; Chlamydophila pneumoniae infection, caused by Chlamydophilapneumoniae; Cholera, caused by Vibrio cholerae; Chromoblastomycosis,caused by usually Fonsecaea pedrosoi; Clonorchiasis, caused byClonorchis sinensis; Clostridium difficile infection, caused byClostridium difficile; Coccidioidomycosis, caused by Coccidioidesimmitis and Coccidioides posadasii; Colorado tick fever (CTF), caused byColorado tick fever virus (CTFV); Common cold (Acute viralrhinopharyngitis; Acute coryza), caused by usually rhinoviruses andcoronaviruses; Creutzfeldt-Jakob disease (CJD), caused by CJD prion;Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-Congohemorrhagic fever virus; Cryptococcosis, caused by Cryptococcusneoformans; Cryptosporidiosis, caused by Cryptosporidium genus;Cutaneous larva migrans (CLM), caused by usually Ancylostoma brazilienseand multiple other parasites; Cyclosporiasis, caused by Cyclosporacayetanensis; Cysticercosis, caused by Taenia solium; Cytomegalovirusinfection, caused by Cytomegalovirus; Dengue fever, caused by Dengueviruses (DEN-1, DEN-2, DEN-3 and DEN-4)-Flaviviruses; Dientamoebiasis,caused by Dientamoeba fragilis; Diphtheria, caused by Corynebacteriumdiphtheriae; Diphyllobothriasis, caused by Diphyllobothrium;Dracunculiasis, caused by Dracunculus medinensis; Ebola hemorrhagicfever, caused by Ebolavirus (EBOV); Echinococcosis, caused byEchinococcus genus; Ehrlichiosis, caused by Ehrlichia genus;Enterobiasis (Pinworm infection), caused by Enterobius vermicularis;Enterococcus infection, caused by Enterococcus genus; Enterovirusinfection, caused by Enterovirus genus; Epidemic typhus, caused byRickettsia prowazekii; Erythema infectiosum (Fifth disease), caused byParvovirus B19; Exanthem subitum, caused by Human herpesvirus 6 (HHV-6)and Human herpesvirus 7 (HHV-7); Fasciolopsiasis, caused by Fasciolopsisbuski; Fasciolosis, caused by Fasciola hepatica and Fasciola gigantica;Fatal familial insomnia (FFI), caused by FFI prion; Filariasis, causedby Filarioidea superfamily; Food poisoning caused by Clostridiumperfringens; Free-living amebic infection; Fusobacterium infection,caused by Fusobacterium genus; Gas gangrene (Clostridial myonecrosis),caused by usually Clostridium perfringens or other Clostridium species;Geotrichosis, caused by Geotrichum candidum;Gerstmann-Straussler-Scheinker syndrome (GSS), caused by GSS prion;Giardiasis, caused by Giardia intestinalis; Glanders, caused byBurkholderia mallei; Gnathostomiasis, caused by Gnathostoma spinigerumand Gnathostoma hispidum; Gonorrhea, caused by Neisseria gonorrhoeae;Granuloma inguinale (Donovanosis), caused by Klebsiella granulomatis;Group A streptococcal infection, caused by Streptococcus pyogenes; GroupB streptococcal infection, caused by Streptococcus agalactiae;Haemophilus influenzae infection, caused by Haemophilus influenzae;Hand, foot and mouth disease (HFMD), caused by Enteroviruses, mainlyCoxsackie A virus and Enterovirus 71 (EV71); Hantavirus PulmonarySyndrome (HPS), caused by Sin Nombre virus; Helicobacter pyloriinfection, caused by Helicobacter pylori; Hemolytic-uremic syndrome(HUS), caused by Escherichia coli O157:H7; Hemorrhagic fever with renalsyndrome (HFRS), caused by Bunyaviridae family; Hepatitis A, caused byHepatitis A Virus; Hepatitis B, caused by Hepatitis B Virus; HepatitisC, caused by Hepatitis C Virus; Hepatitis D caused by Hepatitis D Virus;Hepatitis E, caused by Hepatitis E Virus; Herpes simplex, caused byHerpes simplex virus 1 and 2 (HSV-1 and HSV-2); Histoplasmosis, causedby Histoplasma capsulatum; Hookworm infection, caused by Ancylostomaduodenale and Necator americanus; Human bocavirus infection, caused byHuman bocavirus (HBoV); Human ewingii ehrlichiosis, caused by Ehrlichiaewingii; Human granulocytic anaplasmosis (HGA), caused by Anaplasmaphagocytophilum; Human metapneumovirus infection, caused by Humanmetapneumovirus (hMPV); Human monocytic ehrlichiosis, caused byEhrlichia chaffeensis; Human papillomavirus (HPV) infection, caused byHuman papillomavirus (HPV); Human parainfluenza virus infection, causedby Human parainfluenza viruses (HPIV); Hymenolepiasis, caused byHymenolepis nana and Hymenolepis diminuta; Epstein-Barr Virus InfectiousMononucleosis (Mono), caused by Epstein-Ban Virus (EBV); Influenza(flu), caused by Orthomyxoviridae family; Isosporiasis, caused byIsospora Belli; Kawasaki disease (cause unknown but evidence supportsthat it is infectious); Keratitis; Kingella kingae infection, caused byKingella kingae; Kuru, caused by Kuru prion; Lassa fever, caused byLassa virus; Legionellosis (Legionnaires' disease), caused by Legionellapneumophila; Legionellosis (Pontiac fever), caused by Legionellapneumophila; Leishmaniasis, caused by Leishmania genus; Leprosy, causedby Mycobacterium leprae and Mycobacterium lepromatosis; Leptospirosis,caused by Leptospira genus; Listeriosis, caused by Listeriamonocytogenes; Lyme disease (Lyme borreliosis), caused by usuallyBorrelia burgdorferi and other Borrelia species; Lymphatic filariasis(Elephantiasis), caused by Wuchereria bancrofti and Brugia malayi;Lymphocytic choriomeningitis, caused by Lymphocytic choriomeningitisvirus (LCMV); Malaria, caused by Plasmodium genus; Marburg hemorrhagicfever (MHF), caused by Marburg virus; Measles, caused by Measles virus;Melioidosis (Whitmore's disease), caused by Burkholderia pseudomallei;Meningitis; Meningococcal disease, caused by Neisseria meningitidis;Metagonimiasis, caused by usually Metagonimus yokagawai;Microsporidiosis, caused by Microsporidia phylum; Molluscum contagiosum(MC), caused by Molluscum contagiosum virus (MCV); Mumps, caused byMumps virus; Murine typhus (Endemic typhus), caused by Rickettsia typhi;Mycoplasma pneumonia, caused by Mycoplasma pneumoniae; Mycetoma, causedby numerous species of bacteria (Actinomycetoma) and fungi (Eumycetoma);Myiasis, caused by parasitic dipterous fly larvae; Neonatalconjunctivitis (Ophthalmia neonatorum), caused by most commonlyChlamydia trachomatis and Neisseria gonorrhoeae; (New) VariantCreutzfeldt-Jakob disease (vCJD, nvCJD), caused by vCJD prion;Nocardiosis, caused by usually Nocardia asteroides and other Nocardiaspecies; Onchocerciasis (River blindness), caused by Onchocercavolvulus; Paracoccidioidomycosis (South American blastomycosis), causedby Paracoccidioides brasiliensis; Paragonimiasis, caused by usuallyParagonimus westermani and other Paragonimus species; Pasteurellosis,caused by Pasteurella genus; Pediculosis capitis (Head lice), caused byPediculus humanus capitis; Pediculosis corporis (Body lice), caused byPediculus humanus corporis; Pediculosis pubis (Pubic lice, Crab lice),caused by Phthirus pubis; Pelvic inflammatory disease (PID); Pertussis(Whooping cough), caused by Bordetella pertussis; Plague, caused byYersinia pestis; Pneumococcal infection, caused by Streptococcuspneumoniae; Pneumocystis pneumonia (PCP), caused by Pneumocystisjirovecii; Pneumonia; Poliomyelitis, caused by Poliovirus; Prevotellainfection, caused by Prevotella genus; Primary amoebicmeningoencephalitis (PAM), caused by usually Naegleria fowleri;Progressive multifocal leukoencephalopathy, caused by JC virus;Psittacosis, caused by Chlamydophila psittaci; Q fever, caused byCoxiella burnetii; Rabies, caused by Rabies virus; Rat-bite fever,caused by Streptobacillus moniliformis and Spirillum minus; Respiratorysyncytial virus infection, caused by Respiratory syncytial virus (RSV);Rhinosporidiosis, caused by Rhinosporidium seeberi; Rhinovirusinfection, caused by Rhinovirus; Rickettsial infection, caused byRickettsia genus; Rickettsialpox, caused by Rickettsia akari; RiftValley fever (RVF), caused by Rift Valley fever virus; Rocky mountainspotted fever (RMSF), caused by Rickettsia rickettsii; Rotavirusinfection, caused by Rotavirus; Rubella, caused by Rubella virus;Salmonellosis, caused by Salmonella genus; SARS (Severe AcuteRespiratory Syndrome), caused by SARS coronavirus; Scabies, caused bySarcoptes scabiei; Schistosomiasis, caused by Schistosoma genus; Sepsis;Shigellosis (Bacillary dysentery), caused by Shigella genus; Shingles(Herpes zoster), caused by Varicella zoster virus (VZV); Smallpox(Variola), caused by Variola major or Variola minor; Sporotrichosis,caused by Sporothrix schenckii; Staphylococcal food poisoning, caused byStaphylococcus genus; Staphylococcal infection, caused by Staphylococcusgenus; Strongyloidiasis, caused by Strongyloides stercoralis; Syphilis,caused by Treponema pallidum; Taeniasis, caused by Taenia genus; Tetanus(Lockjaw), caused by Clostridium tetani; Tinea barbae (Barber's itch),caused by usually Trichophyton genus; Tinea capitis (Ringworm of theScalp), caused by usually Trichophyton tonsurans; Tinea corporis(Ringworm of the Body), caused by usually Trichophyton genus; Tineacruris (Jock itch), caused by usually Epidermophyton floccosum,Trichophyton rubrum, and Trichophyton mentagrophytes; Tinea manuum(Ringworm of the Hand), caused by Trichophyton rubrum; Tinea nigra,caused by usually Hortaea werneckii; Tinea pedis (Athlete's foot),caused by usually Trichophyton genus; Tinea unguium (Onychomycosis),caused by usually Trichophyton genus; Tinea versicolor (Pityriasisversicolor), caused by Malassezia genus; Toxocariasis (Ocular LarvaMigrans (OLM)), caused by Toxocara canis or Toxocara cati; Toxocariasis(Visceral Larva Migrans (VLM)), caused by Toxocara canis or Toxocaracati; Toxoplasmosis, caused by Toxoplasma gondii; Trichinellosis, causedby Trichinella spiralis; Trichomoniasis, caused by Trichomonasvaginalis; Trichuriasis (Whipworm infection), caused by Trichuristrichiura; Tuberculosis, caused by usually Mycobacterium tuberculosis;Tularemia, caused by Francisella tularensis; Ureaplasma urealyticuminfection, caused by Ureaplasma urealyticum; Venezuelan equineencephalitis, caused by Venezuelan equine encephalitis virus; Venezuelanhemorrhagic fever, caused by Guanarito virus; Viral pneumonia; West NileFever, caused by West Nile virus; White piedra (Tinea blanca), caused byTrichosporon beigelii; Yersinia pseudotuberculosis infection, caused byYersinia pseudotuberculosis; Yersiniosis, caused by Yersiniaenterocolitica; Yellow fever, caused by Yellow fever virus; Zygomycosis,caused by Mucorales order (Mucormycosis) and Entomophthorales order(Entomophthoramycosis).

When the protein or peptide of interest is an antigen, any Bacilluscereus family member can be used to express the fusion protein. Bacillusthuringiensis or Bacillus mycoides are preferred.

To prepare a vaccine, the antigen of interest is incorporated into thefusion protein by known methods such as PCR splicing by overlappingextension, restriction endonuclease digestion and ligation, or de novogene synthesis. The fusion protein gene is then introduced into arecombinant Bacillus cereus family member by transfection,transformation, conjugation, electroporation or other known methods. Therecombinant Bacillus cereus family member is then grown in culture media(e.g., minimal liquid media) and allowed to sporulate. Preferably,sporulation continues to completion before the spores are collected andstored. Spores can be collected by either centrifugation or swabbing ofspores off of growth plates and introduction into liquid media (e.g.,PBS or water) followed by centrifugation and washing of the resultingspore pellet in liquid media. Prior to use, the spore pellet can beresuspended in liquid media to a desired concentration for use orinjection. Where the vaccine is to comprise exosporium fragments, theexosporium fragments can be prepared using any of the methods describedin section XIX.H above.

The desired concentration of recombinant Bacillus cereus family memberspores or exosporium fragments in a vaccine is based on the size of thesubject, the amount of active antigen on the surface of the spores, andthe presence and concentration of adjuvants in the vaccine formulation.A vaccine of the invention can contain conventional adjuvants includingpharmaceutically acceptable carriers.

A method of producing an immunogenic response in a subject is provided.The method comprises administering a vaccine containing recombinantBacillus cereus family member spores expressing fusion proteins orexosporium fragments comprising fusion proteins as described herein tothe subject.

The vaccine as described herein is suitable for intravenous,intrarterial, intraperitoneal, intramuscular, subcutaneous,intrapleural, topical, oral, intranasal, intradermal, transepithelialadministration or by inhalation.

The vaccine can be administered to a subject which is human, murine,avian, porcine, bovine, ovine, feline, canine, equine, caprine,reptilian or a non-human primate. The subject is preferably mammalianand most preferably human.

XXIII. Remediation

When the protein or peptide of interest is a remediation protein orpeptide, a toxic substance is catalytically converted by the remediationprotein or peptide to a non-toxic or less toxic substance.

When the remediation protein or peptide comprises an enzyme, the enzymeis displayed and stabilized on the outside of the spore and can bedelivered into contaminated soil or contaminated water in a form whichis active against a target pollutant or target chemical.

Suitable enzymes depend upon the pollutant or chemical being targetedfor remediation.

To prepare a remediation composition, the enzyme of interest isincorporated into the fusion protein by known methods such as PCRsplicing by overlapping extension, restriction endonuclease digestionand ligation, or de novo gene synthesis. The fusion protein gene is thenintroduced into a recombinant Bacillus cereus family member bytransfection, transformation, conjugation, electroporation or otherknown methods. The recombinant Bacillus cereus family member is thengrown in culture media (e.g., minimal liquid media) and allowed tosporulate. Preferably, sporulation continues to completion before thespores are collected and stored. Spores can be collected by eithercentrifugation or swabbing of spores off of growth plates andintroduction into liquid media (e.g., PBS or water) followed bycentrifugation and washing of the resulting spore pellet in liquidmedia. Prior to use, the spore pellet can be resuspended in liquid mediato a desired concentration for use. Alternatively, the spore pellet canbe formulated into granules at a desired concentration for use andapplication to the contaminated environment. Where exosporium fragmentsare to be used for remediation, the exosporium fragments can be preparedusing any of the methods described in section XIX.H above.

A method of reducing contaminants in an environment is provided. Themethod comprises exposing a contaminated environment to a recombinantBacillus cereus family member spore that express the fusion protein asdescribed above in paragraphs [00171], [00173]-[00175] and [00177] ofSection I wherein the protein or peptide of interest comprises aremediation enzyme.

A further method for reducing contaminants in an environment isprovided. The method comprises exposing a contaminated environment toexosporium fragments. The exosporium fragments are derived from arecombinant Bacillus cereus family member described in Section IVhereinabove and comprise the fusion protein. The fusion proteincomprises a remediation enzyme.

Yet another method for reducing contaminants in an environment isprovided. The method comprises exposing a contaminated environment tospores of a recombinant Bacillus cereus family member. The recombinantBacillus cereus family member is a recombinant Bacillus cereus familymember as described above in Section II.

In the methods for reducing contaminants that comprise exposing acontaminated environment to exosporium fragments or to a recombinantBacillus cereus family member as described above in Section II, thetargeting sequence, exosporium protein, or exosporium protein fragmentcan be any of the targeting sequences, exosporium proteins, orexosporium protein fragments described herein. In particular, thetargeting sequence, exosporium protein, or exosporium protein fragmentcan comprise any of the targeting sequences, exosporium protein, orexosporium protein fragments described above in paragraphs[00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

When the protein or peptide of interest is a remediation enzyme, anyBacillus cereus family member can be used to express the fusion protein.Bacillus thuringiensis, Bacillus cereus, or Bacillus mycoides arepreferred.

The recombinant Bacillus cereus family member spores can comprise anendophytic strain of bacteria for phytoremediation, such as Bacilluscereus family member EE349, Bacillus cereus family member EE439,Bacillus thuringiensis EE417, Bacillus cereus EE444, or Bacillusthuringiensis EE319.

The contaminated environment to be treated can be gas, liquid,semi-liquid, gel, film, semi-solid, or solid. The solid environment canbe soil such as surface soil and subsurface soil, compost, crop residue,leaves, mulch, cut trees, a biofilm, a slime layer, mold, sludge, sand,slag, sediment, sewage, waste rock, nuclear waste, munitions andordnance, hospital waste, junked auto parts, metal cuttings, insulationwaste, food waste, asbestos, batteries, industrial scrap, landfillwaste, wood waste, textile waste, glass waste, leather waste, rubberwaste, plastic waste, electronic component waste, agricultural waste,photographic waste, ceramic waste, pharmaceutical waste, wax, spentcatalysts, or a combination thereof. The liquid environment can bedrinking water, groundwater, surface water, brine, storage tanks,lagoons, an aquatic system, industrial wastewater, acid mine drainage,spent autofluid, spent plating baths, degreasing solutions, dry cleaningsolutions, machine coolants, drilling fluid waste, cutting fluid waste,hydraulic fracturing fluid waste, lubricant waste, paint, greywater,oily wastewater, pulp mill effluent, a water treatment system, a septicsystem, a sewer system, a precipitation lagoon, a holding pond, a lake,a river, or combinations thereof. The gaseous environment can be air, aflue gas such as emissions from power plants, waste incinerators,crematoria or refineries, a process exhaust stream, landfill gas,natural gas, propane gas, or a combination thereof.

The contaminated environment can be contaminated by various contaminantsincluding, but not limited to, a chemical warfare agent comprising sarin(GB; o-isopropyl methylphosphonofluoridate); soman (GD; o-pinacolylmethylphosphonofluoridate); cyclosarin (GF; o-cyclohexylmethylphosphonofluoridate); VX (O-ethylS-[2-(diisopropylamino)ethyl]methylphosphonothioate); tabun (GA;N,N-dimethylethyl phosphoroamidocyanidate), DFP (diisopropyiphosphorofluoridate), or a mustard agent; an inorganic compoundcomprising arsenic, antimony, barium, beryllium, cadmium, chromium,copper, iron, lead, manganese, mercury, nickel, selenium, silver, tin,thallium, uranium, zinc or a combination thereof; an organic compoundcomprising a polycyclic aromatic hydrocarbon (PAH), a chlorinatedaromatic compound, a chlorinated aliphatic compound, a nitroaromaticcompound (NAC), a phenolic compound, a cyano compound, dioxin, or acombination thereof; a crude oil, a refined oil, a fuel oil, a dieseloil, a gasoline, a hydraulic oil, and kerosene, or a volatileconstituent thereof such as benzene, toluene, ethylbenzene, xylene, ornaphthalene; an explosive, a fertilizer, a pesticide, an insecticide, oran herbicide

The concentration of recombinant spores or exosporium fragments neededto treat a contaminated environment is based on factors including thevolume or area to be treated, the extent of the target chemical,pollutant or organic matter present, the amount of time available fortreatment, and amount of active enzyme on the surface of the spores.

The recombinant Bacillus cereus family member spores or exosporiumfragments can contact the contaminated environment by incorporating thespores or exosporium fragments into a stream containing the contaminant,contacting a stream containing the contaminant with an immobilizationmaterial containing the spores or exosporium fragments (e.g., a filter,membrane, sponge or cassette), incorporating the spores or exosporiumfragments into granules to be mixed with the contaminated environment,spraying the spores or exosporium fragments onto or into thecontaminated environment, injecting the spores or exosporium fragmentsinto the contaminated environment, or drenching the contaminatedenvironment with the spores or exosporium fragments.

The spores can be combined with bacterial inoculants, chemicals,solvents, and other products that can expedite the decompositionprocess.

The remediation enzyme includes, but is not limited to, a phosphatebinding protein, a protease, a carbohydrate hydrolyase, a lipase, aphospholipase, a nuclease, a nutrient binding protein, a cellulase, anoxidoreductase, a monooxygenase, a diooxygenase, a laccase, a ligninperoxidase, a manganese peroxidase, a peroxidase, a dehalogenase, acatalase, an amylase, a reductase, an oxidase, an amidase, a ligninase,a xylanase, a pectinase, a xylosidase, an endoglucanase, anexoglucanase, a glucosidase, a biofilm inhibitory peptide, anherbicide-degrading enzyme, a pesticide-degrading enzyme (e.g., apyrethrinase), or a combination thereof.

Where the enzyme comprises an herbicide-degrading enzyme or apesticide-degrading enzyme, the recombinant Bacillus cereus familymember suitably comprises a strain of bacteria that is capable ofdegrading an herbicide or a pesticide. For example, the strain ofbacteria that is capable of degrading an herbicide or a pesticide cancomprise Bacillus cereus family member EE349 (NRRL No. B-50928),Bacillus cereus family member EE-B00377 (NRRL B-67119); Bacilluspseudomycoides EE-B00366 (NRRL B-67120); or Bacillus mycoides EE-B00363(NRRL B-67121).

A method for phytoremediation of contaminated soil is also provided. Themethod comprises introducing recombinant Bacillus cereus family memberspores into contaminated soil; or applying the recombinant Bacilluscereus family member spores to a plant planted in contaminated soil, ora plant seed for planting in contaminated soil, or an area ofcontaminated soil surrounding a plant or a plant seed; wherein therecombinant Bacillus cereus family member spores express a fusionprotein comprising at least one protein or peptide of interest and atargeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of the recombinantBacillus cereus family member spore, wherein the fusion protein is thefusion protein as described above wherein the protein or peptide ofinterest comprises a remediation enzyme, and wherein the recombinantBacillus cereus family member comprises an endophytic strain of bacteriaor a root colonizing strain of bacteria. For example, the recombinantspore-forming bacterium can comprise an endophytic strain of bacteria.

A further method for phytoremediation of contaminated soil is provided.The method comprises expressing a remediation enzyme in a Bacilluscereus family member spore, wherein the expression of the remediationenzyme in the recombinant Bacillus cereus family member spore isincreased as compared to the expression of the remediation enzyme in awild-type Bacillus cereus family member spore.

Another method for phytoremediation of contaminated soil is alsoprovided. The method comprises introducing a recombinant spore-formingbacterium into contaminated soil; or applying the recombinantspore-forming bacterium to a plant planted in contaminated soil, or aplant seed to be planted in contaminated soil, or an area ofcontaminated soil surrounding a plant or a plant seed. The recombinantspore-forming bacterium expresses a fusion protein comprising at leastone protein or peptide of interest and a spore coat protein that targetsthe fusion protein to the surface of a spore of the bacterium. The sporecoat protein comprises a CotB protein, a CotC protein, a CgeA protein, aCotB/H protein, a Cot G protein, a spore coat protein X protein, or aCotY protein. The recombinant spore-forming bacterium comprises anendophytic strain of bacteria or a root colonizing strain of bacteria.The protein or peptide of interest comprises a remediation enzyme.

Another method for phytoremediation of contaminated soil is alsoprovided. The method comprises introducing exosporium fragments intocontaminated soil or applying exosporium fragments to a plant planted incontaminated soil, or a plant seed to be planted in contaminated soil,or an area of contaminated soil surrounding a plant or a plant seed. Theexosporium fragments are derived from spores of a recombinant Bacilluscereus family member described in Section IV herein above and comprisethe fusion protein. The fusion protein comprises a remediation enzyme.

Yet another method for phytoremediation of contaminated soil isprovided. The method comprises introducing spores of a recombinantBacillus cereus family member into contaminated soil. Alternatively, themethod comprises applying spores of a recombinant Bacillus cereus familymember to a plant planted in contaminated soil, or a plant seed to beplanted in contaminated soil, or an area of contaminated soilsurrounding a plant or a plant seed. The recombinant Bacillus cereusfamily member is a recombinant Bacillus cereus family member asdescribed above in Section II, and the fusion protein comprises aremediation enzyme.

In the methods for phytoremediation of contaminated soil that involvethe use of exosporium fragments or a recombinant Bacillus cereus familymember as described above in Section II, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium proteins, or exosporium proteinfragments described herein. In particular, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium proteins, or exosporium proteinfragments described above in paragraphs [00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

The remediation enzyme is displayed on the outside of the spores andwithin the plant so that both the plant and spores can convert thetarget contaminant. The plant can take up the target contaminant whilethe spores convert the contaminant into a non-toxic or less toxic formwithin the plant or its root system.

The recombinant Bacillus cereus family member spores can comprise anendophytic strain of bacteria, such as Bacillus cereus family memberEE349, Bacillus cereus family member EE439, Bacillus thuringiensisEE417, Bacillus cereus EE444, or Bacillus thuringiensis EE319, Bacillusthuringiensis EE-B00184, Bacillus cereus family member EE-B00377,Bacillus pseudomycoides EE-B00366, or Bacillus mycoides EE-B00363.

The spores or the exosporium fragments can be applied to the plant orthe plant seed, and the plant or plant grown from the plant seed istolerant to a target contaminant to be remediated from the contaminatedsoil

In the method for phytoremediation, recombinant Bacillus cereus familymembers undergo sporulation within the plant.

The recombinant Bacillus cereus family member spores can be introducedinto the plant growth medium by various methods such as soil drench atthe time of planting. The spores can also be coated onto the plant seedas a seed treatment.

Preferably, the plant to be treated with the remediation enzyme istolerant to the target contaminant so that the plant is not injured bythe target contaminant.

The concentration of recombinant spores needed for the phytoremediationmethod is based on factors including volume or area to be treated, theability of the endophytic strains to colonize the plant roots, theextent that the target contaminant is present, and the amount of activeenzyme on the surface of the spores.

A further method for reducing contaminants in an environment isprovided. The method comprises exposing a contaminated environment tospores of a Bacillus cereus family member strain that is capable ofdegrading an herbicide or a pesticide. The contaminants in theenvironment comprise an herbicide, a pesticide, or a combinationthereof. The Bacillus cereus family member strain that is capable ofdegrading an herbicide or a pesticide comprises Bacillus cereus familymember EE349 (NRRL No. B-50928), Bacillus cereus family member EE-B00377(NRRL B-67119); Bacillus pseudomycoides EE-B00366 (NRRL B-67120);Bacillus mycoides EE-B00363 (NRRL B-67121), or a combination thereof.

The Bacillus cereus family member strain that is capable of degrading anherbicide or a pesticide can comprise a recombinant Bacillus cereusfamily member that expresses a fusion protein comprising at least oneprotein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member. Theprotein or peptide of interest preferably comprises anherbicide-degrading enzyme, a pesticide-degrading enzyme, or acombination thereof.

In this way, dual pesticide or herbicide degrading activity can beobtained since both the Bacillus cereus family member strains and theherbicide-degrading or pesticide-degrading enzymes in the fusion proteinwill exert pesticide- and/or herbicide-degrading activity. Theherbicides and/or pesticides that are degraded by the Bacillus cereusfamily strain that is capable of degrading an herbicide or a pesticidecan be the same as or different from the herbicides and/or pesticidesthat are degraded by the herbicide-degrading enzyme or thepesticide-degrading enzyme. Thus, where an environment is contaminatedwith a single type of herbicide or pesticide, dual degrading actionagainst that single herbicide or pesticide can be obtained.Alternatively, where an environment is contaminated with more than onetype of herbicide or pesticide, dual degrading action against two ormore different herbicides or pesticides can be obtained.

In the methods of reducing contaminants involving the use of one of theBacillus cereus family member strains described herein that is capableof degrading an herbicide or a pesticide, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium proteins, or exosporium proteinfragments described herein. In particular, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium proteins, or exosporium proteinfragments described above in paragraphs [00782]-[00801].

XXIV. Breaking Emulsions or Gels in a Hydraulic Fracturing Fluid

A method of treating a hydraulic fracturing fluid to break an emulsionor gel within the fluid is provided. The method comprises adding sporesof a recombinant Bacillus cereus family member spores to a hydraulicfracturing fluid. The recombinant Bacillus cereus family memberexpresses a fusion protein comprising at least one protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member spore. Such a fusionprotein is described above wherein the protein or peptide of interestcomprises an enzyme suitable for breaking the emulsion or gel.

The recombinant Bacillus cereus family member can comprise any of therecombinant Bacillus cereus family members described herein that expressa fusion protein.

A further method of treating a hydraulic fracturing fluid to break anemulsion or gel within the fluid is provided. The method comprisesadding exosporium fragments to a hydraulic fracturing fluid. Theexosporium fragments are derived from a recombinant Bacillus cereusfamily member described in Section IV hereinabove and comprise thefusion protein. The fusion protein comprises an enzyme suitable forbreaking the emulsion or gel.

The enzyme is selected based upon the target emulsion or gel to betreated and the pH of the hydraulic fracturing fluid. Enzymes include,but are not limited to, a hemicellulase, an amylase, a pectinase, acarbohydrate hydrolyase, a cellulase, an agarase, a polygalacturonase,an endoglucanase, or a combination thereof.

The emulsion or gel contains a polymer or other component which theenzyme can digest. The emulsion or gel can comprise a polymer, Arabicagum, agar, xanthan gum, cellulose, carboxymethylcellulose,carboxymethylhydroxyethyl cellulose, hydroxyethyl methylcellulose, guar,a guar derivative, or a combination thereof.

When the protein or peptide of interest is an enzyme for breaking anemulsion or gel, any Bacillus cereus family member can be used toexpress the fusion protein. Bacillus thuringiensis or Bacillus mycoidesare preferred.

The spores or exosporium fragments can be injected into a well that isin contact with a subterranean hydrocarbon-containing formation such asa sandstone reservoir or a carbonate reservoir.

The concentration of spores or exosporium fragments needed is based onfactors including the size of the well to be treated, the type ofemulsion or gel, the amount of active enzyme on the surface of thespores or exosporium fragments, and the presence and concentration ofadjuvants delivered with the enzymes.

The enzymes can digest polymers or other components within the emulsionor gel, or can dissolve such components so that the hydraulic fracturingfluid can be pumped out of the well.

In the methods of treating a hydraulic fracturing fluid to break anemulsion or gel within the fluid, any of the targeting sequences,exosporium proteins, or exosporium protein fragments described hereincan be used. In particular, the targeting sequence, exosporium protein,or exosporium protein fragment can comprise any of the targetingsequences, exosporium protein, or exosporium protein fragments describedabove in paragraphs [00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

XXV. Feedstock Processing

Feedstock is generated from plants that are harvested for their biomass,and processed into feed (bailing, silage, extrusion, pelleting, etc).The plant biomass that constitutes the feedstock is often difficult todigest due to the fibrous nature of the material. The presence ofenzymes can greatly assist in the degradation of this fibrous material,leading to a more digestible and easier to process material. Enzymes aretraditionally added after the feedstock has been processed and upondelivery to the organism that is ingesting the feedstock. Enzymesdelivered in feedstock can improve health and weight gain of targetanimals, as well as reduce the environmental impact of the wasteproducts of animals fed such enzyme-supplemented feed.

These same systems can be utilized to pretreat feedstock that isdestined for biofuel production, including processing into bioethanol,biodiesel, or other biofuels.

Many species of spores have the ability to persist on foliar surfaces,such as leaves, stems, and fruit, for long periods of time. By usingspore display technologies as described herein to display the enzymes onthese spores, active enzyme is provided to the feedstock that will bepresent as the feedstock is harvested. These target enzymes can also bedelivered to the feedstock plant at planting, either through delivery ofrecombinant spores on the plant seeds, or delivery of the recombinantspores to the plant growth medium or area around the plant.

A method for delivering enzymes to a plant is provided. The methodcomprises introducing into a plant growth medium a recombinant Bacilluscereus family member that expresses a fusion protein comprising at leastone protein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member or aformulation comprising a recombinant Bacillus cereus family member asdescribed herein; or applying to a plant, a plant seed, or an areasurrounding a plant or a plant seed the recombinant Bacillus cereusfamily member or the formulation comprising a recombinant Bacilluscereus family member. The protein or peptide of interest comprises anenzyme. The enzyme can be physically attached to the exosporium of therecombinant Bacillus cereus family member.

Another method for delivering enzymes to a plant is provided. The methodcomprises introducing into a plant growth medium a recombinantspore-forming bacterium or a formulation comprising the recombinantspore-forming bacterium; or applying to a plant, a plant seed, or anarea surrounding a plant or a plant seed the recombinant spore-formingbacterium or a formulation comprising the recombinant spore-formingbacterium. The recombinant spore-forming bacterium expresses a fusionprotein comprising at least one protein or peptide of interest and aspore coat protein that targets the fusion protein to the surface of aspore of the bacterium. The spore coat protein comprises a CotB protein,a CotC protein, a CgeA protein, a CotB/H protein, a Cot G protein, aspore coat protein X protein, or a CotY protein. The recombinantspore-forming bacterium comprises an endophytic strain of bacteria. Theprotein or peptide of interest comprises an enzyme, and the enzyme isphysically attached to the spore coat of the recombinant spore-formingbacterium

Yet another method for delivering enzymes to a plant is provided. Themethod comprises introducing exosporium fragments or a formulationcontaining the exosporium fragments into a plant growth medium; orapplying exosporium fragments or a formulation containing the exosporiumfragments to a plant, a plant seed, or an area surrounding a plant or aplant seed. The exosporium fragments are derived from spores of arecombinant Bacillus cereus family member described in Section IVhereinabove and comprise the fusion protein. The protein or peptide ofinterest comprises an enzyme.

Where the method for delivering enzymes to a plant comprises the use ofexosporium fragments, the method can further comprise treating the plantwith a penetrating agent, a surfactant, a detergent, an oil, or acombination thereof.

Optimal bacteria strains for these methods include, but are not limitedto, Bacillus cereus family members, including Bacillus cereus, Bacillusmycoides, Bacillus thuringiensis, and Bacillus pseudomycoides, as wellas other Bacillus spore formers, including Bacillus megaterium, Bacillusfirmus, Bacillus Plexus, Bacillus subtilis clade members, Bacilluspumilus, Bacillus licheniformis, and Bacillus subtilis.

Application can be directly onto the plant material, optionally inconjunction with adjuvants, such as nonionic or other surfactants. Therecombinant Bacillus cereus family member can be applied to foliage ofthe plant prior to harvest such as by spraying onto the foliage.

Application to the plant seed is generally performed as a seed dip, aslurry, or a polymer-based seed coating. Optionally, the application canbe done in conjunction with seed applied inoculants, fungicides,insecticides, or nematocides.

Application to the plant growth medium or area around the plant can beperformed prior to planting, at planting, or post planting of seeds,optionally in conjunction with fertilizers, fungicides, herbicides, orinsecticides.

The enzyme is suitable for degrading biomass, digesting cellulosicmaterial, aiding digestion in a digestive system of a target animal towhich the plant can be fed, or for biofuel production (e.g., forproduction of bioethanol or biodiesel).

The enzyme includes, but is not limited to, a nonspecific protease, ametalloprotease, a cellulase, a xylanase, a phosphatase, anendoglucanase, an exoglucanase, a β-glucosidase, an amylase, apectinase, a xylosidase, a lipase, a phospholipase, or a combinationthereof.

The selection of enzymes may depend on the feedstock and the intendeduse of the feedstock. The enzymes are preferably degradative enzymes.

Enzymes of interest in the protease family include nonspecificproteases, such as serine proteases, histidine proteases, aspartateproteases, as well as metalloproteases.

Enzymes of interest in the cellulase family would include exoglucanases,endoglucanases, β-1,3 glucosidases, cellulases, hemicellulases,a-glucosidases.

Enzymes of interest in the xylanases family include xylosidases,endoxylanases, exoxylanases, pectinases, methyl pectinases,polygalacturonase.

Enzymes of interest in the phosphatases include acid phosphatases,alkaline phosphatases, polyphosphatases, phytases, monophosphatases, anddiphosphatases.

Many of these enzymes are also beneficial to plant growth.

These enzymes can not only “predigest” some of the feedstock to increaseabsorption of key nutrients by a target animal to which the feedstock isfed, but can also aid digestion in the digestive system of the targetanimal.

The “predigestion” of cellulosic material at harvest can liberate freecellulose during processing for bioethanol and biofuel production, aswell as preprocessing of oils destined for biofuel production.

The bacterium can be an endophytic bacterium. Selection of endophyticrecombinant bacteria will allow for the bacteria to enter into theplant, but also colonize and grow inside the plant tissues. This willestablish a growing number of recombinant spore forming organisms insidethe plant as it grows from use of a relatively minor amount ofrecombinant spores on the seed or with the seed at planting. Uponharvest of the plant biomass material, the bacterial will undergosporulation, creating new enzymes in planta, which are active on thefeedstock as it is harvested, transported, and utilized, for example,either as animal feed or for biofuel production. This can significantlyreduce the input cost of degradative enzymes as compared to existingtechniques. This is a unique method of delivering digestive enzymes tothe biomass prior to industrial processing.

While the optimal bacterial strains are as described above, selection ofendophytic strains will increase efficacy. Preferably, the endophyticbacteria comprises Bacillus cereus family member EE349, Bacillus cereusfamily member 439, Bacillus thuringiensis EE417, Bacillus cereus EE444,Bacillus megaterium EE385, Bacillus sp. EE387, Bacillus circulans EE388,Bacillus subtilis EE405, Lysinibacillus fusiformis EE442, Lysinibacillussphaericus EE443, or a combination thereof.

The plant can be a crop selected from corn, alfalfa, wheat, a pasturecrop, a forage crop, soybean, switchgrass, jicama, sweet sorghum,sugarcane, or a combination thereof, and other biofuel and bioethanolfeedstocks.

For the methods for delivering enzymes to a plant, any of the targetingsequences, exosporium proteins, or exosporium protein fragmentsdescribed herein can be used.

XXVI. Use of Spores in Altering Properties of Target Plants

The recombinant Bacillus cereus family members and recombinantspore-forming bacterium as described herein allow for the interaction ofsurface displayed signaling molecules impacting biochemical pathways,and a number of other proteins that benefit plant health. The presenceof the spore displayed proteins or peptides can lead to alteration inthe metabolism of the target plant, leading to changes in thecomposition of the plant, its fruit, or other properties orcharacteristics.

The expression of fusion proteins can be directly used to alter thecomposition of the target plant. Selection of different enzymes leads tovarying effects on the target plant.

A method for altering a property of a plant is provided. The methodcomprises introducing into a plant growth medium a recombinant Bacilluscereus family member that expresses a fusion protein comprising at leastone protein or peptide of interest and a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member or aformulation comprising a recombinant Bacillus cereus family member asdescribed herein; or applying to a plant, a plant seed, or an areasurrounding a plant or a plant seed the recombinant Bacillus cereusfamily member or the formulation comprising a recombinant Bacilluscereus family member. The protein or peptide of interest comprises aplant signaling molecule or an enzyme that affects plant composition,and the protein or peptide of interest can be physically attached to theexosporium of the recombinant Bacillus cereus family member.

Another method for altering a property of a plant is provided. Themethod comprises introducing into a plant growth medium a recombinantspore-forming bacterium or a formulation comprising the recombinantspore-forming bacterium; or applying to a plant, a plant seed, or anarea surrounding a plant or a plant seed the recombinant spore-formingbacterium or a formulation comprising the recombinant spore-formingbacterium. The recombinant spore-forming bacterium expresses a fusionprotein comprising at least one protein or peptide of interest and aspore coat protein that targets the fusion protein to the surface of aspore of the bacterium. The spore coat protein comprises a CotB protein,a CotC protein, a CgeA protein, a CotB/H protein, a Cot G protein, aspore coat protein X protein, or a CotY protein. The recombinantspore-forming bacterium comprises an endophytic strain of bacteria. Theprotein or peptide of interest comprises a plant signaling molecule oran enzyme that affects plant composition, and the protein or peptide ofinterest can be physically attached to the spore coat of the recombinantspore-forming bacterium

Yet another method for altering a property of a plant is provided. Themethod comprises introducing exosporium fragments or a formulationcontaining the exosporium fragments into a plant growth medium; orapplying exosporium fragments or a formulation containing the exosporiumfragments to a plant, a plant seed, or an area surrounding a plant or aplant seed. The exosporium fragments are derived from spores of arecombinant Bacillus cereus family member described in Section IVhereinabove and comprise the fusion protein. The protein or peptide ofinterest comprises a plant signaling molecule or an enzyme that affectsplant composition.

Where the method for altering a property of a plant comprises the use ofexosporium fragments, the method can further comprise treating the plantwith a penetrating agent, a surfactant, a detergent, an oil, or acombination thereof.

The target bacterium preferably survives or thrives in the environmentand on the roots of the target plant. Optimal bacteria strains for thesemethods include, but are not limited to, Bacillus cereus family memberEE349, Bacillus cereus family member 439, Bacillus thuringiensis EE417,Bacillus cereus EE444, Bacillus megaterium EE385, Bacillus sp. EE387,Bacillus circulans EE388, Bacillus subtilis EE405, Lysinibacillusfusiformis EE442, or Lysinibacillus sphaericus EE443.

The plant signaling molecules or enzymes can also be delivered to theplant at planting, either through delivery of recombinant spores on theplant seeds, or delivery of the recombinant spores to the plant growthmedium or area around the plant.

Application can be directly onto the plant material, optionally inconjunction with adjuvants, such as nonionic or other surfactants. Therecombinant Bacillus cereus family member, the recombinant spore-formingbacterium, or the exosporium fragments can be applied to foliage of theplant prior to harvest such as by spraying onto the foliage.

Application to the plant seed is generally performed as a seed dip, aslurry, or a polymer-based seed coating. Optionally, the application canbe done in conjunction with seed applied inoculants, fungicides,insecticides, or nematocides.

Application to the plant growth medium or area around the plant can beperformed prior to planting, at planting, or post planting of seeds,optionally in conjunction with fertilizers, fungicides, herbicides, orinsecticides.

The enzyme includes, but is not limited to, comprises endoglucanases,proteases, phospholipases, aminocarboxy-1-propanedeaminase,aminocyclopropane-1-carboxylic acid deaminases, lipases, or acombination thereof.

The plant signaling molecules include, but are not limited to, flg22 andflagellin peptides, cryptogein, harpins, harpin-like proteins, enzymesthat degrade or modify a bacterial, fungal, or plant nutrient source, ora combination thereof.

The enzymes or plant signaling molecules can cause desired metabolicchanges to the host plant, including increasing the macronutrient andmicronutrient uptake or content of the plant tissues through enlargementof the root systems, increasing the protein content of plants such asgrains, cereals, and fruit through modifications to metabolism andincreased nitrogen uptakes, and modifications to oil content inrapeseed, canola, soybeans and sunflower, sugar content (sucrose) ingrapes, sugar cane, switchgrass, sweet sorghum and other biofuelfeedstock, medicinal compound content, and cannabinoid content inmarijuana. These alterations not only increase the value of the plantsof interest, but also increase the utility of these plants in variousindustries such as biofuel formation, sugar production, and feedstockproduction.

For the methods for altering a property of a plant, any of the targetingsequences, exosporium proteins, or exosporium protein fragmentsdescribed herein can be used.

XXVII. Disinfection

A method of disinfecting a surface is provided. The method comprisesexposing a surface to a recombinant Bacillus cereus family member thatexpresses a fusion protein as described above in paragraphs[00172]-[00175] and [00179] of Section I, wherein the protein or peptideof interest comprises an antibacterial protein or peptide.

A further method of disinfecting a surface is provided. The methodcomprises exposing a surface to exosporium fragments. The exosporiumfragments are derived from a recombinant Bacillus cereus family memberdescribed in Section IV hereinabove and comprise the fusion protein. Thefusion protein comprises an antibacterial protein or peptide.

Yet another method of disinfecting a surface is provided. The methodcomprises exposing a surface to a recombinant Bacillus cereus familymember. The recombinant Bacillus cereus family member is a recombinantBacillus cereus family member as described above in Section II.

In the methods for disinfecting a surface that comprise exposing asurface to exosporium fragments or to a recombinant Bacillus cereusfamily member as described above in Section II, the targeting sequence,exosporium protein, or exosporium protein fragment can be any of thetargeting sequences, exosporium proteins, or exosporium proteinfragments described herein. In particular, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium protein, or exosporium proteinfragments described above in paragraphs [00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

The antibacterial protein or peptide minimizes or prevents viral agents,bacteria, amoebas, pests, or molds from forming on or binding to thesurface.

The antibacterial protein or peptide includes, but is not limited to,proteases, nucleases, antimicrobial peptides, LysM, LfcinB, lysostaphin,albumin, defensins, bacteriocins, lipopeptides, innate immune systempeptides, lysozyme, lyticase, or a combination thereof.

The recombinant Bacillus cereus family member spores can be used inconjunction with other antimicrobial agents, including disinfectants,cleaners, antibiotics, antifungals, and antivirals.

Although any of the Bacillus cereus family can be utilized to expressthe fusion proteins, either Bacillus thuringiensis or Bacillus mycoidesis preferred.

For these methods, any of the targeting sequences, exosporium proteins,or exosporium protein fragments described herein can be used.

XXVIII. Other Uses

The fusion proteins wherein the protein or peptide of interest is anenzyme or recombinant Bacillus cereus members wherein the protein orpeptide of interest is an enzyme that can be used for grease, oil, orfat treatment or degumming; leather hide processing; biofuel, biodiesel,or bioethanol formation; sugar processing or conversion; starchtreatment; paper or linen processing; animal or fungal byproducttreatment or amino acid recovery; targeted digestion of facility wastes;feed or food additives; dietary supplements; animal nutrition;industrial cleaning; grain processing; cosmetic manufacturing; odorcontrol; food or beverage processing; brewing enhancement or additives;detergent additives; or textile or yarn processing.

By displaying an enzyme on the outside of the spore or on exosporiumfragments, the enzyme can be stabilized, immobilized, and able to bereused.

Industrial processes generally involve harsh conditions, including hightemperatures, presence of solvents, and large amounts of organic matter.These conditions hinder traditional enzymes. Expression of the targetenzyme on the surface of the spore or on exosporium fragments allows forresistance to high temperatures and harsh conditions, and allows for theenzymes to be reisolated and reused.

Key enzymes of interest for such uses include: β-lactamases, proteases,lipases, phospholipases, cellulases, endoglucanases, exogluconases,pectinases, ligninases, amylases (e.g., α-amylases, β-amylases, orglucoamylases), polygalacturonases, glucosidases, galactosidases,carbohydrate hydrolyases, cell wall hydrolases, nucleases,hemicellulases, xylanases, mannases, laccases, lactases, esterases(e.g., pectin methyl esterases), phytases, phosphatases, invertases,glucose oxidases, catalases, lyticases, acetolactate decarboxylase, andureases.

Preferred enzymes for grease, oil, or fat treatment or degumming, or forcosmetic manufacturing include lipases, phospholipases, esterases, andproteases.

Preferred enzymes for leather hide processing include lipases,proteases, peptidases, collagenases, and phospholipases.

Preferred enzymes for biofuel, biodiesel, or bioethanol formation caninclude, but are not limited to, lipases and esterases.

Preferred enzymes for sugar processing or conversion, for grainprocessing, and for textile or yarn processing include carbohydratehydrolases, amylases, mannases, glucoamylases, invertases, cellulases,hemicellulases, pectinases, pectin methyl esterases, xylanases,endoglucanases, exoglucanases, glucosidases, galactosidases, laccases,lactases, catalases, and glucose oxidases.

Preferred enzymes for starch treatment include amylases andglucoamylases.

Preferred enzymes for paper or linen processing include cellulases,hemicellulases, xylanases, endoglucanases, laccases, ligninases,exoglucanases, phytases, catalases, and glucosidases.

Preferred enzymes for animal or fungal byproduct treatment or amino acidrecovery include proteases, peptidases, lipases, lyticases, cell wallhydrolases, phospholipases, endoglucanases, cellulases, glucanases andcarbohydrate hydrolases.

Preferred enzymes for targeted digestion of facility wastes, industrialcleaning, detergent additives, and odor control include lipases,phospholipases, proteases, peptidases, amylases, lyticases, cell wallhydrolases, glucoamylases, cellulases, hemicellulases, xylanases,esterases, glucosidases, galactosidases, laccases, lactases, ureases,phytases, phosphatases, and carbohydrate hydrolases.

Preferred enzymes for feed or food additives, dietary supplements,animal nutrition, brewing additives, beverage additives, or wineprocessing include mannases, laccases, lyticases, proteases, peptidases,carbohydrate hydrolases, pectinases, pectin methyl esterases, esterases,lipases, cellulases, hemicellulases, xylanases, phytases, phosphatases,invertases, glucosidases, galactosidases, lactases, catalases,glucanases, endoglucanases, acetolactate decarboxylase, and glucoseoxidases.

Although any of the Bacillus cereus family can be utilized to expressthe fusion proteins for these uses, either Bacillus thuringiensis orBacillus mycoides is preferred.

A use of fusion proteins comprising an enzyme as the protein or peptideof interest or a recombinant Bacillus cereus family member expressing afusion protein comprising an enzyme as the protein or peptide ofinterest is provided. The fusion protein can be any of the fusionproteins described above in paragraphs [00171]-[00175], [00177], and[00179] of Section I. The use can be a use for grease, oil, or fattreatment or degumming; leather hide processing; biofuel, biodiesel, orbioethanol formation; sugar processing or conversion; starch treatment;paper or linen processing; animal or fungal byproduct treatment or aminoacid recovery; targeted digestion of facility wastes; feed or foodadditives; dietary supplements; animal nutrition; industrial cleaning;grain processing; cosmetic manufacturing; odor control; food or beverageprocessing; brewing enhancement or additives; detergent additives; ortextile or yarn processing.

A use of exosporium fragments is also provided. The use can be forgrease, oil, or fat treatment or degumming; leather hide processing;biofuel, biodiesel, or bioethanol formation; sugar processing orconversion; starch treatment; paper or linen processing; animal orfungal byproduct treatment or amino acid recovery; targeted digestion offacility wastes; feed or food additives; dietary supplements; animalnutrition; industrial cleaning; grain processing; cosmeticmanufacturing; odor control; food or beverage processing; brewingenhancement or additives; detergent additives; or textile or yarnprocessing. The exosporium fragments are derived from a recombinantBacillus cereus family member described in Section IV hereinabove andcomprise the fusion protein. The fusion protein comprises an enzyme.

A further use of a recombinant Bacillus cereus family member isprovided. The recombinant Bacillus cereus family member is a recombinantBacillus cereus family member as described above in Section II. The usecan be for grease, oil, or fat treatment or degumming; leather hideprocessing; biofuel, biodiesel, or bioethanol formation; sugarprocessing or conversion; starch treatment; paper or linen processing;animal or fungal byproduct treatment or amino acid recovery; targeteddigestion of facility wastes; feed or food additives; dietarysupplements; animal nutrition; industrial cleaning; grain processing;cosmetic manufacturing; odor control; food or beverage processing;brewing enhancement or additives; detergent additives; or textile oryarn processing. The fusion protein comprises an enzyme.

In the uses of exosporium fragments or the recombinant Bacillus cereusfamily members as described above in Section II, the targeting sequence,exosporium protein, or exosporium protein fragment can be any of thetargeting sequences, exosporium proteins, or exosporium proteinfragments described herein. In particular, the targeting sequence,exosporium protein, or exosporium protein fragment can comprise any ofthe targeting sequences, exosporium protein, or exosporium proteinfragments described above in paragraphs [00782]-[00801].

The fusion protein can be expressed under the control of a sporulationpromoter native to the targeting sequence, exosporium protein, orexosporium protein fragment of the fusion protein or a portion thereofand/or under the control of a high-expression sporulation promoter. Thepromoter can be any of the promoters described above in Section III.

Having described the invention in detail, it will be apparent thatmodifications and variations are possible without departing from thescope of the invention defined in the appended claims.

EXAMPLES

The following non-limiting examples are provided to further illustratethe present invention.

Example 1. Use of a Recombinant Bacillus cereus Family Member Displayinga Lipase or an Endoglucanase to Stimulate Plant Growth in Soybeans

The Bacillus subtilis lipase and endoglucanase genes were amplified viapolymerase chain reaction (PCR) using the following primers shown belowin Table 16:

TABLE 16 lipase endoglucanase forward ggatccatggctgaacacaggatccatgaaacggtc atcc (SEQ ID NO: 37) aatc (SEQ ID NO: 39) reverseggatccttaattcgtattct ggatccttactaatttggtt ggcc (SEQ ID NO: 38)ctgt (SEQ ID NO: 40)

To create fusion constructs, genes were fused to the native bclApromoter of Bacillus thuringiensis DNA encoding the first 35 amino acidsof BclA (amino acids 1-35 of SEQ ID NO:1) using the splicing byoverlapping extension (SOE) technique. Correct amplicons were clonedinto the E. coli/Bacillus shuttle vector pHP13, and correct clonesscreened by DNA sequencing. Correct clones were electroporated intoBacillus thuringiensis (Cry-, plasmid-) and screened for chloramphenicolresistance. Correct transformants were grown in brain heart infusionbroth overnight at 30° C., plated onto nutrient agar plates, andincubated at 30° C. for 3 days. Spores expressing the fusion construct(BEMD spores) were collected off of the plates by washing in phosphatebuffered saline (PBS) and purified by centrifugation and additionalwashes in PBS. Non-transformed control Bacillus thuringiensis (B.t.)spores were created identically.

Soybeans (strain Jake 011-28-04) were planted 2.54 cm deep in 10 cm deeppots filled with standard loam topsoil. Spores were diluted to aconcentration of 1×10⁴/ml in 50 ml of water and applied to each seed atplanting. Plants were grown under ideal light using T5 lamps, 54 watts,and exposed to 11 hours of light a day under controlled temperatureconditions between 15.5-25.5° C. Plants were watered to saturation everythree days over a two week trial. At the end of two weeks, the height ofeach plant was measured and measurements were normalized to controlBacillus thuringiensis spores. Two independent trials were performed.

Results are shown in Table 17, together with the standard error of themean. In both trials, soybeans grown in the presence of BEMD sporesdisplaying either lipase or endoglucanase grew significantly taller thancontrol B.t. spore treated soybeans (statistical analysis assayed via at-test).

TABLE 17 Soybeans Avg. Height, Comparison Treatment cm to Control SEMTrial #1 Control Bt 14.034 100.0% .521 Lipase, BEMD 17.93 127.8% .395Endocellulase, BEMD 16.31 116.2% .411 Trial #2 Control Bt 15.39 100.0%.749 Lipase, BEMD 19.15 124.4% .428 Endocellulase, BEMD 17.65 114.7%.313

Example 2. Use of a Recombinant Bacillus cereus Family Member Displayingan Endoglucanase to Stimulate Plant Growth in Corn

BEMD spores expressing endoglucanase were created in an identicalfashion as described above in Example 1. Field corn was planted 3.8 cmdeep in 10 cm deep pots filled with standard loam topsoil. Spores,control and BEMD expressing endoglucanase, were diluted to aconcentration of 1×10⁴/ml in 50 ml of water and applied to each plant atplanting. A water-only control was also included. Plants were grownunder ideal light using T5 lamps, 54 watts, and exposed to 11 hours oflight a day under controlled temperature conditions between 15.5-25.5°C. Plants were watered to saturation every three days over the one weektrial. At the end of one week, the height of each plant was measured,and measurements were normalized to control Bacillus thuringiensisspores.

Results are shown in Table 18, together with the standard error of themean. Corn grown in the presence of BEMD spores displaying endoglucanasegrew significantly taller than both control B.t. spore treated soybeansand water-only control plants (statistical analysis assayed via at-test).

TABLE 18 Height, cm Comparison SEM H₂O 15.44   100% 0.318 Bt 18.92122.50% 0.645 BEMD Endo 22.71 143.40% 0.616

Example 3. Use of a Recombinant Bacillus cereus Family Member Displayingan Endoglucanase or a Protease to Stimulate Plant Growth in Wheat

BEMD spores expressing endoglucanase were created in an identicalfashion as described above in Example 1. BEMD spores expressing E. coliprotease PtrB were created using similar methods to those describedabove in Example 1 and the following primers: ggatccatgctaccaaaagcc(forward, SEQ ID NO: 41) and ggatccttagtccgcaggcgtagc (reverse, SEQ IDNO: 42).

Winter hard wheat was planted 2.54 cm deep in 10 cm deep pots filledwith standard loam topsoil. Spores, control and BEMD expressingendoglucanase or protease, were diluted to a concentration of 1×10⁴/mlin 50 ml of water and applied to each plant at planting. A water-onlycontrol was also included. Plants were grown under ideal light using T5lamps, 54 watts, and exposed to 11 hours of light a day under controlledtemperature conditions between 15.5-25.5° C. Plants were watered tosaturation every three days over the one week trial. At the end of oneweek, the height of each plant was measured, and measurements werenormalized to control water only plants.

Results are shown in Table 19, together with the standard error of themean. Wheat grown in the presence of BEMD spores displayingendoglucanase or protease grew significantly taller than control B.t.spore treated or water control soybeans (statistical analysis assayedvia a t-test).

TABLE 19 Height, cm Comparison SEM H₂O 18.11   100% 0.721 Bt Control19.96 110.33% 0.752 BEMD Endo 24.76 136.80% 0.21 BEMD 22.35 123.40%0.354 Protease

Example 4. Use of Recombinant Bacillus cereus Family Members Displayingan Endoglucanase to Stimulate Plant Growth in Ryegrass

BEMD spores expressing endoglucanase were created in an identicalfashion as described above in Example 1. Perennial ryegrass was planted6.4 mm deep in 10 cm deep pots filled with standard loam topsoil.Spores, both control and BEMD expressing endoglucanase, were diluted toa concentration of 1×10⁴/ml in 50 ml of water and applied to each plantat planting. A water-only control was also included. Plants were grownunder ideal light using T5 lamps, 54 watts, and exposed to 11 hours oflight a day under controlled temperature conditions between 15.5-25.5°C. Plants were watered to saturation every three days over the two weektrial. At the end of two weeks, the height of each plant was measured,and measurements were normalized to control water only plants.

Results are shown in Table 20, together with the standard error of themean. Ryegrass grown in the presence of BEMD spores displayingendocellulase grew significantly taller than control B.t. spore treatedor water control ryegrass (statistical analysis assayed via a t-test).

TABLE 20 Height, cm Comparison SEM H₂O 11.43 100.0% 0.137 Bt Control12.29 107.7% 0.128 BEMD 12.78 111.9% 0.137 Endo

Example 5. Use of Recombinant Bacillus cereus Family Members DisplayingEnzymes Involved in the Synthesis or Activation of Plant Hormones toStimulate Plant Growth

The BEMD system can also be used to display enzymes involved in thesynthesis of plant hormones. For example, the plant hormoneindole-3-acetic acid is a potent growth stimulator in plants.Indole-3-acetic acid is synthesized in vivo from tryptophan by theenzymes tryptophan monooxygenase and indole-3-acetamide hydrolase.Indole-3-acetic acid and other auxin hormones can also be synthesized invivo from tryptophan and/or indole by the enzymes nitrilase, tryptophanaminotransferase, indole-3-acetaldehyde dehydrogenase, indole-3-pyruvatedecarboxylase, amine oxidase, tryptophan decarboxylase, and tryptophanside chain oxidases.

The BEMD system can also be used to display enzymes involved in themodification of plant growth hormones into bioactive or inactive forms.For example, nitrilase can be expressed on the BEMD system to catalyzethe conversion of indole-3-acetonitrile into the bioactiveindole-3-acetic acid. Additionally, inactive forms of plant hormones,such as indole-3-acetonitrile can be added into the plant growth mediawith the BEMD-expressed nitrilase to provide a gradual release of activehormone into the plant growth media. Many other inactive or less activeforms of plant hormones can be modified using their correspondingenzymes.

Related plant growth hormones (auxins) include indole-3-pyruvic acid,indole-3-acetaldoxime, indole-3-acetamide, indole-3-acetonitrile,indole-3-ethanol, indole-3-pyruvate, indole-3-butyric acid, phenylaceticacids, 4-chloroindole-3-acetic acid, and indole-3-acetaldoxime. Thesehormones are synthesized from tryptophan and/or indole in vivo via theenzymes tryptophan monooxygenase, indole-3-acetamide hydrolase,nitrilase, nitrile hydrolase, acetolactate synthetase, alphaacetolactate decarboxylase, tryptophan aminotransferase,indole-3-acetaldehyde dehydrogenase, indole-3-pyruvate decarboxylase,amine oxidase, tryptophan decarboxylase, and tryptophan side chainoxidases.

Growth hormones of the cytokinin family can also be synthesized byenzymes expressed in the BEMD system. Examples of cytokinins includekinetin, zeatin (cis and trans), 6-benzylaminopurine, dihydroxyzeatin,N6-(D2-isopentenyl) adenine, ribosylzeatin, N6-(D2-isopentenyl)adenosine, 2 methylthio-cis-ribosylzeatin, cis ribosylzeatin,ribosylzeatin-5-monosphosphate, N6-methylaminopurine,N6-dimethylaminopurine, 2′-deoxyzeatin riboside,4-hydroxy-3-methyl-trans-2-butenylaminopurine, ortho-topolin,meta-topolin, benzyladenine, ortho-methyltopolin, andmeta-methyltopolin. These plant growth stimulating compounds aresynthesized in vivo from mevalonate or adenosine mono/di/triphosphate byenzymes including adenosine phosphate isopentenyltransferases,phosphatases, adenosine kinases, adenine phosphoribosyltransferase,CYP735A, 5′ribonucleotide phosphohydrolase, adenosine nucleosidases,zeatin cis-trans isomerase, zeatin O-glucosyltransferases,β-glucosidases, cis-hydroxylases, CK cis-hydroxylases, CKN-glucosyltransferases, 2,5-ribonucleotide phosphohydrolases, adenosinenucleosidases, purine nucleoside phosphorylases, and zeatin reductases.

Using methods similar to those described above in Example 1, any ofthese enzymes can be incorporated into the BEMD system for display onBEMD spores by creating a fusion construct comprising the enzyme and atargeting sequence that targets the expressed enzyme to the exosporiumwhen the fusion construct is expressed in a Bacillus cereus familymember. A recombinant Bacillus cereus family member expressing such aconstruct can then be added to the soil or other plant growth medium orapplied directly to plant foliage using methods similar to thosedescribed above in Example 1 for stimulation of plant growth.

The plant growth medium can be supplemented with precursors orsubstrates for the enzymes. For example, the plant growth medium can besupplemented with tryptophan, adenosine monophosphates, adenosinediphosphates, adenosine triphosphates, or indole. Suitableconcentrations of these substrates are between 100 nM and 100 μM.

Example 6. Use of Recombinant Bacillus cereus Family Members DisplayingProteases or Peptidases that Cleave Proteins, Peptides, Proproteins, orPreproproteins into Bioactive Peptides for Stimulation of Plant Growth

Proteases and peptidases can be expressed in the BEMD system that canenzymatically cleave available proteins in the plant growth media tobioactive peptides that can act on the plant directly or indirectly.Examples include the enzymatic cleavage of soybean meal, yeast extract,or other protein rich meals added to the plant growth medium into activepeptides that can directly stimulate plant growth. Bioactive peptidesgenerated by enzymatic cleavage of protein meals include RHPP and RKN16D10, potent stimulators of plant root development. Additionally,proproteins or preproproteins can be cleaved into active forms byBEMD-expressed proteases and peptidases to their bioactive forms.Inactive proproteins or preproproteins can be added in the plant growthmedium to facilitate their gradual cleavage by BEMD proteases and slowrelease of bioactive proteins.

Using methods similar to those described above in Example 1, any ofthese proteases and peptidases can be incorporated into the BEMD systemfor display on BEMD spores by creating a fusion construct comprising theprotease or peptidase and a targeting sequence that targets theexpressed enzyme to the exosporium when the fusion construct isexpressed in a Bacillus cereus family member. A recombinant Bacilluscereus family member expressing such a construct can then be added tosoil or other plant growth medium supplemented with soybean meal, yeastextract, or another-protein-rich meal for stimulation of plant growth.The soybean meal, yeast extract, or other protein-rich meal is suitablyadded to the plant growth medium in the form of a liquid compositioncomprising about 10 μg/L to about 100 mg/L of the protein meal, yeastextract, or other protein-rich meal.

Example 7. Use of BEMD Spores Expressing the Protease PtrB forStimulation of Plant Growth

BEMD spores expressing E. coli protease PtrB were created as describedabove in Example 3. Soybean seeds were planted 2.54 cm deep in 10 cmdeep pots filled with standard loam topsoil. Spores, both control andBEMD expressing protease, were diluted to a concentration of 1×10⁴/ml in50 ml of water and applied to each plant at planting. A water-onlycontrol was also included. Soybean meal at 25 mg/pot was added in waterat planting. Plants were grown under ideal light using T5 lamps, 54watts, and exposed to 13 hours of light a day under controlledtemperature conditions between 15.5-25.5° C. Plants were watered tosaturation every three days over the one week trial. At the end of twoweeks, the height of each plant was measured, and measurements werenormalized to control water only plants.

Results are shown in Table 21, together with the standard error of themean as a percentage of water control. Soy grown in the presence of BEMDspores displaying protease grew significantly taller than control B.t.spore treated or water control soybeans (statistical analysis assayedvia a t-test). The addition of soybean meal to water control or B.thuringiensis control plants had little effect. By contrast, in thepresence of the soybean meal and the BEMD protease system, the soybeanplants responded significantly over all other treatments.

TABLE 21 SEM, as Soybean Height Normalized percentage Treatment Meal(cm) to water of water Water only No 12.10   100% 3.1% Water only 25mg/pot 12.43 102.7% 7.4% B. thuringiensis No 12.52 103.5% 5.2% B.thuringiensis 25 mg/pot 11.99  99.1% 5.0% BEMD Protease No 12.97 107.2%6.1% BEMD Protease 25 mg/pot 14.44 119.3% 4.8%

Example 8. Use of Recombinant Bacillus cereus Family Members DisplayingProteins or Peptides Involved in the Stimulation of Plant Growth

The BEMD system can also be used to display proteins or peptides thatare directly involved in the promotion of plant growth. For example,plant peptide hormones or non-hormone peptides that stimulate plantgrowth can be expressed in the BEMD system. For example, non-hormonepeptides that directly bind to and active plant receptors can beexpressed in the BEMD system to directly act on receptors in the plantand roots of target plants. Such peptide hormones and non-hormonepeptides include phytosulfokine, calcalva 3 (CLV3), systemin, RKN 16D10,Hg-Syv46, eNOD40, NOD family proteins, ZmlGF, SCR/SP11 family proteinsand peptides, RHPP, POLARIS, and KTI. These peptides and relatedpeptides can be expressed in the BEMD system and delivered to plantgrowth medium or directly applied to foliage to stimulate plant growth.

Using methods similar to those described above in Example 1, any ofthese proteins or peptides can be incorporated into the BEMD system fordisplay on BEMD spores by creating a fusion construct comprising theenzyme and a targeting sequence that targets the expressed enzyme to theexosporium when the fusion construct is expressed in a Bacillus cereusfamily member. A recombinant Bacillus cereus family member expressingsuch a construct can then be added to the soil or other plant growthmedium or applied directly to plant foliage using methods similar tothose described above in Example 1 for stimulation of plant growth.

Example 9. Use of BEMD Spores Expressing POLARIS or KTI for Stimulationof Plant Growth

BEMD spores expressing the plant peptide POLARIS and soy peptide KTIwere created by synthesizing genes coding for the POLARIS or KITpeptides linked to the targeting sequence of SEQ ID NO: 96. The geneswere then introduced genes into Bacillus thuringiensis and spores weremade as described in Example 1. Soybean seeds were planted 2.54 cm deepin 10 cm deep pots filled with standard loam topsoil. BEMD sporesexpressing POLARIS or KTI were diluted to a concentration of 1×10⁴/ml in50 ml of water and applied to each plant at planting. A water-onlycontrol was also included. Pure POLARIS and KTI peptides were alsotested for their effects on soybeans at 0.05 mg/pot. Plants were grownunder ideal light using T5 lamps, 54 watts, and exposed to 13 hours oflight a day under controlled temperature conditions between 15.5-25.5°C. Plants were watered to saturation every three days over the two weektrial. At the end of two weeks, the height of each plant was measured,the roots measured, and measurements were normalized to control wateronly plants.

Results are shown in Table 22, together with the standard error of themean as a percentage of water control. Soy grown in the presence of BEMDspores displaying POLARIS grew taller and had a slight increase in rootdevelopment than water control soybeans. The presence of free KTIpeptide led to a significant stunting of the plants, losing between 6-8%of their heights, but adding 15% to the length of the roots. Expressionof KTI on the BEMD system led to the root growth benefit, but withoutthe stunting effect on the plant height. Importantly, the presence ofthe Bacillus thuringiensis control spores with the free KTI peptide didnot prevent the stunting effect of KTI, while the BEMD with KTIdisplayed no such stunting.

TABLE 22 Roots Height, Normalized Normalized Treatment Peptide to WaterSEM to Water SEM Water No 100% 6.8%  100% 4.3% Water KTI, 0.05 115% 8.4%91.8% 3.1% mg/Pot BEMD No 106.3%   7.9% 107.3%  1.7% POLARIS BEMD KTI No113.3%   5.8% 99.4% 3.4% B. thuringiensis KTI, 0.05 115% 7.7% 93.4% 4.2%mg/pot

Example 10. Use of Recombinant Bacillus cereus Family Members DisplayingEnzymes that Degrade or Modify a Bacterial, Fungal, or Plant NutrientSource to Stimulate Plant Growth and/or Process Nutrients

The BEMD system can also be used to display enzymes that degrade ormodify beneficially a bacterial, fungal, or plant nutrient sourcepresent in soil or another plant growth medium. Such enzymes degradeproducts present in the soil or other plant growth medium into formsthat can easily be taken up by plants and/or the beneficial bacteriaand/or fungi of the rhizosphere. Such enzymes include, for example,glucoside hydrolases to degrade complex carbohydrates, cellulases todegrade cellulose; lipases to degrade lipids, including oil, fats, andwaxes; lignin oxidases to degrade lignin and humic acids; proteases todegrade polypeptides; phospholipases to degrade membranes; amidases andnitrogenases to recover nitrogen; amylases to process starches;nucleases to recover nucleotides, pectinases to break down pectin,sulfatases to recover sulfur, and xylanases to break down xylans andarabinoxylans. The resultant products, including simple sugars, aminoacids, fatty acids, and other nutrients will be readily available fordirect uptake by plants and/or for stimulating beneficial bacteriaand/or fungi to grow and thrive in the rhizospheres of the plants.

In addition, enzymes and other biological molecules can be utilized torelease or sequester phosphate, nitrogen, and other key elementalnutrients for plant uptake from their various organic and inorganicforms in soil. For example, phosphatases can be used to degradephosphates in the environment into usable inorganic phosphates for plantuse. The phosphates can be naturally occurring phosphates present in aplant growth medium. Alternatively or in addition, the plant growthmedium can be supplemented with phosphates such as trimetaphosphate, acommon agricultural amendment. Examples of useful phosphatases includephosphoric monoester hydrolases, phosphomonoesterases, phosphoricdiester hydrolases, phosphodiesterases, triphosphoric monoesterhydrolases, phosphoryl anhydride hydrolases, pyrophosphatases, phytase,trimetaphosphatases, and triphosphatases. For example, the enzymestrimetaphosphatase, triphosphatase, and pyrophosphatase sequentiallybreak down trimetaphosphate into usable inorganic phosphate.

The nitrogenase family of enzymes converts atmospheric nitrogen (N₂)into ammonia, thereby converting nitrogen that would otherwise beinaccessible to plants into a usable form. Suitable enzymes belong tothe Nif family of nitrogenases.

Chemical energy can also be directly added into the plant growth mediumas adenosine-3-triphosphate, ferrodoxin, or additional enzymes thatcreate such energy into the BEMD system. These are cofactors for thenitrogenases and are limited in soil. Thus, such cofactors can be addedto soil to enhance the reactions described above.

Other supplements that can be added to the plant growth medium includestarches, cellulose and cellulose derivatives, pectins, xylans andarabinoxylans, fats, waxes, oils, phytic acids, lignins, humic acids,and other nutrient sources that the above enzyme classes exert activityupon.

Using methods similar to those described above in Example 1, any ofthese enzymes can be incorporated into the BEMD system for display onBEMD spores by creating a fusion construct comprising the enzyme and atargeting sequence for targeting the fusion construct to the exosporiumof a Bacillus cereus family member. The fusion construct can then beexpressed in a Bacillus cereus family member, and this recombinantBacillus cereus family member can be added to soil or another plantgrowth medium using methods similar to those described above in Example1 for stimulation of plant growth.

Example 11. Use of BEMD Spores Expressing a Phosphatase for Stimulationof Plant Growth

BEMD spores expressing Bacillus subtilis Phosphatase A4 (PhoA4) werecreated by synthesizing a gene coding for PhoA4 linked to the targetingsequence of SEQ ID NO: 96. This gene was then introduced into Bacillusthuringiensis and spores were made as in Example 1. Corn was planted2.54 cm deep in 10 cm deep pots filled with standard loam topsoil. BEMDspores expressing PhoA4, were diluted to a concentration of 1×10⁴/ml in50 ml of water and applied to each plant at planting. A water-onlycontrol was also included. Polyphosphate was added to pots in liquid ata rate of 0.5 mg/pot. Plants were grown under ideal light using T5lamps, 54 watts, and exposed to 13 hours of light a day under controlledtemperature conditions between 15.5-25.5° C. Plants were watered tosaturation every three days over the two week trial. At the end of twoweeks, the height of each plant was measured, and measurements werenormalized to control water only plants.

Results are shown in Table 23. Corn grown in the presence of BEMD sporesdisplaying PhoA4 exhibit enhanced growth, especially in the presence ofadded polyphosphate. This effect was greater than the effect of thepolyphosphate alone.

TABLE 23 Growth, Comparison Treatment Additive to Water Water None  100% Water Polyphosphate 110.8% BEMD PhoA4 None 108.3% BEMD PhoA4Polyphosphate 114.8%

Example 12. Use of Recombinant Bacillus cereus Family Members DisplayingEnzymes Involved in the Synthesis of 2,3-Butanediol or the Synthesis orActivation of Gibberellic Acid for Stimulation of Plant Growth

The BEMD system can also be used display enzymes involved in thesynthesis of the plant-growth promoting compound 2,3-butanediol. Invivo, 2,3-butanediol is synthesized by beneficial bacteria and fungi inthe rhizosphere from acetoin, diacetyl, acetolactate, or pyruvate by theenzymes acetolactate synthetase, α-acetolactate decarboxylase, pyruvatedecarboxylase, diacetyl reductase, butanediol dehydrogenases, andacetoin reductase.

The BEMD system can also be used to display enzymes involved in thesynthesis or activation of the plant-growth promoting compoundgibberellic acid. Gibberellic acid can be produced from inactive or lessactive forms via the action of enzymes, including but not limited tohydroxylamine reductases, 2-oxogluturate dioxygenases, gibberellin 2B/3Bhydrolases, gibberellin 3-oxidases, and gibberellin 20-oxidases.

Any of these enzymes can be incorporated into the BEMD system fordisplay on BEMD spores using methods similar to those described above inExample 1. A fusion construct can be prepared that comprises the enzymeand a targeting sequence that targets the enzyme to the exosporium whenthe fusion construct is expressed in a Bacillus cereus family member.The fusion construct is then expressed in a Bacillus cereus familymember, and the Bacillus cereus family member is added to soil oranother plant growth medium for stimulation of plant growth.

To increase the effect of the enzymes displayed on BEMD, the soil can besupplemented with substrates for the enzymes. For example, the soil orother plant growth medium can be supplemented with acetoin, which is asubstrate for acetoin reductase; pyruvate, which is a substrate forpyruvate decarboxylase; diacetyl, which is a substrate for diacetylreductase; and/or acetolactate, which is a substrate for acetolactatedecarboxylase. Alternatively or in addition, the soil or other plantgrowth medium can be supplemented with less potent or inactive forms ofgibberellic acid, which will converted into more active forms by theenzymes described above in the soil or other plant growth medium.

Example 13. Use of Recombinant Bacillus cereus Family Members DisplayingProteases for Protecting Plants from Pathogens

The BEMD system can also be used display proteases that protect plantsfrom one or more pathogens. For example, certain bacterial pathogens cancommunicate between individual members via secretion of bacteriallactone homoserines or related signaling molecules. Thus, proteasesspecific for bacterial lactone homoserine signaling molecules canprotect plants from such bacterial pathogens by disrupting communicationbetween bacteria, a step essential for the bacteria to secrete toxinsand upregulate virulence factors. Suitable proteases specific forbacterial lactone homoserine signaling molecules include endopeptidasesand exopeptidases.

Proteases specific for bacterial lactone homoserine signaling moleculescan be incorporated into the BEMD system using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the protease and a targeting sequence that targets theprotease to the exosporium when the fusion construct is expressed in aBacillus cereus family member. The fusion construct is then expressed ina Bacillus cereus family member, and the Bacillus cereus family memberis added to soil or another plant growth medium. The protease can thendegrade the bacterial lactone homoserine signaling molecules, blocking akey step in the virulence of these organisms and thereby helping toprotect the plant from these pathogens. Other proteases and peptidaseswork effectively in this capacity on the BEMD system as demonstratedabove in Example 6 and 7.

Example 14. Use of Recombinant Bacillus cereus Family Members DisplayingAntimicrobial Proteins and Peptides for Protecting Plants from Pathogens

The BEMD system can also be used display enzymes that exhibitantibacterial and/or antifungal activities that can help protect plantsfrom one or more pathogens. For example, antimicrobial proteins andpeptides such as bacteriocins, lysozymes (e.g., LysM), siderophores,avidins, streptavidins, conalbumin, albumin, lactoferrins (e.g.,LfcinB), or TasA can all be expressed in the BEMD system to exert theireffect on bacterial and fungal pathogens of plants. Bacteriocins,albumin, conalbumin, lysozymes, and lactoferrin exert directantimicrobial action on their targets, whereas siderophores, avidins,and streptavidins bind essential nutrients that pathogens require forvirulence. For example, the peptide LfcinB of lactoferrin, whenexpressed on the surface of the BEMD system would lyse bacteria cellsthat are susceptible to the lactoferrin peptides in the plant growthmedium. These proteins and peptides have specific action on selectmicrobes, and can selectively target a group of pathogens withoutobstructing all microbes in the plant growth medium.

Any of these proteins or peptides can be incorporated into the BEMDsystem for display on BEMD spores using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the enzyme and a targeting sequence that targets the enzyme tothe exosporium when the fusion construct is expressed in a Bacilluscereus family member. The fusion construct is then expressed in aBacillus cereus family member, and the Bacillus cereus family member isadded to soil or another plant growth medium for protection of plantsfrom one or more pathogens.

Example 15. Use of BEMD Spores Expressing Antimicrobial Peptides forProtecting Plants from Bacteria

Genes were synthesized that coded for either of two antimicrobialpeptides, LfcinB (derived from bovine lactoferrin) and LysM (derivedfrom chicken lysozyme), linked to a BclA targeting sequence (SEQ ID NO:96), under the control of the BclA promoter (SEQ ID NO: 215). The geneswere introduced into Bacillus thuringiensis BT013A and spores were madeby growing an overnight culture of the transformed Bacillus in brainheart infusion broth, plating onto nutrient agar plates at 30° C. andallowing to grow for 3 days. Spores were washed off the plates andrinsed 3× in PBS. Staphylococcus epidermidis cultures were grownovernight in TSB broth at 37° C. The overnight culture was thenpelleted, washed in PBS, and resuspended in PBS at an Abs595=0.2. 1×10⁴BEMD expressing the LysM or LfcinB peptides was incubated in the PBSwith the S. epidermidis for 3 hours at 37° C., with shaking A controlsample of S. epidermidis was left untreated (no BEMD spores). After the3 hour incubation, dilution plates of the S. epidermidis were made andincubated at 37° C. overnight. S. epidermidis cultures were counted thenext day, and percent killing quantified. In Table 24 below, a record ofthe killing activity was recorded. The BEMD expressed peptides killed asignificant number of S. epidermidis cells. This would directlytranslate into killing of bacteria on the rhizosphere, seed, or otherplant material. The selection of peptides specific to certain classes ofbacteria can also skew the population of the microorganisms near theplant in a beneficial way, or can selectively target key pathogens.

TABLE 24 Treatment Survival % Killed None 100%   0% BEMD LysM 71% 29%BEMD LfcinB 23% 77%

Example 16. Use of Recombinant Bacillus cereus Family Members DisplayingEnzymes for Protecting Plants from Pathogens

The BEMD system can also be used display enzymes that protect plantsfrom one or more pathogens. For example, yeast and mold cell walls aredegraded by enzymes such as β-1,3-glucanases, β-1,4-glucanases,β-1,6-glucanases, chitosanases, chitinases, chitosanase-like proteins,and lyticases. Bacteria cell walls are degraded by enzymes selected fromproteinases, proteases, mutanolysin, stapholysin, and lysozymes. Each ofthese cell wall degrading enzymes can be expressed on the BEMD systemand added to plant growth medium for selective inhibition of pathogenicmicrobes in the rhizosphere.

The BEMD system can also be used to display enzymes or proteins thatprotect plants from insect or worm pathogens, for example by suppressinginsect and/or worm predation of desired plants. Examples of suchproteins and enzymes of interest include endotoxins, Cry toxins, otherinsecticidal protein toxins, protease inhibitors, cysteine proteases,the Cry5B protein, the Cry 21A protein, chitinase, protease inhibitorproteins, protease inhibitor peptides, trypsin inhibitors, and arrowheadprotease inhibitors.

Any of these proteins or peptides can be incorporated into the BEMDsystem for display on BEMD spores using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the enzyme and a targeting sequence that targets the enzyme tothe exosporium when the fusion construct is expressed in a Bacilluscereus family member. The fusion construct is then expressed in aBacillus cereus family member, and the Bacillus cereus family member isadded to soil or another plant growth medium for protection of plantsfrom pathogens.

Example 17. Use of BEMD Spores Expressing an Antifungal Enzyme forProtecting Plants, and Demonstration of Efficacy Against Saccharomyces

A gene was synthesized that encoded an antifungal enzyme,β-1,3-glucanase from Bacillus subtilis, linked to a BclA targetingsequence (SEQ ID NO: 96) under the control of the BclA promoter (SEQ IDNO: 215). The gene was and introduced into Bacillus thuringiensis BT013Aand pores were made by growing an overnight culture of the transformedBacillus in brain heart infusion broth, plating onto nutrient agarplates at 30° C., and allowing to grow for 3 days. Spores were washedoff the plates and rinsed 3× in PBS. Saccharomyces cerevisiae cultureswere grown overnight in YZ broth at 37° C. The overnight culture wasthen pelleted, washed in PBS, and resuspended in PBS at an Abs595=0.2.1×10⁴ BEMD expressing β-1,3-glucanase was incubated in the PBS with theSaccharomyces for 1 hour at 37° C., with shaking A control sample ofSaccharomyces was left untreated (no BEMD spores). After the 3 hourincubation, dilution plates of the Saccharomyces were made and incubatedat 37° C. overnight. Saccharomyces cultures were counted the next day,and percent killing quantified. In Table 25 below shows the killingactivity of the BEMD spores expressing β-1,3-glucanase. TheBEMD-expressed enzyme killed a significant number of Saccharomycescells. This would directly translate into killing of fungalmicroorganisms on the rhizosphere, seed, or other plant material. Theselection of proteins specific to certain classes of fungi can also skewthe population of the microorganisms near the plant in a beneficial way,or can selectively target key fungal pathogens.

TABLE 25 Treatment Survival % Killed None 100%  0% BEMD β-1,3-glucanase 83% 17%

Example 18. Use of Recombinant Bacillus cereus Family Members DisplayingPlant Immune System Stimulatory Peptides or Proteins for ProtectingPlants from Pathogens

The BEMD system can also be used display plant immune system enhancerpeptides and proteins. These proteins can be expressed on the outside ofthe BEMD spore and delivered into the plant growth medium to stimulatethe plant immune system to allow the plant to protect itself from plantpathogens. Example proteins and peptides include harpin, α-elastins,β-elastins, systemins, phenylalanine ammonia-lyase, elicitins,defensins, cryptogein, and flagellin proteins and peptides. Exposure ofplants to these proteins and peptides will stimulate resistance to manyplant pathogens in plants.

Any of these proteins or peptides can be incorporated into the BEMDsystem for display on BEMD spores using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the enzyme and a targeting sequence that targets the enzyme tothe exosporium when the fusion construct is expressed in a Bacilluscereus family member. The fusion construct is then expressed in aBacillus cereus family member, and the Bacillus cereus family member isadded to soil or another plant growth medium for protection of plantsfrom pathogens.

Example 19. Use of Recombinant Bacillus cereus Family Members Displayinga Root or Leaf Binding Protein or Peptide to Immobilize the RecombinantBacillus cereus Family Member on a Root System of a Plant or on PlantLeaves

Root and leaf binding proteins and peptides can also be incorporatedinto the BEMD system to allow the BEMD spores to be immobilized on aroot system or on leaves of a plant. Display of such root or leafbinding ligands on the BEMD spores allows for targeting of the spores tothe root system of a plant or to substructures of the root system or tothe leaves or to substructures of leaves to maintain the BEMD spores atan optimal location for other displayed biological molecules and enzymesto be effective.

For example, rhicadhesin is a root binding ligand that binds to roothairs. Thus, display of rhicadhesin on the BEMD spores thus targets thespores to root hairs. Additional proteins that could be utilized forselective binding to plant roots or leaves include adhesins, flagellin,omptins, lectins, pili proteins, curlus proteins, intimins, invasins,agglutinin, afimbrial proteins, TasA, or YuaB.

Such root or leaf binding proteins and peptides can be incorporated intothe BEMD system using methods similar to those described above inExample 1. A fusion construct can be prepared that comprises the root orleaf binding protein or peptide and a targeting sequence that targetsthe protein or peptide to the exosporium when the construct is expressedin a Bacillus cereus family member. The fusion construct containing theroot or leaf binding ligand is then expressed in a Bacillus cereusfamily member. Such fusion constructs can be coexpressed with one ormore additional fusion constructs comprising any of the beneficialenzymes discussed herein (e.g., an enzyme involved in the synthesis of aplant hormone, an enzyme that degrades a nutrient source, or a proteasesthat protects a plant from a pathogen). The recombinant Bacillus cereusfamily member is added to soil or another plant growth medium, orapplied to the leaves of a plant. The root or leaf binding ligandtargets the Bacillus cereus family member to the root system of theplant or to the leaves of the plant and immobilizes it there, thusallowing the coexpressed fusion construct to exert its effects in closeproximity to the root or leaf system.

Example 20. Use of Recombinant Bacillus cereus Family Members DisplayingProteins or Enzymes to Enhance Stress Resistance of Plants

Proteins, peptides, and enzymes that enhance stress resistance in aplant can be incorporated into the BEMD system and delivered to targetplants via addition to roots, leaves, or the plant growth medium. Duringperiods of stress, plants release stress-related compounds, includingaminocyclopropane-1-carboxlic acid (ACC), reactive oxygen species, andothers, resulting in a negative impact on plant growth. The BEMD systemcan be used to display enzymes that degrade such stress-relatedcompounds, such as aminocyclopropane-1-carboxylic acid deaminase,superoxide dismutases, oxidases, catalases, and other enzymes that acton reactive oxygen species. Such enzymes reduce the amount of thesestress-related compounds and allow plants to continue to grow and eventhrive under stressed conditions.

Any of these proteins or peptides can be incorporated into the BEMDsystem for display on BEMD spores using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the enzyme and a targeting sequence that targets the enzyme tothe exosporium when the fusion construct is expressed in a Bacilluscereus family member. The fusion construct is then expressed in aBacillus cereus family member, and the Bacillus cereus family member isadded to soil or to another plant growth medium or applied to the leavesof a plant for enhancing the stress resistance of a target plant.

Example 21. Preparation of BEMD Spores Expressing the Protective EnzymeCatalase

A gene was synthesized that encoded the protective enzyme catalase fromBacillus cereus linked to a BetA targeting sequence (SEQ ID NO: 97)under the control of the BetA promoter (SEQ ID NO: 197). This gene wasand introduced into Bacillus thuringiensis BT013A. Spores were made bygrowing an overnight culture of the transformed Bacillus and wildtypestrain in brain heart infusion broth, plating onto nutrient agar platesat 30° C., and allowing to grow for 3 days. Spores were washed off theplates and rinsed 3× in PBS. 3 drops of hydrogen peroxide was added toeach spore pellet. The enzyme catalase converts the hydrogen peroxideinto water and O₂ gas. The control spores did not bubble, while theBEMD-catalase spores readily did, demonstrating enzyme activity on thesurface of the spores. Other protective enzymes can be displayed in asimilar fashion and delivered to the plant to act upon free radicalsproduced during stress by the plants.

Example 22. Use of Recombinant Bacillus cereus Family Members DisplayingProteins or Enzymes that Protect Seeds or Plants from an EnvironmentalStress

Proteins, peptides, and enzymes that protect a plant from anenvironmental stress can be incorporated into the BEMD system anddelivered to target plants via addition to roots, leaves, fruit, or theplant growth medium. During periods of freezing, plants can be damagedby the effect of ice. The BEMD system can be used to display peptides,proteins, or enzymes that protect plants from such effects. For example,the BEMD system can be used to display choline dehydrogenases, which actby producing protective products that protect the plant or seed fromfrost. Substrates for these enzymes (e.g., choline and/or cholinederivatives) can also be added to the plant growth medium. Addition ofsuch substrates can enhance the amount of protectant (betaine andrelated chemistries) produced in the plant environment by the BEMDexpressed enzymes. Betaine derivatives are known to protect seeds fromcold stress.

Any of these proteins or peptides can be incorporated into the BEMDsystem for display on BEMD spores using methods similar to thosedescribed above in Example 1. A fusion construct can be prepared thatcomprises the enzyme and a targeting sequence that targets the enzyme tothe exosporium when the fusion construct is expressed in a Bacilluscereus family member. The fusion construct is then expressed in aBacillus cereus family member, and the Bacillus cereus family member isadded to soil or to another plant growth medium or applied to the leavesof a plant for protecting the plant from environmental stresses andfactors.

Example 23. Enhanced Expression of Fusion Constructs on the BEMD Systemby Use of Enhanced or Alternative Promoter Elements

The BEMD system can display a wide range of proteins, peptides, andenzymes using one or more of the targeting sequences described herein.Some of these targeting sequences have a high affinity for theexosporium which would be beneficial for fusion protein expression, buttheir low fusion protein expression level limits their use on the BEMDsystem. For such fusion proteins and sequences, alternativehigh-expression sporulation promoters can be used instead of the nativepromoters.

For example, SEQ ID NO: 13 (amino acids 1-39 of B. weihenstephensisKBAB4 gene 3572) provides a very effective N-terminal sequence for thedelivery of proteins to the exosporium of Bacillus cereus familymembers, as shown in Table 26 below. All genes were synthesized in theircomplete form (including promoter regions and regions coding for fusionproteins) as described herein. When the native promoter elements for B.weihenstephensis KBAB4 gene 3572 (SEQ ID NO: 217) were used to express afusion protein comprising the targeting sequence of SEQ ID NO: 13 fusedto a β-galactosidase enzyme (from E. coli), a low level of fusionprotein was expressed, leading to a reduction in enzyme activity on thesurface of the spore. Enzyme activity was measure by the conversion of0.5M o-nitrophenylgalactoside in solution over 10 minutes. Enzymeconversion was measured with a spectrophotometer at ABS₅₄₀. Replacementof the native promoter elements of the B. weihenstephensis KBAB4 gene3572 with the high-expression promoters of SEQ ID NO: 197 (B. anthracisBetA/BAS3290) or SEQ ID NO: 218 (B. weihenstephensis KBAB4 YVTNβ-propeller protein) led to a dramatic increase in the enzymaticactivity of the spores. On the other hand, replacement of the nativepromoter elements for B. weihenstephensis KBAB4 gene 3572 with thepromoter native to B. anthracis Sterne BAS1882 (SEQ ID NO: 216) led to adecrease in the enzymatic activity of the spores. The expression levelof the targeting sequence of SEQ ID NO: 13 fused to β-galactosidase wasmuch lower (0.38×) when driven by the promoter of BAS1882 (SEQ ID NO:216), and was greatly improved when driven from the BetA promoter (SEQID NO: 197) or YVTN protein promoter (SEQ ID NO: 218).

TABLE 26 β-galactosidase activity on BEMD system, Promoter FusionProtein normalized Fold Change SEQ ID NO: 217 SEQ ID NO: 13-   100%β-galactosidase SEQ ID NO: 197 SEQ ID NO: 13- 213.4% 2.13Xβ-galactosidase SEQ ID NO: 218 SEQ ID NO: 13- 220.7% 2.21Xβ-galactosidase SEQ NO: ID 216 SEQ ID NO: 13-  38.1% 0.38Xβ-galactosidase

Example 24. Isolation and Identification of Plant-Growth PromotingBacterial Strains

Soil samples from rhizospheres of the healthiest and most resistantpotato (Solanum tuberosum), yellow summer squash (Cucurbita pepo),tomato (Solanum lycopersicum), and pole bean (Phaseolus coccineus)plants were collected, diluted in sterile water, and spread ontonutrient agar plates. Bacterial isolates that demonstrated high growthrates and were able to be passaged and propagated were selected forfurther study. The selected strains were grown in minimal media (KH₂PO₄3 g, Na₂HPO₄ 6 g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O0.013 g, and glucose 1 g, per L dry weight). Overnight cultures (30° C.)of selected strains were spun down, media decanted off, and resuspendedin an equal amount of distilled water. Ten lettuce seeds per treatmentwere planted at a depth of 1 cm in loam top soil (Columbia, Mo.) thatwas sieved to remove large debris. Seeds were inoculated at planting in4 cm pots with 0.5 μl of resuspended bacteria in water mixed into 10 mlof H₂O. Ten ml of H₂O was sufficient to deliver the bacteria into the 3in³ (7.62 cm³) of soil as well as saturate the soil for propergermination of seeds. Plants were grown at temperatures between 65-75°F. (18-24° C.) with 11 hours of light/day, and 5 ml of watering every 3days. After one week, plant heights and leaf diameters, as well asoverall health of the plants were collected. Initial screening ofrhizosphere isolates resulted in obtaining greater than 200 distinctspecies of bacteria and fungi from the rhizosphere of the four plants.Some of the bacterial species are described in Table 27. Identifiedstrains are indicated by their proper bacterial identifications. Otherstrains are indicated by their unknown identification number. Inoculantsgiving results near control (+/−2%) were not included in the table.

TABLE 27 Butterhead Lettuce Bacterial Inoculant Avg. Height (cm)Comparison SEM Uninoculated 1.8 Control .07 Paracoccus kondratiavae 2111.1% .05 NC35 B. aryabhattai CAP53 3.65 202.8% .45 B. flexus BT0542.45 136.1% .11 Bacillus mycoides strain 2.17 120.4% .21 BT155 B.aryabhattai CAP56 2.1 116.7% .20 B. nealsonii BOBA57 2.8 155.6% .03 E.cloacae CAP12 2.4 133.3% .41 Unknown 8 1.77  77.8% .65 Unknown 122 1.9105.6% .11 Unknown 15 1.4  77.8% .41 Unknown 39 1.8 100.0% .20 Unknown401 2 111.1% .21 Unknown 402 1.53  85.2% .27 Unknown 41 1.45  80.6% .31Unknown 42 1.4  77.8% .15 Unknown 44 2.2 133.3% .08 Unknown 51 1.83102.9% .21

Bacterial strains that produced the greatest effect on the overall planthealth and plant height in the initial lettuce trial were subjected tofurther identification. Bacterial strains were grown overnight in LuriaBertani broth at 37° C., and overnight cultures were spun down in acentrifuge. Media was decanted and the remaining bacterial pellet wassubjected to chromosomal DNA isolation using the Qiagen BacterialChromosomal DNA Isolation kit. Chromosomal DNA was subjected to PCRamplification of the 16S rRNA coding regions using the primers E338F5′-ACT CCT ACG GGA GGC AGC AGT-3′ (SEQ ID NO: 298), E1099R A 5′-GGG TTGCGC TCG TTG C-3′ (SEQ ID NO: 299), and E1099R B 5′-GGG TTG CGC TCG TTAC-3′ (SEQ ID NO: 300). PCR amplicons were purified using a Promega PCRpurification kit, and the resultant amplicons were diluted and sent tothe University of Missouri DNA Core for DNA sequencing. DNA sequenceswere compared to the NCBI BLAST database of bacterial isolates, andgenus and species were identified by direct comparison to known strains.Top identified species are indicated in Table 27. In many cases, 16SrRNA DNA sequences were only able to delineate the genus of the selectedbacterial strain. In cases where a direct identification was notforthcoming, additional biochemistry analyses, using methods standard inthe field, were performed to differentiate strains at the species andstrain levels, and are listed in Table 28.

TABLE 28 E. cloacae P. kondratiavae B. aryabhattai B. flexus B. mycoidesB. aryabhattai B. nealsoni Test CAP12 NC35 CAP53 BT054 BT155 CAP56BOBA57 Urease − − − − − − + Catalase + + + + + + + Oxidase − + + + − − −Nitrate + + − + + − + Growth, 5% NaCl + − + + − + + Growth, 7.5% NaCl −− + + − + − Growth, 42° C. + + + + + + + Growth, 50° C. − − + + − + −Growth, pH 5 + − + + − + − Growth, pH 9 + + + + + + + Acid, Cellobiose +− + + + + − Acid, Lactose + − + + + − + Acid, Starch − − − + − + −

Example 25. Isolation and Identification of Additional Plant-GrowthPromoting Bacterial Strains

Soil samples from agricultural fields near Gas, Kans. were collected,diluted in sterile water, and spread onto nutrient agar plates.Bacterial isolates that demonstrated high growth rates and were able tobe passaged and propagated were selected for further study. The selectedstrains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6 g, NH₄Cl 1 g,NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, and glucose 1 g, perL dry weight). Overnight cultures (30° C.) of selected strains were spundown, media decanted off, and resuspended in an equal amount ofdistilled water. Corn seeds were coated with commercial seed polymermixed with water alone (1.6 μl per seed total) or commercial seedpolymer containing selected bacterial strains (1.6 μl per seed total).Coated seeds were planted in (3 inch) 7.62 cm diameter pots at a depthof 1 inch (2.54 cm) in loam top soil (Columbia, Mo.) that was sieved toremove large debris. Plants were grown at temperatures between 18-24° C.(65-75° F.) with 11 hours of light/day, and 50 ml of watering atplanting and every 3 days. After two weeks, plant heights and leafdiameters, as well as overall health of the plants were collected. Forgermination assays and determining 3 day root length, seeds were coatedas indicated above and evenly dispersed at 10 seeds per paper towel. Thepaper towels were wetted with 10 mls of water, rolled up, placed in asmall plastic bag and incubated at 30° C. or placed on a germinationheat mat at 27-30° C. (80-85° F.). Root measurements were recorded after3 days. Initial screening of rhizosphere isolates resulted in obtaininggreater than 100 distinct species of bacteria and fungi from therhizosphere. Some of the bacterial species are described in Table 29.Identified strains are indicated by their proper bacterialidentifications.

TABLE 29 Corn Seed Treatments Avg. Height Avg. Root Length (2 weeks) (3days) normalized to normalized to polymer control polymer controlBacterial Inoculant (%) (%) Polymer control 100 100 B. mycoides EE118111.1 189.1 B. subtilis EE148 99.4 172.8 Alcaligenes faecalis EE107111.5 129.2 B. mycoides EE141 109.2 143.5 B. mycoides BT46-3 105.6 141.3B. cereus family member EE128 105.6 — B. thuringiensis BT013A 101.8103.8 Paenibacillus massiliensis BT23 104.2 139.4 B. cereus familymember EE349 105.2 — B. subtilis EE218 106.6 — B. megaterium EE281 107.8—

Bacterial strains that produced the greatest effect on plant health aredescribed in Table 29. Bacterial strains were grown overnight in LuriaBertani broth at 37° C., and overnight cultures were spun down in acentrifuge. Media was decanted and the remaining bacterial pellet wassubjected to chromosomal DNA isolation using the Qiagen BacterialChromosomal DNA Isolation kit. Chromosomal DNA was subjected to PCRamplification of the 16S rRNA coding regions using the primers E338F5′-ACT CCT ACG GGA GGC AGC AGT-3′ (SEQ ID NO: 298), E1099R A 5′-GGG TTGCGC TCG TTG C-3′ (SEQ ID NO: 299), and E1099R B 5′-GGG TTG CGC TCG TTAC-3′ (SEQ ID NO: 300). PCR amplicons were purified using a Promega PCRpurification kit, and the resultant amplicons were diluted and sent tothe University of Missouri DNA Core for DNA sequencing. DNA sequenceswere compared to the NCBI BLAST database of bacterial isolates, andgenus and species were identified by direct comparison to known strains.Top identified species are indicated in Table 16. In many cases, 16SrRNA DNA sequences were only able to delineate the genus of the selectedbacterial strain. In cases where a direct identification was notforthcoming, additional biochemistry analyses, using methods standard inthe field, were performed to differentiate strains at the species andstrain levels, and the differentiated strains are listed in Table 30.

TABLE 30 B. cereus B. cereus B. family B. B. B. Paenibacillus B.Alcaligenes B. family B. thuringiensis member subtilis subtilismegaterium massiliensis mycoides faecalis mycoides member mycoides TestBT013A EE349 EE148 EE218 EE281 BT23 BT46-3 EE107 EE118 EE128 EE141Motility + + + + + + − + − − − Rhizoid − − − − − + + − + − + ColonyCatalase + + + + + + + + + + + Oxidase + − − − − − − + − − − Nitrate + +wk − − − + + + + + Growth, + wk − + + − + + − + − 5% NaCl Growth, Wk −− + + − − − − − − 7.5% NaCl Growth, − + + + + + + + − + − 42° C. Growth,− − − − − − − − − − − 50° C. Growth, Wk − + + + − wk + − + − pH 5Growth, + + − + + − wk + + + − pH 9 Acid, − − wk + − + + wk + − wkCellobiose Acid, − + + + + − + + − + wk Lactose Acid, − + − + + − +wk + + − Starch wk = weak growth or low growth

Example 26. Testing of Plant-Growth Promoting Bacterial Strains onAlfalfa

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight). Overnight cultures (30° C.) of selectedstrains were spun down, media decanted off, and bacteria resuspended inan equal amount of distilled water. Ten Zeba-coated alfalfa seeds wereplanted for each treatment at a depth of 0.6 cm in loam top soil(Columbia, Mo.) that was sieved to remove large debris. Seeds wereinoculated at planting with 0.5 μl of resuspended bacteria in watermixed into 10 ml of H₂O. Ten ml of H₂O was sufficient to deliver thebacteria into the 3 in³ (7.62 cm³) of soil as well as saturate the soilfor proper germination of seeds. Plants were grown at temperaturesbetween 65-75° F. (18-24° C.) with 11 hours of light/day, and 5 ml ofwatering every 3 days. Alfalfa was allowed to grow for 1 week to analyzeemergence and initial outgrowth of plants under described conditions.Identified strains indicated by their proper bacterial identificationsand final height data are listed in Table 31.

TABLE 31 Alfalfa Avg. Height Bacterial Inoculant (cm) Comparison SEMUninoculated 4.82 — .008 B. aryabhattai CAP56 4.85 101.20% .016 B.nealsonii BOBA57 4.86 101.70% .021 E. cloacae CAP12 5.6 116.23% .020

Example 27. Testing of Plant-Growth Promoting Bacterial Strains onCucumbers

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight). Overnight cultures (30° C.) of selectedstrains were spun down, media decanted off, and resuspended in equalamount of distilled water. Ten cucumber seeds were planted for eachtreatment at a depth of 1 cm in loam top soil (Columbia, Mo.) that wassieved to remove large debris. Seeds were inoculated at planting with0.5 μl of resuspended bacteria in water mixed into 10 ml of H₂O. Ten mlof H₂O was sufficient to deliver the bacteria into the 3 in³ (7.62 cm³)of soil as well as saturate the soil for proper germination of seeds.Plants were grown at temperatures between 65-75° F. (18-24° C.) with 11hours of light/day, and 5 ml of watering every 3 days. Cucumbers wereallowed to grow for 2 weeks to analyze emergence and initial outgrowthof plants under described conditions. Identified strains indicated bytheir proper bacterial identifications and final height data are listedin Table 32.

TABLE 32 Cucumbers Bacterial Inoculant Avg. Height (cm) Comparison SEMUninoculated 11.23 — .067 B. aryabhattai CAP53 11.5 102.00% .023 B.aryabhattai CAP56 11.35 101.20% .035 B. nealsonii BOBA57 11.33 101.10%.014

Example 28. Testing of Plant-Growth Promoting Bacterial Strains onYellow Squash

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight). Overnight cultures (30° C.) of selectedstrains were spun down, media decanted off, and resuspended in an equalamount of distilled water. Ten yellow squash seeds were planted for eachtreatment at a depth of 1 cm in loam top soil (Columbia, Mo.) that wassieved to remove large debris. Seeds were inoculated at planting with0.5 μl of resuspended bacteria in water mixed into 10 ml of H₂O. Ten mlof H₂O was sufficient to deliver the bacteria into the 3 in³ (7.62 cm³)of soil as well as saturate the soil for proper germination of seeds.Plants were grown at temperatures between 65-75° F. (18-24° C.) with 11hours of light/day, and 5 ml of watering every 3 days. Squash wasallowed to grow for 2 weeks to analyze emergence and initial outgrowthof plants under described conditions. Identified strains indicated bytheir proper bacterial identifications, final height data, and finalleaf diameter (by span of the two leaves) data are listed in Table 33.

TABLE 33 Avg. Yellow Leaf Bacterial Height Squash Diameter Inoculant(cm) Comparison SEM (cm) Comparison Uninoculated 10.16 — .028 5.08 — B.aryabhattai 11.75 115.60% .055 7.25 142.60% CAP53 B. flexus BT054 11.88116.90% .017 6.36 125.20% Bacillus mycoides 11.92 117.20% .051 6.33124.60% BT155 B. aryabhattai 11.95 117.60% .027 6.33 124.60% CAP56 B.nealsonii 11.89 117.00% .118 6.42 126.40% BOBA57 E. cloacae 11.42112.30% .039 6.83 134.40% CAP12

Example 29. Testing of Plant-Growth Promoting Bacterial Strains onRyegrass

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight). Overnight cultures (30° C.) of selectedstrains were spun down, media decanted off, and resuspended in an equalamount of distilled water. Thirty ryegrass seeds were planted for eachtreatment at a depth of 0.3 cm in loam top soil (Columbia, Mo.) that wassieved to remove large debris. Seeds were inoculated at planting with0.5 μl of resuspended bacteria in water mixed into 10 ml of H₂O. Ten mlof H₂O was sufficient to deliver the bacteria into the 3 in³ (7.62 cm³)of soil as well as saturate the soil for proper germination of seeds.Plants were grown at temperatures between 65-75° F. (18-24° C.) with 11hours of light/day, and 5 ml of watering every 3 days. Ryegrass wasallowed to grow for 1.5 weeks to analyze emergence and initial outgrowthof plants under described conditions. Identified strains indicated bytheir proper bacterial identifications and height data are listed inTable 34.

TABLE 34 Ryegrass Bacterial Inoculant Avg. Height (cm) Comparison SEMUninoculated 1.61 — .023 B. aryabhattai CAP53 2.01 124.70% .012 B.flexus BT054 2.21 137.30% .034 Bacillus mycoides BT155 2.29 142.20% .049B. aryabhattai CAP56 2.19 136.00% .009 B. nealsonii BOBA57 2.29 142.40%.045 E. cloacae CAP12 1.98 122.50% .015

Example 30. Testing of Plant-Growth Promoting Bacterial Strains on Corn

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight). Overnight cultures (30° C.) of selectedstrains were spun down, media decanted off, and resuspended in an equalamount of distilled water. Ten corn seeds were planted for eachtreatment at a depth of 2.5 cm in loam top soil (Columbia, Mo.) that wassieved to remove large debris. Seeds were inoculated at planting with0.5 μl of resuspended bacteria in water mixed into 10 ml of H₂O. Ten mlof H₂O was sufficient to deliver the bacteria into the 3 in³ (7.62 cm³)of soil as well as saturate the soil for proper germination of seeds.Plants were grown at temperatures between 65-75° F. (18-24° C.) with 11hours of light/day, and 5 ml of watering every 3 days. Corn was allowedto grow for 2 weeks to analyze emergence and initial outgrowth of plantsunder described conditions. Identified strains indicated by their properbacterial identifications and final height data are listed in Table 35.

TABLE 35 Corn Avg. Height Bacterial Inoculant (cm) Comparison SEMUninoculated 8.9 — .039 B. aryabhattai CAP53 11.01 123.60% .081 B.flexus BT054 9.96 112.00% .095 Bacillus mycoides strain BT155 9.6107.90% .041 B. aryabhattai CAP56 9.54 107.10% .088 B. nealsonii BOBA579.23 103.70% .077

Example 31. Testing of Plant-Growth Promoting Bacterial Strains onSoybeans

The selected strains were grown in minimal media (KH₂PO₄ 3 g, Na₂HPO₄ 6g, NH₄Cl 1 g, NaCl 0.50 g, MgSO₄ 7H₂O 0.15 g, CaCl₂ 2H₂O 0.013 g, andglucose 1 g, per L dry weight, or for Bradyrhizobium or Rhizobium onyeast mannitol media). Overnight cultures (30° C.) of selected strainswere spun down, media decanted off, and resuspended in equal amount ofdistilled water. Ten soybean seeds were planted for each treatment at adepth of 2.5 cm in loam top soil (Columbia, Mo.) that was sieved toremove large debris. Seeds were inoculated at planting with 0.5 μl ofresuspended bacteria in water mixed into 10 ml of H₂O. When testing twobacterial strains, 0.5 μl of each resuspended bacteria was mixed into 10ml of H₂O. Ten ml of H₂O was sufficient to deliver the bacteria into the3 in³ (7.62 cm³) of soil as well as saturate the soil for propergermination of seeds. Plants were grown at temperatures between 65-75°F. (18-24° C.) with 11 hours of light/day, and 5 ml of watering every 3days. Soybeans were allowed to grow for 2 weeks to analyze emergence andinitial outgrowth of plants under described conditions. Identifiedstrains indicated by their proper bacterial identifications and finalheight data are listed in Table 36. Co-inoculation of bacteria strainsin the present invention with members of the Bradyrhizobium sp. orRhizobium sp. lead to an increase in plant growth compared to eitherinoculant alone.

TABLE 36 Soybeans Ave. Height Bacterial Inoculant (cm) Comparison SEMUninoculated 13.94 — .089 B. aryabhattai CAP53 16.32 117.1% .146 B.flexus BT054 17.85 128.0% .177 Bacillus mycoides strain BT155 18.93135.8% .117 B. aryabhattai CAP56 17.23 123.6% .133 B. aryabhattai CAP5316.32 117.1% .077 B. aryabhattai CAP53 and 16.72 119.9% .182Bradyrhizobium sp. B. aryabhattai CAP53 and 17.32 124.2% .086 Rhizobiumsp. Bradyrhizobium sp. 14.25 102.2% Rhizobium sp. 14.75 105.8%

Example 32. Bacillus cereus Family Members with Plant Growth PromotingAttributes

Bacillus mycoides strain BT155, Bacillus mycoides strain EE118, Bacillusmycoides strain EE141, Bacillus mycoides strain BT46-3, Bacillus cereusfamily member strain EE349, Bacillus thuringiensis strain BT013A, andBacillus megaterium strain EE281 were grown in Luria Bertani broth at37° C. and overnight cultures were spun down, media decanted off, andresuspended in equal amount of distilled water. 20 corn seeds wereplanted for each treatment at a depth of 2.5 cm in loam top soil(Columbia, Mo.) that was sieved to remove large debris. Seeds wereinoculated at planting with 0.5 μl of resuspended bacteria in watermixed into 50 ml of H₂O. Fifty ml of H₂O was sufficient to deliver thebacteria into the 29 in³ (442.5 cm³) of soil as well as saturate thesoil for proper germination of seeds. Plants were grown at temperaturesbetween 65-72° F. with 13 hours of light/day, and 5 ml of watering every3 days. Seedlings were allowed to grow for 2 weeks to analyze emergenceand initial outgrowth of plants under described conditions. Identifiedstrains indicated by their proper bacterial identifications and finalheight data are listed in Table 37.

TABLE 37 Avg. Height, cm, Bacterial Inoculant Corn Percentage SEM, H₂OControl 11.41   100% .123 B. mycoides EE118 12.43 108.9% .207 B.mycoides EE141 12.84 112.5% .231 B. mycoides BT46-3 11.81 103.5% .089Bacillus thuringiensis 12.05 105.6% .148 BT013A Bacillus cereus family13.12 114.9% .159 member EE128 Bacillus mycoides BT155 12.85 112.6% .163Bacillus megaterium EE281 11.99 105.1% .098

All plant growth promoting bacteria tested had a beneficial effect oncorn height at two weeks under the described conditions. The Bacilluscereus family member EE128 strain had the greatest effect in this trial,giving a greater than at 14% boost in corn height.

Example 33. Enhanced Selection of Bacillus cereus Family Members toScreen for Plant Growth-Promoting and Other Beneficial Activities asBEMD Expression Host

The BEMD system can be used to display a wide range of proteins,peptides, and enzymes using any of the targeting sequences describedherein to provide beneficial agricultural effects. Additional beneficialeffects can be obtained by selecting an expression host (a Bacilluscereus family member) having inherent beneficial attributes. Manystrains of members of the Bacillus cereus family have plant-growthpromoting benefits. Additionally, many Bacillus cereus family memberstrains provide have protective effects, through direct fungicidal,insecticidal, nematocidal, or other protective activities. By using suchstrains these as the expression host for the BEMD system, the end sporeproduct would have a combination of positive benefits in agriculture.

Table 38 provides results for an experiment wherein a fusion protein wasexpressed in various Bacillus cereus family member strains. All strainsare expressed a fusion protein comprising amino acids 1-35 of SEQ ID NO:1 and the phosphatase PhoA4 from Bacillus subtilis, a beneficial enzymefor enhanced phosphate uptake in corn. The gene was synthesized, clonedinto the pMK4 vector, and introduced into each of the Bacillus spp.indicated in Table 38 below. Strains were taken into sporulation byincubation at 30° C. on nutrient agar plates containing chloramphenicol10 μg/ml for three days. Spores were collected, washed, and applied tocorn at planting at a rate of 1×10⁵ CFU/ml in 50 ml of water per 7.62 cmdiameter pot with 5 mg polyphosphate per pot. Corn was grown in siltloam soil for two weeks. Plants were grown under ideal light using T5lamps, 54 watts, and exposed to 13 hours of light a day under controlledtemperature conditions between 15.5-25.5° C. Plants were watered tosaturation every three days over a two week trial. At the end of twoweeks, the height of each plant was measured and measurements werenormalized to control Bacillus thuringiensis spores. Expression of theSEQ ID NO: 1-Phosphatase fusion protein led to an increase in cornheight at 2 weeks regardless of the expression host strain selected. Asshown in Table 38, use of a plant-growth promoting Bacillus cereusfamily member further increased corn height

TABLE 38 Height at 2 weeks, Bacillus Species Strain Fusion ProteinNormalized B. thuringiensis Strain BT013A None   100% B. thuringiensisStrain BT013A SEQ ID NO: 1- 117.4% Phosphatase B. mycoides Strain EE141None 107.3% B. mycoides Strain EE141 SEQ ID NO: 1- 123.3% Phosphatase B.cereus family Strain EE128 None 124.1% member B. cereus family StrainEE128 SEQ ID NO: 1- 131.7% member Phosphatase B. mycoides Strain BT155None 104.8% B. mycoides Strain BT155 SEQ ID NO: 1- 121.9% Phosphatase

Example 34. Use of Various Targeting Sequences to Expressβ-Galactosidase on the Surface of Bacillus thuringiensis

A wide variety of targeting sequences that that have a high degreehomology with amino acids 20-35 of BclA (amino acids 20-35 of SEQ IDNO: 1) can be used to display enzymes, proteins, and peptides on thesurface of Bacillus cereus family members. Several targeting sequenceswere compared by making fusion proteins containing the targetingsequences linked to Bacillus subtilis lipase. Fusion constructs weresynthesized using the promoters native to the targeting sequence, clonedinto the replicating plasmid pMK4, and introduced into Bacillusthuringiensis BT013A. Strains were taken into sporulation by incubationat 30° C. on nutrient agar plates containing chloramphenicol 10 μg/mlfor 3 days. Spores were collected, washed, and resuspended in PBS at arate of 1×10⁸/ml. 1×10⁵ spores for each fusion construct spores weresuspended in 400 μl dH₂O. The reactions were warmed with the reactioncomponents to the desired reaction temperature (40° C.). 200 μl workingbuffer was added (9:1 Solution A: Solution B). Solution A was 50 mM TrispH 10 and 13.6 mM deoxycholic acid and Solution B was 3 mg/mlp-nitrophenyl palmitate in isopropanol. The reaction was incubated at40° C. for 10 minutes and placed on ice, centrifuged to remove spores,and absorbance at 420 nm was recorded. The results are shown in Table 39below. Activity was normalized to a control fusion protein comprisingamino acids 1-35 of SEQ ID NO: 1 fused to Bacillus subtilis lipase.

TABLE 39 Strain Targeting sequence Enzyme Relative activity B.thuringiensis Amino acids 1-35 of Lipase   100% BT013A SEQ ID NO: 1 B.thuringiensis Amino acids 1-27 of Lipase  92.5% BT013A SEQ ID NO: 3 B.thuringiensis Amino acids 1-28 of Lipase  13.5% BT013A SEQ ID NO: 7 B.thuringiensis Amino acid 1-24 of Lipase  24.8% BT013A SEQ ID NO: 9 B.thuringiensis Amino acid 1-33 of Lipase  98.5% BT013A SEQ ID NO: 13 B.thuringiensis Amino acid 1-33 of Lipase 107.8% BT013A SEQ ID NO: 21 B.thuringiensis SEQ ID NO: 96 Lipase 137.1% BT013A B. thuringiensis SEQ IDNO: 98 Lipase 146.3% BT013A B. thuringiensis SEQ ID NO: 100 Lipase115.7% BT013A B. thuringiensis SEQ ID NO: 104 Lipase  81.5% BT013A

Several targeting sequences linked to lipase result in higher expressionlevels and activity of enzyme on the surface of spores. In particular,SEQ ID NOs. 96, 98, and 100, each containing a shorter targetingsequence, resulted in enhanced fusion expression on the surface of theBEMD spores. All the fusion proteins containing targeting sequencestested resulted in surface display of lipase.

Example 35. Use of Various Exosporium Sequences to Express Lipase on theSurface of Bacillus thuringiensis and Demonstration of Fusion ProteinLocalization to the Exosporium Surface

A wide variety of exosporium proteins can be used to display enzymes,proteins, and peptides on the surface of Bacillus cereus family members.Several different exosporium proteins were compared by making fusionproteins containing the exosporium proteins linked to Bacillus subtilislipase as described in Example 34. Fusion constructs were synthesizedusing the promoter native to the exosporium protein indicated in Table40 below, cloned into the replicating plasmid pMK4, and introduced intoBacillus thuringiensis BT013A. Spores displaying the various exosporiumprotein-Bacillus subtilis 168 lipase fusions were made by growing thetransformed bacteria in brain heart infusion broth with selectivepressure from 10 μg/ml chloramphenicol, plating onto nutrient agarplates, and incubating at 30° C. for 3 days. After 3 days, the sporeswere washed off the plates, purified by centrifugation, and resuspendedin PBS at 1×10⁸ CFU/ml.

1×10⁵ spores for each fusion construct were resuspended in 400 μl dH₂O.The reactions were warmed with the reaction components to the desiredreaction temperature (40° C.). 200 μl of working buffer was added (9:1Solution A:Solution B). Solution A was 50 mM Tris pH 10 and 13.6 mMdeoxycholic acid and Solution B was 3 mg/ml p-nitrophenyl palmitate inisopropanol. The reaction was incubated at 40° C. for 10 minutes andplaced on ice, centrifuged to remove spores and absorbance at 420 nm wasrecorded. Results are shown in Table 40 below. Activity was normalizedto SEQ ID NO: 109 linked to lipase.

TABLE 40 Strain Exosporium protein Enzyme Relative activity B.thuringiensis SEQ ID NO: 109 Lipase   100% BT013A B. thuringiensis SEQID NO: 110 Lipase 134.5% BT013A B. thuringiensis SEQ ID NO: 113 Lipase 17.8% BT013A B. thuringiensis SEQ ID NO: 117 Lipase  19.8% BT013A B.thuringiensis SEQ ID NO: 118 Lipase  8.2% BT013A

Use of the exosporium proteins of SEQ ID NOs. 109 and 110 resulted inthe highest enzyme activity on the spore. All the fusion proteinscontaining exosporium proteins resulted in surface display of activeBacillus subtilis 168 lipase, albeit at different levels.

Additional exosporium proteins were demonstrated to result in targetingof fusion proteins to the exosporium using the fluorescent reportermCherry. Fusion constructs were created that contained the exosporiumproteins of SEQ ID NOs. 111, 120, and 110 linked to the mCherryreporter. Spores were grown for 1.5 days, collected, and resuspended asdescribed above. 7 μl of fluorescent spores were put under a Nikon E1000microscope and imaged during late sporulation. Circular localization ina ring is indicative of outer spore layer localization, and theappearance matches that of an exosporium protein. Fluorescent microscopyresults are shown in FIG. 2. Panels A, B, and C of FIG. 2 arefluorescent microscopy images of spores expressing fusion proteinscomprising the exosporium proteins of SEQ ID NOs. 111, 120, and 110,respectively, and the mCherry reporter. All three fusions demonstratedhigh levels of fluorescence and exosporium localization, demonstratingtheir potential utility for the expression of foreign proteins on thesurface of the exosporium.

Example 36. Use of Various Targeting Sequences and Exosporium Proteinsto Express Phosphatase in Bacillus subtilis Spores and Effects of thePhosphatase-Expressing Spores in Soybeans

BEMD spores expressing Bacillus subtilis EE148 Phosphatase A4 (PhoA4)were created by gene synthesis of the genes coding for various targetingsequences and exosporium proteins under the control of their nativepromoters linked to PhoA4. The synthesized genes were cloned into pMK4and introduced into Bacillus thuringiensis BT013A. Spores displaying thevarious exosporium protein-Bacillus subtilis EE148 PhoA4 fusions weremade by growing the transformed bacteria in brain heart infusion brothwith selective pressure from 10 μg/ml chloramphenicol, plating ontonutrient agar plates, and incubating at 30° C. for three days. Afterthree days, the spores were washed off the plates, purified bycentrifugation, and resuspended in PBS at 1×10⁸ CFU/ml.

Soybeans were planted 2.54 cm deep in 10 cm deep pots filled withstandard loam topsoil. BEMD spores expressing PhoA4 were diluted to aconcentration of 1×10⁴/ml in 50 ml of water and applied to each plant atplanting. A water-only control was also included. Polyphosphate wasadded to pots in liquid at a rate of 0.5 mg/pot. Plants were grown underideal light using T5 lamps, 54 watts, and exposed to 13 hours of light aday under controlled temperature conditions between 15.5-25.5° C. Plantswere watered to saturation every three days over the two week trial. Atthe end of two weeks, the height of each plant was measured, andmeasurements were normalized to control water-only plants.

Results are shown in Table 41. Soy grown in the presence of BEMD sporesexpressing fusion proteins containing PhoA4 linked to various targetingsequences and exosporium proteins with different fusion partners withPhoA4 all exhibited enhanced growth, but the extent of the effect varieddepending on the targeting sequence or exosporium protein used.

TABLE 41 Targeting sequence or Height at exosporium protein 2 weeks,Bacillus species linked to PhoA4 Normalized H2O (No bacteria) N/A   100%Bacillus thuringiensis Amino acids 1-35 of   100% Strain BT013A SEQ IDNO: 1 Bacillus thuringiensis Amino acids 1-28 of 117.4% Strain BT013ASEQ ID NO: 3 Bacillus thuringiensis Amino acids 1-33 of 107.3% StrainBT013A SEQ ID NO: 21 Bacillus thuringiensis SEQ ID NO: 96 123.3% StrainBT013A Bacillus thuringiensis SEQ ID NO: 98 124.1% Strain BT013ABacillus thuringiensis SEQ ID NO: 109 131.7% Strain BT013A Bacillusthuringiensis SEQ ID NO: 110 104.8% Strain BT013A

Example 37. Co-Application of BEMD Spores and Seed Treatments, LiquidFertilizers, and Other Additives

BEMD spores expressing fusion proteins were tested for compatibilitywith various seed treatments. The BEMD spores expressed fusion proteinscomprising the targeting sequence of amino acids 1-35 SEQ ID NO: 1linked to a phosphatase (PhoA4) from Bacillus subtilis EE148 or thePOLARIS peptide. The synthesized genes were cloned into pMK4 andintroduced into Bacillus thuringiensis BT013A. Spores displaying thevarious exosporium protein-Bacillus subtilis EE148 PhoA4 or POLARISfusions were made by growing the transformed bacteria in brain heartinfusion broth with selective pressure from 10 μg/ml chloramphenicol,plating onto nutrient agar plates, and incubating at 30° C. for threedays. After three days, the spores were washed off the plates, purifiedby centrifugation, and resuspended in PBS at 1×10⁸ CFU/ml.

Plants were grown under ideal light using T5 lamps, 54 watts, andexposed to 13 hours of light a day under controlled temperatureconditions between 15.5-25.5° C. Plants were watered to saturation everythree days over the two week trial. At the end of two weeks, the heightof each plant was measured, and measurements were normalized to controlwater only plants. Results are shown in Table 42 below. Drench=appliedto soil at 50 ml per pot. Polymer=ACCELERON seed coating polymer only.BEMD spores were added at 1×10⁴ cells/50 ml for drench applications.BEMD spores were added at 1.3×10⁴/cells/seed for seed coatingapplications. 10-34-0 and 6-24-6 are standard commercial starterfertilizer compositions. 10-34-0 is liquid ammonium phosphate. 6-24-6 islow salt liquid phosphate fertilizer with an ortho/poly formulation.Colorant=Becker Underwood red seed coating coloring agent. MACHO, APRON,and CRUISER are commercial fungicides used on seeds. MACHO contains theactive ingredient imidacloprid, APRON contains the active ingredientmefenoxam, and CRUISER contains a mixture of the active ingredientsthiamethoxam, mefenoxam, and fludioxonil. The spores were found to becompatible with many seed applications and retained their ability tostimulate plant growth in corn.

TABLE 42 Corn height at 2 BEMD treatment Chemical weeks, normalized NoneNone (Water Drench)   100% None Polymer Only 101.3% BEMD PhoA4 N/A(Drench) 111.3% BEMD POLARIS N/A (Drench) 106.7% BEMD PhoA4 Polymer109.3% BEMD POLARIS Polymer 107.3% BEMD PhoA4 Polymer + Colorant 102.3%BEMD PhoA4 Polymer + MACHO 107.9% BEMD PhoA4 Polymer + APRON 112.3% BEMDPhoA4 Polymer + CRUISER 116.8% BEMD PhoA4 Polymer + Colorant + 113.7%MACHO + APRON + CRUISER None 10-34-0 Starter 108.5% (Drench) BEMD PhoA410-34-0 Starter 114.7% Fertilizer (Drench) None 6-24-6 Starter 102.6%Fertilizer (Drench) BEMD PhoA4 6-24-6 Starter 112.9% Fertilizer (Drench)

BEMD spores were found to be compatible with all seed coating amendmentstested. There was a slight decrease in activity when BEMD PhA4 sporeswere combined with colorant and polymer alone, but the spores regainedfull activity with colorant in combination with other fungicides. BEMDspores also worked well with liquid fertilizers. Starter fertilizerscontributed to plant growth most likely through direct nutrientsupplementation. BEMD spores worked with both starter fertilizers,suggesting that phosphatase activity can still lead to increased plantgrowth in the presence of excess nutrients. Combinations of BEMD sporeswith fungicides exhibited greater increases in plant growth than BEMDspores alone, likely due to protection given to young corn plants duringearly growth.

Example 38. The Use of the BEMD Spores as a Foliar Addition for ReducingStress Inhibition of Growth on Corn

The BEMD spore display system can be used to deliver enzymes that canalleviate some stress from growing plants in the field or greenhouse. Toaccomplish this, enzymes were selected that selectively act uponreactive oxygen species in soil. Reactive oxygen species are a keymarker of stress in plants.

BEMD spores expressing fusion proteins comprising the targeting sequenceof amino acids 1-35 of SEQ ID NO: 1 linked to chitosanase, superoxidedismutase, catalase, or β1,3 glucanase from Bacillus thuringiensisBT013A were generated. The synthesized genes were cloned into pMK4 andintroduced into Bacillus thuringiensis BT013A. Spores displaying thevarious protein fusions were made by growing the transformed bacteria inbrain heart infusion broth with selective pressure from 10 μg/mlchloramphenicol, plating onto nutrient agar plates, and incubating at30° C. for three days. After three days, the spores were washed off theplates, purified by centrifugation, and resuspended in PBS at 1×10⁸CFU/ml.

Three week old corn plants at the V5 stage were grown under ideal lightusing T5 lamps, 54 watts, and exposed to 13 hours of light a day undercontrolled temperature conditions between 15.5-25.5° C. Plants werewatered to saturation every three days over the course of the trial. Asthe plants reach V5, BEMD spores or positive control chemicals weresprayed on the leaves at either 1×10⁵ BEMD spores/ml or at therecommended rates for the chemicals. A total of 1 ml of spray wasapplied to each plant individually. Plant heights were taken just priorto the application of the foliar sprays. The corn plants were thenstressed by warming to 32.2° C. and decreasing watering to once perweek. Plants were kept under stressed conditions for two weeks. At theend of the two weeks, plant heights were again measured, and visualappearance recorded. Under these stressed conditions, plant growth wasminimal in control treatments. The ability to continue to grow understressed conditions was measured by an increase in plant height over thetwo week span as compared to the water-only control. Results are shownin Table 43 below.

TABLE 43 Change in plant Height over 2 week Treatment Rate stress NoneNone   0% Bacillus thuringiensis 1 ml/plant −1.6%   BT013A spores BEMDChitosanase 1 ml/plant 0.3% BEMD Chitosanase 1 ml/plant and 5 mM 4.7%and Chitosan BEMD Superoxide 1 ml/plant 8.3% Dismutase BEMD B1, 3 1ml/plant 4.9% Glucanase Salicylic Acid 1 ml/plant 5.8% Benzothiadiazole1 ml/plant 7.3% (BTH) BEMD Catalase 1 ml/plant −0.5%  

Several destressing enzymes were applied to corn using the BEMD system,as shown in Table 43 above. Control spores had no significant effect(decrease in plant height of −1.6%. The BEMD chitosanase enzyme had apositive effect when combined with its substrate, chitosan. The two bestperforming enzymes were BEMD β-1,3-glucanase and BEMD superoxidedismutase. BEMD β-1,3-glucanase has a primarily antifungal activity, butcan also have direct effects on plants. Salicylic acid and BTH werepositive controls for the foliar assay, and positive responses were seenfor both. This foliar delivery method can be used for deliveringdestressing enzymes to the plants at various times of the season.

Example 39. Expression Levels of Fusion Proteins Using Various Sigma-KContaining Promoters

As shown in Example 23 above, replacing native promoter of a targetingsequence, exosporium protein, or exosporium protein fragment can greatlyaffect the level of fusion protein expressed on the exosporium of aBacillus cereus family spore. For example, replacing the native BclApromoter with the BclB promoter greatly reduces the level of fusionprotein on the surface of Bacillus cereus family member spores.Alternatively, replacement of native BclB promoter with the BclApromoter increases fusion protein levels on the exosporium dramatically.

Relative promoter expression levels for various exosporium proteinsunder the control of their native sporulation promoters were obtainedfrom microarray data from Bergman et al., 2008. The relative expressionlevels were determined during late sporulation timing (300 minutes afterthe start of the experiment), when sigma K promoters are most active.Sigma K promoters are key promoters for expression of exosporiumlocalized genes and associated proteins. Relative expression is theincrease in a gene's expression level when compared to the average ofall other genes of the chromosome at all given times. Table 44 belowshows the relative expression levels of a variety of sigma K drivengenes in Bacillus cereus family members.

TABLE 44 Relative Expression Protein (Promoter SEQ ID NO.) (Foldincrease in mRNA) CotO (SEQ ID NO: 226) 79.21 Rhamnose (SEQ ID NO: 225)75.69 BclC (SEQ ID NO: 179) 14.44 Sigma K (SEQ ID NO: 227) 64 BclAadjacent US Glycosyl transferase 72.25 promoter 1 (SEQ ID NO: 229) BclAadjacent DS Glycosyl transferase 73.96 promoter 2 (SEQ ID NO: 230) BclA(SEQ ID NO: 215) 77.44 ExsY (SEQ ID NO: 220) 32.49 YjcA (SEQ ID NO: 222)64 YjcB (SEQ ID NO: 223) 70.56 BxpB/ExsFA (SEQ ID NO: 224) 30.25 InhA(SEQ ID NO: 228) 34.25

Example 40. Preparation and Testing of BEMD Spores Expressing a FusionProtein Comprising a Nitric Oxide Synthase, and Use of Such Spores forStimulating Germination of Plant Seeds

BEMD spores expressing a fusion protein containing amino acids 20-35 ofBclA, a 6-alanine linker, and the nitric oxide synthase enzyme fromBacillus subtilis 168 were generated. The nitric oxide synthase (NOS)enzyme from Bacillus subtilis 168 was gene synthesized in fusion to theBclA promoter, ribosomal binding site (RBS), start codon and amino acids20-35 of BclA. A six-alanine linker region was included to separate theBclA targeting sequence from the NOS enzymes. The amino acids sequencesof these fusion proteins, including the methionine encoded by the BclAstart codon, amino acids 20-35 of BclA, the six-amino acid linker, andthe NOS enzyme, are provided above in Table 9. These clones weresubcloned in the shuttle vector pHP13 via digestion with XhoI andligation into the SalI site of pHP13. Correct constructs were sequencedand verified, transformed into E. coli cells. The resultant plasmidswere transformed into Bacillus thuringiensis BT013A and Bacillusmycoides EE155.

The recombinant Bacillus thuringiensis BT013A and Bacillus mycoidesEE155 transformed with the plasmids encoding the NOS fusion proteinswere then induced to sporulate by swabbing the bacteria onto nutrientagar plates and incubating the plates at 30° C. for 72 hours. After 72hours, the bacterial spores were collected from the plate by swabbinginto sterile phosphate buffered saline (PBS), and were purified bydensity centrifugation three times.

The spores were then applied to commercial corn and soy hybrid seeds atrates of 1×10⁵ spores/seed. The soybean hybrid variety was BECK 335NR,which contains the cyst nematode protection gene, the ROUNDUP READYglyphosate resistance gene, and the K-gene for Phytophthora resistance.The corn hybrid variety was BECK 5540RR, which contains the ROUNDUPREADY glyphosate resistance gene. The seeds were then lightly dustedwith L-arginine. A control set of seeds was dusted with L-arginine, butwith no spores. Seeds were then placed between two paper towels, whichwere then wetted with 25 ml of H₂O. The paper towels were then rolled,placed into a small sandwich bag, and sealed tightly. These bags werethen placed in a 30° C. incubator and allowed to germinate for 24, or 48hours. The number of seeds germinated at each timepoint was measured,and the results compared to untreated and control seeds. The results ofthese experiments are shown in Tables 45 and 46 below.

TABLE 45 Increase in germination rate in hybrid soybean seeds treatedwith spores of recombinant Bacillus cereus family members expressing afusion protein containing nitric oxidesynthase. Germination GerminationTreatment Day 1 (%) Day 2 (%) Naked soybean seed 15.0% 92.3% Soybeanseed plus L-Arginine 20.5% 94.9% Soybean seed plus B. 28.9% 97.5%thuringiensis BT013A expressing B. subtilis NOS fusion protein Soybeanseed with L-arginine 30.0% 97.5% and B. mycoides EE155 expressing B.subtilis NOS

TABLE 46 Increase in germination rate in hybrid corn seeds treated withspores of recombinant Bacillus cereus family members expressing a fusionprotein containing nitric oxide synthase. Germination GerminationTreatment Day 1 (%) Day 2 (%) Naked corn seed 0.0% 77.5% Corn seed plusL-Arginine 4.1% 80.5% Corn seed plus B. thuringiensis 6.5% 82.5% BT013Aexpressing B. subtilis NOS fusion protein Corn seed with L-arginine andB. 4.3% 95.0% mycoides EE155 expressing B. subtilis NOS

As can be seen from Tables 45 and 46, treatment of seeds with L-arginineand a recombinant Bacillus cereus family member expressing a fusionprotein comprising a nitric oxide synthase enzyme led to an increase inthe number of germinated seeds, in both soybeans and corn.

Example 41. Preparation and Testing of BEMD Spores Expressing a FusionProtein Comprising Nucleic Acid Binding Proteins

BEMD spores expressing a fusion protein containing amino acids 20-35 ofBclA, an eight-alanine linker, and the non-specific DNA binding proteinSASPα from Bacillus subtilis 168 or the non-specific DNA binding proteinSASPγ from Bacillus subtilis 168. DNA encoding SASPα and SASPγ was genesynthesized in frame with the BclA promoter, RBS, start codon BclA andamino acids 20-35 of BclA. An eight alanine linker region was includedbetween the BclA targeting sequence and the RNA/DNA binding proteins.The linker allows for greater flexibility and protein folding of thefusion proteins. The amino acid sequences for these fusion proteins,including the methionine encoded by the BclA start codon, amino acids20-35 of BclA, the eight-amino acid linker, and the SASPα or SASPγprotein are provided above in Table 11. The synthesized genes weredigested with XhoI, and ligated into the SalI site of pHP13 to generatethe plasmids pHP13-BclA20-35-SASPα and pHP13-BclA20-25-SASPγ. pHP13 is awell characterized 5.5 kbp shuttle vector plasmid having chloramphenicoland erythromycin resistance cassettes. It was constructed by theligation of plasmids pE194, pC194, and pUC9.

Correct clones were subjected to DNA sequencing and transformed into theSCS110 strain of E. coli. The plasmid DNA was then purified, andtransformed into the Bacillus thuringiensis BT013A. These bacteria werethen induced to sporulate by swabbing onto nutrient agar plates for 72hours at 30° C. The spores were collected and purified as describedabove in the immediately preceding example.

To assess the ability of the recombinant spores to bind nucleic acids,the recombinant Bacillus cereus family members transformed with theplasmids encoding the SASPα and SASPγ fusion proteins were thenincubated in PBS with random DNA primers that contained a fluoresceintag on the 5′ ends. A control using non-recombinant spores was alsoincluded in the experiment. The spores were incubated for ten minuteswith 50 mM tagged DNA, and then washed by centrifugation for one minuteat 10,000 rpm. The supernatant was removed, and the spores wereresuspended in 1 ml of PBS. The spores were again pelleted and thesupernatant removed after centrifugation, and then subjected toanalysis. The fluorescein-labeled DNA treated spores were examined underan E600 Nikon fluorescent microscope and DNA binding was determined bythe change in the total fluorescence overall as compared to the controlspores that did not contain the DNA-binding fusion proteins. The resultsthis assays are shown in Table 47 below.

TABLE 47 DNA binding to recombinant Bacillus cereus family member sporesexpressing a fusion protein comprising a DNA binding protein TreatmentDNA Binding (Normalized) B. thuringiensis BT013A   100% spores(non-recombinant) B. thuringiensis BT013A 341.2% spores expressing BclA-SASPα fusion protein B. thuringiensis BT013A 250.1% spores expressingBclA- SASPγ fusion protein

In addition, FIG. 3 shows DNA binding to spores as measured byfluorescein-labeled DNA binding. In FIG. 3, “control” refers tonon-recombinant B. thuringiensis BT013A spores (non-recombinant),“SASPa” refers to B. thuringiensis BT013A spores expressing BclA-SASPαfusion protein, and SASPc refers to B. thuringiensis BT013A sporesexpressing BclA-SASPγ fusion protein.

As can be seen from the data shown in Table 47 and FIG. 3, the sporesexpressing the SASPα or SASPγ fusion proteins bound a significantlygreater amount of DNA than the non-recombinant spores, demonstrating astrong affinity of these spores for DNA.

Example 42. Preparation and Testing of BEMD Spores Expressing a FusionProtein Comprising a Nuclease

In addition to the non-specific DNA and RNA binding proteins discussedabove in the immediately preceding example, nucleases can also be usedto both bind to and cleave nucleic acid molecules. BEMD sporesexpressing a fusion protein containing amino acids 20-35 of BclA and anendonuclease enzyme were generated and assayed for their ability to bindto and cleave DNA.

The Bacillus subtilis endonuclease 1 was PCR amplified and fused inframe to the BclA promoter, RBS, start codon and amino acids 20-35 ofBclA. This construct was then cloned into the pHP13 plasmid to createthe plasmid pHP13-BclA20-35-endonuclease. This construct was sequencedand transformed into and propagated in E. coli. The plasmid DNA was thenisolated from the E. coli and introduced into Bacillus thuringiensisBT013A. Spores were created and purified as described in Example 40above.

Endonuclease activity was assayed by incubating recombinant sporesexpressing the endonuclease fusion protein and non-recombinant controlspores in PBS at a concentration of 1×10⁸ spores/ml in PBS with 300 ngof salmon sperm DNA and 1 μg/ml DAPI (4′,6-diamidino-2-phenylindole) DNAstain. The reaction was allowed to proceed continue for 10 minutes at37° C. After 10 minutes, the supernatant was assayed for cleaved DNAusing a fluorometer. As DNA is cleaved, the DAPI stain is released fromthe individual freed nucleotides, and thus cleavage can be determined byloss of DAPI staining over time. The results of this assay are shown inTable 48 below.

TABLE 48 Nuclease Activity and DNA binding by BEMD spores expressing anendonuclease fusionprotein Loss of DNA Spore-bound DNA signal(fluorescence on Treatment Construct (supernatant) spores) Bacillusthuringiensis —  5%  5.3% BT013A Spores Bacillus thuringiensis BclA- 65%21.9% BT013A Spores endonuclease

The data provided above in Table 48 show that the endonuclease fusionprotein was expressed on the exosporium of the Bacillus thuringiensisBT013A spores, and was able to cleave the salmon sperm DNA as evidencedby the loss of DAPI signal in the supernatant. Surprisingly, a portionof the endonuclease bound the DNA tightly without cleaving it, retainingthe DAPI fluorescence signal on the spores, even after washing thespores to remove excess DNA. This demonstrates that not all the DNA wasprocessed, and that nucleases expressed on the outside of the spore canbind DNA tightly. To increase this effect, a nuclease having aninactivated active site could be used in the fusion protein, which wouldlead to less cleavage of the DNA and even more binding DNA on thespores.

Example 43. Agricultural Use of Spores Expressing Fusion ProteinsContaining Nucleic Acid Binding Proteins or Peptides

The recombinant Bacillus cereus family or recombinant spore-formingbacteria members expressing fusion proteins comprising nucleic acidbinding proteins or peptides can be used in agriculture to delivernucleic acids to a plant growth medium (e.g., soil) and/or to plants.For example, the recombinant Bacillus cereus family members orrecombinant spore-forming bacteria can be delivered to plants via seedtreatment, in furrow/soil drench treatment, or foliar treatment.Furthermore, the fusion proteins comprising nucleic acid bindingproteins or peptides can be expressed in any of the endophytic Bacilluscereus family members or any of the other endophytic Bacillus speciesdescribed herein, enabling delivery of nucleic acids bound to thenucleic acid binding proteins internally to the plant, where they wouldbe more effective in reaching their target cells. For example, thefusion proteins comprising nucleic acid binding proteins can beexpressed in the endophytic strain Bacillus cereus family member EE349.Expression of another fusion protein (comprising endoglucanase as theprotein of interest) in this strain is described in Example 51hereinbelow, demonstrating that the fusion proteins expressed in thisendophytic strain are delivered internally to plants. Thus, expressionof the fusion proteins comprising SASPα, SASPγ, Hfq, or a nucleasehaving an inactivated active site in endophytic Bacillus cereus familymember strains such as Bacillus cereus family member EE349 can provide ameans to deliver RNA and DNA (e.g., RNAi or rDNA) internally to a plant.Other non-specific binding nucleic acid binding proteins or peptidescould also be used in the fusion proteins for this purpose.

Example 44. Preparation of BEMD Spores that Express a Fusion Protein andAlso Overexpress a Protein that Modulates Expression of Fusion Proteins

Overexpression of various exosporium proteins (referred to herein as“modulator proteins”) in a recombinant Bacillus cereus family memberexpressing any of the fusion proteins described herein can modulate(increase or decrease) the expression level of the fusion protein. Thesemodulator proteins include ExsY, ExsFA/BxpB, CotY, CotO, ExsFB, InhA1,InhA2, ExsJ, ExsH, YjcA, YjcB, BclC, AcpC, InhA3, alanine racemase 1,alanine racemase 2, BclA, BclB, BxpB, BclE, BetA/BAS3290, CotE, ExsA,ExsK, ExsB, YabG, Tgl, superoxide dismutase 1 (SODA1), and superoxidedismutase 2 (SODA2).

The ability to control the expression level of the fusion protein allowsfor control of the amount of the protein or peptide of interest of thefusion protein that is displayed on the outside of the spore of therecombinant Bacillus cereus family member. For example, when the proteinor peptide of interest of the fusion protein comprises a plant growthstimulating protein or peptide (e.g., an enzyme that degrades ormodifies a bacterial, fungal, or plant nutrient source), the recombinantBacillus cereus family member expressing the fusion protein produces aspore that when applied to a seed, plant, or plant growth medium, has abeneficial effect on the plant due to the action of the plant growthstimulating protein or peptide. Modulation of the expression level ofthe fusion protein results in modulation of the level of the peptide orprotein of interest that is displayed on the outside of the recombinantBacillus cereus family member spore. In some cases, increasing the levelof fusion protein expression would be beneficial (e.g., where there is adesire to increase the expression of an enzyme and thereby increase theamount of enzyme per spore that can be delivered to a plant). In othercases, decreasing the level of fusion protein expression would bebeneficial (e.g., where there is a desire to decrease the expression ofa protein and thereby decrease the amount of protein per spore that isdelivered to a plant, for example, where high levels of the proteinwould have detrimental effects on the plant).

To generate plasmids for expression of fusion proteins in Bacilluscereus family members, PCR fragments were generated that contained theBclA promoter (SEQ ID NO: 85), start codon, and amino acids 20-35 ofBclA fused in frame to either Bacillus subtilis 168 endoglucanase or theβ-galactosidase gene from E. coli DH5α. These PCR fragments weredigested with XhoI and ligated into the SalI site of the pSUPER plasmidto generate the plasmids pSUPER-BclA 20-35-Endoglucanase and pSUPER-BclA20-35-βgal, respectively. The pSUPER plasmid was generated throughfusion of the pUC57 plasmid (containing an ampicillin resistancecassette) with the pBC16-1 plasmid from Bacillus (containing atetracycline resistance). This 5.5 kbp plasmid can replicate in both E.coli and Bacillus spp.

The pSUPER-BclA 20-35-Endoglucanase and pSUPER-BclA 20-35-βgal plasmidswere transformed into and propagated in dam methylase negative E. colistrains. The sequences of the pSUPER-BclA 20-35-Endoglucanase andpSUPER-BclA 20-35-βgal plasmids were verified by DNA sequencing.

The pSUPER-BclA 20-35-Endoglucanase and pSUPER-BclA 20-35-βgal plasmidswere transformed into the host strains Bacillus thuringiensis BT013A(for pSUPER-BclA 20-35-Endo) or Bacillus mycoides BT155 (pSUPER-BclA20-35-(3 gal). These transformed strains expressed either theβ-galactosidase enzyme or the endoglucanase enzyme on the outside of thespore.

To generate plasmids for overexpression of modulator proteins, PCRfragments containing the native promoter regions for and genes encodingExsFA/BxpB, CotO, ExsFB, YjcB, BclC, AcpC, BclA, BclB, BxpB, and CotEwere generated, digested with SalI, and ligated into the pHP13 plasmid.The nucleotide sequences for the native promoter regions are providedabove in Table 3. The pHP13 plasmid is a multicopy plasmid and thereforeresults in high expression levels of the encoded modulator proteins whenthe plasmids are transformed into a Bacillus cereus family member hostcell. The pHP13 plasmids containing the promoter regions and genesencoding ExsFA/BxpB, CotO, ExsFB, YjcB, BclC, AcpC, BclA, BclB, BxpB,BclE, BetA/BAS3290, and CotE are referred to herein as pHP13-ExsFA/BxpB,pHP13-CotO, pHP13-ExsFB, pHP13-YjcB, pHP13-BclC, pHP13-AcpC, pHP13-BclA,pHP13-BclB, pHP13-BxpB, and pHP13-CotE, respectively.

The pHP13 plasmids containing the promoter regions and genes encodingthe modulator proteins were transformed into and propagated in E. colistrains. The sequences of these plasmids were verified by DNAsequencing.

The pHP13 plasmids encoding the modulator proteins were transformed intoBacillus thuringiensis BT013A containing pSUPER-BclA 20-35-Endoglucanaseor Bacillus mycoides BT155 containing pSUPER-BclA 20-35-βgal. Theresultant recombinant bacteria were plated onto nutrient agar platescontaining 10 μg/ml chloramphenicol to select for the pHP13 plasmids and10 μg/ml tetracycline to select for the pSUPER plasmids. Bacteriacontaining both plasmids were then grown in brain heart infusion brothovernight with both tetracycline and chloramphenicol. The overnightcultures were then swabbed onto nutrient agar, and bacteria were allowedto sporulate at 30° C. for 72 hours. After 72 hours, the bacterialspores were collected from the plate by swabbing into sterile PBS, andwere purified by density centrifugation three times. The pure sporeswere then diluted to 1×10⁸ CFU/ml, and assayed for enzyme activity usingon a population of 1×10⁸ colony forming units (CFU).

Example 45. Enhanced or Diminished Expression of Fusion Proteins on theBEMD System by Overexpression of a Protein that Modulates Expression ofthe Fusion Construct

The recombinant Bacillus mycoides EE155 spores generated as describedabove in the immediately preceding example were assayed forβ-galactosidase activity, and the recombinant Bacillus thuringiensisBT013A spores generated as described above in the immediate precedingexample were assayed for endoglucanase activity.

β-galactosidase activity was assayed by measuring hydrolysis of thechromogenic substrate ortho-Nitrophenyl-β-galactoside (ONPG). Acommercial source of β-galactosidase was used to prepare standards (0.2μg, 0.4 μg, and 0.8 μg from a 100 μg/mL stock). 250 μl of sporepreparation was pelleted and the spores were resuspended in 50 μL, ofenzyme dilution buffer (10 mM TRIS, pH 7.6, 0.2 M NaCl₂, 5% glycerol).600 μl of prewarmed 37° C. substrate mixture (10 mM KCl, 1 mMMgSO₄.7H₂O, 100 mM NaH₂PO₄, pH 7.5) containing 1.14 mg/mL ONPG was addedto each sample and standard. Each reaction was incubated at roomtemperature for 2 minutes. 250 μl of 1M sodium carbonate was added tostop the reaction. The solution was centrifuged for 5 min at 14,000×g toremove the spores from the absorbance reading. The absorbance wasdetermined at 420 nm using an IMPLEN nanospectrophotometer model P330.Samples were performed in triplicate with a blank for each reaction. Theresults of this assay are shown below in Table 49.

TABLE 49 Effects of overexpression of exosporium proteins on theexpression levels of BclA 20-35-βgal. Plasmid encoding fusion Plasmidencoding Enzyme Activity protein modulator protein (Normalized) — —   0% pSUPER-BclA 20-35-βgal —   100% pSUPER-BclA 20-35-βgal pHP13-CotO112.8% pSUPER-BclA 20-35-βgal pHP13-CotE 135.4% pSUPER-BclA 20-35-βgalpHP13-YjcB  45.4% pSUPER-BclA 20-35-βgal pHP13-BclA 144.7% pSUPER-BclA20-35-βgal pHP13-BclB 132.6% pSUPER-BclA 20-35-βgal pHP13-AcpC  76.1%pSUPER-BclA 20-35-βgal pHP13-BxpB   103%

As can be seen from results shown in Table 49, overexpression of CotO,CotE, BclA, BclB, and BxpB increased the expression of the fusionprotein containing β-galactosidase, resulting in increased enzymeactivity on the spores. By contrast, overexpression of YjcB or AcpCdecreased the expression of the fusion protein containingβ-galactosidase, resulting in decreased enzyme activity on the spores.

The assay for endoglucanase activity was performed by determiningcellulase activity using a carboxymethylcellulose (CMC) substrate and adinitrosalicylic acid (DNS reagent). A commercial source of cellulaseenzyme was used to prepare standards in 50 mM citrate buffer, pH 4.8. 1%CMC (carboxymethylcellulose sodium salt) was prepared in 50 mM citratebuffer, pH 4.8 to serve as the substrate for the reaction. 250 μl ofspore preparation was pelleted and the spores were resuspended in 150 μLof 50 mM citrate buffer, pH 4.8. The reaction was carried out with areagent composed of 1% DNS, 1% NaOH, 0.05% Na₂SO₄, 0.2% phenol, and18.2% Rochelle salts. 150 μl of the sample was mixed with 250 μl of the1% CMC substrate and incubated in a water bath at 50° C. for 15 minutes.300 μl of DNS reagent was added and the samples boiled at 100° C. for 10minutes and then cooled on ice. The solution was centrifuged for 5minutes at 14,000×g to remove the spores from the absorbance reading.The absorbance was determined at 540 nm using an IMPLENnanospectrophotometer model P330. Samples were performed in triplicatewith a blank for each reaction. The results from this assay are shown inTable 50 below.

TABLE 50 Effects of overexpression of exosporium proteins on theexpression levels of BclA 20-35-Endoglucanase. Plasmid encoding fusionPlasmid encoding Enzyme Activity protein modulator protein (Normalized)— —    0% pSUPER-BclA 20-35- —   100% endoglucanase pSUPER-BclA 20-35-pHP13-CotO 215.7% endoglucanase pSUPER-BclA 20-35- pHP13-CotE 125.5%endoglucanase pSUPER-BclA 20-35- pHP13-YjcB  89.3% endoglucanasepSUPER-BclA 20-35- pHP13-BclB 193.0% endoglucanase pSUPER-BclA 20-35-pHP13-AcpC  33.7% endoglucanase pSUPER-BclA 20-35- pHP13-BxpB 202.3%endoglucanase pSUPER-BclA 20-35- pHP13-BclC  3.2% endoglucanase

As shown in Table 50, overexpression of CotO, CotE, BclB, and BxpBincreased expression of the fusion protein containing endoglucanase,resulting in increased enzyme activity on the spores. Overexpression ofYjcB, AcpC, or BclC, on the other hand, decreased expression of thefusion protein, resulting in decreased enzyme activity on the spores.

In sum, overexpression of CotO, CotE, BclB, or BxpB increased expressionof both fusion proteins, resulting in increased activity of bothβ-galactosidase and endogloconase on spores expressing the BclA20-35-βgal or BclA 20-35-endoglucanase fusion proteins, respectively.Overexpression of YjcB or AcpC on the other hand, decreased expressionof both fusion proteins, resulting in decreased activity ofβ-galactosidase and endogloconase on spores expressing the BclA20-35-βgal or BclA 20-35-endoglucanase fusion proteins, respectively.Overexpression of BclC and BclA20-35 tagged eGFP also decreasedexpression of the BclA 20-35-endoglucanase fusion protein, whileoverexpression of BclA increased expression of the BclA 20-35-βgalfusion protein.

Example 46. Effects of BEMD Spores Expressing a Fusion Protein andOverexpressing a Modulator Protein on Corn Growth

Application of recombinant Bacillus thuringiensis BT103A and Bacillusmycoides BT155 spores expressing a fusion protein comprising Bacillussubtilis 168 endoglucanase to corn results in increased seedling vigorand growth response over the course of two weeks. Alternations in theexpression level of the fusion protein comprising endoglucanase inducedby overexpression of a modulator protein in such spores as describedabove in the immediately preceding example results in correspondingalterations in the effects of the BEMD spores on corn growth.

To demonstrate this, pSUPER-BclA 20-35-Endoglucanase and the pHP13-CotOor pHP13-BclB were coexpressed in Bacillus thuringiensis BT013A. Sporeswere created on nutrient agar as described above in Example 40. Thespores were diluted to a concentration of 1×10⁴ spores/50 ml water, andthe 50 ml of water was added to commercial hybrid corn seed in pottingsoil at planting. The corn hybrid variety was BECK 5540RR, whichcontains the ROUNDUP READY glyphosate resistance gene. The corn seedswere coated with a fungicide and a biological inoculant.

Plants were grown under artificial light for 14 hours a day and plantgrowth over a ten day period was determined. Plants were watered everythree days over the course of the experiment. After ten days, the plantswere measured for height and normalized against the height of untreatedcorn plants. The results of these experiments are shown in Table 51below.

TABLE 51 Effects of BEMD spores expressing a fusion protein comprisingan endogloconase and overexpressing a modulator protein on hybrid corngrowth Corn Growth Plasmid (Normalized to encoding pSUPER-BclA 20-Plasmid encoding modulator Expression 35 Endoglucanase fusion proteinprotein Strain alone control) pSUPER-BclA 20- None Bacillus   100%35-Endoglucanase thuringiensis BT013A pSUPER-BclA 20- pHP13- Bacillus103.8% 35-Endoglucanase CotO thuringiensis BT013A pSUPER-BclA 20- pHP13-Bacillus 107.6% 35-Endoglucanase BclB thuringiensis BT013A

As shown in Table 51, overexpression of the exosporium proteins CotO andBclB increased the effects of the BclA 20-35-endoglucanase fusionprotein on corn seedling growth and vigor at 10 days. These effectscorrelate with the expression levels of the fusion protein in BEMDspores expressing BclA 20-35-endoglucanase and pHP13-CotO or pHP13-BclB,indicating that the effects on seedling growth and vigor areattributable to the alteration of fusion protein expression levels bythe modulator proteins

Example 47. Genetic Inactivation of Bacillus cereus Family Members andUse of Such Inactivated Bacillus cereus Family Members for Expression ofFusion Proteins

As described above, overexpression of germination spore protease (GPR)in its active form in the forespore of a Bacillus cereus family memberduring sporulation results in proteolytic cleavage of proteins in theforespore and inactivation of the spore. Similarly, overexpression of anon-specific endonuclease in the forespore during sporulation destroysthe DNA in the spore, leading to an inactivated spore particle in apercentage of the spore population.

A plasmid encoding a non-specific endonuclease under the control of asigma G promoter was generated. The non-specific endonuclease 1 fromBacillus subtilis 168 and a sigma G promoter (SEQ ID NO: 235) were genesynthesized and ligated into the pHP13 plasmid using the SalI site togenerate the plasmid pHP13-SigG-nuclease. Correct clones were sequencedand transformed into and propagated in E. coli cells. Plasmid DNA wasisolated from the E. coli cells and transformed into Bacillusthuringiensis BT013A. Correct clones were verified by PCR. The aminoacid sequence for Bacillus subtilis 168 endonuclease 1 is provided abovein Table 4.

Bacillus thuringiensis BT013A cells expressing the sigma G endonucleasewere created and purified on nutrient agar plates as described above inExample 40. Spores were quantified visually using a hemocytometer,diluted, and dilution plated onto nutrient agar plates. The ratio oflive spores to killed spores was calculated by determining the changefrom visual counting to plate counts. Control spores (untreated) wereincluded in each assay. Additionally, 1×10⁸ spores were UV irradiatedfor 10 minutes using a handheld UV lamp, and the assay repeated. Thevisual count and plate count were again compared to assess sporekilling. The results from these assays are shown in Table 52 below.

TABLE 52 Viability of Bacillus cereus family member spores expressing anon- specific nuclease under the control of a sigma G promoter TreatmentLive Ratio UV Live Ratio Bacillus thuringiensis BT013A  100% 61.3%Bacillus thuringiensis BT013A 70.4% 24.5% expressing SigG-endonuclease

As can be seen from Table 52, expression of endonuclease 1 under thecontrol of a sigma G promoter decreased cell viability by about 30% inspores that were not exposed to UV irradiation and by about 75% inspores that were exposed to UV irradiation.

Co-expression of both a germination spore protease and a nonspecificendonuclease under the control of sigma G promoters would be expected tofurther decrease spore viability.

Example 48. Preparation of Exosporium Fragments from RecombinantBacillus cereus Family Members Comprising a Knockout of the CotE Gene

The plasmid pUCpE was constructed that contained the pUC19 backbone,which is able to replicate in E. coli, as well as the origin ofreplication erythromycin resistance cassette from pE194. This constructis able to replicate in both E. coli and Bacillus spp. A 1 kb DNA regionthat corresponding to the upstream region of the CotE gene and a 1 kbregion corresponding to the downstream region of the gene CotE were PCRamplified from Bacillus anthracis ΔSterne. The two 1 kb regions werethen spliced together using splicing by overlapping extension via 15 bphomologous overhangs that corresponded to the opposing PCR amplicons.This 2 kb fragment was digested with XhoI (in external primers) andligated into the SalI site of pUCpE. This plasmid construct was verifiedby digestion and DNA sequencing. A Gram-positive omega-kanamycinresistance gene was digested with BamHI and placed between the two 1-kbregions. The final construct was again PCR verified and sequenced, andthe final plasmid was introduced into Bacillus anthracis ΔSterne.Correct clones were screened by looking for both erythromycin resistanceand kanamycin resistance.

Clones were passaged under high temperature (40° C.) in brain heartinfusion broth in the presence of kanamycin (25 μg/ml) and wereroutinely struck for isolation onto LB agar plates containing kanamycinand grown at 30° C. Individual colonies were toothpicked onto LB agarplates containing erythromycin 5 μg/ml and grown at 30° C. Clones thatmaintained kanamycin resistance but lost erythromycin resistance(signifying loss of the plasmid but recombination and removal of theCotE gene) were grown in brain heart infusion broth plus kanamycin, andchromosomal DNA was isolated using a Qiagen Chromosomal DNA isolationkit. Proper deletion of the CotE gene was determined by PCRamplification of the CotE gene region and loss of CotE, and gain of thekanamycin resistance cassette.

A construct was generated (pHP13-AcpC-eGFP) that encoded the exosporiumprotein ApcC (acid phosphatase) fused in frame to the fluorescentreporter protein eGFP (enhanced green fluorescent protein). ThepHP13-ApcC-eGFP construct included the native ApcC promoter, ribosomalbinding site, and coding sequence for ApcC (from B. anthracis ΔSterne),fused in frame to eGFP (from pGFPuv). This construct was generated byPCR amplification of the individual AcpC and eGFP genes withcorresponding primers that contained a 15 bp overlapping regioncorresponding to the alternate amplicons. The two PCR amplicons werethen purified, and combined into a second PCR reaction using externalprimers that contained XhoI sites. The two amplicons prime each otherwith their compatible ends, and create a fusion PCR amplicons, that werepurified and digested with XhoI for 1 hour at 37° C. The spliced PCRproduct was cloned into the SalI site of pHP13, and correct clones weresequence verified and transformed into SCS110 E. coli. The plasmid DNAwas subsequently isolated from the E. coli and introduced into B.anthracis ΔSterne CotE::Kan generated as described above, which wasgrown in brain heart infusion broth containing 10 μg/ml chloramphenicolovernight at 30° C. One milliliter of this culture was inoculated intonutrient broth (50 ml) in a baffled flask and grown at 30° C. for 3days. Spores were collected via centrifugation at 10,000×g for 5minutes, and the supernatant (containing the broken exosporiumfragments) was filtered through a 100,000 Da membrane filter to obtainpurified exosporium fragments containing the fusion proteins.

A transmission electron micrograph showing the CotE knockout spores isprovided in FIG. 4. The closed arrows indicate fragments of exosporiumthat have been separated from the spores, and the open arrow indicates aspore from which the exosporium has been removed.

The purification of the exosporium fragments was performed as follows:CotE::kan spores were grown in brain heart infusion broth overnight at30° C. and swabbed onto nutrient agar plates and grown at 30° C. for 3days. After 3 days, the spores were collected by swabbing the plateswith cotton swabs wetted with PBS and resuspended into 1 ml of PBS in amicrocentrifuge tube. The spores were separated from the culture bycentrifugation, and supernatant containing the exosporium fragmentsfiltered through a 0.22 μM filter to remove any residual spores. Thefiltrate was then filtered through a 100 kDa filter to collectexosporium fragments but allow free proteins to pass through the filter.The 100 kDa filter was washed, and the collected exosporium fragmentsboiled in SDS buffer for 5 minutes and separated by SDS-PAGEelectrophoresis. FIG. 5 provides a photograph of an SDS-PAGE gel showingthe purified exosporium fragments (lane 2) and a protein marker standard(lane 1). The exosporium fragments shown in lane 2 represent theindividual proteins that constitute the exosporium fragments. Only asubset of bands that would normally be seen in a whole spore SDS-PAGEpreparation are apparent.

Ten microliters of the exosporium fragment preparation containing theAcpC-eGFP fusion protein was tested for activity in a phosphatase assayagainst pNPP (p-nitrophenyl polyphosphate). Acid phosphatase activitywas detected by spectrophotometry based on release of p-nitrophenol fromphosphate through phosphatase activity. Briefly, 1 ml of 10 mM pNPP inphosphate buffer at pH 6.0 was incubated with exosporium fragments in a1 ml microcentrifuge tube and allowed to incubate at 37° C. for 10minutes. After 10 minutes, the tube was centrifuged for 1 minute toremove excess spores, and the supernatant read on a spectrophotometer at420 nm for free p-nitrophenol. It was found that the purified exosporiumfragments were able to effectively release the phosphate groups frompNPP, demonstrating that the ApcC was present in the exosporiumfragments. The results of this assay are shown in FIG. 6. In FIG. 6,“CotE control spores” refers to CotE knock-out spores alone (notexpressing the AcpC-eGFP fusion protein), “CotE Acp-eGFP” refers to theCotE knock-out spores expressing the AcpC-eGFP fusion protein, and “CotEAcpC-eGFP fragments” refers to the exosporium fragments obtained asdescribed above from the CotE knock-out spores expressing the AcpC-eGFPfusion protein.

These results demonstrate that mutations that disrupt the exosporium,such as a knock-out mutation in the CotE gene, can be used to generateexosporium fragments that are substantially free of spores, anddemonstrates that these exosporium fragments contain fusion proteinsthat are targeted to the exosporium.

Example 49. Expression of Fusion Proteins in Recombinant Bacillus cereusFamily Members that are Capable of Degrading Herbicides, and Use of SuchRecombinant Bacillus cereus Family Members for Stimulation of PlantGrowth

Recombinant Bacillus cereus family members expressing fusion proteinscan have potent effects on plant health and growth, as illustrated, forexample, in Examples 1-4, 7, 9, 11, 33, 36, 37, and 38 above. The fusionproteins comprising a targeting sequence, an exosporium protein, or anexosporium protein fragment described herein can be used in a number ofdifferent species and strains within the Bacillus cereus family, whichincludes Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis,Bacillus mycoides, Bacillus pseudomycoides, Bacillus samanii, Bacillusgaemokensis, Bacillus weihenstephensis, and Bacillus toyoiensis. Manymembers of the Bacillus cereus family are potent degraders of organicand inorganic material in the environment, and some Bacillus cereusfamily members have the ability to degrade herbicides. Expression of thefusion proteins in such strains would be advantageous since this wouldprovide herbicide degrading activity, thereby alleviating the stress onplants that can be caused by the use of herbicides, in addition to theability to stimulate plant growth or confer other benefits to planthealth, depending on the peptide or protein of interest selected forinclusion in the fusion protein.

Bacillus cereus family member EE349 was isolated, identified, andcharacterized as described above in Example 25, and was found to havethe ability to stimulate plant growth. This strain has further beenfound to have the ability to degrade multiple herbicides, includingsulfonylureas and aryl triazines.

To demonstrate the ability of Bacillus cereus family member EE349 todegrade herbicides, 1×10⁵ Bacillus cereus family member EE349 sporeswere coated onto lentils planted into soil containing variousconcentrations of sulfentrazone. The seeds were allowed to grow at 24°C. for 3 weeks on a 13 hour day/night cycle, with watering every 3 days.After 3 weeks, the plants were measured for root growth. A control setof seeds without Bacillus cereus family member EE349 was planted underidentical conditions.

The results of this experiment can be seen in FIG. 7. In FIG. 7,“protected” refers to seeds treated with Bacillus cereus family memberEE349, and “unprotected” refers to untreated seeds. The y-axis shows theroot length normalized against a water-only control. FIG. 7 shows thatas the concentration of the herbicide was increased, the inhibition ofroot growth also increased. However, application of Bacillus cereusfamily member EE349 to seeds alleviated the majority of this inhibition,even at full strength of the herbicide in soil. Thus, as can be seenfrom FIG. 7, Bacillus cereus family member EE349 can act as a safener.

Moreover, the ability of Bacillus cereus family member EE349 to expressfusion proteins is demonstrated in Example 51 below. Thus, Bacilluscereus family member EE349 can be used as a dual-purpose safener andhost for expression of the fusion proteins comprising a targetingsequence, an exosporium protein, or an exosporium protein fragment thattargets the fusion protein to the exosporium.

Example 50. Preparation of Recombinant Bacillus cereus Family Membersthat Overexpress Exosporium Enzymes and Effects of Such RecombinantBacillus cereus Family Members on Plants

The exosporiums of Bacillus cereus family members naturally containvarious natural enzymes that can have beneficial effects on plants. Forexample, the exosporiums of Bacillus cereus family members containenzymes involved in nutrient solubilization (e.g., acid phosphatasessuch as AcpC), inosine uridine hydrolases, proteases (e.g.,metalloproteases such as InhA1, InhA2, and InhA3), enzymes that catalyzethe degradation of free radicals (e.g., superoxide dismutases such asSODA1 and SODA2), arginases, and alanine racemases. Overexpression ofsuch enzymes in Bacillus cereus family members can provide recombinantBacillus cereus family members that will have beneficial effects whenapplied to seeds, plants, a plant growth media, or an area surrounding aplant or a plant seed.

The metalloproteases InhA2 and InhA3, acid phosphatase (AcpC), andsuperoxide dismutase 1 and 2 were PCR amplified with their nativepromoters with primers that contained XhoI sites (amino acid sequencesfor InhA2, InhA3, AcpC, SODA1 and SODA 2 are provided above in Tables 1and 2, and nucleotide sequences for the native promoters for theseproteins are provided above in Table 3). The PCR products were digestedwith XhoI, and cloned into the E. coli/Bacillus shuttle vector pHP13 viaits SalI site. Correct clones were verified by PCR and DNA sequencing.The plasmids were introduced into Bacillus thuringiensis BT013A andBacillus mycoides EE155. Correct clones were screened by plating onto LBagar plates containing chloramphenicol. Overnight cultures of correctclones were grown in brain heart infusion broth containingchloramphenicol, and 1 ml of this overnight culture was inoculated into50 ml of nutrient broth and cultured for 3 days at 30° C. Sporulationwas verified via light microscopy. Spores were then subjected toenzymatic assays.

Bacillus mycoides EE155 spores overexpressing AcpC (i.e., sporescontaining the pHP13-AcpC (acid phosphatase) plasmid) were assayed forphosphatase activity. One milliliter of the sporulation culture pelletedand the pellet was resuspended in 1 ml of PBS, and tested for activityin a phosphatase assay against pNPP (p-nitrophenyl polyphosphate) asdescribed above in Example 48. The AcpC overexpressing spores had a muchhigher phosphatase activity, as illustrated in FIG. 8. In FIG. 8, they-axis shows units of phosphatase activity, indicated by the release ofp-nitrophenol.

The increased acid phosphatase activity observed for the Bacillusmycoides EE155 spores modified to overexpress AcpC can solubilizenutrients in the environment upon the addition of such spores to a plantgrowth medium or application of such spores to a plant seed, a plant, oran area surrounding a plant or a plant seed. Since phosphate is a veryimportant nutrient for plant growth and development, this can increaseplant growth and provide beneficial effects on plant health.

Similarly, superoxide dismutase is a very powerful antioxidant protein.Overexpression of a superoxide dismutase in a Bacillus cereus familymember would provide spores having the ability to degrade free radicals,which exert stress on plants. Removal of the free radicals wouldalleviate some of this stress and lead to increased plant vigor understressful conditions. Bacillus thuringiensis BT013A sporesoverexpressing SODA1 and SODA2 (i.e., spores transformed with thepHP13-SODA1 and pHP13-SODA2 plasmids, respectively) can be subjected toenzymatic analysis. One milliliter of the sporulation culture can bepelleted and the pellet and resuspended in 1 ml of dH₂O containingxanthine. Xanthine oxidase can then be added to the reaction mixture, aswell as cytochrome C Inhibition of the degradation of cytochrome C inthis assay indicates activity of the superoxide dismutase.

Bacillus mycoides EE155 spores overexpressing a zinc metalloprotease(i.e., spores transformed with the pHP13-InhA2 plasmid) were subjectedto enzymatic analysis. One milliliter of the sporulation culture waspelleted and the pellet was resuspended in 1 ml of PBS. The spores werethen reacted with 0.5% azocasein, a protease substrate, for 5 minutes.These reaction mixtures were precipitated with TCA (trichloroaceticacid) to remove undigested casein, and the absorbance of the remainingfree azo dye was read at ABS595. The spores overexpressing InhA2generated 211% more protease activity as compared to non-recombinantBacillus mycoides EE155 spores.

Examples 3 and 7 above illustrate that expression of a protease on theexosporium of a Bacillus cereus family member can provide beneficialeffects on plants. The Bacillus thuringiensis BT013A spores InhA1,InhA2, or InhA3 would have similar effects upon introduction into aplant growth medium, or application to plant seeds, plants, or an areasurrounding a plant or a plant seed.

Example 51. Expression of Fusion Proteins in an Endophytic Bacilluscereus Family Strain

Bacillus cereus family member EE349 was found to have the ability togrow endophytically and to be capable as serving as a host strain forthe BEMD system. To demonstrate the ability of Bacillus cereus familymember EE349 to grow endophytically and to serve as a host strain forthe BEMD system, Bacillus cereus family member EE349 was transformedwith the pSUPER-BclA 20-35-endoglucanase plasmid (described above inExample 44). Spores were made and purified as described above in Example40.

These spores were diluted to a concentration of 1×10⁵ spores/50 mlwater, and the 50 ml of water was then added to commercial hybrid cornseed in potting soil at planting. The corn seeds were coated with afungicide and a biological inoculant. The corn hybrid variety was BECK5475RR, which contains the ROUNDUP READY glyphosate resistance gene andAQUAMAX drought resistance gene. Plants were grown under artificiallight for 14 hours a day and plant growth over a ten day period wasdetermined. Plants were watered every three days over the course of theexperiment. After ten days, the plants were measured for height andnormalized against the height of untreated corn plants. The results ofthese experiments are shown in Table 53.

TABLE 53 Effects of an endophytic Bacillus cereus family memberexpressing the BclA 20-35-endoglucanase fusion protein on corn seedlinggrowth Corn Growth Plasmid Expression Strain (Normalized) None (Control)None   100% None Bacillus cereus family member 104.1% EE349 pSUPER-BclA20-35- Bacillus cereus family member 111.5% endoglucanase EE349

As can be seen from the data shown in Table 53, expression of thepSUPER-BclA 20-35-endoglucanase in the endophytic strain Bacillus cereusfamily member EE349 resulted in increased corn growth as compared tountreated plants, or plants treated with Bacillus cereus family memberEE349 alone.

Bacillus cereus family member 349 expressing the BclA20-35-endoglucanase was then isolated from the inside of the cornplants. The ten day old plants were extracted from the soil and washedto remove excess debris. The plants were then inverted, exposed to 5%bleach for ten minutes, washed in water, exposed to hydrogen peroxide(10%) for ten minutes, washed again in water, and the stalks split witha sterile razor blade. The split halves of the stalks were placed facedown onto nutrient agar plates for two hours. After two hours, thestalks were removed, and the agar plates incubated at 30° C. for 48hours. After 48 hours, the plates were examined for colony morphology,and Bacillus cereus family member colonies found internal to the plantwere toothpicked onto nutrient agar and nutrient agar plus tetracyclineplates (to select for bacteria containing the pSUPER-20-35BclA-endoglucanase plasmid). The resultant increase in Bacillus cereusfamily member 349 colony numbers is indicated shown in Table 54. Theseresults demonstrate the ability of the BEMD system to be introduced intothe target plant by expression in an endophytic strain of the Bacilluscereus family.

TABLE 54 Endophytic assay on Bacillus cereus family member EE349Endophytic Bacillus cereus Tetracycline resistant Bacteria familybacteria Bacillus cereus Treatment (Total) (all strains) family membersH₂O (Control) 156 31 0 Bacillus cereus 221 64 21 family member EE349transformed with pSUPER-20- 35 BclA- endoglucanase

Tetracycline resistant Bacillus clones were grown overnight at 30° C. inbrain heart infusion broth plus tetracycline, and spun down at 10,000×gfor 5 minutes. The supernatant was removed, and the pellet frozenovernight at −20 C. Chromosomal DNA was then extracted from each clone,and the presence of the pSUPER-20-35 BclA-endoglucanase plasmiddetermined by transformation of the chromosomal DNA (containing theplasmid) into DH5α E. coli cells and plating on LB plus ampicillinplates. Correct clones were subjected to DNA sequence analysis, whichverified that Bacillus cereus family member 349 was internal to theplant (endophytic) and contained the plasmid.

Many endophytic bacteria were found in the corn seedlings, with a numberof different strains and species within the Bacillus cereus family foundinside both the control and the EE349 treated plants. The tetracyclineresistant Bacillus cereus family members (indicating the presence of thepSUPER-20-35 BclA-endoglucanase plasmid) were only found in the treatedcorn seedlings, and all had the same colony morphology of the originalexpression host, Bacillus cereus family members EE349. The presence ofthe pSUPER 20-35 BclA-endoglucanase plasmid was verified by PCRamplification using unique primers.

Example 52. Isolation, Identification, and Characterization ofEndophytic Bacillus cereus Family Bacterial Strains

In addition to the endophytic strain Bacillus cereus family member 349discussed above in the immediately preceding example, several otherBacillus cereus family members that have the ability to growendophytically were also identified: Bacillus cereus family memberEE439, Bacillus thuringiensis EE417, Bacillus cereus EE444, Bacillusthuringiensis EE319, Bacillus thuringiensis EE-B00184, Bacillus mycoidesEE-B00363, Bacillus pseudomycoides EE-B00366, and Bacillus cereus familymember EE-B00377.

To obtain these additional Bacillus cereus family members, commercialhybrid corn seed was planted in potting soil and allowed to grow. Thecorn seeds were coated with a fungicide and a biological inoculant.Plants were grown under artificial light for 14 hours a day and plantgrowth over a 14 day period was determined. Plants were watered everythree days over the course of the experiment. After 14 days, the plantswere extracted from the soil and washed to remove excess debris. Theplants were then inverted, exposed to 5% bleach for ten minutes, washedin water, exposed to hydrogen peroxide (10%) for ten minutes, washedagain in water, and the stalks split with a sterile razor blade. Thesplit halves of the stalks were placed face down onto nutrient agarplates for two hours. After two hours, the stalks were removed, and theagar plates incubated at 30° C. for 48 hours. After 48 hours, the plateswere examined for colony morphology, and Bacillus cereus family membercolonies found internal to the plant were toothpicked onto nutrientagar. These were then were grown overnight at 30° C. in brain heartinfusion broth, and spun down at 10,000×g for 5 minutes. The supernatantwas removed, and the pellet frozen overnight at −20° C. Chromosomal DNAwas then extracted from each clone, and the identity of each colonyverified by PCR using 16S rRNA primers and amplicons were sent for DNAsequencing and identification. The 16S rRNA sequences for these strainsare provided above in Table 13.

Example 53. Isolation, Identification, and Characterization ofAdditional Endophytic Bacterial Strains (Non-Bacillus cereus FamilyMembers

The endophytic bacterial strains Bacillus megaterium EE385, Bacillus sp.EE387, Bacillus circulans EE388, Bacillus subtilis EE405, Lysinibacillusfusiformis EE442, Lysinibacillus spp. EE443, and Bacillus pumilusEE-B00143 were isolated from corn seedlings. Two week old corn seedlingswere first sterilized. The plants were extracted them from the soil andwashed them to remove excess debris. The plants were then inverted,exposed to 5% bleach for ten minutes, washed in water, exposed tohydrogen peroxide (10%) for ten minutes, and washed again in water. Thestalks were then split with a sterile razor blade. The split halves ofthe stalks were placed face down onto nutrient agar plates for twohours. After two hours, the plant stems were removed from the plates,and the plates were then incubated at 30° C. for 48 hours. Bacillicolonies that were endophytic were selected for further analysis. Thesestrains were grown up in brain heart infusion broth overnight at 30° C.,and the cultures subjected to extraction of DNA using a QiagenChromosomal DNA Kit. The DNA was PCR amplified to obtain the 16S rRNAgene, which was sent for DNA sequencing. The resultant sequences BLASTsearched using the NCBI databases to establish the identity of theBacilli species. The 16S rRNA sequences are provided above in Table 14.

Example 54. Expression of Fusion Proteins Comprising a Spore CoatProtein in Endophytic Bacillus Bacterial Strains

The endophytic bacterial strains Bacillus thuringiensis EE319, Bacillusfirmus A30, and Bacillus lichenformis A4 were transformed to containplasmids encoding various spore coat proteins fused to endoglucanase.The plasmids pHP13-CotC-endoglucanase and pHP13-CgeA-endoglucanase werecreated. Each of these plasmids encoded the spore coat protein (CotC orCgeA) fused in frame with to a polyalanine linker containing eightalanine residues and endoglucanase. The polyalanine linker andendoglucanase were fused to the carboxy terminus of the spore coatproteins.

To create the plasmids encoding the fusion proteins, the endoglucanasegene from Bacillus subtilis 168 was PCR amplified. The genes encodingthe spore coat proteins CotC and CgeA were also PCR amplified from thechromosomal DNA of Bacillus subtilis 168 (CotC) or Bacillusamyloliquefaciens (CgeA). Correct amplicons were then subject tosplicing by overlapping extension PCR to generate the fusion protein DNAfragment through annealing of homologous 15 bp overhangs. Externalprimers were each engineered to contain XhoI sites. The amplicons werecleaned up with a Promega PCR clean up kit, and the DNA digested withXhoI and ligated into the SalI site of pHP13. The plasmid DNAs were thensequenced, transformed into E. coli cells, and the DNA introduced intothe various endophytic Bacillus strains.

Spores of each of the recombinant Bacillus species expressing the fusionproteins were generated by swabbing overnight cultures onto nutrientagar plates, which were then incubated at 30° C. for 72 hours. After 72hours, bacterial spores were collected from the plates by swabbing intosterile PBS. Spores were purified by density centrifugation three times,diluted to 1×10⁸ CFU/ml, and assayed for endogloconase activity asdescribed above in Example 45. The results of this assay are shown inTable 55 below and in FIG. 9.

TABLE 55 Endogloconase activity in Bacillus spores expressing fusionproteins CotC-endoglucanase or CgeA-endoglucanase Enzyme Reading/Plasmid Expression Strain Activity Spore Control Bacillus firmus A30.201 Spore Control Bacillus thuringiensis .206 BT013A pHP13-CgeA-Bacillus firmus A30 .818 endoglucanase pHP13-CotC- Bacillusthuringiensis 1.738 endoglucanase EE319 pHP13-CotC- Bacilluslicheniformis 0.414 endoglucanase A4

In FIG. 9, CotC1, CotC2, and CotC3 are three separate experimentalsporulation cultures of Bacillus thuringiensis EE319 withpHP13-CotC-Endo.

Example 55. Effects of Bacillus Spores Expressing Fusion ProteinsCotC-Endoglucanase, CotB-Endoglucanase, or CgeA-Endoglucanase on Growthof Corn and Soy Seeds

Spores of the recombinant Bacillus species expressing the fusionproteins comprising a spore coat protein and endoglucanase (e.g., theCotC-endoglucanase, CotB-endoglucanase, or CgeA-endoglucanase fusionproteins described above in the immediately preceding example) can betested for their effects on the growth of plants (e.g., corn and soy) asfollows. Spores can be generated as described above in the immediatelypreceding example, washed, diluted to 1×10⁸ CFU/ml in water, and appliedto plant seeds (e.g., corn and soy seeds) at a rate of 1×10⁵⁷spores/seed. The spores can then be applied either as a seed treatmentor as a soil drench. The plants can be planted 1″ deep in 4″ pots, andgrown at 18.3° C. with a 13 hour light/dark cycle. After two weeks,plant height and root length can be determined.

Example 56. Delivery of Probiotic Bacteria to Animals by Feeding PlantsComprising Such Bacteria to the Animal

Probiotic bacteria can be delivered to animals (e.g., livestock, fish,or other animals) by applying the probiotic bacteria to a plant seed, toa plant growth medium (e.g., by in furrow application to soil), to aplant (e.g., by foliar application) or to an area surrounding a plant ora plant seed, and subsequently feeding such plants or plants grown fromthe plant seeds to the animal. Bacteria can be applied to plant leavesor stems while plants are growing, and will colonize the phylloplane(leaf and stem surface). The plants can be subjected to processing intoanimal feed prior to feeding to the animal.

The use of endophytic strains of bacteria in such methods allows thebacteria to survive and persist in plant tissue, such that they will beingested in significant numbers by the animal upon ingestion of plantmatter from the plant. For example, the strains Bacillus cereus familymember EE349, Bacillus cereus family member EE439, Bacillusthuringiensis EE417, Bacillus cereus EE444, Bacillus megaterium EE385,Bacillus sp. EE387, Bacillus circulans EE388, Bacillus subtilis EE405,Lysinibacillus fusiformis EE442, Lysinibacillus spp. EE443, and Bacilluspumilus EE-B00143 are thought to be probiotic and are endophytic and canbe used in these methods.

Any of these strains or other probiotic and endophytic strains can begrown and spores generated as described above in Example 40. The sporescan then be applied to a plant growth medium, a plant seed, a plant, oran area surrounding a plant or a plant seed. Plants grown in the plantgrowth medium, plants grown from the plant seeds, plants to which thebacteria were applied, or plants or plant seeds grown in an area towhich the bacteria were applied can grow and subsequently be fed to ananimal. Endophytic bacteria can colonize the internal tissue of theplant, and replicate to great numbers inside the plant. The bacteriawill sporulate upon the use of traditional harvesting methods, allowingfor prolonged storage of plant matter (e.g., as hay or silage) that canlater be fed to a target animal.

Only a small amount of bacteria needs to be used in these methods, sincethe endophytic bacteria will naturally colonize and proliferate on andin the plants.

Example 57. Delivery of Beneficial Enzymes to Animals by Feeding to theAnimals Plants Comprising a Recombinant Bacillus cereus Family Member orOther Recombinant Bacteria Expressing a Fusion Protein Comprising theBeneficial Enzyme

The recombinant Bacillus cereus family members expressing a fusionprotein comprising a protein or peptide of interest and a targetingsequence, exosporium protein, or exosporium protein fragment thattargets the fusion protein to the exosporium that are described hereincan also be used to deliver beneficial enzymes to animals. Therecombinant Bacillus cereus family members can be fed directly to theanimals (e.g., by mixing a recombinant Bacillus cereus family memberinto animal feed that is subsequently fed to the animal). Alternatively,the methods described above in the immediately preceding example fordelivering bacteria to animals can be used in connection withrecombinant Bacillus cereus family member expressing a fusion proteinthat comprises a protein or peptide that has beneficial effects in ananimal (e.g., an enzyme that aids digestion of plant matter).

Enzymes present in feed for livestock, fish, and other animals canimpact the nutrient uptake, yield, and health of the animal that ingeststhe enzymes. Enzymes that are beneficial for animal health include, forexample, xylanases, phytases, phosphatases, proteases, cellulases,endoglucanases, glucanases, amylases, lipases, phospholipases,glycosylases, galactanases, α-galactosidases, amylases, pectinases,biotinases, and polygalacturonases, among others. The BEMD system can beused to express such enzymes on the surface of the exosporium.Recombinant Bacillus cereus family members expressing a fusion proteincomprising one of these enzymes can be applied to a plant growth medium,a plant seed, a plant, or an area surrounding a plant or a plant seed.Similarly, the recombinant bacteria that express a fusion proteincomprising one of these enzymes and a spore coat protein that targetsthe fusion protein to a surface of a spore of the bacterium can be usedin these methods. The recombinant bacteria can be applied to a plantgrowth medium, a plant seed, a plant, or an area surrounding a plant ora plant seed. Plants grown in the plant growth medium, plants grown fromthe plant seeds, plants to which the bacteria were applied, or plants orplant seeds grown in an area to which the bacteria were applied can begrown and subsequently fed to an animal, and the beneficial enzymethereby delivered to the animal. The bacteria will sporulate upon theuse of traditional harvesting methods, allowing for prolonged storage ofplant matter (e.g., as hay or silage) that can later be fed to a targetanimal.

Endophytic strains of Bacillus cereus family members can be used ashosts for expression of the fusion proteins comprising a protein orpeptide of interest (e.g., an enzyme having beneficial effects inanimals) and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium. Forexample, the endophytic strains Bacillus cereus family member EE349,Bacillus cereus family member EE439, Bacillus thuringiensis EE417,Bacillus cereus EE444, and Bacillus thuringiensis EE319 described hereincan be used as hosts.

Additional Bacillus cereus family members can be selected to be appliedto the aerial portions of the plant, as these bacteria do not have to beendophytic to colonize the phylloplane. For example, Bacillus mycoidesBT155, Bacillus mycoides EE118, Bacillus mycoides EE141, Bacillusmycoides BT46-3, Bacillus cereus family member EE218, Bacillusthuringiensis BT013A, Bacillus thuringiensis EE-B00184, Bacillusmycoides EE-B00363, Bacillus pseudomycoides EE-B00366, or Bacilluscereus family member EE-B00377 can be used for this purpose.

Similarly, endophytic strains of recombinant bacteria can be used ashosts for the expression of fusion proteins comprising a protein orpeptide of interest and a spore coat protein that targets the fusionprotein to a surface of a spore of the bacterium. For example, theendophytic strains Bacillus megaterium EE385, Bacillus sp. EE387,Bacillus circulans EE388, Bacillus subtilis EE405, Lysinibacillusfusiformis EE442, Lysinibacillus spp. EE443, or Bacillus pumilusEE-B00143 can be used as hosts.

The use of endophytic strains of bacteria in these methods allows thebacteria to survive and persist in plant tissue, such that both thebacteria and the fusion proteins expressed by the bacteria will beingested in significant numbers by the animal upon ingestion of plantmatter from the plant. Thus, through a simple addition of therecombinant Bacillus cereus family member or other recombinant bacteriaat planting, beneficial enzymes can be spread throughout the planttissue and delivered to animals upon ingestion of plant matter.

Example 58. Use of Various Targeting Sequences to Express Endoglucanaseon the Surface of Bacillus cereus Family Member Spores, and Use of SuchSpores for Promoting Plant Growth

The pSUPER plasmid was modified by cloning of a PCR generated fragmentthrough homologous recombination that fused the BclA promoter, startcodon, and amino acids 20-35 of BclA (amino acids 20-35 of SEQ ID NO: 1)in frame with Bacillus subtilis 168 endoglucanase (pSUPER-BclA20-35-Endo) as described above in Example 44. This plasmid was thensubjected to inverse PCR to amplify the entire plasmid backbone, butleaving out the sequence corresponding to amino acids 20-35 of BclA.This inverse PCR product was combined with a PCR product that amplifiedthe equivalent region from each of SEQ ID NOs. 5, 15, 25, 81, 85, 87, oramino acids 20-33 of SEQ ID NO: 1. Thus, constructs were created thatcontained each of the following targeting sequences fused in frame withBacillus subtilis 168 endoglucanase: (1) amino acids 20-35 of SEQ ID NO:1; (2) amino acids 23-38 of SEQ ID NO: 5; (3) amino acids 28-43 of SEQID NO: 15; (4) amino acids 9-24 of SEQ ID NO: 25; (5) amino acids 23-38of SEQ ID NO: 81; (6) amino acids 13-28 of SEQ ID NO: 85; (7) aminoacids 13-28 of SEQ ID NO: 87; and (8) amino acids 20-33 of SEQ ID NO: 1.Each construct contained the wildtype BclA promoter and a methionine atthe start codon, followed by the targeting sequence fused in frame tothe Bacillus subtilis endoglucanase gene. Each of these constructs wastransformed into E. coli and plated to obtain single colonies on Luriaplates plus ampicillin (100 μg/ml). Plasmids from each single colonywere grown up in overnight cultures in Luria broth plus ampicillin, andpurified using a WIZARD SV miniprep kit, and sequences were verified bySanger sequencing. DNA was also quantified via spectrophotometry, andthe DNA was introduced into Bacillus thuringiensis BT013A. In addition,the pSUPER-BclA-20-35 Endo construct was introduced into Bacillusthuringiensis BT013A which had the native BclA protein removed from itsgenome through homologous recombination (BclA knockout, “BclA KO”).Correct colonies were screened by plating on nutrient broth platecontaining antibiotic (tetracycline at 10 μg/ml). Each positive colonywas grown up in brain heart infusion broth at 30° C. overnight at 300rpm, with antibiotic, and genomic DNA was purified and re-sequenced toverify genetic purity. Verified colonies were grown overnight in brainheart infusion broth with 10 μg/ml tetracycline, and induced tosporulate through sporulation in a yeast extract-based media.

Each of the production runs in the yeast extract-based media werecollected at 48 hours post production of spores, and subjected to enzymecomparison of the resultant spores using the methodology described abovein Example 45. The absorbance was determined at 540 nm using an IMPLENnanophotometer model P330. There were three samples and a blank for eachreaction. The results from the enzyme readings are shown in Table 56.

For corn, 1 μl of each of the whole broth for each of the constructs wasplaced onto each seed. For summer squash, 2 μl of whole broth for eachconstruct was placed onto each seed. To accomplish this, 50 seeds wereplaced in a 50 ml conical bottom polypropylene tube and vortexed lightlyusing a vortex mixer. To this swirling of seeds, 50 μl (for corn) or 100μl (for squash) of broth containing the recombinant spores was slowlypipetted into the tube, and the vortexing action coated the seeds withan even coating of the whole cell broth from each construct. These seedswere then planted at 1″ deep into native soil using a 39.6 cm³ (15.6in³) planting pot, with two seeds per pot. The pots were then watered tosaturation, and the plants allowed to germinate. The plants were grownin a controlled growth room, set to 70° F. during the day, and 60° F.during the evening, with a light period of 14 hours/day, underartificial light conditions, for 14 days. After 14 days, the plants weremeasured for height, and results were normalized to a control group thatreceived only water as treatment on the seeds.

TABLE 56 Enzyme levels and plant growth phenotypes. Endo Enzyme SequenceSequence Corn Squash Average Plant Targeting Levels Identity to AAIdentity to AA Growth Growth Phenotype Sequence (mU/ml) 20-35 of BclA25-35 of BclA Phenotype Phenotype Change Control (H₂O) 0 mU/ml N/A N/A  100%   100%   100% AA 20-35 of BclA 38.2  100%  100%   112%  94.7%103.4% (SEQ ID NO: 1) AA 23-38 of 33.5 50.0% 72.7% 106.7% 102.3% 104.5%SEQ ID NO: 5 AA 28-43 of 16.7 68.8% 81.8% 115.7% 103.4% 109.6% SEQ IDNO: 15 AA 9-24 of 25.7 56.3% 63.6% 118.4% 107.1% 112.8% SEQ ID NO: 25 AA23-38 of 21.5 50.0% 72.7% 106.7%  98.3% 102.5% SEQ ID NO: 81 AA 13-28 of38.3 43.8% 54.5%  99.7% 100.5% 100.1% SEQ ID NO: 85 AA 13-28 of 14.443.8% 54.5% 102.6% 104.1% 103.4% SEQ ID NO: 87 AA 20-33 of 30.5 N/A 100% 104.6% 100.7% 102.7% SEQ ID NO: 1 AA 20-35 of 100.8  100%  100% NDND ND SEQ ID NO: 1 in BT013A BclA KO AA = amino acids ND = notdetermined

The above data show that each of these constructs was able to stimulateplant growth and show that the use of different targeting sequencesallows for control of the expression level of the enzyme on the outsideof the spore.

Use of amino acids 20-35 of SEQ ID NO: 1 or AA 13-28 of SEQ ID NO: 85 asthe targeting sequence resulted in the highest levels of enzymeproduction. This is surprising considering the low degree of identitybetween these targeting sequences (43.8% identity over the entire lengthof the targeting sequence). Use of amino acids 28-43 of SEQ ID NO: 15 oramino acids 9-24 of SEQ ID NO: 25 resulted in the largest plant responseacross the two plant types. Expression of the fusion protein containingamino acids 20-25 of SEQ ID NO: 1 as the targeting sequence in theBT013A BclA KO host led to very large (263.8%) increase in the amount ofenzyme activity on the surface of the spores as compared to expressionof the same fusion protein in the wild-type strain.

Example 59. Use of Various Targeting Sequences and Exosporium Proteinsto Express Phospholipase, Lipase, and Endoglucanase on the Surface ofBacillus cereus Family Member Spores, and Use of Such Spores forPromoting Plant Growth

The pSUPER plasmid was modified by cloning of a PCR generated fragment(XhoI digestion and ligation) that fused the BclA promoter, start codon,and amino acids 20-35 of BclA (amino acids 20-35 of SEQ ID NO: 1)followed by a six alanine linker sequence in frame with either Bacillusthuringiensis phosphatidylcholine-specific phospholipase C gene (PC-PLC)(pSUPER-BclA 20-35-PL) or Bacillus subtilis lipase LipA(pSUPER-BclA-20-35-Lipase), or Bacillus subtilis endoglucanase eglS(pSUPER-BclA-20-35-Endo) as described above in Example 44. Theseplasmids were then subjected to inverse PCR to amplify the entireplasmid backbone, but leaving out the sequence corresponding to theamino acids 20-35 of BclA. This inverse PCR product was combined with aPCR product that amplified the equivalent region from each of SEQ IDNOs. 5 (i.e., amino acids 23-38 of SEQ ID NO: 5), 15 (i.e., amino acids28-43 of SEQ ID NO: 15), and 25 (i.e., amino acids 9-24 of SEQ ID NO:25; the full-length exosporium proteins of SEQ ID NOs. 120, 111, 121,108, and 114; or amino acids 20-33, 20-31, 21-33, 23-33, or 23-31 of SEQID NO: 1. Each of these constructs contained the wild-type BclApromoter, a methionine at the start codon, followed by the targetingsequence or exosporium protein fused in frame to the Bacillus cereusphosphatidylcholine-specific phospholipase C, Bacillus subtilis 168Lipase LipA, or Bacillus subtilis 168 eglS endoglucanase gene. Each ofthese constructs was screened for correct transformants as described inExample 58 above.

Each of the production runs in the yeast extract-based media werecollected at 48 hours post production of spores, and subjected to enzymecomparison of the resultant spores. Determination of enzyme data forendoglucanase was performed as described above in Example 58. For thephospholipase C enzyme assay, 1 ml of recombinant spores was pelleted at10,000×g for 3 minutes, and supernatant removed and discarded. The sporepellet was then resuspended in 500 μl reaction buffer (0.25 mM Tris-HCL,60% glycerol, 20 mM o-nitrophenyl phosphorylcholine, pH 7.2). A negativecontrol for enzyme assays contained BT013A spores with no enzymeexpression. Each sample was incubated at 37° C. for 18 hours,centrifuged again to remove the spores, diluted 1:1 in water, and theAbs540 read using a spectrophotometer. This was compared to a standardcurve against commercially purchased phospholipase and lipase controlsto establish the U/ml of activity. The results from the enzyme readingsare shown in Tables 57 and Table 58.

TABLE 57 Endoglucanase Enzyme Levels Targeting Sequence, Experiment #1Endoglucanase Levels (mU/ml) Control (H₂O) 0 mU/ml AA 20-35 SEQ ID NO: 138.2 SEQ ID NO: 120 25.7 SEQ ID NO: 111 29.7 SEQ ID NO: 121 24.4 SEQ IDNO: 108 24.0 SEQ ID NO: 114 11.0 AA 20-33 of SEQ ID NO: 1 30.5 TargetingSequence, Experiment #2 Endoglucanase Levels (mU/ml) AA 20-31 of SEQ IDNO: 1 48.22 AA 21-33 of SEQ ID NO: 1 60.86 AA 23-33 of SEQ ID NO: 119.93 AA 23-31 of SEQ ID NO: 1 45.31 AA 20-35 of SEQ ID NO: 1 54.1  AA =Amino acids

Many of the targeting sequences and exosporium proteins were able todisplay a large amount of active enzymes on the surface of the spores,including SEQ ID NOs. 108, 111, 114, 120, and 121. Amino acids 20-31,21-33, and 23-31 of SEQ ID NO: 1 provided similar enzyme expressionlevels to amino acids 20-35 of SEQ ID NO: 1, indicating that smallerfragments are adequate for the display of enzymes on the surface of thespores. Only amino acids 23-33 of SEQ ID NO: 1 exhibited a diminishedenzyme display level on the spores.

TABLE 58 Phospholipase Enzyme levels Targeting Sequence PC-PLC EnzymeLevels Lipase Enzyme Levels Control (H₂O) 0.0 0.0 AA 20-35 SEQ .787 .436ID NO: 1 AA 23-38 of .688 .602 SEQ ID NO: 5 AA 28-43 of .372 .228 SEQ IDNO: 15 AA 9-24 of SEQ .247 .359 ID NO: 25 SEQ ID NO: 114 .446 .798 SEQID NO: 120 3.612 .753 SEQ ID NO: 111 .738 .329 AA = Amino acids

Similar to the results shown above in Table 57, the highest levels ofphospholipase or lipase on the spore surface were observed when aminoacids 20-35 of SEQ ID NO: 1, amino acids 23-38 of SEQ ID NO: 5, or theexosporium protein sequence of SEQ ID NO: 120 were used.

The effects of these spores expressing several of these constructs onnodulation in soybeans are shown below in Table 59.

TABLE 59 Phospholipase Plant Responses Nodulation per Targeting SequencePlant (Soybean) Control (H₂O) 9.8 Strain Control (Bacillus thuringiensisBT013A) 8.2 Bacillus thuringiensis BT013A expressing a fusion 14.0protein of AA 20-35 of SEQ ID NO: 1 and phospholipase

Soybeans plants were coated as above, but the assay was run out to 3weeks' time. Plants were carefully removed, dirt washed gently off ofthe roots, and nodules counted for each plant. As shown in Table 59,addition of spores displaying phospholipase onto the seeds of soybeanallows for an accelerated number of nodules on the plants, which is apositive indication for both early growth as well as eventual increasesin yield in soybeans.

Example 60. Binding of MIR319 RNA and Random RNA 1 to Bacillus cereusSpores Expressing a Fusion Protein Containing a Nucleic Acid BindingProtein, and Use of Such Spores to Deliver RNA to Plants

DNA and RNA can be bound to Bacillus cereus family member spores thatexpress fusion proteins containing a targeting sequence and a nucleicacid binding protein or peptide on their exosporium, as described in theabove Examples and in the Description. The spores act as a deliverymechanism, delivering the target nucleic acid (e.g., a miRNA) to thetarget plant. To demonstrate this ability of the recombinant Bacilluscereus family member spores, a common miRNA, MIR319 was delivered tosoybeans using spores expressing a fusion protein containing amino acids20-35 of SEQ ID NO: 1 fused in frame to the known DNA binding gene SspC.MIR319 has different effects on plant phenotype in different plants, andeven within different parts of the same plant. For example, in somespecies, treatment of leaves with MIR319 leads to curling of leaves,whereas in other species, application of MIR319 leads to stressresistance. MIR319 is ubiquitous across plant genomes, is a globalregulator of pathways, and its delivery into various plants leads tovarious phenotypes.

TABLE 60 RNAs used in this study RNA 3′ Sequence 5′ Sequence MIR319UUGGACUGAAGGGUGCUCCC GAGCUCUCUUCAGUCCACUC  (SEQ ID NO: 306)(SEQ ID NO: 307) or AGAGCGUCCUUCAGUCCACUC (SEQ ID NO: 308) RandomGAGCCCATGGTTGAATGAGT ACTCATTCAACCATGGGCTC  RNA #1 (SEQ ID NO: 309)(SEQ ID NO: 310)

Synthetic MIR319 microRNA from Glycine max (soybean) was designed tomatch the MIR319 sequence available in miRBase (miRBase.org, centralrepository for microRNA sequences). Two partially complementary singlestranded sequences were synthesized by Integrated DNA Technologies (IDT,Iowa) to represent the 3′ and 5′ mature gene products known to exist invivo (two different versions of the 5′ sequence were used). Likewise,two single stranded RNAs were synthesized with random sequences notmatching anything in the soy genome as a control. The double stranded(ds) gene products were made by combining the two single stranded (ss)products at 95° C. for 10 min and then cooling slowly at roomtemperature to allow for annealing. Bacillus thuringiensis expressing afusion protein containing the BclA promoter, a methionine residue as thestart codon, and amino acids 20-35 of SEQ ID NO: 1 fused in frame to theknown DNA binding gene SspC (an α/β type SASP, Small Acid-soluble SporeProtein C of Bacillus thuringiensis BT013A) was engineered by standardcloning procedures as described above in Example 58. This construct(SspC-BclA) was created in E. coli, transformed into Bacillusthuringiensis BT013A and clones verified by DNA sequencing. B.thuringiensis spores expressing SspC-BclA were obtained by an overnightgrowth of transformed bacteria in brain heart infusion broth (BHI) for 2days in a yeast extract-based media until a density of 2×10⁸ spores permilliliter (ml) was achieved with less than 1% vegetative cells. DNA wasextracted from an aliquot of the parent BHI culture and sent forsequencing to confirm incorporation of the SspC-BclA plasmid. To preparespores for seed treatments, 1 ml of spore culture in the yeastextract-based media was pelleted by centrifugation and resuspended in100 μl of water. This concentrated suspension was counted and sporeswere used at 6×10⁸ spores/ml. For each soy seed, 1 μl of spores wascombined with 10 μl of RNA at 10 μM and incubated at 30° C. for 2 hours(scaled up for multiple seeds). After this incubation spores werepelleted (carrying bound RNA) and unbound excess RNA in the supernatantwas discarded and the pellet was resuspended in 10 μl of water. Sampleswere applied to the seeds as follows: 39.6 cm³ (15.6 in³) of Timberlinebrand commercial top soil was prepared in each pot and a 1 inchindentation was made where 2 ml of water was applied and a single seedwas set on top. The 10 μl spore+ bound RNA sample was applied bymicropipetting directly on to the top of the seed. Seeds were allowed tosit for 30 min and then the adjacent soil was pushed to loosely coverthe seed. The seeds were allowed to germinate for 4 days in anartificial light plant growth room with a 13/11 hour light/day cycle,and at 21° C. day/15° C. night temperature range. On day 14 soy plantswere uprooted, photographed and measured. Heights were normalized towater control treated plants (See Table 61).

Example 41 above describes the ability of the SspC-BclA recombinantBacillus cereus family member spores to bind to and hold DNA. To assessRNA binding ability of the SspC-BclA expressing spores, biotin labeledrandom RNA sequences were synthesized by IDT and incubated with thespores exactly as was done for the treatments described above (1 μl ofspores at 6×10⁸ spores/ml+10 μl of 10 μM RNA for 2 hours at 30° C.,pelleted and resuspended in 10 μl of water). Avidin conjugated toFluorescein (FITC) (Life Technologies) was added to the 10 μl spore+RNAsample at 20 μg/ml final concentration and incubated for 1 hour at roomtemperature in the dark. Avidin is known to bind biotin and FITC is afluorescent tracer. Spores were pelleted once again to remove excessunbound avidin-FITC and resuspended in 4% paraformaldehyde made in PBSand stored at 4° C. overnight in the dark. Spores were inspected forfluorescence and photographed (See Table 62). In addition, as shown inFIG. 10, the Sspc-BclA tagged spores were able to bind and retain bothssRNA and dsRNA, as shown by the FITC-avidin labeling of spores in thepresence of the ssRNA or dsRNA bound with biotin. To generate theresults shown in FIG. 10, spores were incubated with either double orsingle stranded RNA (of a random sequence) tagged with biotin anddetected with avidin conjugated to fluorescein (FITC). No fluorescencewas detected on spores incubated with water only. Brightfield andcorresponding fluorescent images were taken with 40× objective and 10×ocular lenses.

As can be seen in Table 61 below, the major effect of MIR319 as a seedtreatment on soybeans is on root growth and overall height. Curly rootswere defined as having at least two 180° turns. Heights were measuredalong the main stalk. When soybean plants were uprooted and assayed forthe presence of “curly roots”, a phenotype observed by our groupspecific to soybeans, no evidence of curly roots was found in the watercontrol, the BT013A strain control, the double stranded (dsRNA) RNAalone control, or the spores alone (carrier control). The only evidenceof curly roots is noted when both the SspC-BclA spores (the carrier) wasdelivered to the seed with the dsRNA (60% curly roots) (also see FIG.10). FIG. 11 also shows the phenotypic changes in the soybean plantswhen exposed to SspC-BclA spores combined with ds MIR319 RNA. When thespores are used to deliver the RNA, the impact of the RNA is amplified,leading to an increased stunting and curly root phenotype in FIG. 11. Togenerate the results shown in FIG. 11, soy seeds were treated withdouble stranded (ds) MIR319 with or without prior binding to B.thuringiensis spores expressing SspC-BclA. Application of dsMIR319resulted in slightly taller plants on average; however, application ofdsMIR319 bound to spores resulted in “curly” roots defined as having atleast two 180° turns and overall less height. The median sample fromeach experimental condition is shown. Images were taken using a digitalcamera with plants together in a single image.

As an RNA control, a random set of ssRNA (single-stranded) and dsRNA wasapplied to soybeans. In these experiments, the random ssRNA had noeffect when applied alone, while the dsRNA had a stunting effect on theheight of the plants when delivered to the seeds. In both cases, whenthe spores (carrier) were used in conjunction with either the randomssRNA or the dsRNA version, the stunting phenotype was increasedsignificantly (33% and 27.8% stunted, respectively). This stunting isnot evident in the spore (carrier control) alone samples. These data,when taken together, demonstrate the ability of the spores to amplifyand specifically deliver ssRNA and dsRNA to plants by application to theseed, and demonstrate the ability of two different RNAs (Random #1 andMIR319) to affect phenotype when delivered via Bacillus cereus sporesexpressing a fusion protein containing a DNA/RNA binding protein.

TABLE 61 Root and Height effect of MIR319 on soybean development SeedTreatment % Curly Height (5 replicates each) Roots (Normalized toControl) Water (Control) 0   100% Water + Spores (Control) 0 105.21% Random ssRNA #1 no spores 0 102.62%  Random ssRNA #1 + spores 0 69.62%dsMIR319 no spores 0 125.30%  dsMIR319 + spores    60%  67.10% RandomdsRNA #1 no spores 0 82.40% Random dsRNA #1 + spores 0 54.61%

TABLE 62 Fluorescence detection on SspC-BclA expression spores withbound biotin labeled RNA Fluoresence Detected Spore Treatment on SporesSpores + Water (control for background spore fluorescence) Not detectedSpores + Water + Avidin-Fitc (control for background Not Detectedspore + FITC fluorescence) Spores + biotin labeled ssRNA + Avidin-FITCDetected Spores + biotin labeled dsRNA + Avidin-FITC Detected

As can be seen in Table 62, no fluorescence was detected on the sporeswithout the presence of RNA. Both single stranded (ss) and doublestranded (ds) RNA was detected on the spores.

Example 61. Delivery of Nucleic Acids to Caenorhabditis elegansNematodes by Ingestion of Recombinant Bacillus thuringiensis SporesExpressing a Fusion Protein

Delivery of RNA and DNA to nematodes has a great deal of applications inboth plant science, animal health, and in basic research. Nematodescause a great deal of damage and yield loss to commercial andnon-commercial growing operations for key crops, and parasitic nematodescause high morbidity in humans and other animals in many impoverishedareas of the world. Delivery of RNA and DNA has the potential toalleviate and treat many nematode problems, and delivery of RNA and DNAconstructs has been demonstrated to be useful in impacting targetnematodes. This example illustrates the utility of the RNA/DNA deliverymechanism described above in Example 60 in delivering spores tonematodes.

Wild type C. elegans nematodes were purchased from Carolina Biological(North Carolina) and maintained at 23° C. on NGM-Lite agar plates coatedwith OP50 E. coli for food. Two different Bacillus thuringiensis BT013Astrains were engineered by standard cloning procedures to express aminoacids 20-35 of SEQ ID NO: 1 fused in frame to green fluorescent protein(GFP) or mCherry to trace the presence of spores in the gut. These greenor red fluorescently tagged spores were obtained by an overnight growthin BHI (brain heart infusion) medium, followed by three days in a yeastextract-based media until a density of approximately 2×10⁸ spores permilliliter (ml) was achieved with less than 1% vegetative cells. Toprepare spores for feeding to nematodes, 1 ml of spore culture in mediawas pelleted by centrifugation and resuspended in 100 μl of water toremove excess media. This concentrated suspension was counted anddiluted to 1×10⁸ spores/ml. To feed spores to the worms, 1 μl of thespore suspension containing both the red and green fluorescently taggedspores was added to a 60 mm NGM-lite agar plate with 10 μl of PBS(phosphate buffered saline) to aid in spreading. No other food sourcewas made available. Twenty wild type nematodes of various ages weretransferred to the plates immediately. Living nematodes were checked 5hours later for ingestion of spores using standard fluorescencemicroscopy.

As can be seen in FIG. 12 and Table 63, the centralized gut of thenematodes fluoresced when fed recombinant Bacillus cereus family memberspores expressing the fusion protein containing the targeting sequenceand GFP, whereas the gut did not fluoresce when fed OP50 E. coli(standard food). Images were taken of live nematodes with 4× objectiveand 10× ocular lenses. This demonstrates the ability of these spores tobe both ingested and delivery of a “cargo” of target proteins,exemplified by the green fluorescence protein. Other Exosporium proteinsand targeting proteins can also be used interchangeably with a targetingsequence to deliver RNA and DNA to a nematode or other target organism.Other recombinant Bacillus cereus family member spores can also be useddue to the high degree of conserved nature of the exosporium and itscreation on the surface of the spore.

TABLE 63 C. elegans fluorescence detected in the gut Green FluorescenceFood Source Detected in gut OP50 E. coli (control) No GFP expressing B.Yes (High) thuringiensis BT013A

Example 62. Construction, Purification, and Uses of Exosporium Fragments

Knock out (KO) Mutants: To make exsY and cotE knockout (KO) mutantstrains of Bacillus thuringiensis BT013A, the plasmid pKOKI shuttle andintegration vector was constructed that contained the pUC57 backbone,which is able to replicate in E. coli, as well as the origin ofreplication erythromycin resistance cassette from pE194. This constructis able to replicate in both E. coli and Bacillus spp. A 1 kb DNA regionthat corresponded to the upstream region of the cotE gene and a 1 kbregion that corresponded to the downstream region of the gene cotE werePCR amplified from Bacillus thuringiensis BT013A. A second construct wasmade that contained the 1 kb DNA region that corresponded to theupstream region of the exsY gene and a 1 kb region that corresponded tothe downstream region of the gene exsY, both of which were PCR amplifiedfrom Bacillus thuringiensis BT013A. For each construct, the two 1 kbregions were then spliced together using homologous recombination withoverlapping regions with the pKOKI plasmid. This plasmid construct wasverified by digestion and DNA sequencing. Clones were screened bylooking for erythromycin resistance.

Clones were passaged under high temperature (40° C.) in brain heartinfusion broth. Individual colonies were toothpicked onto LB agar platescontaining erythromycin 5 μg/ml, grown at 30° C., and screened for thepresence of the pKOKI plasmid as a free plasmid by colony PCR. Coloniesthat had an integration event were continued through passaging to screenfor single colonies that lost erythromycin resistance (signifying lossof the plasmid but recombination and removal of the exsY or cotE gene).Verified deletions were confirmed by PCR amplification and sequencing ofthe target region of the chromosome. The pSUPER-BclA 20-35 Endo plasmid(described above in Example 58) was transformed into each of the exsYand cotE KO mutants. As described above in Example 48, the cotE KOmutant was also transformed with the pSUPER BclA 20-35 eGFP plasmid(made as described above in Example 44, but with endoglucanase swappedfor eGFP by homologous recombination).

Dominant Negative Mutants:

To create a dominant negative mutant, we PCR amplified the N-terminalhalf and the C-terminal half of CotO (Seq ID NO: 126), containing theamino acids 1-81 and 81-199 respectively, and cloned these fragmentsinto the pHP13 vector using homologous recombination (the pHP13 vectoris described above in Example 1). Correct clones were verified by Sangersequencing. Each of the two CotO dominant negative mutants wasintroduced into Bacillus thuringiensis BT013A that contained thepSUPER-BclA 20-35 Endo construct, which produces endoglucanase on thesurface of the spore as illustrated above in Example 58.

Exosporium Fragment Creation:

For each of the two KO mutants, and both of the dominant negativemutants, an overnight culture was grown in BHI media at 30° C., 300 rpm,in baffled flasks with antibiotic selection. One milliliter of thisovernight culture was inoculated into a yeast extract-based media (50ml) in a baffled flask and grown at 30° C. for 3 days. An aliquot ofspores was removed, 1% Tween was added, and the spores were agitated byvortexing for one minute. The spores were collected via centrifugationat 10,000×g for 5 minutes, and supernatant containing the exosporiumfragments was filtered through a 0.22 μM filter to remove any residualspores. The supernatant (containing the broken exosporium fragments) wasfiltered through a 100,000 Da membrane filter to obtain purifiedexosporium fragments containing the fusion proteins. Smaller MW proteinswere removed by passaging through the 100 kDa filter. No spores werefound in the filtrate or retentate of the supernatant.

Transmission electron micrographs are provided in FIG. 15 showing intactspores of Bacillus thuringiensis BT013A (panel A) surrounded by attachedexosporium, and spores of the Bacillus thuringiensis BT013A CotEknock-out mutant (panel B), from which the exosporium has detached.Arrows in panel A of FIG. 15 indicate the exosporium of intact spores,while arrows in panel B of FIG. 15 indicate exosporium that has detachedfrom the spores. Panel C of FIG. 15 shows a transmission electronmicrograph of a purified exosporium fragment preparation of derived fromthe Bacillus thuringiensis BT013A CotE knock-out (prepared as describedabove by vortexing, centrifugation, and filtration of the supernatant),visualized by negative staining Images were taken on a JEOL JEM 1400transmission electron microscope. No visible exosporium fragments wereobserved when control spores (Bacillus thuringiensis BT013A without theCotE knockout, expressing the BclA 20-35 Endo fusion protein, data notshown) were subjected to same vortexing, centrifugation, filtrationprocedures described above.

Presence of BclA 20-35 Endoglucanase in Exosporium Fragments Collectionfrom the CotE and ExsY Knockout and CotO Dominant Negative Mutants:

Exosporium fragments were created and purified as described above thatcontained the pSUPER BclA 20-35-Endo plasmid that creates an exosporiumthat contains the endoglucanase enzymes on the surface of the spores.Exosporium fragments containing this construct were created from thecotE knockout mutant spores, exsY knockout mutant spores, CotON-terminal dominant mutant spores, or CotO C-terminal dominant mutantspores. In each of these experiments, the amount of activity for theendoglucanase on the exosporium fragments was quantified as a percentageof the total enzyme levels. These results were compared against awildtype construct that did not contain any mutants, but did contain thepSUPER BclA 20-35-Endo plasmid.

Effects of Exosporium Fragments on Plant Growth:

These exosporium fragments were then delivered as a seed treatment ontosoybean seeds (as described in Example 59 above). A wild-type control(B. thuringiensis BT013A expressing the BclA 20-35 Endo construct) wasalso coated onto soybeans seeds. For each experiment, 1 μl of exosporiumfragments from each construct, or a 1:2, a 1:4, or a 1:8 dilution of thefragments was applied to each seed.

TABLE 64 Exosporium Fragment Enzyme Activity and Plant Growth ResponseEndoglucanase Soy Plant Soy Plant Activity, Soy Plant Growth GrowthExosporium Growth Response, Response, Presence Fragments Response, 1:41:8 of Mutation Construct (mU/ml) 1:2 dilution dilution dilution Spores?Wild-type BclA 20-35 10.3 93.1% 92.2% 83.4% No BT013A Endo cotE KO BclA20-35 269.0 121.4% 110.7% 90.7% No Endo exsY KO BclA 20-35 238.0 107.7%89.1% 90.7% No Endo CotO NTD BclA 20-35 22.4 99.6% N/A N/A No dominantEndo CotO CTD BclA 20-35 27.5 95.8% N/A N/A No dominant Endo

These results demonstrate that mutations that disrupt the exosporium,such as a knock-out mutation in the cotE or exsY gene, or a dominantnegative mutation in the CotO protein, can be used to generateexosporium fragments that are substantially free of spores, anddemonstrates that these exosporium fragments contain fusion proteinsthat are targeted to the exosporium. These fragments can be utilized topromote plant growth and in other applications. There was a small amountof background endoglucanase activity in the exosporium fragmentpreparation from the BT013 strain having no mutations and expressing theBclA 20-25 Endo construct (BT013A BclA 20-35 Endo). This was unexpectedand may represent a low level of unstable exosporium that is beingreleased from spores and captured during the exosporium fragmentcollection process. CotE and ExsY KO strains contain the highest amountof enzyme in the exosporium fragment fraction. The CotO dominantnegative mutants that express a fusion protein also have an elevatedlevel of enzyme in the exosporium fragment fraction as well.

The exosporium fragments from the CotE and ExsY mutants (not expressingBclA 20-35 Endo) applied directly to plants had a negative effect ongrowth and were removed from this experiment. When the exosporiumfragments from BT013A BclA 20-35 Endo were applied to soybeans, therewas a negative growth phenotype. When exosporium fragments from the CotEor ExsY mutants expressing the BclA 20-35 Endo fusion protein were addedto soybeans, a substantial increase in growth rate occurred (+28.3% and+14.8% over BT013A BclA 20-35 Endo fragments). The CotE mutantexosporium fragments were still active at the 1:4 dilution, but the ExsYexosporium fragments were no longer giving a growth benefit to thesoybeans at this dilution. The CotO dominant negative mutants expressingthe BclA 20-35 Endo fusion protein gave a small increase in soybeangrowth compared to the fragments from BT013A BclA 20-35 Endo, giving+6.5% and +2.7% growth, respectively.

Example 63. Additional Demonstration of the Utility of EndophyticBacillus cereus Family Members and Other Recombinant Bacillus Species toDeliver Peptides, Proteins, and Enzymes Endophytically to the Plant

Bacillus thuringiensis EE417, Bacillus thuringiensis EE-B00184, Bacilluscereus EE439, and Bacillus sp. EE387 were found to have the ability togrow endophytically and to be capable as serving as a host strain forthe BEMD system (See Examples 52 and 53). To demonstrate the ability ofthese Bacilli to grow endophytically and to serve as a host strain forthe BEMD system, each of these strains was transformed with thepMK4-BclA 20-35-eGFP plasmid (described above in Example 62). Sporeswere made and purified as described above in Example 40.

These spores were diluted to a concentration of 1×10⁸/ml, and 1 μl ofwhole cell broth was then added to commercial hybrid corn seed inpotting soil at planting. The corn seeds were coated with a fungicideand a biological inoculant. The corn hybrid variety was BECK 6175YE,which contains the ROUNDUP READY glyphosate resistance gene and AQUAMAXdrought resistance gene. Plants were grown under artificial light for 14hours a day and plant growth over a ten day period was determined.Plants were watered every three days over the course of the experiment.

Bacillus thuringiensis EE417, Bacillus thuringiensis EE-B00184, Bacilluscereus EE439, and Bacillus sp. EE387, expressing the BclA 20-35-eGFPwere then isolated from the inside of the corn plants. The ten day oldplants were extracted from the soil and washed to remove excess debris.The plants were then inverted, washed in water, exposed to 5% bleach forten minutes, washed in water, exposed to 70% ethanol for ten minutes,washed again in water, and the stalks split with a sterile razor blade.The split halves of the stalks were placed face down onto nutrient agarplates for two hours at 30° C. After two hours, the stalks were removed,and the agar plates incubated at 30° C. for 48 hours. After 48 hours,the plates were examined for colony morphology, and Bacillus coloniesfound internal to the plant were toothpicked onto nutrient agar andnutrient agar plus chloramphenicol plates (to select for bacteriacontaining the pMK4-20-35 BclA-eGFP plasmid). Results are shown in Table65. These results demonstrate the ability of the BEMD system to beintroduced into the target plant by expression in an endophytic strainof the Bacillus cereus family. FIG. 13 also demonstrates the ability ofBacillus thuringiensis EE-B00184 to express eGFP on the spores, asevidenced by fluorescent microscopy. In FIG. 13, arrows denote singlespores. FIG. 14 demonstrates the ability of the isolated bacterialcolonies from plants to fluoresce green, demonstrating that they do infact deliver the protein of interest (herein eGFP) inside the plants.FIG. 14 shows fluorescence of colonies of endophytic bacteria isolatedfrom inside corn plants on plates, illuminated with a GFP filtered lamp.

TABLE 65 Endophytic delivery of “cargo” proteins % Bacillus % Bacilluscolonies + colonies + Strain Endophytic “Cargo” for plasmid for eGFPBacillus thuringiensis Yes BclA 20-35 29.8% 29.8% EE417 eGFP Bacillusthuringiensis Yes BclA 20-35 38.9% 38.9% EE-B00184 eGFP Bacillus sp.EE387 Yes BclA 20-35   50%   50% eGFP Bacillus cereus Yes BclA 20-3523.9% 23.9% EE439 eGFP

To further demonstrate the ability of these endophytic strains toexpress proteins on the surface of the spores, the following constructswere introduced into Bacillus sp. EE387: pHP13 plasmid withendoglucanase fused to either: BclA 20-35, CotB, CotG, CotC, CgeA, InhA,InhA2, InhA1, CotY, or AcpC (amino acids 20-25 of SEQ ID NO: 1 or SEQ IDNOs. 252, 256, 253, 254, 108, 121, 114, 111, and 120, respectively). ThepSUPER BclA-20-35 Endo construct described above in Example 58 was alsointroduced into Bacillus thuringiensis EE-B00184, another endophyticstrain. Transformed cells were screen by PCR and Sanger sequencing.Spores for each of these constructs was made by growing up an overnightculture in BHI plus selection (chloramphenicol), and 500 μl of eachculture was swabbed onto nutrient broth agar plates and allowed toincubate at 30° C. for 3 days. After 3 days, the spores were swabbed offinto PBS, diluted to a concentration of 1×10⁸/ml, spun down to recoverthe spores, and enzyme measurement of the spores was performed asdescribed above in Example 58. The enzyme concentration was calculatedas mU/ml for each construct. The ability of Bacillus sp. EE387 toexpress fusion proteins on its spore surface is indicated by the levelsof enzyme. Bacillus sp. EE387 was able to express all of the sporefusion proteins on its surface, but AcpC (SEQ ID NO: 120) was a superiorfusion protein for this strain. This finding was surprising sinceBacillus sp. EE387 is not a Bacillus cereus family member strain anddoes not have an exosporium, yet exhibited surface expression of fusionproteins containing exosporium proteins or targeting sequences derivedfrom exosporium proteins (e.g., CotY, AcpC, and amino acids 20-35 of SEQID NO: 1).

TABLE 66 Endophytic strains Bacillus sp. EE387 (EE387) and Bacillusthuringiensis EE-B00184 (EE-B00184) expressing fusion proteinsExosporium Protein or Host Endoglucanase Targeting Sequence Endophyticactivity Fusion Partner Strain (mU/ml) CotB (SEQ ID NO: 252) EE387 4.0CotG (SEQ ID NO: 256) EE387 4.2 CotC (SEQ ID NO: 253) EE387 4.4 CgeA(SEQ ID NO: 254) EE387 4.1 AA 20-35 of SEQ ID NO: 1 EE387 16.3 InhA (SEQID NO: 108) EE387 7.5 InhA2 (SEQ ID NO: 121) EE387 6.0 CotY (SEQ ID NO:111) EE387 4.9 AcpC (SEQ ID NO: 120) EE387 36.0 InhA1 (SEQ ID NO: 114)EE387 4.5 AA 20-35 of SEQ ID NO: 1 EE-B00184 95.8

These endophytic strains can also be administered to the plant throughaddition into the plant growth medium, including soil, irrigation, andgranular formulations. Endophytic strains can also enter the targetplant through the aerial portions of the plants. These create a uniqueand effective delivery mechanism for delivering proteins and peptides ofinterest into the plant, or in the case of DNA and RNA binding proteins,delivering RNA and DNA into the plant.

These data, in Bacillus sp. EE387 also demonstrate demonstrates thatamino acids 20-35 of BclA (SEQ ID NO: 1), and SEQ ID NOs. 108, 121, and120 all have noticeably positive data in Bacillus strains outside of theBacillus cereus family. Bacillus thuringiensis EE-B00184 is also anexceptional host expression system. These levels are both noticeable andpositive, indicating a conserved mechanism for attachment may be presentin other Bacillus species for these proteins.

Spore Surface Expression of Bacillus thuringiensis EE-B00184.

Bacillus thuringiensis EE-B00184 was transformed with pSUPER BclA 20-35eGFP, and allowed to sporulate as described above. Spores were pelleted,washed, and subjected to fluorescence microscopy to demonstrate thespore surface laden with eGFP proteins in FIG. 13.

Example 64. Expression of Fusion Proteins in Herbicide- andPesticide-Degrading Bacillus cereus Family Member Strains

Examples 49 and 51 above demonstrate the ability of theherbicide-degrading strain Bacillus cereus family member EE349 in bothdegrading herbicides and serving as a host strain for expression of afusion protein attached the exosporium of its spores. To furtherdemonstrate the ability of herbicide-degrading strains to produce enzymeladen exosporium on their spores, we introduced the pHP13 CotC-Endo (SEQID NO: 253), pSUPER AcpC-Endo (SEQ ID NO: 120), pSUPER InhA2-Endo (SEQID NO: 121) and pSUPER 23-38 SEQ ID NO:5-Endo) into Bacillus cereusfamily member EE-B00377. A description of pHP13 CotC-Endo can be foundin Example 54, a description of pSUPER AcpC-Endo and pSUPER InhA2-Endocan be found in Example 59, and a description of pSUPER 23-38 SEQ IDNO:5-Endo can be found in Example 58. Bacillus cereus family memberEE-B00377 was identified as a potent degrader of pyrethrin, dicamba, and2,4-D. Herbicide and pesticide degradation was verified by both growthon the herbicide or pesticide as a nutrient source, as well as byreduction of dicamba and 2,4-D in the presence of the herbicide orpesticide-degrading strain. Plasmids were made and cells transformedidentically to Example 48 above. Each construct was verified by Sangersequencing. Spores were created by using the sporulation media andconditions outlined in Example 48. Enzyme activity was also performed asin Example 58 above.

TABLE 67 Enzyme expression levels of fusion proteins in pesticidedegrading strain Bacillus cereus family member EE-B00377. Endoglucanaseactivity Expression Construct (mU/ml) CotC-Endo (SEQ ID NO: 253) 46.9AcpC-Endo (SEQ ID NO: 120) 4.3 pSUPER 23-38 SEQ ID NO: 5-Endo 108

As can be seen in Table 67, Bacillus cereus family member EE-B00377 isable to produce endoglucanase and display the endoglucanase on itsexosporium using several different exosporium proteins or targetingsequences. Of the constructs tested, amino acids 23-38 of SEQ ID NO: 5or SEQ ID NO: 253 gave the highest enzymes levels in this strain.

This example demonstrates the ability of the spore displayed system tobe expressed in herbicide- and pesticide-degrading strains. This systemcan be used to express other target proteins on the surface of thespores, including those that act on herbicides or pesticides themselves,such as herbicide-degradation enzymes, pesticide-degradation enzymes,metabolic enzymes, reductases, oxidases, and other useful enzymes forthe breakdown of pesticides alone or in the presence of plants.

Example 65. Use of Free Nitric Oxide Synthase (NOS) and Spore-Bound NOSto Enhance Plant Germination

Example 40 demonstrates the ability of nitric oxide synthetase (NOS)from Bacillus subtilis 168 to stimulate germination when attached to theexosporium of Bacillus cereus family members, and delivering thatNOS—spore protein fusion to seeds or in the vicinity of seeds. In thisexample, free NOS from Bacillus thuringiensis BT013A (SEQ ID NO: 261)and free eNOS (epithelial NOS from bovine neutrophils, Sigma-Aldrich,Cat No N1533) can also help induce germination, or increased outgrowthof seeds exposed to NOS. The pHP13 BclA-BT NOS, pHP13 BclA-BS NOS, andpHP13 BclA-SODA (superoxide dismutase) plasmids were made in identicalfashion to pHP13 BclA-BS NOS that described in Example 40 and weretransformed into Bacillus thuringiensis BT013A. pHP13 BclA-BT NOScontains the BclA promoter, start codon, BclA amino acids 20-35, a 6alanine linker, and the Bacillus thuringiensis BT013A NOS gene (seeTable 9, SEQ ID NO: 263). pHP13 BclA-BS NOS contains the BclA promoter,start codon, BclA amino acids 20-35, a 6 alanine linker, and theBacillus subtilis 168 NOS gene (see Table 9, SEQ ID NO: 264). pHP13BclA-SODA contains the BclA promoter, BclA amino acids 20-35, a 6alanine linker, and the Bacillus cereus superoxide dismutase 1 (SODA1)gene (SEQ ID NO: 155).

Table 68 shows the results of a soil germination assay. In this assay,commercial variety BECK'S 294NR (ROUNDUP READY) was coated with either 1μl water (control) or 1 μl of water spiked with 34.2 mU of BovineNeutrophil eNOS. 50 seeds of each were then planted and grown asdescribed in Example 58, but with 4 seeds per pot. After 7 days, theplants were measured for height. As can be seen in Table 68, thepresence of the eNOS allowed for increased outgrowth of the seeds,leading to a 30.7% increase in shoot height of the treated soybeans.

TABLE 68 Influence of free eNOS on plant height in soybeans. TreatmentHeight Normalized to Control H₂O, 1 μl/seed 100.0% H₂O with 34.2 mUeNOS/seed 130.7%

In addition to the soil germination test described above, standardgermination assays were performed as described in Example 40. Forsoybeans, we choose 2 year old soybean seed with a lower germinationrate, and coated 1 μl on each of 50 seeds with the treatments.Treatments were H₂O control (water), L-arginine, Bacillus thuringiensisBT013A (strain control), Bacillus thuringiensis BT013A with pHP13BclA-BT NOS, and Bacillus thuringiensis BT013A with pHP13 BclA BS NOS.The results for soybeans are shown in Table 69 below.

TABLE 69 Influence of spore-displayed NOS on germination rate insoybeans. Treatment Germination Rate H₂O, 1 μl/seed 38% H₂O Control withL-Arginine 58% Bacillus thuringiensis BT013A (strain control) 52%Bacillus thuringiensis BT013A with BS NOS 82% Bacillus thuringiensisBT013A with BT NOS 54%

Standard germination assays were also performed as described above forcommercial hybrids of sorghum. Each sorghum seed was coated with 0.5 μlon each of 50 seeds with the treatments. Treatments were H₂O control(water), L-arginine, Bacillus thuringiensis BT013A (strain control),Bacillus thuringiensis BT013A with pHP13 BclA-BS NOS, Bacillusthuringiensis BT013A with pHP13 BclA-BT NOS. After 4 days, the seedswere measured for shoot height and root length to examine increasedoutgrowth of the seeds, and all data were normalized to the watercontrol. The results are shown in Table 70 below. The addition of eitherBT NOS or BS NOS led to a greatly increased root length and shootgrowth, with the difference most evident in the BS NOS treatment.

TABLE 70 Spore bound NOS and increased sorghum outgrowth Root GrowthShoot Growth Treatment (Normalized) (Normalized) H₂O, 1 μl/seed 100.0%  100.0%   H₂O Control with L-Arginine 109%  89% Bacillus thuringiensisBT013A  75% 145% (strain control) Bacillus thuringiensis BT013A 163%293% with BS NOS Bacillus thuringiensis BT013A 141% 190% with BT NOS

The sorghum experiment above was repeated, but with slightly differenttreatments. Treatments were H₂O control (water), Bacillus thuringiensisBT013A (strain control), Bacillus thuringiensis BT013A with pHP13BclA-SODA, or free bovine eNOS. After 4 days, the seeds were measuredfor shoot height and root length to look at increased outgrowth of theseeds, and all data normalized to the water control. The results areshown in Table 71 below. The addition of either BT SODA or free NOS(eNOS) leads to a greatly increased root length and shoot growth.

TABLE 71 Spore bound SODA and free NOS and increased sorghum outgrowthRoot Growth Shoot Growth Treatment (Normalized) (Normalized) H₂O, 0.5μl/seed 100.0%   100.0%   Bacillus thuringiensis BT013A  79% 117%(strain control) Bacillus thuringiensis BT013A 125% 228% with pHP13BclA-SODA 1 Free eNOS, 34.2 mU/seed 123% 311%

Taken together, these results demonstrate that overexpression of nitricoxide synthetases from multiple sources can be added to seeds andincrease their germination rate and outgrowth of seeds, in both soil andtraditional germination methods. This effect can is also found whenadding free NOS to seeds. The addition of superoxide dismutase with thespores also leads to an increase in the outgrowth of seeds. L-arginineassisted in the germination rate increases when utilized alone, orassisted in a lesser extent when mixed with NOS enzymes.

The NOS genes are prevalent in a variety of microorganisms, and thesemicroorganisms can be genetically modified to enhance their ability toexpress NOS on the seed, or in the vicinity of the seed in plant growthmedia. Expression of NOS on a spore leads provides a superior deliverysystem, as vegetative microorganisms are more fragile and do not surviveon the seed for long periods of time. Expression on spores using thetargeting sequences, exosporium proteins, exosporium protein fragments,and spore coat proteins described herein would all be viable ways ofdelivery the NOS to seeds.

Example 66. Modulation of Enzyme Expression and Plant Growth

As demonstrated in Examples 44, 45, and 46, overexpression of amodulator protein in a recombinant Bacillus cereus family member thatco-expresses a fusion protein can lead to increased and decreased levelsof that fusion protein being incorporated into the exosporium. Fusionproteins and constructs were made and spores made as described above inExamples 44 and 45. Growth assays were performed as described above inExample 46.

As can be seen in Table 72, expression of the pSUPER BclA 20-35 Endofusion proteins on the surface of the Bacillus thuringiensis BT013Aspores using amino acids 20-35 of SEQ ID NO: 1 as the targeting sequenceled to increased growth in corn, soy, and squash. This effect can beincreased when a second exosporium protein is overexpressed. Each of theCotO, BxpB, and YjcB overexpression strains had a pronounced effect oncorn, soy, and/or squash growth, with increases most prominent in corn.

TABLE 72 Spore bound SODA and free NOS and increased sorghum outgrowthCorn Soy Squash Treatment Growth Growth Growth H₂O, 1.0 μl/seed 100.0%100.0% 100.0% Bacillus thuringiensis 103.8% 108.8% 105.8% BT013A withpSUPER BclA 20-35 Endo (Base) Base with pHP13 BclA-CotO 109.6% 106.4%105.2% Base with pHP13 BclA-BxpB 106.8% 117.2% 113.9% Base with pHP13BclA-YjcB 110.4% 122.4% 106.7%

Overexpression of other modulator proteins can also modulate fusionprotein expression levels as well as plant growth effects, includingthose described herein and in Examples 44 and 45 above. Each of thesecan be used to alter or tailor the enzyme levels to desired effectivelevels.

Example 67. Overexpression of Exosporium Proteins and Effects of onPlants

Overexpression of naturally occurring spore and exosporium proteins canimpact the effect that plant growth promoting, endophytic, and otherBacillus cereus family members have on plants. Expression of variousexosporium proteins as part of a fusion protein or as free enzyme canhave beneficial effects on plants, as illustrated above for phosphatases(Examples 11 and 36), nitric oxide synthetase (Example 65), andproteases such as InhA (Examples 3, 6, 7, 13). Other exosporium andspore proteins, such as alanine racemase and inosine uridine preferringhydrolases, can prevent or delay germination of spores, and theiroverexpression will make spore less prone to quick germination, anunwanted side effect in the use of many types of spores. Lastly, sporesthat overexpress certain exosporium proteins can alter the overallassembly of the exosporium, leading to alterations in the binding ofspores to plants. An example of this can be seen in Table 73 below.

Spores were created as described for Bacillus thuringiensis BT013A inExample 58. Growth assays were performed by placement of 1 μl of wholecell broth from each construct per corn seed, or 2 μl per squash seed.Treatment of seeds, planting, and data recording was performed as inExample 58.

Bacillus mycoides strain EE155, a plant growth promoting strain of theBacillus cereus family, was transformed with overexpression plasmids asdescribed in Example 44. Overexpression of exosporium proteins in thisstrain directly led to an increase in the binding of the spores to theplant, and leads to higher plant growth promotion. Specifically,overexpression of BclB, BclA, CotO, CotE led to enhanced plant growthpromotion. Other exosporium proteins can be overexpressed that can leadto alterations in the structure of the exosporium, including ExsY,ExsFA/BxpB, CotY, CotO, ExsFB, InhA1, InhA2, ExsJ, ExsH, YjcA, YjcB,BclC, AcpC, InhA3, alanine racemase 1, alanine racemase 2, BclA, BclB,BxpA, BclE, BetA/BAS3290, CotE, ExsA, ExsK, ExsB, YabG, Tgl, superoxidedismutase 1 (SODA1), and superoxide dismutase 2 (SODA2). Overexpressionor mutation of any of these genes will lead to alterations of exosporiumstructure, and lead to potentiating the plant growth benefits associatedwith members of the Bacillus cereus family.

TABLE 73 Overexpression of exosporium proteins in Bacillus mycoidesEE155 Overexpression Squash Growth Corn Growth protein on plasmid(Normalized to (Normalized Bacteria pHP13 control) to control) Bacillusmycoides N/A (Control)   100%   100% B155 Bacillus mycoides BclB 116.3%101.4% B155 Bacillus mycoides BclA 106.8% 108.5% B155 Bacillus mycoidesCotE 134.5% 106.3% B155 Bacillus mycoides CotO 118.6% 111.7% B155

Example 68. Plant Tissues Binding Through Use of Exosporium DisplayedBinding Proteins

Spores that are useful for the display of exogenous and endogenousproteins can be utilized as fusion partners to enhance spore binding tosurfaces, including plant tissue. To demonstrate this attribute,Bacillus thuringiensis BT013A spores were transformed with plasmidspSUPER BclA 20-35 TasA, pSUPER BclA 20-35 Expansin, pSUPER BclA 20-35Endo, and pSUPER BclA 20-35 Control. TasA and expansin are plant bindingproteins. The control plasmid contained the BclA promoter, a start codonand amino acids 20-35 of SEQ ID NO: 1, but did not include a fusionpartner. These constructs were prepared as in identical fashion to theothers described in above in Example 58.

To perform the tissue binding assay, 2 week old corn plants and 3 weekold soybean plants were grown as described in Example 58, but withoutany seed treatment. The primary leaf and first trifoliate of the plantswas then swabbed with 1 ml of spores containing each of the aboveconstructs. The leaves were allowed to dry, clipped from the plants andplaced into a 50 ml conical tube with 10 ml of water, and vortexedheavily. The spores that were released from the leaf into the water werecounted on a hemacytometer, and the counts compared to those expected ifno spores bound to the leaves. This experiment was repeated in tentimes, and a second experiment was performed which involved plating ofthe water onto antibiotic plates (tetracycline plus nutrient agar)overnight at 30° C. The final counts are shown in Table 74.

TABLE 74 Plant tissue binding is increased with binding proteinexpression on spores Change in Change in Overall Binding BindingTreatment Binding from Binding % from (Construct) Crop % control (plateassay) control Control (BclA Corn 42.9% N/A   0% N/A 20-35 Control) BclA20-35 Corn 75.9%   +33% 15.6% +15.6% Endoglucansae BclA 20-35 Corn 38.4% −4.5% 41.1% +41.1% Expansin BclA 20-35 Corn 54.9%   +12%  100%  +100%TasA Control (BclA Soy 58.3% N/A 65.2% N/A 20-35 Control) BclA 20-35 Soy93.7% +35.4%   61%  −4.2% Endoglucansae BclA 20-35 Soy 87.9% +29.6%99.1% +33.9    Expansin BclA 20-35 Soy 75.7% +20.8% 91.7% +26.5% TasA

As can be seen from Table 74, the control BT013A spores have a highaffinity for the BT013A spores for soybeans, with 58.3% and 65.2% of thespores bound for the controls. Despite this, expression ofendoglucanase, expansin, or TasA on the surface of the spores led to anincrease in binding of spores to the soy leaves, with many sporepreparations approaching 100% bound to the leaves. In corn, there wasmuch less binding for the control spores, especially in the plate assay.The results from the plate assay are the most striking, with an increasein each of the expression constructs, with TasA at 100% of spores boundin that assay.

These binding proteins can also be utilized in any of the recombinantspore forming microorganisms, utilizing any of the expression systems orfusion partners described herein. This system would also be useful inconjunction with the exosporium strips, to create a protein deliverysystem that is both cell free and binds tightly to leaves.

Example 69. Use of Recombinant Spore-Forming Bacteria Expressing FusionProteins Containing Cot/Cge Proteins and an Enzyme for Promoting PlantGrowth

Coat proteins form protein layers that are found on all Bacillus speciesspores described to date, as well as related genera Virginibacillus,Lysinibacillus, Clostridia, and Paenibacillus. Fusion of proteins orpeptides of interest to the coat proteins allows expression of foreignproteins on the surface of the spore, and delivery of these proteins orpeptides of interest to plants. To demonstrate the ability of the coatproteins to deliver enzymes to plants, a series of constructs werecreated. The pHP13 plasmid from the Bacillus Genetic Stock Culturecollection was used to clone each of the constructs described below intothe multiple cloning site using homologous recombination utilizing theirnative promoter elements.

CotB, CotG, and CotC from Bacillus subtilis M01099 or CgeA from Bacillusamyloliquefaciens was fused in frame with the endoglucanase eglS genefrom Bacillus subtilis 168, the lipA lipase gene from Bacillus subtilis168, or the pc-plc gene from Bacillus thuringiensis BT013A. Theseconstructs were cloned into pHP13 via homologous recombination, verifiedby Sanger sequencing, and transformed into Bacillus subtilis EE405,Bacillus subtilis A09, Bacillus cereus family member EE439, Bacillus sp.EE398, or Bacillus thuringiensis EE-B00184. Each transformant was alsoscreened for correct clones by Sanger sequencing. After confirmation ofthe clones, each clone was grown up in brain heart infusion broth (BHI)plus tetracycline (10 μg/ml) overnight at 30° C., and 100 μl of theovernight culture was swabbed onto nutrient agar plates plustetracycline. These plates were incubated at 30° C. for 3 days, andspores were collected by swabbing with a water-wettened cotton swab andresuspended in water.

Spores for endoglucanase assays were then diluted to 1×10⁸ CFU/ml inwater, and assayed for enzyme activity by utilizing the chromophore 4chloro 2 nitrophenyl cellotetrose (4C2NC, 3 mM in water). For thismethod, 50 μl of spores was placed into a 96 well plate, and 50 μl of a300 nM 4C2NC solution added to each plate. The plate was then incubatedat 30° C. and absorbance at 410 nm read after 0.5 hours. In all cases,the respective strain control absorbance was subtracted out of the totalabsorbance of each clone to negate any background activity.

Spores for lipases assays were diluted to 1×10⁸ CFU/ml in water, andassayed for enzyme activity in a second method utilizing the chromophore4-nitrophenyl palmitate (4NP, 3 mM in water). For this method, 50 μl ofspores was placed into a 96 well plate, and 50 μl of a 300 nM 4NPsolution added to each plate. The plate was then incubated at 30° C. andabsorbance at 410 nm read after 0.5 hours. In all cases, the respectivestrain control absorbance was subtracted out of the total absorbance ofeach clone to negate any background activity.

Spores for phospholipase assays were diluted to 1×10⁸ CFU/ml in water,and assayed for enzyme activity as described above for phospholipase inExample 58. In all cases, the respective strain control absorbance wassubtracted out of the total absorbance of each clone to negate anybackground activity.

Plant growth responses and treatments were applied and collected asdescribed for squash in Example 58 above. All heights were normalizedagainst a strain control with no enzyme displayed on the spores.

TABLE 75 Coat protein fusions and their enzyme expression levels.Endoglucanase Lipase Phospholipase Plant growth Enzyme Enzyme Enzymeresponse Fusion Activity, Activity, Activity, above strain Treatmentpartner (Absorbance (Absorbance (Absorbance control, (Construct) forendo minus control) minus control) minus control) Squash Bacillussubtilis N/A 0.0 0.0 0.0   100% A09 Strain Control A09 CotB 0.01 0.03.198 101.5% A09 CotG ND .117 .196 101.0% A09 CotC 0.09 .069 .154  99.4%A09 CgeA 0.13 0 .218 ND Bacillus subtilis N/A 0.0 0.0 0.0   100% EE405Strain Control EE405 CgeA 1.84 ND ND 104.7% B. thuringiensis N/A 0.0 0.00.0   100% EE184 strain control EE184 CotB 2.42 .262 1.37  95.5% EE184CotG 2.41 0 .330   105% EE184 CotC 2.00 0.08 .373 119.4% EE184 CgeA 2.70.520 0 110.1% Bacillus sp. N/A ND 0.0 0.0   100% EE387 strain controlEE387 CotB ND .071 .163 108.0% EE387 CotG ND .104 .140 105.6% EE387 CotCND .168 .196 106.3% EE387 CgeA ND .124 .187 108.5% N/A = not applicableND = not determined

The data in Table 75 demonstrate that the coat proteins work broadly ona number of plant benefiting enzymes, in both Bacillus cereus familymembers (EE184, EE439) and non-Bacillus cereus family members (EE405,A09, and EE387 from here and Example 65). Addition of spore displayedenzymes, endoglucanase in this example, leads to an increased plantgrowth phenotype in most cases.

In view of the above, it will be seen that the several objects of theinvention are achieved and other advantageous results attained.

As various changes could be made in the above products, compositions,and methods without departing from the scope of the invention, it isintended that all matter contained in the above description and shown inthe accompanying drawings shall be interpreted as illustrative and notin a limiting sense.

What is claimed is:
 1. A recombinant Bacillus cereus family member thatexpresses a fusion protein comprising: at least one protein or peptideof interest; a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member; and an amino acid linkerbetween the targeting sequence, the exosporium protein, or theexosporium protein fragment and the protein or peptide of interest,wherein the linker comprises a polyalanine linker, a polyglycine linker,or a linker comprising a mixture of both alanine and glycine residues;and wherein the recombinant Bacillus cereus family member comprises amutation that results in Bacillus cereus family member spores having anexosporium that is easier to remove from the spore as compared to theexosporium of a wild-type spore.
 2. The recombinant Bacillus cereusfamily member of claim 1, wherein the recombinant Bacillus cereus familymember: (i) comprises a mutation in a CotE gene; (ii) comprises amutation in an ExsY gene; (iii) comprises a mutation in a CotY gene;(iv) comprises a mutation in an ExsA gene; or (v) comprises a mutationin a CotO gene.
 3. The recombinant Bacillus cereus family member ofclaim 2, wherein the recombinant Bacillus cereus family member comprisesa mutation in a CotE gene.
 4. The recombinant Bacillus cereus familymember of claim 3, wherein the mutation in the CotE gene partially orcompletely inhibits the ability of CotE to attach the exosporium to thespore.
 5. The recombinant Bacillus cereus family member of claim 3,wherein the mutation in the CotE gene comprises a knock-out of the CotEgene or a dominant negative form of the CotE gene.
 6. The recombinantBacillus cereus family member of claim 2, wherein the recombinantBacillus cereus family member comprises a mutation in an ExsY gene. 7.The recombinant Bacillus cereus family member of claim 6, wherein themutation in the ExsY gene partially or completely inhibits the abilityof ExsY to complete the formation of the exosporium or attach theexosporium to the spore.
 8. The recombinant Bacillus cereus familymember of claim 6, wherein the mutation in the ExsY gene comprises aknock-out of the ExsY gene.
 9. The recombinant Bacillus cereus familymember of claim 2, wherein the recombinant Bacillus cereus family membercomprises a mutation in a CotY gene.
 10. The recombinant Bacillus cereusfamily member of claim 9, wherein the mutation in the CotY genecomprises a knock-out of the CotY gene.
 11. The recombinant Bacilluscereus family member of claim 9, wherein the mutation in the CotY generesults in the formation of a fragile exosporium.
 12. The recombinantBacillus cereus family member of claim 2, wherein the recombinantBacillus cereus family member comprises a mutation in an ExsA gene. 13.The recombinant Bacillus cereus family member of claim 12, wherein themutation in the ExsA gene comprises a knock-out of the ExsA gene. 14.The recombinant Bacillus cereus family member of claim 12, wherein themutation in the ExsA gene results in the formation of a fragileexosporium.
 15. The recombinant Bacillus cereus family member of claim2, wherein the recombinant Bacillus cereus family member comprises amutation in a CotO gene.
 16. The recombinant Bacillus cereus familymember of claim 15, wherein the mutation in the CotO gene comprises aknock-out of the CotO gene or a dominant negative form of the CotO gene.17. The recombinant Bacillus cereus family member of claim 15, whereinthe mutation in the CotO gene causes the exosporium to form in strips.18. The recombinant Bacillus cereus family member of claim 1, whereinthe targeting sequence, exosporium protein, or exosporium proteinfragment comprises: (1) a targeting sequence comprising an amino acidsequence having at least about 43% identity with amino acids 20-35 ofSEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 54%; (2) a targeting sequence comprising amino acids 1-35 of SEQID NO: 1; (3) a targeting sequence comprising amino acids 20-35 of SEQID NO: 1; (4) a targeting sequence comprising SEQ ID NO: 1; (5) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 2; (6) a targeting sequence comprising aminoacids 2-35 of SEQ ID NO: 1; (7) a targeting sequence comprising aminoacids 5-35 of SEQ ID NO: 1; (8) a targeting sequence comprising aminoacids 8-35 of SEQ ID NO: 1; (9) a targeting sequence comprising aminoacids 10-35 of SEQ ID NO: 1; (10) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 1; (11) a targeting sequence comprising aminoacids 1-27 of SEQ ID NO: 3; (12) a targeting sequence comprising aminoacids 12-27 of SEQ ID NO: 3; (13) a targeting sequence comprising SEQ IDNO: 3; (14) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 4; (15) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 3; (16) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 3; (17) a targetingsequence comprising amino acids 8-27 of SEQ ID NO: 3; (18) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 3; (19) a targetingsequence comprising amino acids 1-38 of SEQ ID NO: 5; (20) a targetingsequence comprising amino acids 23-38 of SEQ ID NO: 5; (21) a targetingsequence comprising SEQ ID NO: 5; (22) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 6;(23) a targeting sequence comprising amino acids 2-38 of SEQ ID NO: 5;(24) a targeting sequence comprising amino acids 5-38 of SEQ ID NO: 5;(25) a targeting sequence comprising amino acids 8-38 of SEQ ID NO: 5;(26) a targeting sequence comprising amino acids 10-38 of SEQ ID NO: 5;(27) a targeting sequence comprising amino acids 15-38 of SEQ ID NO: 5;(28) a targeting sequence comprising amino acids 20-38 of SEQ ID NO: 5;(29) a targeting sequence comprising amino acids 1-28 of SEQ ID NO: 7;(30) a targeting sequence comprising amino acids 13-28 of SEQ ID NO: 7;(31) a targeting sequence comprising SEQ ID NO: 7; (32) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 8; (33) a targeting sequence comprising amino acids 2-28of SEQ ID NO: 7; (34) a targeting sequence comprising amino acids 5-28of SEQ ID NO: 7; (35) a targeting sequence comprising amino acids 8-28of SEQ ID NO: 7; (36) a targeting sequence comprising amino acids 10-28of SEQ ID NO: 7; (37) a targeting sequence comprising amino acids 1-24of SEQ ID NO: 9; (38) a targeting sequence comprising amino acids 9-24of SEQ ID NO: 9; (39) a targeting sequence comprising SEQ ID NO: 9; (40)an exosporium protein comprising an amino acid sequence having at least85% identity with SEQ ID NO: 10; (41) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 9; (42) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 9; (43) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 9; (44) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO:11; (45) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 11; (46) a targeting sequence comprisingSEQ ID NO: 11; (47) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 12; (48) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 11; (49) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 11; (50) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 11; (51) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 11; (52) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 11; (53) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 13; (54) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 13; (55) atargeting sequence comprising SEQ ID NO:13; (56) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:14; (167) a targeting sequence comprising amino acids 10-43 of SEQID NO: 47; (168) a targeting sequence comprising amino acids 15-43 ofSEQ ID NO: 47; (169) a targeting sequence comprising amino acids 20-43of SEQ ID NO: 47; (170) a targeting sequence comprising amino acids25-43 of SEQ ID NO: 47; (171) a targeting sequence comprising aminoacids 1-32 of SEQ ID NO: 49; (172) a targeting sequence comprising aminoacids 17-32 of SEQ ID NO: 49; (173) a targeting sequence comprising SEQID NO: 49; (174) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 50; (175) a targetingsequence comprising amino acids 2-32 of SEQ ID NO: 49; (176) a targetingsequence comprising amino acids 5-32 of SEQ ID NO: 49; (177) a targetingsequence comprising amino acids 8-32 of SEQ ID NO: 49; (178) a targetingsequence comprising amino acids 10-32 of SEQ ID NO: 49; (179) atargeting sequence comprising amino acids 15-32 of SEQ ID NO: 49; (180)a targeting sequence comprising amino acids 1-33 of SEQ ID NO: 51; (181)a targeting sequence comprising amino acids 18-33 of SEQ ID NO: 51;(182) a targeting sequence comprising SEQ ID NO: 51; (183) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 52; (184) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 51; (185) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 51; (186) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 51; (187) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 51; (188) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 51; (189) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 53; (190) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 53; (191) a targeting sequencecomprising SEQ ID NO: 53; (192) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 54;(193) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 53;(194) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 53;(57) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 13;(58) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 13;(59) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 13;(60) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 13;(61) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 13;(62) a targeting sequence comprising amino acids 1-43 of SEQ ID NO: 15;(63) a targeting sequence comprising amino acids 28-43 of SEQ ID NO: 15;(64) a targeting sequence comprising SEQ ID NO:15; (65) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:16; (66) a targeting sequence comprising amino acids 2-43of SEQ ID NO: 15; (67) a targeting sequence comprising amino acids 5-43of SEQ ID NO: 15; (68) a targeting sequence comprising amino acids 8-43of SEQ ID NO: 15; (69) a targeting sequence comprising amino acids 10-43of SEQ ID NO: 15; (70) a targeting sequence comprising amino acids 15-43of SEQ ID NO: 15; (71) a targeting sequence comprising amino acids 20-43of SEQ ID NO: 15; (72) a targeting sequence comprising amino acids 25-43of SEQ ID NO: 15; (73) a targeting sequence comprising amino acids 1-27of SEQ ID NO: 17; (74) a targeting sequence comprising amino acids 12-27of SEQ ID NO: 17; (75) a targeting sequence comprising SEQ ID NO:17;(76) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:18; (77) a targeting sequencecomprising amino acids 2-27 of SEQ ID NO: 17; (78) a targeting sequencecomprising amino acids 5-27 of SEQ ID NO: 17; (79) a targeting sequencecomprising amino acids 8-27 of SEQ ID NO: 17; (80) a targeting sequencecomprising amino acids 10-27 of SEQ ID NO: 17; (81) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 19; (82) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 19; (83) a targeting sequencecomprising SEQ ID NO:19; (84) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:20; (85) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 19; (86) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 19; (87) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 19; (88) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 19; (89) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 19; (90) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 21; (91) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 21; (92) atargeting sequence comprising SEQ ID NO:21; (93) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:22; (94) a targeting sequence comprising amino acids 2-33 of SEQID NO: 21; (95) a targeting sequence comprising amino acids 5-33 of SEQID NO: 21; (96) a targeting sequence comprising amino acids 8-33 of SEQID NO: 21; (97) a targeting sequence comprising amino acids 10-33 of SEQID NO: 21; (98) a targeting sequence comprising amino acids 15-33 of SEQID NO: 21; (99) a targeting sequence comprising amino acids 1-24 of SEQID NO: 23; (100) a targeting sequence comprising amino acids 9-24 of SEQID NO: 23; (101) a targeting sequence comprising SEQ ID NO:23; (102) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:24; (103) a targeting sequence comprising aminoacids 2-24 of SEQ ID NO:23; (104) a targeting sequence comprising aminoacids 5-24 of SEQ ID NO: 23; (105) a targeting sequence comprising aminoacids 8-24 of SEQ ID NO: 23; (106) a targeting sequence comprising aminoacids 1-24 of SEQ ID NO: 25; (107) a targeting sequence comprising aminoacids 9-24 of SEQ ID NO: 25; (108) a targeting sequence comprising SEQID NO:25; (109) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:26; (110) a targetingsequence comprising amino acids 2-24 of SEQ ID NO: 25; (111) a targetingsequence comprising amino acids 5-24 of SEQ ID NO: 25; (112) a targetingsequence comprising amino acids 8-24 of SEQ ID NO: 25; (113) a targetingsequence comprising amino acids 1-30 of SEQ ID NO: 27; (114) a targetingsequence comprising amino acids 15-30 of SEQ ID NO: 27; (115) atargeting sequence comprising SEQ ID NO:27; (116) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:28; (117) a targeting sequence comprising amino acids 2-30 of SEQID NO: 27; (118) a targeting sequence comprising amino acids 5-30 of SEQID NO: 27; (119) a targeting sequence comprising amino acids 8-30 of SEQID NO: 27; (120) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 27; (121) a targeting sequence comprising amino acids 1-33 ofSEQ ID NO: 29; (122) a targeting sequence comprising amino acids 18-33of SEQ ID NO: 29; (123) a targeting sequence comprising SEQ ID NO:29;(124) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:30; (125) a targeting sequencecomprising amino acids 2-33 of SEQ ID NO: 29; (126) a targeting sequencecomprising amino acids 5-33 of SEQ ID NO: 29; (127) a targeting sequencecomprising amino acids 8-33 of SEQ ID NO: 29; (128) a targeting sequencecomprising amino acids 10-33 of SEQ ID NO: 29; (129) a targetingsequence comprising amino acids 15-33 of SEQ ID NO: 29; (130) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 31; (131) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 31; (132) atargeting sequence comprising SEQ ID NO:31; (133) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:32; (134) a targeting sequence comprising amino acids 2-24 of SEQID NO: 31; (135) a targeting sequence comprising amino acids 5-24 of SEQID NO: 31; (136) a targeting sequence comprising amino acids 8-24 of SEQID NO: 31; (137) a targeting sequence comprising amino acids 1-15 of SEQID NO: 33; (138) a targeting sequence comprising SEQ ID NO:33; (139) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:34; (140) a targeting sequence comprising aminoacids 1-16 of SEQ ID NO: 35; (141) a targeting sequence comprising SEQID NO:35; (142) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:36; (143) a targetingsequence comprising amino acids 1-29 of SEQ ID NO:43; (144) a targetingsequence comprising amino acids 14-29 of SEQ ID NO: 43; (145) atargeting sequence comprising SEQ ID NO: 43; (146) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 44; (147) a targeting sequence comprising amino acids 2-29 of SEQID NO: 43; (148) a targeting sequence comprising amino acids 5-29 of SEQID NO: 43; (149) a targeting sequence comprising amino acids 8-29 of SEQID NO: 43; (150) a targeting sequence comprising amino acids 10-29 ofSEQ ID NO: 43; (151) a targeting sequence comprising amino acids 1-35 ofSEQ ID NO: 45; (152) a targeting sequence comprising amino acids 20-35of SEQ ID NO: 45; (153) a targeting sequence comprising SEQ ID NO: 45;(154) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 46; (155) a targeting sequencecomprising amino acids 2-35 of SEQ ID NO: 45; (156) a targeting sequencecomprising amino acids 5-35 of SEQ ID NO: 45; (157) a targeting sequencecomprising amino acids 8-35 of SEQ ID NO: 45; (158) a targeting sequencecomprising amino acids 10-35 of SEQ ID NO: 45; (159) a targetingsequence comprising amino acids 15-35 of SEQ ID NO: 45; (160) atargeting sequence comprising amino acids 1-43 of SEQ ID NO: 47; (161) atargeting sequence comprising amino acids 28-43 of SEQ ID NO: 47; (162)a targeting sequence comprising SEQ ID NO: 47; (163) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 48; (164) a targeting sequence comprising amino acids2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising amino acids5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising amino acids8-43 of SEQ ID NO: 47; (195) a targeting sequence comprising amino acids8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 53; (197) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 53; (198) a targeting sequence comprisingamino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequence comprisingamino acids 15-30 of SEQ ID NO: 55; (200) a targeting sequencecomprising SEQ ID NO: 55; (201) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 56;(202) a targeting sequence comprising amino acids 2-30 of SEQ ID NO: 55;(203) a targeting sequence comprising amino acids 5-30 of SEQ ID NO: 55;(204) a targeting sequence comprising amino acids 8-30 of SEQ ID NO: 55;(205) a targeting sequence comprising amino acids 10-30 of SEQ ID NO:55; (206) a targeting sequence comprising amino acids 1-130 of SEQ IDNO: 57; (207) a targeting sequence comprising amino acids 115-130 of SEQID NO: 57; (208) a targeting sequence comprising SEQ ID NO: 57; (209) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 58; (210) a targeting sequence comprising aminoacids 2-130 of SEQ ID NO: 57; (211) a targeting sequence comprisingamino acids 5-130 of SEQ ID NO: 57; (212) a targeting sequencecomprising amino acids 10-130 of SEQ ID NO: 57; (213) a targetingsequence comprising amino acids 20-130 of SEQ ID NO: 57; (214) atargeting sequence comprising amino acids 30-130 of SEQ ID NO: 57; (215)a targeting sequence comprising amino acids 40-130 of SEQ ID NO: 57;(216) a targeting sequence comprising amino acids 50-130 of SEQ ID NO:57; (217) a targeting sequence comprising amino acids 60-130 of SEQ IDNO: 57; (218) a targeting sequence comprising amino acids 70-130 of SEQID NO: 57; (219) a targeting sequence comprising amino acids 80-130 ofSEQ ID NO: 57; (220) a targeting sequence comprising amino acids 90-130of SEQ ID NO: 57; (221) a targeting sequence comprising amino acids100-130 of SEQ ID NO: 57; (222) a targeting sequence comprising aminoacids 110-130 of SEQ ID NO: 57; (223) an exosporium protein fragmentcomprising an amino acid sequence having at least 85% identity with SEQID NO: 95; (224) a targeting sequence comprising SEQ ID NO: 96; (225) atargeting sequence comprising SEQ ID NO: 97; (226) a targeting sequencecomprising SEQ ID NO: 98; (227) a targeting sequence comprising SEQ IDNO: 99; (228) a targeting sequence comprising SEQ ID NO: 100; (229) atargeting sequence comprising SEQ ID NO: 101; (230) a targeting sequencecomprising SEQ ID NO: 102; (231) a targeting sequence comprising SEQ IDNO: 103; (232) a targeting sequence comprising SEQ ID NO: 104; (233) atargeting sequence comprising SEQ ID NO: 105; (234) a targeting sequencecomprising SEQ ID NO: 106; (235) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 108;(236) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 109; (237) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 110; (238) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 111; (239) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 112; (240) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 113;(241) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 114; (242) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 115; (243) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 116; (244) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 117; (245) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 118;(246) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 119; (247) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 120; (248) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 121; (249) atargeting sequence comprising amino acids 22-31 of SEQ ID NO: 1; (250) atargeting sequence comprising amino acids 22-33 of SEQ ID NO: 1; (251) atargeting sequence comprising amino acids 20-31 of SEQ ID NO: 1; (252) atargeting sequence comprising amino acids 14-23 of SEQ ID NO: 3; (253) atargeting sequence comprising amino acids 14-25 of SEQ ID NO: 3; (254) atargeting sequence comprising amino acids 12-23 of SEQ ID NO: 3; (255) atargeting sequence comprising amino acids 1-30 of SEQ ID NO: 59; (256) atargeting sequence comprising SEQ ID NO: 59; (257) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 60; (258) a targeting sequence comprising amino acids 2-30 of SEQID NO: 59; (259) a targeting sequence comprising amino acids 4-30 of SEQID NO: 59; (260) a targeting sequence comprising amino acids 6-30 of SEQID NO: 59; (261) a targeting sequence comprising amino acids 1-33 of SEQID NO: 61; (262) a targeting sequence comprising amino acids 18-33 ofSEQ ID NO: 61; (263) a targeting sequence comprising SEQ ID NO: 61;(264) an exosporium protein comprising an amino acid sequence having atleast 85% sequence identity with SEQ ID NO: 62; (265) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 61; (266) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 61; (267) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 61; (268) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 61; (269)a targeting sequence comprising amino acids 1-35 of SEQ ID NO: 63; (270)a targeting sequence comprising SEQ ID NO: 63; (271) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 64; (272) a targeting sequence comprising amino acids2-35 of SEQ ID NO: 63; (273) a targeting sequence comprising amino acids5-35 of SEQ ID NO: 63; (274) a targeting sequence comprising amino acids8-35 of SEQ ID NO: 63; (275) a targeting sequence comprising amino acids10-35 of SEQ ID NO: 63; (276) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 63; (277) a targeting sequence comprisingamino acids 1-24 of SEQ ID NO: 65; (278) a targeting sequence comprisingamino acids 9-24 of SEQ ID NO: 65; (279) a targeting sequence comprisingSEQ ID NO: 65; (280) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 66; (281) atargeting sequence comprising SEQ ID NO: 107; (282) a targeting sequencecomprising amino acids 2-24 of SEQ ID NO: 65; (283) a targeting sequencecomprising amino acids 5-24 of SEQ ID NO: 65; (284) a targeting sequencecomprising amino acids 1-27 of SEQ ID NO: 67; (285) a targeting sequencecomprising amino acids 12-27 of SEQ ID NO: 67; (286) a targetingsequence comprising SEQ ID NO: 67; (287) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 68; (288) an targeting sequence comprising amino acids 2-27 ofSEQ ID NO: 67; (289) a targeting sequence comprising amino acids 5-27 ofSEQ ID NO: 67; (290) a targeting sequence comprising amino acids 10-27of SEQ ID NO: 67; (291) a targeting sequence comprising amino acids 1-38of SEQ ID NO: 69; (292) a targeting sequence comprising amino acids23-38 of SEQ ID NO: 69; (293) a targeting sequence comprising SEQ ID NO:69; (294) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 70; (295) a targeting sequencecomprising amino acids 2-38 of SEQ ID NO: 69; (296) a targeting sequencecomprising amino acids 5-38 of SEQ ID NO: 69; (297) a targeting sequencecomprising amino acids 10-38 of SEQ ID NO: 69; (298) a targetingsequence comprising amino acids 15-38 of SEQ ID NO: 69; (299) anexosporium protein comprising SEQ ID NO: 72; (300) a targeting sequencecomprising SEQ ID NO: 73; (301) an exosporium protein comprising anamino acid sequence having at least 95% identity with SEQ ID NO: 74;(302) a targeting sequence comprising amino acids 1-42 of SEQ ID NO: 75;(303) a targeting sequence comprising amino acids 27-42 of SEQ ID NO:75; (304) a targeting sequence comprising SEQ ID NO: 75; (305) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 76; (306) a targeting sequence comprising aminoacids 2-42 of SEQ ID NO: 75; (307) a targeting sequence comprising aminoacids 5-42 of SEQ ID NO: 75; (308) a targeting sequence comprising aminoacids 10-42 of SEQ ID NO: 75; (309) a targeting sequence comprisingamino acids 15-42 of SEQ ID NO: 75; (310) a targeting sequencecomprising amino acids 20-42 of SEQ ID NO: 75; (311) a targetingsequence comprising amino acids 25-42 of SEQ ID NO: 75; (312) atargeting sequence comprising amino acids 1-24 of SEQ ID NO: 77; (313) atargeting sequence comprising amino acids 9-24 of SEQ ID NO: 77; (314) atargeting sequence comprising SEQ ID NO: 77; (315) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 78; (316) a targeting sequence comprising amino acids 2-24 of SEQID NO: 77; (317) a targeting sequence comprising amino acids 5-24 of SEQID NO: 77; (318) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 80; (319) a targetingsequence comprising amino acids 1-38 of SEQ ID NO: 81; (320) a targetingsequence comprising amino acids 23-38 of SEQ ID NO: 81; (321) atargeting sequence comprising SEQ ID NO: 81; (322) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 82; (323) a targeting sequence comprising amino acids 2-38 of SEQID NO: 81; (324) a targeting sequence comprising amino acids 5-38 of SEQID NO: 81; (325) a targeting sequence comprising amino acids 10-38 ofSEQ ID NO: 81; (326) a targeting sequence comprising amino acids 15-38of SEQ ID NO: 81; (327) a targeting sequence comprising amino acids20-38 of SEQ ID NO: 81; (328) a targeting sequence comprising aminoacids 1-34 of SEQ ID NO: 83; (329) a targeting sequence comprising SEQID NO: 83; (330) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 84; (331) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 86; (332) a targeting sequence comprising amino acids1-28 of SEQ ID NO: 87; (333) a targeting sequence comprising amino acids13-28 of SEQ ID NO: 87; (334) a targeting sequence comprising SEQ ID NO:87; (335) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 88; (336) a targeting sequencecomprising amino acids 2-28 of SEQ ID NO: 87; (337) a targeting sequencecomprising amino acids 5-28 of SEQ ID NO: 87; (338) a targeting sequencecomprising amino acids 10-28 of SEQ ID NO: 87; (339) a targetingsequence comprising amino acids 1-28 of SEQ ID NO: 89; (340) a targetingsequence comprising SEQ ID NO: 89; (341) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 90; (342) a targeting sequence comprising amino acids 2-28 of SEQID NO: 89; (343) a targeting sequence comprising amino acids 5-28 of SEQID NO: 89; (344) a targeting sequence comprising amino acids 10-28 ofSEQ ID NO: 89; (345) a targeting sequence comprising amino acids 1-93 ofSEQ ID NO: 91; (346) a targeting sequence comprising SEQ ID NO: 91;(347) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 92; (348) a targeting sequencecomprising amino acids 2-93 of SEQ ID NO: 91; (349) a targeting sequencecomprising amino acids 10-93 of SEQ ID NO: 91; (350) a targetingsequence comprising amino acids 20-93 of SEQ ID NO: 91; (351) atargeting sequence comprising amino acids 30-93 of SEQ ID NO: 91; (352)a targeting sequence comprising amino acids 40-93 of SEQ ID NO: 91;(353) a targeting sequence comprising amino acids 50-93 of SEQ ID NO:91; (354) a targeting sequence comprising amino acids 60-93 of SEQ IDNO: 91; (355) a targeting sequence comprising amino acids 1-130 of SEQID NO: 93; (356) a targeting sequence comprising SEQ ID NO: 93; (357) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 94; (358) a targeting sequence comprising aminoacids 2-130 of SEQ ID NO: 93; (359) a targeting sequence comprisingamino acids 10-130 of SEQ ID NO: 93; (360) a targeting sequencecomprising amino acids 20-130 of SEQ ID NO: 93; (361) a targetingsequence comprising amino acids 30-130 of SEQ ID NO: 93; (362) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 122; (363) a targeting sequence consisting ofamino acids 20-33 of SEQ ID NO: 1; (364) a targeting sequence consistingof amino acids 21-33 of SEQ ID NO: 1; (365) a targeting sequenceconsisting of amino acids 23-31 of SEQ ID NO: 1; (366) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 96; (367) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 96;(368) a targeting sequence consisting of amino acids 12-25 of SEQ ID NO:3; (369) a targeting sequence consisting of amino acids 13-25 of SEQ IDNO: 3; (370) a targeting sequence consisting of amino acids 15-23 of SEQID NO: 3; (371) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 97; (372) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 98; (373) a targeting sequence consisting of amino acids23-36 of SEQ ID NO: 5; (374) a targeting sequence consisting of aminoacids 23-34 of SEQ ID NO: 5; (375) a targeting sequence consisting ofamino acids 24-36 of SEQ ID NO: 5; (376) a targeting sequence consistingof amino acids 26-34 of SEQ ID NO: 5; (377) a targeting sequenceconsisting of amino acids 13-26 of SEQ ID NO: 7; (378) a targetingsequence consisting of amino acids 13-24 of SEQ ID NO: 7; (379) atargeting sequence consisting of amino acids 14-26 of SEQ ID NO: 7;(380) a targeting sequence consisting of amino acids 16-24 of SEQ ID NO:7; (381) a targeting sequence consisting of amino acids 9-22 of SEQ IDNO: 9; (382) a targeting sequence consisting of amino acids 9-20 of SEQID NO: 9; (383) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 9; (384) a targeting sequence consisting of amino acids 12-20of SEQ ID NO: 9; (385) a targeting sequence consisting of amino acids1-15 of SEQ ID NO: 105; (386) a targeting sequence consisting of aminoacids 1-13 of SEQ ID NO: 105; (387) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 11; (388) a targeting sequenceconsisting of amino acids 18-29 of SEQ ID NO: 11; (389) a targetingsequence consisting of amino acids 19-31 of SEQ ID NO: 11; (390) atargeting sequence consisting of amino acids 1-15 of SEQ ID NO: 98;(391) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:98; (392) a targeting sequence consisting of amino acids 18-31 of SEQ IDNO: 13; (393) a targeting sequence consisting of amino acids 18-29 ofSEQ ID NO: 13; (394) a targeting sequence consisting of amino acids19-31 of SEQ ID NO: 13; (395) a targeting sequence consisting of aminoacids 21-29 of SEQ ID NO: 13; (396) a targeting sequence consisting ofamino acids 1-15 of SEQ ID NO: 99; (397) a targeting sequence consistingof amino acids 1-13 of SEQ ID NO: 99; (398) a targeting sequenceconsisting of amino acids 28-41 of SEQ ID NO: 15; (399) a targetingsequence consisting of amino acids 28-39 of SEQ ID NO: 15; (400) atargeting sequence consisting of amino acids 29-41 of SEQ ID NO: 15;(401) a targeting sequence consisting of amino acids 31-39 of SEQ ID NO:15; (402) a targeting sequence consisting of amino acids 12-25 of SEQ IDNO: 17; (403) a targeting sequence consisting of amino acids 13-25 ofSEQ ID NO: 17; (404) a targeting sequence consisting of amino acids 1-15of SEQ ID NO: 100; (405) a targeting sequence consisting of amino acids18-31 of SEQ ID NO: 19; (406) a targeting sequence consisting of aminoacids 18-29 of SEQ ID NO: 19; (407) a targeting sequence consisting ofamino acids 19-31 of SEQ ID NO: 19; (408) a targeting sequenceconsisting of amino acids 21-29 of SEQ ID NO: 19; (409) a targetingsequence consisting of amino acids 18-31 of SEQ ID NO: 21; (410) atargeting sequence consisting of amino acids 18-29 of SEQ ID NO: 21;(411) a targeting sequence consisting of amino acids 19-31 of SEQ ID NO:21; (412) a targeting sequence consisting of amino acids 21-29 of SEQ IDNO: 21; (413) a targeting sequence consisting of amino acids 1-15 of SEQID NO: 101; (414) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 101; (415) a targeting sequence consisting of amino acids9-22 of SEQ ID NO: 23; (416) a targeting sequence consisting of aminoacids 9-20 of SEQ ID NO: 23; (417) a targeting sequence consisting ofamino acids 10-22 of SEQ ID NO: 23; (418) a targeting sequenceconsisting of amino acids 12-20 of SEQ ID NO: 23; (419) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 102; (420) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 102;(421) a targeting sequence consisting of amino acids 9-22 of SEQ ID NO:25; (422) a targeting sequence consisting of amino acids 9-20 of SEQ IDNO: 25; (423) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 25; (424) a targeting sequence consisting of amino acids12-20 of SEQ ID NO: 25; (425) a targeting sequence consisting of aminoacids 1-15 of SEQ ID NO: 103; (426) a targeting sequence consisting ofamino acids 1-13 of SEQ ID NO: 103; (427) a targeting sequenceconsisting of amino acids 15-28 of SEQ ID NO: 27; (428) a targetingsequence consisting of amino acids 15-26 of SEQ ID NO: 27; (429) atargeting sequence consisting of amino acids 16-28 of SEQ ID NO: 27;(430) a targeting sequence consisting of amino acids 18-26 of SEQ ID NO:27; (431) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 104; (432) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 104; (433) a targeting sequence consisting of amino acids1-13 of SEQ ID NO: 33; (434) a targeting sequence consisting of aminoacids 1-11 of SEQ ID NO: 33; (435) a targeting sequence consisting ofamino acids 3-11 of SEQ ID NO: 33; (436) a targeting sequence consistingof amino acids 1-14 of SEQ ID NO: 35; (437) a targeting sequenceconsisting of amino acids 1-12 of SEQ ID NO: 35; (438) a targetingsequence consisting of amino acids 2-14 of SEQ ID NO: 35; (439) atargeting sequence consisting of amino acids 14-27 of SEQ ID NO: 43;(440) a targeting sequence consisting of amino acids 14-25 of SEQ ID NO:43; (441) a targeting sequence consisting of amino acids 15-27 of SEQ IDNO: 43; (442) a targeting sequence consisting of amino acids 20-33 ofSEQ ID NO: 45; (443) a targeting sequence consisting of amino acids20-31 of SEQ ID NO: 45; (444) a targeting sequence consisting of aminoacids 21-33 of SEQ ID NO: 45; (445) a targeting sequence consisting ofamino acids 1-15 of SEQ ID NO: 106; (446) a targeting sequenceconsisting of amino acids 1-13 of SEQ ID NO: 106; (447) a targetingsequence consisting of amino acids 28-41 of SEQ ID NO: 47; (448) atargeting sequence consisting of amino acids 28-39 of SEQ ID NO: 47;(449) a targeting sequence consisting of amino acids 18-31 of SEQ ID NO:53; (450) a targeting sequence consisting of amino acids 18-29 of SEQ IDNO: 53; (451) a targeting sequence consisting of amino acids 19-31 ofSEQ ID NO: 53; (452) a targeting sequence comprising amino acids 18-31of SEQ ID NO: 61; (453) a targeting sequence comprising amino acids18-29 of SEQ ID NO: 61; (454) a targeting sequence comprising aminoacids 19-31 of SEQ ID NO: 61; (455) a targeting sequence comprisingamino acids 9-22 of SEQ ID NO: 65; (456) a targeting sequence comprisingamino acids 9-20 of SEQ ID NO: 65; (457) a targeting sequence comprisingamino acids 10-22 of SEQ ID NO: 65; (458) a targeting sequencecomprising amino acids 1-15 of SEQ ID NO: 107; (459) a targetingsequence comprising amino acids 1-13 of SEQ ID NO: 107; (460) atargeting sequence comprising amino acids 12-25 of SEQ ID NO: 67; (461)a targeting sequence comprising amino acids 12-23 of SEQ ID NO: 67;(462) a targeting sequence comprising amino acids 13-25 of SEQ ID NO:67; (463) a targeting sequence comprising amino acids 15-23 of SEQ IDNO: 67; (464) a targeting sequence comprising amino acids 23-36 of SEQID NO: 69; (465) a targeting sequence comprising amino acids 23-34 ofSEQ ID NO: 69; (466) a targeting sequence comprising amino acids 24-36of SEQ ID NO: 69; (467) a targeting sequence comprising amino acids26-34 of SEQ ID NO: 69; (468) a targeting sequence comprising aminoacids 27-40 of SEQ ID NO: 75; (469) a targeting sequence comprisingamino acids 27-38 of SEQ ID NO: 75; (470) a targeting sequencecomprising amino acids 9-22 of SEQ ID NO: 77; (471) a targeting sequencecomprising amino acids 9-20 of SEQ ID NO: 77; (472) a targeting sequencecomprising amino acids 10-22 of SEQ ID NO: 77; (473) a targetingsequence comprising amino acids 12-20 of SEQ ID NO: 77; (474) atargeting sequence comprising amino acids 23-36 of SEQ ID NO: 81; (475)a targeting sequence comprising amino acids 23-34 of SEQ ID NO: 81;(476) a targeting sequence comprising amino acids 24-36 of SEQ ID NO:81; (477) a targeting sequence comprising amino acids 26-34 of SEQ IDNO: 81; (478) a targeting sequence comprising amino acids 13-26 of SEQID NO: 87; (479) a targeting sequence comprising amino acids 13-24 ofSEQ ID NO: 87; or (480) a targeting sequence comprising amino acids14-26 of SEQ ID NO:
 87. 19. The recombinant Bacillus cereus familymember of claim 18, wherein the targeting sequence comprises an aminoacid sequence having at least about 50% identity with amino acids 20-35of SEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 63%.
 20. The recombinant Bacillus cereus family member of claim18, wherein the targeting sequence comprises an amino sequence having atleast about 62% identity with amino acids 20-35 of SEQ ID NO: 1, whereinthe identity with amino acids 25-35 is at least about 72%.
 21. Therecombinant Bacillus cereus family member of claim 18, wherein thetargeting sequence comprises an amino acid sequence having at leastabout 81% identity with amino acids 20-35 of SEQ ID NO: 1, wherein theidentity with amino acids 25-35 is at least about 90%.
 22. Therecombinant Bacillus cereus family member of claim 18, wherein thetargeting sequence or exosporium protein comprises: (a) an amino acidsequence consisting of 16 amino acids and having at least about 43%identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identitywith amino acids 25-35 is at least about 54%; (b) amino acids 1-35 ofSEQ ID NO: 1; (c) amino acids 20-35 of SEQ ID NO: 1; (d) SEQ ID NO: 1;(e) SEQ ID NO: 96; or (f) SEQ ID NO:
 120. 23. The recombinant Bacilluscereus family member of claim 18, wherein the targeting sequencecomprises SEQ ID NO:
 96. 24. The recombinant Bacillus cereus familymember of claim 18, wherein the exosporium protein or an exosporiumprotein fragment comprises an amino acid sequence having at least 95%identity with SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26,28, 30, 32, 34, 36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68,70, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110, 111, 112,113, 114, 115, 116, 117, 118, 119, 120, 121, or
 122. 25. The recombinantBacillus cereus family member of claim 1, wherein the targetingsequence, exosporium protein, or exosporium protein fragment comprisesthe amino acid sequence GXT at its carboxy terminus, wherein X is anyamino acid.
 26. The recombinant Bacillus cereus family member of claim1, wherein the targeting sequence, exosporium protein, or exosporiumprotein fragment further comprises a methionine, serine, or threonineresidue at the amino acid position immediately preceding the first aminoacid of the targeting sequence, exosporium protein, or exosporiumprotein fragment or at the position of the targeting sequence thatcorresponds to amino acid 20 of SEQ ID NO:
 1. 27. The recombinantBacillus cereus family member of claim 1, wherein the protein or peptideof interest comprises a plant growth stimulating protein or peptide, aprotein or peptide that protects a plant from a pathogen, a protein orpeptide that enhances stress resistance in a plant, a plant bindingprotein or peptide, an enzyme that catalyzes the production of nitricoxide, or a nucleic acid binding protein or peptide.
 28. The recombinantBacillus cereus family member of claim 27, wherein the protein orpeptide of interest comprises a plant growth stimulating protein orpeptide.
 29. The recombinant Bacillus cereus family member of claim 28,wherein the plant growth stimulating protein or peptide comprises apeptide hormone or a non-hormone peptide.
 30. The recombinant Bacilluscereus family member of claim 29, wherein the peptide hormone comprisesa phytosulfokine, clavata 3 (CLV3), systemin, Zm1GF, or a SCR/SP11; orwherein the non-hormone peptide comprises a RKN 16D10, Hg-Syv46, aneNOD40 peptide, melittin, mastoparan, Mas7, RHPP, POLARIS, or kunitztrypsin inhibitor (KTI).
 31. The recombinant Bacillus cereus familymember of claim 27, wherein the protein or peptide of interest comprisesa protein or peptide that protects a plant from a pathogen.
 32. Therecombinant Bacillus cereus family member of claim 31, wherein theprotein or peptide that protects a plant from a pathogen comprises aplant immune system enhancer protein or peptide.
 33. The recombinantBacillus cereus family member of claim 32, wherein the plant immunesystem enhancer protein or peptide comprises a harpin, a harpin-likeprotein, an α-elastin, a β-elastin, a systemin, a phenylalanineammonia-lyase, an elicitin, a defensin, a cryptogein, a flagellinprotein, or a flagellin peptide.
 34. The recombinant Bacillus cereusfamily member of claim 31, wherein the protein or peptide that protectsa plant from a pathogen has antibacterial activity, antifungal activity,or both antibacterial and antifungal activity; or wherein the protein orpeptide that protects a plant from a pathogen has insecticidal activity,helminthicidal activity, suppresses insect or worm predation, or acombination thereof.
 35. The recombinant Bacillus cereus family memberof claim 34, wherein the protein or peptide that protects a plant from apathogen comprises a bacteriocin, a lysozyme, a lysozyme peptide, anavidin, a streptavidin, a non-ribosomal active peptide, a conalbumin, analbumin, a lactoferrin, a lactoferrin peptide, TasA, an insecticidalbacterial toxin, an endotoxin, a Cry toxin, a protease inhibitor proteinor peptide, a cysteine protease, or a chitinase.
 36. The recombinantBacillus cereus family member of claim 35, wherein the protein orpeptide that protects a plant from a pathogen comprises an insecticidalbacterial toxin and the insecticidal bacterial toxin comprises a VIPinsecticidal toxin; wherein the protein or peptide that protects a plantfrom a pathogen comprises a protease inhibitor protein or peptide andthe protease inhibitor protein or peptide comprises a trypsin inhibitoror an arrowhead protease inhibitor; or wherein the protein or peptidethat protects a plant from a pathogen comprises a Cry toxin and the Crytoxin comprises a Cry toxin from Bacillus thuringiensis.
 37. Therecombinant Bacillus cereus family member of claim 31, wherein theprotein that protects a plant from a pathogen comprises an enzyme. 38.The recombinant Bacillus cereus family member of claim 37, wherein theenzyme comprises a protease or a lactonase, wherein the protease orlactonase is specific for a bacterial lactone homoserine signalingmolecule.
 39. The recombinant Bacillus cereus family member of claim 37,wherein the enzyme is specific for a cellular component of a bacteriumor fungus, the enzyme comprising a β-1,3-glucanase, a β-1,4-glucanase, aβ-1,6-glucanase, a chitosanase, a chitinase, a chitosanase-like enzyme,a lyticase, a peptidase, a proteinase, a protease, a mutanolysin, astapholysin, or a lysozyme.
 40. The recombinant Bacillus cereus familymember of claim 27, wherein the wherein the protein or peptide ofinterest comprises at least one protein or peptide that enhances stressresistance in a plant.
 41. The recombinant Bacillus cereus family memberof claim 40, wherein the protein or peptide that enhances stressresistance in a plant comprises an enzyme that degrades a stress-relatedcompound, the stress-related compound comprisingaminocyclopropane-1-carboxylic acid (ACC), a reactive oxygen species,nitric oxide, an oxylipin, a phenolic, or a combination thereof.
 42. Therecombinant Bacillus cereus family member of claim 41, wherein theprotein or peptide that enhances stress resistance in a plant comprisesan enzyme that degrades a stress-related compound, and the enzymecomprises a superoxide dismutase, an oxidase, a catalase, anaminocyclopropane-1-carboxylic acid deaminase, a peroxidase, anantioxidant enzyme, or an antioxidant peptide.
 43. The recombinantBacillus cereus family member of claim 40, wherein the protein orpeptide that enhances stress resistance in a plant comprises a proteinor peptide that protects a plant from an environmental stress, theenvironmental stress comprising drought, flood, heat, freezing, salt,heavy metals, low pH, high pH, or a combination thereof.
 44. Therecombinant Bacillus cereus family member of claim 27, wherein thefusion protein comprises at least one plant binding protein or peptide.45. The recombinant Bacillus cereus family member of claim 44, whereinthe plant binding protein or peptide comprises an adhesin, arhicadhesin, a flagellin, an omptin, a lectin, an expansin, a biofilmstructural protein, TasA, YuaB, a pilus protein, a curlus protein, anintimin, an invasin, an agglutinin, an afimbrial protein.
 46. Therecombinant Bacillus cereus family member of claim 27, wherein theprotein or peptide of interest comprises a nucleic acid binding proteinor peptide.
 47. The recombinant Bacillus cereus family member of claim46, wherein the nucleic acid binding protein or peptide comprises anuclease having an inactivated active site.
 48. The recombinant Bacilluscereus family member of claim 1, wherein the protein or peptide ofinterest comprises an enzyme involved in the production or activation ofa plant growth stimulating compound.
 49. The recombinant Bacillus cereusfamily member of claim 48, wherein the plant growth stimulating compoundcomprises 2,3-butanediol or a plant growth hormone, the plant growthhormone comprising a cytokinin or a cytokinin derivative, ethylene, anauxin or an auxin derivative, a gibberellic acid or a gibberellic acidderivative, abscisic acid or an abscisic acid derivative, a jasmonicacid or a jasmonic acid derivative.
 50. The recombinant Bacillus cereusfamily member of claim 48, wherein the enzyme involved in the productionor activation of a plant growth stimulating compound comprises anacetoin reductase, an indole-3-acetamide hydrolase, a tryptophanmonooxygenase, an acetolactate synthetase, an α-acetolactatedecarboxylase, a pyruvate decarboxylase, a diacetyl reductase, abutanediol dehydrogenase, an aminotransferase, a tryptophandecarboxylase, an amine oxidase, an indole-3-pyruvate decarboxylase, anindole-3-acetaldehyde dehydrogenase, a tryptophan side chain oxidase, anitrile hydrolase, a nitrilase, a peptidase, a protease, an adenosinephosphate isopentenyltransferase, a phosphatase, an adenosine kinase, anadenine phosphoribosyltransferase, CYP735A, a 5′ribonucleotidephosphohydrolase, an adenosine nucleosidase, a zeatin cis-transisomerase, a zeatin O-glucosyltransferase, a β-glucosidase, acis-hydroxylase, a CK cis-hydroxylase, a CK N-glucosyltransferase, a2,5-ribonucleotide phosphohydrolase, an adenosine nucleosidase, a purinenucleoside phosphorylase, a zeatin reductase, a hydroxylamine reductase,a 2-oxoglutarate dioxygenase, a gibberellic 2B/3B hydrolase, agibberellin 3-oxidase, a gibberellin 20-oxidase, a chitosanase, achitinase, a β-1,3-glucanase, a β-1,4-glucanase, a β-1,6-glucanase, anaminocyclopropane-1-carboxylic acid deaminase, or an enzyme involved inproducing a nod factor.
 51. The recombinant Bacillus cereus familymember of claim 50, wherein the enzyme involved in the production oractivation of a plant growth stimulating compound comprises a proteaseor peptidase that cleaves proteins, peptides, proproteins, orpreproproteins to create a bioactive peptide, the protease or peptidasecomprising subtilisin, an acid protease, an alkaline protease, aproteinase, an endopeptidase, an exopeptidase, thermolysin, papain,pepsin, trypsin, pronase, a carboxylase, a serine protease, a glutamicprotease, an aspartate protease, a cysteine protease, a threonineprotease, or a metalloprotease.
 52. The recombinant Bacillus cereusfamily member of claim 1, wherein the protein or peptide of interestcomprises an enzyme.
 53. The recombinant Bacillus cereus family memberof claim 52, wherein the enzyme comprises an enzyme that degrades ormodifies a bacterial, fungal, or plant nutrient source.
 54. Therecombinant Bacillus cereus family member of claim 52, wherein theenzyme comprises a cellulase, a lipase, a lignin oxidase, a protease, aglycoside hydrolase, a phosphatase, a nitrogenase, a nuclease, anamidase, a nitrate reductase, a nitrite reductase, an amylase, anammonia oxidase, a ligninase, a glucosidase, a phospholipase, a phytase,a pectinase, a glucanase, a sulfatase, a urease, a xylanase, or achitosanase.
 55. The recombinant Bacillus cereus family member of claim54, wherein the enzyme comprises a phospholipase and the phospholipasecomprises a phospholipase A1, a phospholipase A2, a phospholipase C, aphospholipase D, or a lysophospholipase.
 56. The recombinant Bacilluscereus family member of claim 55, wherein the phospholipase comprises aphospholipase C and the phospholipase C comprises an amino acid sequencehaving at least 85% identity with SEQ ID NO:
 312. 57. The recombinantBacillus cereus family member of claim 55, wherein the phospholipasecomprises a phospholipase C and the phospholipase C comprises an aminoacid sequence having at least 95% identity with SEQ ID NO:
 312. 58. Therecombinant Bacillus cereus family member of claim 54, wherein theenzyme comprises a cellulase and the cellulase comprises anendocellulase, an exocellulase, or a β-glucosidase.
 59. The recombinantBacillus cereus family member of claim 58, wherein the cellulasecomprises an endocellulase, and the endocellulase comprises anendoglucanase.
 60. The recombinant Bacillus cereus family member ofclaim 58, wherein the cellulase comprises an endocellulase, and theendocellulase comprises a Bacillus subtilis endoglucanase, a Bacillusthuringiensis endoglucanase, a Bacillus cereus endoglucanase, or aBacillus clausii endoglucanase.
 61. The recombinant Bacillus cereusfamily member of claim 60, wherein the cellulase comprises a Bacillussubtilis endoglucanase, and the Bacillus subtilis endoglucanasecomprises an amino acid sequence having at least 85% identity with SEQID NO:
 311. 62. The recombinant Bacillus cereus family member of claim60, wherein the cellulase comprises a Bacillus subtilis endoglucanase,and the Bacillus subtilis endoglucanase comprises an amino acid sequencehaving at least 95% identity with SEQ ID NO:
 311. 63. The recombinantBacillus cereus family member of claim 54, wherein the enzyme comprisesa lipase and the lipase comprises a Bacillus subtilis lipase, a Bacillusthuringiensis lipase, a Bacillus cereus lipase, or a Bacillus clausiilipase.
 64. The recombinant Bacillus cereus family member of claim 54,wherein the enzyme comprises a lignin oxidase, and the lignin oxidasecomprises a lignin peroxidase, a laccase, a glyoxal oxidase, aligninase, or a manganese peroxidase.
 65. The recombinant Bacilluscereus family member of claim 54, wherein the enzyme comprises aprotease, and the protease comprises a subtilisin, an acid protease, analkaline protease, a proteinase, a peptidase, an endopeptidase, anexopeptidase, a thermolysin, a papain, a pepsin, a trypsin, a pronase, acarboxylase, a serine protease, a glutamic protease, an aspartateprotease, a cysteine protease, a threonine protease, or ametalloprotease.
 66. The recombinant Bacillus cereus family member ofclaim 54, wherein the enzyme comprises a phosphatase, and thephosphatase comprises a phosphoric monoester hydrolase, aphosphomonoesterase, a phosphoric diester hydrolase, aphosphodiesterase, a triphosphoric monoester hydrolase, a phosphorylanhydride hydrolase, a pyrophosphatase, a phytase, a trimetaphosphatase,or a triphosphatase.
 67. The recombinant Bacillus cereus family memberof claim 54, wherein the enzyme comprises a nitrogenase, and thenitrogenase comprises a Nif family nitrogenase.
 68. The recombinantBacillus cereus family member of claim 54, wherein the enzyme comprisesa chitosanase, the chitosanase comprising an amino acid sequence havingat least 85% identity with SEQ ID NO:
 313. 69. The recombinant Bacilluscereus family member of claim 54, wherein the enzyme comprises achitosanase, the chitosanase comprising an amino acid sequence having atleast 95% identity with SEQ ID NO:
 313. 70. The recombinant Bacilluscereus family member of claim 1, wherein the recombinant Bacillus cereusfamily member comprises Bacillus anthracis, Bacillus cereus, Bacillusthuringiensis, Bacillus mycoides, Bacillus pseudomycoides, Bacillussamanii, Bacillus gaemokensis, Bacillus weihenstephensis, Bacillustoyoiensis, or a combination thereof.
 71. The recombinant Bacilluscereus family member of claim 70, wherein the recombinant Bacilluscereus family member comprises Bacillus mycoides BT155 (NRRL No.B-50921), Bacillus mycoides EE118 (NRRL No. B-50918), Bacillus mycoidesEE141 (NRRL No. B-50921), Bacillus mycoides BT46-3 (NRRL No. B-50922),Bacillus cereus family member EE128 (NRRL No. B-50917), Bacillusthuringiensis BT013A (NRRL No. B-50924), Bacillus cereus family memberEE349 (NRRL No. B-50928); Bacillus cereus family member EE-B00377 (NRRLB-67119); Bacillus pseudomycoides EE-B00366 (NRRL B-67120); Bacillusmycoides EE-B00363 (NRRL B-67121); Bacillus cereus family member EE439(NRRL B-50979); Bacillus thuringiensis EE417 (NRRL B-50979); Bacilluscereus EE444 (NRRL B-50977); Bacillus thuringiensis EE319 (NRRLB-50983); or Bacillus thuringiensis EE-B00184 (NRRL B-67122).
 72. Therecombinant Bacillus cereus family member of claim 71, wherein therecombinant Bacillus cereus family member comprises Bacillusthuringiensis BT013A (NRRL No. B-50924).
 73. The recombinant Bacilluscereus family member of claim 71, wherein the recombinant Bacilluscereus family member comprises Bacillus cereus family member EE349 (NRRLNo. B-50928).
 74. The recombinant Bacillus cereus family member of claim1, wherein the recombinant Bacillus cereus family member comprises aninactivating mutation in its BclA gene.
 75. The recombinant Bacilluscereus family member of claim 74, wherein the inactivating mutation inthe BclA gene comprises a knock-out of the BclA gene.
 76. A formulationcomprising exosporium fragments derived from spores of a recombinantBacillus cereus family member of claim 1 and an agriculturallyacceptable carrier.
 77. The formulation of claim 76, wherein theexosporium fragments are derived from spores of a recombinant Bacilluscereus family member expressing a fusion protein comprising SEQ ID NO:96 and a phospholipase C comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:
 312. 78. The formulation of claim 76,wherein the exosporium fragments are derived from spores of arecombinant Bacillus cereus family member expressing a fusion proteincomprising SEQ ID NO: 96 and a Bacillus subtilis endoglucanasecomprising an amino acid sequence having at least 85% identity with SEQID NO:
 311. 79. A plant seed coated with exosporium fragments derivedfrom spores of a recombinant Bacillus cereus family member of claim 1.80. A method for stimulating plant growth comprising: introducingexosporium fragments into a plant growth medium; or applying exosporiumfragments to a plant, a plant seed, or an area surrounding a plant or aplant seed; wherein the exosporium fragments are derived from spores ofa recombinant Bacillus cereus family member of claim 1 and comprise thefusion protein, and the fusion protein comprises a cellulase, a lipase,a lignin oxidase, a protease, a glycoside hydrolase, a phosphatase, anitrogenase, a nuclease, an amidase, a nitrate reductase, a nitritereductase, an amylase, an ammonia oxidase, a ligninase, a glucosidase, aphospholipase, a phytase, a pectinase, a glucanase, a sulfatase, aurease, a xylanase, or a chitosanase.
 81. The method of claim 80,wherein the cellulase comprises a Bacillus subtilis endoglucanase, andthe Bacillus subtilis endoglucanase comprises an amino acid sequencehaving at least 85% identity with SEQ ID NO:
 311. 82. The method ofclaim 80, wherein the phospholipase comprises a phospholipase C and thephospholipase C comprises an amino acid sequence having at least 85%identity with SEQ ID NO:
 312. 83. The method of claim 80, wherein thechitosanase comprises an amino acid sequence having at least 85%identity with SEQ ID NO:
 313. 84. A method for protecting a plant from apathogen or enhancing stress resistance in a plant comprising:introducing exosporium fragments into a plant growth medium; or applyingexosporium fragments to a plant, a plant seed, or an area surrounding aplant or a plant seed; wherein the exosporium fragments are derived fromspores of a recombinant Bacillus cereus family member of claim 1 andcomprise the fusion protein, and the fusion protein comprises a proteinor peptide that protects a plant from a pathogen or a protein or peptidethat enhances stress resistance in a plant.
 85. A method forimmobilizing exosporium fragments on a plant comprising: introducingexosporium fragments into a plant growth medium; or applying exosporiumfragments to a plant, a plant seed, or an area surrounding a plant or aplant seed; wherein the exosporium fragments are derived from spores ofa recombinant Bacillus cereus family member of claim 1 and comprise thefusion protein, and the fusion protein comprises a plant binding proteinor peptide.
 86. A recombinant Bacillus cereus family member thatexpresses a fusion protein comprising at least one protein or peptide ofinterest and a targeting sequence, exosporium protein, or exosporiumprotein fragment that targets the fusion protein to the exosporium ofthe recombinant Bacillus cereus family member, wherein the protein orpeptide of interest comprises: a phospholipase, the phospholipasecomprising a phospholipase A1, a phospholipase A2, a phospholipase C, aphospholipase D, or a lysophospholipase; a phosphomonoesterasecomprising PhoA4; a phytase, wherein the phytase comprises Bacillussubtilis EE148 phytase or Bacillus thuringiensis BT013A phytase; achitosanase comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 313; a Cry toxin from Bacillus thuringiensis,wherein the Cry toxin from Bacillus thuringiensis comprises a Cry5Bprotein or a Cry21A protein; a superoxide dismutase, the superoxidedismutase comprising superoxide dismutase 1 (SODA1) or superoxidedismutase 2 (SODA2); a protein or peptide that protects a plant from anenvironmental stress, wherein the protein or peptide that protects theplant from an environmental stress comprises an ice nucleation protein,a prolinase, a phenylalanine ammonia lyase, an isochorismate synthase,an isochorismate pyruvate lyase, or a choline dehydrogenase; an enzymethat catalyzes the production of nitric oxide; a nucleic acid bindingprotein or peptide, wherein the nucleic acid binding protein or peptidecomprises an Hfq protein or a small acid-soluble spore protein (SASP);or a nucleic acid binding protein or peptide, wherein a nucleic acidmolecule is bound to the nucleic acid binding protein or peptide, thenucleic acid molecule comprising a modulating RNA molecule; an RNAimolecule; a microRNA; an aptamer; or a DNA molecule that encodes amodulating RNA molecule, an RNAi molecule, a microRNA, or an aptamer;and wherein the recombinant Bacillus cereus family member comprises amutation that results in Bacillus cereus family member spores having anexosporium that is easier to remove from the spore as compared to theexosporium of a wild-type spore.
 87. The recombinant Bacillus cereusfamily member of claim 86, wherein the fusion protein further comprisesan amino acid linker between the targeting sequence, the exosporiumprotein, or the exosporium protein fragment and the protein or peptideof interest.
 88. The recombinant Bacillus cereus family member of claim87, wherein the linker comprises a polyalanine linker, a polyglycinelinker, or a linker comprising a mixture of both alanine and glycineresidues.
 89. The recombinant Bacillus cereus family member of claim 86,wherein the recombinant Bacillus cereus family member: (i) comprises amutation in a CotE gene; (ii) comprises a mutation in an ExsY gene;(iii) comprises a mutation in a CotY gene; (iv) comprises a mutation inan ExsA gene; or (v) comprises a mutation in a CotO gene.
 90. Therecombinant Bacillus cereus family member of claim 89, wherein therecombinant Bacillus cereus family member comprises a mutation in a CotEgene.
 91. The recombinant Bacillus cereus family member of claim 90,wherein the mutation in the CotE gene partially or completely inhibitsthe ability of CotE to attach the exosporium to the spore.
 92. Therecombinant Bacillus cereus family member of claim 90, wherein themutation in the CotE gene comprises a knock-out of the CotE gene or adominant negative form of the CotE gene.
 93. The recombinant Bacilluscereus family member of claim 89, wherein the recombinant Bacilluscereus family member comprises a mutation in an ExsY gene.
 94. Therecombinant Bacillus cereus family member of claim 93, wherein themutation in the ExsY gene partially or completely inhibits the abilityof ExsY to complete the formation of the exosporium or attach theexosporium to the spore.
 95. The recombinant Bacillus cereus familymember of claim 93, wherein the mutation in the ExsY gene comprises aknock-out of the ExsY gene.
 96. The recombinant Bacillus cereus familymember of claim 89, wherein the recombinant Bacillus cereus familymember comprises a mutation in a CotY gene.
 97. The recombinant Bacilluscereus family member of claim 96, wherein the mutation in the CotY genecomprises a knock-out of the CotY gene.
 98. The recombinant Bacilluscereus family member of claim 96, wherein the mutation in the CotY generesults in the formation of a fragile exosporium.
 99. The recombinantBacillus cereus family member of claim 89, wherein the recombinantBacillus cereus family member comprises a mutation in an ExsA gene. 100.The recombinant Bacillus cereus family member of claim 99, wherein themutation in the ExsA gene comprises a knock-out of the ExsA gene. 101.The recombinant Bacillus cereus family member of claim 99, wherein themutation in the ExsA gene results in the formation of a fragileexosporium.
 102. The recombinant Bacillus cereus family member of claim89, wherein the recombinant Bacillus cereus family member comprises amutation in a CotO gene.
 103. The recombinant Bacillus cereus familymember of claim 102, wherein the mutation in the CotO gene comprises aknock-out of the CotO gene or a dominant negative form of the CotO gene.104. The recombinant Bacillus cereus family member of claim 102, whereinthe mutation in the CotO gene causes the exosporium to form in strips.105. The recombinant Bacillus cereus family member of claim 86, whereinthe targeting sequence, exosporium protein, or exosporium proteinfragment comprises: (1) a targeting sequence comprising an amino acidsequence having at least about 43% identity with amino acids 20-35 ofSEQ ID NO: 1, wherein the identity with amino acids 25-35 is at leastabout 54%; (2) a targeting sequence comprising amino acids 1-35 of SEQID NO: 1; (3) a targeting sequence comprising amino acids 20-35 of SEQID NO: 1; (4) a targeting sequence comprising SEQ ID NO: 1; (5) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 2; (6) a targeting sequence comprising aminoacids 2-35 of SEQ ID NO: 1; (7) a targeting sequence comprising aminoacids 5-35 of SEQ ID NO: 1; (8) a targeting sequence comprising aminoacids 8-35 of SEQ ID NO: 1; (9) a targeting sequence comprising aminoacids 10-35 of SEQ ID NO: 1; (10) a targeting sequence comprising aminoacids 15-35 of SEQ ID NO: 1; (11) a targeting sequence comprising aminoacids 1-27 of SEQ ID NO: 3; (12) a targeting sequence comprising aminoacids 12-27 of SEQ ID NO: 3; (13) a targeting sequence comprising SEQ IDNO: 3; (14) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 4; (15) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 3; (16) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 3; (17) a targetingsequence comprising amino acids 8-27 of SEQ ID NO: 3; (18) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 3; (19) a targetingsequence comprising amino acids 1-38 of SEQ ID NO: 5; (20) a targetingsequence comprising amino acids 23-38 of SEQ ID NO: 5; (21) a targetingsequence comprising SEQ ID NO: 5; (22) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO: 6;(23) a targeting sequence comprising amino acids 2-38 of SEQ ID NO: 5;(24) a targeting sequence comprising amino acids 5-38 of SEQ ID NO: 5;(25) a targeting sequence comprising amino acids 8-38 of SEQ ID NO: 5;(26) a targeting sequence comprising amino acids 10-38 of SEQ ID NO: 5;(27) a targeting sequence comprising amino acids 15-38 of SEQ ID NO: 5;(28) a targeting sequence comprising amino acids 20-38 of SEQ ID NO: 5;(29) a targeting sequence comprising amino acids 1-28 of SEQ ID NO: 7;(30) a targeting sequence comprising amino acids 13-28 of SEQ ID NO: 7;(31) a targeting sequence comprising SEQ ID NO: 7; (32) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 8; (33) a targeting sequence comprising amino acids 2-28of SEQ ID NO: 7; (34) a targeting sequence comprising amino acids 5-28of SEQ ID NO: 7; (35) a targeting sequence comprising amino acids 8-28of SEQ ID NO: 7; (36) a targeting sequence comprising amino acids 10-28of SEQ ID NO: 7; (37) a targeting sequence comprising amino acids 1-24of SEQ ID NO: 9; (38) a targeting sequence comprising amino acids 9-24of SEQ ID NO: 9; (39) a targeting sequence comprising SEQ ID NO: 9; (40)an exosporium protein comprising an amino acid sequence having at least85% identity with SEQ ID NO: 10; (41) a targeting sequence comprisingamino acids 2-24 of SEQ ID NO: 9; (42) a targeting sequence comprisingamino acids 5-24 of SEQ ID NO: 9; (43) a targeting sequence comprisingamino acids 8-24 of SEQ ID NO: 9; (44) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO:11; (45) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 11; (46) a targeting sequence comprisingSEQ ID NO: 11; (47) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 12; (48) atargeting sequence comprising amino acids 2-33 of SEQ ID NO: 11; (49) atargeting sequence comprising amino acids 5-33 of SEQ ID NO: 11; (50) atargeting sequence comprising amino acids 8-33 of SEQ ID NO: 11; (51) atargeting sequence comprising amino acids 10-33 of SEQ ID NO: 11; (52) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 11; (53) atargeting sequence comprising amino acids 1-33 of SEQ ID NO: 13; (54) atargeting sequence comprising amino acids 18-33 of SEQ ID NO: 13; (55) atargeting sequence comprising SEQ ID NO:13; (56) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO:14; (57) a targeting sequence comprising amino acids 2-33 of SEQID NO: 13; (58) a targeting sequence comprising amino acids 5-33 of SEQID NO: 13; (59) a targeting sequence comprising amino acids 8-33 of SEQID NO: 13; (60) a targeting sequence comprising amino acids 10-33 of SEQID NO: 13; (61) a targeting sequence comprising amino acids 15-33 of SEQID NO: 13; (62) a targeting sequence comprising amino acids 1-43 of SEQID NO: 15; (63) a targeting sequence comprising amino acids 28-43 of SEQID NO: 15; (64) a targeting sequence comprising SEQ ID NO:15; (65) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO:16; (66) a targeting sequence comprising aminoacids 2-43 of SEQ ID NO: 15; (67) a targeting sequence comprising aminoacids 5-43 of SEQ ID NO: 15; (68) a targeting sequence comprising aminoacids 8-43 of SEQ ID NO: 15; (69) a targeting sequence comprising aminoacids 10-43 of SEQ ID NO: 15; (70) a targeting sequence comprising aminoacids 15-43 of SEQ ID NO: 15; (71) a targeting sequence comprising aminoacids 20-43 of SEQ ID NO: 15; (72) a targeting sequence comprising aminoacids 25-43 of SEQ ID NO: 15; (73) a targeting sequence comprising aminoacids 1-27 of SEQ ID NO: 17; (74) a targeting sequence comprising aminoacids 12-27 of SEQ ID NO: 17; (75) a targeting sequence comprising SEQID NO:17; (76) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:18; (77) a targetingsequence comprising amino acids 2-27 of SEQ ID NO: 17; (78) a targetingsequence comprising amino acids 5-27 of SEQ ID NO: 17; (79) a targetingsequence comprising amino acids 8-27 of SEQ ID NO: 17; (80) a targetingsequence comprising amino acids 10-27 of SEQ ID NO: 17; (81) a targetingsequence comprising amino acids 1-33 of SEQ ID NO: 19; (82) a targetingsequence comprising amino acids 18-33 of SEQ ID NO: 19; (83) a targetingsequence comprising SEQ ID NO:19; (84) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:20;(85) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 19;(86) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 19;(87) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 19;(88) a targeting sequence comprising amino acids 10-33 of SEQ ID NO: 19;(89) a targeting sequence comprising amino acids 15-33 of SEQ ID NO: 19;(90) a targeting sequence comprising amino acids 1-33 of SEQ ID NO: 21;(91) a targeting sequence comprising amino acids 18-33 of SEQ ID NO: 21;(92) a targeting sequence comprising SEQ ID NO:21; (93) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:22; (94) a targeting sequence comprising amino acids 2-33of SEQ ID NO: 21; (95) a targeting sequence comprising amino acids 5-33of SEQ ID NO: 21; (96) a targeting sequence comprising amino acids 8-33of SEQ ID NO: 21; (97) a targeting sequence comprising amino acids 10-33of SEQ ID NO: 21; (98) a targeting sequence comprising amino acids 15-33of SEQ ID NO: 21; (99) a targeting sequence comprising amino acids 1-24of SEQ ID NO: 23; (100) a targeting sequence comprising amino acids 9-24of SEQ ID NO: 23; (101) a targeting sequence comprising SEQ ID NO:23;(102) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:24; (103) a targeting sequencecomprising amino acids 2-24 of SEQ ID NO:23; (104) a targeting sequencecomprising amino acids 5-24 of SEQ ID NO: 23; (105) a targeting sequencecomprising amino acids 8-24 of SEQ ID NO: 23; (106) a targeting sequencecomprising amino acids 1-24 of SEQ ID NO: 25; (107) a targeting sequencecomprising amino acids 9-24 of SEQ ID NO: 25; (108) a targeting sequencecomprising SEQ ID NO:25; (109) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO:26; (110) atargeting sequence comprising amino acids 2-24 of SEQ ID NO: 25; (111) atargeting sequence comprising amino acids 5-24 of SEQ ID NO: 25; (112) atargeting sequence comprising amino acids 8-24 of SEQ ID NO: 25; (113) atargeting sequence comprising amino acids 1-30 of SEQ ID NO: 27; (114) atargeting sequence comprising amino acids 15-30 of SEQ ID NO: 27; (115)a targeting sequence comprising SEQ ID NO:27; (116) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:28; (117) a targeting sequence comprising amino acids2-30 of SEQ ID NO: 27; (118) a targeting sequence comprising amino acids5-30 of SEQ ID NO: 27; (119) a targeting sequence comprising amino acids8-30 of SEQ ID NO: 27; (120) a targeting sequence comprising amino acids10-30 of SEQ ID NO: 27; (121) a targeting sequence comprising aminoacids 1-33 of SEQ ID NO: 29; (122) a targeting sequence comprising aminoacids 18-33 of SEQ ID NO: 29; (123) a targeting sequence comprising SEQID NO:29; (124) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:30; (125) a targetingsequence comprising amino acids 2-33 of SEQ ID NO: 29; (126) a targetingsequence comprising amino acids 5-33 of SEQ ID NO: 29; (127) a targetingsequence comprising amino acids 8-33 of SEQ ID NO: 29; (128) a targetingsequence comprising amino acids 10-33 of SEQ ID NO: 29; (129) atargeting sequence comprising amino acids 15-33 of SEQ ID NO: 29; (130)a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 31; (131)a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 31; (132)a targeting sequence comprising SEQ ID NO:31; (133) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO:32; (134) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 31; (135) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 31; (136) a targeting sequence comprising amino acids8-24 of SEQ ID NO: 31; (137) a targeting sequence comprising amino acids1-15 of SEQ ID NO: 33; (138) a targeting sequence comprising SEQ IDNO:33; (139) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO:34; (140) a targetingsequence comprising amino acids 1-16 of SEQ ID NO: 35; (141) a targetingsequence comprising SEQ ID NO:35; (142) an exosporium protein comprisingan amino acid sequence having at least 85% identity with SEQ ID NO:36;(143) a targeting sequence comprising amino acids 1-29 of SEQ ID NO:43;(144) a targeting sequence comprising amino acids 14-29 of SEQ ID NO:43; (145) a targeting sequence comprising SEQ ID NO: 43; (146) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 44; (147) a targeting sequence comprising aminoacids 2-29 of SEQ ID NO: 43; (148) a targeting sequence comprising aminoacids 5-29 of SEQ ID NO: 43; (149) a targeting sequence comprising aminoacids 8-29 of SEQ ID NO: 43; (150) a targeting sequence comprising aminoacids 10-29 of SEQ ID NO: 43; (151) a targeting sequence comprisingamino acids 1-35 of SEQ ID NO: 45; (152) a targeting sequence comprisingamino acids 20-35 of SEQ ID NO: 45; (153) a targeting sequencecomprising SEQ ID NO: 45; (154) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 46;(155) a targeting sequence comprising amino acids 2-35 of SEQ ID NO: 45;(156) a targeting sequence comprising amino acids 5-35 of SEQ ID NO: 45;(157) a targeting sequence comprising amino acids 8-35 of SEQ ID NO: 45;(158) a targeting sequence comprising amino acids 10-35 of SEQ ID NO:45; (159) a targeting sequence comprising amino acids 15-35 of SEQ IDNO: 45; (160) a targeting sequence comprising amino acids 1-43 of SEQ IDNO: 47; (161) a targeting sequence comprising amino acids 28-43 of SEQID NO: 47; (162) a targeting sequence comprising SEQ ID NO: 47; (163) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 48; (164) a targeting sequence comprising aminoacids 2-43 of SEQ ID NO: 47; (165) a targeting sequence comprising aminoacids 5-43 of SEQ ID NO: 47; (166) a targeting sequence comprising aminoacids 8-43 of SEQ ID NO: 47; (167) a targeting sequence comprising aminoacids 10-43 of SEQ ID NO: 47; (168) a targeting sequence comprisingamino acids 15-43 of SEQ ID NO: 47; (169) a targeting sequencecomprising amino acids 20-43 of SEQ ID NO: 47; (170) a targetingsequence comprising amino acids 25-43 of SEQ ID NO: 47; (171) atargeting sequence comprising amino acids 1-32 of SEQ ID NO: 49; (172) atargeting sequence comprising amino acids 17-32 of SEQ ID NO: 49; (173)a targeting sequence comprising SEQ ID NO: 49; (174) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 50; (175) a targeting sequence comprising amino acids2-32 of SEQ ID NO: 49; (176) a targeting sequence comprising amino acids5-32 of SEQ ID NO: 49; (177) a targeting sequence comprising amino acids8-32 of SEQ ID NO: 49; (178) a targeting sequence comprising amino acids10-32 of SEQ ID NO: 49; (179) a targeting sequence comprising aminoacids 15-32 of SEQ ID NO: 49; (180) a targeting sequence comprisingamino acids 1-33 of SEQ ID NO: 51; (181) a targeting sequence comprisingamino acids 18-33 of SEQ ID NO: 51; (182) a targeting sequencecomprising SEQ ID NO: 51; (183) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 52;(184) a targeting sequence comprising amino acids 2-33 of SEQ ID NO: 51;(185) a targeting sequence comprising amino acids 5-33 of SEQ ID NO: 51;(186) a targeting sequence comprising amino acids 8-33 of SEQ ID NO: 51;(187) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:51; (188) a targeting sequence comprising amino acids 15-33 of SEQ IDNO: 51; (189) a targeting sequence comprising amino acids 1-33 of SEQ IDNO: 53; (190) a targeting sequence comprising amino acids 18-33 of SEQID NO: 53; (191) a targeting sequence comprising SEQ ID NO: 53; (192) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 54; (193) a targeting sequence comprising aminoacids 2-33 of SEQ ID NO: 53; (194) a targeting sequence comprising aminoacids 5-33 of SEQ ID NO: 53; (195) a targeting sequence comprising aminoacids 8-33 of SEQ ID NO: 53; (196) a targeting sequence comprising aminoacids 10-33 of SEQ ID NO: 53; (197) a targeting sequence comprisingamino acids 15-33 of SEQ ID NO: 53; (198) a targeting sequencecomprising amino acids 1-30 of SEQ ID NO: 55; (199) a targeting sequencecomprising amino acids 15-30 of SEQ ID NO: 55; (200) a targetingsequence comprising SEQ ID NO: 55; (201) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 56; (202) a targeting sequence comprising amino acids 2-30 of SEQID NO: 55; (203) a targeting sequence comprising amino acids 5-30 of SEQID NO: 55; (204) a targeting sequence comprising amino acids 8-30 of SEQID NO: 55; (205) a targeting sequence comprising amino acids 10-30 ofSEQ ID NO: 55; (206) a targeting sequence comprising amino acids 1-130of SEQ ID NO: 57; (207) a targeting sequence comprising amino acids115-130 of SEQ ID NO: 57; (208) a targeting sequence comprising SEQ IDNO: 57; (209) an exosporium protein comprising an amino acid sequencehaving at least 85% identity with SEQ ID NO: 58; (210) a targetingsequence comprising amino acids 2-130 of SEQ ID NO: 57; (211) atargeting sequence comprising amino acids 5-130 of SEQ ID NO: 57; (212)a targeting sequence comprising amino acids 10-130 of SEQ ID NO: 57;(213) a targeting sequence comprising amino acids 20-130 of SEQ ID NO:57; (214) a targeting sequence comprising amino acids 30-130 of SEQ IDNO: 57; (215) a targeting sequence comprising amino acids 40-130 of SEQID NO: 57; (216) a targeting sequence comprising amino acids 50-130 ofSEQ ID NO: 57; (217) a targeting sequence comprising amino acids 60-130of SEQ ID NO: 57; (218) a targeting sequence comprising amino acids70-130 of SEQ ID NO: 57; (219) a targeting sequence comprising aminoacids 80-130 of SEQ ID NO: 57; (220) a targeting sequence comprisingamino acids 90-130 of SEQ ID NO: 57; (221) a targeting sequencecomprising amino acids 100-130 of SEQ ID NO: 57; (222) a targetingsequence comprising amino acids 110-130 of SEQ ID NO: 57; (223) anexosporium protein fragment comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 95; (224) a targeting sequencecomprising SEQ ID NO: 96; (225) a targeting sequence comprising SEQ IDNO: 97; (226) a targeting sequence comprising SEQ ID NO: 98; (227) atargeting sequence comprising SEQ ID NO: 99; (228) a targeting sequencecomprising SEQ ID NO: 100; (229) a targeting sequence comprising SEQ IDNO: 101; (230) a targeting sequence comprising SEQ ID NO: 102; (231) atargeting sequence comprising SEQ ID NO: 103; (232) a targeting sequencecomprising SEQ ID NO: 104; (233) a targeting sequence comprising SEQ IDNO: 105; (234) a targeting sequence comprising SEQ ID NO: 106; (235) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 108; (236) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 109;(237) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 110; (238) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 111; (239) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 112; (240) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 113; (241) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 114;(242) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 115; (243) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 116; (244) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 117; (245) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 118; (246) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 119;(247) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 120; (248) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 121; (249) a targeting sequence comprising amino acids 22-31 ofSEQ ID NO: 1; (250) a targeting sequence comprising amino acids 22-33 ofSEQ ID NO: 1; (251) a targeting sequence comprising amino acids 20-31 ofSEQ ID NO: 1; (252) a targeting sequence comprising amino acids 14-23 ofSEQ ID NO: 3; (253) a targeting sequence comprising amino acids 14-25 ofSEQ ID NO: 3; (254) a targeting sequence comprising amino acids 12-23 ofSEQ ID NO: 3; (255) a targeting sequence comprising amino acids 1-30 ofSEQ ID NO: 59; (256) a targeting sequence comprising SEQ ID NO: 59;(257) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 60; (258) a targeting sequencecomprising amino acids 2-30 of SEQ ID NO: 59; (259) a targeting sequencecomprising amino acids 4-30 of SEQ ID NO: 59; (260) a targeting sequencecomprising amino acids 6-30 of SEQ ID NO: 59; (261) a targeting sequencecomprising amino acids 1-33 of SEQ ID NO: 61; (262) a targeting sequencecomprising amino acids 18-33 of SEQ ID NO: 61; (263) a targetingsequence comprising SEQ ID NO: 61; (264) an exosporium proteincomprising an amino acid sequence having at least 85% sequence identitywith SEQ ID NO: 62; (265) a targeting sequence comprising amino acids2-33 of SEQ ID NO: 61; (266) a targeting sequence comprising amino acids5-33 of SEQ ID NO: 61; (267) a targeting sequence comprising amino acids10-33 of SEQ ID NO: 61; (268) a targeting sequence comprising aminoacids 15-33 of SEQ ID NO: 61; (269) a targeting sequence comprisingamino acids 1-35 of SEQ ID NO: 63; (270) a targeting sequence comprisingSEQ ID NO: 63; (271) an exosporium protein comprising an amino acidsequence having at least 85% identity with SEQ ID NO: 64; (272) atargeting sequence comprising amino acids 2-35 of SEQ ID NO: 63; (273) atargeting sequence comprising amino acids 5-35 of SEQ ID NO: 63; (274) atargeting sequence comprising amino acids 8-35 of SEQ ID NO: 63; (275) atargeting sequence comprising amino acids 10-35 of SEQ ID NO: 63; (276)a targeting sequence comprising amino acids 15-35 of SEQ ID NO: 63;(277) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 65;(278) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 65;(279) a targeting sequence comprising SEQ ID NO: 65; (280) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 66; (281) a targeting sequence comprising SEQ ID NO:107; (282) a targeting sequence comprising amino acids 2-24 of SEQ IDNO: 65; (283) a targeting sequence comprising amino acids 5-24 of SEQ IDNO: 65; (284) a targeting sequence comprising amino acids 1-27 of SEQ IDNO: 67; (285) a targeting sequence comprising amino acids 12-27 of SEQID NO: 67; (286) a targeting sequence comprising SEQ ID NO: 67; (287) anexosporium protein comprising an amino acid sequence having at least 85%identity with SEQ ID NO: 68; (288) an targeting sequence comprisingamino acids 2-27 of SEQ ID NO: 67; (289) a targeting sequence comprisingamino acids 5-27 of SEQ ID NO: 67; (290) a targeting sequence comprisingamino acids 10-27 of SEQ ID NO: 67; (291) a targeting sequencecomprising amino acids 1-38 of SEQ ID NO: 69; (292) a targeting sequencecomprising amino acids 23-38 of SEQ ID NO: 69; (293) a targetingsequence comprising SEQ ID NO: 69; (294) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 70; (295) a targeting sequence comprising amino acids 2-38 of SEQID NO: 69; (296) a targeting sequence comprising amino acids 5-38 of SEQID NO: 69; (297) a targeting sequence comprising amino acids 10-38 ofSEQ ID NO: 69; (298) a targeting sequence comprising amino acids 15-38of SEQ ID NO: 69; (299) an exosporium protein comprising SEQ ID NO: 72;(300) a targeting sequence comprising SEQ ID NO: 73; (301) an exosporiumprotein comprising an amino acid sequence having at least 95% identitywith SEQ ID NO: 74; (302) a targeting sequence comprising amino acids1-42 of SEQ ID NO: 75; (303) a targeting sequence comprising amino acids27-42 of SEQ ID NO: 75; (304) a targeting sequence comprising SEQ ID NO:75; (305) an exosporium protein comprising an amino acid sequence havingat least 85% identity with SEQ ID NO: 76; (306) a targeting sequencecomprising amino acids 2-42 of SEQ ID NO: 75; (307) a targeting sequencecomprising amino acids 5-42 of SEQ ID NO: 75; (308) a targeting sequencecomprising amino acids 10-42 of SEQ ID NO: 75; (309) a targetingsequence comprising amino acids 15-42 of SEQ ID NO: 75; (310) atargeting sequence comprising amino acids 20-42 of SEQ ID NO: 75; (311)a targeting sequence comprising amino acids 25-42 of SEQ ID NO: 75;(312) a targeting sequence comprising amino acids 1-24 of SEQ ID NO: 77;(313) a targeting sequence comprising amino acids 9-24 of SEQ ID NO: 77;(314) a targeting sequence comprising SEQ ID NO: 77; (315) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 78; (316) a targeting sequence comprising amino acids2-24 of SEQ ID NO: 77; (317) a targeting sequence comprising amino acids5-24 of SEQ ID NO: 77; (318) an exosporium protein comprising an aminoacid sequence having at least 85% identity with SEQ ID NO: 80; (319) atargeting sequence comprising amino acids 1-38 of SEQ ID NO: 81; (320) atargeting sequence comprising amino acids 23-38 of SEQ ID NO: 81; (321)a targeting sequence comprising SEQ ID NO: 81; (322) an exosporiumprotein comprising an amino acid sequence having at least 85% identitywith SEQ ID NO: 82; (323) a targeting sequence comprising amino acids2-38 of SEQ ID NO: 81; (324) a targeting sequence comprising amino acids5-38 of SEQ ID NO: 81; (325) a targeting sequence comprising amino acids10-38 of SEQ ID NO: 81; (326) a targeting sequence comprising aminoacids 15-38 of SEQ ID NO: 81; (327) a targeting sequence comprisingamino acids 20-38 of SEQ ID NO: 81; (328) a targeting sequencecomprising amino acids 1-34 of SEQ ID NO: 83; (329) a targeting sequencecomprising SEQ ID NO: 83; (330) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 84;(331) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 86; (332) a targeting sequencecomprising amino acids 1-28 of SEQ ID NO: 87; (333) a targeting sequencecomprising amino acids 13-28 of SEQ ID NO: 87; (334) a targetingsequence comprising SEQ ID NO: 87; (335) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 88; (336) a targeting sequence comprising amino acids 2-28 of SEQID NO: 87; (337) a targeting sequence comprising amino acids 5-28 of SEQID NO: 87; (338) a targeting sequence comprising amino acids 10-28 ofSEQ ID NO: 87; (339) a targeting sequence comprising amino acids 1-28 ofSEQ ID NO: 89; (340) a targeting sequence comprising SEQ ID NO: 89;(341) an exosporium protein comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 90; (342) a targeting sequencecomprising amino acids 2-28 of SEQ ID NO: 89; (343) a targeting sequencecomprising amino acids 5-28 of SEQ ID NO: 89; (344) a targeting sequencecomprising amino acids 10-28 of SEQ ID NO: 89; (345) a targetingsequence comprising amino acids 1-93 of SEQ ID NO: 91; (346) a targetingsequence comprising SEQ ID NO: 91; (347) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 92; (348) a targeting sequence comprising amino acids 2-93 of SEQID NO: 91; (349) a targeting sequence comprising amino acids 10-93 ofSEQ ID NO: 91; (350) a targeting sequence comprising amino acids 20-93of SEQ ID NO: 91; (351) a targeting sequence comprising amino acids30-93 of SEQ ID NO: 91; (352) a targeting sequence comprising aminoacids 40-93 of SEQ ID NO: 91; (353) a targeting sequence comprisingamino acids 50-93 of SEQ ID NO: 91; (354) a targeting sequencecomprising amino acids 60-93 of SEQ ID NO: 91; (355) a targetingsequence comprising amino acids 1-130 of SEQ ID NO: 93; (356) atargeting sequence comprising SEQ ID NO: 93; (357) an exosporium proteincomprising an amino acid sequence having at least 85% identity with SEQID NO: 94; (358) a targeting sequence comprising amino acids 2-130 ofSEQ ID NO: 93; (359) a targeting sequence comprising amino acids 10-130of SEQ ID NO: 93; (360) a targeting sequence comprising amino acids20-130 of SEQ ID NO: 93; (361) a targeting sequence comprising aminoacids 30-130 of SEQ ID NO: 93; (362) an exosporium protein comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 122;(363) a targeting sequence consisting of amino acids 20-33 of SEQ ID NO:1; (364) a targeting sequence consisting of amino acids 21-33 of SEQ IDNO: 1; (365) a targeting sequence consisting of amino acids 23-31 of SEQID NO: 1; (366) a targeting sequence consisting of amino acids 1-15 ofSEQ ID NO: 96; (367) a targeting sequence consisting of amino acids 1-13of SEQ ID NO: 96; (368) a targeting sequence consisting of amino acids12-25 of SEQ ID NO: 3; (369) a targeting sequence consisting of aminoacids 13-25 of SEQ ID NO: 3; (370) a targeting sequence consisting ofamino acids 15-23 of SEQ ID NO: 3; (371) a targeting sequence consistingof amino acids 1-15 of SEQ ID NO: 97; (372) a targeting sequenceconsisting of amino acids 1-13 of SEQ ID NO: 98; (373) a targetingsequence consisting of amino acids 23-36 of SEQ ID NO: 5; (374) atargeting sequence consisting of amino acids 23-34 of SEQ ID NO: 5;(375) a targeting sequence consisting of amino acids 24-36 of SEQ ID NO:5; (376) a targeting sequence consisting of amino acids 26-34 of SEQ IDNO: 5; (377) a targeting sequence consisting of amino acids 13-26 of SEQID NO: 7; (378) a targeting sequence consisting of amino acids 13-24 ofSEQ ID NO: 7; (379) a targeting sequence consisting of amino acids 14-26of SEQ ID NO: 7; (380) a targeting sequence consisting of amino acids16-24 of SEQ ID NO: 7; (381) a targeting sequence consisting of aminoacids 9-22 of SEQ ID NO: 9; (382) a targeting sequence consisting ofamino acids 9-20 of SEQ ID NO: 9; (383) a targeting sequence consistingof amino acids 10-22 of SEQ ID NO: 9; (384) a targeting sequenceconsisting of amino acids 12-20 of SEQ ID NO: 9; (385) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 105; (386) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 105;(387) a targeting sequence consisting of amino acids 18-31 of SEQ ID NO:11; (388) a targeting sequence consisting of amino acids 18-29 of SEQ IDNO: 11; (389) a targeting sequence consisting of amino acids 19-31 ofSEQ ID NO: 11; (390) a targeting sequence consisting of amino acids 1-15of SEQ ID NO: 98; (391) a targeting sequence consisting of amino acids1-13 of SEQ ID NO: 98; (392) a targeting sequence consisting of aminoacids 18-31 of SEQ ID NO: 13; (393) a targeting sequence consisting ofamino acids 18-29 of SEQ ID NO: 13; (394) a targeting sequenceconsisting of amino acids 19-31 of SEQ ID NO: 13; (395) a targetingsequence consisting of amino acids 21-29 of SEQ ID NO: 13; (396) atargeting sequence consisting of amino acids 1-15 of SEQ ID NO: 99;(397) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:99; (398) a targeting sequence consisting of amino acids 28-41 of SEQ IDNO: 15; (399) a targeting sequence consisting of amino acids 28-39 ofSEQ ID NO: 15; (400) a targeting sequence consisting of amino acids29-41 of SEQ ID NO: 15; (401) a targeting sequence consisting of aminoacids 31-39 of SEQ ID NO: 15; (402) a targeting sequence consisting ofamino acids 12-25 of SEQ ID NO: 17; (403) a targeting sequenceconsisting of amino acids 13-25 of SEQ ID NO: 17; (404) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 100; (405) atargeting sequence consisting of amino acids 18-31 of SEQ ID NO: 19;(406) a targeting sequence consisting of amino acids 18-29 of SEQ ID NO:19; (407) a targeting sequence consisting of amino acids 19-31 of SEQ IDNO: 19; (408) a targeting sequence consisting of amino acids 21-29 ofSEQ ID NO: 19; (409) a targeting sequence consisting of amino acids18-31 of SEQ ID NO: 21; (410) a targeting sequence consisting of aminoacids 18-29 of SEQ ID NO: 21; (411) a targeting sequence consisting ofamino acids 19-31 of SEQ ID NO: 21; (412) a targeting sequenceconsisting of amino acids 21-29 of SEQ ID NO: 21; (413) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 101; (414) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 101;(415) a targeting sequence consisting of amino acids 9-22 of SEQ ID NO:23; (416) a targeting sequence consisting of amino acids 9-20 of SEQ IDNO: 23; (417) a targeting sequence consisting of amino acids 10-22 ofSEQ ID NO: 23; (418) a targeting sequence consisting of amino acids12-20 of SEQ ID NO: 23; (419) a targeting sequence consisting of aminoacids 1-15 of SEQ ID NO: 102; (420) a targeting sequence consisting ofamino acids 1-13 of SEQ ID NO: 102; (421) a targeting sequenceconsisting of amino acids 9-22 of SEQ ID NO: 25; (422) a targetingsequence consisting of amino acids 9-20 of SEQ ID NO: 25; (423) atargeting sequence consisting of amino acids 10-22 of SEQ ID NO: 25;(424) a targeting sequence consisting of amino acids 12-20 of SEQ ID NO:25; (425) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 103; (426) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 103; (427) a targeting sequence consisting of amino acids15-28 of SEQ ID NO: 27; (428) a targeting sequence consisting of aminoacids 15-26 of SEQ ID NO: 27; (429) a targeting sequence consisting ofamino acids 16-28 of SEQ ID NO: 27; (430) a targeting sequenceconsisting of amino acids 18-26 of SEQ ID NO: 27; (431) a targetingsequence consisting of amino acids 1-15 of SEQ ID NO: 104; (432) atargeting sequence consisting of amino acids 1-13 of SEQ ID NO: 104;(433) a targeting sequence consisting of amino acids 1-13 of SEQ ID NO:33; (434) a targeting sequence consisting of amino acids 1-11 of SEQ IDNO: 33; (435) a targeting sequence consisting of amino acids 3-11 of SEQID NO: 33; (436) a targeting sequence consisting of amino acids 1-14 ofSEQ ID NO: 35; (437) a targeting sequence consisting of amino acids 1-12of SEQ ID NO: 35; (438) a targeting sequence consisting of amino acids2-14 of SEQ ID NO: 35; (439) a targeting sequence consisting of aminoacids 14-27 of SEQ ID NO: 43; (440) a targeting sequence consisting ofamino acids 14-25 of SEQ ID NO: 43; (441) a targeting sequenceconsisting of amino acids 15-27 of SEQ ID NO: 43; (442) a targetingsequence consisting of amino acids 20-33 of SEQ ID NO: 45; (443) atargeting sequence consisting of amino acids 20-31 of SEQ ID NO: 45;(444) a targeting sequence consisting of amino acids 21-33 of SEQ ID NO:45; (445) a targeting sequence consisting of amino acids 1-15 of SEQ IDNO: 106; (446) a targeting sequence consisting of amino acids 1-13 ofSEQ ID NO: 106; (447) a targeting sequence consisting of amino acids28-41 of SEQ ID NO: 47; (448) a targeting sequence consisting of aminoacids 28-39 of SEQ ID NO: 47; (449) a targeting sequence consisting ofamino acids 18-31 of SEQ ID NO: 53; (450) a targeting sequenceconsisting of amino acids 18-29 of SEQ ID NO: 53; (451) a targetingsequence consisting of amino acids 19-31 of SEQ ID NO: 53; (452) atargeting sequence comprising amino acids 18-31 of SEQ ID NO: 61; (453)a targeting sequence comprising amino acids 18-29 of SEQ ID NO: 61;(454) a targeting sequence comprising amino acids 19-31 of SEQ ID NO:61; (455) a targeting sequence comprising amino acids 9-22 of SEQ ID NO:65; (456) a targeting sequence comprising amino acids 9-20 of SEQ ID NO:65; (457) a targeting sequence comprising amino acids 10-22 of SEQ IDNO: 65; (458) a targeting sequence comprising amino acids 1-15 of SEQ IDNO: 107; (459) a targeting sequence comprising amino acids 1-13 of SEQID NO: 107; (460) a targeting sequence comprising amino acids 12-25 ofSEQ ID NO: 67; (461) a targeting sequence comprising amino acids 12-23of SEQ ID NO: 67; (462) a targeting sequence comprising amino acids13-25 of SEQ ID NO: 67; (463) a targeting sequence comprising aminoacids 15-23 of SEQ ID NO: 67; (464) a targeting sequence comprisingamino acids 23-36 of SEQ ID NO: 69; (465) a targeting sequencecomprising amino acids 23-34 of SEQ ID NO: 69; (466) a targetingsequence comprising amino acids 24-36 of SEQ ID NO: 69; (467) atargeting sequence comprising amino acids 26-34 of SEQ ID NO: 69; (468)a targeting sequence comprising amino acids 27-40 of SEQ ID NO: 75;(469) a targeting sequence comprising amino acids 27-38 of SEQ ID NO:75; (470) a targeting sequence comprising amino acids 9-22 of SEQ ID NO:77; (471) a targeting sequence comprising amino acids 9-20 of SEQ ID NO:77; (472) a targeting sequence comprising amino acids 10-22 of SEQ IDNO: 77; (473) a targeting sequence comprising amino acids 12-20 of SEQID NO: 77; (474) a targeting sequence comprising amino acids 23-36 ofSEQ ID NO: 81; (475) a targeting sequence comprising amino acids 23-34of SEQ ID NO: 81; (476) a targeting sequence comprising amino acids24-36 of SEQ ID NO: 81; (477) a targeting sequence comprising aminoacids 26-34 of SEQ ID NO: 81; (478) a targeting sequence comprisingamino acids 13-26 of SEQ ID NO: 87; (479) a targeting sequencecomprising amino acids 13-24 of SEQ ID NO: 87; or (480) a targetingsequence comprising amino acids 14-26 of SEQ ID NO:
 87. 106. Therecombinant Bacillus cereus family member of claim 105, wherein thetargeting sequence comprises an amino acid sequence having at leastabout 50% identity with amino acids 20-35 of SEQ ID NO: 1, wherein theidentity with amino acids 25-35 is at least about 63%.
 107. Therecombinant Bacillus cereus family member of claim 105, wherein thetargeting sequence comprises an amino sequence having at least about 62%identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identitywith amino acids 25-35 is at least about 72%.
 108. The recombinantBacillus cereus family member of claim 105, wherein the targetingsequence comprises an amino acid sequence having at least about 81%identity with amino acids 20-35 of SEQ ID NO: 1, wherein the identitywith amino acids 25-35 is at least about 90%.
 109. The recombinantBacillus cereus family member of claim 105, wherein the targetingsequence or exosporium protein comprises: (a) an amino acid sequenceconsisting of 16 amino acids and having at least about 43% identity withamino acids 20-35 of SEQ ID NO: 1, wherein the identity with amino acids25-35 is at least about 54%; (b) amino acids 1-35 of SEQ ID NO: 1; (c)amino acids 20-35 of SEQ ID NO: 1; (d) SEQ ID NO: 1; (e) SEQ ID NO: 96;or (f) SEQ ID NO:
 120. 110. The recombinant Bacillus cereus familymember of claim 105, wherein the targeting sequence comprises SEQ ID NO:96.
 111. The recombinant Bacillus cereus family member of claim 105,wherein the exosporium protein or an exosporium protein fragmentcomprises an amino acid sequence having at least 95% identity with SEQID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34,36, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 76, 78, 80,82, 84, 86, 88, 90, 92, 94, 95, 108, 109, 110, 111, 112, 113, 114, 115,116, 117, 118, 119, 120, 121, or
 122. 112. The recombinant Bacilluscereus family member of claim 86, wherein the targeting sequence,exosporium protein, or exosporium protein fragment comprises the aminoacid sequence GXT at its carboxy terminus, wherein X is any amino acid.113. The recombinant Bacillus cereus family member of claim 86, whereinthe targeting sequence, exosporium protein, or exosporium proteinfragment further comprises a methionine, serine, or threonine residue atthe amino acid position immediately preceding the first amino acid ofthe targeting sequence, exosporium protein, or exosporium proteinfragment or at the position of the targeting sequence that correspondsto amino acid 20 of SEQ ID NO:
 1. 114. The recombinant Bacillus cereusfamily member of claim 86, wherein the protein or peptide of interestcomprises a phospholipase, the phospholipase comprising a phospholipaseA1, a phospholipase A2, a phospholipase C, a phospholipase D, or alysophospholipase.
 115. The recombinant Bacillus cereus family member ofclaim 114, wherein the phospholipase comprises a phospholipase C. 116.The recombinant Bacillus cereus family member of claim 115, wherein thephospholipase C comprises an amino acid sequence having at least 85%identity with SEQ ID NO:
 312. 117. The recombinant Bacillus cereusfamily member of claim 116, wherein the phospholipase C comprises anamino acid sequence having at least 95% identity with SEQ ID NO: 312.118. The recombinant Bacillus cereus family member of claim 86, whereinthe protein or peptide of interest comprises comprises aphosphomonoesterase comprising PhoA4.
 119. The recombinant Bacilluscereus family member of claim 86, wherein the protein or peptide ofinterest comprises a phytase, wherein the phytase comprises Bacillussubtilis EE148 phytase or Bacillus thuringiensis BT013A phytase. 120.The recombinant Bacillus cereus family member of claim 86, wherein theprotein or peptide of interest comprises a chitosanase comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 313.121. The recombinant Bacillus cereus family member of claim 120, whereinthe protein or peptide of interest comprises a chitosanase comprising anamino acid sequence having at least 95% identity with SEQ ID NO: 313.122. The recombinant Bacillus cereus family member of claim 86, whereinthe protein or peptide of interest comprises a Cry toxin from Bacillusthuringiensis, wherein the Cry toxin from Bacillus thuringiensiscomprises a Cry5B protein or a Cry21A protein.
 123. The recombinantBacillus cereus family member of claim 86, wherein the protein orpeptide of interest comprises a superoxide dismutase, the superoxidedismutase comprising superoxide dismutase 1 (SODA1) or superoxidedismutase 2 (SODA2).
 124. The recombinant Bacillus cereus family memberof claim 123, wherein the superoxide dismutase comprises an amino acidsequence having at least 85% identity with SEQ ID NO: 155 or
 156. 125.The recombinant Bacillus cereus family member of claim 124, wherein thesuperoxide dismutase comprises an amino acid sequence having at least95% identity with SEQ ID NO: 155 or
 156. 126. The recombinant Bacilluscereus family member of claim 86, wherein the protein or peptide ofinterest comprises a protein or peptide that protects a plant from anenvironmental stress, wherein the protein or peptide that protects aplant from an environmental stress comprises an ice nucleation protein,a prolinase, a phenylalanine ammonia lyase, an isochorismate synthase,an isochorismate pyruvate lyase, or a choline dehydrogenase.
 127. Therecombinant Bacillus cereus family member of claim 86, wherein theprotein or peptide of interest comprises an enzyme that catalyzes theproduction of nitric oxide.
 128. The recombinant Bacillus cereus familymember of claim 127, wherein the enzyme that catalyzes the production ofnitric oxide comprises a nitric oxide synthase or an arginase.
 129. Therecombinant Bacillus cereus family member of claim 128, wherein theenzyme that catalyzes the production of nitric oxide comprises a nitricoxide synthase, the nitric oxide synthase comprising a Bacillusthuringiensis nitric oxide synthase or a Bacillus subtilis nitric oxidesynthase.
 130. The recombinant Bacillus cereus family member of claim129, wherein the nitric oxide synthase comprises a nitric oxide synthasefrom Bacillus thuringiensis BT013A or Bacillus subtilis
 168. 131. Therecombinant Bacillus cereus family member of claim 130, wherein thenitric oxide synthase comprises an amino acid sequence having at least85% identity with SEQ ID NO: 260 or
 261. 132. The recombinant Bacilluscereus family member of claim 131, wherein the nitric oxide synthasecomprises an amino acid sequence having at least 95% identity with SEQID NO: 260 or
 261. 133. The recombinant Bacillus cereus family member ofclaim 86, wherein the protein or peptide of interest comprises a nucleicacid binding protein or peptide, wherein the nucleic acid bindingprotein or peptide comprises an Hfq protein or a small acid-solublespore protein (SASP).
 134. The recombinant Bacillus cereus family memberof claim 133, wherein the SASP comprises a SASPα, a SASPβ, or a SASPγ.135. The recombinant Bacillus cereus family member of claim 134, whereinthe nucleic acid binding protein or peptide comprises an amino acidsequence having at least 95% identity with any of SEQ ID NOs: 264-266.136. The recombinant Bacillus cereus family member of claim 133, whereinthe nucleic acid binding protein or peptide comprises an amino acidsequence having at least 85% identity with any of SEQ ID NOs: 264-266.137. The recombinant Bacillus cereus family member of claim 133, whereinthe fusion protein comprises SEQ ID NO: 267, 268, or
 269. 138. Therecombinant Bacillus cereus family member of claim 86, wherein theprotein or peptide of interest comprises a nucleic acid binding proteinor peptide, wherein a nucleic acid molecule is bound to the nucleic acidbinding protein or peptide, the nucleic acid molecule comprising amodulating RNA molecule; an RNAi molecule; a microRNA; an aptamer; or aDNA molecule that encodes a modulating RNA molecule, an RNAi molecule, amicroRNA, or an aptamer.
 139. The recombinant Bacillus cereus familymember of claim 86, wherein the recombinant Bacillus cereus familymember comprises Bacillus anthracis, Bacillus cereus, Bacillusthuringiensis, Bacillus mycoides, Bacillus pseudomycoides, Bacillussamanii, Bacillus gaemokensis, Bacillus weihenstephensis, Bacillustoyoiensis, or a combination thereof.
 140. The recombinant Bacilluscereus family member of claim 139, wherein the recombinant Bacilluscereus family member comprises Bacillus mycoides BT155 (NRRL No.B-50921), Bacillus mycoides EE118 (NRRL No. B-50918), Bacillus mycoidesEE141 (NRRL No. B-50921), Bacillus mycoides BT46-3 (NRRL No. B-50922),Bacillus cereus family member EE128 (NRRL No. B-50917), Bacillusthuringiensis BT013A (NRRL No. B-50924), Bacillus cereus family memberEE349 (NRRL No. B-50928); Bacillus cereus family member EE-B00377 (NRRLB-67119); Bacillus pseudomycoides EE-B00366 (NRRL B-67120); Bacillusmycoides EE-B00363 (NRRL B-67121); Bacillus cereus family member EE439(NRRL B-50979); Bacillus thuringiensis EE417 (NRRL B-50979); Bacilluscereus EE444 (NRRL B-50977); Bacillus thuringiensis EE319 (NRRLB-50983); or Bacillus thuringiensis EE-B00184 (NRRL B-67122).
 141. Therecombinant Bacillus cereus family member of claim 140, wherein therecombinant Bacillus cereus family member comprises Bacillusthuringiensis BT013A (NRRL No. B-50924).
 142. The recombinant Bacilluscereus family member of claim 140, wherein the recombinant Bacilluscereus family member comprises Bacillus cereus family member EE349 (NRRLNo. B-50928).
 143. The recombinant Bacillus cereus family member ofclaim 86, wherein the recombinant Bacillus cereus family membercomprises an inactivating mutation in its BclA gene.
 144. Therecombinant Bacillus cereus family member of claim 143, wherein theinactivating mutation in the BclA gene comprises a knock-out of the BclAgene.
 145. A formulation comprising exosporium fragments derived fromspores of a recombinant Bacillus cereus family member of claim 86 and anagriculturally acceptable carrier.
 146. A formulation of claim 145,wherein the exosporium fragments are derived from spores of arecombinant Bacillus cereus family member expressing a fusion proteincomprising SEQ ID NO: 96 and a phospholipase C comprising an amino acidsequence having at least 85% identity with SEQ ID NO:
 312. 147. A plantseed coated with exosporium fragments derived from spores of arecombinant Bacillus cereus family member of claim
 86. 148. A plant seedof claim 147, wherein the exosporium fragments are derived from sporesof a recombinant Bacillus cereus family member expressing a fusionprotein comprising SEQ ID NO: 96 and a phospholipase C comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 312.149. A method for stimulating plant growth comprising: introducingexosporium fragments into a plant growth medium; or applying exosporiumfragments to a plant, a plant seed, or an area surrounding a plant or aplant seed; wherein the exosporium fragments are derived from spores ofa recombinant Bacillus cereus family member of claim 86 and comprise thefusion protein, and the fusion protein comprises: a phospholipase A1, aphospholipase A2, a phospholipase C, a phospholipase D, or alysophospholipase; a phosphomonoesterase comprising PhoA4; a phytase,wherein the phytase comprises Bacillus subtilis EE148 phytase orBacillus thuringiensis BT013A phytase; or a chitosanase comprising anamino acid sequence having at least 85% identity with SEQ ID NO: 313.150. The method of claim 149, wherein the fusion protein comprises aphospholipase C.
 151. The method of claim 150, wherein the phospholipaseC comprises an amino acid sequence having at least 85% identity with SEQID NO:
 312. 152. The method of claim 149, wherein the fusion proteincomprises a chitosanase comprising an amino acid sequence having atleast 85% identity with SEQ ID NO:
 313. 153. A method for protecting aplant from a pathogen or enhancing stress resistance in a plantcomprising: introducing exosporium fragments into a plant growth medium;or applying exosporium fragments to a plant, a plant seed, or an areasurrounding a plant or a plant seed; wherein the exosporium fragmentsare derived from spores of a recombinant Bacillus cereus family memberof claim 86 and comprise the fusion protein, and the fusion proteincomprises: a chitosanase comprising an amino acid sequence having atleast 85% identity with SEQ ID NO: 313; a Cry toxin from Bacillusthuringiensis, wherein the Cry toxin from Bacillus thuringiensiscomprises a Cry5B protein or a Cry21A protein; a superoxide dismutase,the superoxide dismutase comprising superoxide dismutase 1 (SODA1) orsuperoxide dismutase 2 (SODA2); or a protein or peptide that protects aplant from an environmental stress, wherein the protein or peptide thatprotects the plant from an environmental stress comprises an icenucleation protein, a prolinase, a phenylalanine ammonia lyase, anisochorismate synthase, an isochorismate pyruvate lyase, or a cholinedehydrogenase.
 154. A method for stimulating germination of a plant seedcomprising: introducing exosporium fragments into a plant growth medium;or applying exosporium fragments to a plant seed or an area surroundinga plant or a plant seed; wherein the exosporium fragments are derivedfrom spores of a recombinant Bacillus cereus family member, wherein therecombinant Bacillus cereus family member: expresses a fusion proteincomprising: (a) a superoxide dismutase or an enzyme that catalyzes theproduction of nitric oxide; and (b) a targeting sequence, exosporiumprotein, or exosporium protein fragment that targets the fusion proteinto the exosporium of the recombinant Bacillus cereus family member; andcomprises a mutation that results in Bacillus cereus family memberspores having an exosporium that is easier to remove from the spore ascompared to the exosporium of a wild-type spore.
 155. The method ofclaim 154, wherein the method further comprises applying L-arginine tothe plant growth medium the plant seed, or the area surrounding theplant or the plant seed.
 156. The method of claim 154, wherein thefusion protein comprises a superoxide dismutase.
 157. A method fordelivering nucleic acids to a plant comprising: introducing exosporiumfragments into a plant growth medium; or applying exosporium fragmentsto a plant, a plant seed, or an area surrounding a plant or a plantseed; wherein the exosporium fragments are derived from spores of arecombinant Bacillus cereus family member, wherein the recombinantBacillus cereus family member: expresses a fusion protein comprising:(a) a nucleic acid binding protein or peptide, wherein the nucleic acidbinding protein or peptide is bound to a nucleic acid molecule; and (b)a targeting sequence, exosporium protein, or exosporium protein fragmentthat targets the fusion protein to the exosporium of the recombinantBacillus cereus family member; and comprises a mutation that results inBacillus cereus family member spores having an exosporium that is easierto remove from the spore as compared to the exosporium of a wild-typespore.
 158. The method of claim 157, wherein the nucleic acid moleculecomprises a modulating RNA molecule; an RNAi molecule; a microRNA; anaptamer; or a DNA molecule that encodes a modulating RNA molecule, anRNAi molecule, a microRNA, or an aptamer.
 159. The method of claim 157,wherein the nucleic acid binding protein or peptide comprises a nucleasehaving an inactivated active site.